Equitable Holdings, Inc. Form 10-Q Quarterly Report Filed 2025-08-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

———————————————

FORM 10-Q


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2025


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 001-38469

————————————————

Equitable Holdings, Inc.

(Exact name of registrant as specified in its charter)


Delaware						90-0226248
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

1345 Avenue of the Americas, New York, New York 10105

(Address of principal executive offices) (Zip Code)

(212) 554-1234

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol

Name of each exchange on which registered

Common Stock

EQH

New York Stock Exchange

Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A

EQH PR A

New York Stock Exchange

Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C

EQH PR C

New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an “emerging growth company”. See definition of “accelerated filer,” “large accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of August 7, 2025, 299,536,468 shares of the registrant’s Common Stock, $0.01 par value, were outstanding.

Table of Contents

TABLE OF CONTENTS


		Page
PART I - FINANCIAL INFORMATION
Item 1.	Consolidated Financial Statements
	Consolidated Balance Sheets, June 30, 2025 (Unaudited) and December 31, 2024	4
	Consolidated Statements of Income (Loss), Three and Six Months Ended June 30, 2025 and 2024 (Unaudited)	5
	Consolidated Statements of Comprehensive Income (Loss), Three and Six Months Ended June 30, 2025 and 2024 (Unaudited)	6
	Consolidated Statements of Equity, Three and Six Months Ended June 30, 2025 and 2024 (Unaudited)	8
	Consolidated Statements of Cash Flows, Six Months Ended June 30, 2025 and 2024 (Unaudited)	9
	Notes to Consolidated Financial Statements:
	Note 1 - Organization	11
	Note 2 - Significant Accounting Policies	12
	Note 3 - Investments	15
	Note 4 - Derivatives	29
	Note 5 - Closed Block	36

	Note 6 - DAC and Other Deferred Assets/Liabilities	37
	Note 7 - Fair Value Disclosures	39
	Note 8 - Liabilities for Future Policyholder Benefits	57
	Note 9 - Market Risk Benefits	61


	Note 10 - Policyholder Account Balances	63
	Note 11 - Employee Benefit Plans	68
	Note 12 - Income Taxes	69

	Note 13 - Equity	69
	Note 14 - Short-term and Long-term Debt	72
	Note 15 - Redeemable Noncontrolling Interest	73
	Note 16 - Commitments and Contingent Liabilities	74

	Note 17 - Business Segment Information	77
	Note 18 - Insurance Group Statutory Financial Information	84
	Note 19 - Earnings per Common Share	85




	Note 20 - Revision of Prior Period Financial Statements	86
	Note 21 - Subsequent Events	91
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	92
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	135
Item 4.	Controls and Procedures	135

PART II - OTHER INFORMATION
Item 1.	Legal Proceedings	136
Item 1A.	Risk Factors	136
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	136
Item 3.	Defaults Upon Senior Securities	136
Item 4.	Mine Safety Disclosures	136
Item 5.	Other Information	136
Item 6.	Exhibits	138

Signatures		145

Table of Contents

NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INFORMATION

Certain of the statements included or incorporated by reference in this Quarterly Report on Form 10-Q constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “expects,” “believes,” “anticipates,” “forecasts,” “intends,” “seeks,” “aims,” “plans,” “assumes,” “estimates,” “projects,” “should,” “would,” “could,” “may,” “will,” “shall” or variations of such words are generally part of forward-looking statements. Forward-looking statements are made based on management’s current expectations and beliefs concerning future developments and their potential effects upon Equitable Holdings, Inc. (“Holdings”) and its consolidated subsidiaries. These forward-looking statements include, but are not limited to, statements regarding projections, estimates, forecasts and other financial and performance metrics and projections of market expectations. “We,” “us” and “our” refer to Holdings and its consolidated subsidiaries, unless the context refers only to Holdings as a corporate entity. There can be no assurance that future developments affecting Holdings will be those anticipated by management. Forward-looking statements include, without limitation, all matters that are not historical facts.

These forward-looking statements are not a guarantee of future performance and involve risks and uncertainties, and there are certain important factors that could cause actual results to differ, possibly materially, from expectations or estimates reflected in such forward-looking statements, including, among others: (i) conditions in the financial markets and economy, including the impact of geopolitical conflicts, changes in tariffs and trade barriers, and related economic conditions, equity market declines and volatility, interest rate fluctuations, impacts on our goodwill and changes in liquidity and access to and cost of capital; (ii) operational factors, including reliance on the payment of dividends to Holdings by its subsidiaries, protection of confidential customer information or proprietary business information, operational failures by us or our service providers, potential strategic transactions, changes in accounting standards, and catastrophic events, such as the outbreak of pandemic diseases; (iii) credit, counterparties and investments, including counterparty default on derivative contracts, failure of financial institutions, defaults by third parties and affiliates and economic downturns, defaults and other events adversely affecting our investments; (iv) our reinsurance and hedging programs; (v) our products, structure and product distribution, including variable annuity guaranteed benefits features within certain of our products, variations in statutory capital requirements, financial strength and claims-paying ratings, state insurance laws limiting the ability of our insurance subsidiaries to pay dividends and key product distribution relationships; (vi) estimates, assumptions and valuations, including risk management policies and procedures, potential inadequacy of reserves and experience differing from pricing expectations, amortization of deferred acquisition costs and financial models; (vii) our Asset Management segment, including fluctuations in assets under management and the industry-wide shift from actively-managed investment services to passive services; (viii) recruitment and retention of key employees and experienced and productive financial professionals; (ix) subjectivity of the determination of the amount of allowances and impairments taken on our investments; (x) legal and regulatory risks, including federal and state legislation affecting financial institutions, insurance regulation and tax reform; (xi) risks related to our common stock and (xii) general risks, including strong industry competition, information systems failing or being compromised and protecting our intellectual property.

Forward-looking statements should be read in conjunction with the other cautionary statements, risks, uncertainties and other factors identified in Holdings’ Annual Report on Form 10-K for the year ended December 31, 2024, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q, including in the section entitled “Risk Factors,” and elsewhere in this Quarterly Report on Form 10-Q. You should read this Form 10-Q completely and with the understanding that actual future results may be materially different from expectations. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.

Other risks, uncertainties and factors, including those discussed under “Risk Factors,” in our Annual Report on Form 10-K could cause our actual results to differ materially from those projected in any forward-looking statements we make. Readers should read carefully the factors described in “Risk Factors” in our Annual Report on Form 10-K to better understand the risks and uncertainties inherent in our business and underlying any forward-looking statements.

Throughout this Quarterly Report on Form 10-Q we use certain defined terms and abbreviations, which are summarized in the “Glossary” and “Acronyms” sections.

Table of Contents

Part I FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Table of Contents

EQUITABLE HOLDINGS, INC.

Consolidated Balance Sheets

June 30, 2025 (Unaudited) and December 31, 2024




	June 30, 2025		December 31, 2024
	(in millions, except share data)
ASSETS
Investments:
Fixed maturities available-for-sale, at fair value (amortized cost of $86,819 and $84,717) (allowance for credit losses of $3 and $2)	$	80,094	$	76,641
Fixed maturities, at fair value using the fair value option (1)	2,428		2,053
Mortgage loans on real estate (net of allowance for credit losses of $305 and $278) (1)	21,536		20,072

Policy loans	4,355		4,330
Other equity investments (1)	3,789		3,719
Trading securities, at fair value	1,295		1,089
Other invested assets (1)	8,301		8,537
Total investments	121,798		116,441
Cash and cash equivalents (1)	14,957		6,964
Cash and securities segregated, at fair value	483		500
Broker-dealer related receivables	1,933		1,961
Deferred policy acquisition costs	7,361		7,170
Goodwill and other intangible assets, net	5,342		5,371
Amounts due from reinsurers (allowance for credit losses of $7 and $8)	7,501		7,899


Current and deferred income taxes	1,749		2,003
Purchased market risk benefits	5,543		7,376
Other assets (1)	3,962		4,462

Assets for market risk benefits	776		863
Separate Accounts assets	131,683		134,717
Total Assets	$	303,088	$	295,727
LIABILITIES
Policyholders’ account balances	$	123,359	$	110,929
Liability for market risk benefits	10,187		11,810
Future policy benefits and other policyholders’ liabilities	17,557		17,613
Broker-dealer related payables	1,454		775

Customer related payables	1,885		1,933
Amounts due to reinsurers	1,350		1,421

Long-term debt	4,332		3,833


Notes issued by consolidated variable interest entities, at fair value using the fair value option (1)	2,471		2,116
Other liabilities (1)	5,847		7,032

Separate Accounts liabilities	131,683		134,717
Total Liabilities	$	300,125	$	292,179
Redeemable noncontrolling interest (1) (2)	$	358	$	125
Commitments and contingent liabilities (3)
EQUITY
Equity attributable to Holdings:
Preferred stock and additional paid-in capital, $1 par value and $25,000 liquidation preference	$	1,228	$	1,507
Common stock, $0.01 par value, 2,000,000,000 shares authorized; 472,699,844 and 477,801,636 shares issued, respectively; 301,768,056 and 309,900,248 shares outstanding, respectively	5		5
Additional paid-in capital	1,901		2,336
Treasury stock, at cost,170,931,788 and 167,901,388 shares, respectively	(4,423)		(4,198)
Retained earnings	9,870		10,627
Accumulated other comprehensive income (loss)	(7,432)		(8,712)
Total equity attributable to Holdings	1,149		1,565
Noncontrolling interest	1,456		1,858
Total Equity	2,605		3,423
Total Liabilities, Redeemable Noncontrolling Interest and Equity	$	303,088	$	295,727

______________

(1) See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.

(2) See Note 15 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.

(3) See Note 16 of the Notes to these Consolidated Financial Statements for details of commitments and contingent liabilities.

See Notes to Consolidated Financial Statements (Unaudited).

Table of Contents

EQUITABLE HOLDINGS, INC.

Consolidated Statements of Income (Loss)

Three and Six Months Ended June 30, 2025 and 2024 (Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions, except per share data)
REVENUES
Policy charges and fee income	$	626	$	617	$	1,262	$	1,231
Premiums	260		282		564		567
Net derivative gains (losses)	(1,374)		(208)		(575)		(1,584)
Net investment income (loss)	1,355		1,167		2,603		2,377
Investment gains (losses), net:
Credit and intent to sell losses on available for sale debt securities and loans	(54)		(15)		(54)		(35)
Other investment gains (losses), net	(17)		(1)		(31)		(20)
Total investment gains (losses), net	(71)		(16)		(85)		(55)
Investment management and service fees	1,272		1,240		2,557		2,518
Other income	294		425		612		683
Total revenues	2,362		3,507		6,938		5,737

BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits	787		667		1,546		1,344
Remeasurement of liability for future policy benefits	(13)		(7)		(15)		(2)
Change in market risk benefits and purchased market risk benefits	(606)		(132)		66		(1,220)
Interest credited to policyholders’ account balances	796		599		1,474		1,178
Compensation and benefits	592		577		1,193		1,197
Commissions and distribution-related payments	488		463		989		900
Interest expense	61		62		116		119
Amortization of deferred policy acquisition costs	193		169		381		341
Other operating costs and expenses	427		428		1,377		980
Total benefits and other deductions	2,725		2,826		7,127		4,837
Income (loss) from continuing operations, before income taxes	(363)		681		(189)		900
Income tax (expense) benefit	80		(116)		56		(140)
Net income (loss)	(283)		565		(133)		760
Less: Net income (loss) attributable to the noncontrolling interest (1)	66		137		153		240
Net income (loss) attributable to Holdings	(349)		428		(286)		520
Less: Preferred stock dividends	18		26		32		40
Net income (loss) available to Holdings’ common shareholders	$	(367)	$	402	$	(318)	$	480

EARNINGS PER COMMON SHARE
Net income (loss) applicable to Holdings’ common shareholders per common share:
Basic	$	(1.21)	$	1.24	$	(1.04)	$	1.47
Diluted	$	(1.21)	$	1.23	$	(1.04)	$	1.45
Weighted average common shares outstanding (in millions):
Basic	303.2		324.2		305.5		327.2
Diluted	303.2		327.3		305.5		330.4

______________

(1) Includes redeemable noncontrolling interest. See Note 15 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.

See Notes to Consolidated Financial Statements (Unaudited).

Table of Contents

EQUITABLE HOLDINGS, INC.

Consolidated Statements of Comprehensive Income (Loss)

Three and Six Months Ended June 30, 2025 and 2024 (Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
COMPREHENSIVE INCOME (LOSS)
Net income (loss)	$	(283)	$	565	$	(133)	$	760
Other comprehensive income (loss) net of income taxes:
Change in unrealized gains (losses), net of reclassification adjustment	309		(409)		918		(922)
Change in market risk benefits - instrument-specific credit risk	(170)		(159)		414		(139)
Change in liability for future policy benefits - current discount rate	(29)		67		(92)		165
Change in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment	9		11		26		19
Foreign currency translation adjustment	26		9		37		(2)
Total other comprehensive income (loss), net of income taxes	145		(481)		1,303		(879)
Comprehensive income (loss)	(138)		84		1,170		(119)
Less: Comprehensive income (loss) attributable to the noncontrolling interest	76		140		176		239
Comprehensive income (loss) attributable to Holdings	$	(214)	$	(56)	$	994	$	(358)

See Notes to Consolidated Financial Statements (Unaudited).

EQUITABLE HOLDINGS, INC.

Consolidated Statements of Equity

For the Three and Six Months Ended June 30, 2025 and 2024 (Unaudited)


	Three Months Ended June 30,
	Equity Attributable to Holdings
	Preferred Stock and Additional Paid-In Capital		Common Stock		Additional Paid-in Capital		Treasury Stock		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total Holdings Equity		Non-controlling Interest		Total Equity
			(in millions)
Balance, beginning of period	$	1,507	$	5	$	2,305	$	(4,296)	$	10,447	$	(7,567)	$	2,401	$	1,804	$	4,205
Stock compensation	—		—		19		1		—		—		20		3		23
Purchase of treasury stock	—		—		15		(250)		—		—		(235)		—		(235)
Reissuance of treasury stock	—		—		—		—		1		—		1		—		1
Retirement of common stock	—		—		—		122		(122)		—		—		—		—
Purchase of AB Holding units	—		—		(443)		—		—		—		(443)		(329)		(772)
Dividends paid to noncontrolling interest	—		—		—		—		—		—		—		(99)		(99)

Dividends on common stock (cash dividends declared per common share of $0.27)	—		—		—		—		(82)		—		(82)		—		(82)
Redemption of preferred stock	(279)		—		—		—		—		—		(279)		—		(279)
Dividends on preferred stock	—		—		—		—		(18)		—		(18)		—		(18)
Net income (loss)	—		—		—		—		(349)		—		(349)		68		(281)
Other comprehensive income (loss)	—		—		—		—		—		135		135		10		145
Other	—		—		5		—		(7)		—		(2)		(1)		(3)
June 30, 2025	$	1,228	$	5	$	1,901	$	(4,423)	$	9,870	$	(7,432)	$	1,149	$	1,456	$	2,605


Balance, beginning of period	$	1,562	$	5	$	2,322	$	(3,801)	$	10,095	$	(8,191)	$	1,992	$	1,723	$	3,715
Stock compensation	—		—		16		(2)		—		—		14		12		26
Purchase of treasury stock	—		—				(247)		—		—		(247)		—		(247)
Reissuance of treasury stock	—		—		—		—		—		—		—		—		—
Retirement of common stock	—		—		—		118		(118)		—		—		—		—
Purchase of AB Holding units	—		—		—		—		—		—		—		(28)		(28)
Dividends paid to noncontrolling interest	—		—		—		—		—		—		—		(90)		(90)

Dividends on common stock (cash dividends declared per common share of $0.24)	—		—		—		—		(78)		—		(78)		—		(78)
Dividends on preferred stock	—		—		—		—		(26)		—		(26)		—		(26)


Net income (loss)	—		—		—		—		428		—		428		121		549

Other comprehensive income (loss)	—		—		—		—		—		(484)		(484)		3		(481)
Other	—		—		(1)		—		—		—		(1)		—		(1)
June 30, 2024	$	1,562	$	5	$	2,337	$	(3,932)	$	10,301	$	(8,675)	$	1,598	$	1,741	$	3,339

See Notes to Consolidated Financial Statements (Unaudited).

Table of Contents

EQUITABLE HOLDINGS, INC.

Consolidated Statements of Equity

Three and Six Months Ended June 30, 2025 and 2024 (Unaudited)


	Six Months Ended June 30,
	Equity Attributable to Holdings
	Preferred Stock and Additional Paid-In Capital		Common Stock		Additional Paid-in Capital		Treasury Stock		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total Holdings Equity		Non-controlling Interest		Total Equity
	(in millions)
Balance, beginning of period	$	1,507	$	5	$	2,336	$	(4,198)	$	10,627	$	(8,712)	$	1,565	$	1,858	$	3,423

Stock compensation	—		—		37		25		—		—		62		11		73
Purchase of treasury stock	—		—		10		(507)		—		—		(497)		—		(497)
Reissuance of treasury stock	—		—		—		—		(19)		—		(19)		—		(19)
Retirement of common stock	—		—		—		257		(257)		—		—		—		—
Purchase of AB Holding units	—		—		(443)		—		—		—		(443)		(359)		(802)
Dividends paid to noncontrolling interest	—		—		—		—		—		—		—		(229)		(229)

Dividends on common stock (cash dividends declared per common share of $0.51)	—		—		—		—		(156)		—		(156)		—		(156)
Dividends on preferred stock	—		—		—		—		(32)		—		(32)		—		(32)
Redemption of preferred stock	(279)		—		—		—		—		—		(279)		—		(279)
Net income (loss)	—		—		—		—		(286)		—		(286)		152		(134)
Other comprehensive income (loss)	—		—		—		—		—		1,280		1,280		23		1,303
Other	—		—		(39)		—		(7)		—		(46)		—		(46)
June 30, 2025	$	1,228	$	5	$	1,901	$	(4,423)	$	9,870	$	(7,432)	$	1,149	$	1,456	$	2,605


Balance, beginning of period	$	1,562	$	5	$	2,328	$	(3,712)	$	10,250	$	(7,797)	$	2,636	$	1,739	$	4,375
Stock compensation	—		—		32		17		—		—		49		21		70
Purchase of treasury stock	—		—		(2)		(498)		—		—		(500)		—		(500)
Reissuance of treasury stock	—		—		—		—		(17)		—		(17)		—		(17)
Retirement of common stock	—		—		—		261		(261)		—		—		—		—
Purchase of AB Holding units	—		—		—		—		—		—		—		(34)		(34)
Dividends paid to noncontrolling interest	—		—		—		—		—		—		—		(189)		(189)

Dividends on common stock (cash dividends declared per common share of $0.46)	—		—		—		—		(151)		—		(151)				(151)
Dividends on preferred stock	—		—		—		—		(40)		—		(40)		—		(40)

Net income (loss)	—		—		—		—		520		—		520		206		726
Other comprehensive income (loss)	—		—		—		—		—		(878)		(878)		(1)		(879)
Other	—		—		(21)		—		—		—		(21)		(1)		(22)
June 30, 2024	$	1,562	$	5	$	2,337	$	(3,932)	$	10,301	$	(8,675)	$	1,598	$	1,741	$	3,339

See Notes to Consolidated Financial Statements (Unaudited).

Table of Contents

EQUITABLE HOLDINGS, INC.

Consolidated Statements of Cash Flows

Six Months Ended June 30, 2025 and 2024 (Unaudited)


	Six Months Ended June 30,
	2025		2024
	(in millions)
Cash flows from operating activities:
Net income (loss)	$	(133)	$	760
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances	1,474		1,178
Policy charges and fee income	(1,262)		(1,231)
Net derivative (gains) losses	575		1,584
Credit and intent to sell losses on available for sale debt securities and loans	54		35
Investment (gains) losses, net	31		20
(Gains) losses on businesses held-for-sale	—		(135)
Realized and unrealized (gains) losses on trading securities	(39)		(43)
Loss on novation	499		—
AB Retirement plan losses	21		—
Non-cash long term incentive compensation expense	48		53
Amortization and depreciation	433		434
Remeasurement of liability for future policy benefits	(15)		(2)
Change in market risk benefits	66		(1,220)
Equity (income) loss from limited partnerships	(87)		(58)
Changes in:
Net broker-dealer and customer related receivables/payables	(26)		(168)
Reinsurance recoverable	(562)		(628)
Segregated cash and securities, net	17		276
Capitalization of deferred policy acquisition costs	(574)		(561)
Future policy benefits	201		275
Current and deferred income taxes	(129)		149
Other, net	(93)		205
Net cash provided by (used in) operating activities	$	499	$	923

Cash flows from investing activities:
Proceeds from the sale/maturity/pre-payment of:
Fixed maturities, available-for-sale	$	9,368	$	5,284
Fixed maturities, at fair value using the fair value option	299		399
Mortgage loans on real estate	664		460
Trading account securities	269		512

Short term investments	132		571
Other	283		331
Payment for the purchase/origination of:
Fixed maturities, available-for-sale	(11,576)		(10,523)
Fixed maturities, at fair value using the fair value option	(709)		(426)
Mortgage loans on real estate	(2,103)		(1,148)
Trading account securities	(395)		(1,446)
Short term investments	(99)		(384)
Other	(83)		(473)


Cash settlements related to derivative instruments, net	571		(1,438)

Investment in capitalized software, leasehold improvements and EDP equipment	(17)		(99)
Other, net	(321)		453
Net cash provided by (used in) investing activities	$	(3,717)	$	(7,927)

See Notes to Consolidated Financial Statements (Unaudited).

Table of Contents

EQUITABLE HOLDINGS, INC.

Consolidated Statements of Cash Flows

Six Months Ended June 30, 2025 and 2024 (Unaudited)


	Six Months Ended June 30,
	2025		2024
	(in millions)
Cash flows from financing activities:
Policyholders’ account balances:
Deposits	$	14,931	$	9,033
Withdrawals	(4,637)		(4,719)
Transfers (to) from Separate Accounts	932		832
Payments of market risk benefits	(366)		(376)
Repayment of short-term financings	—		(254)
Change in collateralized pledged assets	17		(75)
Change in collateralized pledged liabilities	1,298		4,829


Issuance of long-term debt	495		—
Repayment of long term debt	—		(565)

Proceeds from collateralized loan obligations	46		—
Repayment of collateralized loan obligations	(38)		—
Proceeds from notes issued by consolidated VIEs	1,203		176
Repayment of notes issued by consolidated VIEs	(839)		—
Dividends paid on common stock	(156)		(151)
Dividends paid on preferred stock	(32)		(40)
Redemption of preferred stock	(279)		—
Purchase of AllianceBernstein Units	(758)		—
Purchase of AB Holding Units to fund long-term incentive compensation plan awards, net	(44)		(34)
Purchase of treasury shares	(497)		(500)
Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds	173		291
Distribution to noncontrolling interest of consolidated subsidiaries	(229)		(189)
Change in securities lending	(33)		36
Other, net	(17)		15
Net cash provided by (used in) financing activities	$	11,170	$	8,309

Effect of exchange rate changes on cash and cash equivalents	$	41	$	(13)
Change in cash and cash equivalents	7,993		1,292
Cash and cash equivalents, beginning of period	6,964		8,239
Change in cash of businesses held-for-sale	—		153
Cash and cash equivalents, end of period	$	14,957	$	9,684






Non-cash transactions from investing and financing activities:






Right-of-use assets obtained in exchange for lease obligations	$	24	$	222

______________

(1)See Note 1 of the Notes to these Consolidated Financial Statements for details on Novation.

See Notes to Consolidated Financial Statements (Unaudited).

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited)

1) ORGANIZATION

Equitable Holdings, Inc. is the holding company for a diversified financial services organization. The Company conducts operations in six segments: Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management and Legacy. The Company’s management evaluates the performance of each of these segments independently. Effective April 1, 2024, the Company renamed its Investment Management and Research segment to Asset Management following the close of the previously announced joint venture between AllianceBernstein and Societe Generale. Following the close of the transaction, Bernstein Research Services (“BRS”) business results are no longer consolidated within the financial results for AllianceBernstein and Equitable Holdings, Inc.

•The Individual Retirement segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income.

•The Group Retirement segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities and not-for-profit entities, as well as small and medium-sized businesses.

•The Asset Management segment provides diversified investment management and related services globally to a broad range of clients through three main client channels - Institutional, Retail and Private Wealth. The Asset Management segment reflects the business of AB Holding and ABLP and their subsidiaries (collectively, AB).

•The Protection Solutions segment includes the Company’s life insurance and group employee benefits (“EB”) businesses.

•The Wealth Management segment is an emerging leader in the wealth management space with a differentiated advice value proposition that offers discretionary and non-discretionary investment advisory accounts, financial planning and advice, life insurance, and annuity products.

•The Legacy segment consists of our capital intensive fixed-rate GMxB business written prior to 2011.

The Company reports certain activities and items that are not included in our segments in Corporate and Other. Corporate and Other includes certain of our financing and investment expenses. It also includes closed block of life insurance (the “Closed Block”), run-off variable annuity reinsurance business, run-off group pension business, run-off health business, benefit plans for our employees, certain strategic investments and certain unallocated items, including capital and related investments, interest expense and corporate expense. AB’s results of operations are reflected in the Asset Management segment. Accordingly, Corporate and Other does not include any items applicable to AB.

As of June 30, 2025 and December 31, 2024, the Company’s economic interest in AB was approximately 69% and 62%, respectively. The General Partner of AB is a wholly owned subsidiary of the Company. Because the General Partner has the authority to manage and control the business of AB, AB is consolidated in the Company’s financial statements for all periods presented. The increase in economic interest was due to the purchase of AB Holding Units relating to the AB Tender Offer transaction completed on April 3, 2025.

RGA Reinsurance Transaction

On February 23, 2025, Equitable Financial, as well as Equitable America and Equitable Financial L&A, entered into a master transaction agreement with Reinsurance Group of America (“RGA”) pursuant to which at closing and subject to the terms and conditions set forth in such agreement, RGA would enter into reinsurance agreements, as reinsurer, with each such subsidiary, as ceding company, to effect the RGA Reinsurance Transaction. The transaction closed on July 31, 2025, see Note 21 of the Notes to these Consolidated Financial Statements.

Novation

Effective January 17, 2025, Equitable Financial novated certain legacy variable annuity policies sold between 2006-2008, comprised of non-New York “Accumulator” policies containing fixed rate Guaranteed Minimum Income Benefit and/or Guaranteed Minimum Death Benefit guarantees reinsured by Venerable under the combined co-insurance and modified coinsurance basis agreement executed on June 1, 2021.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

As a result of the novation of certain Legacy VA policies completed during the first quarter 2025, the Company recorded a loss of $499 million in pre-tax net income and an increase of $263 million in pre-tax AOCI, for a total impact loss of $236 million. The negative net income impact is mostly driven by the reduction of the purchased market risk benefits (“MRB”) asset of $2.0 billion and the reduction of Liability for MRBs of $1.6 billion, offset by a decrease in reinsurance deposit liability of $183 million. Purchased MRB asset reduction is larger than the direct MRB liability reduction since the Venerable reinsurance assets sit in a collateralized trust and thus materially reduce the non-performance risk. Deposit account liability decreases as novation leads to faster amortization of the liability. The novation impact from the base contracts and the contracts in payout status is less material, as the increase in policyholders’ account balance of $33 million and decrease in liability for future policyholders’ benefits of $458 million are largely offset by a decrease in Amounts due from reinsurers of $432 million.

AB Tender Offer

On February 24, 2025, Holdings commenced a cash tender offer (the “AB Tender Offer”) to purchase up to 46 million AB Holding Units at a price of $38.50 per unit, less any applicable tax withholding, for an aggregate purchase price of $1.8 billion. On April 3, 2025, Holdings purchased 19.7 million AB Holdings Units pursuant to the AB Tender Offer for an aggregate cost of $758 million. The AB Holdings Units accepted for purchase represented approximately 17.9% of the outstanding units at the time of purchase. At June 30, 2025, Holdings owned approximately 68.6% of the economic interest in AllianceBernstein L.P., the operating partnership of AB Holding.

2) SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Principles of Consolidation

The unaudited interim consolidated financial statements (the “consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to the Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”).

In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024.

The accompanying unaudited consolidated financial statements present the consolidated results of operations, financial condition, and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation.

All significant intercompany transactions and balances have been eliminated in consolidation. The terms “second quarter 2025” and “second quarter 2024” refer to the three months ended June 30, 2025 and 2024, respectively. The terms “first six months of 2025” and “first six months of 2024” refer to the six months ended June 30, 2025 and 2024, respectively.

Future Adoption of New Accounting Pronouncements


Description	Effective Date and Method of Adoption	Effect on the Financial Statement or Other Significant Matters
ASU 2023-09: Income Taxes (Topic 740): Improvements to Income Tax Disclosures

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


Description	Effective Date and Method of Adoption	Effect on the Financial Statement or Other Significant Matters
The ASU enhanced existing income tax disclosures primarily related to the rate reconciliation and income taxes paid information. With regard to the improvements to disclosures of rate reconciliation, a public business entity is required on an annual basis to (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. Similarly, a public entity is required to provide the amount of income taxes paid (net of refunds received) disaggregated by (1) federal, state, and foreign taxes and by (2) individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received). The ASU also includes certain other amendments to improve the effectiveness of income tax disclosures, for example, an entity is required to provide (1) pretax income (or loss) from continuing operations disaggregated between domestic and foreign, and (2) income tax expense (or benefit) from continuing operations disaggregated by federal, state, and foreign.	The ASU will be effective for annual periods beginning after December 15, 2024. Entities are required to apply the ASU on a prospective basis.	The adoption of ASU 2023-09 is not expected to materially impact the Company’s financial position, results of operation, or cash flows.


ASU 2024-03: Accounting Standards Update No. 2024-03-Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40)
This ASU requires a public business entity to disclose specific information about certain costs and expenses in the notes to its financial statements for interim and annual reporting periods. The objective of the disclosure requirements is to provide disaggregated information about a public business entity’s expenses to help investors (a) better understand the entity’s performance, (b) better assess the entity’s prospects for future cash flows, and (c) compare an entity’s performance over time and with that of other entities. The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the notes to the financial statements.	The ASU will be effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. Entities are required to apply the ASU on a prospective basis.	The Company is currently assessing the impact to the financial statements of this ASU.

Accounting and Consolidation of VIEs

For all new investment products and entities developed by the Company, the Company first determines whether the entity is a VIE, which involves determining an entity’s variability and variable interests, identifying the holders of the equity investment at risk and assessing the five characteristics of a VIE. Once an entity is determined to be a VIE, the Company then determines whether it is the primary beneficiary of the VIE based on its beneficial interests. If the Company is deemed to be the primary beneficiary of the VIE, the Company consolidates the entity.

Quarterly, management of the Company reviews its investment management agreements and its investments in, and other financial arrangements with, certain entities that hold client AUM to determine the entities the Company is required to consolidate under this guidance. These entities include certain mutual fund products, hedge funds, structured products, group trusts, collective investment trusts, and limited partnerships.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The analysis performed to identify variable interests held, determine whether entities are VIEs or VOEs, and evaluate whether the Company has a controlling financial interest in such entities requires the exercise of judgment and is updated on a continuous basis as circumstances change or new entities are developed. The primary beneficiary evaluation generally is performed qualitatively based on all facts and circumstances, including consideration of economic interests in the VIE held directly and indirectly through related parties and entities under common control, as well as quantitatively, as appropriate.

Consolidated VIEs

Consolidated CLOs

The Company is the investment manager of certain asset-backed investment vehicles, commonly referred to as CLOs, and certain other vehicles for which the Company earns fee income for investment management services. The Company may sell or syndicate investments through these vehicles, principally as part of the strategic investing activity as part of its investment management businesses. Additionally, the Company may invest in securities issued by these vehicles which are eliminated in consolidation of the CLOs.

As of June 30, 2025 and December 31, 2024, respectively, Equitable Financial holds $123 million and $128 million of equity interests in the CLOs. The Company consolidated the CLOs as of June 30, 2025 and December 31, 2024 as it is the primary beneficiary due to the combination of both its equity interest held by Equitable Financial and the majority ownership of AB, which functions as the CLO’s loan manager. The assets of the CLOs are legally isolated from the Company’s creditors and can only be used to settle obligations of the CLOs. The liabilities of the CLOs are non-recourse to the Company and the Company has no obligation to satisfy the liabilities of the CLOs. As of June 30, 2025, Equitable Financial holds $0 million of equity interests in a SPE established to purchase loans from the market in anticipation of a new CLO transaction. The Company consolidated the SPE as of June 30, 2025 as it is the primary beneficiary due to the combination of both its equity interest held by Equitable Financial and the majority ownership of AB, which functions as the SPE loan manager.

Resulting from this consolidation in the Company’s consolidated balance sheets are fixed maturities, at fair value using the fair value option with total assets of $2.4 billion and $2.1 billion and total liabilities of $2.5 billion and $2.1 billion at June 30, 2025 and December 31, 2024, respectively. The unpaid outstanding principal balance of the notes and short-term borrowing is $2.3 billion and $1.9 billion at June 30, 2025 and December 31, 2024.

Consolidated Limited Partnerships and LLCs

As of June 30, 2025 and December 31, 2024 the Company consolidated limited partnerships and LLCs for which it was identified as the primary beneficiary under the VIE model. Included in other invested assets, mortgage loans on real estate, other equity investments, trading securities, cash and other liabilities in the Company’s consolidated balance sheets at June 30, 2025 and December 31, 2024 are total net assets of $2.7 billion and $2.1 billion, respectively related to these VIEs.

Consolidated AB-Sponsored Investment Funds

Included in the Company’s consolidated balance sheets as of June 30, 2025 and December 31, 2024 are assets of $421 million and $85 million, liabilities of $35 million and $0 million, and redeemable noncontrolling interests of $242 million and $32 million, respectively, associated with the consolidation of AB-sponsored investment funds under the VIE model. Also included in the Company’s consolidated balance sheets as of June 30, 2025 and December 31, 2024 are assets of $64 million and $73 million, liabilities of $2 million and $1 million, and redeemable noncontrolling interests of $20 million and $17 million, respectively, from consolidation of AB-sponsored investment funds under the VOE model.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Non-Consolidated VIEs

As of June 30, 2025 and December 31, 2024 respectively, the Company held approximately $3.1 billion and $3.0 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including CLOs, hedge funds, private equity funds and real estate-related funds. The Company continues to reflect these equity interests in the consolidated balance sheets as other equity investments and applies the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are approximately $377.4 billion and $350.7 billion as of June 30, 2025 and December 31, 2024 respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $3.1 billion and $3.0 billion and approximately $1.1 billion and $1.2 billion of unfunded commitments as of June 30, 2025 and December 31, 2024, respectively. The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations.

Non-Consolidated AB-Sponsored Investment Products

As of June 30, 2025 and December 31, 2024, the net assets of investment products sponsored by AB that are non-consolidated VIEs are approximately $46.4 billion and $46.9 billion, respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is its investment of $19 million and $17 million as of June 30, 2025 and December 31, 2024, respectively. The Company has no further commitments to or economic interest in these VIEs.

Revision of Previously Issued Financial Statements

During the period ended March 31, 2025, the Company identified an immaterial error related to the initial bookkeeping of ceded accrued fees within policyholders’ account balance ultimately impacting the initial deposit accounting of a reinsurance transaction. The impact of this error to prior periods’ financial statements was not considered to be material. To improve the consistency and comparability of the financial statements, management voluntarily revised the financial statements to include the revisions discussed herein. As a result of the determination to revise previously issued financial statements for the deposit accounting discussed above, management also has corrected other previously identified but uncorrected errors and errors recorded in incorrect periods including, a) pension liability overstatement due to a reconciling item, b) incorrect FX impacting the FABN carrying value, c) incorrect inputs ratio in our MRB modeling and incorrect inputs in the deposit accounting calculation, d) the hedging impact of Treasury Inflation-Protected Securities (TIPS) hedging income was incorrectly recorded in Accumulated other comprehensive income, e) error in the manual accrual in an input calculation in the treasury package overstating Policyholders’ account balance and Interest credited to policyholders, f) incorrect actuarial indication impacting the Liability for MRB and purchased MRB, and g) incorrect allocation of earned premiums to loss ratio impacting reserves.

See Note 20 of the Notes to these Financial Statements for details of the revision.

3) INVESTMENTS

Fixed Maturities AFS

The components of fair value and amortized cost for fixed maturities classified as AFS on the consolidated balance sheets excludes accrued interest receivable because the Company elected to present accrued interest receivable within other assets. Accrued interest receivable on AFS fixed maturities as of June 30, 2025 and December 31, 2024 was $740 million and $693 million, respectively. There was no accrued interest written off for AFS fixed maturities for the three and six months ended June 30, 2025 and 2024.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The following tables provide information relating to the Company’s fixed maturities classified as AFS:

AFS Fixed Maturities by Classification


	Amortized Cost		Allowance for Credit Losses		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
	(in millions)
June 30, 2025
Fixed Maturities:
Corporate (1)	$	53,506	$	3	$	579	$	5,378	$	48,704
U.S. Treasury, government and agency	5,983		—		3		1,467		4,519
States and political subdivisions	467		—		2		84		385
Foreign governments	690		—		2		117		575
Residential mortgage-backed (2)	5,505		—		60		111		5,454
Asset-backed (3)	15,774		—		117		49		15,842
Commercial mortgage-backed	4,840		—		20		303		4,557
Redeemable preferred stock	54		—		4		—		58
Total at June 30, 2025	$	86,819	$	3	$	787	$	7,509	$	80,094

December 31, 2024:
Fixed Maturities:
Corporate (1)	$	55,218	$	2	$	251	$	6,116	$	49,351
U.S. Treasury, government and agency	5,801		—		—		1,513		4,288
States and political subdivisions	472		—		2		88		386
Foreign governments	689		—		1		136		554
Residential mortgage-backed (2)	4,520		—		15		152		4,383
Asset-backed (3)	13,660		—		96		57		13,699
Commercial mortgage-backed	4,301		—		5		385		3,921
Redeemable preferred stock	56		—		3		—		59
Total at December 31, 2024	$	84,717	$	2	$	373	$	8,447	$	76,641

______________

(1)Corporate fixed maturities include both public and private issues.

(2)Includes publicly traded agency pass-through securities and collateralized obligations.

(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.

The contractual maturities of AFS fixed maturities as of June 30, 2025 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or pre-pay obligations with or without call or pre-payment penalties.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Contractual Maturities of AFS Fixed Maturities


	Amortized Cost (Less Allowance for Credit Losses)		Fair Value
	(in millions)
June 30, 2025
Contractual maturities:
Due in one year or less	$	2,620	$	2,605
Due in years two through five	16,176		15,949
Due in years six through ten	17,589		17,200
Due after ten years	24,258		18,429
Subtotal	60,643		54,183
Residential mortgage-backed	5,505		5,454
Asset-backed	15,774		15,842
Commercial mortgage-backed	4,840		4,557
Redeemable preferred stock	54		58
Total at June 30, 2025	$	86,816	$	80,094

The following table shows proceeds from sales, gross gains (losses) from sales and allowance for credit losses for AFS fixed maturities:

Proceeds from Sales, Gross Gains (Losses) from Sales and Allowance for Credit and Intent to Sell Losses for AFS Fixed Maturities


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Proceeds from sales	$	2,961	$	1,331	$	4,263	$	1,775
Gross gains on sales	$	7	$	5	$	9	$	5
Gross losses on sales	$	(30)	$	(3)	$	(33)	$	(27)

Net (increase) decrease in Allowance for Credit and Intent to Sell losses	$	(13)	$	(3)	$	(19)	$	(5)

The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts:

AFS Fixed Maturities - Credit and Intent to Sell Loss Impairments


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Balance, beginning of period	$	53	$	48	$	47	$	48
Previously recognized impairments on securities that matured, paid, prepaid or sold	(5)		(4)		(5)		(8)
Recognized impairments on securities impaired to fair value this period (1)	—		—		—		—
Credit losses recognized this period on securities for which credit losses were not previously recognized	12		3		17		6
Additional credit losses this period on securities previously impaired	1		3		2		4


Balance, end of period	$	61	$	50	$	61	$	50

______________

(1)Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The tables below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI:

Net Unrealized Gains (Losses) on AFS Fixed Maturities


	Three Months Ended June 30, 2025
	Net Unrealized Gains (Losses) on Investments		Policyholders’ Liabilities		Deferred Income Tax Asset (Liability)		AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
	(in millions)
Balance, beginning of period	$	(7,226)	$	66	$	279	$	(6,881)
Net investment gains (losses) arising during the period	466		—		—		466
Reclassification adjustment:
Included in net income (loss)	36		—		—		36
Excluded from net income (loss)	—		—		—		—
Other	—		—		(33)		(33)
Impact of net unrealized investment gains (losses)	—		—		(106)		(106)
Net unrealized investment gains (losses) excluding credit losses	(6,724)		66		140		(6,518)
Net unrealized investment gains (losses) with credit losses	2		—		—		2
Balance, end of period	$	(6,722)	$	66	$	140	$	(6,516)

	Three Months Ended June 30, 2024
Balance, beginning of period	$	(7,660)	$	63	$	358	$	(7,239)
Net investment gains (losses) arising during the period	(555)		—		—		(555)
Reclassification adjustment:
Included in net income (loss)	—		—		—		—
Excluded from net income (loss)	—		—		—		—
Other	—		—		(4)		(4)
Impact of net unrealized investment gains (losses)	—		4		117		121
Net unrealized investment gains (losses) excluding credit losses	(8,215)		67		471		(7,677)
Net unrealized investment gains (losses) with credit losses	1		—		—		1
Balance, end of period	$	(8,214)	$	67	$	471	$	(7,676)


	Six Months Ended June 30, 2025
	Net Unrealized Gains (Losses) on Investments		Policyholders’ Liabilities		Deferred Income Tax Asset (Liability)		AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
	(in millions)
Balance, beginning of period	$	(8,074)	$	71	$	464	$	(7,539)
Net investment gains (losses) arising during the period	1,310		—		—		1,310
Reclassification adjustment:
Included in net income (loss)	44		—		—		44
Excluded from net income (loss)	—		—		—		—
Other	—		—		(41)		(41)
Impact of net unrealized investment gains (losses)	—		(5)		(283)		(288)
Net unrealized investment gains (losses) excluding credit losses	(6,720)		66		140		(6,514)
Net unrealized investment gains (losses) with credit losses	(2)		—		—		(2)
Balance, end of period	$	(6,722)	$	66	$	140	$	(6,516)

	Six Months Ended June 30, 2024
Balance, beginning of period	$	(6,999)	$	50	$	226	$	(6,723)

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


Net investment gains (losses) arising during the period	(1,238)		—		—		(1,238)
Reclassification adjustment:
Included in net income (loss)	26		—		—		26

Other	—		—		(7)		(7)
Impact of net unrealized investment gains (losses)	—		17		251		268
Net unrealized investment gains (losses) excluding credit losses	(8,211)		67		470		(7,674)
Net unrealized investment gains (losses) with credit losses	(3)		—		1		(2)
Balance, end of period	$	(8,214)	$	67	$	471	$	(7,676)

The following tables disclose the fair values and gross unrealized losses of the 3,685 issues as of June 30, 2025 and the 4,307 issues as of December 31, 2024 that are not deemed to have credit losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated:

AFS Fixed Maturities in an Unrealized Loss Position for Which No Allowance Is Recorded


	Less Than 12 Months				12 Months or Longer				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
	(in millions)
June 30, 2025
Fixed Maturities:
Corporate	$	4,283	$	61	$	27,192	$	5,299	$	31,475	$	5,360
U.S. Treasury, government and agency	67		1		4,210		1,466		4,277		1,467
States and political subdivisions	—		—		261		84		261		84
Foreign governments	19		—		459		117		478		117
Residential mortgage-backed	488		4		826		107		1,314		111
Asset-backed	1,334		9		672		40		2,006		49
Commercial mortgage-backed	286		1		2,869		302		3,155		303

Total at June 30, 2025	$	6,477	$	76	$	36,489	$	7,415	$	42,966	$	7,491

December 31, 2024:
Fixed Maturities:
Corporate	$	9,147	$	205	$	28,684	$	5,901	$	37,831	$	6,106
U.S. Treasury, government and agency	117		4		4,107		1,509		4,224		1,513
States and political subdivisions	40		—		271		88		311		88
Foreign governments	59		1		460		135		519		136
Residential mortgage-backed	1,986		26		851		126		2,837		152
Asset-backed	974		7		692		50		1,666		57
Commercial mortgage-backed	409		6		2,893		379		3,302		385

Total at December 31, 2024	$	12,732	$	249	$	37,958	$	8,188	$	50,690	$	8,437

The Company maintains a diversified portfolio of AFS securities across industries and issuers and does not have exposure to any single issuer in excess of 0.5% of total fixed maturities. The largest exposure to a single issuer held as of June 30, 2025 and December 31, 2024 was $427 million and $400 million, respectively, representing 16.4% and 11.7% of the consolidated equity of the Company.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the NAIC Designation (as defined below) of 3 (medium investment grade), 4 or 5 (below investment grade) or 6 (in or near default). As of June 30, 2025 and December 31, 2024, respectively, approximately $2.1 billion and $1.9 billion, or 2.4% and 2.3%, of the $86.8 billion and $84.7 billion aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had gross unrealized losses of $67 million and $64 million as of June 30, 2025 and December 31, 2024, respectively.

As of June 30, 2025 and December 31, 2024, respectively, the $7.4 billion and $8.2 billion of gross unrealized losses of twelve months or more were primarily concentrated in corporate securities. In accordance with the policy described in Note 2 of the Notes to these Consolidated Financial Statements, the Company concluded that an adjustment to the allowance for credit losses for these securities was not warranted at either June 30, 2025 or December 31, 2024. As of June 30, 2025 and December 31, 2024, the Company neither intended to sell the securities nor was it more likely than not required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis.

Based on the Company’s evaluation both qualitatively and quantitatively of the drivers of the decline in fair value of fixed maturity securities as of June 30, 2025, the Company determined that the unrealized loss was primarily due to increases in interest rates and credit spreads.

Securities Lending

The Company enters into securities lending agreements with an agent bank whereby blocks of securities are loaned to third parties, primarily major brokerage firms. As of June 30, 2025 and December 31, 2024, the estimated fair value of loaned securities was $983 million and $134 million. The agreements require a minimum of 102% of the fair value of the loaned securities to be held as cash or security collateral, calculated daily. We do not have the right to sell or pledge the securities posted as collateral. To further minimize the credit risks related to these programs, the financial condition of counterparties is monitored on a regular basis. As of June 30, 2025 and December 31, 2024, collateral received was in the amount of $1.0 billion and $137 million, of which $104 million and $137 million, respectively, is cash collateral. A securities lending payable for the overnight and continuous loans is included in other liabilities in the amount of cash collateral received. Securities lending transactions are used to generate income. Income and expenses associated with these transactions are reported as Net investment income and were not material for the six months ended June 30, 2025 and 2024.

Mortgage Loans on Real Estate

Accrued interest receivable on commercial, agricultural and residential mortgage loans as of June 30, 2025 and December 31, 2024 was $110 million and $96 million, respectively. There was no accrued interest written off for commercial, agricultural and residential mortgage loans for the six months ended June 30, 2025 and 2024.

There were no mortgage loans foreclosed during the six months ended June 30, 2025.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Allowance for Credit Losses on Mortgage Loans

The change in the allowance for credit losses for commercial, agricultural and residential mortgage loans were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Allowance for credit losses on mortgage loans:
Commercial mortgages:
Balance, beginning of period	$	254	$	288	$	259	$	272
Current-period provision for expected credit losses	39		9		34		25
Write-offs charged against the allowance	—		(75)		—		(75)
Recoveries of amounts previously written off	—		—		—		—
Net change in allowance	39		(66)		34		(50)
Balance, end of period	$	293	$	222	$	293	$	222

Agricultural mortgages:
Balance, beginning of period	$	13	$	6	$	15	$	6
Current-period provision for expected credit losses	—		3		(2)		3
Write-offs charged against the allowance	(8)		—		(8)		—
Recoveries of amounts previously written off	—		—		—		—
Net change in allowance	(8)		3		(10)		3
Balance, end of period	$	5	$	9	$	5	$	9

Residential mortgages:
Balance, beginning of period	$	5	$	3	$	4	$	1
Current-period provision for expected credit losses	2		—		3		2
Write-offs charged against the allowance	—		—		—		—
Recoveries of amounts previously written off	—		—		—		—
Net change in allowance	2		—		3		2
Balance, end of period	$	7	$	3	$	7	$	3

Total allowance for credit losses	$	305	$	234	$	305	$	234

The change in the allowance for credit losses is attributable to:

•increases/decreases in the loan balance due to new originations, maturing mortgages, and loan amortization; and

•changes in credit quality and economic assumptions.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Credit Quality Information

The Company’s commercial and agricultural mortgage loans segregated by risk rating exposure were as follows:

Loan to Value (“LTV”) Ratios (1) (3)


	June 30, 2025
	Amortized Cost Basis by Origination Year
	2025		2024		2023		2022		2021		Prior		Revolving Loans Amortized Cost Basis		Revolving Loans Converted to Term Loans Amortized Cost Basis		Total
	(in millions)
Commercial and agricultural mortgage loans:
Commercial:
0% - 50%	$	60	$	185	$	268	$	203	$	206	$	1,736	$	—	$	—	$	2,658
50% - 70%	1,003		1,431		881		1,551		612		2,363		436		277		8,554
70% - 90%	292		73		316		764		698		1,756		122		205		4,226
90% plus	—		—		—		547		558		1,217		—		—		2,322
Total commercial	$	1,355	$	1,689	$	1,465	$	3,065	$	2,074	$	7,072	$	558	$	482	$	17,760

Agricultural:
0% - 50%	$	77	$	47	$	100	$	149	$	198	$	1,105	$	—	$	—	$	1,676
50% - 70%	56		158		52		133		128		364		—		—		891
70% - 90%	—		—		—		—		—		—		—		—		—
90% plus	—		—		—		—		—		25		—		—		25
Total agricultural	$	133	$	205	$	152	$	282	$	326	$	1,494	$	—	$	—	$	2,592


Total commercial and agricultural mortgage loans:
0% - 50%	$	137	$	232	$	368	$	352	$	404	$	2,841	$	—	$	—	$	4,334
50% - 70%	1,059		1,589		933		1,684		740		2,727		436		277		9,445
70% - 90%	292		73		316		764		698		1,756		122		205		4,226
90% plus	—		—		—		547		558		1,242		—		—		2,347
Total commercial and agricultural mortgage loans	$	1,488	$	1,894	$	1,617	$	3,347	$	2,400	$	8,566	$	558	$	482	$	20,352

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Debt Service Coverage (“DSC”) Ratios (2) (3)


	June 30, 2025
	Amortized Cost Basis by Origination Year
	2025		2024		2023		2022		2021		Prior		Revolving Loans Amortized Cost Basis		Revolving Loans Converted to Term Loans Amortized Cost Basis		Total
	(in millions)
Commercial and agricultural mortgage loans:
Commercial:
Greater than 2.0x	$	67	$	208	$	175	$	1,016	$	1,081	$	3,255	$	—	$	—	$	5,802
1.8x to 2.0x	60		103		58		50		208		1,090		113		184		1,866
1.5x to 1.8x	85		472		233		753		48		1,209		59		165		3,024
1.2x to 1.5x	817		716		514		664		531		743		—		95		4,080
1.0x to 1.2x	326		190		475		260		74		669		386		38		2,418
Less than 1.0x	—		—		10		322		132		106		—		—		570
Total commercial	$	1,355	$	1,689	$	1,465	$	3,065	$	2,074	$	7,072	$	558	$	482	$	17,760

Agricultural:
Greater than 2.0x	$	17	$	9	$	5	$	40	$	34	$	193	$	—	$	—	$	298
1.8x to 2.0x	17		12		17		23		53		100		—		—		222
1.5x to 1.8x	11		48		10		44		27		283		—		—		423
1.2x to 1.5x	38		46		44		88		135		505		—		—		856
1.0x to 1.2x	30		71		45		63		67		372		—		—		648
Less than 1.0x	20		19		31		24		10		41		—		—		145
Total agricultural	$	133	$	205	$	152	$	282	$	326	$	1,494	$	—	$	—	$	2,592


Total commercial and agricultural mortgage loans:
Greater than 2.0x	$	84	$	217	$	180	$	1,056	$	1,115	$	3,448	$	—	$	—	$	6,100
1.8x to 2.0x	77		115		75		73		261		1,190		113		184		2,088
1.5x to 1.8x	96		520		243		797		75		1,492		59		165		3,447
1.2x to 1.5x	855		762		558		752		666		1,248		—		95		4,936
1.0x to 1.2x	356		261		520		323		141		1,041		386		38		3,066
Less than 1.0x	20		19		41		346		142		147		—		—		715
Total commercial and agricultural mortgage loans	$	1,488	$	1,894	$	1,617	$	3,347	$	2,400	$	8,566	$	558	$	482	$	20,352

______________

(1)The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan.

(2)The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service.

(3)Residential mortgage loans are excluded from the above tables.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

LTV Ratios (1) (3)


	December 31, 2024
	Amortized Cost Basis by Origination Year
	2024		2023		2022		2021		2020		Prior		Revolving Loans Amortized Cost Basis		Revolving Loans Converted to Term Loans Amortized Cost Basis		Total
	(in millions)
Commercial and agricultural mortgage loans:
Commercial:
0% - 50%	$	185	$	363	$	137	$	212	$	269	$	1,548	$	—	$	—	$	2,714
50% - 70%	1,501		910		1,622		628		318		2,083		441		201		7,704
70% - 90%	—		246		707		918		396		1,187		101		206		3,761
90% plus	—		—		616		322		309		1,290		—		—		2,537
Total commercial	$	1,686	$	1,519	$	3,082	$	2,080	$	1,292	$	6,108	$	542	$	407	$	16,716

Agricultural:
0% - 50%	$	49	$	98	$	160	$	202	$	269	$	882	$	—	$	—	$	1,660
50% - 70%	160		59		126		130		144		273		—		—		892
70% - 90%	—		—		—		—		—		16		—		—		16
90% plus	—		—		—		—		—		—		—		—		—
Total agricultural	$	209	$	157	$	286	$	332	$	413	$	1,171	$	—	$	—	$	2,568


Total commercial and agricultural mortgage loans:
0% - 50%	$	234	$	461	$	297	$	414	$	538	$	2,430	$	—	$	—	$	4,374
50% - 70%	1,661		969		1,748		758		462		2,356		441		201		8,596
70% - 90%	—		246		707		918		396		1,203		101		206		3,777
90% plus	—		—		616		322		309		1,290		—		—		2,537
Total commercial and agricultural mortgage loans	$	1,895	$	1,676	$	3,368	$	2,412	$	1,705	$	7,279	$	542	$	407	$	19,284

DSC Ratios (2) (3)


	December 31, 2024
	Amortized Cost Basis by Origination Year
	2024		2023		2022		2021		2020		Prior		Revolving Loans Amortized Cost Basis		Revolving Loans Converted to Term Loans Amortized Cost Basis		Total
	(in millions)
Commercial and agricultural mortgage loans:
Commercial:
Greater than 2.0x	$	208	$	176	$	609	$	1,255	$	916	$	3,318	$	—	$	—	$	6,482
1.8x to 2.0x	103		75		50		149		376		607		176		182		1,718
1.5x to 1.8x	472		211		727		—		—		1,060		44		189		2,703
1.2x to 1.5x	756		566		542		433		—		661		—		—		2,958

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	December 31, 2024
	Amortized Cost Basis by Origination Year
	2024		2023		2022		2021		2020		Prior		Revolving Loans Amortized Cost Basis		Revolving Loans Converted to Term Loans Amortized Cost Basis		Total
	(in millions)
1.0x to 1.2x	147		482		643		193		—		359		322		36		2,182
Less than 1.0x	—		9		511		50		—		103		—		—		673
Total commercial	$	1,686	$	1,519	$	3,082	$	2,080	$	1,292	$	6,108	$	542	$	407	$	16,716

Agricultural:
Greater than 2.0x	$	12	$	5	$	41	$	34	$	57	$	157	$	—	$	—	$	306
1.8x to 2.0x	11		17		24		54		28		79		—		—		213
1.5x to 1.8x	49		11		44		27		120		175		—		—		426
1.2x to 1.5x	47		46		89		138		113		422		—		—		855
1.0x to 1.2x	71		47		63		68		87		307		—		—		643
Less than 1.0x	19		31		25		11		8		31		—		—		125
Total agricultural	$	209	$	157	$	286	$	332	$	413	$	1,171	$	—	$	—	$	2,568


Total commercial and agricultural mortgage loans:
Greater than 2.0x	$	220	$	181	$	650	$	1,289	$	973	$	3,475	$	—	$	—	$	6,788
1.8x to 2.0x	114		92		74		203		404		686		176		182		1,931
1.5x to 1.8x	521		222		771		27		120		1,235		44		189		3,129
1.2x to 1.5x	803		612		631		571		113		1,083		—		—		3,813
1.0x to 1.2x	218		529		706		261		87		666		322		36		2,825
Less than 1.0x	19		40		536		61		8		134		—		—		798
Total commercial and agricultural mortgage loans	$	1,895	$	1,676	$	3,368	$	2,412	$	1,705	$	7,279	$	542	$	407	$	19,284

______________

(1)The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan.

(2)The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service.

(3)Residential mortgage loans are excluded from the above tables.

The amortized cost of residential mortgage loans by credit quality indicator and origination year was as follows:


	June 30, 2025
	Amortized Cost Basis by Origination Year
	2025		2024		2023		2022		2021		Prior		Total
	(in millions)
Performance indicators:
Performing	$	85	$	700	$	393	$	178	$	128	$	4	$	1,488
Nonperforming	—		—		1		—		—		—		1
Total	$	85	$	700	$	394	$	178	$	128	$	4	$	1,489

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	December 31, 2024
	Amortized Cost Basis by Origination Year
	2024		2023		2022		2021		2019		Prior		Total
	(in millions)
Performance indicators:
Performing	$	313	$	428	$	186	$	133	$	4	$	2	$	1,066
Nonperforming	—		—		—		—		—		—		—
Total	$	313	$	428	$	186	$	133	$	4	$	2	$	1,066

Past-Due and Nonaccrual Mortgage Loan Status

The aging analysis of past-due mortgage loans were as follows:

Age Analysis of Past Due Mortgage Loans (1)


	Accruing Loans												Non-accruing Loans		Total Loans		Non-accruing Loans with No Allowance		Interest Income on Non-accruing Loans
	Past Due								Current		Total
	30-59 Days		60-89 Days		90 Days or More		Total
	(in millions)
June 30, 2025:
Mortgage loans:
Commercial	$	—	$	—	$	—	$	—	$	17,642	$	17,642	$	118	$	17,760	$	—	$	1
Agricultural	33		9		46		88		2,477		2,565		27		2,592		25		—
Residential	—		—		5		5		1,483		1,488		1		1,489		1		—
Total	$	33	$	9	$	51	$	93	$	21,602	$	21,695	$	146	$	21,841	$	26	$	1

December 31, 2024:
Mortgage loans:
Commercial	$	—	$	—	$	—	$	—	$	16,659	$	16,659	$	57	$	16,716	$	—	$	1
Agricultural	12		1		33		46		2,486		2,532		36		2,568		—		—
Residential	—		1		—		1		1,065		1,066		—		1,066		—		—
Total	$	12	$	2	$	33	$	47	$	20,210	$	20,257	$	93	$	20,350	$	—	$	1

______________

(1)Amounts presented at amortized cost basis.

As of June 30, 2025 and December 31, 2024, the amortized cost of problem mortgage loans that had been classified as non-accrual loans were $89 million and $36 million, respectively.

Loan Modifications

During the three and six months ended June 30, 2025, the Company granted a modification splitting a $15 million agricultural mortgage loan into three notes. The loans have an amortized cost of $9 million, which is fully attributed to the first note, and represent 0.3% of total agricultural loans.

During 2024, the Company granted a modification splitting a commercial mortgage loan into two notes. One note retaining the original loan terms and the second note with an increased interest rate to market terms and required management of excess cash. The loans have an amortized cost of $65 million and represents 0.4% of total commercial mortgage loans.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

During 2023, the Company granted a modification of interest rates on four commercial mortgage loans, but not to market terms and required management of excess cash. The loans have an amortized cost of $228 million which represents 1.3% of total commercial mortgage loans. Two of the four loans also have term extensions of 17 months to 4 years.

The impact to Investment income or gains (losses) as a result of these modifications was not material to the consolidated financial statements.

The above modifications are performing in accordance with their restructured terms.

Equity Securities

The breakdown of unrealized and realized gains and (losses) on equity securities was as follows:

Unrealized and Realized Gains (Losses) from Equity Securities


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period	$	(2)	$	(6)	$	(2)	$	9
Net investment gains (losses) recognized on securities sold during the period	2		3		2		2
Unrealized and realized gains (losses) on equity securities	$	—	$	(3)	$	—	$	11

Trading Securities

As of June 30, 2025 and December 31, 2024, respectively, the fair value of the Company’s trading securities was $1.3 billion and $1.1 billion. As of June 30, 2025 and December 31, 2024, respectively, trading securities included the General Account’s investment in Separate Accounts had carrying values of $56 million and $64 million.

The breakdown of net investment income (loss) from trading securities was as follows:

Net Investment Income (Loss) from Trading Securities


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period	$	50	$	6	$	33	$	42
Net investment gains (losses) recognized on securities sold during the period	(10)		—		6		1
Unrealized and realized gains (losses) on trading securities	40		6		39		43
Interest and dividend income from trading securities	25		21		34		32
Net investment income (loss) from trading securities	$	65	$	27	$	73	$	75

Fixed maturities, at fair value using the fair value option

The breakdown of net investment income (loss) from fixed maturities, at fair value using the fair value option were as follows:

Net Investment Income (Loss) from Fixed Maturities, at Fair Value using the Fair Value Option


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period	$	5	$	(2)	$	12	$	(5)
Net investment gains (losses) recognized on securities sold during the period	(1)		2		1		3
Unrealized and realized gains (losses) from fixed maturities	4		—		13		(2)
Interest and dividend income from fixed maturities	(4)		23		(4)		28
Net investment income (loss) from fixed maturities	$	—	$	23	$	9	$	26

Net Investment Income

The following tables provides the components of Net investment income by investment type:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Fixed maturities	$	938	$	842	$	1,874	$	1,655
Mortgage loans on real estate	256		239		516		473
Other equity investments	39		(8)		83		52
Policy loans	52		56		107		110
Trading securities	65		27		73		75
Other investment income	40		21		17		45
Fixed maturities, at fair value using the fair value option	—		23		9		26
Gross investment income (loss)	1,390		1,200		2,679		2,436
Investment expenses	(35)		(33)		(76)		(59)
Net investment income (loss)	$	1,355	$	1,167	$	2,603	$	2,377

Investment Gains (Losses), Net

Investment gains (losses), net, including changes in the valuation allowances and credit losses were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Fixed maturities	$	(11)	$	(1)	$	(19)	$	(27)
Mortgage loans on real estate	(61)		(14)		(68)		(32)

Other	1		(1)		2		4
Investment gains (losses), net	$	(71)	$	(16)	$	(85)	$	(55)

For the three and six months ended June 30, 2025 and 2024, respectively, investment results passed through to certain participating group annuity contracts as interest credited to policyholders’ account balances totaled $0 million, $1 million, $0 million and $1 million.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

4) DERIVATIVES

The Company uses derivatives as part of its overall asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a “Derivative Use Plan” approved by applicable states’ insurance law. Derivatives are generally not accounted for using hedge accounting, with the exception of TIPS and cash flow hedges, which are discussed further below. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, fund performance, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, bond and bond-index total return swaps, swaptions, variance swaps and equity options, credit and foreign exchange derivatives, as well as bond and repo transactions to support the hedging. The derivative contracts are collectively managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in capital markets. In addition, as part of its hedging strategy, the Company targets an asset level for all variable annuity products at or above a CTE98 level under most economic scenarios (CTE is a statistical measure of tail risk which quantifies the total asset requirement (“TAR”) to sustain a loss if an event outside a given probability level has occurred. CTE98 denotes the financial resources a company would need to cover the average of the worst 2% of scenarios.)

Derivatives Utilized to Hedge Exposure to Variable Annuities with Guarantee Features

The Company has issued and continues to offer variable annuity products with GMxB features which are accounted for as MRBs. The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders’ account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB, in the event of annuitization, being higher than what accumulated policyholders’ account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with products that have a GMxB feature and are accounted for as MRBs is that under-performance of the financial markets could result in the GMxB features benefits being higher than what accumulated policyholders’ account balances would support.

For GMxB features, the Company retains certain risks including basis, credit spread, and some volatility risk and risk associated with actual experience compared to expected actuarial assumptions for mortality, lapse and surrender, withdrawal and policyholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMxB features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps and a portion of exposure to credit risk is hedged using total return swaps on fixed income indices. Additionally, the Company is party to total return swaps for which the reference U.S. Treasury securities are contemporaneously purchased from the market and sold to the swap counterparty. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. The Company has also purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company. The reinsurance of these features is accounted for as purchased MRBs. In addition, on June 1, 2021, we ceded legacy variable annuity policies sold by Equitable Financial between 2006-2008 (the “Block”), comprised of non-New York “Accumulator” policies containing fixed rate GMIB and/or GMDB guarantees to CS Life. As this contract provides full risk transfer and thus has the same risk attributes as the underlying direct contracts, the benefits of this treaty are accounted for in the same manner as the underlying gross reserves and therefore the amounts due from reinsurers related to excess benefits are accounted for as purchased MRBs.

The Company has in place an economic hedge program using U.S. Treasury futures to partially protect the overall profitability of future variable annuity sales against declining interest rates.

Derivatives Utilized to Hedge Crediting Rate Exposure on SCS, SIO, MSO and IUL Products/Investment Options

The Company hedges crediting rates in the SCS variable annuity, SIO in the EQUI-VEST variable annuity series, MSO in the variable life insurance products and IUL insurance products. These products permit the contract owner to participate in the performance of an index, ETF or commodity price movement up to a cap for a set period of time. They also contain a protection feature, in which the Company will absorb, up to a certain percentage, the loss of value in an index, ETF or commodity price, which varies by product segment.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

In order to support the returns associated with these features, the Company enters into derivative contracts whose payouts, in combination with fixed income investments, emulate those of the index, ETF or commodity price, subject to caps and buffers, thereby substantially reducing any exposure to market-related earnings volatility.

Derivatives Used to Hedge Equity Market Risks Associated with the General Account’s Seed Money Investments in Retail Mutual Funds

The Company’s General Account seed money investments in retail mutual funds expose us to market risk, including equity market risk which is partially hedged through equity-index futures contracts to minimize such risk.

Derivatives Used for General Account Investment Portfolio

The Company purchased CDS to mitigate its exposure to a reference entity through cash positions. These positions do not replicate credit spreads.

The Company purchased 30-year TIPS and other sovereign bonds, both inflation linked and non-inflation linked, as General Account investments and enters into asset or cross-currency basis swaps, to result in payment of the given bond’s coupons and principal at maturity in the bond’s specified currency to the swap counterparty in return for fixed dollar amounts. These swaps, when considered in combination with the bonds, together result in a net position that is intended to replicate a dollar-denominated fixed-coupon cash bond with a yield higher than a term-equivalent U.S. Treasury bond.

Derivatives Utilized to Hedge Exposure to Foreign Currency Denominated Cash Flows

The Company purchases private placement debt securities and issues funding agreements in the FABN program in currencies other than its functional U.S. dollar currency. The Company enters into cross currency swaps with external counterparties to hedge the exposure of the foreign currency denominated cash flows of these instruments. The foreign currency received from or paid to the cross currency swap counterparty is exchanged for fixed U.S. dollar amounts with improved net investment yields or net product costs over equivalent U.S. dollar denominated instruments issued at that time. The transactions are accounted for as cash flow hedges when they are designated in hedging relationships and qualify for hedge accounting.

These cross currency swaps are for the period the foreign currency denominated private placement debt securities and funding agreement are outstanding, with the longest cross currency swap expiring in 2033. Since these cross currency swaps are designated and qualify as cash flow hedges, the corresponding interest accruals are recognized in Net investment income and in interest credited to policyholders’ account balances.

The tables below present quantitative disclosures about the Company’s derivative instruments designated in hedging relationships and derivative instruments which have not been designated in hedging relationships, including those embedded in other contracts required to be accounted for as derivative instruments.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The following table presents the gross notional amount and fair value of the Company’s derivatives:

Derivative Instruments by Category


	June 30, 2025								December 31, 2024
			Fair Value								Fair Value
	Notional Amount		Derivative Assets		Derivative Liabilities		Net Derivatives		Notional Amount		Derivative Assets		Derivative Liabilities		Net Derivatives
	(in millions)
Derivatives: designated for hedge accounting (1)
Cash flow hedges:
Currency swaps	$	2,962	$	90	$	157	$	(67)	$	2,940	$	111	$	95	$	16
Interest swaps	952		—		335		(335)		952		—		306		(306)
Total: designated for hedge accounting	3,914		90		492		(402)		3,892		111		401		(290)
Derivatives: not designated for hedge accounting (1)
Equity contracts:
Futures	17,100		—		3		(3)		14,530		3		—		3
Swaps	16,942		59		71		(12)		16,264		65		19		46
Options	66,287		22,575		4,925		17,650		70,685		20,647		4,319		16,328
Interest rate contracts:
Futures	9,716		—		—		—		9,310		—		—		—
Swaps	610		12		5		7		672		—		41		(41)
Options	50		5		—		5		—		—		—		—
Credit contracts:
Credit default swaps	437		11		20		(9)		275		12		10		2
Currency contracts:
Currency swaps	771		—		31		(31)		828		26		—		26
Currency forwards	83		15		17		(2)		28		17		17		—
Other freestanding contracts:
Margin	—		1,173		—		1,173		—		796		—		796
Collateral	—		155		16,634		(16,479)		—		137		16,908		(16,771)
Total: not designated for hedge accounting	111,996		24,005		21,706		2,299		112,592		21,703		21,314		389

Embedded derivatives:
SCS, SIO, MSO and IUL indexed features (2)	—		—		18,311		(18,311)		—		—		17,212		(17,212)
Total embedded derivatives	—		—		18,311		(18,311)		—		—		17,212		(17,212)

Total derivative instruments	$	115,910	$	24,095	$	40,509	$	(16,414)	$	116,484	$	21,814	$	38,927	$	(17,113)

______________

(1)Reported in other invested assets in the consolidated balance sheets.

(2)Reported in policyholders’ account balances in the consolidated balance sheets.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The following table presents the effects of derivative instruments on the consolidated statements of income and comprehensive income (loss):

Derivative Instruments by Category


	Three Months Ended June 30, 2025								Six Months Ended June 30, 2025
	Net Derivative Gains (Losses) (1)		Net Investment Income		Interest Credited To Policyholders Account Balances		AOCI		Net Derivative Gains (Losses) (1)		Net Investment Income		Interest Credited To Policyholders Account Balances		AOCI
	(in millions)
Derivatives: designated for hedge accounting
Cash flow hedges:
Currency swaps	$	—	$	9	$	73	$	(151)	$	—	$	15	$	106	$	(188)
Interest swaps	—		(8)		—		13		—		(11)		—		(8)
Total: designated for hedge accounting	—		1		73		(138)		—		4		106		(196)
Derivatives: not Designated for hedge accounting
Equity contracts:
Futures	472		—		—		—		272		—		—		—
Swaps	(1,204)		—		—		—		(499)		—		—		—
Options	4,235		—		—		—		1,590		—		—		—
Interest rate contracts:
Futures	(98)		—		—		—		(121)		—		—		—
Swaps	(16)		—		—		—		(1)		—		—		—
Options	(1)		—		—		—		(2)		—		—		—
Credit contracts:
Credit default swaps	(3)		—		—		—		(3)		—		—		—
Currency contracts:
Currency swaps	(57)		—		—		—		(87)		—		—		—
Currency forwards	(6)		—		—		—		(6)		—		—		—
Other freestanding contracts:
Margin	—		—		—		—		—		—		—		—
Collateral	—		—		—		—		—		—		—		—
Total: not designated for hedge accounting	3,322		—		—		—		1,143		—		—		—

Embedded derivatives:
SCS, SIO,MSO and IUL indexed features	(4,696)		—		—		—		(1,718)		—		—		—
Total embedded derivatives	(4,696)		—		—		—		(1,718)		—		—		—

Total derivative instruments	$	(1,374)	$	1	$	73	$	(138)	$	(575)	$	4	$	106	$	(196)

______________

(1)Reported in net derivative gains (losses) in the consolidated statements of income (loss).

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Three Months Ended June 30, 2024								Six Months Ended June 30, 2024
	Net Derivatives Gains (Losses) (1)		Net Investment Income		Interest Credited To Policyholders Account Balances		AOCI		Net Derivatives Gains (Losses) (1)		Net Investment Income		Interest Credited To Policyholders Account Balances		AOCI
	(in millions)
Derivatives: designated for hedge accounting
Cash flow hedges:
Currency swaps	$	—	$	4	$	(5)	$	22	$	1	$	7	$	(23)	$	38
Interest swaps	—		(17)		—		13		—		(14)		—		6
Total: designated for hedge accounting	—		(13)		(5)		35		1		(7)		(23)		44
Derivatives: not Designated for hedge accounting
Equity contracts:
Futures	50		—		—		—		291		—		—		—
Swaps	(99)		—		—		—		(1,214)		—		—		—
Options	1,225		—		—		—		4,021		—		—		—
Interest rate contracts:
Futures	(1)		—		—		—		(11)		—		—		—
Swaps	(88)		—		—		—		(253)		—		—		—
Credit contracts:
Credit default swaps	—		—		—		—		(1)		—		—		—
Currency contracts:
Currency swaps	1		—		—		—		13		—		—		—
Currency forwards	—		—		—		—		1		—		—		—



Total: not designated for hedge accounting	1,088		—		—		—		2,847		—		—		—

Embedded derivatives:
SCS, SIO,MSO and IUL indexed features	(1,296)		—		—		—		(4,432)		—		—		—
Total embedded derivatives	(1,296)		—		—		—		(4,432)		—		—		—

Total derivative instruments (1)	$	(208)	$	(13)	$	(5)	$	35	$	(1,584)	$	(7)	$	(23)	$	44

______________

(1)Reported in net derivative gains (losses) in the consolidated statements of income (loss).

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The following table presents a roll-forward of cash flow hedges recognized in AOCI:

Roll-forward of Cash flow hedges in AOCI


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Balance, beginning of period	$	22	$	(21)	$	80	$	(31)
Amount recorded in AOCI
Currency swaps	(91)		19		(81)		19
Interest swaps	—		(9)		(29)		(17)
Total amount recorded in AOCI	(91)		10		(110)		2
Amount reclassified from (to) income to AOCI
Currency swaps (1)	(60)		3		(107)		20
Interest swaps (1)	13		21		21		22
Total amount reclassified from (to) income to AOCI	(47)		24		(86)		42
Balance, end of period (2)	$	(116)	$	13	$	(116)	$	13

______________

(1) Currency swaps income is reported in Net investment income in the consolidated statements of income (loss). Interest swaps income is reported in net derivative gains (losses) in the consolidated statements of income (loss).

(2) The Company does not estimate the amount of the deferred losses in AOCI at June 30, 2025, and 2024 which will be released and reclassified into net income (loss) over the next 12 months as the amounts cannot be reasonably estimated.

Equity-Based and Treasury Futures Contracts Margin

All outstanding equity-based and treasury futures contracts as of June 30, 2025 and December 31, 2024 are exchange-traded and net settled daily in cash. As of June 30, 2025 and December 31, 2024, respectively, the Company had open exchange-traded futures positions on: (i) the S&P 500, Nasdaq, Russell 2000 and Emerging Market indices, having initial margin requirements of $1.1 billion and $704 million, (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $110 million and $99 million, and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200 and EAFE indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $1 million and $11 million.

Collateral Arrangements

The Company generally has executed a CSA under the ISDA Master Agreement it maintains with each of its OTC derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. As of June 30, 2025 and December 31, 2024, respectively, the Company held $16.6 billion and $16.9 billion in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. The unrestricted cash collateral is reported in other invested assets. The Company posted collateral of $155 million and $137 million as of June 30, 2025 and December 31, 2024, respectively, in the normal operation of its collateral arrangements. The Company is exposed to losses in the event of non-performance by counterparties to financial derivative transactions with a positive fair value. The Company manages credit risk by: (i) entering into derivative transactions with highly rated major international financial institutions and other creditworthy counterparties governed by master netting agreements, as applicable; (ii) trading through central clearing and OTC parties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single party credit exposures which are subject to periodic management review.

Substantially all of the Company’s derivative agreements have zero thresholds which require daily full collateralization by the party in a liability position. In addition, certain of the Company’s derivative agreements contain credit-risk related contingent features; if the credit rating of one of the parties to the derivative agreement is to fall below a certain level, the party with positive fair value could request termination at the then fair value or demand immediate full collateralization from the party whose credit rating fell and is in a net liability position.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

As of June 30, 2025 and December 31, 2024, there were no net liability derivative positions with counterparties with credit risk-related contingent features whose credit rating has fallen. All derivatives have been appropriately collateralized by the Company or the counterparty in accordance with the terms of the derivative agreements.

The following tables present information about the Company’s offsetting of financial assets and liabilities and derivative instruments:

Offsetting of Financial Assets and Liabilities and Derivative Instruments

As of June 30, 2025


	Gross Amount Recognized		Gross Amount Offset in the Balance Sheets		Net Amount Presented in the Balance Sheets		Gross Amount not Offset in the Balance Sheets (3)		Net Amount
	(in millions)
Assets:
Derivative assets (1)	$	24,095	$	17,684	$	6,411	$	(4,509)	$	1,902
Secured lending	104		—		104		—		104
Other financial assets	1,786		—		1,786		—		1,786
Other invested assets	$	25,985	$	17,684	$	8,301	$	(4,509)	$	3,792

Liabilities:
Derivative liabilities (2)	$	17,689	$	17,684	$	5	$	—	$	5
Secured lending	104		—		104		—		104
Other financial liabilities	5,738		—		5,738		—		5,738
Other liabilities	$	23,531	$	17,684	$	5,847	$	—	$	5,847

______________

(1)Excludes Asset Management segment’s derivative assets of consolidated VIEs/VOEs.

(2)Excludes Asset Management segment’s derivative liabilities of consolidated VIEs/VOEs.

(3)Financial instruments/collateral sent (held).

As of December 31, 2024


	Gross Amount Recognized		Gross Amount Offset in the Balance Sheets		Net Amount Presented in the Balance Sheets		Gross Amount not Offset in the Balance Sheets (3)		Net Amount
	(in millions)
Assets:
Derivative assets (1)	$	21,814	$	14,924	$	6,890	$	(6,080)	$	810
Secured Lending	137		—		137		—		137
Other financial assets	1,510		—		1,510		—		1,510
Other invested assets	$	23,461	$	14,924	$	8,537	$	(6,080)	$	2,457

Liabilities:
Derivative liabilities (2)	$	15,634	$	14,924	$	710	$	—	$	710
Secured Lending	137		—		137		—		137
Other financial liabilities	6,185		—		6,185		—		6,185
Other liabilities	$	21,956	$	14,924	$	7,032	$	—	$	7,032

______________

(1)Excludes Asset Management segment’s derivative assets of consolidated VIEs/VOEs.

(2)Excludes Asset Management segment’s derivative liabilities of consolidated VIEs/VOEs.

(3)Financial instruments sent (held).

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

5) CLOSED BLOCK

As a result of demutualization, the Company’s Closed Block was established in 1992 for the benefit of certain individual participating policies that were in force on that date. Assets, liabilities and earnings of the Closed Block are specifically identified to support its participating policyholders.

Assets allocated to the Closed Block insure solely to the benefit of the Closed Block policyholders and will not revert to the benefit of the Company. No reallocation, transfer, borrowing or lending of assets can be made between the Closed Block and other portions of the Company’s General Account, any of its Separate Accounts or any affiliate of the Company without the approval of the New York State Department of Financial Services (the “NYDFS”). Closed Block assets and liabilities are carried on the same basis as similar assets and liabilities held in the General Account. For more information on the Closed Block, see Note 6 to the Company's consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024.

Summarized financial information for the Company’s Closed Block is as follows:



	June 30, 2025		December 31, 2024
	(in millions)
Closed Block Liabilities:
Future policy benefits, policyholders’ account balances and other	$	5,100	$	5,213

Other liabilities	47		62
Total Closed Block liabilities	5,147		5,275

Assets Designated to the Closed Block:
Fixed maturities AFS, at fair value (amortized cost of $2,674 and $2,888) (allowance for credit losses of $0 and$0)	2,591		2,746
Mortgage loans on real estate (net of allowance for credit losses of $22 and $21)	1,498		1,531
Policy loans	510		523
Cash and other invested assets	161		17
Other assets	107		130
Total assets designated to the Closed Block	4,867		4,947

Excess of Closed Block liabilities over assets designated to the Closed Block	280		328
Amounts included in AOCI:
Net unrealized investment gains (losses), net of income tax: $17 and $30	(66)		(112)
Maximum future earnings to be recognized from Closed Block assets and liabilities	$	214	$	216

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The Company’s Closed Block revenues and expenses were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Revenues:
Premiums and other income	$	24	$	26	$	51	$	55
Net investment income (loss)	48		51		99		103
Investment gains (losses), net	—		—		(1)		(1)
Total revenues	72		77		149		157

Benefits and Other Deductions:
Policyholders’ benefits and dividends	72		64		146		141
Other operating costs and expenses	1		—		1		—
Total benefits and other deductions	73		64		147		141
Net income (loss), before income taxes	(1)		13		2		16
Income tax (expense) benefit	—		(2)		(1)		(3)
Net income (loss)	$	(1)	$	11	$	1	$	13

6) DAC AND OTHER DEFERRED ASSETS/LIABILITIES

The following table presents a reconciliation of DAC to the consolidated balance sheets:


	June 30		December 31
	2025		2024
	(in millions)
Protection Solutions
Term	$	301	$	314
Universal Life	171		170
Variable Universal Life	1,122		1,083
Indexed Universal Life	186		186
Individual Retirement
GMxB Core	1,599		1,605
EQUI-VEST Individual	154		154
Investment Edge	250		225
SCS	2,107		1,938
Legacy Segment
GMxB Legacy	494		517
Group Retirement
EQUI-VEST Group	776		768
Momentum	80		83
Corporate and Other	103		107
Other	18		20
Total	$	7,361	$	7,170

Annually, or as circumstances warrant, the Company reviews the associated decrements assumptions (i.e., mortality and lapse) based on our multi-year average of companies experience with actuarial judgements to reflect other observable industry trends. In addition to DAC, the unearned revenue liability and sales inducement asset (“SIA”) use similar techniques and quarterly update processes for balance amortization.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Changes in the DAC asset were as follows:


	Six Months Ended June 30, 2025
	Protection Solutions								Individual Retirement								Legacy		Group Retirement				Corporate and Other		Total
	Term		UL		VUL		IUL		GMxB Core		EI		IE		SCS		GMxB Legacy		EG		Momentum		CB (1)
	(in millions)
Balance, beginning of period	$	314	$	170	$	1,083	$	186	$	1,605	$	154	$	225	$	1,938	$	517	$	768	$	83	$	107	$	7,150
Capitalization	5		7		72		6		70		5		36		326		9		31		5		—		572
Amortization (2)	(18)		(6)		(33)		(6)		(76)		(5)		(11)		(157)		(32)		(23)		(8)		(4)		(379)
Balance, end of period	$	301	$	171	$	1,122	$	186	$	1,599	$	154	$	250	$	2,107	$	494	$	776	$	80	$	103	$	7,343

______________

(1)“CB” defined as Closed Block.

(2)DAC amortization of $2 million related to Other not reflected in table above.


	Six Months Ended June 30, 2024
	Protection Solutions								Individual Retirement								Legacy		Group Retirement				Corporate and Other		Total
	Term		UL		VUL		IUL		GMxB Core		EI		IE		SCS		GMxB Legacy		EG		Momentum		CB
	(in millions)
Balance, beginning of period	$	337	$	174	$	987	$	188	$	1,602	$	155	$	172	$	1,571	$	555	$	742	$	82	$	116	$	6,681
Capitalization	8		4		77		5		74		6		29		306		14		32		5		—		560
Amortization (1)	(19)		(6)		(30)		(6)		(74)		(6)		(8)		(131)		(31)		(21)		(2)		(5)		(339)
Balance, end of period	$	326	$	172	$	1,034	$	187	$	1,602	$	155	$	193	$	1,746	$	538	$	753	$	85	$	111	$	6,902

______________

(1) DAC amortization of $2 million related to Other not reflected in table above.

Changes in the Individual Retirement sales inducement assets were as follows:


	Six Months Ended June 30,
	2025				2024
	GMxB Core		GMxB Legacy		GMxB Core		GMxB Legacy
	(in millions)
Balance, beginning of period	$	117	$	160	$	127	$	179
Capitalization	1		—		1		—
Amortization	(6)		(9)		(6)		(10)
Balance, end of period	$	112	$	151	$	122	$	169

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Changes in the Protection Solutions unearned revenue liability were as follows:


	Six Months Ended June 30,
	2025						2024
	UL		VUL		IUL		UL		VUL		IUL
	(in millions)

Balance, beginning of period	$	114	$	840	$	250	$	107	$	754	$	210
Capitalization	7		74		23		8		65		28
Amortization	(4)		(27)		(8)		(4)		(24)		(7)
Balance, end of period	$	117	$	887	$	265	$	111	$	795	$	231

7) FAIR VALUE DISCLOSURES

U.S. GAAP establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value:

Level 1 Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data.

Level 3 Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability.

The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value can neither be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument.

Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued are also considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Assets and liabilities measured at fair value on a recurring basis are summarized below:

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Fair Value Measurements as of June 30, 2025


	Level 1		Level 2		Level 3		Total
	(in millions)
Assets:
Investments
Fixed maturities, AFS:
Corporate (1)	$	—	$	46,695	$	2,009	$	48,704
U.S. Treasury, government and agency	—		4,519		—		4,519
States and political subdivisions	—		385		—		385
Foreign governments	—		575		—		575
Residential mortgage-backed (2)	—		5,423		31		5,454
Asset-backed (3)	—		14,906		936		15,842
Commercial mortgage-backed	—		4,538		19		4,557
Redeemable preferred stock	—		58		—		58
Total fixed maturities, AFS	—		77,099		2,995		80,094
Fixed maturities, at fair value using the fair value option	—		2,018		410		2,428
Other equity investments (4)	307		265		12		584
Trading securities	368		800		127		1,295
Other invested assets:
Short-term investments	—		5		—		5
Assets of consolidated VIEs/VOEs	37		424		1		462
Swaps	—		(438)		—		(438)
Credit default swaps	—		(9)		—		(9)
Futures	(3)		—		—		(3)
Options	—		17,655		—		17,655
Total other invested assets	34		17,637		1		17,672
Cash equivalents	6,066		—		—		6,066
Segregated securities	—		483		—		483
Purchased market risk benefits	—		—		5,543		5,543
Assets for market risk benefits	—		—		776		776
Separate Accounts assets (5)	128,654		2,528		—		131,182
Total Assets	$	135,429	$	100,830	$	9,864	$	246,123

Liabilities:
Notes issued by consolidated VIE’s, at fair value using the fair value option (6)	$	—	$	2,294	$	158	$	2,452
SCS, SIO, MSO and IUL indexed features’ liability	—		18,311		—		18,311
Liabilities of consolidated VIEs and VOEs	1		17		—		18
Liabilities for market risk benefits	—		—		10,187		10,187
Contingent payment arrangements	—		—		8		8
Total Liabilities	$	1	$	20,622	$	10,353	$	30,976

______________

(1)Corporate fixed maturities includes both public and private issues.

(2)Includes publicly traded agency pass-through securities and collateralized obligations.

(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.

(4)Includes short position equity securities of $12 million that are reported in other liabilities.

(5)Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate. As of June 30, 2025, the fair value of such investments was $287 million.

(6)Accrued interest payable of $19 million is reported in Notes issued by consolidated VIE’s, at fair value using the fair value option in the consolidated balance sheets, which is not required to be measured at fair value on a recurring basis.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Fair Value Measurements as of December 31, 2024


	Level 1		Level 2		Level 3		Total
	(in millions)
Assets:
Investments
Fixed maturities, AFS:
Corporate (1)	$	—	$	46,879	$	2,472	$	49,351
U.S. Treasury, government and agency	—		4,288		—		4,288
States and political subdivisions	—		386		—		386
Foreign governments	—		554		—		554
Residential mortgage-backed (2)	—		4,383		—		4,383
Asset-backed (3)	—		13,467		232		13,699
Commercial mortgage-backed (2)	—		3,913		8		3,921
Redeemable preferred stock	—		59		—		59
Total fixed maturities, AFS	—		73,929		2,712		76,641
Fixed maturities, at fair value using the fair value option	—		1,778		275		2,053
Other equity investments (4)	319		251		53		623
Trading securities	433		576		80		1,089
Other invested assets:
Short-term investments	—		36		—		36
Assets of consolidated VIEs/VOEs	16		137		2		155
Swaps	—		(259)		—		(259)
Credit default swaps	—		2		—		2
Futures	3		—		—		3
Options	—		16,328		—		16,328
Total other invested assets	19		16,244		2		16,265
Cash equivalents	5,356		45		—		5,401
Segregated securities	2		498		—		500
Purchased market risk benefits	—		—		7,376		7,376
Assets for market risk benefits	—		—		863		863
Separate Accounts assets (5)	131,714		2,489		—		134,203
Total Assets	$	137,843	$	95,810	$	11,361	$	245,014

Liabilities:
Notes issued by consolidated VIE’s, at fair value using the fair value option (6)	$	—	$	1,933	$	172	$	2,105
SCS, SIO, MSO and IUL indexed features’ liability	—		17,212		—		17,212

Liabilities for market risk benefits	—		—		11,810		11,810
Contingent payment arrangements	—		—		9		9
Total Liabilities	$	—	$	19,145	$	11,991	$	31,136

______________

(1)Corporate fixed maturities includes both public and private issues.

(2)Includes publicly traded agency pass-through securities and collateralized obligations.

(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.

(4)Includes short position equity securities of $20 million that are reported in other liabilities.

(5)Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate. As of December 31, 2024, the fair value of such investments was $320 million.

(6)Accrued interest payable of $11 million is reported in Notes issued by consolidated VIE’s, at fair value using the fair value option in the consolidated balance sheets, which is not required to be measured at fair value on a recurring basis.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Public Fixed Maturities

The fair values of the Company’s public fixed maturities, including those accounted for using the fair value option, are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs.

Private Fixed Maturities

The fair values of the Company’s private fixed maturities, including those accounted for using the fair value option are determined from prices obtained from independent valuation service providers. Prices not obtained from an independent valuation service provider are determined by using a discounted cash flow model or a market comparable company valuation technique. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model or a market comparable company valuation technique may also incorporate unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made.

Notes issued by consolidated VIE’s, at fair value using the fair value option

These notes are based on the fair values of corresponding fixed maturity collateral. The CLO liabilities are also reduced by the fair value of the beneficial interests the Company retains in the CLO and the carrying value of any beneficial interests that represent compensation for services. As the notes are valued based on the reference collateral, they are classified as Level 2 or 3.

Freestanding Derivative Positions

The net fair value of the Company’s freestanding derivative positions as disclosed in Note 4 of the Notes to these Consolidated Financial Statements are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the OTC derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including overnight index swap curves, and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable.

Level Classifications of the Company’s Financial Instruments

Financial Instruments Classified as Level 1

Investments classified as Level 1 primarily include redeemable preferred stock, trading securities, cash equivalents and Separate Accounts assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and NAV for transacting subscriptions and redemptions of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less and are carried at cost as a proxy for fair value measurement due to their short-term nature.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Financial Instruments Classified as Level 2

Investments classified as Level 2 are measured at fair value on a recurring basis and primarily include U.S. government and agency securities, certain corporate debt securities and financial assets and liabilities accounted for using the fair value option, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Segregated securities classified as Level 2 are U.S. Treasury bills segregated by AB in a special reserve bank custody account for the exclusive benefit of brokerage customers, as required by Rule 15c3-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)and for which fair values are based on quoted yields in secondary markets.

Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as pre-payment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. The Company’s AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors.

Certain Company products, such as the SCS, EQUI-VEST variable annuity products, IUL and the MSO fund available in some life contracts, offer investment options which permit the contract owner to participate in the performance of an index, ETF or commodity price. These investment options, which depending on the product and on the index selected, can currently have one, three, five or six year terms, provide for participation in the performance of specified indices, ETF or commodity price movement up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g., holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices, ETF or commodity prices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are classified as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on data obtained from independent valuation service providers.

Financial Instruments Classified as Level 3

The Company’s investments classified as Level 3 primarily include corporate debt securities and financial assets and liabilities accounted for using the fair value option, such as private fixed maturities and asset-backed securities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification are fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated to market observable data.

The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following:

•Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals);

•Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals);

•Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages;

•Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include either a five year or an annual reset; or

•Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life.

The Company also issues certain benefits on its variable annuity products that are accounted for as MRBs carried at fair value and are also considered Level 3 for fair value leveling.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The GMIBNLG feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates applied to the contract’s benefit base if and when the contract account value is depleted and the NLG feature is activated. The optional GMIB feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates.

The GMWB feature allows the policyholder to withdraw at a minimum, over the life of the contract, an amount based on the contract’s benefit base. The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract’s benefit base. The GMAB feature increases the contract account value at the end of a specified period to a GMAB base. The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base. The GMDB feature guarantees that the benefit paid upon death will not be less than a guaranteed benefit base. If the contract’s account value is less than the benefit base at the time a death claim is paid, the amount payable will be equal to the benefit base.

The MRBs fair value will be equal to the present value of benefits less the present value of ascribed fees. Considerable judgment is utilized by management in determining the assumptions used in determining present value of benefits and ascribed fees related to lapse rates, withdrawal rates, utilization rates, non-performance risk, volatility rates, annuitization rates and mortality (collectively, the significant MRB assumptions).

Purchased MRB assets, which are accounted for as MRBs carried at fair value are also considered Level 3 for fair value leveling. The purchased MRB asset fair value reflects the present value of reinsurance premiums, net of recoveries, adjusted for risk margins and nonperformance risk over a range of market consistent economic scenarios while the MRB asset and liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins and nonperformance risk, attributable to the MRB asset and liability over a range of market-consistent economic scenarios.

The valuations of the MRBs and purchased MRB assets incorporate significant non-observable assumptions related to policyholder behavior, risk margins and projections of equity Separate Accounts funds. The credit risks of the counterparty and of the Company are considered in determining the fair values of its MRBs and purchased MRB assets after taking into account the effects of collateral arrangements. Incremental adjustment to the risk-free curve for counterparty non-performance risk is made to the fair values of the purchased MRB assets. Risk margins were applied to the non-capital markets inputs to the MRBs and purchased MRB valuations.

After giving consideration to collateral arrangements, the Company reduced the fair value of its purchased MRB asset by $69 million and $382 million as of June 30, 2025 and December 31, 2024, respectively, to recognize incremental counterparty non-performance risk.

The Company’s Level 3 liabilities include contingent payment arrangements associated with acquisitions in 2020 by AB. At each reporting date, AB estimates the fair values of the contingent consideration expected to be paid based upon revenue and discount rate projections, using unobservable market data inputs, which are included in Level 3 of the valuation hierarchy. The Company’s consolidated VIEs/VOEs hold investments that are classified as Level 3, primarily corporate bonds that are vendor priced with no ratings available, bank loans, non-agency collateralized mortgage obligations and asset-backed securities.

Transfers of Financial Instruments Between Levels 2 and 3

During the six months ended June 30, 2025, fixed maturities with fair values of $882 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, fixed maturities with fair value of $367 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 47.9% of total equity as of June 30, 2025.

During the six months ended June 30, 2024, fixed maturities with fair values of $141 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, fixed maturities with fair value of $136 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 8.3% of total equity as of June 30, 2024.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The tables below present reconciliations for all Level 3 assets and liabilities and changes in unrealized gains (losses). Not included below are the changes in balances related to MRBs and purchased MRBs level 3 assets and liabilities, which are included in Note 9 of the Notes to these Consolidated Financial Statements.


	Three Months Ended June 30, 2025
	Corporate		State and Political Subdivisions		Asset-backed		RMBS		CMBS
	(in millions)
Balance, beginning of period	$	1,831	$	—	$	648	$	—	$	8
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)	2		—		—		—		—
Investment gains (losses), net	—		—		—		—		—
Subtotal	2		—		—		—		—
Other comprehensive income (loss)	17		—		3		1		1
Purchases	279		—		398		14		11
Sales	(292)		—		(11)				(5)
Settlements	—		—		—		(3)		—
Other	—		—		—		—		—
Activity related to consolidated VIEs/VOEs	—		—		—		—		—
Transfers into Level 3 (1)	98		—		—		19		4
Transfers out of Level 3 (1)	74		—		(102)		—		—
Balance, end of period	$	2,009	$	—	$	936	$	31	$	19
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)	$	—	$	—	$	—	$	—	$	—
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)	$	14	$	—	$	—	$	—	$	—

______________

(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.

(2)For instruments held as of June 30, 2025, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Three Months Ended June 30, 2025
	Fixed maturities, at FVO		Other Equity Investments (3)		Trading Securities, at Fair Value		Notes issued by consolidated VIE’s		Contingent Payment Arrangement
	(in millions)
Balance, beginning of period	$	263	$	18	$	109	$	(168)	$	(8)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)	(1)		1		—		—		—
Investment gains (losses), net	—		—		—		—		—
Subtotal	(1)		1		—		—		—
Other comprehensive income (loss)	—		—		—		—		—
Purchases	87		11		18		—		—
Debt issuances	—		—		—		(2)		—
Sales	(27)		(16)		—		—		—
Settlements	—		—		—		12		—
Other	—		—		—		—		—
Activity related to consolidated VIEs/VOEs	—		(1)		—		—		—
Transfers into Level 3 (1)	63		—		—		—		—
Transfers out of Level 3 (1)	25		—		—		—		—
Balance, end of period	$	410	$	13	$	127	$	(158)	$	(8)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)	$	(1)	$	1	$	—	$	—	$	—
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)	$	—	$	—	$	—	$	—	$	—

______________

(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.

(3)Other Equity Investments include other invested assets.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Three Months Ended June 30, 2024
	Corporate		State and Political Subdivisions		Asset-backed		RMBS		CMBS
	(in millions)
Balance, beginning of period	$	2,338	$	—	$	71	$	—	$	7
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)	2		—		—		—		—
Investment gains (losses), net	(1)		—		—		—		—
Subtotal	1		—		—		—		—
Other comprehensive income (loss)	1		—		—		—		—
Purchases	542		—		(2)		—		—
Sales	(365)		—		(12)		—		—
Settlements	—		—		—		—		—
Other	—		—		—		—		—
Activity related to consolidated VIEs/VOEs	—		—		—		—		—
Transfers into Level 3 (1)	—		—		—		—		—
Transfers out of Level 3 (1)	1		—		—		—		—
Balance, end of period	$	2,518	$	—	$	57	$	—	$	7
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)	$	—	$	—	$	—	$	—	$	—
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)	$	1	$	—	$	—	$	—	$	—

______________

(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.

(2)For instruments held as of June 30, 2024, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Three Months Ended June 30, 2024
	Fixed maturities, at FVO		Other Equity Investments (3)		Trading Securities, at Fair Value		Separate Accounts Assets		Contingent Payment Arrangement
	(in millions)
Balance, beginning of period	$	244	$	58	$	61	$	1	$	(254)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)	(12)		—		—		—		—
Investment gains (losses), net	—		—		(4)		—		—
Subtotal	(12)		—		(4)		—		—
Other comprehensive income (loss)	—		—		—		—		—
Purchases	(33)		(38)		—		(1)		—
Sales	(18)		39		—		—		—
Settlements	—		—		—		—		2
Other	—		—		—		—		(3)
Activity related to consolidated VIEs/VOEs	—		—		—		—		—
Transfers into Level 3 (1)	16		—		—		—		—
Transfers out of Level 3 (1)	27		—		—		—		—
Balance, end of period	$	224	$	59	$	57	$	—	$	(255)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)	$	(12)	$	—	$	—	$	—	$	—
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)	$	—	$	—	$	—	$	—	$	—

______________

(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.

(3)Other Equity Investments include other invested assets.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Six Months Ended June 30, 2025
	Corporate		State and Political Subdivisions		Asset-backed		RMBS		CMBS
	(in millions)
Balance, beginning of period	$	2,472	$	—	$	232	$	—	$	8
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)	3		—		—		—		—
Investment gains (losses), net	(3)		—		—		—		—
Subtotal	—		—		—		—		—
Other comprehensive income (loss)	28		—		6		1		1
Purchases	424		—		784		14		11
Debt issuances	—		—		—				—
Sales	(390)		—		(133)		(3)		(5)
Settlements	—		—		—		—		—
Other	—		—		—		—		—
Activity related to consolidated VIEs/VOEs	—		—		—		—		—
Transfers into Level 3 (1)	98		—		149		19		4
Transfers out of Level 3 (1)	(623)		—		(102)		—		—
Balance, end of period	$	2,009	$	—	$	936	$	31	$	19
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)	$	—	$	—	$	—	$	—	$	—
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)	$	22	$	—	$	3	$	1	$	—

______________

(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Six Months Ended June 30, 2025
	Fixed maturities, at FVO		Other Equity Investments (1)		Trading Securities, at Fair Value		Notes issued by consolidated VIE’s		Contingent Payment Arrangement
	(in millions)
Balance, beginning of period	$	275	$	55	$	80	$	(172)	$	(9)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)	1		1		—		—		—
Investment gains (losses), net	(4)		—		—		—		—
Subtotal	(3)		1		—		—		—
Other comprehensive income (loss)	—		—		—		—		—
Purchases	199		14		47		—		—
Debt issuances	—		—		—		(3)		—
Sales	(41)		(16)		—		—		—
Settlements	—		—		—		17		1
Other	—		—		—		—		—
Activity related to consolidated VIEs/VOEs	—		(1)		—		—		—
Transfers into Level 3 (2)	95		2		—		—		—
Transfers out of Level 3 (2)	(115)		(42)		—		—		—
Balance, end of period	$	410	$	13	$	127	$	(158)	$	(8)

Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (3)	$	(1)	$	1	$	—	$	—	$	—
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (3)	$	—	$	—	$	—	$	—	$	—

______________

(1)Other Equity Investments include other invested assets.

(2)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.

(3)For instruments held as of June 30, 2025, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Six Months Ended June 30, 2024
	Corporate		State and Political Subdivisions		Asset-backed		CMBS
	(in millions)
Balance, beginning of period	$	2,158	$	27	$	47	$	7
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)	4		—		—		—
Investment gains (losses), net	(2)		—		—		—
Subtotal	2		—		—		—
Other comprehensive income (loss)	11		—		—		—
Purchases	757		—		46		—
Sales	(421)		—		(22)		—
Settlements	—		—		—		—
Other	—		—		—		—
Activity related to consolidated VIEs/VOEs	—		—		—		—
Transfers into Level 3 (1)	57		—		—		—
Transfers out of Level 3 (1)	(46)		(27)		(14)		—
Balance, end of period	$	2,518	$	—	$	57	$	7
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)	$	—	$	—	$	—	$	—
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)	$	11	$	—	$	—	$	—

______________

(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.


	Six Months Ended June 30, 2024
	Fixed maturities, at FVO		Other Equity Investments (1)		Trading Securities, at Fair Value		Contingent Payment Arrangement
	(in millions)
Balance, beginning of period	$	181	$	57	$	61	$	(253)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)	4		1		—		—
Investment gains (losses), net	—		—		(4)		—
Subtotal	4		1		(4)		—
Other comprehensive income (loss)	—		—		—		—
Purchases	47		4		—		—
Sales	(33)		(3)		—		—
Settlements	—		—		—		3
Other	—		—		—		(5)
Activity related to consolidated VIEs/VOEs	—		—		—		—
Transfers into Level 3 (2)	79		—		—		—

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Six Months Ended June 30, 2024
	Fixed maturities, at FVO		Other Equity Investments (1)		Trading Securities, at Fair Value		Contingent Payment Arrangement
	(in millions)
Transfers out of Level 3 (2)	(54)		—		—		—
Balance, end of period	$	224	$	59	$	57	$	(255)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (3)	$	—	$	1	$	(4)	$	—
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (3)	$	31	$	—	$	—	$	—

_____________

(1)Other Equity Investments include other invested assets.

(2)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.

(3)For instruments held as of June 30, 2024, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Quantitative and Qualitative Information about Level 3 Fair Value Measurements

The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities:

Quantitative Information about Level 3 Fair Value Measurements as of June 30, 2025

Fair
Value

Valuation

Technique

Significant

Unobservable Input

Range

Weighted Average (2)

(Dollars in millions)

Assets:

Investments:

Fixed maturities, AFS:

Corporate

1,119

Market comparable
companies

EBITDA multiples

Discount rate

Cash flow multiples

Loan to value

4.6x - 36.3x

7.9% - 19.7%

2.0x - 14.5x

(0.3)% - 54.7%

13.9x

3.2%

6.0x

9.1%

Trading securities, at fair value (5)

Discounted cash flow

Earnings multiple

Discount factor

Discount years

8.6x

10.0%

Market comparable
companies

EBITDA Multiples

Cashflow Multiples

8.5x - 26.3x

4.3x - 14.5x

16.2x

7.9x

Purchased MRB asset (1) (2) (4)

5,543

Discounted cash flow

Lapse rates

Withdrawal rates

GMIB Utilization rates

Non-performance risk

Volatility rates - Equity

Mortality: Ages 0-40

Ages 41-60

Ages 61-115

0.24%-13.05%

0.06%-11.65%

0.04%-66.70%

7 bps - 92 bps

13%-31%

0.01%-0.17%

0.06%-0.52%

0.32%-41.20%

2.18%

0.50%

6.71%

10 bps

23%

3.35%

(same for all ages)

Liabilities:

AB Contingent consideration payable

Discounted cash flow

Expected revenue growth rates

Discount rate

2.0% - 13.3%

1.9% - 1.9%

6.8%

1.9%

Direct MRB (1) (2) (3) (4)

9,411

Discounted cash flow

Non-performance risk

Lapse rates

Withdrawal rates

Annuitization rates

Mortality: Ages 0-40

Ages 41-60

Ages 61-115

105 bps

0.24%-36.18%

0.00%-11.65%

0.04%-100.00%

0.01%-0.17%

0.06%-0.52%

0.32%-41.20%

105 bps

3.72%

0.57%

5.09%

2.92%

(same for all ages)

______________

(1)Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.

(2)Lapses and pro-rata withdrawal rates were developed as a function of the policy account value. Dollar for dollar withdrawal rates were developed as a function of the dollar for dollar threshold, the dollar for dollar limit. Utilization rates were developed as a function of the benefit base.

(3)MRB liabilities are shown net of MRB assets. Net amount is made up of $10.2 billion of MRB liabilities and $776 million of MRB assets.

(4)Includes Legacy and Core products.

(5)Certain newly acquired Level 3 Trading securities are not presented as cost basis approximates fair value as of June 30, 2025.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Quantitative Information about Level 3 Fair Value Measurements as of December 31, 2024

Fair
Value

Valuation
Technique

Significant
Unobservable Input

Range

Weighted Average (2)

(Dollars in millions)

Assets:

Investments:

Fixed maturities, AFS:

Corporate

402

Matrix pricing model

Spread over benchmark

70 bps - 220 bps

153 bps

981

Market comparable companies

EBITDA multiples

Discount rate

Cash flow multiples

Loan to value

4.7x - 36.5x

8.4% - 34.9%

1.8x-11.8x

0.0%-56.4%

12.2x

3.9%

4.5x

15.0%

Trading securities, at fair value (5)

Discounted cash flow

Earnings multiple

Discounts factor

Discount years

8.6x

10.0%

Market comparable companies

Cashflow Multiples

8.4x - 8.4x

8.4x

Purchased MRB asset (1) (2) (4)

7,376

Discounted cash flow

Lapse rates

Withdrawal rates

GMIB Utilization rates

Non-performance risk

Volatility rates - Equity

Mortality: Ages 0-40

Ages 41-60

Ages 61-115

0.24% - 13.05%

0.06% - 11.65%

0.04% - 66.70%

33 bps - 93 bps

12% - 29%

0.01% - 0.17%

0.06% - 0.52%

0.32% - 41.20%

2.17%

0.48%

6.75%

34 bps

23%

3.36%

(same for all ages)

Liabilities:

AB Contingent consideration payable

Discounted cash flow

Expected revenue growth rates

Discount rate

2.0% - 29.3%

1.9% - 10.4%

5.5%

7.3%

Direct MRB (1) (2) (3) (4)

10,947

Discounted cash flow

Non-performance risk

Lapse rates

Withdrawal rates

Annuitization rates

Mortality: Ages 0-40

Ages 41-60

Ages 61-115

94 bps

0.24% - 36.18%

0.00% - 11.65%

0.04% - 100.00%

0.01% - 0.17%

0.06% - 0.52%

0.32% - 41.20%

94 bps

3.57%

0.58%

5.15%

3.00%

(same for all ages)

______________

(1)Mortality rates vary by age and demographic characteristic such as gender and benefits elected with the policy. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.

(3)MRB liabilities are shown net of MRB assets. Net amount is made up of $11.8 billion of MRB liabilities and $863 million of MRB assets.

(4)Includes Legacy and Core products.

(5)Certain newly acquired Level 3 Trading securities are not presented as cost basis approximates fair value as of December 31, 2024.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Level 3 Financial Instruments for which Quantitative Inputs are Not Available

Certain Privately Placed Debt Securities with Limited Trading Activity

Excluded from the tables above as of June 30, 2025 and December 31, 2024, respectively, are approximately $2.3 billion and $1.7 billion of Level 3 fair value measurements of investments for which the underlying quantitative inputs are not developed by the Company and are not readily available. These investments primarily consist of certain privately placed debt securities with limited trading activity, including residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company reporting significantly higher or lower fair value measurements for these Level 3 investments.

•The fair value of private placement securities is determined by application of a matrix pricing model or a market comparable company value technique. The significant unobservable input to the matrix pricing model valuation technique is the spread over the industry-specific benchmark yield curve. Generally, an increase or decrease in spreads would lead to directionally inverse movement in the fair value measurements of these securities. The significant unobservable input to the market comparable company valuation technique is the discount rate. Generally, a significant increase (decrease) in the discount rate would result in significantly lower (higher) fair value measurements of these securities.

•Residential mortgage-backed securities classified as Level 3 primarily consist of non-agency paper with low trading activity. Included in the tables above as of June 30, 2025 and December 31, 2024, there were no Level 3 securities that were determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Generally, a change in spreads would lead to directionally inverse movement in the fair value measurements of these securities.

•Asset-backed securities classified as Level 3 primarily consist of non-agency mortgage loan trust certificates, including subprime and Alt-A paper, credit risk transfer securities, and equipment financings. Included in the tables above as of June 30, 2025 and December 31, 2024, there were no securities that were determined by the application of matrix-pricing for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Significant increases (decreases) in spreads would have resulted in significantly lower (higher) fair value measurements.

Other Equity Investments

Included in other equity investments classified as Level 3 are venture capital securities in the Technology, Media and Telecommunications industries. The fair value measurements of these securities include significant unobservable inputs including an enterprise value to revenue multiples and a discount rate to account for liquidity and various risk factors. Significant increases (decreases) in the enterprise value to revenue multiple inputs in isolation would have resulted in a significantly higher (lower) fair value measurement. Significant increases (decreases) in the discount rate would have resulted in a significantly lower (higher) fair value measurement.

Market Risk Benefits

Significant unobservable inputs with respect to the fair value measurement of the purchased MRB assets and MRB liabilities identified in the table above are developed using Company data. Future policyholder behavior is an unobservable market assumption and, as such, all aspects of policyholder behavior are derived based on recent historical experience. These policyholder behaviors include lapses, pro-rata withdrawals, dollar for dollar withdrawals, GMIB utilization, deferred mortality and payout phase mortality. Many of these policyholder behaviors have dynamic adjustment factors based on the relative value of the rider as compared to the account value in different economic environments. This applies to all variable annuity related products; products with GMxB riders including but not limited to GMIB, GMDB, and GWL.

Lapse rates are adjusted at the contract level based on a comparison of the value of the GMxB rider and the current policyholder account value, which include other factors such as considering surrender charges. Generally, lapse rates are assumed to be lower in periods when a surrender charge applies. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. For valuing purchased MRB assets and MRB liabilities, lapse rates vary throughout the period over which cash flows are projected.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Carrying Value of Financial Instruments Not Otherwise Disclosed in Note 3 and Note 4 of the Notes to these Consolidated Financial Statements

The carrying values and fair values for financial instruments not otherwise disclosed in Note 3 and Note 4 of the Notes to these Consolidated Financial Statements were as follows:

Carrying Values and Fair Values for Financial Instruments Not Otherwise Disclosed


	Carrying Value		Fair Value
			Level 1		Level 2		Level 3		Total
	(in millions)
June 30, 2025:
Mortgage loans on real estate	$	21,536	$	—	$	—	$	20,468	$	20,468
Policy loans	$	4,355	$	—	$	—	$	4,648	$	4,648
Policyholders’ liabilities: Investment contracts	$	2,698	$	—	$	—	$	2,667	$	2,667
FHLB funding agreements	$	7,083	$	—	$	7,041	$	—	$	7,041
FABN funding agreements	$	9,278	$	—	$	9,110	$	—	$	9,110
Funding agreement-backed commercial paper (FABCP)	$	1,546	$	—	$	1,581	$	—	$	1,581

Long-term debt	$	4,332	$	—	$	4,277	$	—	$	4,277
Separate Accounts liabilities	$	12,207	$	—	$	—	$	12,207	$	12,207


December 31, 2024:
Mortgage loans on real estate	$	20,072	$	—	$	—	$	18,567	$	18,567
Policy loans	$	4,330	$	—	$	—	$	4,559	$	4,559
Policyholders’ liabilities: Investment contracts	$	2,046	$	—	$	—	$	1,996	$	1,996
FHLB funding agreements	$	7,167	$	—	$	7,113	$	—	$	7,113
FABN funding agreements	$	5,725	$	—	$	5,481	$	—	$	5,481
Funding agreement-backed commercial paper (FABCP)	$	74	$	—	$	75	$	—	$	75

Long-term debt	$	3,833	$	—	$	3,722	$	—	$	3,722
Separate Accounts liabilities	$	12,055	$	—	$	—	$	12,055	$	12,055

Mortgage Loans on Real Estate

Fair values for commercial, agricultural and residential mortgage loans on real estate are measured by discounting future contractual cash flows to be received on the mortgage loan using interest rates at which loans with similar characteristics and credit quality would be made. The discount rate is derived based on the appropriate U.S. Treasury rate with a like term to the remaining term of the loan to which a spread reflective of the risk premium associated with the specific loan is added. Fair values for mortgage loans anticipated to be foreclosed and problem mortgage loans are limited to the fair value of the underlying collateral, if lower.

Policy Loans

The fair value of policy loans is calculated by discounting expected cash flows based upon the U.S. Treasury yield curve and historical loan repayment patterns.

Policyholder Liabilities - Investment Contracts and Separate Accounts Liabilities

The fair values for deferred annuities and certain annuities, which are included in policyholders’ account balances, and liabilities for investment contracts with fund investments in Separate Accounts, are estimated using projected cash flows discounted at rates reflecting current market rates. Significant unobservable inputs reflected in the cash flows include lapse rates and withdrawal rates. Incremental adjustments may be made to the fair value to reflect non-performance risk. Certain other products such as the Company’s association plans contracts, supplementary contracts not involving life contingencies, Access Accounts and Escrow Shield Plus product reserves are held at book value.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

FHLB Funding Agreements

The fair values of Equitable Financial’s FHLB long term funding agreements’ fair values are determined based on indicative market rates published by the FHLB, provided to AB and modeled for each note’s FMV. FHLB short-term funding agreements’ fair values are reflective of notional/par value plus accrued interest.

FABN Funding Agreements

The fair values of Equitable Financial’s FABN funding agreements are determined by Bloomberg’s evaluated pricing service, which uses direct observations or observed comparables.

FABCP Funding Agreements

The fair value of Equitable Financial’s FABCP funding agreements are reflective of the notional/par value outstanding.

Short-term Debt

The Company’s short-term debt primarily includes long-term debt that has been reclassified to short-term due to an upcoming maturity date within one year. The fair values for the Company’s short-term debt are determined by Bloomberg’s evaluated pricing service, which uses direct observations or observed comparables.

Long-term Debt

The fair values for the Company’s long-term debt are determined by Bloomberg’s evaluated pricing service, which uses direct observations or observed comparables.

Financial Instruments Exempt from Fair Value Disclosure or Otherwise Not Required to be Disclosed

Exempt from Fair Value Disclosure Requirements

Certain financial instruments are exempt from the requirements for fair value disclosure, such as insurance liabilities other than financial guarantees and investment contracts, limited partnerships accounted for under the equity method and pension and other postretirement obligations.

Otherwise Not Required to be Included in the Table Above

The Company’s investment in COLI policies are recorded at their cash surrender value and therefore are not required to be included in the table above. See Note 2 of the Notes to these Consolidated Financial Statements for further description of the Company’s accounting policy related to its investment in COLI policies.

8) LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS

The following table reconciles the net liability for future policy benefits and liability of death benefits to the liability for future policy benefits in the consolidated balance sheets:


	June 30, 2025		December 31, 2024
	(in millions)
Reconciliation
Term	$	1,287	$	1,285
Payout	4,936		5,050
Group Pension - Benefit Reserve & DPL	447		460
Health	1,336		1,362
UL	1,271		1,246
Subtotal	9,277		9,403
Whole Life Closed Block and Open Block products	5,083		5,204
Other (1)	915		901
Future policyholder benefits total	15,275		15,508
Other policyholder funds and dividends payable	2,282		2,105
Total	$	17,557	$	17,613

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

_____________

(1)Primarily consists of future policy benefits related to Protective Life and Annuity, Assumed Life and Disability, Group Life Run off, Variable Interest Sensitive Life rider and EB.

The following table summarizes balances and changes in the liability for future policy benefits for nonparticipating traditional and limited pay contracts:


	Six Months Ended June 30, 2025								Six Months Ended June 30, 2024
	Protection Solutions		Individual Retirement		Corporate & Other				Protection Solutions		Individual Retirement		Corporate & Other
	Term		Payout		Group Pension		Health		Term		Payout		Group Pension		Health
	(in millions)
Present Value of Expected Net Premiums
Balance, beginning of period	$	1,932	$	—	$	—	$	(25)	$	2,133	$	—	$	—	$	(21)
Beginning balance at original discount rate	1,959		—		—		(26)		2,058		—		—		(22)
Effect of changes in cash flow assumptions	—		—		—		—		(18)		—		—		(3)
Effect of actual variances from expected experience	(54)		—		—		(2)		(51)		—		—		2
Adjusted beginning of period balance	1,905		—		—		(28)		1,989		—		—		(23)
Issuances	20		—		—		—		26		—		—		—
Interest accrual	47		—		—		(1)		49		—		—		—
Net premiums collected	(90)		—		—		3		(95)		—		—		1

Ending Balance at original discount rate	1,882		—		—		(26)		1,969		—		—		(22)
Effect of changes in discount rate assumptions	—		—		—		1		(21)		—		—		1
Balance, end of period	$	1,882	$	—	$	—	$	(25)	$	1,948	$	—	$	—	$	(21)

Present Value of Expected Future Policy Benefits
Balance, beginning of period	$	3,216	$	5,050	$	460	$	1,337	$	3,480	$	4,464	$	490	$	1,484
Beginning balance of original discount rate	3,215		5,390		514		1,555		3,330		4,680		536		1,672
Effect of changes in cash flow assumptions (1)	—		(468)		—		—		(20)		—		—		—
Effect of actual variances from expected experience	(73)		(3)		—		(7)		(66)		(2)		1		7
Adjusted beginning of period balance	3,142		4,919		514		1,548		3,244		4,678		537		1,679
Issuances	22		398		—		—		28		522		—		—
Interest accrual	79		99		9		25		82		89		9		27
Benefits payments	(120)		(251)		(31)		(75)		(116)		(228)		(31)		(79)
Ending Balance at original discount rate	3,123		5,165		492		1,498		3,238		5,061		515		1,627
Effect of changes in discount rate assumptions	45		(229)		(45)		(187)		6		(359)		(58)		(234)
Balance, end of period	$	3,168	$	4,936	$	447	$	1,311	$	3,244	$	4,702	$	457	$	1,393
Impact of flooring LFPB at zero	1		—		—		—		1		—		—		—
Net liability for future policy benefits	1,287		4,936		447		1,336		1,297		4,702		457		1,414
Less: Reinsurance recoverable	2		(1,027)		—		(1,044)		14		(1,144)		—		(1,116)
Net liability for future policy benefits, after reinsurance recoverable	$	1,289	$	3,909	$	447	$	292	$	1,311	$	3,558	$	457	$	298

Weighted-average duration of liability for future policyholder benefits (years)	6.8		7.6		6.9		8.3		6.9		7.9		7.0		8.6

______________

(1)For the first quarter 2025, this is the net income impact due to novation as described in Note 1.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses related to nonparticipating traditional and limited payment contracts:


	June 30, 2025		December 31, 2024
	(in millions)
Term
Expected future benefit payments and expenses (undiscounted)	$	5,444	$	5,613
Expected future gross premiums (undiscounted)	6,424		6,597
Expected future benefit payments and expenses (discounted; AOCI basis)	3,168		3,216
Expected future gross premiums (discounted; AOCI basis)	3,473		3,507

Payout
Expected future benefit payments and expenses (undiscounted)	7,338		7,686
Expected future gross premiums (undiscounted)	—		—
Expected future benefit payments and expenses (discounted; AOCI basis)	4,814		4,938
Expected future gross premiums (discounted; AOCI basis)	—		—

Group Pension
Expected future benefit payments and expenses (undiscounted)	603		630
Expected future gross premiums (undiscounted)	—		—
Expected future benefit payments and expenses (discounted; AOCI basis)	425		436
Expected future gross premiums (discounted; AOCI basis)	—		—

Health
Expected future benefit payments and expenses (undiscounted)	2,053		2,139
Expected future gross premiums (undiscounted)	65		70
Expected future benefit payments and expenses (discounted; AOCI basis)	1,299		1,323
Expected future gross premiums (discounted; AOCI basis)	$	52	$	55

The table below summarizes the revenue and interest related to nonparticipating traditional and limited payment contracts:


	Six Months Ended June 30,

	2025		2024			2025		2024
	Gross Premium				Interest Accretion
	(in millions)
Revenue and Interest Accretion
Term	$	161	$	171		$	32	$	33
Payout	116		127			105		99
Group Pension	—		—			9		9
Health	5		6			26		28
Total	$	282	$	304		$	172	$	169

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The following table provides the weighted average interest rates for the liability for future policy benefits:


	June 30, 2025		December 31, 2024
Weighted Average Interest Rate
Term
Interest accretion rate	5.6	%	5.6	%
Current discount rate	5.0	%	5.2	%
Payout
Interest accretion rate	4.5	%	4.4	%
Current discount rate	5.1	%	5.3	%
Group Pension
Interest accretion rate	3.4	%	3.4	%
Current discount rate	5.0	%	5.2	%
Health
Interest accretion rate	3.4	%	3.4	%
Current discount rate	5.2	%	5.4	%

The following table provides the balance, changes in and the weighted average durations of the additional insurance liabilities:


	Six Months Ended June 30,
		2025		2024
		Protection Solutions
		UL
		(in millions)
Balance, beginning of period		$	1,246	$	1,208
Beginning balance before AOCI adjustments		1,302		1,245
Effect of changes in interest rate & cash flow assumptions and model changes		—		—
Effect of actual variances from expected experience		4		(1)
Adjusted beginning of period balance		1,306		1,244
Interest accrual		29		27
Net assessments collected		34		35
Benefit payments		(45)		(35)

Ending balance before shadow reserve adjustments		1,324		1,271
Effect of reserve adjustment recorded in AOCI		(53)		(51)
Balance, end of period		$	1,271	$	1,220

Net liability for additional liability		$	1,271	$	1,220
Less: Reinsurance recoverable		—		—
Net liability for additional liability, after reinsurance recoverable		$	1,271	$	1,220

Weighted-average duration of additional liability - death benefit (years)		19.1		19.5

The following tables provide the revenue, interest and weighted average interest rates, related to the additional insurance liabilities:


	Six Months Ended June 30,

	2025		2024			2025		2024
	Assessments				Interest Accretion
	(in millions)
Revenue and Interest Accretion
UL	$	316	$	338		$	29	$	27
Total	$	316	$	338		$	29	$	27

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Six Months Ended June 30,

		2025		2024

Weighted Average Interest Rate
UL		4.5	%	4.5	%
Interest accretion rate		4.5	%	4.5	%

The discount rate used for additional insurance liabilities reserve is based on the crediting rate at issue.

9) MARKET RISK BENEFITS

The following table presents the balances and changes to the balances for MRBs for the GMxB benefits on deferred variable annuities:


	Three Months Ended June 30,
	2025								2024
	Individual Retirement		Legacy						Individual Retirement		Legacy
	GMxB Core		GMxB Legacy		Purchased MRB		Net Legacy		GMxB Core		GMxB Legacy		Purchased MRB		Net Legacy
	(in millions)
Balance, beginning of period	$	717	$	9,505	$	(5,973)	$	3,532	$	323	$	11,715	$	(8,343)	$	3,372
Balance BOP before changes in the instrument specific credit risk	495		9,336		(5,957)		3,379		71		11,319		(8,312)		3,007
Model changes and effect of changes in cash flow assumptions	(7)		8		5		13		—		—		—		—
Actual market movement effect	(173)		(620)		264		(356)		(4)		45		5		50
Interest accrual	10		96		(58)		38		15		152		(111)		41
Attributed fees accrued (1)	109		161		(39)		122		111		198		(56)		142
Benefit payments	(12)		(285)		128		(157)		(12)		(310)		162		(148)
Actual policyholder behavior different from expected behavior	7		22		(14)		8		9		—		(10)		(10)
Changes in future economic assumptions	(42)		(232)		140		(92)		(72)		(518)		346		(172)
Issuances	(2)		—		—		—		—		—		—		—
Balance EOP before changes in the instrument-specific credit risk	385		8,486		(5,531)		2,955		118		10,886		(7,976)		2,910
Changes in the instrument-specific credit risk (2)	268		326		(10)		316		294		546		(22)		524
Balance, end of period	$	653	$	8,812	$	(5,541)	$	3,271	$	412	$	11,432	$	(7,998)	$	3,434

Weighted-average age of policyholders (years)	65.9		74.0		73.4		N/A		64.9		73.3		72.9		N/A
Net amount at risk	$	2,953	$	15,835	$	7,099	N/A		$	2,867	$	19,710	$	10,443	N/A

______________

(1)Attributed fees accrued represents the portion of the fees needed to fund future GMxB claims.

(2)Changes are recorded in OCI except for reinsurer credit which is reflected in the consolidated income statement.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Six Months Ended June 30,
	2025								2024
	Individual Retirement		Legacy						Individual Retirement		Legacy
	GMxB Core		GMxB Legacy		Purchased MRB (3)		Net Legacy		GMxB Core		GMxB Legacy		Purchased MRB (3)		Net Legacy
	(in millions)
Balance, beginning of period	$	496	$	10,508	$	(7,372)	$	3,136	$	597	$	13,425	$	(9,448)	$	3,977
Balance BOP before changes in the instrument specific credit risk	163		9,735		(7,368)		2,367		319		13,023		(9,409)		3,614
Model changes and effect of changes in cash flow assumptions (4)	(7)		(1,336)		1,860		524		—		—		169		169
Actual market movement effect	(102)		(271)		148		(123)		(163)		(747)		397		(350)
Interest accrual	25		202		(122)		80		31		313		(224)		89
Attributed fees accrued (1)	203		326		(99)		227		206		398		(136)		262
Benefit payments	(23)		(565)		257		(308)		(22)		(632)		331		(301)
Actual policyholder behavior different from expected behavior	20		42		(14)		28		14		(23)		(1)		(24)
Changes in future economic assumptions	105		353		(193)		160		(265)		(1,446)		897		(549)
Issuances	1		—		—		—		(2)		—		—		—
Balance EOP before changes in the instrument-specific credit risk	385		8,486		(5,531)		2,955		118		10,886		(7,976)		2,910
Changes in the instrument-specific credit risk (2)	268		326		(10)		316		294		546		(22)		524
Balance, end of period	$	653	$	8,812	$	(5,541)	$	3,271	$	412	$	11,432	$	(7,998)	$	3,434

Weighted-average age of policyholders (years)	65.9		74.0		73.4		N/A		64.9		73.3		72.9		N/A
Net amount at risk	$	2,953	$	15,835	$	7,099	N/A		$	2,867	$	19,710	$	10,443	N/A

_____________

(1)Attributed fees accrued represents the portion of the fees needed to fund future GMxB claims.

(2)Changes are recorded in OCI except for reinsurer credit which is reflected in the consolidated income statement.

(3)Purchased MRB is the impact of non-affiliated reinsurance.

(4)Includes the net income impact of the novation, as described in Note 1, in the first quarter of 2025 and the impact primarily of a non-affiliated recapture of reinsurance completed in the first quarter of 2024.

The following table reconciles MRBs by the amounts in an asset position and amounts in a liability position to the MRB amounts in the consolidated balance sheets:


	June 30, 2025										December 31, 2024
	Direct Asset		Direct Liability		Net Direct MRB		Purchased MRB		Total		Direct Asset		Direct Liability		Net Direct MRB		Purchased MRB		Total
	(in millions)
Individual Retirement
GMxB Core	$	(449)	$	1,102	$	653	$	—	$	653	$	(514)	$	1,010	$	496	$	—	$	496
Legacy Segment
GMxB Legacy	(204)		9,016		8,812		(5,541)		3,271		(230)		10,738		10,508		(7,372)		3,136
Other (1)	(123)		69		(54)		(2)		(56)		(119)		62		(57)		(4)		(61)
Total	$	(776)	$	10,187	$	9,411	$	(5,543)	$	3,868	$	(863)	$	11,810	$	10,947	$	(7,376)	$	3,571

______________

(1)Other primarily includes SCS.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

10) POLICYHOLDER ACCOUNT BALANCES

The following table reconciles the policyholders account balances to the policyholders’ account balance liability in the consolidated balance sheets:


	June 30, 2025		December 31, 2024
	(in millions)
Policyholders’ account balance reconciliation
Protection Solutions
Universal Life	$	4,973	$	5,065
Variable Universal Life	5,061		4,982
Legacy Segment
GMxB Legacy	253		226
Individual Retirement
GMxB Core	(27)		(4)
SCS	71,542		65,267
EQUI-VEST Individual	1,932		2,037
Group Retirement
EQUI-VEST Group	11,130		11,158
Momentum	498		527
Other (1)	10,071		8,658
Balance (exclusive of Funding Agreements)	105,433		97,916
Funding Agreements	17,926		13,013
Balance, end of period	$	123,359	$	110,929

_____________

(1)Primarily reflects products IR Payout, IR Other, Indexed Universal Life, Investment Edge, Group Pension, Closed Block and Corporate and Other.

The following table summarizes the balances and changes in policyholder’s account balances:


	Six Months Ended June 30, 2025
	Protection Solutions				Legacy		Individual Retirement						Group Retirement
	Universal Life		Variable Universal Life		GMxB Legacy		GMxB Core		SCS (1)		EQUI-VEST Individual		EQUI-VEST Group		Momentum
	(Dollars in millions)
Balance, beginning of period	$	5,065	$	4,982	$	226	$	(4)	$	65,267	$	2,037	$	11,158	$	527



Premiums received	300		60		5		91		5		18		293		26
Policy charges	(335)		(139)		18		4		(24)		—		(3)		—
Surrenders and withdrawals	(43)		(2)		(32)		(15)		(2,534)		(127)		(688)		(53)
Benefit payments	(122)		(70)		(8)		(1)		(179)		(33)		(32)		(1)
Net transfers from (to) separate account	—		117		5		(106)		6,760		8		237		(7)
Interest credited (2)	108		113		6		4		2,247		29		165		6
Other (4)	—		—		33		—		—		—		—		—
Balance, end of period	$	4,973	$	5,061	$	253	$	(27)	$	71,542	$	1,932	$	11,130	$	498

Weighted-average crediting rate	3.83%		3.67%		2.78%		1.97%		N/A		2.96%		2.75%		2.48%
Net amount at risk (3)	$	32,105	$	117,332	$	15,835	$	2,953	$	—	$	100	$	7	$	—
Cash surrender value	$	3,323	$	3,176	$	452	$	202	$	68,284	$	1,927	$	11,084	$	499

______________

(1)SCS sales are recorded as a Separate Account liability until they are swept into the General Account. This sweep is recorded as Net Transfers from (to) separate account.

(2)SCS and EQUI-VEST Group includes amounts related to the change in embedded derivative.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

(3)For life insurance products, the net amount at risk is death benefit less account value for the policyholder. For variable annuity products, the net amount at risk is the maximum GMxB NAR for the policyholder.

(4)Includes the PAB from the policies novated to Venerable, as described in Note 1.


	Six Months Ended June 30, 2024
	Protection Solutions				Legacy		Individual Retirement						Group Retirement
	Universal Life		Variable Universal Life		GMxB Legacy		GMxB Core		SCS (1)		EQUI-VEST Individual		EQUI-VEST Group		Momentum
	(Dollars in millions)
Balance, beginning of period	$	5,202	$	4,850	$	618	$	36	$	49,002	$	2,322	$	11,563	$	608

Premiums received	327		61		36		119		9		15		305		37
Policy charges	(359)		(130)		18		—		(10)		—		(3)		—
Surrenders and withdrawals	(45)		(25)		(43)		(18)		(1,897)		(168)		(806)		(69)
Benefit payments	(106)		(56)		(49)		(1)		(149)		(26)		(35)		(1)
Net transfers from (to) separate account	—		86		3		(117)		6,325		6		170		(6)
Interest credited (2)	110		95		12		4		4,698		33		175		6
Other	—		—		—		—		—		—		—		—
Balance, end of period	$	5,129	$	4,881	$	595	$	23	$	57,978	$	2,182	$	11,369	$	575

Weighted-average crediting rate	3.80%		3.71%		2.74%		1.67%		N/A		2.98%		2.67%		2.32%
Net amount at risk (3)	$	34,364	$	116,133	$	19,710	$	2,867	$	1	$	104	$	9	$	—
Cash surrender value	$	3,393	$	3,172	$	531	$	252	$	54,146	$	2,176	$	11,313	$	576

______________

(1)SCS sales are recorded as a Separate Account liability until they are swept into the General Account. This sweep is recorded as Net Transfers from (to) separate account.

(2)SCS and EQUI-VEST includes amounts related to the change in embedded derivative.

(3)For life insurance products, the net amount at risk is the death benefit less account value for the policyholder. For variable annuity products, the net amount at risk is the maximum GMxB NAR for the policyholder.

The following table presents the account values by range of guaranteed minimum crediting rates and the related range of the difference in basis points, between rates being credited policyholders and the respective guaranteed minimums:


June 30, 2025
Product	Range of Guaranteed Minimum Crediting Rate	At Guaranteed Minimum		1 Basis Point - 50 Basis Points Above		51 Basis Points - 150 Basis Points Above		Greater Than 150 Basis Points Above		Total
( in millions)
Protection Solutions
Universal Life	0.00% - 1.50%	$	—	$	—	$	—	$	6	$	6
	1.51% - 2.50%	—		88		277		655		1,020
	Greater than 2.50%	3,262		656		—		—		3,918
	Total	$	3,262	$	744	$	277	$	661	$	4,944

Variable Universal Life	0.00% - 1.50%	$	15	$	10	$	112	$	52	$	189
	1.51% - 2.50%	38		370		232		—		640
	Greater than 2.50%	3,651		27		4		—		3,682
	Total	$	3,704	$	407	$	348	$	52	$	4,511
Legacy Segment

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


June 30, 2025
Product	Range of Guaranteed Minimum Crediting Rate	At Guaranteed Minimum		1 Basis Point - 50 Basis Points Above		51 Basis Points - 150 Basis Points Above		Greater Than 150 Basis Points Above		Total
( in millions)
GMxB Legacy	0.00% - 1.50%	$	—	$	62	$	3	$	—	$	65
	1.51% - 2.50%	17		—		—		—		17
	Greater than 2.50%	371		—		—		—		371
	Total	$	388	$	62	$	3	$	—	$	453

Individual Retirement
GMxB Core	0.00% - 1.50%	$	—	$	10	$	148	$	—	$	158
	1.51% - 2.50%	11		—		—		—		11
	Greater than 2.50%	37		—		—		—		37
	Total	$	48	$	10	$	148	$	—	$	206

EQUI-VEST Individual	0.00% - 1.50%	$	—	$	30	$	159	$	—	$	189
	1.51% - 2.50%	12		67		—		—		79
	Greater than 2.50%	1,664		—		—		—		1,664
	Total	$	1,676	$	97	$	159	$	—	$	1,932

Group Retirement
EQUI-VEST Group	0.00% - 1.50%	$	1	$	945	$	2,194	$	262	$	3,402
	1.51% - 2.50%	342		—		—		—		342
	Greater than 2.50%	5,988		—		—		—		5,988
	Total	$	6,331	$	945	$	2,194	$	262	$	9,732

Momentum	0.00% - 1.50%	$	—	$	—	$	251	$	86	$	337
	1.51% - 2.50%	74		26		—		—		100
	Greater than 2.50%	55		—		5		—		60
	Total	$	129	$	26	$	256	$	86	$	497


December 31, 2024
Product	Range of Guaranteed Minimum Crediting Rate	At Guaranteed Minimum		1 Basis Point - 50 Basis Points Above		51 Basis Points - 150 Basis Points Above		Greater Than 150 Basis Points Above		Total
( in millions)
Protection Solutions
Universal Life	0.00% - 1.50%	$	—	$	—	$	—	$	6	$	6
	1.51% - 2.50%	—		90		284		655		1,029
	Greater than 2.50%	3,402		598		—		—		4,000
	Total	$	3,402	$	688	$	284	$	661	$	5,035

Variable Universal Life	0.00% - 1.50%	$	24	$	13	$	94	$	40	$	171
	1.51% - 2.50%	37		357		223		—		617
	Greater than 2.50%	3,667		2		20		—		3,689
	Total	$	3,728	$	372	$	337	$	40	$	4,477
Legacy Segment

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


December 31, 2024
Product	Range of Guaranteed Minimum Crediting Rate	At Guaranteed Minimum		1 Basis Point - 50 Basis Points Above		51 Basis Points - 150 Basis Points Above		Greater Than 150 Basis Points Above		Total
( in millions)
GMxB Legacy	0.00% - 1.50%	$	67	$	3	$	—	$	—	$	70
	1.51% - 2.50%	19		—		—		—		19
	Greater than 2.50%	401		—		—		—		401
	Total	$	487	$	3	$	—	$	—	$	490
Individual Retirement
GMxB Core	0.00% - 1.50%	$	11	$	160	$	—	$	—	$	171
	1.51% - 2.50%	12		—		—		—		12
	Greater than 2.50%	52		—		—		—		52
	Total	$	75	$	160	$	—	$	—	$	235

EQUI-VEST Individual	0.00% - 1.50%	$	42	$	198	$	—	$	—	$	240
	1.51% - 2.50%	38		—		—		—		38
	Greater than 2.50%	1,758		—		—		—		1,758
	Total	$	1,838	$	198	$	—	$	—	$	2,036




Group Retirement
EQUI-VEST Group	0.00% - 1.50%	$	720	$	2,391	$	33	$	258	$	3,402
	1.51% - 2.50%	349		—		—		—		349
	Greater than 2.50%	6,076		—		—		—		6,076
	Total	$	7,145	$	2,391	$	33	$	258	$	9,827

Momentum	0.00% - 1.50%	$	—	$	—	$	269	$	88	$	357
	1.51% - 2.50%	79		29		—		—		108
	Greater than 2.50%	56		—		5		—		61
	Total	$	135	$	29	$	274	$	88	$	526

Separate Account - Summary

The following table reconciles the Separate Account liabilities to the Separate Account liability balance in the consolidated balance sheets:


	June 30, 2025		December 31, 2024
	(in millions)
Separate Account Reconciliation
Protection Solutions
Variable Universal Life	$	18,968	$	18,176
Legacy Segment
GMxB Legacy	28,275		33,199
Individual Retirement
GMxB Core	30,057		30,411
EQUI-VEST Individual	4,756		4,782
Investment Edge	5,072		4,885
Group Retirement
EQUI-VEST Group	31,714		30,546
Momentum	5,008		4,813
Other (1)	7,833		7,905
Total	$	131,683	$	134,717

______________

(1)Primarily reflects Corporate and Other products and Group Retirement products including Association and Group Retirement Other.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The following table presents the balances of and changes in Separate Account liabilities:


	Six Months Ended June 30, 2025
	Protection Solutions		Legacy		Individual Retirement						Group Retirement
	VUL		GMxB Legacy		GMxB Core		EQUI-VEST Individual		Investment Edge		EQUI-VEST Group		Momentum
	(in millions)
Balance, beginning of period	$	18,176	$	33,199	$	30,411	$	4,782	$	4,885	$	30,546	$	4,813

Premiums and deposits	664		118		934		49		901		1,252		330
Policy charges	(292)		(265)		(252)		(2)		—		(8)		(12)
Surrenders and withdrawals	(350)		(1,499)		(1,861)		(237)		(242)		(1,271)		(433)
Benefit payments	(54)		(364)		(145)		(36)		(17)		(32)		(5)
Investment performance (1)	941		907		864		208		247		1,464		308
Net transfers from (to) General Account	(117)		(5)		106		(8)		(702)		(237)		7
Other charges (2)	—		(3,816)		—		—		—		—		—
Balance, end of period	$	18,968	$	28,275	$	30,057	$	4,756	$	5,072	$	31,714	$	5,008

Cash surrender value	$	18,600	$	28,071	$	29,218	$	4,724	$	4,983	$	31,412	$	5,001

_____________

(1)Investment performance is reflected net of M&E fees.

(2)Other charges include the Separate Account value novated to Venerable, as described in Note 1.


	Six Months Ended June 30, 2024
	Protection Solutions		Legacy		Individual Retirement						Group Retirement
	VUL		GMxB Legacy		GMxB Core		EQUI-VEST Individual		Investment Edge		EQUI-VEST Group		Momentum
	(in millions)
Balance, beginning of period	$	15,821	$	33,794	$	29,829	$	4,582	$	4,275	$	26,959	$	4,421
Premiums and deposits	616		112		1,000		40		739		1,180		379
Policy charges	(287)		(324)		(249)		(1)		—		(8)		(11)
Surrenders and withdrawals	(330)		(1,629)		(1,720)		(248)		(254)		(1,113)		(476)
Benefit payments	(30)		(385)		(135)		(26)		(15)		(32)		(7)
Investment performance (1)	1,508		(3)		117		(7)		(465)		(170)		6
Net transfers from (to) General Account	(86)		2,401		1,634		445		308		2,409		390
Other charges	—		—		—		—		—		—		—
Balance, end of period	$	17,212	$	33,966	$	30,476	$	4,785	$	4,588	$	29,225	$	4,702

Cash surrender value	$	16,840	$	33,702	$	29,644	$	4,752	$	4,501	$	28,935	$	4,694

______________

(1)Investment performance is reflected net of M&E fees.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The following table presents the aggregate fair value of Separate Account assets by major asset category:


	June 30, 2025
	Protection Solutions		Individual Retirement		Group Retirement		Corp & Other		Legacy Segment		Total
	(in millions)
Asset Type
Debt securities	$	49	$	1	$	9	$	17	$	—	$	76
Common Stock	68		37		512		1,731		—		2,348
Mutual Funds	19,417		41,709		38,075		637		28,299		128,137
Bonds and Notes	101		3		1		1,017		—		1,122
Total	$	19,635	$	41,750	$	38,597	$	3,402	$	28,299	$	131,683


	December 31, 2024
	Protection Solutions		Individual Retirement		Group Retirement		Corp & Other		Legacy Segment		Total
	(in millions)
Asset Type
Debt securities	$	51	$	1	$	14	$	13	$	—	$	79
Common Stock	68		36		472		1,631		—		2,207
Mutual Funds	18,611		42,029		36,779		659		33,214		131,292
Bonds and Notes	98		4		1		1,036		—		1,139
Total	$	18,828	$	42,070	$	37,266	$	3,339	$	33,214	$	134,717

11) EMPLOYEE BENEFIT PLANS

Pension Plans

Holdings and Equitable Financial Retirement Plans

Holdings sponsors the MONY Life Retirement Income Security Plan for Employees, which is a frozen qualified defined benefit plan covering eligible employees and financial professionals. Equitable Financial sponsors the Equitable Retirement Plan (the “Equitable Financial QP”), which was frozen on December 31, 2013 but reopened on January 1, 2025 and is a qualified defined benefit plan covering eligible employees and financial professionals. These pension plans are non-contributory, and their benefits are generally based on a cash balance formula and/or, for certain participants, years of service and average earnings over a specified period. Holdings and Equitable Financial also sponsor certain nonqualified deferred compensation plans, including the Equitable Excess Retirement Plan, that provide retirement benefits in excess of the amount permitted under the tax law for the qualified plans. Holdings has assumed primary liability for both plans. Equitable Financial remains secondarily liable for its obligations under the Equitable Financial QP and would recognize such liability in the event Holdings does not perform.

AB Retirement Plans

AB maintained a qualified, non-contributory, defined benefit retirement plan (the “Retirement Plan”) covering current and former employees who were employed by AB in the United States prior to October 2, 2000. During 2024, the Compensation Committee of the AB Board of Directors approved the termination of the Retirement Plan, effective May 22, 2024. AB began the process of settling benefits with vested participants and all lump sum disbursements elected by plan participants were distributed in December 2024 in the amount of $35 million. The remaining Retirement Plan participants who did not elect a lump sum disbursement elected to roll over their benefit to a group annuity contract from a qualified insurance company to administer all future payments. During the six months ended June 30, 2025, AB settled all future obligations under the Retirement Plan and transferred the remaining benefit obligations to a qualified third party insurance provider under a group annuity contract. The final annuity premium transferred was $59 million. Following the settlement related to the annuity purchase, the plans funded status was in a deficit and AB funded an additional $2 million to cover all remaining obligations. As a result of the settlement, AB recognized a non-cash settlement of approximately $21 million related to Retirement Plan losses and the reclassification from accumulated other comprehensive loss to general and administrative expenses in the unaudited consolidated statements of income.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Net Periodic Pension Expense

Components of net periodic pension expense for the Company’s plans were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Service cost	$	7	$	2	$	15	$	4
Interest cost	28		31		56		59
Expected return on assets	(33)		(37)		(67)		(73)
Prior period service cost amortization	—		(1)		(1)		(1)

Net amortization	11		14		23		28
Impact of settlement	—		—		21		—
Net Periodic Pension Expense	$	13	$	9	$	47	$	17

12) INCOME TAXES

Income tax expense for the three and six months ended June 30, 2025 and 2024 was computed using an estimated annual effective tax rate (“ETR”), with discrete items recognized in the period in which they occur. The estimated ETR is revised, as necessary, at the end of successive interim reporting periods.

In 2022, the Company established a valuation allowance against its deferred tax asset related to unrealized capital losses in the available for sale securities portfolio. In 2023, management took actions to increase its available liquidity so that the Company has the ability and intent to hold the majority of securities in its available for sale portfolio to recovery. For liquidity and other purposes, the Company maintains a smaller pool of securities that it does not intend to hold to recovery. The Company maintains a valuation allowance against the deferred tax asset on available for sale securities that will not be held to recovery. Adjustments to the valuation allowance due to changes in the portfolio’s unrealized capital loss are recorded in OCI. Adjustments to the valuation allowance due to new facts or evidence are recorded in net income.

For the three and six months ended June 30, 2025, the Company recorded increases to the valuation allowance of $33 million and $41 million, respectively, due to changes in the value of unrealized losses in the available for sale portfolio that will not be held to recovery. These adjustments were recorded in OCI. As of June 30, 2025, a valuation allowance of $258 million remains against the portion of the deferred tax asset that is still not more-likely-than-not to be realized.

The Company uses the aggregate portfolio approach related to the stranded or disproportionate income tax effects in accumulated other comprehensive income related to available for sale securities. Under this approach, the disproportionate tax effect remains intact as long as the investment portfolio remains.

13) EQUITY

Preferred Stock

Preferred stock authorized, issued and outstanding was as follows:


	June 30, 2025			December 31, 2024
Series	Shares Authorized	Shares Issued	Shares Outstanding	Shares Authorized	Shares Issued	Shares Outstanding
Series A	32,000	32,000	32,000	32,000	32,000	32,000
Series B	20,000	6,613	6,613	20,000	17,773	17,773
Series C	12,000	12,000	12,000	12,000	12,000	12,000
Total	64,000	50,613	50,613	64,000	61,773	61,773

On April 11, 2025, Holdings redeemed and retired $279 million of Series B Preferred Stock using proceeds from our Junior Subordinated Debt issuance.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Dividends declared per share were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Series A dividends declared	$	328	$	328	$	656	$	656
Series B dividends declared	$	619	$	619	$	619	$	619
Series C dividends declared	$	269	$	269	$	538	$	538

Common Stock

Dividends declared per share of common stock were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Dividends declared	$	0.27	$	0.24	$	0.51	$	0.46

Share Repurchase

On February 5, 2024, the Company’s Board of Directors (the “Board”) authorized a new $1.3 billion share repurchase program. On February 13, 2025, Holdings’s Board approved an additional $1.5 billion under Holdings’s share repurchase program. Under this program, the Company may, from time to time purchase shares of its common stock through various means. The Company may choose to suspend or discontinue the repurchase program at any time. The repurchase program does not obligate the Company to purchase any particular number of shares. As of June 30, 2025, Holdings had authorized capacity of approximately $1.5 billion remaining in its share repurchase program.

Holdings repurchased a total of 4.8 million and 9.8 million shares of its common stock at an average price of $51.71 and $50.79 through open market repurchases, ASRs and privately negotiated transactions for the three and six months ended June 30, 2025, respectively and repurchased a total of 6.3 million and 13.8 million shares of its common stock at an average price of $39.21 and $36.31 through open market repurchases, ASRs and privately negotiated transactions for the three and six months ended June 30, 2024, respectively.

During the three and six months ended June 30, 2025, Holdings repurchased 2.4 million and 4.7 million shares, of its common stock through open market repurchases. During the three and six months ended June 30, 2024, Holdings repurchased 3.2 million and 6.4 million shares, of its common stock through open market repurchases.

In March 2025, Holdings established an obligation to enter into an ASR with a third-party financial institution to repurchase an aggregate of $38 million of Holdings’ common stock. Pursuant to the ASR, Holdings made a pre-payment of $38 million and received initial delivery of 567,270 of Holdings’ shares. The ASR terminated in April 2025, at which time an additional 201,068 shares of common stock were received.

In March 2025, Holdings established an obligation to enter into an ASR with a third-party financial institution to repurchase an aggregate of $102 million of Holdings’ common stock. Pursuant to the ASR, on April 2, 2025, Holdings made a pre-payment of $102 million and received initial delivery of 1.6 million of Holdings’ shares. The ASR will be terminated in April 2025, at which time 629,617 additional shares of common stock were received.

In December 2024, Holdings established an obligation to enter into an ASR with a third-party financial institution to repurchase an aggregate of $105 million of Holdings’ common stock. Pursuant to the ASR, on January 3, 2025, Holdings made a pre-payment of $105 million and received initial delivery of 1.8 million of Holdings’ shares. The ASR terminated in February 2025, at which time 274,630 additional shares of common stock were received.

In December 2024, Holdings established an obligation to enter into an ASR with a third-party financial institution to repurchase an aggregate of $32 million of Holdings’ common stock. Pursuant to the ASR, in December, Holdings made a pre-payment of $32 million and received initial delivery of 550,301 of Holdings’ shares. The ASR terminated in January 2025, at which time an additional 105,468 shares of common stock were received.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Accumulated Other Comprehensive Income (Loss)

AOCI represents cumulative gains (losses) on items that are not reflected in net income (loss). The balances are as follows:


	June 30, 2025		December 31, 2024
	(in millions)
Unrealized gains (losses) on investments	$	(6,501)	$	(7,334)
Market risk benefits - instrument -specific credit risk component	(601)		(1,125)
Liability for future policy benefits - current discount rate component	255		372
Defined benefit pension plans	(553)		(579)
Foreign currency translation adjustments	(51)		(88)
Total accumulated other comprehensive income (loss)	(7,451)		(8,754)
Less: Accumulated other comprehensive income (loss) attributable to noncontrolling interest	(19)		(42)
Accumulated other comprehensive income (loss) attributable to Holdings	$	(7,432)	$	(8,712)

The components of OCI, net of taxes for follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Change in net unrealized gains (losses) on investments:
Net unrealized gains (losses) arising during the period	$	335	$	(443)	$	993	$	(986)
(Gains) losses reclassified into net income (loss) during the period (1)	28		—		34		21
Net unrealized gains (losses) on investments	363		(443)		1,027		(965)
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other	(54)		34		(109)		43
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $124, $(102), $297 and $(235))	309		(409)		918		(922)
Change in LFPB discount rate and MRB credit risk, net of tax
Changes in instrument-specific credit risk - market risk benefits (net of deferred income tax expense (benefit) of $(45), $(42), $110 and $(37))	(170)		(159)		414		(139)
Changes in current discount rate - liability for future policy benefits (net of deferred income tax expense (benefit) of $(8), $18, $(25) and $44)	(29)		67		(92)		165
Change in defined benefit plans:
Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost)	9		11		26		19
Change in defined benefit plans (net of deferred income tax expense (benefit) of $3, $7, $1 and $5)	9		11		26		19
Foreign currency translation adjustments:
Foreign currency translation gains (losses) arising during the period	26		9		37		(2)

Foreign currency translation adjustment	26		9		37		(2)
Total other comprehensive income (loss), net of income taxes	145		(481)		1,303		(879)

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Less: Other comprehensive income (loss) attributable to noncontrolling interest	10		3		23		(1)
Other comprehensive income (loss) attributable to Holdings	$	135	$	(484)	$	1,280	$	(878)

______________

(1)See “reclassification adjustments” in Note 3 of the Notes to these Consolidated Financial Statements. Reclassification amounts presented net of income tax expense (benefit) of $(7) million, $0 million, $(9) million and $(6) million for the three and six months ended June 30, 2025 and 2024, respectively.

Investment gains and losses reclassified from AOCI to net income (loss) primarily consist of realized gains (losses) on sales and credit losses of AFS securities and are included in total investment gains (losses), net on the consolidated statements of income (loss). Amounts reclassified from AOCI to net income (loss) as related to defined benefit plans primarily consist of amortization of net (gains) losses and net prior service cost (credit) recognized as a component of net periodic cost and reported in compensation and benefits in the consolidated statements of income (loss). Amounts presented in the table above are net of tax.

14) SHORT-TERM AND LONG-TERM DEBT

Borrowings

Our financial strategy going forward will remain subject to market conditions and other factors. For example, we may from time to time enter into additional bank or other financing arrangements, including public or private debt, structured facilities and contingent capital arrangements, under which we could incur additional indebtedness.

The following table sets forth the Company’s total consolidated borrowings. Short-term and long-term debt consists of the following:


	June 30,		December 31,
	2025		2024
	(in millions)
Short-term debt:




Total short-term debt	$	—	$	—
Long-term debt:
Senior Debenture due 2028	250		250
Senior Note due 2028	1,495		1,494
Senior Note due 2029	305		303
Senior Note due 2033	497		497
Senior Note due 2048	1,290		1,289
Junior Sub Debt Securities due 2055	495		—
Total long-term debt	4,332		3,833
Total short and long-term debt	$	4,332	$	3,833

Junior Subordinated Debt Securities

On March 26, 2025, Holdings issued $500 million aggregate principal amount of 6.7% Fixed-to-Fixed Reset Rate Junior Subordinated Debt Securities due 2055 (the “Junior Subordinated Debt Securities”). These amounts were recorded net of the underwriting discount and issuance costs of $6 million. Interest will be paid (i) from, and including, March 26, 2025 to, but excluding, March 28, 2035 at the rate of 6.7% per annum and (ii) from, and including, March 28, 2035, during each interest period, at a rate per annum equal to the five-year Treasury rate as of the most recent reset interest determination date, in each case to be reset on each interest reset date, plus 2.4%, payable semi-annually in arrears on March 28 and September 28 of each year, beginning on September 28, 2025, and on the maturity date.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

15) REDEEMABLE NONCONTROLLING INTEREST

The changes in the components of redeemable noncontrolling interests were as follows:



	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Balance, beginning of period	$	289	$	991	$	125	$	770
Net earnings (loss) attributable to redeemable noncontrolling interests	(2)		16		1		34

Purchase/change of redeemable noncontrolling interests	71		81		232		284
Balance, end of period	$	358	$	1,088	$	358	$	1,088

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

16) COMMITMENTS AND CONTINGENT LIABILITIES

Litigation and Regulatory Matters

Litigation, regulatory and other loss contingencies arise in the ordinary course of the Company’s activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek, or they may be required only to state an amount sufficient to meet a court’s jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including, among other things, insurers’ sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, product design, features and accompanying disclosure, COI increases, payments of death benefits and the reporting and escheatment of unclaimed property, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters.

The outcome of a litigation or regulatory matter is difficult to predict, and the amount or range of potential losses associated with these or other loss contingencies requires significant management judgment. It is not possible to predict the ultimate outcome or to provide reasonably possible losses or ranges of losses for all pending regulatory matters, litigation and other loss contingencies. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters, nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company’s litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company’s results of operations or cash flows in a particular quarterly or annual period.

For some matters, the Company is able to estimate a range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of June 30, 2025, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $100 million.

For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company’s accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews.

As with other financial services companies, Equitable Financial periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Obligations under Funding Agreements

Pre-Capitalized Trust Securities (“P-Caps”)

In April 2019, pursuant to separate Purchase Agreements among Holdings, Credit Suisse Securities (USA) LLC, as representative of the several initial purchasers, and the Trusts (as defined below), Pine Street Trust I, a Delaware statutory trust (the “2029 Trust”), completed the issuance and sale of 600,000 of its Pre-Capitalized Trust Securities redeemable February 15, 2029 (the “2029 P-Caps”) for an aggregate purchase price of $600 million and Pine Street Trust II, a Delaware statutory trust (the “2049 Trust” and, together with the 2029 Trust, the “Trusts”), completed the issuance and sale of 400,000 of its Pre-Capitalized Trust Securities redeemable February 15, 2049 (the “2049 P-Caps” and, together with the 2029 P-Caps, the “P-Caps”) for an aggregate purchase price of $400 million in each case to qualified institutional buyers in reliance on Rule 144A that are also “qualified purchasers” for purposes of Section 3(c)(7) of the Investment Company Act of 1940, as amended.

In June 2024, the Company exercised its issuance right under the Facility Agreement, dated April 5, 2019 (the “2029 Trust Facility Agreement”) to issue $600 million principal amount of the Company’s 4.572% Senior Notes due 2029 (the “2029 Notes”) in exchange for the portfolio of principal and interest strips of U.S. Treasury securities held by the 2029 Trust (the “2029 Trust Eligible Assets”). Following the Company’s exercise of its issuance right under the 2029 Trust Facility Agreement, the Company: (i) issued $600 million principal amount of the 2029 Notes to the 2029 Trust on June 6, 2024 in exchange for the 2029 Trust Eligible Assets; (ii) waived its right to repurchase the 2029 Notes; and (iii) directed the trustee of the 2029 Trust to dissolve the 2029 Trust in accordance with its declaration of trust and deliver the 2029 Notes to the beneficial holders of the 2029 P-Caps pro rata in respect of each 2029 P-Cap. The 2029 Trust was dissolved on June 11, 2024 and the beneficial holders of the 2029 P-Caps received the 2029 Notes through the facilities of The Depository Trust Company. See Note 14 of the Notes to these Consolidated Financial Statements for additional details on the 2029 Notes.

In addition, in June 2024, pursuant to the Purchase Agreement among Holdings, TD Securities (USA) LLC, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as representative of the several initial purchasers, and Pine Street Trust III, a Delaware statutory trust ( “2054 Trust”), completed the issuance and sale of 600,000 of its Pre-Capitalized Trust Securities redeemable May 15, 2054 (the “2054 P-Caps”) for an aggregate purchase price of $600 million to qualified institutional buyers in reliance on Rule 144A that are also “qualified purchasers” for purposes of Section 3(c)(7) of the Investment Company Act of 1940, as amended.

The P-Caps are an off-balance sheet contingent funding arrangement that, upon Holdings’ election, gives Holdings the right over a thirty-year period to issue senior notes to the 2049 Trust and the 2054 Trusts. The Trust have invested the proceeds from the respective sales of their P-Caps in separate portfolios of principal and/or interest strips of U.S. Treasury securities. In return, Holdings will, in the case of the 2054 Trust, pay, and in the case of the 2049 Trust, continue to pay, a semi-annual facility fee to the 2049 Trust and 2054 Trust calculated at a rate of 2.715% and 1.779% per annum, respectively, which will be applied to the unexercised portion of the contingent funding arrangement and Holdings will reimburse the Trusts for certain expenses. The facility fees are recorded in other operating costs and expenses in the consolidated statements of income (loss).

FHLB

As a member of the FHLB, Equitable Financial and Equitable America have access to collateralized borrowings. They also may issue funding agreements to the FHLB. Both the collateralized borrowings and funding agreements would require Equitable Financial or Equitable America to pledge qualified mortgage-backed assets and/or government securities as collateral. Equitable Financial and Equitable America issue short-term funding agreements to the FHLB and use the funds for asset, liability, and cash management purposes. Equitable Financial and Equitable America issue long-term funding agreements to the FHLB and use the funds for spread lending purposes.

Entering into FHLB membership, borrowings and funding agreements requires the ownership of FHLB stock and the pledge of assets as collateral. Equitable Financial has purchased FHLB stock of $323 million and pledged collateral with a carrying value of $11.0 billion as of June 30, 2025. Equitable America has purchased FHLB stock of $5 million and pledged collateral with a carrying value of $245 million as of June 30, 2025.

Funding agreements are reported in policyholders’ account balances in the consolidated balance sheets. For other instruments used for asset/liability and cash management purposes, see “Offsetting of Financial Assets and Liabilities and Derivative Instruments” included in Note 4 of the Notes to these Consolidated Financial Statements. The table below summarizes the Company’s activity of funding agreements with the FHLB.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Change in FHLB Funding Agreements during the Six Months Ended June 30, 2025


	Outstanding Balance at December 31, 2024		Issued During the Period		Repaid During the Period		Long-term Agreements Maturing Within One Year		Long-term Agreements Maturing Within Five Years		Outstanding Balance at June 30, 2025
	(in millions)
Short-term funding agreements:
Due in one year or less	$	5,843	$	34,894	$	(35,194)	$	409	$	—	$	5,952
Long-term funding agreements:
Due in years two through five	829		200		—		(388)		—		641
Due in more than five years	493		—		—		(21)		—		472
Total long-term funding agreements	1,322		200		—		(409)		—		1,113
Total funding agreements (1)	$	7,165	$	35,094	$	(35,194)	$	—	$	—	$	7,065

_____________

(1)The $18 million and $2 million difference between the funding agreements carrying value shown in fair value table for June 30, 2025 and December 31, 2024, respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates.

FABN

Under the FABN programs, Equitable Financial and Equitable America may issue funding agreements in U.S. dollar or other foreign currencies, in each case, to a Delaware special purpose statutory trust (the “Trust”) in exchange for the proceeds from issuances of fixed and floating rate medium-term marketable notes issued by the applicable Trust from time to time (the “Trust Notes”). The funding agreements have matching interest, maturity and currency payment terms to the applicable Trust Notes. The Company hedges the foreign currency exposure of foreign currency denominated funding agreements using cross currency swaps as discussed in Note 4 of the Notes to these Consolidated Financial Statements. As of June 30, 2025, the maximum aggregate principal amount of Trust Notes permitted to be outstanding at any one time is $16.0 billion. Funding agreements issued to the applicable Trust, including any foreign currency transaction adjustments, are reported in policyholders’ account balances in the consolidated balance sheets. Foreign currency transaction adjustments to policyholder’s account balances are recognized in net income (loss) as an adjustment to interest credited to policyholders’ account balances and are offset in interest credited to policyholders’ account balances by a release of AOCI from deferred changes in fair value of designated and qualifying cross currency swap cash flow hedges. The table below summarizes activity of funding agreements under the FABN programs.

Change in FABN Funding Agreements during the Six Months Ended June 30, 2025


	Outstanding Balance at December 31, 2024		Issued During the Period		Repaid During the Period		Long-term Agreements Maturing Within One Year		Long-term Agreements Maturing Within Five Years		Foreign Currency Transaction Adjustment		Outstanding Balance at June 30, 2025
	(in millions)
Short-term funding agreements:
Due in one year or less	$	1,050	$	300	$	—	$	450	$	—	$	—	$	1,800
Long-term funding agreements:
Due in years two through five	4,393		3,100		—		(450)		—		107		7,150
Due in more than five years	300		—		—		—		—		—		300
Total long-term funding agreements	4,693		3,100		—		(450)		—		107		7,450
Total funding agreements (1)	$	5,743	$	3,400	$	—	$	—	$	—	$	107	$	9,250

_____________

(1)The $28 million and $18 million difference between the funding agreements notional value shown and carrying value table as of June 30, 2025 and December 31, 2024, respectively, reflects the remaining amortization of the issuance cost of the funding agreements and the foreign currency transaction adjustment.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

FABCP

In May 2023, Equitable Financial and Equitable America established a FABCP program, pursuant to which a SPLLC may issue commercial paper and deposit the proceeds with Equitable Financial or Equitable America pursuant to a funding agreement issued by Equitable Financial or Equitable America to the SPLLC. The current maximum aggregate principal amount permitted to be outstanding at any one time under the FABCP program is $3.0 billion for Equitable Financial and $1.0 billion for Equitable America. As of June 30, 2025, Equitable Financial and Equitable America had $1.6 billion and $0 million outstanding under the program, respectively.

Guarantees and Other Commitments

The Company provides certain guarantees or commitments to affiliates and others. As of June 30, 2025, these arrangements include commitments by the Company to provide equity financing of $1.1 billion to certain limited partnerships and real estate joint ventures under certain conditions as well as a guarantee of a subsidiary’s performance under a reinsurance arrangement that will no longer be in effect once certain conditions at the subsidiary are met and notice is provided. Management believes the Company will not incur material losses as a result of these commitments.

The Company had $17 million of undrawn letters of credit related to reinsurance as of June 30, 2025. The Company had $502 million of commitments under existing mortgage loan agreements as of June 30, 2025.

The Company is the obligor under certain structured settlement agreements it had entered into with unaffiliated insurance companies and beneficiaries. To satisfy its obligations under these agreements, the Company owns single premium annuities issued by previously wholly-owned life insurance subsidiaries. The Company has directed payment under these annuities to be made directly to the beneficiaries under the structured settlement agreements. A contingent liability exists with respect to these agreements should the previously wholly-owned subsidiaries be unable to meet their obligations. Management believes the need for the Company to satisfy those obligations is remote.

17) BUSINESS SEGMENT INFORMATION

We have six reportable segments: Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management and Legacy.

These segments reflect the manner by which the Company’s chief operating decision maker (“CODM”) views and manages the business. A brief description of these segments follows:

•The Individual Retirement (“IR”) segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income.

•The Group Retirement (“GR”) segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities, and not-for-profit entities, as well as small and medium-sized businesses.

•The Asset Management (“AM”) segment provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail and Private Wealth.

•The Protection Solutions (“PS”) segment includes our life insurance and group EB businesses.

•The Wealth Management (“WM”) segment offers discretionary and non-discretionary investment advisory accounts, financial planning and advice, life insurance, and annuity products through Equitable Advisors.

•The Legacy (“L”) segment primarily consists of the capital intensive fixed-rate GMxB business written in the Individual Retirement market prior to 2011.

The CODM is the chief executive officer and President of Holdings. The CODM evaluates the reported measure of a segment’s profit or loss in assessing segment performance and deciding how to allocate resources. Significant segment expenses are part of the CODM review and are critically important to understand the level of profitability of operating segments but also the overall company performance. This assessment will inform the way the allocation of resources will be done among the different operating segments.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Measurement

Operating earnings (loss) is the financial measure which primarily focuses on the Company’s segments’ results of operations as well as the underlying profitability of the Company’s core business. By excluding items that can be distortive and unpredictable such as investment gains (losses) and investment income (loss) from derivative instruments, the Company believes operating earnings (loss) by segment enhances the understanding of the Company’s underlying drivers of profitability and trends in the Company’s segments.

Operating earnings is calculated by adjusting each segment’s net income (loss) attributable to Holdings for the following items:

•Items related to variable annuity product features, which include: (i) changes in the fair value of MRB and purchased MRB, including the related attributed fees and claims, offset by derivatives and other securities used to hedge the MRB which result in residual net income volatility as the change in fair value of certain securities is reflected in OCI and due to our statutory capital hedge program; and (ii) market adjustments to deposit asset or liability accounts arising from reinsurance agreements which do not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk;

•Investment (gains) losses, which includes credit loss impairments of securities/investments, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances;

•Net actuarial (gains) losses, which includes actuarial gains and losses as a result of differences between actual and expected experience on pension plan assets or projected benefit obligation during a given period related to pension, other postretirement benefit obligations, and the one-time impact of the settlement of the defined benefit obligation;

•Other adjustments, which primarily include restructuring costs related to severance and separation, lease write-offs related to non-recurring restructuring activities, net derivative gains (losses) on certain Non-GMxB derivatives, net investment income from certain items including consolidated VIE investments, seed capital mark-to-market adjustments, unrealized gain/losses and realized capital gains/losses from sales or disposals of select securities, certain legal accruals; a bespoke deal to repurchase UL policies from one entity that had invested in numerous policies purchased in the life settlement market, which disposed of the risk of additional COI litigation by that entity related to those UL policies, impact of the annual actuarial assumption updates attributable to LFPB when the majority of the impact relates to the non-core business; and

•Income tax expense (benefit) related to the above items and non-recurring tax items, which includes the effect of uncertain tax positions for a given audit period and changes to the deferred tax valuation allowance.

The General Account investment portfolio is used to support the insurance and annuity liabilities of our Individual Retirement, Group Retirement, Protection Solutions and Legacy business segments.

During the third quarter 2024, the Company moved revenues and expenses related to payout annuitizations from the Legacy segment to the Individual Retirement segment. Now all payout annuities are reported within the Individual Retirement segment as the block is managed on an aggregate basis. Prior periods have been recast to reflect this change.

Revenues derived from any customer did not exceed 10% of revenues for the three and six months ended June 30, 2025 and 2024.

The Company accounts for inter-segment sales and transfers as if the sales or transfers were to third parties, that is, at current market prices.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

The table below presents operating earnings (loss) by segment and Corporate and Other (C&O):


	Three Months Ended June 30, 2025
	IR		GR		AM		PS		WM		L		C&O		Eliminations		Total
	(in millions)
Segment revenues	$	1,006	$	309	$	1,094	$	825	$	471	$	100	$	226	$	(230)	$	3,801

Benefits and other deductions
Policyholders’ benefits	76		—		—		603		—		—		108		—		787
Interest credited to policyholders’ account balances	408		68		—		145		—		9		175		—		805
Commissions and distribution related payments	101		44		197		41		296		29		2		(222)		488
Amortization of deferred policy acquisition costs	127		16		—		32		—		15		3		—		193
Compensation and benefits	6		9		429		27		82		5		11		—		569
Interest expense and financing fees	—		—		9		—		—		—		69		(6)		72
Significant segment expenses	718		137		635		848		378		58		368		(228)		2,914
Other segment items (1)	31		23		196		46		24		8		32		(2)		358
Income taxes	(42)		(25)		(48)		11		(18)		(6)		36		—		(92)
Less: Operating (earnings) loss attributable to the noncontrolling interest	—		—		84		—		—		—		1		—		85
Operating earnings (loss)	$	215	$	124	$	131	$	(58)	$	51	$	28	$	(139)	$	—	$	352

_____________

(1)Other segment items include Remeasurement for liability for future policy benefits and Other operating expenses and costs. Additionally, other segment items reflected in Asset Management segment is primarily driven by other operating expense and costs related to general and administrative costs and promotion and servicing expenses.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Three Months Ended June 30, 2024
	IR		GR		AM		PS		WM		L		C&O		Eliminations		Total
	(in millions)
Segment revenues	$	888	$	283	$	1,051	$	834	$	442	$	117	$	230	$	(227)	$	3,618

Benefits and other deductions
Policyholders’ benefits	78		—		—		473		—		—		116		—		667
Interest credited to policyholders’ account balances	281		56		—		128		—		8		125		—		598
Commissions and distribution related payments	80		45		180		43		282		40		7		(214)		463
Amortization of deferred policy acquisition costs	111		8		—		32		—		15		3		—		169
Compensation and benefits	14		8		420		37		78		7		(1)		—		563
Interest expense and financing fees	—		—		12		—		—		—		58		(7)		63
Significant segment expenses	564		117		612		713		360		70		308		(221)		2,523
Other segment items (1)	38		21		201		38		21		15		47		(6)		375
Income taxes	(40)		(20)		(42)		(12)		(17)		(4)		16		—		(119)
Less: Operating (earnings) loss attributable to the noncontrolling interest	—		—		95		(1)		—		—		12		—		106
Operating earnings (loss)	$	246	$	125	$	101	$	72	$	44	$	28	$	(121)	$	—	$	495

_____________

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Six Months Ended June 30, 2025
	IR		GR		AM		PS		WM		L		C&O		Eliminations		Total
	(in millions)
Segment revenues	$	2,003	$	625	$	2,182	$	1,651	$	934	$	220	$	430	$	(460)	$	7,585

Benefits and other deductions
Policyholders’ benefits	168		—		—		1,159		—		—		219		—		1,546
Interest credited to policyholders’ account balances	773		131		—		266		—		16		282		—		1,468
Commissions and distribution related payments	199		87		398		83		589		65		8		(440)		989
Amortization of deferred policy acquisition costs	251		31		—		64		—		30		5		—		381
Compensation and benefits	24		21		851		65		164		12		24		—		1,161
Interest expense and financing fees	—		—		16		2		—		—		122		(10)		130
Significant segment expenses	1,415		270		1,265		1,639		753		123		660		(450)		5,675
Other segment items (1)	76		53		381		100		51		35		63		(10)		749
Income taxes	(81)		(48)		(89)		14		(33)		(10)		53		—		(194)
Less: Operating (earnings) loss attributable to the noncontrolling interest	—		—		190		1		—		—		3		—		194
Operating earnings (loss)	$	431	$	254	$	257	$	(75)	$	97	$	52	$	(243)	$	—	$	773

_____________

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Six Months Ended June 30, 2024
	IR		GR		AM		PS		WM		L		C&O		Eliminations		Total
	(in millions)
Segment revenues	$	1,728	$	574	$	2,144	$	1,658	$	865	$	246	$	485	$	(443)	$	7,257

Benefits and other deductions
Policyholders’ benefits	155		—		—		960		—		—		229		—		1,344
Interest credited to policyholders’ account balances	529		108		—		256		—		17		267		—		1,177
Commissions and distribution related payments	157		89		353		83		542		80		10		(414)		900
Amortization of deferred policy acquisition costs	220		23		—		62		—		31		5		—		341
Compensation and benefits	31		18		867		73		156		16		1		—		1,162
Interest expense and financing fees	—		—		29		—		—		—		114		(17)		126
Significant segment expenses	1,092		238		1,249		1,434		698		144		626		(431)		5,050
Other segment items (1)	72		46		409		90		48		31		108		(12)		792
Income taxes	(80)		(41)		(86)		(19)		(32)		(10)		39		—		(229)
Less: Operating (earnings) loss attributable to the noncontrolling interest	—		—		193		(1)		—		—		22		—		214
Operating earnings (loss)	$	484	$	249	$	207	$	116	$	87	$	61	$	(232)	$	—	$	972

_____________

The table below presents a reconciliation to net income (loss) attributable to Holdings:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Net income (loss) attributable to Holdings	$	(349)	$	428	$	(286)	$	520
Adjustments related to:
Variable annuity product (1)	934		81		1,145		411
Investment (gains) losses	71		16		85		55
Net actuarial (gains) losses related to pension and other postretirement benefit obligations	11		14		22		31
Other adjustments (2)	(137)		(33)		68		58
Income tax expense (benefit) related to above adjustments	(185)		(16)		(277)		(116)
Non-recurring tax items	7		5		16		13
Operating earnings (loss)	$	352	$	495	$	773	$	972

_____________

(1)As a result of the novation of certain Legacy VA policies completed during the first quarter of 2025, the Company recorded a loss of $499 million in pre-tax net income and an increase of $263 million in pre-tax AOCI, for a total impact loss of $236 million for the six months ended June 30, 2025.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

three and six months ended June 30, 2025, respectively, and certain gross legal expenses related to the COI litigation of $106 million for the six months ended June 30, 2024.

Segment revenues is a measure of the Company’s revenue by segment as adjusted to exclude certain items. The following table reconciles segment revenues to total revenues by excluding the following items:

•Items related to variable annuity product features, which include certain changes in the fair value of the derivatives and other securities we use to hedge these features and changes in the fair value of the embedded derivatives reflected within the net derivative results of variable annuity product features;

•Investment (gains) losses, which includes credit loss impairments of securities/investments, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances;

•Other adjustments, which primarily includes net derivative gains (losses) on certain Non-GMxB derivatives and Net investment income from certain items including consolidated VIE investments, seed capital mark-to-market adjustments and unrealized gain/losses associated with equity securities.

The table below presents revenues by segment and C&O:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Segment revenues:
Individual Retirement (1)	$	1,006	$	888	$	2,003	$	1,728
Group Retirement (1)	309		283		625		574
Asset Management (2)	1,094		1,051		2,182		2,144
Protection Solutions (1)	825		834		1,651		1,658
Wealth Management (3)	471		442		934		865
Legacy (1)	100		117		220		246
Corporate and Other (1)	226		230		430		485
Eliminations	(230)		(227)		(460)		(443)

Adjustments related to:
Variable annuity product features, excluding change in MRBs (4)	(1,549)		(210)		(574)		(1,629)
Investment gains (losses), net	(71)		(16)		(85)		(55)
Other adjustments to segment revenues (4)	181		115		12		164
Total revenues	$	2,362	$	3,507	$	6,938	$	5,737

______________

(1)Includes investment expenses charged by AB of $42 million and $76 million for the three and six months ended June 30, 2025, respectively, and $37 million and $73 million for the three and six months ended June 30, 2024, respectively, for services provided to the Company.

(2)Inter-segment investment management and other fees of $44 million and $86 million for the three and six months ended June 30, 2025, respectively, and $42 million and $84 million for the three and six months ended June 30, 2024, respectively, are included in segment revenues of the Asset Management segment.

(3)Inter-segment distribution fees of $222 million and $440 million for the three and six months ended June 30, 2025, respectively, and $214 million and $414 million for the three and six months ended June 30, 2024, respectively, are included in segment revenues of the Wealth Management segment.

(4)Prior periods were revised to conform with current presentation.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

Total assets by segment were as follows:


	June 30, 2025		December 31, 2024
	(in millions)
Total assets by segment:
Individual Retirement	$	118,774	$	110,358
Group Retirement	53,804		51,269
Asset Management	10,705		10,514
Protection Solutions	43,693		41,583
Wealth Management	222		168
Legacy	36,368		42,373
Corporate and Other	39,522		39,462
Total assets	$	303,088	$	295,727

18) INSURANCE STATUTORY FINANCIAL INFORMATION

Prescribed and Permitted Accounting Practices

As of June 30, 2025, the following five prescribed and permitted practices resulted in net income (loss) and capital and surplus that is different from the statutory surplus that would have been reported had NAIC statutory accounting practices been applied.

Equitable Financial was granted a permitted practice by the NYDFS to apply SSAP 108, Derivatives Hedging Variable Annuity Guarantees on a retroactive basis from January 1, 2021 through June 30, 2021, after reflecting the impacts of our reinsurance transaction with Venerable. The permitted practice was amended to also permit Equitable Financial to adopt SSAP 108 prospectively as of July 1, 2021 and to consider the impact of both the interest rate derivatives and the General Account assets used to fully hedge the interest rate risk inherent in its variable annuity guarantees when determining the amount of the deferred asset or liability under SSAP 108. Application of the permitted practice partially mitigates the New York Insurance Regulation 213 (“Reg 213”) impact of the Venerable transaction on Equitable Financial’s statutory capital and surplus and enables Equitable Financial to more effectively neutralize the impact of interest rates on its statutory surplus and to better align with our economic hedging program. The impact of applying this permitted practice relative to SSAP 108 as written was a decrease of approximately $155 million in statutory special surplus funds as of June 30, 2025. The Reinsurance Treaty reduced the amount of interest rate hedging needed at Equitable Financial going forward, affecting future deferrals, but leaves our historical SSAP 108 deferred amounts unchanged. The permitted practice also reset Equitable Financial’s unassigned surplus to zero as of June 30, 2021 to reflect the transformative nature of the Venerable transaction.

The Manual has been adopted as a component of prescribed or permitted practices by the State of New York. However, Reg 213 adopted in May of 2019 and as amended in February 2020 and March 2021, differs from the NAIC variable annuity reserve and capital framework. Reg 213 requires Equitable Financial to carry statutory basis reserves for its variable annuity contract obligations equal to the greater of those required under (i) the NAIC standard or (ii) a revised version of the NYDFS requirement in effect prior to the adoption of the first amendment for contracts issued prior to January 1, 2020, and for policies issued after that date a new standard that in current market conditions imposes more conservative reserving requirements for variable annuity contracts than the NAIC standard.

The impact of the application of Reg 213 was a decrease of approximately $123 million in statutory surplus as of June 30, 2025 compared to statutory surplus under the NAIC variable annuity framework. Our hedging program is designed to hedge the economics of our insurance liabilities and largely offsets Reg 213 and NAIC framework reserve movements due to interest rates and equities. The NYDFS allows domestic insurance companies a five year phase-in provision for Reg 213 reserves. As of September 30, 2022, Equitable Financial’s Reg 213 reserves were 100% phased-in. As of June 30, 2025, given the prevailing market conditions and business mix, there are $111 million Reg 213 redundant reserves over the US RBC CTE 98 TAR.

During the fourth quarter 2020, Equitable Financial received approval from NYDFS for its proposed amended Plan of Operation for Separate Account No. 68 (“SA 68”) for our SCS product and Separate Account No. 69 (“SA 69”) for our EQUI-VEST product Structured Investment Option, to change the accounting basis of these two non-insulated Separate Accounts from fair value to book value in accordance with Section 1414 of the Insurance Law to align with how we manage and measure our overall General Account asset portfolio. In order to facilitate this change and comply

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

with Section 4240(a)(10), the Company also sought approval to amend the Plans to remove the requirement to comply with Section 4240(a)(5)(iii) and substitute it with a commitment to comply with Section 4240(a)(5)(i). Similarly, the Company updated the reserves section of each Plan to reflect the fact that Regulation 128 would no longer be applicable upon the change in accounting basis. We applied this change effective January 1, 2021. The impact of the application is an increase of approximately $770 million in statutory surplus as of June 30, 2025.

During 2022, Equitable America received approval from the Arizona Department of Insurance and Financial Institutions pursuant to A.R.S. 20-515 for Separate Account No. 68A (“SA 68A”) for our SCS product, Separate Account No. 69A (“SA 69A”) for our EQUI-VEST product Structured Investment Option and Separate Account No. 71A (“SA 71A”) for our Investment Edge Structured Investment Option, to permit us to use book value as the accounting basis of these three non-insulated Separate Accounts instead of fair value in accordance with the Manual to align with how we manage and measure our overall General Account asset portfolio. The impact of the application is a decrease of approximately $920 million in statutory surplus as of June 30, 2025.

The Arizona Department of Insurance and Financial Institutions granted to Equitable America a permitted practice to deviate from SSAP No. 108 by applying special accounting treatment for specific derivatives hedging variable annuity benefits subject to fluctuations as a result of interest rate sensitivities. The permitted practice expands on SSAP No. 108 hedge accounting to include equity risks for the full scope of Variable Annuity (VA) contracts (i.e., not just the rider guarantees but for the VA total contract). The permitted practice allows Equitable America to adopt SSAP 108 retroactively from October 1, 2023 and applies to both directly held VA hedges as well as VA hedges in the Equitable America funds withheld asset that resulted from the Reinsurance Treaty. In the calculation of the amount of excess VA equity and interest rate derivative hedging gains/losses to defer (including Net investment income on our Equity Total Return Swaps), the permitted practice allows us to compare our total equity and interest derivatives gains and losses to 100% of our target liability change. Any hedge gain or loss deferrals will follow SSAP No. 108 amortization rules (i.e. 10-year straight line). The impact of applying this revised permitted practice relative to SSAP 108 was an increase of approximately $1.4 billion in statutory special surplus funds as of June 30, 2025.

19) EARNINGS PER COMMON SHARE

The following table presents a reconciliation of net income (loss) and weighted-average common shares used in calculating basic and diluted earnings per common share:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions, except per share data)
Weighted-average common shares outstanding:
Weighted-average common shares outstanding — basic	303.2		324.2		305.5		327.2
Effect of dilutive potential common shares:
Employee share awards (1)	—		3.1		—		3.2
Weighted-average common shares outstanding — diluted	303.2		327.3		305.5		330.4

Net income (loss):
Net income (loss)	$	(283)	$	565	$	(133)	$	760
Less: Net income (loss) attributable to the noncontrolling interest	66		137		153		240
Net income (loss) attributable to Holdings	(349)		428		(286)		520
Less: Preferred stock dividends	18		26		32		40
Net income (loss) available to Holdings’ common shareholders	$	(367)	$	402	$	(318)	$	480

Earnings per common share:
Basic	$	(1.21)	$	1.24	$	(1.04)	$	1.47
Diluted	$	(1.21)	$	1.23	$	(1.04)	$	1.45

______________

(1)Calculated using the treasury stock method.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

For the three and six months ended June 30, 2025 and 2024, 5.0 million, 5.5 million, 3.0 million and 3.1 million, respectively, of outstanding stock awards, were not included in the computation of diluted EPS because their effect was anti-dilutive.

20) REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS

Management assessed the materiality of this change within prior period financial statements based upon SEC Staff Accounting Bulletin Number 99, Materiality, which is since codified in ASC 250, Accounting Changes and Error Corrections. The prior period comparative financial statements that are presented herein have been revised.

The following tables present line items for prior period financial statements that have been affected by the revision. For these line items, the tables detail the amounts as previously reported, the impact upon those line items due to the revision, and the amounts as currently revised within the financial statements.

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	June 30, 2024
	As Previously Reported		Impact of Revisions		As Revised
	(in millions)
Consolidated Balance Sheets:
ASSETS
















Amounts due from reinsurers	$	8,237	$	(150)	$	8,087


Current and deferred income taxes	2,117		12		2,129
Purchased market risk benefits	7,993		9		8,002
Other assets	3,825		3		3,828
Assets for market risk benefits	803		(4)		799


Total Assets	$	287,769	$	(130)	$	287,639
LIABILITIES
Policyholders’ account balances	$	104,072	$	(23)	$	104,049
Liability for market risk benefits	12,593		19		12,612
Future policy benefits and other policyholders’ liabilities	17,417		16		17,433



Amounts due to reinsurers	1,363		10		1,373





Other liabilities	6,718		(106)		6,612


Total Liabilities	283,296		(84)		283,212


EQUITY




Retained earnings	10,317		(16)		10,301
Accumulated other comprehensive income (loss)	(8,645)		(30)		(8,675)
Total equity attributable to Holdings	1,644		(46)		1,598
Noncontrolling interest	1,741		—		1,741
Total Equity	3,385		(46)		3,339
Total Equity and Redeemable NCI	4,473		(46)		4,427
Total Liabilities, Redeemable Noncontrolling Interest and Equity	$	287,769	$	(130)	$	287,639

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Three Months Ended June 30, 2024		Six Months Ended June 30, 2024
	As Previously Reported		Impact of Revisions		As Revised		As Previously Reported		Impact of Revisions		As Revised
	(in millions, except per share data)
Consolidated Statements of Income (Loss)
REVENUES

Premiums	$	282	$	—	$	282	$	557	$	10	$	567

Net investment income (loss)	1,166		1		1,167		2,385		(8)		2,377




Investment management and service fees	1,240		—		1,240		2,518		—		2,518
Other income	429		(4)		425		688		(5)		683
Total revenues	3,510		(3)		3,507		5,740		(3)		5,737

BENEFITS AND OTHER DEDUCTIONS

Remeasurement of liability for future policy benefits	(8)		1		(7)		(7)		5		(2)
Change in market risk benefits and purchased market risk benefits	(133)		1		(132)		(1,233)		13		(1,220)
Interest credited to policyholders’ account balances	605		(6)		599		1,171		7		1,178




Other operating costs and expenses	427		1		428		980		—		980
Total benefits and other deductions	2,829		(3)		2,826		4,812		25		4,837
Income (loss) from continuing operations, before income taxes	681		—		681		928		(28)		900
Income tax (expense) benefit	(116)		—		(116)		(146)		6		(140)
Net income (loss)	565		—		565		782		(22)		760
Less: Net (income) loss attributable to the noncontrolling interest	137		—		137		240		—		240
Net income (loss) attributable to Holdings	428		—		428		542		(22)		520
Less: Preferred stock dividends	26		—		26		40		—		40
Net income (loss) available to Holdings’ common shareholders	$	402	$	—	$	402	$	502	$	(22)	$	480

EARNINGS PER COMMON SHARE
Basic	$	1.24	$	—	$	1.24	$	1.53	$	(0.06)	$	1.47
Diluted	$	1.23	$	—	$	1.23	$	1.52	$	(0.07)	$	1.45
Shares Outstanding:
Basic	324.2		—		324.2		327.2		—		327.2
Diluted	327.3		—		327.3		330.4		—		330.4

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Three Months Ended June 30, 2024		Six Months Ended June 30, 2024
	As Previously Reported		Impact of Revisions		As Revised		As Previously Reported		Impact of Revisions		As Revised
	(in millions)
Consolidated Statements of Comprehensive Income (Loss)
Net income (loss)	$	565	$	—	$	565	$	782	$	(22)	$	760
Other comprehensive income (loss) net of income taxes:
Change in unrealized gains (losses), net of reclassification adjustment	(408)		(1)		(409)		(921)		(1)		(922)
Change in market risk benefits - instrument-specific credit risk	(153)		(6)		(159)		(128)		(11)		(139)

Change in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment	10		1		11		18		1		19
Foreign currency translation adjustment	8		1		9		(3)		1		(2)
Total other comprehensive income (loss), net of income taxes	(476)		(5)		(481)		(869)		(10)		(879)
Comprehensive income (loss)	89		(5)		84		(87)		(32)		(119)
Less: Comprehensive income (loss) attributable to the noncontrolling interest	140		—		140		239		—		239
Comprehensive income (loss) attributable to Holdings	$	(51)	$	(5)	$	(56)	$	(326)	$	(32)	$	(358)


	Three Months Ended June 30, 2024						Six Months Ended June 30, 2024
	As Previously Reported		Impact of Revisions		As Revised		As Previously Reported		Impact of Revisions		As Revised
	(in millions)
Consolidated Statements of Equity:
Equity, beginning of period	$	3,755	$	(40)	$	3,715	$	4,388	$	(13)	$	4,375
Total Holdings’ equity, beginning of period	2,032		(40)		1,992		2,649		(13)		2,636



















Retained earnings, beginning of year	10,110		(15)		10,095		10,243		7		10,250








Net income (loss) attributable to Holdings	428		—		428		542		(22)		520


Other	1		(1)		—		1		(1)		—
Retained earnings, end of period	10,317		(16)		10,301		10,317		(16)		10,301
Accumulated other comprehensive income (loss), beginning of year	(8,166)		(25)		(8,191)		(7,777)		(20)		(7,797)




Other comprehensive income (loss)	(479)		(5)		(484)		(868)		(10)		(878)
Accumulated other comprehensive income (loss), end of period	(8,645)		(30)		(8,675)		(8,645)		(30)		(8,675)
Total Holdings’ equity, end of period	1,644		(46)		1,598		1,644		(46)		1,598











Total equity, end of period	$	3,385	$	(46)	$	3,339	$	3,385	$	(46)	$	3,339

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued


	Six Months Ended June 30, 2024
	As Previously Reported		Impact of Revisions		As Revised
	(in millions)
Consolidated Statements of Cash Flows:
Cash flows from operating activities:
Net income (loss)	$	782	$	(22)	$	760
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances	1,171		7		1,178








Amortization and depreciation	429		5		434
Remeasurement of liability for future policy benefits	(7)		5		(2)
Change in market risk benefits	(1,233)		13		(1,220)




Reinsurance recoverable	(626)		(2)		(628)



Current and deferred income taxes	155		(6)		149

Net cash provided by (used in) operating activities	$	923	$	—	$	923

Table of Contents

EQUITABLE HOLDINGS, INC.

Notes to Consolidated Financial Statements (Unaudited), Continued

21) SUBSEQUENT EVENTS

ASR

In June 2025, Holdings established an obligation to enter into an ASR with a third-party financial institution to repurchase an aggregate of $96 million of Holdings’ common stock. Pursuant to the ASR, on July 2, 2025, Holdings made a pre-payment of $96 million and received initial delivery of 1.4 million shares. The ASR terminated in July 2025, at which time an additional 441,333 shares of common stock were received.

AB Unit Exchange

On July 10, 2025, AB and Holdings entered into an Amended and Restated Master Exchange Agreement to increase the AB Units that remain available for exchange from 4.8 million AB Units to 19.7 million AB Units, and Holdings exchanged 19.7 million AB Holding Units for an equal number of limited partnership interests in ABLP. After giving effect to the exchange Holdings continues to own approximately 68.6% of the economic interest in AB.

RGA Reinsurance Agreement

On July 31, 2025, Equitable Financial, as well as Equitable America and Equitable Financial L&A, completed the master transaction agreement with RGA entered into on February 23, 2025 pursuant to which and subject to the terms and conditions set forth in such agreement, RGA entered into reinsurance agreements, as reinsurer, with each such subsidiary, as ceding company, to effect the RGA Reinsurance Transaction.

At the closing of the transaction, (i) each of Equitable Financial and Equitable America entered into a separate coinsurance and modified coinsurance agreement with RGA and (ii) Equitable Financial L&A entered into a coinsurance agreement with RGA, each with an effective date of April 1, 2025, pursuant to which each ceding company ceded to RGA a 75% quota share of such ceding company’s in-force individual life insurance block. At the closing of the transaction, assets supporting the general account liabilities relating to the reinsured contracts were deposited into a trust account for the benefit of Equitable Financial and a trust account for the benefit of Equitable America and Equitable Financial L&A, which assets will secure RGA’s obligations to each ceding company under the applicable reinsurance agreement. Equitable Financial and Equitable America reinsured the applicable separate accounts relating to the applicable reinsured contracts on a modified coinsurance basis. In addition, the investment of assets in each trust account will be subject to investment guidelines and certain capital adequacy related triggers will require enhanced funding. The reinsurance agreements also contain additional counterparty risk management and mitigation provisions. Each ceding company will continue to administer the applicable reinsured contracts.

As part of the transaction, on June 16, 2025, ABLP entered into an investment advisory agreement with RGA, pursuant to which AB will manage certain assets to be specified representing approximately 70% of assets supporting the reserves associated with the ceded policies under the reinsurance agreements.

Credit Facility Revolver

On July 29, 2025, the Company terminated the Amended and Restated Revolving Credit Agreement entered into by the Company on June 24, 2021, as amended and restated from time to time, which provided for a $1.5 billion senior unsecured revolving credit facility, and entered into a new Revolving Credit Agreement which provides for a $1.0 billion five-year senior unsecured revolving credit facility (the “Credit Facility”) with a syndicate of banks.

Table of Contents

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in its entirety and in conjunction with the consolidated financial statements and related notes contained in Part I, Item 1 of this Quarterly Report on Form 10-Q, as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section contained in our Annual Report on Form 10-K for the year ended December 31, 2024 (“2024 Form 10-K”).

In addition to historical data, this discussion contains forward-looking statements about our business, operations and financial performance based on current expectations that involve risks, uncertainties and assumptions. Actual results may differ materially from those discussed in the forward-looking statements as a result of various factors. See the Note Regarding Forward-Looking Statements and Information. Investors are directed to consider the risks and uncertainties discussed in Part II, Item 1A of this Quarterly Report on Form 10-Q, as well as in other documents we have filed with the SEC.

Executive Summary

Overview

We are one of America’s leading financial services companies, providing: (i) advice and solutions for helping Americans set and meet their retirement goals and protect and transfer their wealth across generations; and (ii) a wide range of investment management insights, expertise and innovations to drive better investment decisions and outcomes for clients worldwide.

We manage our business through six segments: Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management and Legacy. We report certain activities and items that are not included in these segments in Corporate and Other. See Note 17 of the Notes to the Consolidated Financial Statements for further information on our segments.

We benefit from our complementary mix of businesses. This business mix provides diversity in our earnings sources, which helps offset fluctuations in market conditions and variability in business results, while offering growth opportunities.

Overview of Recent Developments

RGA Reinsurance Transaction

Novation

Table of Contents

Guaranteed Minimum Death Benefit guarantees reinsured by Venerable under the combined co-insurance and modified coinsurance basis agreement executed on June 1, 2021.

As a result of the novation of certain Legacy VA policies completed during the first quarter 2025, the Company recorded a loss of $499 million in pre-tax net income and an increase of $263 million in pre-tax AOCI, for a total impact loss of $236 million. The negative net income impact is mostly driven by the reduction of the purchased MRB asset of $2.0 billion and the reduction of Liability for MRBs of $1.6 billion, offset by a decrease in reinsurance deposit liability of $183 million. Purchase MRB asset reduction is larger than the direct MRB liability reduction since the Venerable reinsurance assets sit in a collateralized trust and thus materially reduce the non-performance risk. Deposit account liability decreases as novation leads to faster amortization of the liability. The novation impact from the base contracts and the contracts in payout status is less material, as the decrease in policyholders’ account balance of $33 million and decrease in liability for future policyholders’ benefits of $458 million are largely offset by a decrease in Amounts due to reinsurers of $432 million.

Tender Offer and AB Unit Exchange

On February 24, 2025, Holdings commenced the AB Tender Offer to purchase up to 46 million AB Holding Units at a price of $38.50 per unit, less any applicable tax withholding, for an aggregate purchase price of $1.8 billion. On April 3, 2025, Holdings purchased (the “Purchase”) 19.7 million AB Holdings Units pursuant to the AB Tender Offer for an aggregate cost of $758 million. The AB Holdings Units accepted for purchase represent approximately 17.9% of the outstanding units as of March 31, 2025. On July 10, 2025, AB and Holdings entered into an Amended and Restated Master Exchange Agreement to increase the AB Units that remain available for exchange from 4.8 million AB Units to 19.7 million AB Units, and Holdings exchanged 19.7 million AB Holding Units for an equal number of limited partnership interests in ABLP. After giving effect to the exchange Holdings continues to own approximately 68.6% of the economic interest in AB.

Term Loan Agreement

In connection with the commencement of the AB Tender Offer described in the precedent paragraph, Holdings entered into a 364-Day Term Loan Credit Agreement (the “Term Loan Agreement”) with respect to a $500 million senior unsecured delayed-draw term loan (the “Term Loan”). The Term Loan was intended to be used, along with available cash and cash equivalents, to fund the AB Tender Offer and related fees and expenses. The Term Loan was available to be drawn at any time on or prior to April 24, 2025 and would have matured 364 days from the date of funding. However, on April 15, 2025, Holdings elected not to request any such Term Loan, as it was unnecessary to fund the AB Tender Offer, and the Term Loan Agreement was terminated effective April 3, 2025.

Macroeconomic and Industry Trends

Our business and consolidated results of operations are significantly affected by economic conditions and consumer confidence, conditions in the global capital markets and the interest rate environment.

Financial and Economic Environment

Following the sharp pullback in early April, triggered by the rollout of tariffs, U.S. equity markets rebounded quickly as the newly imposed levies were paused to facilitate trade negotiations. Despite concerns stemming from soft consumer sentiment and rising inflation expectations, employment data largely remained resilient and corporate earnings were strong.

A wide variety of factors continue to impact financial and economic conditions. These factors include, among others, uncertainty regarding the federal debt limit, high fuel and energy costs, changes in fiscal or monetary policy and geopolitical tensions. The Russian invasion of the Ukraine, the Israel-Hamas war and broader Middle Eastern hostilities, including with Hezbollah in Lebanon and Iran, and the ensuing conflicts and the sanctions and other measures imposed in response to these conflicts, have significantly contributed to volatility in the financial markets and have increased the level of economic and political uncertainty. Consumer and economic uncertainty due to rapid changes in global trade policies, including announced tariff increases and potential additional tariff increases, continue to cause market volatility and heighten concerns regarding inflation. For further information on the risk of increased volatility in the financial markets to our business, see “Risk Factors—Risks Relating to Conditions in the Financial Markets and the Economy—Conditions in the global capital markets and the economy and Equity market declines and volatility” in the 2024 Form 10-K.

Table of Contents

Stressed conditions, volatility and disruptions in the capital markets, particular markets, or financial asset classes can have an adverse effect on us, in part because we have a large investment portfolio. In addition, our insurance liabilities and derivatives are sensitive to changing market factors, including equity market performance and interest rates. An increase in market volatility could continue to affect our business, including through effects on the yields we earn on invested assets, changes in required reserves and capital and fluctuations in the value of our AUM, AV or AUA from which we derive our fee income. These effects could be exacerbated by uncertainty about future fiscal policy, changes in tax policy, the scope of potential deregulation and levels of global trade.

The potential for increased volatility could pressure sales and reduce demand for our products as consumers consider purchasing alternative products to meet their objectives. In addition, this environment could make it difficult to consistently develop products that are attractive to customers. Financial performance can be adversely affected by market volatility and equity market declines as fees driven by AV and AUM fluctuate, hedging costs increase and revenues decline due to reduced sales and increased outflows.

We monitor the behavior of our customers and other factors, including mortality rates, morbidity rates, annuitization rates and lapse and surrender rates, which change in response to changes in capital market conditions, to ensure that our products and solutions remain attractive and profitable. For additional information on our sensitivity to interest rates and capital market prices, see “Quantitative and Qualitative Disclosures About Market Risk” in the 2024 Form 10-K.

Regulatory Developments

Our U.S. life insurance subsidiaries are regulated primarily at the state level, with some policies and products also subject to federal regulation. Holdings and its insurance subsidiaries are subject to regulation under the insurance holding company laws of various U.S. jurisdictions. On an ongoing basis, regulators refine capital requirements and introduce new reserving standards. Regulations recently adopted or currently under review can potentially impact our statutory reserve, capital requirements and profitability of the industry and result in increased regulation and oversight for the industry.

Insurance Regulation

Regulation of Investments

The NAIC is evaluating the risks associated with insurers’ investments in certain categories of structured securities, including CLOs. In 2023, the NAIC approved interim rules that raise capital requirements for holdings of CLO and other asset-backed security residual interests. Effective January 1, 2024, the NAIC adopted an amendment to the Purposes and Procedures Manual of the NAIC Investment Analysis Office (the “Purposes and Procedures Manual”) to give the NAIC’s Structured Securities Group, housed within the NAIC’s Securities Valuation Office (the “SVO”), responsibility for modeling CLO securities and evaluating tranche level losses across all debt and equity tranches under a series of calibrated and weighted collateral stress scenarios in order to assign NAIC Designations. Under the amended Purposes and Procedures Manual, CLO investments will no longer be broadly exempt from filing with the SVO based on ratings from credit rating providers. The NAIC’s goal is to ensure that the weighted average RBC factor for owning all tranches of a CLO more closely aligns with what would be required for directly owning all of the underlying loan collateral, in order to avoid RBC arbitrage. The Purposes and Procedures Manual requires insurers to begin reporting the financially modeled NAIC Designations for CLOs with their year-end 2025 financial statement. The NAIC is collaborating with interested parties to refine the process for modeling CLO investments.

In related work, the NAIC’s Financial Condition (E) Committee launched a holistic review of the insurance regulatory framework related to insurer investment risk regulation, on which work began in 2023. The primary objective is to highlight areas where the insurance regulatory framework and the SVO can be enhanced to strengthen oversight of insurers’ investments in complex assets. The proposed changes to modernize investment oversight include (i) reducing / eliminating “blind” reliance on credit rating providers while continuing to use them by implementing a due diligence framework that oversees the effectiveness of credit rating providers; and (ii) bolstering the SVO’s risk analysis capabilities by investing in a risk analytics tool and adding specialized personnel. In July 2025, the Financial Committee (E) Committee approved the formation of three new working groups to assist with implementing enhancements to the framework for regulating insurer investments.

In November 2024, the NAIC adopted an amendment to the Purposes and Procedures Manual that sets forth procedures for SVO staff to identify and evaluate a filing-exempt security with an NAIC Designation determined by a rating that appears to be an unreasonable assessment of investment risk. The procedures include, without limitation, sending an information request to insurers that hold the security under review and determining whether the NAIC Designation is three or more notches different from the SVO’s assessment, which would allow the SVO to request the removal of the credit rating from the filing exempt

Table of Contents

process. At any time during the process, an alternate credit rating may be requested and, if one is received, it will be incorporated into the filing exempt process. The Purposes and Procedures Manual amendment is scheduled to become effective on January 1, 2026.

In February 2025, the NAIC announced the formation of a new Risk-Based Capital Model Governance (EX) Task Force. The purpose of the new task force is to provide executive-level oversight and coordination of the various NAIC groups that are reviewing RBC-related standards. The task force is also charged with completing a comprehensive gap analysis by year-end 2025 to identify gaps in the current RBC framework and developing guiding principles for future RBC adjustments. In July 2025, the task force exposed for comment a proposed set of RBC principles with the aim of enhancing RBC precision with respect to asset risk.

Reinsurance

In July 2025, the NAIC’s Life Insurance and Annuities (A) Committee adopted an actuarial guideline that subjects certain post January 1, 2016 offshore reinsurance transactions to enhanced asset adequacy testing. The guideline requires asset adequacy testing for long-duration insurance business that relies heavily on asset returns (i.e., “asset-intensive reinsurance transactions”) within the scope of the guideline that either meet certain size-based thresholds or result in significant reinsurance collectability risk (as determined by the cedent’s appointed actuary). Such asset adequacy testing would be performed using a cash flow testing methodology. The actuarial guideline requires disclosure by the ceding insurer, meaning that it will not require that additional reserves be posted at the reinsurer level (although the ceding insurer may decide to post reserves). It is important to note that domestic regulators will continue to have the authority to take action on known issues, or issues that may become known as part of such new reporting, and may require additional analysis or reserves following such disclosure. The Company is preparing to comply with this new guideline, for which reporting will be required with respect to reserves reported as of December 31, 2025 in an insurer’s annual statement, assuming that the guideline is finally adopted by the NAIC’s Executive (EX) Committee and Plenary in 2025.

Derivatives Regulation and Clearing of Treasury Securities

In 2023, the SEC adopted rules to require that covered clearing agencies have policies and procedures reasonably designed to require every direct participant of the agency to submit for clearing eligible secondary market transactions in U.S. Treasury securities. Participants must clear eligible cash transactions in U.S. Treasury securities beginning on December 31, 2026, and eligible repurchase and reverse repurchase transactions in U.S. Treasury securities beginning on June 30, 2027. As a result, certain transactions between such participants and us will be required to be cleared. The rule’s potential effect on the U.S. Treasury markets is uncertain.

Fiduciary Rules

In 2023, the U.S. Department of Labor (the “DOL”) proposed a regulation to change the definition of “fiduciary” for purposes of the Employee Retirement Income Security Act of 1974 (“ERISA”) and parallel provisions of the Internal Revenue Code of 1986, as amended (the “Code”), when a financial professional, including an insurance producer, provides investment advice, and proposed amendments to various existing prohibited transaction exemptions (“PTEs”), including PTE 84-14 that financial professionals rely on when they make investment recommendations to retirement investors. On April 23, 2024, the DOL finalized and published this new definition of “fiduciary” for purposes of ERISA and parallel provisions of the Code and finalized and published amendments to these PTEs (the new definition and the PTE amendments collectively, the “Final Rule”).

Various industry groups brought litigation against the DOL seeking a variety of remedies for the Final Rule. On July 25, 2024, the U.S. District Court for the Eastern District of Texas (the “E.D. Tex.”) issued a stay of the effective date of portions of the Final Rule. On July 26, 2024, the U.S. District Court for the Northern District of Texas (the “N.D. Tex.”) issued a stay of the effective date of the Final Rule as a whole. As a result of these court opinions, it is uncertain whether the Final Rule will become effective. The DOL appealed the stays issued in these cases to the U.S. Court of Appeals for the Fifth Circuit, but in early 2025, the court granted the DOL’s motion to pause proceedings while it reviews its posture on these cases. While this litigation proceeds, we are evaluating the potential impact of the Final Rule on our business, particularly as it pertains to the sale of insurance products to retirement investors.

Federal Tax Legislation, Regulation and Administration

Enacted Legislation

Table of Contents

On July 4, 2025, President Trump signed into law “An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14,” commonly referred to as the One Big Beautiful Bill Act (the “OBBBA”). This sweeping legislative package is designed to extend the expiring provisions of the Tax Cuts and Jobs Act (“TCJA”) and deliver additional tax relief for individuals and businesses. The tax provisions in the OBBBA are not expected to have a material impact on the Company.

For additional information on regulatory developments and the risks we face, see “Business—Regulation” and “Risk Factors—Legal and Regulatory Risks” in the 2024 Form 10-K.

Revenues

Our revenues come from three principal sources:

•fee income derived from our retirement and protection products and our asset management services;

•premiums from our traditional life insurance and annuity products; and

•investment income from our General Account investment portfolio.

Our fee income varies directly in relation to the amount of the underlying AV or benefit base of our retirement and protection products, the amount of AUM and AUA in our Wealth Management business, and the amount of AUM in our Asset Management business. AV and AUM, each as defined in “Key Operating Measures,” are influenced by changes in economic conditions, primarily equity market returns, as well as net flows. Our premium income is driven by the growth in new policies written and the persistency of our in-force policies, both of which are influenced by a combination of factors, including our efforts to attract and retain customers and market conditions that influence demand for our products. Our investment income is driven by the yield on our General Account investment portfolio and is impacted by the prevailing level of interest rates as we reinvest cash associated with maturing investments and net flows to the portfolio.

Benefits and Other Deductions

Our primary expenses are:

• policyholders’ benefits and interest credited to policyholders’ account balances;

• sales commissions and compensation paid to intermediaries and advisors that distribute our products and services; and

• compensation and benefits provided to our employees and other operating expenses.

Policyholders’ benefits are driven primarily by mortality, customer withdrawals, and benefits which change in response to changes in capital market conditions. In addition, some of our policyholders’ benefits are directly tied to the AV and benefit base of our variable annuity products. Interest credited to policyholders varies in relation to the amount of the underlying AV or benefit base. Sales commissions and compensation paid to intermediaries and advisors vary in relation to premium and fee income generated from these sources, whereas compensation and benefits to our employees are more constant and impacted by market wages and decline with increases in efficiency. Our ability to manage these expenses across various economic cycles and products is critical to the profitability of our company.

Net Income Volatility

We have offered and continue to offer variable annuity products with GMxB features. The future claims exposure on these features is sensitive to movements in the equity markets and interest rates. Accordingly, we have implemented hedging and reinsurance programs designed to mitigate the economic exposure to us from these features due to equity market and interest rate movements. We are using a combination of General Account assets and derivatives to manage duration gap on an economic basis. The changes in the values of the derivatives associated with these programs due to equity and interest rate movements, together with the GMxB MRBs assets and liabilities are recognized in net income in the periods in which they occur, while the General Account asset gains and losses are recognized in OCI resulting in an offset between OCI and net income. In addition, we conduct macro hedging to protect our statutory capital which could also cause net income volatility as further described below. Net income is also impacted by changes in our reinsurers credit spread, while changes in the Company’s credit spread is recorded in OCI. See “—Significant Factors Impacting Our Results—Impact of Hedging and GMxB Reinsurance on Results.”

Table of Contents

In addition to our dynamic hedging strategy, we have static hedge positions designed to mitigate the adverse impact of changing market conditions on our statutory capital. We believe this program will continue to preserve the economic value of our variable annuity contracts and better protect our target variable annuity asset level. However, these static hedge positions increase the size of our derivative positions and may result in additional net income volatility on a period-over-period basis.

Due to the impacts on our net income of equity market and interest rate movements and other items that are not part of the underlying profitability drivers of our business, we evaluate and manage our business performance using Non-GAAP Operating Earnings, a Non-GAAP financial measure that is intended to remove these impacts from our results. See “—Key Operating Measures—Non-GAAP Operating Earnings.”

Significant Factors Impacting Our Results

The following significant factors have impacted, and may in the future impact, our financial condition, results of operations or cash flows.

Impact of Hedging and GMxB Reinsurance on Results

•Variable annuity hedging programs. We use a dynamic hedging program (within this program, generally, we reevaluate our economic exposure at least daily and rebalance our hedge positions accordingly) to mitigate certain risks associated with the GMxB features that are embedded in our liabilities for our variable annuity products. This program utilizes various derivative instruments that are managed in an effort to reduce the economic impact of unfavorable changes in GMxB features’ exposures attributable to movements in the equity markets and interest rates. Although this program is designed to provide a measure of economic protection against the impact of adverse market conditions, it does not qualify for hedge accounting treatment. Accordingly, changes in value of the derivatives will be recognized in the period in which they occur with offsetting changes in reserves recognized in the current period. In addition, we utilize AFS fixed maturity securities in our General Account to mitigate the economic impact of unfavorable changes in GMxB features’ exposures attributable to movements in interest rates. However, the economic effect of interest rate changes on such securities is reflected in OCI, which results in net income volatility as the economic effect of interest rates on our GMxB MRB liabilities is reflected in net income.

•In addition to our dynamic hedging program, we have a hedging program using static hedge positions (derivative positions intended to be HTM with less frequent re-balancing) to protect our statutory capital against stress scenarios. This program, in addition to our dynamic hedge program, has increased the size of our derivative positions, resulting in additional net income volatility. The impacts are most pronounced for variable annuity products.

•GMxB reinsurance contracts. Historically, GMxB reinsurance contracts were used to cede to non-affiliated reinsurers a portion of our exposure to variable annuity products that offer GMxB features. We account for the reinsurance contracts as MRBs and report them at fair value. In addition, on June 1, 2021, we ceded legacy variable annuity policies sold by Equitable Financial between 2006-2008 (the “Block”), comprised of non-New York “Accumulator” policies containing fixed rate GMIB and/or GMDB guarantees.

Effect of Assumption Updates on Operating Results

During the third quarter of each year, we conduct our annual review of the assumptions underlying the valuation of DAC, deferred sales inducement assets, unearned revenue liabilities, liabilities for future policyholder benefits and MRBs for our Individual Retirement, Group Retirement, Protection Solutions, and Legacy segments (assumption reviews are not relevant for the Asset Management and Wealth Management segments). Assumptions are based on a combination of Company experience, industry experience, management actions and expert judgement and reflect our best estimate as of the date of the applicable financial statements.

Table of Contents

Most of the variable annuity products, variable universal life insurance and universal life insurance products we offer maintain policyholder deposits that are reported as liabilities and classified within either Separate Accounts liabilities or policyholder account balances. Our products and riders also impact liabilities for future policyholder benefits, MRBs and unearned revenues and assets for DAC and DSI. The valuation of these assets and liabilities (other than deposits) is based on differing accounting methods depending on the product, each of which requires numerous assumptions and considerable judgment. The accounting guidance applied in the valuation of these assets and liabilities includes, but is not limited to, the following: (i) traditional life insurance products for which assumptions are updated annually to estimate the value of future death, morbidity or income benefits; (ii) universal life insurance and variable life insurance secondary guarantees for which benefit liabilities are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the accumulation period based on total expected assessments; and (iii) certain product guarantees reported as MRBs at fair value.

For further details of our accounting policies and related judgments pertaining to assumption updates, see Note 2 of the Notes to the Consolidated Financial Statements.

Key Operating Measures

In addition to our results presented in accordance with U.S. GAAP, we report Non-GAAP Operating Earnings, and Non-GAAP operating common EPS, each of which is a measure that is not determined in accordance with U.S. GAAP. Management principally uses these Non-GAAP financial measures in evaluating performance because they present a clearer picture of our operating performance and they allow management to allocate resources. Similarly, management believes that the use of these Non-GAAP financial measures, together with relevant U.S. GAAP measures, provide investors with a better understanding of our results of operations and the underlying profitability drivers and trends of our business. These Non-GAAP financial measures are intended to remove from our results of operations the impact of market changes (where there is a mismatch in the valuation of assets and liabilities) as well as certain other expenses which are not part of our underlying profitability drivers or likely to re-occur in the foreseeable future, as such items fluctuate from period-to-period in a manner inconsistent with these drivers. These measures should be considered supplementary to our results that are presented in accordance with U.S. GAAP and should not be viewed as a substitute for the U.S. GAAP measures. Other companies may use similarly titled Non-GAAP financial measures that are calculated differently from the way we calculate such measures. Consequently, our Non-GAAP financial measures may not be comparable to similar measures used by other companies.

We also discuss certain operating measures, including AUM, AUA, AV, Protection Solutions reserves and certain other operating measures, which management believes provide useful information about our businesses and the operational factors underlying our financial performance.

Non-GAAP Operating Earnings

Non-GAAP Operating Earnings is an after-tax Non-GAAP financial measure used to evaluate our financial performance on a consolidated basis that is determined by making certain adjustments to our consolidated after-tax net income attributable to Holdings. The most significant of such adjustments relates to our derivative positions, which protect economic value and statutory capital, and the variable annuity product MRBs. This is a large source of volatility in net income.

Non-GAAP Operating Earnings equals our consolidated after-tax net income attributable to Holdings adjusted to eliminate the impact of the following items:

•Investment (gains) losses, which includes credit loss impairments of securities/investments, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances;

Table of Contents

Because Non-GAAP Operating Earnings excludes the foregoing items that can be distortive or unpredictable, management believes that this measure enhances the understanding of our underlying drivers of profitability and trends in our business, thereby allowing management to make decisions that will positively impact our business.

We use the prevailing corporate federal income tax rate of 21% while taking into account any non-recurring differences for events recognized differently in our financial statements and federal income tax returns as well as partnership income taxed at lower rates when reconciling Net income (loss) attributable to Holdings to Non-GAAP Operating Earnings.

The table below presents a reconciliation of net income (loss) attributable to Holdings to Non-GAAP Operating Earnings:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Net income (loss) attributable to Holdings	$	(349)	$	428	$	(286)	$	520
Adjustments related to:
Variable annuity product features (1)	934		81		1,145		411
Investment (gains) losses	71		16		85		55
Net actuarial (gains) losses related to pension and other postretirement benefit obligations	11		14		22		31
Other adjustments (2)	(137)		(33)		68		58
Income tax expense (benefit) related to above adjustments	(185)		(16)		(277)		(116)
Non-recurring tax items	7		5		16		13
Non-GAAP Operating Earnings	$	352	$	495	$	773	$	972

_____________

(2)Includes a gain of $198 million and $33 million on Non-VA derivatives for the three and six months ended June 30, 2025, respectively. Also includes $14 million of expense related to a disputed billing practice of an AB third-party service provider for the three and six months ended June 30, 2025, respectively, and certain gross legal expenses related to the COI litigation of $106 million for the six months ended June 30, 2024.

We calculate Non-GAAP Operating ROE by dividing Non-GAAP Operating Earnings for the previous twelve calendar months by consolidated average equity attributable to Holdings’ common shareholders, excluding AOCI. AOCI fluctuates period-to-period in a manner inconsistent with our underlying profitability drivers as the majority of such fluctuation is related to the market volatility of the unrealized gains and losses associated with our AFS securities. Therefore, we believe excluding AOCI is more effective for analyzing the trends of our operations.

The following table presents return on average equity attributable to Holdings’ common shareholders, excluding AOCI and Non-GAAP Operating ROE for the trailing twelve months:

Table of Contents


	Trailing Twelve Months Ended June 30, 2025
	(Dollars in millions)
Net income (loss) available to Holdings’ common shareholders	$	402
Average equity attributable to Holdings’ common shareholders, excluding AOCI	$	8,206
Return on average equity attributable to Holdings’ common shareholders, excluding AOCI	4.9		%

Non-GAAP Operating Earnings available to Holdings’ common shareholders	$	1,733
Average equity attributable to Holdings’ common shareholders, excluding AOCI	$	8,206
Non-GAAP Operating ROE	21.1		%

Non-GAAP Operating Common EPS

Non-GAAP operating common EPS is calculated by dividing Non-GAAP Operating Earnings by diluted common shares outstanding. The following table sets forth Non-GAAP operating common EPS:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(per share amounts)
Net income (loss) attributable to Holdings	$	(1.15)	$	1.31	$	(0.94)	$	1.57
Less: Preferred stock dividends	0.06		0.08		0.10		0.12
Net income (loss) available to Holdings’ common shareholders	(1.21)		1.23		(1.04)		1.45
Adjustments related to:
Variable annuity product features (1)	3.08		0.25		3.75		1.24
Investment (gains) losses	0.23		0.05		0.28		0.17
Net actuarial (gains) losses related to pension and other postretirement benefit obligations	0.04		0.04		0.07		0.09
Other adjustments (2)	(0.45)		(0.11)		0.23		0.18
Income tax expense (benefit) related to above adjustments	(0.61)		(0.05)		(0.91)		(0.35)
Non-recurring tax items	0.02		0.02		0.05		0.04
Non-GAAP operating common EPS	$	1.10	$	1.43	$	2.43	$	2.82

______________

(1)As a result of the novation of certain Legacy VA policies completed during the first quarter of 2025, the Company recorded a loss of $1.63 for the six months ended June 30, 2025.

(2)Includes a gain of $0.65 and $0.11 on Non-VA derivatives for the three and six months ended June 30, 2025, respectively. Also includes $0.05 of expense related to a disputed billing practice of an AB third-party service provider for the three and six months ended June 30, 2025, respectively, and certain gross legal expenses related to the COI litigation of $0.32 for the six months ended June 30, 2024.

Assets Under Management

AUM means investment assets that are managed by one of our subsidiaries and includes: (i) assets managed by AB; (ii) the assets in our General Account investment portfolio; and (iii) the Separate Accounts assets of our Individual Retirement, Group Retirement and Protection Solutions businesses. Total AUM reflects exclusions between segments to avoid double counting.

Assets Under Administration

AUA includes non-insurance client assets that are invested in our savings and investment products or serviced by our Equitable Advisors platform. We provide administrative services for these assets and generally record the revenues received as distribution fees.

Account Value

AV generally equals the aggregate policy account value of our retirement products. General Account AV refers to account balances in investment options that are backed by the General Account while Separate Accounts AV refers to Separate Accounts investment assets.

100

Table of Contents

Protection Solutions Reserves

Protection Solutions Reserves equals the aggregate value of policyholders’ account balances and future policy benefits for policies in our Protection Solutions segment.

Consolidated Results of Operations

Our consolidated results of operations are significantly affected by conditions in the capital markets and the economy because we offer market sensitive products. These products have been a significant driver of our results of operations. Because the future claims exposure on these products is sensitive to movements in the equity markets and interest rates, we have in place various hedging and reinsurance programs that are designed to mitigate the economic risk of movements in the equity markets and interest rates. The volatility in net income attributable to Holdings for the periods presented below results from the mismatch between: (i) the change in carrying value of the reserves for GMDB and certain GMIB features that do not fully and immediately reflect the impact of equity and interest market fluctuations; (ii) the change in fair value of products with the GMIB feature that have a no-lapse guarantee; and (iii) our hedging and reinsurance programs.

Ownership and Consolidation of AllianceBernstein

Our indirect, wholly-owned subsidiary, AllianceBernstein Corporation, is the General Partner of AB. Accordingly, AB’s results are fully reflected in our consolidated financial statements. For additional information on our economic interest in AB, see Note 1 of the Notes to the Consolidated Financial Statements.

Consolidated Results of Operations

The following table summarizes our consolidated statements of income (loss):

Consolidated Statements of Income (Loss)


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions, except per share data)
REVENUES
Policy charges and fee income	$	626	$	617	$	1,262	$	1,231
Premiums	260		282		564		567
Net derivative gains (losses)	(1,374)		(208)		(575)		(1,584)
Net investment income (loss)	1,355		1,167		2,603		2,377
Investment gains (losses), net:
Credit losses on available-for-sale debt securities and loans	(54)		(15)		(54)		(35)
Other investment gains (losses), net	(17)		(1)		(31)		(20)
Total investment gains (losses), net	(71)		(16)		(85)		(55)
Investment management and service fees	1,272		1,240		2,557		2,518
Other income	294		425		612		683
Total revenues	2,362		3,507		6,938		5,737

101

Table of Contents


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions, except per share data)
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits	787		667		1,546		1,344
Remeasurement of liability for future policy benefits	(13)		(7)		(15)		(2)
Change in market risk benefits and purchased market risk benefits	(606)		(132)		66		(1,220)
Interest credited to policyholders’ account balances	796		599		1,474		1,178
Compensation and benefits	592		577		1,193		1,197
Commissions and distribution-related payments	488		463		989		900
Interest expense	61		62		116		119
Amortization of deferred policy acquisition costs	193		169		381		341
Other operating costs and expenses	427		428		1,377		980
Total benefits and other deductions	2,725		2,826		7,127		4,837
Income (loss) from continuing operations, before income taxes	(363)		681		(189)		900
Income tax (expense) benefit	80		(116)		56		(140)
Net income (loss)	(283)		565		(133)		760
Less: Net income (loss) attributable to the noncontrolling interest	66		137		153		240
Net income (loss) attributable to Holdings	(349)		428		(286)		520
Less: Preferred stock dividends	18		26		32		40
Net income (loss) available to Holdings’ common shareholders	$	(367)	$	402	$	(318)	$	480

EARNINGS PER COMMON SHARE
Net income (loss) applicable to Holdings’ common shareholders per common share:
Basic	$	(1.21)	$	1.24	$	(1.04)	$	1.47
Diluted	$	(1.21)	$	1.23	$	(1.04)	$	1.45
Weighted average common shares outstanding (in millions):
Basic	303.2		324.2		305.5		327.2
Diluted	303.2		327.3		305.5		330.4


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Non-GAAP Operating Earnings	$	352	$	495	$	773	$	972

The following table summarizes our Non-GAAP Operating Earnings per common share:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(per share amounts)
Non-GAAP Operating Earnings per common share:
Basic	$	1.10	$	1.45	$	2.43	$	2.85
Diluted	$	1.10	$	1.43	$	2.43	$	2.82

Three Months Ended June 30, 2025 Compared to the Three Months Ended June 30, 2024

Net Income (Loss) Attributable to Holdings

Net income attributable to Holdings decreased $777 million to a net loss of $349 million for the three months ended June 30, 2025 from $428 million net income in the three months ended June 30, 2024. The following notable items were the primary drivers for the change in net income (loss):

102

Table of Contents

Unfavorable items included:

•Net derivative losses increased by $1.2 billion mainly due to higher equity market appreciation during the second quarter 2025 compared to the second quarter 2024.

•Interest credited to policyholders’ account balances increased by $197 million mainly due to growth of account values in our Individual Retirement segment and higher interest expense on funding agreements in Corporate and Other.

•Policyholders’ benefits increased by $120 million mainly due to higher net mortality in our Protection Solutions segment.

•Fee-type revenue decreased by $112 million mainly due to the gain on sale of AB’s Bernstein Research Service in 2024, partially offset by higher investment base advisory fees and distribution revenue from higher average AUM in our Asset Management segment.

•Investment losses increased by $55 million mainly due to fixed maturity sales and mortgage valuation losses.

•Commissions and distribution-related payments increased by $25 million mainly due to higher asset-based commissions and sales volume in our Individual Retirement segment and higher payments for the distribution of AB mutual funds resulting from higher average AUM in our Asset Management segment.

•Amortization of DAC increased by $24 million mainly due to growth in the business from sales momentum in our Individual Retirement segment and a favorable one-time adjustment in 2024 in our Group Retirement segment.

•Compensation, benefits, interest and other operating expenses increased by $13 million mainly due to higher base compensation in our Asset Management segment.

These were partially offset by the following favorable items:

•Change in market risk benefits and purchased market risk benefits decreased by $474 million mainly due to more favorable equity market movements during the second quarter 2025 compared to the second quarter 2024. This was partially offset by less favorable interest rate movements during the second quarter 2025 compared to the second quarter 2024.

•Net investment income increased by $188 million mainly due to higher average asset balances, higher alternative investments, and higher income on seed capital investments, partially offset by lower investment yields.

•Income tax benefit was $80 million for the second quarter 2025 compared to income tax expense of $116 million for the second quarter of 2024 mainly due to a pre-tax loss in the second quarter 2025 compared to pre-tax income in the second quarter 2024.

•Net income attributable to noncontrolling interest decreased by $71 million mainly due to lower pre-tax earnings and an increase in average economic ownership of AB.

Non-GAAP Operating Earnings

Non-GAAP Operating Earnings decreased by $143 million to $352 million for the three months ended June 30, 2025 from $495 million in the three months ended June 30, 2024. The following notable items were the primary drivers for the change in Non-GAAP Operating Earnings:

Unfavorable items included:

•Interest credited to policyholders’ account balances increased by $207 million mainly due to growth of account values in our Individual Retirement segment and higher interest expense on funding agreements in Corporate and Other.

•Policyholders’ benefits increased by $120 million mainly due to higher net mortality in our Protection Solutions segment.

103

Table of Contents

•Net derivative losses increased $19 million mainly due to higher losses from economically hedging seed capital investments (primarily offset in Net investment income), which was partially offset by gains due to market changes in total return swaps.

These were partially offset by the following favorable items:

•Net investment income increased by $185 million mainly due to higher average asset balances, higher alternative investments, and higher income on seed capital investments, partially offset by lower investment yields.

•Income tax expense decreased by $27 million primarily due to lower pre-tax earnings.

•Net income attributable to the noncontrolling interest decreased by $21 million mainly due to an increase in average economic ownership of AB, partially offset by higher pre-tax earnings.

Six Months Ended June 30, 2025 Compared to the Six Months Ended June 30, 2024

Net Income (Loss) Attributable to Holdings

Net income attributable to Holdings decreased $806 million to a net loss of $286 million during the six months ended June 30, 2025 from $520 million income in the six months ended June 30, 2024. The following were notable changes in net income (loss):

Unfavorable items included:

•Change in market risk benefits and purchased market risk benefits increased by $1.3 billion mainly due to a decrease in interest rates in the first six months of 2025 compared to an increase in interest rates in the first six months of 2024, further driven by less favorable equity market movements in the first six months of 2025 compared to the first six months of 2024.

•Compensation, benefits, interest and other operating expenses increased by $390 million mainly due to the Venerable novation loss.

•Interest credited to policyholders’ account balances increased by $296 million mainly due to growth of account values in our Individual Retirement segment, higher average account balances in institutional markets in our Group Retirement segment and higher interest expense on funding agreements in Corporate and Other.

•Policyholders’ benefits increased by $202 million mainly due to higher net mortality in our Protection Solutions segment.

•Commissions and distribution-related payments increased by $89 million mainly due to higher asset-based commissions and sales volumes in our Individual Retirement segment and higher payments to financial intermediaries for the distribution of AB mutual funds resulting from higher average AUM in our Asset Management segment.

•Amortization of DAC increased by $40 million mainly due to growth in our Individual Retirement segment from sales momentum.

•Investment losses increased by $30 million mainly due to fixed maturity sales and mortgage valuation losses.

These were partially offset by the following favorable items:

•Net derivative losses decreased $1.0 billion primarily driven by lower equity market appreciation during the first six months of 2025 compared to the first six months of 2024.

•Net investment income increased by $226 million mainly due to higher average asset balances and higher alternative investment income, partially offset by lower investment yields.

•Income tax benefit was $56 million for the first six months of 2025 compared to income tax expense of $140 million for the first six months of 2024 mainly due to a pre-tax loss in the first six months of 2025 compared to pre-tax income in the first six months of 2024.

•Net income attributable to noncontrolling interest decreased by $87 million mainly due to lower pre-tax earnings and an increase in average economic ownership of AB.

See “—Significant Factors Impacting Our Results—Effect of Assumption Updates on Operating Results” for more information regarding assumption updates.

104

Table of Contents

Non-GAAP Operating Earnings

Non-GAAP Operating Earnings decreased by $199 million to $773 million for the six months ended June 30, 2025 from $972 million in the six months ended June 30, 2024. The following were notable changes in Non-GAAP Operating Earnings:

Unfavorable items included:

•Interest credited to policyholders’ account balances increased by $291 million mainly due to growth of account values in our Individual Retirement segment, higher average account balances in institutional markets in our Group Retirement segment and higher interest expense on funding agreements in Corporate and Other.

•Policyholders’ benefits increased by $202 million mainly due to higher net mortality in our Protection Solutions segment.

•Amortization of DAC increased by $40 million mainly due to growth in our Individual Retirement segment from sales momentum.

These were partially offset by the following favorable items:

•Net investment income increased by $256 million mainly due to higher average asset balances and higher alternative investment income, partially offset by lower investment yields.

•Fee-type revenue increased by $82 million mainly driven by higher advisory fee type revenue attributed to higher average asset balances combined with increased distribution fees from higher retirement sales in our Asset Management and Wealth Management segments, and higher average Separate Account values from market appreciation in our Group Retirement segment.

•Compensation, benefits, interest expense and other operating costs decreased by $27 million mainly due to lower base compensation and expenses driven by the sale of BRS, and lower office related expenses, partially offset by the recognition of a $21 million incentive grant gain in the prior year related to AB headquarters relocation to Nashville in our Asset Management segment, and higher variable compensation in our Wealth Management segment.

•Income tax expense decreased by $35 million mainly driven by lower pre-tax earnings in 2025.

•Net income attributable to the noncontrolling interest decreased by $20 million mainly due to a decrease in noncontrolling interest and gains from consolidated VIEs.

Results of Operations by Segment

We manage our business through the following six segments: Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management and Legacy. We report certain activities and items that are not included in our six segments in Corporate and Other. The following section presents our discussion of operating earnings (loss) by segment and AUM, AV and Protection Solutions Reserves by segment, as applicable. Consistent with U.S. GAAP guidance for segment reporting, operating earnings (loss) is our U.S. GAAP measure of segment performance. See Note 17 of the Notes to the Consolidated Financial Statements for further information on our segments.

105

Table of Contents

The following table summarizes operating earnings (loss) on our segments and Corporate and Other:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Operating earnings (loss) by segment:
Individual Retirement	$	215	$	246	$	431	$	484
Group Retirement	124		125		254		249
Asset Management	131		101		257		207
Protection Solutions	(58)		72		(75)		116
Wealth Management	51		44		97		87
Legacy	28		28		52		61
Corporate and Other	(139)		(121)		(243)		(232)
Non-GAAP Operating Earnings	$	352	$	495	$	773	$	972

Effective Tax Rates by Segment

The following table summarizes income tax expense which was allocated to the Company’s business segments:


	Six Months Ended June 30,
		2025		2024
		(percentages)
Effective Tax Rates by Segment:
Retirement and Protection business (1)		16	%	14	%
Asset Management		26	%	29	%
Wealth Management		25	%	27	%
Consolidated Non-GAAP Operating Earnings		20	%	19	%

______________

(1)Includes: Individual Retirement, Group Retirement, Protection Solutions and Legacy.

Individual Retirement

The Individual Retirement segment includes our variable annuity products which primarily meet the needs of individuals saving for retirement or seeking retirement income.

The following table summarizes operating earnings (loss) of our Individual Retirement segment:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024 (1)
	(in millions)
Operating earnings (loss)	$	215	$	246	$	431	$	484

_____________

(1)Prior periods were updated to reflect the impact of moving payout annuity policies from Legacy to Individual Retirement.

106

Table of Contents

Key components of operating earnings (loss) were:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024 (1)
	(in millions)
REVENUES
Policy charges, fee income and premiums	$	208	$	209	$	432	$	417
Net investment income	719		593		1,412		1,142
Net derivative gains (losses)	(5)		(6)		(10)		(11)
Investment management, service fees and other income	84		92		169		180
Segment revenues	$	1,006	$	888	$	2,003	$	1,728

BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits	$	76	$	78	$	168	$	155

Remeasurement of liability for future policy benefits	—		1		(1)		(2)
Interest credited to policyholders’ account balances	408		281		773		529
Commissions and distribution-related payments	101		80		199		157
Amortization of deferred policy acquisition costs	127		111		251		220
Compensation, benefits and other operating costs and expenses	37		51		101		105
Interest expense	—		—		—		—
Segment benefits and other deductions	$	749	$	602	$	1,491	$	1,164

_____________

(1)Prior periods were updated to reflect the impact of moving payout annuity policies from Legacy to Individual Retirement.

The following table summarizes AV for our Individual Retirement segment:




	June 30, 2025		December 31, 2024
	(in millions)
AV (1)
General Account	$	77,375	$	69,020
Separate Accounts	41,207		41,524
Total AV	$	118,582	$	110,544

_____________

(1)AV presented are net of reinsurance.

The following table summarizes a roll-forward of AV for our Individual Retirement segment:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024 (1)
	(in millions)
Balance, beginning of period	$	109,693	$	98,645	$	110,544	$	92,006
Gross premiums	4,837		4,520		9,414		8,876
Surrenders, withdrawals and benefits	(3,134)		(2,667)		(6,280)		(5,376)
Net flows	1,703		1,853		3,134		3,500
Change in market value and reinvestment and policy charges	2,613		492		3,249		2,415
Change in fair value of embedded derivative instruments	4,573		1,272		1,655		4,341

Balance, end of period	$	118,582	$	102,262	$	118,582	$	102,262
Ending embedded derivative	(18,023)		(14,670)		(18,023)		(14,670)
Balance as of end of period net of embedded derivative instruments	$	100,559	$	87,592	$	100,559	$	87,592

_____________

(1)Prior periods were updated to reflect the impact of moving payout annuity policies from Legacy to Individual Retirement.

107

Table of Contents

Three Months Ended June 30, 2025 Compared to the Three Months Ended June 30, 2024 for the Individual Retirement Segment

Operating earnings

Operating earnings decreased $31 million to $215 million during the three months ended June 30, 2025 from $246 million three months ended June 30, 2024. The following notable items were the primary drivers of the change in operating earnings:

Unfavorable items included:

•Interest credited to policyholders’ account balances increased by $127 million mainly due to the growth of account values.

•Commissions and distribution-related payments increased by $21 million mainly due to higher asset-based commissions and sales volumes.

•Amortization of DAC increased by $16 million mainly driven by growth in the business from sales momentum.

These were partially offset by the following favorable items:

•Net investment income increased by $126 million mainly due to higher average asset balances, partially offset by lower investment yields.

Net Flows and AV

•Total AV as of June 30, 2025 was $118.6 billion, an increase of $8.9 billion, compared to March 31, 2025. The increase in AV was primarily due to $7.2 billion of market appreciation and change in fair value of embedded derivative instruments in the second quarter 2025 and $1.7 billion of net inflows.

•Net inflows of $1.7 billion were $150 million lower than in the three months ended June 30, 2024, mainly driven by higher outflows, partially offset by higher gross premiums.

Six Months Ended June 30, 2025 Compared to the Six Months Ended June 30, 2024 for the Individual Retirement Segment

Operating earnings

Operating earnings decreased $53 million to $431 million during the six months ended June 30, 2025 from $484 million in the six months ended June 30, 2024. The following were notable changes in operating earnings (losses):

Unfavorable items included:

•Interest credited to policyholders’ account balances increased by $244 million mainly due to growth of account values.

•Commissions and distribution-related payments increased by $42 million mainly due to higher asset-based commissions and sales volumes.

•Amortization of DAC increased by $31 million mainly due to growth in the business from sales momentum.

•Policyholders’ benefits increased by $13 million mainly due to growth in the payout business, offset by higher premiums.

These were partially offset by the following favorable items:

•Net investment income increased by $270 million mainly due to higher average asset balances, partially offset by lower investment yields.

Net Flows and AV

•The increase in AV of $8.0 billion in the six months ended June 30, 2025 was driven by an increase in investment performance as a result of market depreciation and change in fair value of embedded derivative instruments of $4.9 billion in the six months ended June 30, 2025 and net inflows of $3.1 billion.

108

Table of Contents

•Net inflows of $3.1 billion were $0.4 billion lower than in the six months ended June 30, 2024, mainly driven by higher outflows in the six months ended June 30, 2025.

Group Retirement

The Group Retirement segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities and not-for-profit entities, as well as small and medium-sized businesses.

The following table summarizes operating earnings (loss) of our Group Retirement segment:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Operating earnings (loss)	$	124	$	125	$	254	$	249

Key components of operating earnings (loss) are:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
REVENUES
Policy charges, fee income and premiums	$	80	$	79	$	162	$	152
Net investment income	154		139		305		280
Net derivative gains (losses)	—		—		—		—
Investment management, service fees and other income	75		65		158		142
Segment revenues	$	309	$	283	$	625	$	574

BENEFITS AND OTHER DEDUCTIONS

Interest credited to policyholders’ account balances	68		56		$	131	$	108

Commissions and distribution-related payments	44		45		87		89
Amortization of deferred policy acquisition costs	16		8		31		23
Compensation, benefits and other operating costs and expenses	32		29		74		64

Segment benefits and other deductions	$	160	$	138	$	323	$	284

The following table summarizes AV and AUA for our Group Retirement segment:




	June 30, 2025		December 31, 2024
	(in millions)
AV and AUA
General Account	$	10,038	$	9,341
Separate Accounts and Mutual Funds	32,822		31,313
Total AV and AUA (1)	$	42,860	$	40,654

____________

(1) AV presented are net of reinsurance.

109

Table of Contents

The following table summarizes a roll-forward of AV and AUA for our Group Retirement segment:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Balance, beginning of period	$	39,914	$	38,490	$	40,654	$	36,471
Gross Premiums	1,328		1,570		2,803		2,588
Surrenders, withdrawals and benefits	(1,111)		(1,162)		(2,394)		(2,312)
Net flows	217		408		409		276
Change in market value and reinvestment and policy charges	2,690		362		1,776		2,490
Change in fair value of embedded derivative instruments	39		7		21		30


Balance, end of period	$	42,860	$	39,267	$	42,860	$	39,267
Ending embedded derivative	(74)		(76)		(74)		(76)
Balance as of end of period net of embedded derivative instruments	$	42,786	$	39,191	$	42,786	$	39,191

Three Months Ended June 30, 2025 Compared to the Three Months Ended June 30, 2024 for the Group Retirement Segment

Operating earnings

Operating earnings decreased by $1 million to $124 million during the three months ended June 30, 2025 from $125 million in the three months ended June 30, 2024. The following notable items were the primary drivers of the change in operating earnings:

Unfavorable items included:

•Interest credited to policyholders’ account balances increased by $12 million mainly due to higher average institutional account balances (offset in Net investment income).

•Amortization of DAC increased by $8 million mainly due to a favorable one-time adjustment in 2024.

These were partially offset by the following favorable items:

•Net investment income increased by $15 million due to higher income primarily from higher average asset balances and higher alternative investment income, partially offset by lower investment yields.

See “—Significant Factors Impacting Our Results—Effect of Assumption Updates on Operating Results” for more information regarding assumption updates.

Net Flows and AV

•The increase in AV of $2.9 billion in the three months ended June 30, 2025 was driven primarily by equity market appreciation of $2.7 billion and net inflows of $217 million.

•Net inflows of $217 million for the three months ended June 30, 2025 decreased by $191 million compared to the three months ended June 30, 2024, larger institutional lump sum premiums in 2024, partially offset by higher net flows in tax-exempt and corporate markets.

Six Months Ended June 30, 2025 Compared to the Six Months Ended June 30, 2024 for the Group Retirement Segment

Operating earnings

Operating earnings increased by $5 million to $254 million during the six months ended June 30, 2025 from $249 million during the six months ended June 30, 2024. The following were notable changes in operating earnings (losses):

Favorable items included:

110

Table of Contents

•Fee-type revenue increased by $26 million primarily due to higher average Separate Account values from market appreciation.

•Net investment income increased by $25 million due to higher average asset balances and higher alternative investment income, partially offset by lower investment yields.

These were partially offset by the following unfavorable items:

•Interest credited to policyholders’ account balances increased by $23 million mainly due to higher average account balances in institutional markets (offset in Net investment income).

•Compensation, benefits and other operating costs and expenses increased by $10 million mainly due to higher corporate support functions expense and higher capitalization in 2024.

•Amortization of DAC increased by $8 million mainly due to a favorable one-time adjustment in 2024.

Net Flows and AV

•The increase in AV of $2.2 billion in the six months ended June 30, 2025 was primarily driven by equity market appreciation and net inflows of $409 million.

•Net inflows of $409 million for the six months ended June 30, 2025 improved by $133 million compared to the six months ended June 30, 2024, mainly driven by large institutional lump sum premiums and higher flows in the tax-exempt and corporate markets, partially offset by lower flows in other markets.

Asset Management

The Asset Management segment provides diversified investment management and related services to a broad range of clients around the world. Operating earnings (loss), net of tax, presented here represents our average economic interest in AB of approximately 69%, 65%, 61% and 61% during the three and six months ended June 30, 2025 and 2024, respectively. The increase in economic interest was due to the purchase of AB Holding Units relating to the AB Tender Offer completed on April 3, 2025.


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Operating earnings (loss)	$	131	$	101	$	257	$	207

Key components of operating earnings (loss) were:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
REVENUES

Net investment income (loss)	$	22	$	7	$	25	$	15
Net derivative gains (losses)	(11)		(1)		(24)		(6)
Investment management, service fees and other income	1,083		1,045		2,181		2,135
Segment revenues	$	1,094	$	1,051	$	2,182	$	2,144

BENEFITS AND OTHER DEDUCTIONS


Commissions and distribution related payments	$	197	$	180	$	398	$	353

Compensation, benefits and other operating costs and expenses	625		621		1,232		1,276
Interest expense	9		12		16		29
Segment benefits and other deductions	$	831	$	813	$	1,646	$	1,658

111

Table of Contents

Changes in AUM in the Asset Management segment were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in billions)
Balance, beginning of period	$	784.5	$	758.7	$	792.2	$	725.2
Long-term flows
Sales/new accounts	27.9		31.9		64.0		64.5
Redemptions/terminations	(30.7)		(25.7)		(60.4)		(50.8)
Cash flow/unreinvested dividends	(3.9)		(5.3)		(7.9)		(12.3)
Net long-term (outflows) inflows	(6.7)		0.9		(4.3)		1.4



Market appreciation (depreciation)	51.3		9.9		41.2		42.9
Net change	44.6		10.8		36.9		44.3
Balance, end of period	$	829.1	$	769.5	$	829.1	$	769.5

Average AUM in the Asset Management segment for the periods presented by distribution channel and investment services were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in billions)
Distribution Channel:
Institutions	$	329.0	$	319.6	$	327.5	$	318.2
Retail	331.3		308.0		334.1		301.7
Private Wealth	139.2		127.9		138.9		125.7
Total	$	799.5	$	755.5	$	800.5	$	745.6

Investment Service:
Equity Actively Managed	$	258.5	$	259.7	$	261.7	$	255.9
Equity Passively Managed (1)	67.8		64.2		68.5		63.9
Fixed Income Actively Managed – Taxable	210.2		212.9		210.7		211.0
Fixed Income Actively Managed – Tax-exempt	78.6		64.7		78.1		63.5
Fixed Income Passively Managed (1)	10.1		11.0		10.2		11.1
Alternatives/Multi-Asset Solutions (2)	174.3		143.0		171.3		140.2
Total	$	799.5	$	755.5	$	800.5	$	745.6

____________

(1)Includes index and enhanced index services.

(2)Includes certain multi-asset solutions and services not included in equity of fixed income services.

Three Months Ended June 30, 2025 Compared to the Three Months Ended June 30, 2024 for the Asset Management Segment

Operating earnings

Operating earnings increased $30 million to $131 million during the three months ended June 30, 2025 from $101 million during the three months ended June 30, 2024. The following notable items were the primary drivers of the change in operating earnings:

Favorable items included:

•Fee-type revenue increased by $38 million primarily due to higher investment base advisory fees and higher distribution revenue from higher average AUM, partially offset by lower revenue from performance fees.

112

Table of Contents

•Net investment income increased by $15 million mainly due to higher gains from seed capital investments (partially offset by Net derivative losses).

•Net income attributable to noncontrolling interest decreased by $11 million due to an increase in average economic ownership of AB, partially offset by higher pre-tax earnings.

These were partially offset by the following unfavorable items included:

•Commissions and distribution-related payments increased by $17 million mainly due to higher payments for the distribution of AB mutual funds resulting from higher average AUM.

•Net derivative losses increased by $10 million mainly due to higher losses from economically hedging seed capital investments (primarily offset by Net investment income), which was partially offset by gains due to market changes in total return swaps.

Long-Term Net Flows and AUM

•Total AUM as of June 30, 2025 was $829.1 billion, up $44.6 billion or 5.7%, compared to March 31, 2025. During the second quarter 2025, AUM increased as a result of market appreciation of $51.3 billion, partially offset by net outflows of $6.7 billion. Market appreciation was attributed to Retail of $25.4 billion, Institutions of $17.4 billion, and Private Wealth of $8.5 billion. Net outflows were due to Retail net outflows of $4.8 billion, Institutions net outflows of $1.5 billion and Private Wealth net outflows of $0.4 billion.

Six Months Ended June 30, 2025 Compared to the Six Months Ended June 30, 2024 for the Asset Management Segment

Operating earnings

Operating earnings increased $50 million to $257 million during the six months ended June 30, 2025 from $207 million in the six months ended June 30, 2024. The following were notable changes in operating earnings (losses):

Favorable items included:

•Compensation, benefits, interest expense and other operating costs decreased by $57 million mainly due to lower base compensation and other expenses driven by the sale of BRS, lower interest expense from lower weighted average borrowings, and lower office related expenses, partially offset by the recognition of a $21 million incentive grant gain in the prior year related to AB headquarters relocation to Nashville.

•Fee-type revenue increased by $46 million primarily due to higher investment base advisory fees and higher distribution revenue from higher average AUM, partially offset by lower revenue from BRS due to the sale of this business completed during April 2024.

•Net investment income increased by $10 million mainly due to higher gains from seed capital investments (offset by Net derivative losses).

These were partially offset by the following unfavorable items:

•Commissions and distribution-related payments increased by $45 million mainly due to higher payments to financial intermediaries for the distribution of AB mutual funds resulting from higher average AUM.

•Net derivative losses increased by $18 million mainly due to higher losses from economically hedging seed capital investments (partially offset by Net investment income) and market changes in total return swaps.

Long-Term Net Flows and AUM

•Total AUM as of June 30, 2025 was $829.1 billion, up $36.9 billion, or 4.7%, compared to December 31, 2024. The increase is primarily the result of market appreciation of $41.2 billion, partially offset by net outflows of $4.3 billion. Market depreciation of $41.2 billion is attributed to Institutions of $19.0 billion, Retail of $14.4 billion and Private Wealth of $7.8 billion. Net outflows were driven by Retail net outflows of $3.9 billion and Institutions net outflows of $0.8 billion, partially offset by Private Wealth net inflows of $0.4 billion.

113

Table of Contents

Protection Solutions

The Protection Solutions segment includes our life insurance and EB businesses. We provide a targeted range of products aimed at serving the financial needs of our clients throughout their lives, including VUL, IUL and term life products. In 2015, we entered the EB market and currently offer a suite of dental, vision, life, as well as short- and long-term disability insurance products to small and medium-size businesses.

The following table summarizes operating earnings (loss) of our Protection Solutions segment:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Operating earnings (loss)	$	(58)	$	72	$	(75)	$	116

Key components of operating earnings (loss) were:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
REVENUES
Policy charges, fee income and premiums	$	529	$	532	$	1,063	$	1,060
Net investment income	257		260		508		516
Net derivative gains (losses)	—		(1)		1		(1)
Investment management, service fees and other income	39		43		79		83
Segment revenues	$	825	$	834	$	1,651	$	1,658

BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits	$	603	$	473	$	1,159	$	960
Remeasurement of liability for future policy benefits	(4)		(11)		(6)		(15)

Interest credited to policyholders’ account balances	145		128		266		256
Commissions and distribution related payments	41		43		83		83
Amortization of deferred policy acquisition costs	32		32		64		62
Compensation, benefits and other operating costs and expenses	77		86		171		178
Interest expense	—		—		2		—
Segment benefits and other deductions	$	894	$	751	$	1,739	$	1,524

The following table summarizes Protection Solutions Reserves for our Protection Solutions segment:




	June 30, 2025		December 31, 2024
	(in millions)
Protection Solutions Reserves (1)
General Account	$	18,149	$	18,171
Separate Accounts	19,558		18,753
Total Protection Solutions Reserves	$	37,707	$	36,924

_______________

(1)Does not include Protection Solutions Reserves for our EB business as it is a scaling business and therefore has immaterial in-force policies.

114

Table of Contents

The following table presents our in-force face amounts for our individual life insurance products:




	June 30, 2025		December 31, 2024
	(in billions)
In-force face amount by product: (1)
Universal Life (2)	$	37.2	$	38.5
Indexed Universal Life	25.7		26.2
Variable Universal Life (3)	142.4		141.6
Term	198.2		201.8
Whole Life	1.0		1.1
Total in-force face amount	$	404.5	$	409.2

_______________

(1)Includes individual life insurance and does not include EB as it is a scaling business and therefore has immaterial in-force policies.

(2)UL includes GUL.

(3)VUL includes VL and COLI.

Three Months Ended June 30, 2025 Compared to the Three Months Ended June 30, 2024 for the Protection Solutions Segment

Operating earnings (loss)

Operating earnings decreased by $130 million to an operating loss of $58 million during the three months ended June 30, 2025 from operating earnings of $72 million in the three months ended June 30, 2024. The following notable items were the primary drivers of the change in operating earnings (losses):

Unfavorable items included:

•Policyholders’ benefits increased by $130 million mainly due to higher net mortality.

•Interest credited to policyholders’ account balances increased by $17 million mainly due to a one-time adjustment to amounts credited to reserves related to the MSO feature.

These were partially offset by the following favorable items:

•Income tax benefits was $11 million for the three months ended June 30, 2025 compared to income tax expense of $12 million for the three months ended June 30, 2024 primarily due to the change in pre-tax earnings.

Six Months Ended June 30, 2025 Compared to the Six Months Ended June 30, 2024 for the Protection Solutions Segment

Operating earnings (loss)

Operating earnings decreased $191 million to an operating loss of $75 million during the six months ended June 30, 2025 from operating earnings of $116 million in the six months ended June 30, 2024. The following were notable changes in operating earnings (losses):

Unfavorable items included:

•Policyholders’ benefits increased by $199 million mainly due to higher net mortality.

•Interest credited to policyholders’ account balances increased by $10 million mainly due to a one-time adjustment to amounts credited to reserves related to the MSO feature.

•Remeasurement of liability for future policy benefits increased by $9 million mainly due to lower claims in the first six months of 2024 as compared to the first six months of 2025.

•Net investment income decreased by $8 million mainly due to lower investment yields.

115

Table of Contents

These were partially offset by the following favorable items:

•Income tax benefit was $14 million for the six months ended June 30, 2025 compared to income tax expense of $19 million for the six months ended June 30, 2024 primarily due to the change in pre-tax earnings.

Wealth Management

The Wealth Management segment is an emerging leader in the wealth management space with a differentiated advice value proposition that offers discretionary and non-discretionary investment advisory accounts, financial planning and advice, life insurance, and annuity products.

The following table summarizes operating earnings (loss) of our Wealth Management segment:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Operating earnings (loss)	$	51	$	44	$	97	$	87

Key components of operating earnings (loss) were:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
REVENUES

Net investment income	$	2	$	4	$	5	$	8

Investment management, service fees and other income	469		438		929		857
Segment revenues	$	471	$	442	$	934	$	865

BENEFITS AND OTHER DEDUCTIONS




Commissions and distribution-related payments	$	296	$	282	$	589	$	542

Compensation, benefits and other operating costs and expenses	106		99		215		204

Segment benefits and other deductions	$	402	$	381	$	804	$	746

The following table summarizes revenue by activity type for our Wealth Management segment:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Revenue by Activity Type
Investment management, service fees and other income:
Investment management and advisory fees	$	184	$	161	$	365	$	311
Distribution fees	268		260		531		513
Interest income	11		12		22		25
Service and other income	6		5		11		8
Total Investment management, service fees and other income	$	469	$	438	$	929	$	857

116

Table of Contents

The following table summarizes a roll-forward of AUA for our Wealth Management segment:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Total Wealth Management Assets
Advisory assets:
Beginning, beginning of period	$	66,795	$	57,923	$	65,839	$	54,978
Net new assets	2,027		1,602		4,008		1,563
Market appreciation (depreciation)	4,471		609		3,446		3,593
Advisory ending assets	$	73,293	$	60,134	$	73,293	$	60,134

Brokerage and direct assets	36,972		$	34,652	$	36,972	$	34,652

Balance, end of period (1)	$	110,265	$	94,786	$	110,265	$	94,786

_____________

(1)Some operating metrics have been revised for prior periods. Net New Assets consist of total client deposits into advisory accounts less total client withdrawals from advisory accounts, plus dividends, plus interest, minus advisory fees. AUA reflects adjusted balances with no financial impact.

Three Months Ended June 30, 2025 Compared to the Three Months Ended June 30, 2024 for the Wealth Management Segment

Operating earnings

Operating earnings increased by $7 million to $51 million during the three months ended June 30, 2025 from $44 million in the three months ended June 30, 2024. The following were notable changes in operating earnings:

Favorable items included:

•Investment management, service fees and other income increased by $31 million mainly due to higher advisory fee type revenue attributed to higher average assets balances combined with increased distribution fees from higher retirement sales.

These were partially offset by the following unfavorable items:

•Commissions and distribution-related payments increased by $14 million mainly due to higher distribution and advisory fee type revenue from higher retirement sales and average asset balances.

•Compensation, benefits and other operating costs and expenses increased by $7 million mainly due to higher variable compensation from higher sales.

Net Flows and AV

•The increase in AUA of $6.5 billion in the three months ended June 30, 2025 was mainly driven by market appreciation and strong advisory net flows of $2.0 billion.

•Advisory net inflows of $2.0 billion were $425 million higher than in the three months ended June 30, 2024 mainly driven by increased sales.

Six Months Ended June 30, 2025 Compared to the Six Months Ended June 30, 2024 for the Wealth Management Segment

Operating earnings

Operating earnings increased $10 million to $97 million during the six months ended June 30, 2025 compared to $87 million in the six months ended June 30, 2024. The following were notable changes in operating earnings:

117

Table of Contents

Favorable items included:

•Investment management, service fees and other income increased by $72 million mainly due to higher advisory fee type revenue attributed to higher average asset balances combined with increased distribution fees from higher retirement sales.

These were partially offset by the following unfavorable items:

•Commissions and distribution-related payments increased by $47 million mainly due to higher distribution and advisory fee-type revenue from higher retirement sales and average asset balances.

•Compensation, benefits and other operating costs and expenses increased by $11 million mainly due to mainly due to higher variable compensation from higher sales.

Net Flows and AUA

•The increase in AUA of $7.5 billion in the six months ended June 30, 2025 was mainly driven by strong advisory net flows of $4.0 billion and market appreciation.

•Net new assets of $4.0 billion were $2.4 billion higher than in the six months ended June 30, 2024 driven by higher inflows.

Legacy

The Legacy segment consists of our capital intensive fixed-rate GMxB business written prior to 2011.

The following table summarizes operating earnings (loss) of our Legacy segment:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024 (1)
	(in millions)
Operating earnings (loss)	$	28	$	28	$	52	$	61

_____________

(1)Prior periods were updated to reflect the impact of moving payout annuity policies from Legacy to Individual Retirement.

Key components of operating earnings (loss) were:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024 (1)
	(in millions)
REVENUES
Policy charges, fee income and premiums	$	17	$	8	$	36	$	20
Net investment income	14		14		23		30

Investment management, service fees and other income	69		95		161		196
Segment revenues	$	100	$	117	$	220	$	246

BENEFITS AND OTHER DEDUCTIONS



Interest credited to policyholders’ account balances	9		8		16		17
Commissions and distribution-related payments	29		40		65		80
Amortization of deferred policy acquisition costs	15		15		30		31
Compensation, benefits and other operating costs and expenses	13		22		47		47

Segment benefits and other deductions	$	66	$	85	$	158	$	175

_____________

(1)Prior periods were updated to reflect the impact of moving payout annuity policies from Legacy to Individual Retirement.

118

Table of Contents

The following table summarizes AV for our Legacy segment:



	June 30, 2025		December 31, 2024
	(in millions)
AV (1)
General Account	$	422	$	447
Separate Accounts	20,068		20,911
Total AV	$	20,490	$	21,358

_______________

(1)AV presented are net of reinsurance.

The following table summarizes a roll-forward of AV for our Legacy segment net of the Venerable transaction:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024 (1)
	(in millions)
Balance, beginning of period	$	19,912	$	22,514	$	21,358	$	21,840
Gross Premiums	56		47		105		89
Surrenders, withdrawals and benefits	(636)		(714)		(1,404)		(1,414)
Net flows	(580)		(667)		(1,299)		(1,325)
Investment performance, interest credited and policy charges	1,158		56		431		1,388

Balance, end of period	$	20,490	$	21,903	$	20,490	$	21,903

_____________

(1)Prior periods were updated to reflect the impact of moving payout annuity policies from Legacy to Individual Retirement.

Three Months Ended June 30, 2025 Compared to the Three Months Ended June 30, 2024 for the Legacy Segment

Operating earnings

Operating earnings were flat at $28 million during the three months ended June 30, 2025 and in the three months ended June 30, 2024. This was primarily driven by lower fee-type revenue offset by lower expenses as the business continues to run-off.

Net Flows and AV

•The increase in AV of $578 million in the three months ended June 30, 2025 was driven by positive investment performance of $1.2 billion, partially offset by net outflows of $580 million.

•Net outflows of $580 million were $87 million lower than in the three months ended June 30, 2024, mainly driven by lower surrenders.

Six Months Ended June 30, 2025 Compared to the Six Months Ended June 30, 2024 for the Legacy Segment

Operating earnings

Operating earnings decreased $9 million to $52 million during the six months ended June 30, 2025 from $61 million in the six months ended June 30, 2024. The following were notable changes in operating earnings (losses):

Unfavorable items included:

•Fee-type revenue decreased by $19 million mainly driven by the runoff of unprofitable GMxB business.

These were partially offset by the following favorable items:

119

Table of Contents

•Commissions and distribution-related payments decreased by $15 million mainly due to business runoff.

Net Flows and AV

•The decrease in AV of $0.9 billion in the six months ended June 30, 2025 was driven by net outflows of $1.3 billion, partially offset by market appreciation of $0.4 billion.

•Net outflows of $1.3 billion were $26 million lower than in the six months ended June 30, 2024, mainly driven by higher deposits.

Corporate and Other

Corporate and Other includes some of our financing and investment expenses. It also includes: the Closed Block, run-off variable annuity reinsurance business, run-off group pension business, run-off health business, benefit plans for our employees, certain strategic investments and certain unallocated items, including capital and related investments, interest expense and financing fees and corporate expense. AB’s results of operations are reflected in the Asset Management segment. Accordingly, Corporate and Other does not include any items applicable to AB.

The following table summarizes operating earnings (loss) of Corporate and Other:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in millions)
Operating earnings (loss)	$	(139)	$	(121)	$	(243)	$	(232)

General Account Investment Portfolio

Our investment philosophy is driven by our long-term commitments to clients, robust risk management and strategic asset allocation. Our General Account investment portfolio investment strategy seeks to achieve sustainable risk-adjusted returns by focusing on principal preservation and investment return, subject to duration and liquidity requirements by product as well as diversification of investment risks. Investment activities are undertaken based on established investment guidelines and are required to comply with applicable laws and insurance regulations.

Risk tolerances are established for credit risk, market risk, liquidity risk and concentration risk across issuers and asset classes, each of which seek to mitigate the impact of cash flow variability arising from these risks. Significant interest rate increases and market volatility since 2022 have reduced the fair value of fixed maturities from a net unrealized gain position to a net unrealized loss. As a part of asset and liability management, we maintain a weighted average duration for our General Account investment portfolio that is within an acceptable range of the estimated duration of our liabilities given our risk appetite and hedging programs.

The General Account investment portfolio consists largely of investment grade fixed maturities, short-term investments, commercial, agricultural and residential mortgage loans, alternative investments and other financial instruments. Fixed maturities include publicly issued corporate bonds, government bonds, privately placed notes and bonds, bonds issued by states and municipalities, agency and non-agency mortgage-backed securities and asset-backed securities. In addition, from time to time we use derivatives to hedge our exposure to equity markets, interest rates, foreign currency and credit spreads.

We incorporate ESG factors into the investment processes for a significant portion of our General Account portfolio. As investors with a long-term horizon, we believe that companies with sustainable practices are better positioned to deliver value to stakeholders over an extended period. These companies are more likely to increase sales through sustainable products, reduce energy costs and attract and retain talent. This belief underpins our approach to sustainable investing, where we seek to enhance the sustainability and quality of our investment portfolio.

Investments in our surplus portfolio are generally comprised of a mix of fixed maturity investment grade and below investment grade securities as well as various alternative investments, primarily private equity and real estate equity. Although alternative investments are subject to period over period earnings fluctuations, they have historically achieved returns in excess of the fixed maturity portfolio.

120

Table of Contents

The General Account investment portfolio reflects certain differences from the presentation of the U.S. GAAP Consolidated Financial Statements. This presentation is consistent with how we manage the General Account investment portfolio. For further investment information, see Note 3 and Note 4 of the Notes to the Consolidated Financial Statements.

Investment Results of the General Account Investment Portfolio

The following table summarizes the General Account investment portfolio results with Non-GAAP Operating Earnings adjustments by asset category for the periods indicated. This presentation is consistent with how we measure investment performance for management purposes.


	Three Months Ended June 30,
	2025					2024
	Yield			Amount (2)		Yield		Amount (2)
	(Dollars in millions)
Fixed Maturities:
Income (loss)	4.35	%		$	931	4.31	%	$	839
Ending assets				86,509				79,124
Mortgages:
Income (loss)	4.87	%		256		5.10	%	238
Ending assets				21,536				18,802
Other Equity Investments: (1)
Income (loss)	5.28	%	a	47		6.23	%	55
Ending assets				3,571				3,598
Trading Securities:
Income (loss)	12.80	%		21		1.46	%	2
Ending assets				723				495
Policy Loans:
Income (loss)	4.79	%		52		5.24	%	55
Ending assets				4,355				4,247
Cash and Short-term Investments:
Income (loss)	4.22	%		86		5.58	%	90
Ending assets				12,239				5,817






Total:
Investment income (loss)	4.52	%		1,393		4.60	%	1,279
Less: investment fees (3)	(0.16)	%		(49)		(0.17)	%	(47)
Investment Income, Net	4.36	%		1,344		4.43	%	1,232
Ending Net Assets				$	128,933			$	112,083

121

Table of Contents


	Six Months Ended June 30,								Year Ended December 31
	2025				2024				2024
	Yield		Amount (2)		Yield		Amount (2)		Yield		Amount (2)
	(Dollars in millions)
Fixed Maturities:
Income (loss)	4.37	%	$	1,859	4.36	%	$	1,648	4.39	%	$	3,447
Ending assets			86,509				79,124				84,202
Mortgages:
Income (loss)	4.99	%	516		5.10	%	473		5.14	%	973
Ending assets			21,536				18,802				20,072
Other Equity Investments: (1)
Income (loss)	5.75	%	101		6.23	%	110		5.75	%	203
Ending assets			3,571				3,598				3,495
Trading Securities:
Income (loss)	9.47	%	29		0.73	%	2		5.07	%	16
Ending assets			723				495				527
Policy Loans:
Income (loss)	4.93	%	107		5.23	%	110		5.31	%	225
Ending assets			4,355				4,247				4,330
Cash and Short-term Investments: (3)
Income (loss)	4.26	%	126		4.78	%	146		4.89	%	266
Ending assets			12,239				5,817				3,259



Total:
Investment income (loss)	4.56	%	2,738		4.59	%	2,489		4.63	%	5,130
Less: investment fees	(0.16)	%	(97)		(0.16)	%	(88)		(0.16)	%	(180)
Investment Income, Net	4.40	%	2,641		4.43	%	2,401		4.46	%	4,950
Ending Net Assets			$	128,933			$	112,083			$	115,885

_____________

(1)Includes, as of June 30, 2025, June 30, 2024 and December 31, 2024 respectively, $364 million, $371 million and $431 million of other invested assets. Amounts for certain consolidated VIE investments are shown net of associated non-controlling interest.

(2)Amount for fixed maturities and mortgages represents original cost, reduced by repayments, write-downs, adjusted amortization of premiums, accretion of discount and allowances. Cost for equity securities represents original cost reduced by write-downs; cost for other limited partnership interests represents original cost adjusted for equity in earnings and reduced by distributions.

(3)Cash and Short-term net of collateral expense.

AFS Fixed Maturities

The fixed maturity portfolio consists largely of investment grade corporate debt securities and includes significant amounts of U.S. government and agency obligations. The below investment grade securities in the General Account investment portfolio consist of loans to middle market companies, public high yield securities, bank loans, as well as “fallen angels,” originally purchased as investment grade investments.

AFS Fixed Maturities by Industry

The following table sets forth these fixed maturities by industry category along with their associated gross unrealized gains and losses:

122

Table of Contents

AFS Fixed Maturities by Industry (1)


	Amortized Cost		Allowance for Credit Losses		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value		Percentage of Total (%)
	(Dollars in millions)
As of June 30, 2025
Corporate Securities:
Finance	$	15,524	$	—	$	126	$	1,249	$	14,401	18	%
Manufacturing	11,894		—		116		1,418		10,592		13
Utilities	8,423		—		83		885		7,621		10
Services	7,876		3		116		889		7,100		9
Energy	2,635		—		26		282		2,379		3
Retail and wholesale	3,771		—		54		336		3,489		4
Transportation	2,569		—		52		280		2,341		3
Other	415		—		2		51		366		—
Total corporate securities	53,107		3		575		5,390		48,289		60
U.S. government	5,983		—		3		1,467		4,519		6
Residential mortgage-backed (2)	5,506		—		60		110		5,456		7
Preferred stock	54		—		4		—		58		—
State & political	423		—		2		71		354		—
Foreign governments	690		—		2		117		575		1
Commercial mortgage-backed	4,839		—		20		303		4,556		6
Asset-backed securities (3)	15,907		—		120		50		15,977		20
Total	$	86,509	$	3	$	786	$	7,508	$	79,784	100	%

As of December 31, 2024
Corporate Securities:
Finance	$	16,080	$	1	$	46	$	1,494	$	14,631	18	%
Manufacturing	12,499		—		37		1,583		10,953		14
Utilities	8,476		—		44		1,004		7,516		10
Services	8,899		1		55		1,075		7,878		10
Energy	2,546		—		15		318		2,243		3
Retail and wholesale	2,979		—		34		258		2,755		4
Transportation	1,559		—		11		156		1,414		2
Other	1,665		—		9		225		1,449		2
Total corporate securities	54,703		2		251		6,113		48,839		63
U.S. government	5,801		—		—		1,513		4,288		6
Residential mortgage-backed (2)	4,520		—		15		152		4,383		6
Preferred stock	56		—		3		—		59		—
State & political	472		—		2		88		386		1
Foreign governments	689		—		1		136		554		1
Commercial mortgage-backed	4,301		—		5		385		3,921		5
Asset-backed securities (3)	13,660		—		96		57		13,699		18
Total	$	84,202	$	2	$	373	$	8,444	$	76,129	100	%

______________

(1)Investment data has been classified based on standard industry categorizations for domestic public holdings and similar classifications by industry for all other holdings.

(2)Includes publicly traded agency pass-through securities and collateralized obligations.

(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.

123

Table of Contents

Fixed Maturities Credit Quality

The SVO of the NAIC evaluates the investments of insurers for regulatory reporting purposes and assigns fixed maturities to one of six categories (“NAIC Designations”). NAIC Designations of “1” or “2” include fixed maturities considered investment grade, which include securities rated Baa3 or higher by Moody’s or BBB- or higher by Standard & Poor’s. NAIC Designations of “3” through “6” are referred to as below investment grade, which include securities rated Ba1 or lower by Moody’s and BB+ or lower by Standard & Poor’s. As a result of time lags between the funding of investments and the completion of the SVO filing process, the fixed maturity portfolio typically includes securities that have not yet been rated by the SVO as of each balance sheet date. Pending receipt of SVO ratings, the categorization of these securities by NAIC Designation is based on the expected ratings indicated by internal analysis.

The following table sets forth the General Account’s fixed maturities portfolio by NAIC rating:

AFS Fixed Maturities


NAIC Designation	Rating Agency Equivalent	Amortized Cost		Allowance for Credit Losses		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
		(in millions)
As of June 30, 2025
1................................	Aaa, Aa, A	$	58,605	$	—	$	433	$	4,826	$	54,212
2................................	Baa	26,271		—		339		2,617		23,993
	Investment grade	84,876		—		772		7,443		78,205
3................................	Ba	789		—		6		47		748
4................................	B	715		—		7		8		714
5................................	Caa	116		1		1		10		106
6................................	Ca, C	13		2		—		—		11
	Below investment grade	1,633		3		14		65		1,579
Total Fixed Maturities		$	86,509	$	3	$	786	$	7,508	$	79,784

As of December 31, 2024:
1................................	Aaa, Aa, A	$	56,266	$	—	$	210	$	5,342	$	51,134
2................................	Baa	26,255		—		147		3,043		23,359
	Investment grade	82,521		—		357		8,385		74,493
3................................	Ba	810		—		5		38		777
4................................	B	663		—		7		7		663
5................................	Caa	187		1		3		13		176
6................................	Ca, C	21		1		1		1		20
	Below investment grade	1,681		2		16		59		1,636
Total Fixed Maturities		$	84,202	$	2	$	373	$	8,444	$	76,129

Mortgage Loans

The mortgage portfolio primarily consists of commercial, agricultural, and residential mortgage loans. The investment strategy for the mortgage loan portfolio emphasizes diversification by property type and geographic location with a primary focus on asset quality. The commercial mortgage loan portfolio is backed by high quality properties located in primary markets typically owned by experienced institutional investors with a demonstrated ability to manage their assets through business cycles. Our commercial loan portfolio is monitored on an ongoing basis, assigning credit quality ratings for each loan, with the particular emphasis on loans that are scheduled to mature in the next 12 to 24 months. Scheduled maturities for full year 2025 and 2026, respectively are $2.1 billion and $2.3 billion, or 12% and 13% of the commercial mortgage portfolio. The commercial mortgage portfolio consists of 83% fixed rate loans and 17% floating rate loans. For floating rate loans, the borrower is typically required to purchase an interest rate cap to the scheduled maturity of the loan to protect against rising rates.

124

Table of Contents

Commercial mortgage loans are evaluated annually to determine a current LTV ratio. Property financial statements, current rent roll, lease maturities, tenant creditworthiness, property physical inspections, and forecasted leasing market strength are used to develop projected cash flows. A discounted cash flow methodology which incorporates market data is used to determine property values. The average LTV ratio at origination provided by a certified appraisal firm was 54%. The average LTV ratio was 67% and 67% at June 30, 2025 and December 31, 2024, respectively, which reflects the most recent opinion of value on the underlying collateral.

We use AB CarVal to invest in residential whole loans and other private investments. These investments allow us to leverage AB CarVal’s expertise in asset classes where we are looking to increase exposure. The residential mortgage portfolio primarily consists of purchased closed end, amortizing residential mortgage loans. The investment strategy for the mortgage loan portfolio emphasizes high credit quality borrowers, conservative LTV ratios, superior ability to repay and geographic diversification.

Residential mortgage loans are pooled by loan type (i.e., Jumbo, Agency Eligible, Non-Qualified, etc.) and pooled by similar risk profiles (including consumer credit score and LTV ratios). The portfolio is monitored monthly primarily based on payment activity, occurrence of regional natural disasters and borrower interactions with the mortgage servicer.

The tables below show the breakdown of the amortized cost of the General Account’s investments in mortgage loans by geographic region and property type:

Mortgage Loans by Region and Property Type


	June 30, 2025				December 31, 2024

	Amortized Cost		% of Total		Amortized Cost		% of Total
	(Dollars in millions)
By Region:
U.S. Regions:
Pacific	$	5,811	27	%	$	5,517	27	%
Middle Atlantic	4,313		20		3,861		19
South Atlantic	3,445		16		3,130		15
East North Central	1,437		6		1,183		6
Mountain	1,546		7		1,510		7
West North Central	965		4		953		5
West South Central	1,738		8		1,674		8
New England	941		4		925		5
East South Central	854		4		822		4
Total U.S.	21,050		96		19,575		96
Other Regions:
Europe	791		4		775		4
Total Other	791		4		775		4
Total Mortgage Loans	$	21,841	100	%	$	20,350	100	%

By Property Type:
Office	$	4,644	21	%	$	4,711	23	%
Multifamily	8,199		38		7,397		36
Agricultural loans	2,592		12		2,568		13
Retail	653		3		627		3
Industrial	2,528		12		2,310		11
Hospitality	784		4		720		4
Residential	1,489		7		1,066		5
Other	952		3		951		5
Total Mortgage Loans	$	21,841	100	%	$	20,350	100	%

125

Table of Contents

Other Equity Assets

The following table includes information related to our alternative investments in certain other equity investments and consolidated VIEs, including private equity funds, real estate funds and other alternative investments. These investments are typically structured as limited partnerships or LLCs and are reported to us on a lag of one month and three months for hedge funds and private equity funds, respectively.

At June 30, 2025 and December 31, 2024, the fair value of alternative investments was $3.1 billion and $3.0 billion respectively. Alternative investments were 2.3% and 2.4% of cash and invested assets at June 30, 2025 and December 31, 2024, respectively.

Alternative Investments (1)


	June 30, 2025				December 31, 2024

	Fair Value		%		Fair Value		%
	(in millions)
Private Equity	$	1,637	52	%	$	1,568	52	%
Private Debt	260		8		260		9
Infrastructure	231		7		211		7
Real Estate	672		22		652		22
Hedge Funds	60		2		57		2
Other (2)	266		9		263		8
Total (3)	$	3,126	100	%	$	3,011	100	%

_____________

(1)Reported in Other Equity Investments in the consolidated balance sheets.

(2)Includes CLO equity, co-investments and investments in other strategies. CLO equity investments are consolidated and assets are reported in Fixed Maturities, at fair value using the fair value option in the consolidated balance sheets.

(3)Includes $973 million and $812 million of non-General Account assets as of June 30, 2025 and December 31, 2024, respectively.

Liquidity and Capital Resources

Liquidity refers to our ability to generate adequate amounts of cash from our operating, investment and financing activities to meet our cash requirements with a prudent margin of safety. Capital refers to our long-term financial resources available to support business operations and future growth. Our ability to generate and maintain sufficient liquidity and capital is dependent on the profitability of our businesses, timing of cash flows related to our investments and products, our ability to access the capital markets, general economic conditions and the alternative sources of liquidity and capital described herein. When considering our liquidity and cash flows, we distinguish between the needs of Holdings and the needs of our insurance and non-insurance subsidiaries. We also distinguish and separately manage the liquidity and capital resources of our retirement and protection businesses (our Individual Retirement, Group Retirement, Protection Solutions and Legacy segments) and our Asset Management and Wealth Management segments.

On June 1, 2025 Equitable Financial Bermuda RE Ltd. (“Equitable Bermuda”) entered into an indemnity reinsurance agreement with Equitable America assuming EQUI-VEST variable annuity contracts issued outside the State of New York prior to February 1, 2023. Net retained general account liabilities were reinsured to Equitable Bermuda on a coinsurance funds withheld basis, while Separate Account liabilities relating to such variable annuity contracts were reinsured to Equitable Bermuda on a modified coinsurance basis. Equitable Bermuda’s obligations under the treaty are secured through Equitable America’s retention of certain assets supporting the reinsured liabilities. In exchange for Equitable Bermuda’s agreement to assume these liabilities, the Bermuda Monetary Authority and the Arizona Department of Insurance and Financial Institutions each approved the treaty.

On February 24, 2025, Holdings commenced the AB Tender Offer to purchase up to 46 million AB Holding Units at a price of $38.50 per unit, less any applicable tax withholding, for an aggregate purchase price of $1.8 billion. On April 3, 2025, Holdings purchased 19.7 million AB Holdings Units pursuant to the AB Tender Offer for an aggregate cost of $758 million. The AB Holdings Units accepted for purchase represent approximately 17.9% of the outstanding units as of March 31, 2025. On July 10, 2025, AB and Holdings entered into an Amended and Restated Master Exchange Agreement to increase the AB Units that remain available for exchange from 4.8 million AB Units to 19.7 million AB Units, and Holdings exchanged 19.7 million AB Holding Units for an equal number of limited partnership interests in ABLP. After giving effect to the exchange Holdings continues to own approximately 68.6% of the economic interest in AB.

126

Table of Contents

Separately, our Board approved an additional $1.5 billion of share repurchases under its share repurchase program. The repurchase program does not obligate Holdings to purchase any particular number of shares. As of June 30, 2025, Holdings had authorized capacity of approximately $1.5 billion remaining in its share repurchase program. See Note 13 of the Notes to the Consolidated Financial Statements for additional details on the repurchase program.

Sources and Uses of Liquidity

The Company has sufficient cash flows from operations to satisfy liquidity requirements in 2025.

Cash Flows of Holdings

As a holding company with no business operations of its own, Holdings primarily derives cash flows from dividends from its subsidiaries and distributions related to its economic interest in AB, all of which is currently held outside our insurance company subsidiaries. These principal sources of liquidity are augmented by cash and short-term investments held by Holdings and access to bank lines of credit and the capital markets. The main uses of liquidity for Holdings are interest payments and debt repayment, payment of dividends and other distributions to stockholders (which may include stock repurchases) loans and capital contributions, if needed, to our insurance subsidiaries. Our principal sources of liquidity and our capital position are described in the following paragraphs.

Sources and Uses of Holding Company Highly Liquid Assets

The following table sets forth Holdings’ principal sources and uses of highly liquid assets:


	Six Months Ended June 30,
	2025		2024
	(in millions)
Highly Liquid Assets, beginning of period	$	1,982	$	1,998
Dividends from subsidiaries	327		338

Issuance of loans to affiliates	—		—
Capital contribution from parent company	—		—
Capital contributions to subsidiaries	—		—
M&A Activity	—		—
Purchase of AllianceBernstein Units	(758)		—

Total Business Capital Activity	(431)		338

Purchase of treasury shares	(497)		(500)
Retirement of treasury shares	—		—
Shareholder dividends paid	(156)		(151)
Total Share Repurchases, Dividends and Acquisition Activity	(653)		(651)

Issuance/(redemption) of preferred stock	(279)		—
Preferred stock dividend	(32)		(40)
Total Preferred Stock Activity	(311)		(40)

Issuance of long-term debt	500		600
Repayment of long-term debt	—		(570)
Total External Debt Activity	500		30


Proceeds from loans from affiliates	—		—


Net decrease (increase) in existing facilities to affiliates (1)	60		281

127

Table of Contents


	Six Months Ended June 30,
	2025		2024
	(in millions)
Total Affiliated Debt Activity	60		281

Interest paid on external debt and P-Caps	(106)		(114)
Others, net	(15)		88
Total Other Activity	(121)		(26)

Net increase (decrease) in highly liquid assets	(956)		(68)
Highly Liquid Assets, end of period	$	1,026	$	1,930

_______________

(1) Represents net activity of draws and repayments of existing credit facilities between Holdings and affiliates.

Capital Contribution to Our Subsidiaries

Holdings did not make any capital contributions to its subsidiaries during the six months ended June 30, 2025.

Loans from Our Subsidiaries

There were no new loans from our subsidiaries during the six months ended June 30, 2025.

Cash Distributions from Our Non-Insurance Subsidiaries

During the six months ended June 30, 2025, Holdings received cash distributions of $283 million from AB and $44 million from the investment management contracts with EFIM and EIM.

Distributions from Insurance Subsidiaries

Our insurance companies are subject to limitations on the payment of dividends and other transfers of funds to Holdings and other affiliates under applicable insurance law and regulation. Also, more generally, the ability of our insurance subsidiaries to pay dividends can be affected by market conditions and other factors beyond our control.

Equitable’s primary insurance regulators in the U.S are the NYDFS and the Arizona Department of Insurance and Financial Institutions. Under New York’s insurance laws, which are applicable to Equitable Financial, a domestic stock life insurer may not pay an Ordinary Dividend exceeding an amount calculated based on a statutory formula without prior approval of the NYDFS. Extraordinary Dividends require the insurer to file a notice of its intent to declare the dividends with the NYDFS and obtain prior approval or non-disapproval from the NYDFS. Similarly, under Arizona insurance law, which is applicable to Equitable America, a domestic life insurer may not pay a dividend to its shareholders that exceeds an amount calculated based on a statutory formula without prior approval of the Arizona Department of Insurance and Financial Institutions.

In 2024, Equitable America had Ordinary Dividend capacity of $441 million. In June 2024, Equitable America received approval from Arizona Department of Insurance and Financial Institutions for an Extraordinary Dividend of $300 million. Holdings received an Ordinary Dividend distribution from Equitable America of $441 million during July 2024. Holdings received a dividend distribution from Equitable America of $22 million during September 2024 under the Extraordinary Dividend capacity. Holdings also received a dividend distribution from Equitable America of $238 million in December 2024 under the Extraordinary Dividend capacity. In 2025, Equitable America estimates it will have Ordinary Dividend capacity of $347 million.

Based on the NYDFS formula, Equitable Financial had no Ordinary Dividend capacity in 2024 and 2025.

128

Table of Contents

Distributions from AllianceBernstein

ABLP is required to distribute all of its Available Cash Flow, as defined in the Amended and Restated Partnership Agreement of ABLP, to the holders of AB Units and to the General Partner. Available Cash Flow is defined as the cash flow received by ABLP from operations minus such amounts as the General Partner determines, in its sole discretion, should be retained by ABLP for use in its business, or plus such amounts as the General Partner determines, in its sole discretion, should be released from previously retained cash flow. Distributions by ABLP are made 1% to the General Partner and 99% among the limited partners.

Typically, Available Cash Flow has been the adjusted diluted net income per unit for the quarter multiplied by the number of general and limited partnership interests at the end of the quarter. In future periods, management of AB anticipates that Available Cash Flow will be based on adjusted diluted net income per unit, unless management of AB determines, with the concurrence of the Board of Directors of AB, that one or more adjustments that are made for adjusted net income should not be made with respect to the Available Cash Flow calculation.

AB Holding is required to distribute all of its Available Cash Flow, as defined in the Amended and Restated Agreement of Limited Partnership of AB Holding, to holders of AB Holding Units pro rata in accordance with their percentage interest in AB Holding. Available Cash Flow is defined as the cash distributions AB Holding receives from ABLP minus such amounts as the General Partner determines, in its sole discretion, should be retained by AB Holding for use in its business (such as the payment of taxes) or plus such amounts as the General Partner determines, in its sole discretion, should be released from previously retained cash flow. AB Holding is dependent on the quarterly cash distributions it receives from ABLP, which is subject to the performance of capital markets and other factors beyond our control. Distributions from AB Holding are made pro rata based on the holder’s percentage ownership interest in AB Holding.

As of June 30, 2025, Holdings and its non-insurance company subsidiaries hold approximately 179.5 million AB Units, 19.8 million AB Holding Units and the 1% General Partnership interest in ABLP.

As of June 30, 2025, the ownership structure of ABLP, including AB Units outstanding as well as the General Partner’s 1% interest, was as follows:


Owner	Percentage Ownership
EQH and its subsidiaries	61.9	%
AB Holding	37.5
Unaffiliated holders	0.6
Total	100.0	%

Including both the general partnership and limited partnership interests in AB Holding and ABLP, Holdings and its subsidiaries had an approximate 68.6% economic interest in AB as of June 30, 2025.

Holdings Credit Facilities

On July 29, 2025, Holdings entered into a new Revolving Credit Agreement with respect to a $1.0 billion five-year senior unsecured revolving credit facility (the “Credit Facility”), and terminated the Amended and Restated Revolving Credit Agreement, dated as of June 24, 2021, as amended.

The Credit Facility may provide significant support to our liquidity position when alternative sources of credit are limited. In addition to the Credit Facility, we have letter of credit facilities with an aggregate principal amount of approximately $1.9 billion (the “LOC Facilities”), primarily to be used to support our life insurance business reinsured to EQ AZ Life Re in April 2018. In June 2021, Holdings entered into amendments with each of the issuers of its bilateral letter of credit facilities to effect changes similar to those effected in the then-effective revolving credit facility. The respective facility limits of the bilateral letter of credit facilities remained unchanged. On May 12, 2023, the Company entered into an amendment to the LOC Facilities to replace remaining LIBOR-based benchmark rates with Secured Overnight Financial Rate (“SOFR”) based benchmark rates and to make certain other conforming changes.

In connection with the commencement of the AB Tender Offer described in the precedent paragraph, Holdings entered into the Term Loan Agreement with respect to the Term Loan. The Term Loan was intended to be used, along with available cash and cash equivalents, to fund the AB Tender Offer and related fees and expenses. The Term Loan was available to be drawn at

129

Table of Contents

any time on or prior to April 24, 2025 and would have matured 364 days from the date of funding. However, on April 15, 2025, Holdings elected not to request any such Term Loan, as it was unnecessary to fund the AB Tender Offer, and the Term Loan Agreement was terminated effective April 3, 2025. See Note 14 of the Notes to the Consolidated Financial Statements for additional details.

The Credit Facility and LOC Facilities contain certain administrative, reporting, legal and financial covenants, including requirements to maintain a specified minimum consolidated net worth and to maintain a ratio of indebtedness to total capitalization not in excess of a specified percentage, and limitations on the dollar amount of certain indebtedness that may be incurred by our subsidiaries and the dollar amount of certain secured indebtedness that may be incurred by us, which could restrict our operations and use of funds. The right to borrow funds under the Credit Facility and LOC Facilities is subject to the fulfillment of certain conditions, including compliance with all covenants, and the ability to borrow thereunder is also subject to the continued ability of the lenders that are or will be parties to the facilities to provide funds. As of June 30, 2025, we were in compliance with the covenants under the Credit Facility and LOC Facilities.

Contingent Funding Arrangements

For information regarding activity pertaining to our contingent funding arrangements and other off-balance sheet commitments, see “Commitments and Contingent Liabilities” in Note 16 of the Notes to the Consolidated Financial Statements.

Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock

For information pertaining to our Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock see Note 13 of the Notes to the Consolidated Financial Statements.

Capital Position of Holdings

We manage our capital position to maintain financial strength and credit ratings that facilitate the distribution of our products and provide our desired level of access to the bank and capital markets. Our capital position is supported by the ability of our subsidiaries to generate cash flows and distribute cash to us and our ability to effectively manage the risk of our businesses and to borrow funds and raise capital to meet our operating and growth needs.

Our Board and senior management are directly involved in the development of our capital management policies. Accordingly, capital actions, including proposed changes to the annual capital plan, capital targets and capital policies, are approved by the Board.

Dividends Declared and Paid

The declaration and payment of future dividends is subject to the discretion of our Board and depends on our financial condition, results of operations, cash requirements, future prospects, regulatory restrictions on the payment of dividends by Holdings’ insurance subsidiaries and other factors deemed relevant by the Board.

The payment of dividends will be substantially restricted in the event that we do not declare and pay (or set aside) dividends on the Series A, Series B and Series C Preferred Stock for the last proceeding dividend period. For additional information on our preferred stock, see “—Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock”.

For information regarding activity pertaining to common and preferred dividends declared and paid, see Note 13 of the Notes to the Consolidated Financial Statements.

Share Repurchase Programs

For information regarding activity pertaining to share repurchase programs, see Note 13 of the Notes to the Consolidated Financial Statements.

Sources and Uses of Liquidity of Our Insurance Subsidiaries

The principal sources of liquidity for our insurance subsidiaries are premiums, investment and fee income, deposits associated with our insurance and annuity operations, cash and invested assets, as well as internal borrowings. The principal uses of that liquidity include benefits, claims and dividends paid to policyholders and payments to policyholders in connection with surrenders and withdrawals. Other uses of liquidity include commissions, general and administrative expenses, purchases

130

Table of Contents

of investments, the payment of dividends to Holdings and hedging activity. Certain of our insurance subsidiaries’ principal sources and uses of liquidity are described in the paragraphs that follow.

We manage the liquidity of our insurance subsidiaries with the objective of ensuring that they can meet payment obligations linked to our Individual Retirement, Group Retirement and Protection Solutions businesses and to their outstanding debt and derivative positions, including in our hedging programs, without support from Holdings. We employ an asset/liability management approach specific to the requirements of each of our insurance businesses. We measure liquidity against internally-developed benchmarks that consider the characteristics of our asset portfolio and the liabilities that it supports in both the short-term (the next 12 months) and long-term (beyond the next 12 months). We consider attributes of the various categories of our liquid assets (for example, type of asset and credit quality) in calculating internal liquidity indicators for our insurance and reinsurance operations. Our liquidity benchmarks are established for various stress scenarios and durations, including company-specific and market-wide events. The scenarios we use to evaluate the liquidity of our subsidiaries are defined to allow operating entities to operate without support from Holdings.

Liquid Assets

The investment portfolios of our insurance subsidiaries are a significant component of our overall liquidity. Liquid assets include cash and cash equivalents, short-term investments, U.S. Treasury fixed maturities, fixed maturities that are not designated as HTM and public equity securities. We believe that our business operations and the liquidity profile of our assets provide sufficient liquidity under reasonably foreseeable stress scenarios for each of our insurance subsidiaries.

See “—General Account Investment Portfolio” and Note 3 and Note 4 of the Notes to the Consolidated Financial Statements for a description of our retirement and protection businesses’ portfolio of liquid assets.

Hedging Activities

Because the future claims exposure on our insurance products, and in particular our variable annuity products, is sensitive to movements in the equity markets and interest rates, we have in place various hedging and reinsurance programs that are designed to mitigate the economic risks of movements in the equity markets and interest rates. We use derivatives as part of our overall asset/liability risk management program primarily to reduce exposures to equity market and interest rate risks. In addition, we use credit derivatives to replicate exposure to individual securities or pools of securities as a means of achieving credit exposure similar to bonds of the underlying issuer(s) more efficiently. The derivative contracts are an integral part of our risk management program, especially for the management of our variable annuities program, and are collectively managed to reduce the economic impact of unfavorable movements in capital markets. These derivative transactions require liquidity to meet payment obligations such as payments for periodic settlements, purchases, maturities and terminations as well as liquid assets pledged as collateral related to any decline in the net estimated fair value. Collateral calls represent one of our biggest drivers for liquidity needs for our insurance subsidiaries. Our derivatives contracts reside primarily within Equitable Financial, which has a significantly large investment portfolio.

FHLB Membership

Equitable Financial and Equitable America are members of the FHLB, which provides access to collateralized borrowings and other FHLB products.

See Note 16 of the Notes to the Consolidated Financial Statements for further description of our FHLB program.

FABN

Under the FABN program, Equitable Financial and Equitable America may issue funding agreements in U.S. dollar or other foreign currencies.

See Note 16 of the Notes to the Consolidated Financial Statements for further description of our FABN program.

FABCP

Under the FABCP program, Equitable Financial and Equitable America may issue funding agreements in U.S. dollars to the SPLLC.

See Note 16 of the Notes to the Consolidated Financial Statements for further description of our FABCP program.

131

Table of Contents

Sources and Uses of Liquidity of our Asset Management Segment

The principal sources of liquidity for our Asset Management business include investment management fees and borrowings under its credit facilities and commercial paper program. The principal uses of liquidity include general and administrative expenses, business financing and distributions to holders of AB Units and AB Holding Units plus interest and debt service. The primary liquidity risk for our fee-based Asset Management business is its profitability, which is impacted by market conditions and our investment management performance.

AB Commercial Paper

As of June 30, 2025 and December 31, 2024 AB had $0 million of commercial paper outstanding. The commercial paper is short term in nature, and as such, recorded value is estimated to approximate fair value (and considered a Level 2 security in the fair value hierarchy). Average daily borrowings for the commercial paper outstanding during the second quarter 2025 and full year 2024 were $184 million and $268 million, respectively, with weighted average interest rates of approximately 4.4% and 5.4%, respectively.

AB Credit Facility

AB has an $800 million committed, unsecured senior revolving credit facility (the “AB Credit Facility”) with a group of commercial banks and other lenders which matures on October 13, 2026. The credit facility provides for possible increases in the principal amount by up to an aggregate incremental amount of $200 million. Any such increase is subject to the consent of the affected lenders. The AB Credit Facility is available for AB and SCB LLC for business purposes, including the support of AB’s commercial paper program. Both AB and SCB LLC can draw directly under the AB Credit Facility and AB management expects to draw on the AB Credit Facility from time to time. AB has agreed to guarantee the obligations of SCB LLC under the AB Credit Facility.

The AB Credit Facility contains affirmative, negative and financial covenants, which are customary for facilities of this type, including, among other things, restrictions on dispositions of assets, restrictions on liens, a minimum interest coverage ratio and a maximum leverage ratio. As of June 30, 2025, AB was in compliance with these covenants. The AB Credit Facility also includes customary events of default (with customary grace periods, as applicable), including provisions under which, upon the occurrence of an event of default, all outstanding loans may be accelerated and/or lender’s commitments may be terminated. Also, under such provisions, upon the occurrence of certain insolvency- or bankruptcy-related events of default, all amounts payable under the AB Credit Facility would automatically become immediately due and payable, and the lender’s commitments would automatically terminate.

Amounts under the Credit Facility may be borrowed, repaid and re-borrowed by us from time to time until the maturity of the facility. Voluntary pre-payments and commitment reductions requested by AB are permitted at any time without a fee (other than customary breakage costs relating to the pre-payment of any drawn loans) upon proper notice and subject to a minimum dollar requirement. Borrowings under the AB Credit Facility bear interest at a rate per annum, which will be, at AB’s option, a rate equal to an applicable margin, which is subject to adjustment based on the credit ratings of AB, plus one of the following indices: a term SOFR; a Prime rate; or the Federal Funds rate.

As of June 30, 2025 and December 31, 2024, AB had no amounts outstanding under the AB Credit Facility. During the six months ended June 30, 2025 and full year 2024, AB and SCB LLC did not draw upon the AB Credit Facility.

As of June 30, 2025, SCB LLC has three uncommitted lines of credit with three financial institutions. Two of these lines of credit permit borrowing up to an aggregate of approximately $150 million, with AB named as an additional borrower, while the other line has no stated limit. AB has agreed to guarantee the obligations on SCB LLC under these lines of credit. As of June 30, 2025 and December 31, 2024, SCB LLC had no outstanding balance on these lines of credit. Average daily borrowings during the six months ended June 30, 2025 and the full year 2024 were $0 million and $1 million with weighted average interest rates of approximately 7.5% and 8.5%, respectively.

EQH Facility

AB has a $900 million committed, unsecured senior credit facility (the “EQH Facility”). The EQH Facility matures on August 31, 2029. The EQH Facility is available for AB’s general business purposes. Borrowings under the EQH Facility generally bear interest at a rate per annum based on prevailing overnight commercial paper rates.

132

Table of Contents

The EQH Facility contains affirmative, negative and financial covenants which are substantially similar to those in AB’s committed bank facilities. As of June 30, 2025, AB was in compliance with these covenants. The EQH Facility also includes customary events of default substantially similar to those in AB’s committed bank facilities, including provisions under which, upon the occurrence of an event of default, all outstanding loans may be accelerated and/or the lender’s commitment may be terminated.

Amounts under the EQH Facility may be borrowed, repaid and re-borrowed by AB from time to time until the maturity of the facility. AB or Holdings may reduce or terminate the commitment at any time without penalty upon proper notice. Holdings also may terminate the facility immediately upon a change of control of AB’s General Partner.

As of June 30, 2025 and December 31, 2024, AB had $650 million and $710 million outstanding under the EQH Facility, with interest rates of approximately 4.3% and 4.3%, respectively. Average daily borrowing of the EQH Facility for the first six months of 2025 and full year 2024 were $465 million and $494 million, respectively, with a weighted average interest rates of approximately 4.3% and 5.2%, respectively.

EQH Uncommitted Facility

In addition to the EQH Facility, AB has a $300 million uncommitted, unsecured senior credit facility (the “EQH Uncommitted Facility”) with EQH. The EQH Uncommitted Facility matures August 31, 2029 and is available for AB’s general business purposes. Borrowings under the EQH Uncommitted Facility bear interest generally at a rate per annum based on prevailing overnight commercial paper rates. The EQH Uncommitted Facility contains affirmative, negative and financial covenants, which are substantially similar to those in the EQH Facility. As of June 30, 2025, AB was in compliance with these covenants.

As of June 30, 2025 and December 31, 2024, AB had no amounts outstanding under the EQH Uncommitted Facility. During the first six months of 2025 and full year 2024, AB did not draw upon the EQH Uncommitted Facility.

Statutory Capital of Our Insurance Subsidiaries

Our capital management framework for our insurance subsidiaries is primarily based on statutory RBC standards and the CTE asset standard for our variable annuity business.

RBC requirements are used as minimum capital requirements by the NAIC and the state insurance departments to evaluate the capital condition of regulated insurance companies. RBC is based on a formula calculated by applying factors to various asset, premium, claim, expense and statutory reserve items. The formula takes into account the risk characteristics of the insurer, including asset risk, insurance risk, interest rate risk, market risk and business risk and is calculated on a quarterly basis and made public on an annual basis. The formula is used as an early warning regulatory tool to identify possible inadequately capitalized insurers for purposes of initiating regulatory action, and not as a means to rank insurers generally. These rules apply to our insurance company subsidiaries and not to Holdings. State insurance laws provide insurance regulators the authority to require various actions by, or take various actions against, insurers whose TAC does not meet or exceed certain RBC levels. At the date of the most recent annual statutory financial statements filed with insurance regulators, the TAC of each of these insurance company subsidiaries subject to these requirements was in excess of each of those RBC levels.

See Note 18 of the Notes to the Consolidated Financial Statements for additional information relating to Prescribed and Permitted Statutory Accounting practices and its impact on our statutory surplus.

Captive Reinsurance Companies

We use captive reinsurance companies to more effectively manage our reserves and capital on an economic basis and to enable the aggregation and transfer of risks. Our captive reinsurance companies assume business from affiliates only and are closed to new business. Our captive reinsurance companies are wholly-owned subsidiaries located in the United States and Bermuda. In addition to state insurance regulation, our captive reinsurance companies are subject to internal policies governing its activities. We continue to analyze the use of our existing captive reinsurance structure, as well as additional third-party reinsurance arrangements.

133

Table of Contents

Borrowings

The following table sets forth the Company’s total consolidated borrowings. Short-term and long-term debt consists of the following:



	June 30, 2025		December 31, 2024
	(in millions)
Short-term debt:




Total short-term debt	$	—	$	—
Long-term debt:
Senior Debenture due 2028	250		250
Senior Note due 2028	1,495		1,494
Senior Note due 2029	305		303
Senior Note due 2033	497		497
Senior Note due 2048	1,290		1,289
Junior Sub Debt Securities due 2055	495		—
Total long-term debt	4,332		3,833
Total short and long-term debt	$	4,332	$	3,833

Notes and Debentures

The Senior Notes and Senior Debentures contain customary affirmative and negative covenants, including a limitation on certain liens and a limit on the Company’s ability to consolidate, merge or sell or otherwise dispose of all or substantially all of its assets. The Senior Notes and Senior Debentures also include customary events of default (with customary grace periods, as applicable), including provisions under which, upon the occurrence of an event of default, all outstanding Senior Notes and Senior Debentures may be accelerated. As of June 30, 2025, the Company is in compliance with all debt covenants.

Ratings

Financial strength ratings (which are sometimes referred to as “claims-paying” ratings) and credit ratings are important factors affecting public confidence in an insurer and its competitive position in marketing products. Our credit ratings are also important for our ability to raise capital through the issuance of debt and for the cost of such financing.

Financial strength ratings represent the opinions of rating agencies regarding the financial ability of an insurance company to meet its obligations under an insurance policy. Credit ratings represent the opinions of rating agencies regarding an entity’s ability to repay its indebtedness. The following table summarizes the ratings for Holdings and certain of its subsidiaries. AM Best, S&P and Moody’s have a stable outlook.

AM Best

S&P

Moody’s

Last review date

Feb '25

Mar '25

May '25

Financial Strength Ratings:

Equitable Financial Life Insurance Company

A+

Equitable Financial Life Insurance Company of America

A+

Credit Ratings:

Equitable Holdings, Inc.

bbb+

A-

Baa1

Last review date

Nov 24

Mar '25

AllianceBernstein L.P.

134

Table of Contents

Material Cash Requirement

Our material cash requirements include policyholder obligations, long-term debt, commercial paper, EB, operating leases and various funding commitments. See “Material Cash Requirement” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the 2024 Form 10-K for additional information.

Summary of Critical Accounting Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in our consolidated financial statements included elsewhere herein. For a discussion of our significant accounting policies, see Note 2 of the Notes to the Consolidated Financial Statements. The most critical estimates include those used in determining:

•MRBs and purchased MRBs;

•accounting for reinsurance;

•estimated fair values of investments in the absence of quoted market values and investment impairments;

•estimated fair values of freestanding derivatives;

•goodwill and related impairment;

•measurement of income taxes and the valuation of deferred tax assets; and

•liabilities for litigation and regulatory matters.

In applying our accounting policies, we make subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries while others are specific to our business and operations. Actual results could differ from these estimates.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes to the quantitative and qualitative disclosures about market risk described in the 2024 Form 10-K in “Quantitative and Qualitative Disclosures About Market Risk”.

Item 4. Controls and Procedures

Management, with the participation of the Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of June 30, 2025, the Company’s disclosure controls and procedures were effective.

No change in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) occurred during the quarter ended June 30, 2025 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

135

Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

For information regarding certain legal proceedings pending against us, see Note 16 of the Notes to the Consolidated Financial Statements. Also see “Risk Factors—Legal and Regulatory Risks—Legal proceedings and regulatory actions” included in the 2024 Form 10-K.

Item 1A. Risk Factors

You should carefully consider the risks described in the “Risk Factors” section included in the 2024 Form 10-K. Risks to which we are subject also include, but are not limited to, the factors mentioned under “Note Regarding Forward-Looking Statements and Information” above and the risks of our businesses described elsewhere in this Quarterly Report on Form 10-Q.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about purchases by Holdings during the three months ended June 30, 2025, of its common stock:


Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
4/1/25 through 4/30/25	2,391,212	$	50.55	2,391,212	$	1,579,870,670
5/1/25 through 5/31/25	1,370,584	$	52.53	1,370,584	$	1,507,871,265
6/1/25 through 6/30/25	1,011,876	$	53.37	1,011,876	$	1,453,871,764
Total	4,773,672	$	51.71	4,773,672	$	1,453,871,764

See Note 13 to the Notes to Consolidated Financial Statements for ASR transaction detail during the three months ended June 30, 2025.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Securities Trading Plans of Directors and Executive Officers

A significant portion of the compensation of our executive officers is delivered in the form of equity awards, including restricted stock units and performance shares. All vehicles contain vesting requirements related to service, with performance shares also requiring the satisfaction of certain performance criteria related to corporate performance to obtain a payout. This compensation design is intended to align executive compensation with the performance experienced by our shareholders. Following the delivery of shares of our common stock under those equity awards, once any applicable service- or performance-based vesting standards have been satisfied, our executive officers from time to time engage in the open-market sale of some of those shares. Our executive officers may also engage from time to time in other transactions involving our securities.

Transactions in our securities by our executive officers are required to be made in accordance with our Insider Trading Policy, which, among other things, requires that the transactions be in accordance with applicable U.S. federal securities laws that prohibit trading while in possession of material nonpublic information. Rule 10b5-1 under the Exchange Act provides an affirmative defense that enables prearranged transactions in securities in a manner that avoids concerns about initiating transactions at a future date while possibly in possession of material nonpublic information. Our Insider Trading Policy permits our executive officers to enter into trading plans designed to comply with Rule 10b5-1.

136

Table of Contents

The following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted by our executive officers during the three months ended June 30, 2025, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), referred to as Rule 10b5-1 trading plans. The plans listed below are only executed when the stock price reaches a required minimum. In addition, the executives identified in the table below are required to maintain an ownership of Holdings’ common stock with a value equal to at least a multiple of his annual base salary (6 times for Mr. Pearson, 3 times for Mr. Hurd).

Name and Title

Date of Adoption of Rule 10b5-1 Trading Plan

Scheduled Start Date of Rule 10b5-1 Trading Plan

Scheduled Expiration Date of Rule 10b5-1 Trading Plan(1)

Aggregate Number of Securities to be Purchased or Sold

Mark Pearson

President and Chief Executive Officer

6/15/2025

8/15/2025

8/18/2026

Sale of up to 476,400 shares(2) of common stock in several transactions through the scheduled expiration date in 2025.

Jeffrey Hurd

Chief Operating Officer

5/1/2025

8/15/2025

1/30/2026

Sale of up to 40,740 shares(3) of common stock in several transactions through the scheduled expiration date in 2026.

(1)In each case, a Rule 10b5-1 trading plan may also expire on such earlier date as all transactions under the Rule 10b5-1 trading plan are completed.

(2)326,400 of Mr. Pearson’s shares consist of stock options and 150,000 of Mr. Pearson’s shares consist of common stock already owned.

(3)40,740 of Mr. Hurd’s shares consist of common stock already owned.

Other than as set forth in the table above, during the three months ended June 30, 2025, none of the Company’s directors or executive officers adopted, terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).

137

Table of Contents

Item 6. Exhibits


Number		Description and Method of Filing
3.1		Third Amended and Restated Certificate of Incorporation of Equitable Holdings, Inc. effective May 21, 2025 (incorporated by reference to Exhibit 3.2 of our Current Report on Form 8-K, filed May 28, 2025).
3.2		Equitable Holdings, Inc. Seventh Amended and Restated By-Laws, effective May 21, 2025 (incorporated by reference to Exhibit 3.3 of our Current Report on Form 8-K, filed May 28, 2025).
10.1	†	Amended and Restated Equitable Holdings, Inc. 2019 Omnibus Incentive Plan (incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K, filed May 28, 2025).
10.2		Revolving Credit Agreement, dated as of July 29, 2025, by and between Equitable Holdings, Inc., the Subsidiary Account Parties thereto, the banks party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated by reference to Exhibit 1.1 of our Current Report on Form 8-K, filed July 30, 2025).
31.1	#	Certification of the Registrant’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	#	Certification of the Registrant’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	#	Certification of the Registrant’s Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	#	Certification of the Registrant’s Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
104		Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibits 101).

______________

# Filed herewith.

† Identifies each management contract or compensatory plan or arrangement.

138

Table of Contents

GLOSSARY

Selected Financial Terms


Account Value (“AV”)			Generally equals the aggregate policy account value of our retirement and protection products. General Account AV refers to account balances in investment options that are backed by the General Account while Separate Accounts AV refers to Separate Accounts investment assets.

Alternative investments			Investments in real estate and real estate joint ventures and other limited partnerships.

Assets under administration (“AUA”)			Includes non-insurance client assets that are invested in our savings and investment products or serviced by our Equitable Advisors platform. We provide administrative services for these assets and generally record the revenues received as distribution fees.

Assets under management (“AUM”)			Investment assets that are managed by one of our subsidiaries and includes: (i) assets managed by AB, (ii) the assets in our GAIA portfolio and (iii) the Separate Account assets of our retirement and protection businesses. Total AUM reflects exclusions between segments to avoid double counting.

Combined RBC Ratio			Calculated as the overall aggregate RBC ratio for the Company’s insurance subsidiaries including capital held for its life insurance and variable annuity liabilities and non-variable annuity insurance liabilities.

Conditional tail expectation (“CTE”)			Calculated as the average amount of total assets required to satisfy obligations over the life of the contract or policy in the worst x% of scenarios. Represented as CTE (100 less x). Example: CTE95 represents the worst five percent of scenarios.

Deferred policy acquisition cost (“DAC”)			Represents the incremental costs related directly to the successful acquisition of new and certain renewal insurance policies and annuity contracts and which have been deferred on the consolidated balance sheet as an asset.

Deferred sales inducements (“DSI”)			Represent amounts that are credited to a policyholder’s account balance that are higher than the expected crediting rates on similar contracts without such an inducement and that are an incentive to purchase a contract and also meet the accounting criteria to be deferred as an asset that is amortized over the life of the contract.

Fee-type revenue			Revenue from fees and related items, including policy charges and fee income, premiums, investment management and service fees, and other income.

Gross Premiums			First year premium and renewal premium and deposits


Invested assets			Includes fixed maturity securities, equity securities, mortgage loans, policy loans, alternative investments and short-term investments.

Protection Solutions Reserves			Equals the aggregate value of Policyholders’ account balances and Future policy benefits for policies in our Protection Solutions segment.

Reinsurance			Insurance policies purchased by insurers to limit the total loss they would experience from an insurance claim.

Renewal premium and deposits			Premiums and deposits after the first twelve months of the policy or contract.

Risk-based capital (“RBC”)			Rules to determine insurance company statutory capital requirements. It is based on rules published by the National Association of Insurance Commissioners (“NAIC”).

Total adjusted capital (“TAC”)			Primarily consists of capital and surplus, and the asset valuation reserve.

Product Terms

401(k)			A tax-deferred retirement savings plan sponsored by an employer. 401(k) refers to the section of the Internal Revenue Code of 1986, as amended (the “Code”) pursuant to which these plans are established.

139

Table of Contents


403(b)			A tax-deferred retirement savings plan available to certain employees of public schools and certain tax-exempt organizations. 403(b) refers to the section of the Code pursuant to which these plans are established.

Affluent			Refers to individuals with $250,000 to $999,999 of investable assets.

Annuitant			The person who receives annuity payments or the person whose life expectancy determines the amount of variable annuity payments upon annuitization of an annuity to be paid for life.

Annuitization			The process of converting an annuity investment into a series of periodic income payments, generally for life.


Benefit base			A notional amount (not actual cash value) used to calculate the owner’s guaranteed benefits within an annuity contract. The death benefit and living benefit within the same contract may not have the same benefit base.

Cash surrender value			The amount an insurance company pays (minus any surrender charge) to the policyholder when the contract or policy is voluntarily terminated prematurely.

Dollar-for-dollar withdrawal			A method of calculating the reduction of a variable annuity benefit base after a withdrawal in which the benefit is reduced by one dollar for every dollar withdrawn.

EQUI-VEST Group (“EG”)			A traditional variable deferred annuity without enhanced guaranteed benefits with single and ongoing premiums sold in the tax-exempt 403(b)/457(b) markets.

EQUI-VEST Individual (“EI”)			A traditional variable deferred annuity without enhanced guaranteed benefits sold in the individual market.

Future policy benefits			Future policy benefits for the annuities business are comprised mainly of liabilities for life-contingent income annuities, and liabilities for the variable annuity guaranteed minimum benefits accounted for as insurance. Future policy benefits for the life business are comprised mainly of liabilities for traditional life and certain liabilities for universal and variable life insurance contracts (other than the Policyholders’ account balance).

General Account Investment Portfolio			The invested assets held in the General Account.

General Account			The assets held in the general accounts of our insurance companies as well as assets held in our Separate Accounts on which we bear the investment risk.

GMxB			A general reference to all forms of variable annuity guaranteed benefits, including guaranteed minimum living benefits, or GMLBs (such as GMIBs, GMWBs and GMABs), and guaranteed minimum death benefits, or GMDBs (inclusive of return of premium death benefit guarantees).

GMxB Core			Retirement Cornerstone and Accumulator sold 2011 and later.

GMxB Legacy			Fixed-rate GMxB business written prior to 2011.

Guaranteed income benefit (“GIB”)			An optional benefit which provides the policyholder with a guaranteed lifetime annuity based on predetermined annuity purchase rates applied to a GIB benefit base, with annuitization automatically triggered if and when the contract AV falls to zero.


Guaranteed minimum accumulation benefits (“GMAB”)			An optional benefit (available for an additional cost) which entitles an annuitant to a minimum payment, typically in lump-sum, after a set period of time, typically referred to as the accumulation period. The minimum payment is based on the benefit base, which could be greater than the underlying AV.

Guaranteed minimum death benefits (“GMDB”)			An optional benefit (available for an additional cost) that guarantees an annuitant’s beneficiaries are entitled to a minimum payment based on the benefit base, which could be greater than the underlying AV, upon the death of the annuitant.

140

Table of Contents


Guaranteed minimum income benefits (“GMIB”)			An optional benefit (available for an additional cost) where an annuitant is entitled to annuitize the policy and receive a minimum payment stream based on the benefit base, which could be greater than the underlying AV.

Guaranteed minimum living benefits (“GMLB”)			A reference to all forms of guaranteed minimum living benefits, including GMIBs, GMWBs and GMABs (does not include GMDBs).

Guaranteed minimum withdrawal benefits (“GMWB”)			An optional benefit (available for an additional cost) where an annuitant is entitled to withdraw a maximum amount of their benefit base each year, for which cumulative payments to the annuitant could be greater than the underlying AV.

Guaranteed withdrawal benefit for life (“GWBL”)			An optional benefit (available for an additional cost) where an annuitant is entitled to withdraw a maximum amount of their benefit base each year, for the duration of the policyholder’s life, regardless of account performance.

High net worth			Refers to individuals with $1,000,000 or more of investable assets.

Indexed Universal Life (“IUL”)			A permanent life insurance offering built on a universal life insurance framework that uses an equity-linked approach for generating policy investment returns.

Investment Edge (“IE”)			A traditional variable deferred annuity without enhanced guaranteed benefits that provides tax-efficient distribution.

Living benefits			Optional benefits (available at an additional cost) that guarantee that the policyholder will get back at least his original investment when the money is withdrawn.

Mortality and expense risk fee (“M&E fee”)			A fee charged by insurance companies to compensate for the risk they take by issuing life insurance and variable annuity contracts.


Net flows			Net change in customer account balances in a period including, but not limited to, gross premiums, surrenders, withdrawals and benefits. It excludes investment performance, interest credited to customer accounts and policy charges.

Policyholder account balances			Annuities. Policyholder account balances are held for fixed deferred annuities, the fixed account portion of variable annuities and non-life contingent income annuities. Interest is credited to the policyholder’s account at interest rates we determine which are influenced by current market rates, subject to specified minimums. Life Insurance Policies. Policyholder account balances are held for retained asset accounts, universal life policies and the fixed account of universal variable life insurance policies. Interest is credited to the policyholder’s account at interest rates we determine which are influenced by current market rates, subject to specified minimums.

Return of premium (“ROP”) death benefit			This death benefit pays the greater of the account value at the time of a claim following the owner’s death or the total contributions to the contract (subject to adjustment for withdrawals). The charge for this benefit is usually included in the M&E fee that is deducted daily from the net assets in each variable investment option. We also refer to this death benefit as the Return of Principal death benefit.

Rider			An optional feature or benefit that a policyholder can purchase at an additional cost.

Separate Account			Refers to the separate account investment assets of our insurance subsidiaries excluding the assets held in those Separate Accounts on which we bear the investment risk.

Surrender charge			A fee paid by a contract owner for the early withdrawal of an amount that exceeds a specific percentage or for cancellation of the contract within a specified amount of time after purchase.


Surrender rate			Represents annualized surrenders and withdrawals as a percentage of average AV.

Universal life (“UL”) products			Life insurance products that provide a death benefit in return for payment of specified annual policy charges that are generally related to specific costs, which may change over time. To the extent that the policyholder chooses to pay more than the charges required in any given year to keep the policy in-force, the excess premium will be placed into the AV of the policy and credited with a stated interest rate on a monthly basis.

141

Table of Contents



Variable annuity			A type of annuity that offers guaranteed periodic payments for a defined period of time or for life and gives purchasers the ability to invest in various markets though the underlying investment options, which may result in potentially higher, but variable, returns.

Variable Universal Life (“VUL”)			Universal life products where the excess amount paid over policy charges can be directed by the policyholder into a variety of Separate Account investment options. In the Separate Account investment options, the policyholder bears the entire risk and returns of the investment results.

142

Table of Contents

ACRONYMS

•“AB” or “AllianceBernstein” means AB Holding and ABLP

•“AB Holding” means AllianceBernstein Holding L.P., a Delaware limited partnership

•“AB Holding Units” means units representing assignments of beneficial ownership of limited partnership interests in AB Holding

•“AB Units” means units of limited partnership interests in ABLP

•“ABLP” means AllianceBernstein L.P., a Delaware limited partnership and the operating partnership for the AB business

•“AFS” means available-for-sale

•“AOCI” means accumulated other comprehensive income

•“ASR” means accelerated share repurchase

•“ASU” means Accounting Standards Update

•“BOP” means beginning of period

•“BPs” means basis points

•“BRS” means Bernstein Research Services

•“CDS” means credit default swaps

•“CLO” means collateralized loan obligation

•“CODM” means chief operating decision maker

•“COI” means cost of insurance

•“COLI” means corporate owned life insurance

•“Company” means Equitable Holdings, Inc. with its consolidated subsidiaries

•“CS Life” means Corporate Solutions Life Reinsurance Company, a Delaware corporation and a wholly-owned direct subsidiary of Venerable Insurance and Annuity Company RE

•“CSA” means credit support annex

•“DOL” means U.S. Department of Labor

•“DSC” means debt service coverage

•“EAFE” means European, Australasia, and Far East

•“EB” means Employee Benefits

•“EFS” means Equitable Financial Services, LLC, a Delaware corporation and a wholly-owned direct subsidiary of Holdings

•“EPS” means earnings per share

•“EOP” means end of period

•“Equitable Advisors” means Equitable Advisors, LLC, a Delaware limited liability company, our retail broker/dealer for our retirement and protection businesses and a wholly-owned indirect subsidiary of Holdings

•“Equitable America” means Equitable Financial Life Insurance Company of America (f/k/a MONY Life Insurance Company of America), an Arizona corporation and a wholly-owned indirect subsidiary of Holdings

•“Equitable Financial” means Equitable Financial Life Insurance Company, a New York corporation, a life insurance company and a wholly-owned subsidiary of EFS

•“Equitable Financial L&A” means Equitable Financial Life and Annuity Company, a Colorado corporation and a wholly-owned indirect subsidiary of Holdings

•“Equitable Financial QP” means Equitable Financial sponsored Equitable Retirement Plan

•“EQ AZ Life Re” means EQ AZ Life Re Company, an Arizona corporation and a wholly-owned indirect subsidiary of Holdings.

•“ERISA” means Employee Retirement Income Security Act of 1974

•“ESG” means environmental, social and governance

•“ETF” means exchange traded funds

•“ETR” means effective tax rate

•“Exchange Act” means Securities Exchange Act of 1934, as amended

•“FABCP” means Funding Agreement-Backed Commercial Paper Program

•“FABN” means Funding Agreement Backed Notes Program

•“FHLB” means Federal Home Loan Bank

•“General Partner” means AllianceBernstein Corporation, a Delaware corporation and the general partner of AB Holding and ABLP

•“Holdings” means Equitable Holdings, Inc.

•“HTM” means held-to-maturity

•“ISDA Master Agreement” means International Swaps and Derivatives Association Master Agreement

•“LIBOR” means London Interbank Offered Rate

•“LTV” means loan to value

•“MRBs” means market risk benefits

•“MSO” means Market Stabilizer Option

•“NAIC” means National Association of Insurance Commissioners

•“NAR” means net amount at risk

•“NAV” means net asset value

•“NLG” means no-lapse guarantee

143

Table of Contents

•“NYDFS” means New York State Department of Financial Services

•“OCI” means other comprehensive income

•“OTC” means over-the-counter

•“PTEs” means prohibited transaction exemptions

•“P-Caps” means Pre-Capitalized Trust Securities

•“RGA” means Reinsurance Group of America

•“SCB LLC” means Sanford C. Bernstein & Co., LLC, a registered investment adviser and broker-dealer.

•“SCS” means Structured Capital Strategies

•“SEC” means U.S. Securities and Exchange Commission

•“Series A Preferred Stock” means Holdings’ Series A Fixed Rate Noncumulative Perpetual Preferred Stock

•“Series B Preferred Stock” means Holdings’ Series B Fixed Rate Reset Noncumulative Perpetual Preferred Stock

•“Series C Preferred Stock” means Holdings’ Series C Fixed Rate Reset Noncumulative Perpetual Preferred Stock

•“SIA” means sales inducement asset

•“SIO” means structured investment option

•“SPE” means special purpose entity

•“SVO” means Securities Valuation Office

•“TAR” means total asset requirement

•“TIPS” means treasury inflation-protected securities

•“U.S. GAAP” means accounting principles generally accepted in the United States of America

•“UL” means universal life

•“Venerable” means Venerable Holdings, Inc.

•“VIE” means variable interest entity

•“VOE” means voting interest entity

144

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Equitable Holdings, Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Date: August 11, 2025	EQUITABLE HOLDINGS, INC.

	By:	/s/ Robin M. Raju
		Name:	Robin M. Raju
		Title:	Chief Financial Officer (Principal Financial Officer)

Date: August 11, 2025	By:	/s/ William Eckert
		Name:	William Eckert
		Title:	Chief Accounting Officer (Principal Accounting Officer)

145

Exhibit 31.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark Pearson, President and Chief Executive Officer of Equitable Holdings, Inc., certify that:

1) I have reviewed this Quarterly Report on Form 10-Q of Equitable Holdings, Inc. (the “Registrant”);

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4) The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5) The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: August 11, 2025


/s/ Mark Pearson
Mark Pearson
President and Chief Executive Officer

Exhibit 31.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robin M. Raju, Chief Financial Officer of Equitable Holdings, Inc., certify that:

1) I have reviewed this Quarterly Report on Form 10-Q of Equitable Holdings, Inc. (the “Registrant”);

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: August 11, 2025


/s/ Robin M. Raju
Robin M. Raju
Chief Financial Officer

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Equitable Holdings, Inc. (the “Company”) for the quarter ended June 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Pearson, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 11, 2025


/s/ Mark Pearson
Mark Pearson
President and Chief Executive Officer

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Equitable Holdings, Inc. (the “Company”) for the quarter ended June 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robin M. Raju, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 11, 2025


/s/ Robin M. Raju
Robin M. Raju
Chief Financial Officer

v3.25.2

Cover - shares
6 Months Ended

Jun. 30, 2025

Aug. 07, 2025

Entity Information [Line Items]

Document Type 10-Q

Document Quarterly Report true

Document Period End Date Jun. 30, 2025

Document Transition Report false

Entity File Number 001-38469

Entity Registrant Name Equitable Holdings, Inc.

Entity Incorporation, State or Country Code DE

Entity Tax Identification Number 90-0226248

Entity Address, Address Line One 1345 Avenue of the Americas

Entity Address, City or Town New York

Entity Address, State or Province NY

Entity Address, Postal Zip Code 10105

City Area Code 212

Local Phone Number 554-1234

Entity Current Reporting Status Yes

Entity Interactive Data Current Yes

Entity Filer Category Large Accelerated Filer

Entity Small Business false

Entity Emerging Growth Company false

Entity Shell Company false

Entity Common Stock, Shares Outstanding 299,536,468

Document Fiscal Period Focus Q2

Document Fiscal Year Focus 2025

Amendment Flag false

Entity Central Index Key 0001333986

Current Fiscal Year End Date --12-31

Common Stock

Entity Information [Line Items]

Title of 12(b) Security Common Stock

Trading Symbol EQH

Security Exchange Name NYSE

Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A

Entity Information [Line Items]

Title of 12(b) Security Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A

Trading Symbol EQH PR A

Security Exchange Name NYSE

Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C

Entity Information [Line Items]

Title of 12(b) Security Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C

Trading Symbol EQH PR C

Security Exchange Name NYSE

v3.25.2

Consolidated Balance Sheets - USD ($)
$ in Millions

Jun. 30, 2025

Dec. 31, 2024

Investments:

Fixed maturities available-for-sale, at fair value (amortized cost of $86,819 and $84,717) (allowance for credit losses of $3 and $2) $ 80,094 $ 76,641

Fixed maturities, at fair value using the fair value option ^[1] 2,428 2,053

Mortgage loans on real estate (net of allowance for credit losses of $278 and $279) ^[1] 21,536 20,072

Policy loans 4,355 4,330

Other equity investments ^[1] 3,789 3,719

Trading securities, at fair value 1,295 1,089

Other invested assets ^[1] 8,301 8,537

Total investments 121,798 116,441

Cash and cash equivalents ^[1] 14,957 6,964

Cash and securities segregated, at fair value 483 500

Broker-dealer related receivables 1,933 1,961

Deferred policy acquisition costs 7,361 7,170

Goodwill and other intangible assets, net 5,342 5,371

Amounts due from reinsurers (allowance for credit losses of $7 and $8) 7,501 7,899

Current and deferred income taxes 1,749 2,003

Purchased market risk benefits 5,543 7,376

Other assets ^[1] 3,962 4,462

Assets for market risk benefits 776 863

Separate Accounts assets 131,683 134,717

Total Assets 303,088 295,727

LIABILITIES

Policyholders’ account balances 123,359 110,929

Liability for market risk benefits 10,187 11,810

Future policy benefits and other policyholders’ liabilities 17,557 17,613

Broker-dealer related payables 1,454 775

Customer related payables 1,885 1,933

Amounts due to reinsurers 1,350 1,421

Long-term debt 4,332 3,833

Notes issued by consolidated variable interest entities, at fair value using the fair value option ^[1] 2,471 2,116

Other liabilities ^[1] 5,847 7,032

Separate Accounts liabilities 131,683 134,717

Total Liabilities 300,125 292,179

Redeemable noncontrolling interest ^[1],[2] 358 125

Commitments and contingent liabilities ^[3]

Equity attributable to Holdings:

Preferred stock and additional paid-in capital, $1 par value and $25,000 liquidation preference 1,228 1,507

Common stock, $0.01 par value, 2,000,000,000 shares authorized; 472,699,844 and 477,801,636 shares issued, respectively; 301,768,056 and 309,900,248 shares outstanding, respectively 5 5

Additional paid-in capital 1,901 2,336

Treasury stock, at cost,$170,931,788 and 167,901,388 shares, respectively (4,423) (4,198)

Retained earnings 9,870 10,627

Accumulated other comprehensive income (loss) (7,432) (8,712)

Total equity attributable to Holdings 1,149 1,565

Noncontrolling interest 1,456 1,858

Total Equity 2,605 3,423

Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 303,088 $ 295,727

[1] See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.

[2] See Note 15 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.

[3] See Note 16 of the Notes to these Consolidated Financial Statements for details of commitments and contingent liabilities.

v3.25.2

Consolidated Balance Sheets (Parenthetical) - USD ($)

Jun. 30, 2025

Dec. 31, 2024

Statement of Financial Position [Abstract]

Amortized cost of fixed maturities available-for-sale $ 86,819,000,000 $ 84,717,000,000

Allowance for credit losses of fixed maturities available-for-sale 3,000,000 2,000,000

Allowance for credit losses of mortgage loans on real estate 305,000,000 278,000,000

Allowance for credit losses of amounts due from reinsurers $ 7,000,000 $ 8,000,000

Preferred stock par value (in dollars per share) $ 1 $ 1

Preferred stock, liquidation preference $ 25,000 $ 25,000

Common stock par value (in dollars per share) $ 0.01 $ 0.01

Common stock authorized (in shares) 2,000,000,000 2,000,000,000

Common stock issued (in shares) 472,699,844 477,801,636

Common stock outstanding (in shares) 301,768,056 309,900,248

Treasury stock (in shares) 170,931,788 167,901,388

v3.25.2

Consolidated Statements of Income (Loss) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

REVENUES

Policy charges and fee income $ 626 $ 617 $ 1,262 $ 1,231

Premiums 260 282 564 567

Net derivative gains (losses) (1,374) (208) (575) (1,584)

Net investment income (loss) 1,355 1,167 2,603 2,377

Investment gains (losses), net:

Credit and intent to sell losses on available for sale debt securities and loans (54) (15) (54) (35)

Other investment gains (losses), net (17) (1) (31) (20)

Total investment gains (losses), net (71) (16) (85) (55)

Investment management and service fees 1,272 1,240 2,557 2,518

Other income 294 425 612 683

Total revenues 2,362 3,507 6,938 5,737

BENEFITS AND OTHER DEDUCTIONS

Policyholders’ benefits 787 667 1,546 1,344

Remeasurement of liability for future policy benefits (13) (7) (15) (2)

Change in market risk benefits and purchased market risk benefits (606) (132) 66 (1,220)

Interest credited to policyholders’ account balances 796 599 1,474 1,178

Compensation and benefits 592 577 1,193 1,197

Commissions and distribution-related payments 488 463 989 900

Interest expense 61 62 116 119

Amortization of deferred policy acquisition costs 193 169 381 341

Other operating costs and expenses 427 428 1,377 980

Total benefits and other deductions 2,725 2,826 7,127 4,837

Income (loss) from continuing operations, before income taxes (363) 681 (189) 900

Income tax (expense) benefit 80 (116) 56 (140)

Net income (loss) (283) 565 (133) 760

Less: Net income (loss) attributable to the noncontrolling interest ^[1] 66 137 153 240

Net income (loss) attributable to Holdings (349) 428 (286) 520

Less: Preferred stock dividends 18 26 32 40

Net income (loss) available to Holdings’ common shareholders, basic (367) 402 (318) 480

Net income (loss) available to Holdings’ common shareholders, diluted $ (367) $ 402 $ (318) $ 480

Net income (loss) applicable to Holdings’ common shareholders per common share:

Basic (in dollars per share) $ (1.21) $ 1.24 $ (1.04) $ 1.47

Diluted (in dollars per share) $ (1.21) $ 1.23 $ (1.04) $ 1.45

Weighted average common shares outstanding (in millions):

Basic (in shares) 303.2 324.2 305.5 327.2

Diluted (in shares) 303.2 327.3 305.5 330.4

[1] Includes redeemable noncontrolling interest. See Note 15 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.

v3.25.2

Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Statement of Comprehensive Income [Abstract]

Net income (loss) $ (283) $ 565 $ (133) $ 760

Other comprehensive income (loss) net of income taxes:

Change in unrealized gains (losses), net of reclassification adjustment 309 (409) 918 (922)

Change in market risk benefits - instrument-specific credit risk (170) (159) 414 (139)

Change in liability for future policy benefits - current discount rate (29) 67 (92) 165

Change in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment 9 11 26 19

Foreign currency translation adjustment 26 9 37 (2)

Total other comprehensive income (loss), net of income taxes 145 (481) 1,303 (879)

Comprehensive income (loss) (138) 84 1,170 (119)

Less: Comprehensive income (loss) attributable to the noncontrolling interest 76 140 176 239

Comprehensive income (loss) attributable to Holdings $ (214) $ (56) $ 994 $ (358)

v3.25.2

Consolidated Statements of Equity - USD ($)
$ in Millions

Total

Total Holdings Equity

Preferred Stock and Additional Paid-In Capital

Common Stock

Additional Paid-in Capital

Treasury Stock

Retained Earnings

Accumulated Other Comprehensive Income (Loss)

Non-controlling Interest

Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2023 $ 4,375 $ 2,636 $ 1,562 $ 5 $ 2,328 $ (3,712) $ 10,250 $ (7,797) $ 1,739

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock compensation 70 49 0 0 32 17 0 0 21

Purchase of treasury stock (500) (500) 0 0 (2) (498) 0 0 0

Reissuance of treasury stock (17) (17) 0 0 0 0 (17) 0 0

Retirement of common stock 0 0 0 0 0 261 (261) 0 0

Purchase of AB Holding units (34) 0 0 0 0 0 0 0 (34)

Dividends paid to noncontrolling interest (189) 0 0 0 0 0 0 0 (189)

Dividends on common stock (151) (151) 0 0 0 0 (151) 0

Dividends on preferred stock (40) (40) 0 0 0 0 (40) 0 0

Net income (loss) 726 520 0 0 0 0 520 0 206

Total other comprehensive income (loss), net of income taxes (879) (878) 0 0 0 0 0 (878) (1)

Other (22) (21) 0 0 (21) 0 0 0 (1)

Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2024 3,339 1,598 1,562 5 2,337 (3,932) 10,301 (8,675) 1,741

Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2024 3,715 1,992 1,562 5 2,322 (3,801) 10,095 (8,191) 1,723

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock compensation 26 14 0 0 16 (2) 0 0 12

Purchase of treasury stock (247) (247) 0 0 (247) 0 0 0

Reissuance of treasury stock 0 0 0 0 0 0 0 0 0

Retirement of common stock 0 0 0 0 0 118 (118) 0 0

Purchase of AB Holding units (28) 0 0 0 0 0 0 0 (28)

Dividends paid to noncontrolling interest (90) 0 0 0 0 0 0 0 (90)

Dividends on common stock (78) (78) 0 0 0 0 (78) 0 0

Dividends on preferred stock (26) (26) 0 0 0 0 (26) 0 0

Net income (loss) 549 428 0 0 0 0 428 0 121

Total other comprehensive income (loss), net of income taxes (481) (484) 0 0 0 0 0 (484) 3

Other (1) (1) 0 0 (1) 0 0 0 0

Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2024 3,339 1,598 1,562 5 2,337 (3,932) 10,301 (8,675) 1,741

Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2024 3,423 1,565 1,507 5 2,336 (4,198) 10,627 (8,712) 1,858

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock compensation 73 62 0 0 37 25 0 0 11

Purchase of treasury stock (497) (497) 0 0 10 (507) 0 0 0

Reissuance of treasury stock (19) (19) 0 0 0 0 (19) 0 0

Retirement of common stock 0 0 0 0 0 257 (257) 0 0

Purchase of AB Holding units (802) (443) 0 0 (443) 0 0 0 (359)

Dividends paid to noncontrolling interest (229) 0 0 0 0 0 0 0 (229)

Dividends on common stock (156) (156) 0 0 0 0 (156) 0 0

Dividends on preferred stock (32) (32) 0 0 0 0 (32) 0 0

Redemption of preferred stock (279) (279) (279) 0 0 0 0 0 0

Net income (loss) (134) (286) 0 0 0 0 (286) 0 152

Total other comprehensive income (loss), net of income taxes 1,303 1,280 0 0 0 0 0 1,280 23

Other (46) (46) 0 0 (39) 0 (7) 0 0

Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2025 2,605 1,149 1,228 5 1,901 (4,423) 9,870 (7,432) 1,456

Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2025 4,205 2,401 1,507 5 2,305 (4,296) 10,447 (7,567) 1,804

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock compensation 23 20 0 0 19 1 0 0 3

Purchase of treasury stock (235) (235) 0 0 15 (250) 0 0 0

Reissuance of treasury stock (1) (1) 0 0 0 0 (1) 0 0

Retirement of common stock 0 0 0 0 0 122 (122) 0 0

Purchase of AB Holding units (772) (443) 0 0 (443) 0 0 0 (329)

Dividends paid to noncontrolling interest (99) 0 0 0 0 0 0 0 (99)

Dividends on common stock (82) (82) 0 0 0 0 (82) 0 0

Redemption of preferred stock (279) (279) (279) 0 0 0 0 0 0

Dividends on preferred stock (18) (18) 0 0 0 0 (18) 0 0

Net income (loss) (281) (349) 0 0 0 0 (349) 0 68

Total other comprehensive income (loss), net of income taxes 145 135 0 0 0 0 0 135 10

Other (3) (2) 0 0 5 0 (7) 0 (1)

Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2025 $ 2,605 $ 1,149 $ 1,228 $ 5 $ 1,901 $ (4,423) $ 9,870 $ (7,432) $ 1,456

v3.25.2

Consolidated Statements of Equity (Parenthetical) - $ / shares
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Statement of Stockholders' Equity [Abstract]

Cash dividends declared per common share (in dollars per share) $ 0.27 $ 0.24 $ 0.51 $ 0.46

v3.25.2

Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Cash flows from operating activities:

Net income (loss) $ (133) $ 760

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

Interest credited to policyholders’ account balances 1,474 1,178

Policy charges and fee income (1,262) (1,231)

Net derivative (gains) losses 575 1,584

Credit and intent to sell losses on available for sale debt securities and loans 54 35

Investment (gains) losses, net 31 20

(Gains) losses on businesses held-for-sale 0 (135)

Realized and unrealized (gains) losses on trading securities (39) (43)

Income (Loss) due to Novation in Pre-Tax Net Income 499 0

AB Retirement plan losses 21 0

Non-cash long term incentive compensation expense 48 53

Amortization and depreciation 433 434

Remeasurement of liability for future policy benefits (15) (2)

Change in market risk benefits 66 (1,220)

Equity (income) loss from limited partnerships (87) (58)

Changes in:

Net broker-dealer and customer related receivables/payables (26) (168)

Reinsurance recoverable (562) (628)

Segregated cash and securities, net 17 276

Capitalization of deferred policy acquisition costs (574) (561)

Future policy benefits 201 275

Current and deferred income taxes (129) 149

Other, net (93) 205

Net cash provided by (used in) operating activities 499 923

Proceeds from the sale/maturity/pre-payment of:

Fixed maturities, available-for-sale 9,368 5,284

Fixed maturities, at fair value using the fair value option 299 399

Mortgage loans on real estate 664 460

Trading account securities 269 512

Short term investments 132 571

Other 283 331

Payment for the purchase/origination of:

Fixed maturities, available-for-sale (11,576) (10,523)

Fixed maturities, at fair value using the fair value option (709) (426)

Mortgage loans on real estate (2,103) (1,148)

Trading account securities (395) (1,446)

Short term investments (99) (384)

Other (83) (473)

Cash settlements related to derivative instruments, net 571 (1,438)

Investment in capitalized software, leasehold improvements and EDP equipment (17) (99)

Other, net (321) 453

Net cash provided by (used in) investing activities (3,717) (7,927)

Policyholders’ account balances:

Deposits 14,931 9,033

Withdrawals (4,637) (4,719)

Transfers (to) from Separate Accounts 932 832

Payments of market risk benefits (366) (376)

Repayment of short-term financings 0 (254)

Change in collateralized pledged assets 17 (75)

Change in collateralized pledged liabilities 1,298 4,829

Issuance of long-term debt 495 0

Repayments of Senior Debt 0 (565)

Proceeds from collateralized loan obligations 46 0

Repayment of collateralized loan obligations (38) 0

Proceeds from notes issued by consolidated VIEs 1,203 176

Repayment of notes issued by consolidated VIEs (839) 0

Dividends paid on common stock (156) (151)

Dividends paid on preferred stock (32) (40)

Redemption of preferred stock (279) 0

Purchase of AllianceBernstein Units (758) 0

Purchase of AB Holding Units to fund long-term incentive compensation plan awards, net (44) (34)

Purchase of treasury shares (497) (500)

Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds 173 291

Distribution to noncontrolling interest of consolidated subsidiaries (229) (189)

Change in securities lending (33) 36

Other, net (17) 15

Net cash provided by (used in) financing activities 11,170 8,309

Effect of exchange rate changes on cash and cash equivalents 41 (13)

Change in cash and cash equivalents 7,993 1,292

Cash and cash equivalents, beginning of period 6,964 8,239

Change in cash of businesses held-for-sale 0 153

Cash and cash equivalents, end of period 14,957 9,684

Non-cash transactions from investing and financing activities:

Right-of-use assets obtained in exchange for lease obligations $ 24 $ 222

v3.25.2

ORGANIZATION
6 Months Ended

Jun. 30, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

ORGANIZATION ORGANIZATION
Equitable Holdings, Inc. is the holding company for a diversified financial services organization. The Company conducts operations in six segments: Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management and Legacy. The Company’s management evaluates the performance of each of these segments independently. Effective April 1, 2024, the Company renamed its Investment Management and Research segment to Asset Management following the close of the previously announced joint venture between AllianceBernstein and Societe Generale. Following the close of the transaction, Bernstein Research Services (“BRS”) business results are no longer consolidated within the financial results for AllianceBernstein and Equitable Holdings, Inc.
•The Individual Retirement segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income.
•The Group Retirement segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities and not-for-profit entities, as well as small and medium-sized businesses.
•The Asset Management segment provides diversified investment management and related services globally to a broad range of clients through three main client channels - Institutional, Retail and Private Wealth. The Asset Management segment reflects the business of AB Holding and ABLP and their subsidiaries (collectively, AB).
•The Protection Solutions segment includes the Company’s life insurance and group employee benefits (“EB”) businesses.
•The Wealth Management segment is an emerging leader in the wealth management space with a differentiated advice value proposition that offers discretionary and non-discretionary investment advisory accounts, financial planning and advice, life insurance, and annuity products.
•The Legacy segment consists of our capital intensive fixed-rate GMxB business written prior to 2011.
The Company reports certain activities and items that are not included in our segments in Corporate and Other. Corporate and Other includes certain of our financing and investment expenses. It also includes closed block of life insurance (the “Closed Block”), run-off variable annuity reinsurance business, run-off group pension business, run-off health business, benefit plans for our employees, certain strategic investments and certain unallocated items, including capital and related investments, interest expense and corporate expense. AB’s results of operations are reflected in the Asset Management segment. Accordingly, Corporate and Other does not include any items applicable to AB.
As of June 30, 2025 and December 31, 2024, the Company’s economic interest in AB was approximately 69% and 62%, respectively. The General Partner of AB is a wholly owned subsidiary of the Company. Because the General Partner has the authority to manage and control the business of AB, AB is consolidated in the Company’s financial statements for all periods presented. The increase in economic interest was due to the purchase of AB Holding Units relating to the AB Tender Offer transaction completed on April 3, 2025.
RGA Reinsurance Transaction
On February 23, 2025, Equitable Financial, as well as Equitable America and Equitable Financial L&A, entered into a master transaction agreement with Reinsurance Group of America (“RGA”) pursuant to which at closing and subject to the terms and conditions set forth in such agreement, RGA would enter into reinsurance agreements, as reinsurer, with each such subsidiary, as ceding company, to effect the RGA Reinsurance Transaction. The transaction closed on July 31, 2025, see Note 21 of the Notes to these Consolidated Financial Statements.
Novation
Effective January 17, 2025, Equitable Financial novated certain legacy variable annuity policies sold between 2006-2008, comprised of non-New York “Accumulator” policies containing fixed rate Guaranteed Minimum Income Benefit and/or Guaranteed Minimum Death Benefit guarantees reinsured by Venerable under the combined co-insurance and modified coinsurance basis agreement executed on June 1, 2021.
As a result of the novation of certain Legacy VA policies completed during the first quarter 2025, the Company recorded a loss of $499 million in pre-tax net income and an increase of $263 million in pre-tax AOCI, for a total impact loss of $236 million. The negative net income impact is mostly driven by the reduction of the purchased market risk benefits (“MRB”) asset of $2.0 billion and the reduction of Liability for MRBs of $1.6 billion, offset by a decrease in reinsurance deposit liability of $183 million. Purchased MRB asset reduction is larger than the direct MRB liability reduction since the Venerable reinsurance assets sit in a collateralized trust and thus materially reduce the non-performance risk. Deposit account liability decreases as novation leads to faster amortization of the liability. The novation impact from the base contracts and the contracts in payout status is less material, as the increase in policyholders’ account balance of $33 million and decrease in liability for future policyholders’ benefits of $458 million are largely offset by a decrease in Amounts due from reinsurers of $432 million.
AB Tender Offer
On February 24, 2025, Holdings commenced a cash tender offer (the “AB Tender Offer”) to purchase up to 46 million AB Holding Units at a price of $38.50 per unit, less any applicable tax withholding, for an aggregate purchase price of $1.8 billion. On April 3, 2025, Holdings purchased 19.7 million AB Holdings Units pursuant to the AB Tender Offer for an aggregate cost of $758 million. The AB Holdings Units accepted for purchase represented approximately 17.9% of the outstanding units at the time of purchase. At June 30, 2025, Holdings owned approximately 68.6% of the economic interest in AllianceBernstein L.P., the operating partnership of AB Holding.

v3.25.2

SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended

Jun. 30, 2025

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The unaudited interim consolidated financial statements (the “consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to the Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”).
In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024.
The accompanying unaudited consolidated financial statements present the consolidated results of operations, financial condition, and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation.
All significant intercompany transactions and balances have been eliminated in consolidation. The terms “second quarter 2025” and “second quarter 2024” refer to the three months ended June 30, 2025 and 2024, respectively. The terms “first six months of 2025” and “first six months of 2024” refer to the six months ended June 30, 2025 and 2024, respectively.
Future Adoption of New Accounting Pronouncements
Description
Effective Date and Method of Adoption
Effect on the Financial Statement or Other Significant Matters
ASU 2023-09: Income Taxes (Topic 740): Improvements to Income Tax Disclosures
Description
Effective Date and Method of Adoption
Effect on the Financial Statement or Other Significant Matters
The ASU enhanced existing income tax disclosures primarily related to the rate reconciliation and income taxes paid information. With regard to the improvements to disclosures of rate reconciliation, a public business entity is required on an annual basis to (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. Similarly, a public entity is required to provide the amount of income taxes paid (net of refunds received) disaggregated by (1) federal, state, and foreign taxes and by (2) individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received).
The ASU also includes certain other amendments to improve the effectiveness of income tax disclosures, for example, an entity is required to provide (1) pretax income (or loss) from continuing operations disaggregated between domestic and foreign, and (2) income tax expense (or benefit) from continuing operations disaggregated by federal, state, and foreign.

The ASU will be effective for annual periods beginning after December 15, 2024. Entities are required to apply the ASU on a prospective basis.
The adoption of ASU 2023-09 is not expected to materially impact the Company’s financial position, results of operation, or cash flows.
ASU 2024-03: Accounting Standards Update No. 2024-03-Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40)
This ASU requires a public business entity to disclose specific information about certain costs and expenses in the notes to its financial statements for interim and annual reporting periods. The objective of the disclosure requirements is to provide disaggregated information about a public business entity’s expenses to help investors (a) better understand the entity’s performance, (b) better assess the entity’s prospects for future cash flows, and (c) compare an entity’s performance over time and with that of other entities.
The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the notes to the financial statements.

The ASU will be effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. Entities are required to apply the ASU on a prospective basis.
The Company is currently assessing the impact to the financial statements of this ASU.
Accounting and Consolidation of VIEs
For all new investment products and entities developed by the Company, the Company first determines whether the entity is a VIE, which involves determining an entity’s variability and variable interests, identifying the holders of the equity investment at risk and assessing the five characteristics of a VIE. Once an entity is determined to be a VIE, the Company then determines whether it is the primary beneficiary of the VIE based on its beneficial interests. If the Company is deemed to be the primary beneficiary of the VIE, the Company consolidates the entity.
Quarterly, management of the Company reviews its investment management agreements and its investments in, and other financial arrangements with, certain entities that hold client AUM to determine the entities the Company is required to consolidate under this guidance. These entities include certain mutual fund products, hedge funds, structured products, group trusts, collective investment trusts, and limited partnerships.
The analysis performed to identify variable interests held, determine whether entities are VIEs or VOEs, and evaluate whether the Company has a controlling financial interest in such entities requires the exercise of judgment and is updated on a continuous basis as circumstances change or new entities are developed. The primary beneficiary evaluation generally is performed qualitatively based on all facts and circumstances, including consideration of economic interests in the VIE held directly and indirectly through related parties and entities under common control, as well as quantitatively, as appropriate.
Consolidated VIEs
Consolidated CLOs
The Company is the investment manager of certain asset-backed investment vehicles, commonly referred to as CLOs, and certain other vehicles for which the Company earns fee income for investment management services. The Company may sell or syndicate investments through these vehicles, principally as part of the strategic investing activity as part of its investment management businesses. Additionally, the Company may invest in securities issued by these vehicles which are eliminated in consolidation of the CLOs.
As of June 30, 2025 and December 31, 2024, respectively, Equitable Financial holds $123 million and $128 million of equity interests in the CLOs. The Company consolidated the CLOs as of June 30, 2025 and December 31, 2024 as it is the primary beneficiary due to the combination of both its equity interest held by Equitable Financial and the majority ownership of AB, which functions as the CLO’s loan manager. The assets of the CLOs are legally isolated from the Company’s creditors and can only be used to settle obligations of the CLOs. The liabilities of the CLOs are non-recourse to the Company and the Company has no obligation to satisfy the liabilities of the CLOs. As of June 30, 2025, Equitable Financial holds $0 million of equity interests in a SPE established to purchase loans from the market in anticipation of a new CLO transaction. The Company consolidated the SPE as of June 30, 2025 as it is the primary beneficiary due to the combination of both its equity interest held by Equitable Financial and the majority ownership of AB, which functions as the SPE loan manager.
Resulting from this consolidation in the Company’s consolidated balance sheets are fixed maturities, at fair value using the fair value option with total assets of $2.4 billion and $2.1 billion and total liabilities of $2.5 billion and $2.1 billion at June 30, 2025 and December 31, 2024, respectively. The unpaid outstanding principal balance of the notes and short-term borrowing is $2.3 billion and $1.9 billion at June 30, 2025 and December 31, 2024.
Consolidated Limited Partnerships and LLCs
As of June 30, 2025 and December 31, 2024 the Company consolidated limited partnerships and LLCs for which it was identified as the primary beneficiary under the VIE model. Included in other invested assets, mortgage loans on real estate, other equity investments, trading securities, cash and other liabilities in the Company’s consolidated balance sheets at June 30, 2025 and December 31, 2024 are total net assets of $2.7 billion and $2.1 billion, respectively related to these VIEs.
Consolidated AB-Sponsored Investment Funds
Included in the Company’s consolidated balance sheets as of June 30, 2025 and December 31, 2024 are assets of $421 million and $85 million, liabilities of $35 million and $0 million, and redeemable noncontrolling interests of $242 million and $32 million, respectively, associated with the consolidation of AB-sponsored investment funds under the VIE model. Also included in the Company’s consolidated balance sheets as of June 30, 2025 and December 31, 2024 are assets of $64 million and $73 million, liabilities of $2 million and $1 million, and redeemable noncontrolling interests of $20 million and $17 million, respectively, from consolidation of AB-sponsored investment funds under the VOE model.
Non-Consolidated VIEs
As of June 30, 2025 and December 31, 2024 respectively, the Company held approximately $3.1 billion and $3.0 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including CLOs, hedge funds, private equity funds and real estate-related funds. The Company continues to reflect these equity interests in the consolidated balance sheets as other equity investments and applies the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are approximately $377.4 billion and $350.7 billion as of June 30, 2025 and December 31, 2024 respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $3.1 billion and $3.0 billion and approximately $1.1 billion and $1.2 billion of unfunded commitments as of June 30, 2025 and December 31, 2024, respectively. The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations.
Non-Consolidated AB-Sponsored Investment Products
As of June 30, 2025 and December 31, 2024, the net assets of investment products sponsored by AB that are non-consolidated VIEs are approximately $46.4 billion and $46.9 billion, respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is its investment of $19 million and $17 million as of June 30, 2025 and December 31, 2024, respectively. The Company has no further commitments to or economic interest in these VIEs.
Revision of Previously Issued Financial Statements
During the period ended March 31, 2025, the Company identified an immaterial error related to the initial bookkeeping of ceded accrued fees within policyholders’ account balance ultimately impacting the initial deposit accounting of a reinsurance transaction. The impact of this error to prior periods’ financial statements was not considered to be material. To improve the consistency and comparability of the financial statements, management voluntarily revised the financial statements to include the revisions discussed herein. As a result of the determination to revise previously issued financial statements for the deposit accounting discussed above, management also has corrected other previously identified but uncorrected errors and errors recorded in incorrect periods including, a) pension liability overstatement due to a reconciling item, b) incorrect FX impacting the FABN carrying value, c) incorrect inputs ratio in our MRB modeling and incorrect inputs in the deposit accounting calculation, d) the hedging impact of Treasury Inflation-Protected Securities (TIPS) hedging income was incorrectly recorded in Accumulated other comprehensive income, e) error in the manual accrual in an input calculation in the treasury package overstating Policyholders’ account balance and Interest credited to policyholders, f) incorrect actuarial indication impacting the Liability for MRB and purchased MRB, and g) incorrect allocation of earned premiums to loss ratio impacting reserves.
See Note 20 of the Notes to these Financial Statements for details of the revision.

v3.25.2

INVESTMENTS
6 Months Ended

Jun. 30, 2025

Investments, Debt and Equity Securities [Abstract]

INVESTMENTS INVESTMENTS
Fixed Maturities AFS
The components of fair value and amortized cost for fixed maturities classified as AFS on the consolidated balance sheets excludes accrued interest receivable because the Company elected to present accrued interest receivable within other assets. Accrued interest receivable on AFS fixed maturities as of June 30, 2025 and December 31, 2024 was $740 million and $693 million, respectively. There was no accrued interest written off for AFS fixed maturities for the three and six months ended June 30, 2025 and 2024.
The following tables provide information relating to the Company’s fixed maturities classified as AFS:
AFS Fixed Maturities by Classification

Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value

(in millions)
June 30, 2025
Fixed Maturities:
Corporate (1) $ 53,506 $ 3 $ 579 $ 5,378 $ 48,704
U.S. Treasury, government and agency
5,983 — 3 1,467 4,519
States and political subdivisions 467 — 2 84 385
Foreign governments
690 — 2 117 575
Residential mortgage-backed (2) 5,505 — 60 111 5,454
Asset-backed (3) 15,774 — 117 49 15,842
Commercial mortgage-backed 4,840 — 20 303 4,557
Redeemable preferred stock 54 — 4 — 58
Total at June 30, 2025 $ 86,819 $ 3 $ 787 $ 7,509 $ 80,094
December 31, 2024:
Fixed Maturities:
Corporate (1)
$ 55,218 $ 2 $ 251 $ 6,116 $ 49,351
U.S. Treasury, government and agency
5,801 — — 1,513 4,288
States and political subdivisions
472 — 2 88 386
Foreign governments
689 — 1 136 554
Residential mortgage-backed (2) 4,520 — 15 152 4,383
Asset-backed (3) 13,660 — 96 57 13,699
Commercial mortgage-backed 4,301 — 5 385 3,921
Redeemable preferred stock 56 — 3 — 59
Total at December 31, 2024 $ 84,717 $ 2 $ 373 $ 8,447 $ 76,641
______________
(1)Corporate fixed maturities include both public and private issues.
(2)Includes publicly traded agency pass-through securities and collateralized obligations.
(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.
The contractual maturities of AFS fixed maturities as of June 30, 2025 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or pre-pay obligations with or without call or pre-payment penalties.
Contractual Maturities of AFS Fixed Maturities
Amortized Cost (Less Allowance for Credit Losses) Fair Value
(in millions)
June 30, 2025
Contractual maturities:
Due in one year or less $ 2,620 $ 2,605
Due in years two through five 16,176 15,949
Due in years six through ten 17,589 17,200
Due after ten years 24,258 18,429
Subtotal 60,643 54,183
Residential mortgage-backed 5,505 5,454
Asset-backed 15,774 15,842
Commercial mortgage-backed 4,840 4,557
Redeemable preferred stock 54 58
Total at June 30, 2025 $ 86,816 $ 80,094
The following table shows proceeds from sales, gross gains (losses) from sales and allowance for credit losses for AFS fixed maturities:
Proceeds from Sales, Gross Gains (Losses) from Sales and Allowance for Credit and Intent to Sell Losses for AFS Fixed Maturities

Three Months Ended June 30, Six Months Ended June 30,

2025 2024 2025 2024

(in millions)
Proceeds from sales $ 2,961 $ 1,331 $ 4,263 $ 1,775
Gross gains on sales $ 7 $ 5 $ 9 $ 5
Gross losses on sales $ (30) $ (3) $ (33) $ (27)
Net (increase) decrease in Allowance for Credit and Intent to Sell losses $ (13) $ (3) $ (19) $ (5)
The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts:
AFS Fixed Maturities - Credit and Intent to Sell Loss Impairments
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Balance, beginning of period $ 53 $ 48 $ 47 $ 48
Previously recognized impairments on securities that matured, paid, prepaid or sold (5) (4) (5) (8)
Recognized impairments on securities impaired to fair value this period (1)
— — — —
Credit losses recognized this period on securities for which credit losses were not previously recognized 12 3 17 6
Additional credit losses this period on securities previously impaired 1 3 2 4
Balance, end of period $ 61 $ 50 $ 61 $ 50
______________
(1)Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost.
The tables below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI:

Net Unrealized Gains (Losses) on AFS Fixed Maturities

Three Months Ended June 30, 2025
Net Unrealized Gains (Losses) on Investments Policyholders’ Liabilities
Deferred Income Tax Asset (Liability)
AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
(in millions)
Balance, beginning of period $ (7,226) $ 66 $ 279 $ (6,881)
Net investment gains (losses) arising during the period 466 — — 466
Reclassification adjustment:
Included in net income (loss) 36 — — 36
Excluded from net income (loss) — — — —
Other — — (33) (33)
Impact of net unrealized investment gains (losses) — — (106) (106)
Net unrealized investment gains (losses) excluding credit losses (6,724) 66 140 (6,518)
Net unrealized investment gains (losses) with credit losses 2 — — 2
Balance, end of period $ (6,722) $ 66 $ 140 $ (6,516)
Three Months Ended June 30, 2024
Balance, beginning of period $ (7,660) $ 63 $ 358 $ (7,239)
Net investment gains (losses) arising during the period (555) — — (555)
Reclassification adjustment:
Included in net income (loss) — — — —
Excluded from net income (loss) — — — —
Other
— — (4) (4)
Impact of net unrealized investment gains (losses) — 4 117 121
Net unrealized investment gains (losses) excluding credit losses (8,215) 67 471 (7,677)
Net unrealized investment gains (losses) with credit losses 1 — — 1
Balance, end of period $ (8,214) $ 67 $ 471 $ (7,676)

Six Months Ended June 30, 2025
Net Unrealized Gains (Losses) on Investments Policyholders’ Liabilities
Deferred Income Tax Asset (Liability)
AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
(in millions)
Balance, beginning of period $ (8,074) $ 71 $ 464 $ (7,539)
Net investment gains (losses) arising during the period 1,310 — — 1,310
Reclassification adjustment:
Included in net income (loss) 44 — — 44
Excluded from net income (loss) — — — —
Other — — (41) (41)
Impact of net unrealized investment gains (losses) — (5) (283) (288)
Net unrealized investment gains (losses) excluding credit losses (6,720) 66 140 (6,514)
Net unrealized investment gains (losses) with credit losses (2) — — (2)
Balance, end of period $ (6,722) $ 66 $ 140 $ (6,516)
Six Months Ended June 30, 2024
Balance, beginning of period $ (6,999) $ 50 $ 226 $ (6,723)
Net investment gains (losses) arising during the period (1,238) — — (1,238)
Reclassification adjustment:
Included in net income (loss) 26 — — 26
Other
— — (7) (7)
Impact of net unrealized investment gains (losses) — 17 251 268
Net unrealized investment gains (losses) excluding credit losses (8,211) 67 470 (7,674)
Net unrealized investment gains (losses) with credit losses (3) — 1 (2)
Balance, end of period $ (8,214) $ 67 $ 471 $ (7,676)

The following tables disclose the fair values and gross unrealized losses of the 3,685 issues as of June 30, 2025 and the 4,307 issues as of December 31, 2024 that are not deemed to have credit losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated:
AFS Fixed Maturities in an Unrealized Loss Position for Which No Allowance Is Recorded

Less Than 12 Months 12 Months or Longer Total
Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses
(in millions)
June 30, 2025
Fixed Maturities:
Corporate $ 4,283 $ 61 $ 27,192 $ 5,299 $ 31,475 $ 5,360
U.S. Treasury, government and agency 67 1 4,210 1,466 4,277 1,467
States and political subdivisions — — 261 84 261 84
Foreign governments 19 — 459 117 478 117
Residential mortgage-backed 488 4 826 107 1,314 111
Asset-backed 1,334 9 672 40 2,006 49
Commercial mortgage-backed 286 1 2,869 302 3,155 303
Total at June 30, 2025 $ 6,477 $ 76 $ 36,489 $ 7,415 $ 42,966 $ 7,491
December 31, 2024:
Fixed Maturities:
Corporate $ 9,147 $ 205 $ 28,684 $ 5,901 $ 37,831 $ 6,106
U.S. Treasury, government and agency 117 4 4,107 1,509 4,224 1,513
States and political subdivisions 40 — 271 88 311 88
Foreign governments 59 1 460 135 519 136
Residential mortgage-backed 1,986 26 851 126 2,837 152
Asset-backed 974 7 692 50 1,666 57
Commercial mortgage-backed 409 6 2,893 379 3,302 385
Total at December 31, 2024 $ 12,732 $ 249 $ 37,958 $ 8,188 $ 50,690 $ 8,437

The Company maintains a diversified portfolio of AFS securities across industries and issuers and does not have exposure to any single issuer in excess of 0.5% of total fixed maturities. The largest exposure to a single issuer held as of June 30, 2025 and December 31, 2024 was $427 million and $400 million, respectively, representing 16.4% and 11.7% of the consolidated equity of the Company.
Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the NAIC Designation (as defined below) of 3 (medium investment grade), 4 or 5 (below investment grade) or 6 (in or near default). As of June 30, 2025 and December 31, 2024, respectively, approximately $2.1 billion and $1.9 billion, or 2.4% and 2.3%, of the $86.8 billion and $84.7 billion aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had gross unrealized losses of $67 million and $64 million as of June 30, 2025 and December 31, 2024, respectively.
As of June 30, 2025 and December 31, 2024, respectively, the $7.4 billion and $8.2 billion of gross unrealized losses of twelve months or more were primarily concentrated in corporate securities. In accordance with the policy described in Note 2 of the Notes to these Consolidated Financial Statements, the Company concluded that an adjustment to the allowance for credit losses for these securities was not warranted at either June 30, 2025 or December 31, 2024. As of June 30, 2025 and December 31, 2024, the Company neither intended to sell the securities nor was it more likely than not required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis.
Based on the Company’s evaluation both qualitatively and quantitatively of the drivers of the decline in fair value of fixed maturity securities as of June 30, 2025, the Company determined that the unrealized loss was primarily due to increases in interest rates and credit spreads.
Securities Lending
The Company enters into securities lending agreements with an agent bank whereby blocks of securities are loaned to third parties, primarily major brokerage firms. As of June 30, 2025 and December 31, 2024, the estimated fair value of loaned securities was $983 million and $134 million. The agreements require a minimum of 102% of the fair value of the loaned securities to be held as cash or security collateral, calculated daily. We do not have the right to sell or pledge the securities posted as collateral. To further minimize the credit risks related to these programs, the financial condition of counterparties is monitored on a regular basis. As of June 30, 2025 and December 31, 2024, collateral received was in the amount of $1.0 billion and $137 million, of which $104 million and $137 million, respectively, is cash collateral. A securities lending payable for the overnight and continuous loans is included in other liabilities in the amount of cash collateral received. Securities lending transactions are used to generate income. Income and expenses associated with these transactions are reported as Net investment income and were not material for the six months ended June 30, 2025 and 2024.
Mortgage Loans on Real Estate
Accrued interest receivable on commercial, agricultural and residential mortgage loans as of June 30, 2025 and December 31, 2024 was $110 million and $96 million, respectively. There was no accrued interest written off for commercial, agricultural and residential mortgage loans for the six months ended June 30, 2025 and 2024.
There were no mortgage loans foreclosed during the six months ended June 30, 2025.
Allowance for Credit Losses on Mortgage Loans
The change in the allowance for credit losses for commercial, agricultural and residential mortgage loans were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Allowance for credit losses on mortgage loans:
Commercial mortgages:
Balance, beginning of period $ 254 $ 288 $ 259 $ 272
Current-period provision for expected credit losses 39 9 34 25
Write-offs charged against the allowance — (75) — (75)
Recoveries of amounts previously written off — — — —
Net change in allowance 39 (66) 34 (50)
Balance, end of period $ 293 $ 222 $ 293 $ 222
Agricultural mortgages:
Balance, beginning of period $ 13 $ 6 $ 15 $ 6
Current-period provision for expected credit losses — 3 (2) 3
Write-offs charged against the allowance (8) — (8) —
Recoveries of amounts previously written off — — — —
Net change in allowance (8) 3 (10) 3
Balance, end of period $ 5 $ 9 $ 5 $ 9
Residential mortgages:
Balance, beginning of period $ 5 $ 3 $ 4 $ 1
Current-period provision for expected credit losses 2 — 3 2
Write-offs charged against the allowance — — — —
Recoveries of amounts previously written off — — — —
Net change in allowance 2 — 3 2
Balance, end of period $ 7 $ 3 $ 7 $ 3
Total allowance for credit losses $ 305 $ 234 $ 305 $ 234

The change in the allowance for credit losses is attributable to:
•increases/decreases in the loan balance due to new originations, maturing mortgages, and loan amortization; and
•changes in credit quality and economic assumptions.
Credit Quality Information
The Company’s commercial and agricultural mortgage loans segregated by risk rating exposure were as follows:
Loan to Value (“LTV”) Ratios (1) (3)
June 30, 2025
Amortized Cost Basis by Origination Year
2025 2024 2023 2022 2021 Prior Revolving Loans Amortized Cost Basis Revolving Loans Converted to Term Loans Amortized Cost Basis Total
(in millions)
Commercial and agricultural mortgage loans:
Commercial:
0% - 50% $ 60 $ 185 $ 268 $ 203 $ 206 $ 1,736 $ — $ — $ 2,658
50% - 70% 1,003 1,431 881 1,551 612 2,363 436 277 8,554
70% - 90% 292 73 316 764 698 1,756 122 205 4,226
90% plus — — — 547 558 1,217 — — 2,322
Total commercial $ 1,355 $ 1,689 $ 1,465 $ 3,065 $ 2,074 $ 7,072 $ 558 $ 482 $ 17,760
Agricultural:
0% - 50% $ 77 $ 47 $ 100 $ 149 $ 198 $ 1,105 $ — $ — $ 1,676
50% - 70% 56 158 52 133 128 364 — — 891
70% - 90% — — — — — — — — —
90% plus — — — — — 25 — — 25
Total agricultural $ 133 $ 205 $ 152 $ 282 $ 326 $ 1,494 $ — $ — $ 2,592
Total commercial and agricultural mortgage loans:
0% - 50% $ 137 $ 232 $ 368 $ 352 $ 404 $ 2,841 $ — $ — $ 4,334
50% - 70% 1,059 1,589 933 1,684 740 2,727 436 277 9,445
70% - 90% 292 73 316 764 698 1,756 122 205 4,226
90% plus — — — 547 558 1,242 — — 2,347
Total commercial and agricultural mortgage loans
$ 1,488 $ 1,894 $ 1,617 $ 3,347 $ 2,400 $ 8,566 $ 558 $ 482 $ 20,352
Debt Service Coverage (“DSC”) Ratios (2) (3)
June 30, 2025
Amortized Cost Basis by Origination Year
2025 2024 2023 2022 2021 Prior Revolving Loans Amortized Cost Basis Revolving Loans Converted to Term Loans Amortized Cost Basis Total
(in millions)
Commercial and agricultural mortgage loans:
Commercial:
Greater than 2.0x $ 67 $ 208 $ 175 $ 1,016 $ 1,081 $ 3,255 $ — $ — $ 5,802
1.8x to 2.0x 60 103 58 50 208 1,090 113 184 1,866
1.5x to 1.8x 85 472 233 753 48 1,209 59 165 3,024
1.2x to 1.5x 817 716 514 664 531 743 — 95 4,080
1.0x to 1.2x 326 190 475 260 74 669 386 38 2,418
Less than 1.0x — — 10 322 132 106 — — 570
Total commercial $ 1,355 $ 1,689 $ 1,465 $ 3,065 $ 2,074 $ 7,072 $ 558 $ 482 $ 17,760
Agricultural:
Greater than 2.0x $ 17 $ 9 $ 5 $ 40 $ 34 $ 193 $ — $ — $ 298
1.8x to 2.0x 17 12 17 23 53 100 — — 222
1.5x to 1.8x 11 48 10 44 27 283 — — 423
1.2x to 1.5x 38 46 44 88 135 505 — — 856
1.0x to 1.2x 30 71 45 63 67 372 — — 648
Less than 1.0x 20 19 31 24 10 41 — — 145
Total agricultural $ 133 $ 205 $ 152 $ 282 $ 326 $ 1,494 $ — $ — $ 2,592
Total commercial and agricultural mortgage loans:
Greater than 2.0x $ 84 $ 217 $ 180 $ 1,056 $ 1,115 $ 3,448 $ — $ — $ 6,100
1.8x to 2.0x 77 115 75 73 261 1,190 113 184 2,088
1.5x to 1.8x 96 520 243 797 75 1,492 59 165 3,447
1.2x to 1.5x 855 762 558 752 666 1,248 — 95 4,936
1.0x to 1.2x 356 261 520 323 141 1,041 386 38 3,066
Less than 1.0x 20 19 41 346 142 147 — — 715
Total commercial and agricultural mortgage loans
$ 1,488 $ 1,894 $ 1,617 $ 3,347 $ 2,400 $ 8,566 $ 558 $ 482 $ 20,352
______________
(1)The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan.
(2)The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service.
(3)Residential mortgage loans are excluded from the above tables.
LTV Ratios (1) (3)
December 31, 2024
Amortized Cost Basis by Origination Year
2024 2023 2022 2021 2020 Prior Revolving Loans Amortized Cost Basis Revolving Loans Converted to Term Loans Amortized Cost Basis Total
(in millions)
Commercial and agricultural mortgage loans:
Commercial:
0% - 50% $ 185 $ 363 $ 137 $ 212 $ 269 $ 1,548 $ — $ — $ 2,714
50% - 70% 1,501 910 1,622 628 318 2,083 441 201 7,704
70% - 90% — 246 707 918 396 1,187 101 206 3,761
90% plus — — 616 322 309 1,290 — — 2,537
Total commercial $ 1,686 $ 1,519 $ 3,082 $ 2,080 $ 1,292 $ 6,108 $ 542 $ 407 $ 16,716
Agricultural:
0% - 50% $ 49 $ 98 $ 160 $ 202 $ 269 $ 882 $ — $ — $ 1,660
50% - 70% 160 59 126 130 144 273 — — 892
70% - 90% — — — — — 16 — — 16
90% plus — — — — — — — — —
Total agricultural $ 209 $ 157 $ 286 $ 332 $ 413 $ 1,171 $ — $ — $ 2,568
Total commercial and agricultural mortgage loans:
0% - 50% $ 234 $ 461 $ 297 $ 414 $ 538 $ 2,430 $ — $ — $ 4,374
50% - 70% 1,661 969 1,748 758 462 2,356 441 201 8,596
70% - 90% — 246 707 918 396 1,203 101 206 3,777
90% plus — — 616 322 309 1,290 — — 2,537
Total commercial and agricultural mortgage loans
$ 1,895 $ 1,676 $ 3,368 $ 2,412 $ 1,705 $ 7,279 $ 542 $ 407 $ 19,284

DSC Ratios (2) (3)
December 31, 2024
Amortized Cost Basis by Origination Year
2024 2023 2022 2021 2020 Prior Revolving Loans Amortized Cost Basis Revolving Loans Converted to Term Loans Amortized Cost Basis Total
(in millions)
Commercial and agricultural mortgage loans:
Commercial:
Greater than 2.0x $ 208 $ 176 $ 609 $ 1,255 $ 916 $ 3,318 $ — $ — $ 6,482
1.8x to 2.0x 103 75 50 149 376 607 176 182 1,718
1.5x to 1.8x 472 211 727 — — 1,060 44 189 2,703
1.2x to 1.5x 756 566 542 433 — 661 — — 2,958
December 31, 2024
Amortized Cost Basis by Origination Year
2024 2023 2022 2021 2020 Prior Revolving Loans Amortized Cost Basis Revolving Loans Converted to Term Loans Amortized Cost Basis Total
(in millions)
1.0x to 1.2x 147 482 643 193 — 359 322 36 2,182
Less than 1.0x — 9 511 50 — 103 — — 673
Total commercial $ 1,686 $ 1,519 $ 3,082 $ 2,080 $ 1,292 $ 6,108 $ 542 $ 407 $ 16,716
Agricultural:
Greater than 2.0x $ 12 $ 5 $ 41 $ 34 $ 57 $ 157 $ — $ — $ 306
1.8x to 2.0x 11 17 24 54 28 79 — — 213
1.5x to 1.8x 49 11 44 27 120 175 — — 426
1.2x to 1.5x 47 46 89 138 113 422 — — 855
1.0x to 1.2x 71 47 63 68 87 307 — — 643
Less than 1.0x 19 31 25 11 8 31 — — 125
Total agricultural $ 209 $ 157 $ 286 $ 332 $ 413 $ 1,171 $ — $ — $ 2,568
Total commercial and agricultural mortgage loans:
Greater than 2.0x $ 220 $ 181 $ 650 $ 1,289 $ 973 $ 3,475 $ — $ — $ 6,788
1.8x to 2.0x 114 92 74 203 404 686 176 182 1,931
1.5x to 1.8x 521 222 771 27 120 1,235 44 189 3,129
1.2x to 1.5x 803 612 631 571 113 1,083 — — 3,813
1.0x to 1.2x 218 529 706 261 87 666 322 36 2,825
Less than 1.0x 19 40 536 61 8 134 — — 798
Total commercial and agricultural mortgage loans
$ 1,895 $ 1,676 $ 3,368 $ 2,412 $ 1,705 $ 7,279 $ 542 $ 407 $ 19,284
______________
(1)The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan.
(2)The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service.
(3)Residential mortgage loans are excluded from the above tables.
The amortized cost of residential mortgage loans by credit quality indicator and origination year was as follows:
June 30, 2025
Amortized Cost Basis by Origination Year
2025 2024 2023 2022 2021 Prior Total
(in millions)
Performance indicators:
Performing
$ 85 $ 700 $ 393 $ 178 $ 128 $ 4 $ 1,488
Nonperforming
— — 1 — — — 1
Total
$ 85 $ 700 $ 394 $ 178 $ 128 $ 4 $ 1,489
December 31, 2024
Amortized Cost Basis by Origination Year
2024 2023 2022 2021 2019 Prior Total
(in millions)
Performance indicators:
Performing
$ 313 $ 428 $ 186 $ 133 $ 4 $ 2 $ 1,066
Nonperforming
— — — — — — —
Total
$ 313 $ 428 $ 186 $ 133 $ 4 $ 2 $ 1,066

Past-Due and Nonaccrual Mortgage Loan Status
The aging analysis of past-due mortgage loans were as follows:
Age Analysis of Past Due Mortgage Loans (1)
Accruing Loans Non-accruing Loans Total Loans Non-accruing Loans with No Allowance Interest Income on Non-accruing Loans
Past Due Current Total
30-59 Days 60-89 Days 90 Days or More Total
(in millions)
June 30, 2025:
Mortgage loans:
Commercial $ — $ — $ — $ — $ 17,642 $ 17,642 $ 118 $ 17,760 $ — $ 1
Agricultural 33 9 46 88 2,477 2,565 27 2,592 25 —
Residential
— — 5 5 1,483 1,488 1 1,489 1 —
Total $ 33 $ 9 $ 51 $ 93 $ 21,602 $ 21,695 $ 146 $ 21,841 $ 26 $ 1
December 31, 2024:
Mortgage loans:
Commercial $ — $ — $ — $ — $ 16,659 $ 16,659 $ 57 $ 16,716 $ — $ 1
Agricultural 12 1 33 46 2,486 2,532 36 2,568 — —
Residential
— 1 — 1 1,065 1,066 — 1,066 — —
Total $ 12 $ 2 $ 33 $ 47 $ 20,210 $ 20,257 $ 93 $ 20,350 $ — $ 1
______________
(1)Amounts presented at amortized cost basis.
As of June 30, 2025 and December 31, 2024, the amortized cost of problem mortgage loans that had been classified as non-accrual loans were $89 million and $36 million, respectively.
Loan Modifications
During the three and six months ended June 30, 2025, the Company granted a modification splitting a $15 million agricultural mortgage loan into three notes. The loans have an amortized cost of $9 million, which is fully attributed to the first note, and represent 0.3% of total agricultural loans.

During 2024, the Company granted a modification splitting a commercial mortgage loan into two notes. One note retaining the original loan terms and the second note with an increased interest rate to market terms and required management of excess cash. The loans have an amortized cost of $65 million and represents 0.4% of total commercial mortgage loans.
During 2023, the Company granted a modification of interest rates on four commercial mortgage loans, but not to market terms and required management of excess cash. The loans have an amortized cost of $228 million which represents 1.3% of total commercial mortgage loans. Two of the four loans also have term extensions of 17 months to 4 years.
The impact to Investment income or gains (losses) as a result of these modifications was not material to the consolidated financial statements.
The above modifications are performing in accordance with their restructured terms.
Equity Securities
The breakdown of unrealized and realized gains and (losses) on equity securities was as follows:
Unrealized and Realized Gains (Losses) from Equity Securities
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period $ (2) $ (6) $ (2) $ 9
Net investment gains (losses) recognized on securities sold during the period 2 3 2 2
Unrealized and realized gains (losses) on equity securities $ — $ (3) $ — $ 11
Trading Securities
As of June 30, 2025 and December 31, 2024, respectively, the fair value of the Company’s trading securities was $1.3 billion and $1.1 billion. As of June 30, 2025 and December 31, 2024, respectively, trading securities included the General Account’s investment in Separate Accounts had carrying values of $56 million and $64 million.
The breakdown of net investment income (loss) from trading securities was as follows:
Net Investment Income (Loss) from Trading Securities
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period $ 50 $ 6 $ 33 $ 42
Net investment gains (losses) recognized on securities sold during the period (10) — 6 1
Unrealized and realized gains (losses) on trading securities 40 6 39 43
Interest and dividend income from trading securities 25 21 34 32
Net investment income (loss) from trading securities $ 65 $ 27 $ 73 $ 75
Fixed maturities, at fair value using the fair value option
The breakdown of net investment income (loss) from fixed maturities, at fair value using the fair value option were as follows:
Net Investment Income (Loss) from Fixed Maturities, at Fair Value using the Fair Value Option
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period $ 5 $ (2) $ 12 $ (5)
Net investment gains (losses) recognized on securities sold during the period (1) 2 1 3
Unrealized and realized gains (losses) from fixed maturities 4 — 13 (2)
Interest and dividend income from fixed maturities (4) 23 (4) 28
Net investment income (loss) from fixed maturities $ — $ 23 $ 9 $ 26
Net Investment Income
The following tables provides the components of Net investment income by investment type:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Fixed maturities $ 938 $ 842 $ 1,874 $ 1,655
Mortgage loans on real estate 256 239 516 473
Other equity investments 39 (8) 83 52
Policy loans 52 56 107 110
Trading securities 65 27 73 75
Other investment income 40 21 17 45
Fixed maturities, at fair value using the fair value option — 23 9 26
Gross investment income (loss) 1,390 1,200 2,679 2,436
Investment expenses (35) (33) (76) (59)
Net investment income (loss) $ 1,355 $ 1,167 $ 2,603 $ 2,377
Investment Gains (Losses), Net
Investment gains (losses), net, including changes in the valuation allowances and credit losses were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Fixed maturities $ (11) $ (1) $ (19) $ (27)
Mortgage loans on real estate (61) (14) (68) (32)
Other 1 (1) 2 4
Investment gains (losses), net $ (71) $ (16) $ (85) $ (55)

For the three and six months ended June 30, 2025 and 2024, respectively, investment results passed through to certain participating group annuity contracts as interest credited to policyholders’ account balances totaled $0 million, $1 million, $0 million and $1 million.

v3.25.2

DERIVATIVES
6 Months Ended

Jun. 30, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVES DERIVATIVES
The Company uses derivatives as part of its overall asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a “Derivative Use Plan” approved by applicable states’ insurance law. Derivatives are generally not accounted for using hedge accounting, with the exception of TIPS and cash flow hedges, which are discussed further below. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, fund performance, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, bond and bond-index total return swaps, swaptions, variance swaps and equity options, credit and foreign exchange derivatives, as well as bond and repo transactions to support the hedging. The derivative contracts are collectively managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in capital markets. In addition, as part of its hedging strategy, the Company targets an asset level for all variable annuity products at or above a CTE98 level under most economic scenarios (CTE is a statistical measure of tail risk which quantifies the total asset requirement (“TAR”) to sustain a loss if an event outside a given probability level has occurred. CTE98 denotes the financial resources a company would need to cover the average of the worst 2% of scenarios.)
Derivatives Utilized to Hedge Exposure to Variable Annuities with Guarantee Features
The Company has issued and continues to offer variable annuity products with GMxB features which are accounted for as MRBs. The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders’ account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB, in the event of annuitization, being higher than what accumulated policyholders’ account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with products that have a GMxB feature and are accounted for as MRBs is that under-performance of the financial markets could result in the GMxB features benefits being higher than what accumulated policyholders’ account balances would support.
For GMxB features, the Company retains certain risks including basis, credit spread, and some volatility risk and risk associated with actual experience compared to expected actuarial assumptions for mortality, lapse and surrender, withdrawal and policyholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMxB features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps and a portion of exposure to credit risk is hedged using total return swaps on fixed income indices. Additionally, the Company is party to total return swaps for which the reference U.S. Treasury securities are contemporaneously purchased from the market and sold to the swap counterparty. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. The Company has also purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company. The reinsurance of these features is accounted for as purchased MRBs. In addition, on June 1, 2021, we ceded legacy variable annuity policies sold by Equitable Financial between 2006-2008 (the “Block”), comprised of non-New York “Accumulator” policies containing fixed rate GMIB and/or GMDB guarantees to CS Life. As this contract provides full risk transfer and thus has the same risk attributes as the underlying direct contracts, the benefits of this treaty are accounted for in the same manner as the underlying gross reserves and therefore the amounts due from reinsurers related to excess benefits are accounted for as purchased MRBs.
The Company has in place an economic hedge program using U.S. Treasury futures to partially protect the overall profitability of future variable annuity sales against declining interest rates.
Derivatives Utilized to Hedge Crediting Rate Exposure on SCS, SIO, MSO and IUL Products/Investment Options
The Company hedges crediting rates in the SCS variable annuity, SIO in the EQUI-VEST variable annuity series, MSO in the variable life insurance products and IUL insurance products. These products permit the contract owner to participate in the performance of an index, ETF or commodity price movement up to a cap for a set period of time. They also contain a protection feature, in which the Company will absorb, up to a certain percentage, the loss of value in an index, ETF or commodity price, which varies by product segment.
In order to support the returns associated with these features, the Company enters into derivative contracts whose payouts, in combination with fixed income investments, emulate those of the index, ETF or commodity price, subject to caps and buffers, thereby substantially reducing any exposure to market-related earnings volatility.
Derivatives Used to Hedge Equity Market Risks Associated with the General Account’s Seed Money Investments in Retail Mutual Funds
The Company’s General Account seed money investments in retail mutual funds expose us to market risk, including equity market risk which is partially hedged through equity-index futures contracts to minimize such risk.
Derivatives Used for General Account Investment Portfolio
The Company purchased CDS to mitigate its exposure to a reference entity through cash positions. These positions do not replicate credit spreads.
The Company purchased 30-year TIPS and other sovereign bonds, both inflation linked and non-inflation linked, as General Account investments and enters into asset or cross-currency basis swaps, to result in payment of the given bond’s coupons and principal at maturity in the bond’s specified currency to the swap counterparty in return for fixed dollar amounts. These swaps, when considered in combination with the bonds, together result in a net position that is intended to replicate a dollar-denominated fixed-coupon cash bond with a yield higher than a term-equivalent U.S. Treasury bond.
Derivatives Utilized to Hedge Exposure to Foreign Currency Denominated Cash Flows
The Company purchases private placement debt securities and issues funding agreements in the FABN program in currencies other than its functional U.S. dollar currency. The Company enters into cross currency swaps with external counterparties to hedge the exposure of the foreign currency denominated cash flows of these instruments. The foreign currency received from or paid to the cross currency swap counterparty is exchanged for fixed U.S. dollar amounts with improved net investment yields or net product costs over equivalent U.S. dollar denominated instruments issued at that time. The transactions are accounted for as cash flow hedges when they are designated in hedging relationships and qualify for hedge accounting.
These cross currency swaps are for the period the foreign currency denominated private placement debt securities and funding agreement are outstanding, with the longest cross currency swap expiring in 2033. Since these cross currency swaps are designated and qualify as cash flow hedges, the corresponding interest accruals are recognized in Net investment income and in interest credited to policyholders’ account balances.
The tables below present quantitative disclosures about the Company’s derivative instruments designated in hedging relationships and derivative instruments which have not been designated in hedging relationships, including those embedded in other contracts required to be accounted for as derivative instruments.
The following table presents the gross notional amount and fair value of the Company’s derivatives:

Derivative Instruments by Category
June 30, 2025 December 31, 2024
Fair Value Fair Value
Notional Amount Derivative Assets Derivative Liabilities
Net Derivatives
Notional Amount Derivative Assets Derivative Liabilities
Net Derivatives
(in millions)
Derivatives: designated for hedge accounting (1)
Cash flow hedges:
Currency swaps $ 2,962 $ 90 $ 157 $ (67) $ 2,940 $ 111 $ 95 $ 16
Interest swaps 952 — 335 (335) 952 — 306 (306)
Total: designated for hedge accounting 3,914 90 492 (402) 3,892 111 401 (290)
Derivatives: not designated for hedge accounting (1)
Equity contracts:
Futures 17,100 — 3 (3) 14,530 3 — 3
Swaps 16,942 59 71 (12) 16,264 65 19 46
Options 66,287 22,575 4,925 17,650 70,685 20,647 4,319 16,328
Interest rate contracts:
Futures 9,716 — — — 9,310 — — —
Swaps 610 12 5 7 672 — 41 (41)
Options 50 5 — 5 — — — —
Credit contracts:
Credit default swaps 437 11 20 (9) 275 12 10 2
Currency contracts:
Currency swaps 771 — 31 (31) 828 26 — 26
Currency forwards 83 15 17 (2) 28 17 17 —
Other freestanding contracts:
Margin — 1,173 — 1,173 — 796 — 796
Collateral — 155 16,634 (16,479) — 137 16,908 (16,771)
Total: not designated for hedge accounting 111,996 24,005 21,706 2,299 112,592 21,703 21,314 389
Embedded derivatives:
SCS, SIO, MSO and IUL indexed features (2) — — 18,311 (18,311) — — 17,212 (17,212)
Total embedded derivatives — — 18,311 (18,311) — — 17,212 (17,212)
Total derivative instruments $ 115,910 $ 24,095 $ 40,509 $ (16,414) $ 116,484 $ 21,814 $ 38,927 $ (17,113)
______________
(1)Reported in other invested assets in the consolidated balance sheets.
(2)Reported in policyholders’ account balances in the consolidated balance sheets.
The following table presents the effects of derivative instruments on the consolidated statements of income and comprehensive income (loss):
Derivative Instruments by Category
Three Months Ended June 30, 2025 Six Months Ended June 30, 2025
Net Derivative Gains (Losses) (1)
Net Investment Income
Interest Credited To Policyholders
Account Balances
AOCI
Net Derivative Gains (Losses) (1)
Net Investment Income Interest Credited To Policyholders Account Balances AOCI
(in millions)
Derivatives: designated for hedge accounting
Cash flow hedges:
Currency swaps $ — $ 9 $ 73 $ (151) $ — $ 15 $ 106 $ (188)
Interest swaps — (8) — 13 — (11) — (8)
Total: designated for hedge accounting — 1 73 (138) — 4 106 (196)
Derivatives: not Designated for hedge accounting
Equity contracts:
Futures 472 — — — 272 — — —
Swaps (1,204) — — — (499) — — —
Options 4,235 — — — 1,590 — — —
Interest rate contracts:
Futures (98) — — — (121) — — —
Swaps (16) — — — (1) — — —
Options
(1) — — — (2) — — —
Credit contracts:
Credit default swaps (3) — — — (3) — — —
Currency contracts:
Currency swaps (57) — — — (87) — — —
Currency forwards (6) — — — (6) — — —
Other freestanding contracts:
Margin — — — — — — — —
Collateral — — — — — — — —
Total: not designated for hedge accounting 3,322 — — — 1,143 — — —
Embedded derivatives:
SCS, SIO,MSO and IUL indexed features (4,696) — — — (1,718) — — —
Total embedded derivatives (4,696) — — — (1,718) — — —
Total derivative instruments $ (1,374) $ 1 $ 73 $ (138) $ (575) $ 4 $ 106 $ (196)
______________
(1)Reported in net derivative gains (losses) in the consolidated statements of income (loss).
Three Months Ended June 30, 2024 Six Months Ended June 30, 2024
Net Derivatives Gains (Losses) (1)
Net Investment Income Interest Credited To Policyholders Account Balances AOCI
Net Derivatives Gains (Losses) (1)
Net Investment Income Interest Credited To Policyholders Account Balances AOCI
(in millions)
Derivatives: designated for hedge accounting
Cash flow hedges:
Currency swaps $ — $ 4 $ (5) $ 22 $ 1 $ 7 $ (23) $ 38
Interest swaps — (17) — 13 — (14) — 6
Total: designated for hedge accounting — (13) (5) 35 1 (7) (23) 44
Derivatives: not Designated for hedge accounting
Equity contracts:
Futures 50 — — — 291 — — —
Swaps (99) — — — (1,214) — — —
Options 1,225 — — — 4,021 — — —
Interest rate contracts:
Futures (1) — — — (11) — — —
Swaps (88) — — — (253) — — —
Credit contracts:
Credit default swaps — — — — (1) — — —
Currency contracts:
Currency swaps 1 — — — 13 — — —
Currency forwards — — — — 1 — — —
Total: not designated for hedge accounting 1,088 — — — 2,847 — — —
Embedded derivatives:
SCS, SIO,MSO and IUL indexed features (1,296) — — — (4,432) — — —
Total embedded derivatives (1,296) — — — (4,432) — — —
Total derivative instruments (1)
$ (208) $ (13) $ (5) $ 35 $ (1,584) $ (7) $ (23) $ 44
______________
(1)Reported in net derivative gains (losses) in the consolidated statements of income (loss).
The following table presents a roll-forward of cash flow hedges recognized in AOCI:
Roll-forward of Cash flow hedges in AOCI
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Balance, beginning of period $ 22 $ (21) $ 80 $ (31)
Amount recorded in AOCI
Currency swaps (91) 19 (81) 19
Interest swaps — (9) (29) (17)
Total amount recorded in AOCI (91) 10 (110) 2
Amount reclassified from (to) income to AOCI
Currency swaps (1) (60) 3 (107) 20
Interest swaps (1) 13 21 21 22
Total amount reclassified from (to) income to AOCI
(47) 24 (86) 42
Balance, end of period (2) $ (116) $ 13 $ (116) $ 13
______________
(1) Currency swaps income is reported in Net investment income in the consolidated statements of income (loss). Interest swaps income is reported in net derivative gains (losses) in the consolidated statements of income (loss).
(2) The Company does not estimate the amount of the deferred losses in AOCI at June 30, 2025, and 2024 which will be released and reclassified into net income (loss) over the next 12 months as the amounts cannot be reasonably estimated.
Equity-Based and Treasury Futures Contracts Margin
All outstanding equity-based and treasury futures contracts as of June 30, 2025 and December 31, 2024 are exchange-traded and net settled daily in cash. As of June 30, 2025 and December 31, 2024, respectively, the Company had open exchange-traded futures positions on: (i) the S&P 500, Nasdaq, Russell 2000 and Emerging Market indices, having initial margin requirements of $1.1 billion and $704 million, (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $110 million and $99 million, and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200 and EAFE indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $1 million and $11 million.
Collateral Arrangements
The Company generally has executed a CSA under the ISDA Master Agreement it maintains with each of its OTC derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. As of June 30, 2025 and December 31, 2024, respectively, the Company held $16.6 billion and $16.9 billion in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. The unrestricted cash collateral is reported in other invested assets. The Company posted collateral of $155 million and $137 million as of June 30, 2025 and December 31, 2024, respectively, in the normal operation of its collateral arrangements. The Company is exposed to losses in the event of non-performance by counterparties to financial derivative transactions with a positive fair value. The Company manages credit risk by: (i) entering into derivative transactions with highly rated major international financial institutions and other creditworthy counterparties governed by master netting agreements, as applicable; (ii) trading through central clearing and OTC parties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single party credit exposures which are subject to periodic management review.
Substantially all of the Company’s derivative agreements have zero thresholds which require daily full collateralization by the party in a liability position. In addition, certain of the Company’s derivative agreements contain credit-risk related contingent features; if the credit rating of one of the parties to the derivative agreement is to fall below a certain level, the party with positive fair value could request termination at the then fair value or demand immediate full collateralization from the party whose credit rating fell and is in a net liability position.
As of June 30, 2025 and December 31, 2024, there were no net liability derivative positions with counterparties with credit risk-related contingent features whose credit rating has fallen. All derivatives have been appropriately collateralized by the Company or the counterparty in accordance with the terms of the derivative agreements.
The following tables present information about the Company’s offsetting of financial assets and liabilities and derivative instruments:
Offsetting of Financial Assets and Liabilities and Derivative Instruments
As of June 30, 2025

Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (3) Net Amount
(in millions)
Assets:
Derivative assets (1) $ 24,095 $ 17,684 $ 6,411 $ (4,509) $ 1,902
Secured lending
104 — 104 — 104
Other financial assets 1,786 — 1,786 — 1,786
Other invested assets $ 25,985 $ 17,684 $ 8,301 $ (4,509) $ 3,792
Liabilities:
Derivative liabilities (2) $ 17,689 $ 17,684 $ 5 $ — $ 5
Secured lending
104 — 104 — 104
Other financial liabilities 5,738 — 5,738 — 5,738
Other liabilities $ 23,531 $ 17,684 $ 5,847 $ — $ 5,847
______________
(1)Excludes Asset Management segment’s derivative assets of consolidated VIEs/VOEs.
(2)Excludes Asset Management segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)Financial instruments/collateral sent (held).
As of December 31, 2024

Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (3) Net Amount
(in millions)
Assets:
Derivative assets (1) $ 21,814 $ 14,924 $ 6,890 $ (6,080) $ 810
Secured Lending
137 — 137 — 137
Other financial assets 1,510 — 1,510 — 1,510
Other invested assets $ 23,461 $ 14,924 $ 8,537 $ (6,080) $ 2,457
Liabilities:
Derivative liabilities (2) $ 15,634 $ 14,924 $ 710 $ — $ 710
Secured Lending
137 — 137 — 137
Other financial liabilities 6,185 — 6,185 — 6,185
Other liabilities $ 21,956 $ 14,924 $ 7,032 $ — $ 7,032
______________
(1)Excludes Asset Management segment’s derivative assets of consolidated VIEs/VOEs.
(2)Excludes Asset Management segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)Financial instruments sent (held).

v3.25.2

CLOSED BLOCK
6 Months Ended

Jun. 30, 2025

Closed Block Disclosure [Abstract]

CLOSED BLOCK CLOSED BLOCK
As a result of demutualization, the Company’s Closed Block was established in 1992 for the benefit of certain individual participating policies that were in force on that date. Assets, liabilities and earnings of the Closed Block are specifically identified to support its participating policyholders.
Assets allocated to the Closed Block insure solely to the benefit of the Closed Block policyholders and will not revert to the benefit of the Company. No reallocation, transfer, borrowing or lending of assets can be made between the Closed Block and other portions of the Company’s General Account, any of its Separate Accounts or any affiliate of the Company without the approval of the New York State Department of Financial Services (the “NYDFS”). Closed Block assets and liabilities are carried on the same basis as similar assets and liabilities held in the General Account. For more information on the Closed Block, see Note 6 to the Company's consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024.
Summarized financial information for the Company’s Closed Block is as follows:
June 30, 2025 December 31, 2024
(in millions)
Closed Block Liabilities:
Future policy benefits, policyholders’ account balances and other $ 5,100 $ 5,213
Other liabilities 47 62
Total Closed Block liabilities 5,147 5,275
Assets Designated to the Closed Block:
Fixed maturities AFS, at fair value (amortized cost of $2,674 and $2,888) (allowance for credit losses of $0 and$0)
2,591 2,746
Mortgage loans on real estate (net of allowance for credit losses of $22 and $21)
1,498 1,531
Policy loans 510 523
Cash and other invested assets 161 17
Other assets 107 130
Total assets designated to the Closed Block 4,867 4,947
Excess of Closed Block liabilities over assets designated to the Closed Block 280 328
Amounts included in AOCI:
Net unrealized investment gains (losses), net of income tax: $17 and $30
(66) (112)
Maximum future earnings to be recognized from Closed Block assets and liabilities $ 214 $ 216
The Company’s Closed Block revenues and expenses were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Revenues:
Premiums and other income $ 24 $ 26 $ 51 $ 55
Net investment income (loss) 48 51 99 103
Investment gains (losses), net — — (1) (1)
Total revenues 72 77 149 157
Benefits and Other Deductions:
Policyholders’ benefits and dividends 72 64 146 141
Other operating costs and expenses 1 — 1 —
Total benefits and other deductions 73 64 147 141
Net income (loss), before income taxes (1) 13 2 16
Income tax (expense) benefit — (2) (1) (3)
Net income (loss) $ (1) $ 11 $ 1 $ 13

v3.25.2

DAC AND OTHER DEFERRED ASSETS/LIABILITIES
6 Months Ended

Jun. 30, 2025

Contract Holder Bonus Interest Credits [Abstract]

DAC AND OTHER DEFERRED ASSETS/LIABILITIES DAC AND OTHER DEFERRED ASSETS/LIABILITIES
The following table presents a reconciliation of DAC to the consolidated balance sheets:
June 30 December 31
2025 2024
(in millions)
Protection Solutions
Term $ 301 $ 314
Universal Life
171 170
Variable Universal Life
1,122 1,083
Indexed Universal Life
186 186
Individual Retirement
GMxB Core
1,599 1,605
EQUI-VEST Individual
154 154
Investment Edge 250 225
SCS 2,107 1,938
Legacy Segment
GMxB Legacy 494 517
Group Retirement
EQUI-VEST Group
776 768
Momentum 80 83
Corporate and Other
103 107
Other
18 20
Total $ 7,361 $ 7,170
Annually, or as circumstances warrant, the Company reviews the associated decrements assumptions (i.e., mortality and lapse) based on our multi-year average of companies experience with actuarial judgements to reflect other observable industry trends. In addition to DAC, the unearned revenue liability and sales inducement asset (“SIA”) use similar techniques and quarterly update processes for balance amortization.
Changes in the DAC asset were as follows:
Six Months Ended June 30, 2025
Protection Solutions Individual Retirement Legacy Group Retirement Corporate and Other Total
Term UL VUL IUL GMxB Core EI IE SCS GMxB Legacy EG Momentum CB (1)
(in millions)
Balance, beginning of period $ 314 $ 170 $ 1,083 $ 186 $ 1,605 $ 154 $ 225 $ 1,938 $ 517 $ 768 $ 83 $ 107 $ 7,150
Capitalization 5 7 72 6 70 5 36 326 9 31 5 — 572
Amortization (2)
(18) (6) (33) (6) (76) (5) (11) (157) (32) (23) (8) (4) (379)
Balance, end of period $ 301 $ 171 $ 1,122 $ 186 $ 1,599 $ 154 $ 250 $ 2,107 $ 494 $ 776 $ 80 $ 103 $ 7,343
______________
(1)“CB” defined as Closed Block.
(2)DAC amortization of $2 million related to Other not reflected in table above.

Six Months Ended June 30, 2024
Protection Solutions Individual Retirement Legacy Group Retirement Corporate and Other Total
Term UL VUL IUL GMxB Core EI IE SCS GMxB Legacy EG Momentum
CB
(in millions)
Balance, beginning of period $ 337 $ 174 $ 987 $ 188 $ 1,602 $ 155 $ 172 $ 1,571 $ 555 $ 742 $ 82 $ 116 $ 6,681
Capitalization 8 4 77 5 74 6 29 306 14 32 5 — 560
Amortization (1) (19) (6) (30) (6) (74) (6) (8) (131) (31) (21) (2) (5) (339)
Balance, end of period $ 326 $ 172 $ 1,034 $ 187 $ 1,602 $ 155 $ 193 $ 1,746 $ 538 $ 753 $ 85 $ 111 $ 6,902
______________
(1)    DAC amortization of $2 million related to Other not reflected in table above.
Changes in the Individual Retirement sales inducement assets were as follows:
Six Months Ended June 30,
2025 2024
GMxB Core GMxB Legacy GMxB Core GMxB Legacy
(in millions)
Balance, beginning of period $ 117 $ 160 $ 127 $ 179
Capitalization 1 — 1 —
Amortization (6) (9) (6) (10)
Balance, end of period $ 112 $ 151 $ 122 $ 169
Changes in the Protection Solutions unearned revenue liability were as follows:
Six Months Ended June 30,
2025 2024
UL VUL IUL UL VUL IUL
(in millions)
Balance, beginning of period $ 114 $ 840 $ 250 $ 107 $ 754 $ 210
Capitalization 7 74 23 8 65 28
Amortization (4) (27) (8) (4) (24) (7)
Balance, end of period $ 117 $ 887 $ 265 $ 111 $ 795 $ 231
LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS
The following table reconciles the net liability for future policy benefits and liability of death benefits to the liability for future policy benefits in the consolidated balance sheets:
June 30, 2025 December 31, 2024
(in millions)
Reconciliation
Term $ 1,287 $ 1,285
Payout
4,936 5,050
Group Pension - Benefit Reserve & DPL 447 460
Health 1,336 1,362
UL 1,271 1,246
Subtotal 9,277 9,403
  Whole Life Closed Block and Open Block products 5,083 5,204
Other (1) 915 901
Future policyholder benefits total 15,275 15,508
  Other policyholder funds and dividends payable 2,282 2,105
Total $ 17,557 $ 17,613
_____________
(1)Primarily consists of future policy benefits related to Protective Life and Annuity, Assumed Life and Disability, Group Life Run off, Variable Interest Sensitive Life rider and EB.
The following table summarizes balances and changes in the liability for future policy benefits for nonparticipating traditional and limited pay contracts:
Six Months Ended June 30, 2025 Six Months Ended June 30, 2024
Protection Solutions Individual Retirement Corporate & Other Protection Solutions Individual Retirement Corporate & Other
Term Payout Group Pension Health Term Payout Group Pension Health
(in millions)
Present Value of Expected Net Premiums
Balance, beginning of period $ 1,932 $ — $ — $ (25) $ 2,133 $ — $ — $ (21)
Beginning balance at original discount rate 1,959 — — (26) 2,058 — — (22)
Effect of changes in cash flow assumptions — — — — (18) — — (3)
Effect of actual variances from expected experience (54) — — (2) (51) — — 2
Adjusted beginning of period balance 1,905 — — (28) 1,989 — — (23)
Issuances 20 — — — 26 — — —
Interest accrual 47 — — (1) 49 — — —
Net premiums collected (90) — — 3 (95) — — 1
Ending Balance at original discount rate 1,882 — — (26) 1,969 — — (22)
Effect of changes in discount rate assumptions — — — 1 (21) — — 1
Balance, end of period $ 1,882 $ — $ — $ (25) $ 1,948 $ — $ — $ (21)
Present Value of Expected Future Policy Benefits
Balance, beginning of period $ 3,216 $ 5,050 $ 460 $ 1,337 $ 3,480 $ 4,464 $ 490 $ 1,484
Beginning balance of original discount rate 3,215 5,390 514 1,555 3,330 4,680 536 1,672
Effect of changes in cash flow assumptions (1)
— (468) — — (20) — — —
Effect of actual variances from expected experience (73) (3) — (7) (66) (2) 1 7
Adjusted beginning of period balance 3,142 4,919 514 1,548 3,244 4,678 537 1,679
Issuances 22 398 — — 28 522 — —
Interest accrual 79 99 9 25 82 89 9 27
Benefits payments (120) (251) (31) (75) (116) (228) (31) (79)
Ending Balance at original discount rate 3,123 5,165 492 1,498 3,238 5,061 515 1,627
Effect of changes in discount rate assumptions 45 (229) (45) (187) 6 (359) (58) (234)
Balance, end of period $ 3,168 $ 4,936 $ 447 $ 1,311 $ 3,244 $ 4,702 $ 457 $ 1,393
Impact of flooring LFPB at zero 1 — — — 1 — — —
Net liability for future policy benefits 1,287 4,936 447 1,336 1,297 4,702 457 1,414
Less: Reinsurance recoverable 2 (1,027) — (1,044) 14 (1,144) — (1,116)
Net liability for future policy benefits, after reinsurance recoverable $ 1,289 $ 3,909 $ 447 $ 292 $ 1,311 $ 3,558 $ 457 $ 298
Weighted-average duration of liability for future policyholder benefits (years) 6.8 7.6 6.9 8.3 6.9 7.9 7.0 8.6
______________
(1)For the first quarter 2025, this is the net income impact due to novation as described in Note 1.
The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses related to nonparticipating traditional and limited payment contracts:
June 30, 2025 December 31, 2024
(in millions)
Term
Expected future benefit payments and expenses (undiscounted) $ 5,444 $ 5,613
Expected future gross premiums (undiscounted)
6,424 6,597
Expected future benefit payments and expenses (discounted; AOCI basis) 3,168 3,216
Expected future gross premiums (discounted; AOCI basis) 3,473 3,507
Payout
Expected future benefit payments and expenses (undiscounted) 7,338 7,686
Expected future gross premiums (undiscounted)
— —
Expected future benefit payments and expenses (discounted; AOCI basis) 4,814 4,938
Expected future gross premiums (discounted; AOCI basis) — —
Group Pension
Expected future benefit payments and expenses (undiscounted) 603 630
Expected future gross premiums (undiscounted)
— —
Expected future benefit payments and expenses (discounted; AOCI basis) 425 436
Expected future gross premiums (discounted; AOCI basis) — —
Health
Expected future benefit payments and expenses (undiscounted) 2,053 2,139
Expected future gross premiums (undiscounted)
65 70
Expected future benefit payments and expenses (discounted; AOCI basis) 1,299 1,323
Expected future gross premiums (discounted; AOCI basis) $ 52 $ 55
The table below summarizes the revenue and interest related to nonparticipating traditional and limited payment contracts:
Six Months Ended June 30,
2025 2024 2025 2024
Gross Premium Interest Accretion
(in millions)
Revenue and Interest Accretion
Term $ 161 $ 171 $ 32 $ 33
Payout
116 127 105 99
Group Pension — — 9 9
Health 5 6 26 28
Total $ 282 $ 304 $ 172 $ 169
The following table provides the weighted average interest rates for the liability for future policy benefits:
June 30, 2025 December 31, 2024
Weighted Average Interest Rate
Term
Interest accretion rate 5.6 % 5.6 %
Current discount rate 5.0 % 5.2 %
Payout
Interest accretion rate 4.5 % 4.4 %
Current discount rate 5.1 % 5.3 %
Group Pension
Interest accretion rate 3.4 % 3.4 %
Current discount rate 5.0 % 5.2 %
Health
Interest accretion rate 3.4 % 3.4 %
Current discount rate 5.2 % 5.4 %
The following table provides the balance, changes in and the weighted average durations of the additional insurance liabilities:
Six Months Ended June 30,
2025 2024
Protection Solutions
UL
(in millions)
Balance, beginning of period $ 1,246 $ 1,208
Beginning balance before AOCI adjustments 1,302 1,245
Effect of changes in interest rate & cash flow assumptions and model changes — —
Effect of actual variances from expected experience 4 (1)
Adjusted beginning of period balance 1,306 1,244
Interest accrual 29 27
Net assessments collected 34 35
Benefit payments (45) (35)
Ending balance before shadow reserve adjustments 1,324 1,271
Effect of reserve adjustment recorded in AOCI (53) (51)
Balance, end of period $ 1,271 $ 1,220
Net liability for additional liability $ 1,271 $ 1,220
Less: Reinsurance recoverable — —
Net liability for additional liability, after reinsurance recoverable $ 1,271 $ 1,220
Weighted-average duration of additional liability - death benefit (years) 19.1 19.5
The following tables provide the revenue, interest and weighted average interest rates, related to the additional insurance liabilities:
Six Months Ended June 30,
2025 2024 2025 2024
Assessments Interest Accretion
(in millions)
Revenue and Interest Accretion
UL $ 316 $ 338 $ 29 $ 27
Total $ 316 $ 338 $ 29 $ 27
Six Months Ended June 30,
2025 2024
Weighted Average Interest Rate
UL 4.5 % 4.5 %
Interest accretion rate 4.5 % 4.5 %
The discount rate used for additional insurance liabilities reserve is based on the crediting rate at issue.

v3.25.2

FAIR VALUE DISCLOSURES
6 Months Ended

Jun. 30, 2025

Fair Value Disclosures [Abstract]

FAIR VALUE DISCLOSURES FAIR VALUE DISCLOSURES
U.S. GAAP establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value:
Level 1    Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2    Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data.
Level 3    Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability.
The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value can neither be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument.
Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued are also considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis are summarized below:
Fair Value Measurements as of June 30, 2025

Level 1
Level 2
Level 3
Total

(in millions)
Assets:
Investments
Fixed maturities, AFS:
Corporate (1)
$ — $ 46,695 $ 2,009 $ 48,704
U.S. Treasury, government and agency — 4,519 — 4,519
States and political subdivisions — 385 — 385
Foreign governments — 575 — 575
Residential mortgage-backed (2)
— 5,423 31 5,454
Asset-backed (3)
— 14,906 936 15,842
Commercial mortgage-backed — 4,538 19 4,557
Redeemable preferred stock — 58 — 58
Total fixed maturities, AFS — 77,099 2,995 80,094
Fixed maturities, at fair value using the fair value option — 2,018 410 2,428
Other equity investments (4) 307 265 12 584
Trading securities 368 800 127 1,295
Other invested assets:
Short-term investments — 5 — 5
Assets of consolidated VIEs/VOEs 37 424 1 462
Swaps — (438) — (438)
Credit default swaps
— (9) — (9)
Futures (3) — — (3)
Options — 17,655 — 17,655
Total other invested assets 34 17,637 1 17,672
Cash equivalents 6,066 — — 6,066
Segregated securities — 483 — 483
Purchased market risk benefits — — 5,543 5,543
Assets for market risk benefits — — 776 776
Separate Accounts assets (5)
128,654 2,528 — 131,182
Total Assets $ 135,429 $ 100,830 $ 9,864 $ 246,123
Liabilities:
Notes issued by consolidated VIE’s, at fair value using the fair value option (6)
$ — $ 2,294 $ 158 $ 2,452
SCS, SIO, MSO and IUL indexed features’ liability — 18,311 — 18,311
Liabilities of consolidated VIEs and VOEs 1 17 — 18
Liabilities for market risk benefits — — 10,187 10,187
Contingent payment arrangements — — 8 8
Total Liabilities $ 1 $ 20,622 $ 10,353 $ 30,976
______________
(1)Corporate fixed maturities includes both public and private issues.
(2)Includes publicly traded agency pass-through securities and collateralized obligations.
(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.
(4)Includes short position equity securities of $12 million that are reported in other liabilities.
(5)Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate. As of June 30, 2025, the fair value of such investments was $287 million.
(6)Accrued interest payable of $19 million is reported in Notes issued by consolidated VIE’s, at fair value using the fair value option in the consolidated balance sheets, which is not required to be measured at fair value on a recurring basis.
Fair Value Measurements as of December 31, 2024
Level 1
Level 2
Level 3
Total

(in millions)
Assets:
Investments
Fixed maturities, AFS:
Corporate (1)
$ — $ 46,879 $ 2,472 $ 49,351
U.S. Treasury, government and agency — 4,288 — 4,288
States and political subdivisions — 386 — 386
Foreign governments — 554 — 554
Residential mortgage-backed (2)
— 4,383 — 4,383
Asset-backed (3)
— 13,467 232 13,699
Commercial mortgage-backed (2)
— 3,913 8 3,921
Redeemable preferred stock — 59 — 59
Total fixed maturities, AFS — 73,929 2,712 76,641
Fixed maturities, at fair value using the fair value option — 1,778 275 2,053
Other equity investments (4)
319 251 53 623
Trading securities 433 576 80 1,089
Other invested assets:

Short-term investments — 36 — 36
Assets of consolidated VIEs/VOEs 16 137 2 155
Swaps — (259) — (259)
Credit default swaps
— 2 — 2
Futures 3 — — 3
Options — 16,328 — 16,328
Total other invested assets 19 16,244 2 16,265
Cash equivalents 5,356 45 — 5,401
Segregated securities 2 498 — 500
Purchased market risk benefits — — 7,376 7,376
Assets for market risk benefits — — 863 863
Separate Accounts assets (5)
131,714 2,489 — 134,203
Total Assets $ 137,843 $ 95,810 $ 11,361 $ 245,014
Liabilities:
Notes issued by consolidated VIE’s, at fair value using the fair value option (6)
$ — $ 1,933 $ 172 $ 2,105
SCS, SIO, MSO and IUL indexed features’ liability — 17,212 — 17,212
Liabilities for market risk benefits
— — 11,810 11,810
Contingent payment arrangements — — 9 9
Total Liabilities $ — $ 19,145 $ 11,991 $ 31,136
______________
(1)Corporate fixed maturities includes both public and private issues.
(2)Includes publicly traded agency pass-through securities and collateralized obligations.
(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.
(4)Includes short position equity securities of $20 million that are reported in other liabilities.
(5)Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate. As of December 31, 2024, the fair value of such investments was $320 million.
(6)Accrued interest payable of $11 million is reported in Notes issued by consolidated VIE’s, at fair value using the fair value option in the consolidated balance sheets, which is not required to be measured at fair value on a recurring basis.
Public Fixed Maturities
The fair values of the Company’s public fixed maturities, including those accounted for using the fair value option, are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs.
Private Fixed Maturities
The fair values of the Company’s private fixed maturities, including those accounted for using the fair value option are determined from prices obtained from independent valuation service providers. Prices not obtained from an independent valuation service provider are determined by using a discounted cash flow model or a market comparable company valuation technique. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model or a market comparable company valuation technique may also incorporate unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made.
Notes issued by consolidated VIE’s, at fair value using the fair value option
These notes are based on the fair values of corresponding fixed maturity collateral. The CLO liabilities are also reduced by the fair value of the beneficial interests the Company retains in the CLO and the carrying value of any beneficial interests that represent compensation for services. As the notes are valued based on the reference collateral, they are classified as Level 2 or 3.
Freestanding Derivative Positions
The net fair value of the Company’s freestanding derivative positions as disclosed in Note 4 of the Notes to these Consolidated Financial Statements are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the OTC derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including overnight index swap curves, and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable.
Level Classifications of the Company’s Financial Instruments
Financial Instruments Classified as Level 1
Investments classified as Level 1 primarily include redeemable preferred stock, trading securities, cash equivalents and Separate Accounts assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and NAV for transacting subscriptions and redemptions of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less and are carried at cost as a proxy for fair value measurement due to their short-term nature.
Financial Instruments Classified as Level 2
Investments classified as Level 2 are measured at fair value on a recurring basis and primarily include U.S. government and agency securities, certain corporate debt securities and financial assets and liabilities accounted for using the fair value option, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Segregated securities classified as Level 2 are U.S. Treasury bills segregated by AB in a special reserve bank custody account for the exclusive benefit of brokerage customers, as required by Rule 15c3-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)and for which fair values are based on quoted yields in secondary markets.
Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as pre-payment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. The Company’s AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors.
Certain Company products, such as the SCS, EQUI-VEST variable annuity products, IUL and the MSO fund available in some life contracts, offer investment options which permit the contract owner to participate in the performance of an index, ETF or commodity price. These investment options, which depending on the product and on the index selected, can currently have one, three, five or six year terms, provide for participation in the performance of specified indices, ETF or commodity price movement up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g., holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices, ETF or commodity prices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are classified as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on data obtained from independent valuation service providers.
Financial Instruments Classified as Level 3
The Company’s investments classified as Level 3 primarily include corporate debt securities and financial assets and liabilities accounted for using the fair value option, such as private fixed maturities and asset-backed securities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification are fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated to market observable data.
The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following:
•Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals);
•Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals);
•Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages;
•Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include either a five year or an annual reset; or
•Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life.
The Company also issues certain benefits on its variable annuity products that are accounted for as MRBs carried at fair value and are also considered Level 3 for fair value leveling.
The GMIBNLG feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates applied to the contract’s benefit base if and when the contract account value is depleted and the NLG feature is activated. The optional GMIB feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates.
The GMWB feature allows the policyholder to withdraw at a minimum, over the life of the contract, an amount based on the contract’s benefit base. The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract’s benefit base. The GMAB feature increases the contract account value at the end of a specified period to a GMAB base. The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base. The GMDB feature guarantees that the benefit paid upon death will not be less than a guaranteed benefit base. If the contract’s account value is less than the benefit base at the time a death claim is paid, the amount payable will be equal to the benefit base.
The MRBs fair value will be equal to the present value of benefits less the present value of ascribed fees. Considerable judgment is utilized by management in determining the assumptions used in determining present value of benefits and ascribed fees related to lapse rates, withdrawal rates, utilization rates, non-performance risk, volatility rates, annuitization rates and mortality (collectively, the significant MRB assumptions).
Purchased MRB assets, which are accounted for as MRBs carried at fair value are also considered Level 3 for fair value leveling. The purchased MRB asset fair value reflects the present value of reinsurance premiums, net of recoveries, adjusted for risk margins and nonperformance risk over a range of market consistent economic scenarios while the MRB asset and liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins and nonperformance risk, attributable to the MRB asset and liability over a range of market-consistent economic scenarios.
The valuations of the MRBs and purchased MRB assets incorporate significant non-observable assumptions related to policyholder behavior, risk margins and projections of equity Separate Accounts funds. The credit risks of the counterparty and of the Company are considered in determining the fair values of its MRBs and purchased MRB assets after taking into account the effects of collateral arrangements. Incremental adjustment to the risk-free curve for counterparty non-performance risk is made to the fair values of the purchased MRB assets. Risk margins were applied to the non-capital markets inputs to the MRBs and purchased MRB valuations.
After giving consideration to collateral arrangements, the Company reduced the fair value of its purchased MRB asset by $69 million and $382 million as of June 30, 2025 and December 31, 2024, respectively, to recognize incremental counterparty non-performance risk.
The Company’s Level 3 liabilities include contingent payment arrangements associated with acquisitions in 2020 by AB. At each reporting date, AB estimates the fair values of the contingent consideration expected to be paid based upon revenue and discount rate projections, using unobservable market data inputs, which are included in Level 3 of the valuation hierarchy. The Company’s consolidated VIEs/VOEs hold investments that are classified as Level 3, primarily corporate bonds that are vendor priced with no ratings available, bank loans, non-agency collateralized mortgage obligations and asset-backed securities.
Transfers of Financial Instruments Between Levels 2 and 3
During the six months ended June 30, 2025, fixed maturities with fair values of $882 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, fixed maturities with fair value of $367 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 47.9% of total equity as of June 30, 2025.
During the six months ended June 30, 2024, fixed maturities with fair values of $141 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, fixed maturities with fair value of $136 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 8.3% of total equity as of June 30, 2024.
The tables below present reconciliations for all Level 3 assets and liabilities and changes in unrealized gains (losses). Not included below are the changes in balances related to MRBs and purchased MRBs level 3 assets and liabilities, which are included in Note 9 of the Notes to these Consolidated Financial Statements.
Three Months Ended June 30, 2025
Corporate State and Political Subdivisions Asset-backed RMBS CMBS
(in millions)
Balance, beginning of period $ 1,831 $ — $ 648 $ — $ 8
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 2 — — — —
Investment gains (losses), net — — — — —
Subtotal 2 — — — —
Other comprehensive income (loss) 17 — 3 1 1
Purchases 279 — 398 14 11
Sales (292) — (11) (5)
Settlements — — — (3) —
Other
— — — — —
Activity related to consolidated VIEs/VOEs — — — — —
Transfers into Level 3 (1) 98 — — 19 4
Transfers out of Level 3 (1) 74 — (102) — —
Balance, end of period $ 2,009 $ — $ 936 $ 31 $ 19
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ — $ — $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ 14 $ — $ — $ — $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2025, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Three Months Ended June 30, 2025
Fixed maturities, at FVO Other Equity Investments (3) Trading Securities, at Fair Value
Notes issued by consolidated VIE’s
Contingent Payment Arrangement
(in millions)
Balance, beginning of period $ 263 $ 18 $ 109 $ (168) $ (8)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) (1) 1 — — —
Investment gains (losses), net — — — — —
Subtotal (1) 1 — — —
Other comprehensive income (loss) — — — — —
Purchases 87 11 18 — —
Debt issuances — — — (2) —
Sales (27) (16) — — —
Settlements — — — 12 —
Other
— — — — —
Activity related to consolidated VIEs/VOEs — (1) — — —
Transfers into Level 3 (1) 63 — — — —
Transfers out of Level 3 (1) 25 — — — —
Balance, end of period $ 410 $ 13 $ 127 $ (158) $ (8)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ (1) $ 1 $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ — $ — $ — $ — $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2025, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
(3)Other Equity Investments include other invested assets.
Three Months Ended June 30, 2024
Corporate State and Political Subdivisions Asset-backed RMBS CMBS
(in millions)
Balance, beginning of period $ 2,338 $ — $ 71 $ — $ 7
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 2 — — — —
Investment gains (losses), net (1) — — — —
Subtotal 1 — — — —
Other comprehensive income (loss) 1 — — — —
Purchases 542 — (2) — —
Sales (365) — (12) — —
Settlements — — — — —
Other — — — — —
Activity related to consolidated VIEs/VOEs — — — — —
Transfers into Level 3 (1) — — — — —
Transfers out of Level 3 (1) 1 — — — —
Balance, end of period $ 2,518 $ — $ 57 $ — $ 7
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ — $ — $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ 1 $ — $ — $ — $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2024, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Three Months Ended June 30, 2024
Fixed maturities, at FVO Other Equity Investments (3) Trading Securities, at Fair Value Separate Accounts Assets Contingent Payment Arrangement
(in millions)
Balance, beginning of period $ 244 $ 58 $ 61 $ 1 $ (254)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) (12) — — — —
Investment gains (losses), net — — (4) — —
Subtotal (12) — (4) — —
Other comprehensive income (loss) — — — — —
Purchases (33) (38) — (1) —
Sales (18) 39 — — —
Settlements — — — — 2
Other — — — — (3)
Activity related to consolidated VIEs/VOEs — — — — —
Transfers into Level 3 (1) 16 — — — —
Transfers out of Level 3 (1) 27 — — — —
Balance, end of period $ 224 $ 59 $ 57 $ — $ (255)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ (12) $ — $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ — $ — $ — $ — $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2024, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
(3)Other Equity Investments include other invested assets.
Six Months Ended June 30, 2025
Corporate State and Political Subdivisions Asset-backed RMBS CMBS
(in millions)
Balance, beginning of period $ 2,472 $ — $ 232 $ — $ 8
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 3 — — — —
Investment gains (losses), net (3) — — — —
Subtotal — — — — —
Other comprehensive income (loss) 28 — 6 1 1
Purchases 424 — 784 14 11
Debt issuances
— — — —
Sales (390) — (133) (3) (5)
Settlements — — — — —
Other — — — — —
Activity related to consolidated VIEs/VOEs — — — — —
Transfers into Level 3 (1) 98 — 149 19 4
Transfers out of Level 3 (1) (623) — (102) — —
Balance, end of period $ 2,009 $ — $ 936 $ 31 $ 19
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ — $ — $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ 22 $ — $ 3 $ 1 $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2025, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Six Months Ended June 30, 2025
Fixed maturities, at FVO
Other Equity Investments (1)
Trading Securities, at Fair Value
Notes issued by consolidated VIE’s
Contingent Payment Arrangement
(in millions)
Balance, beginning of period $ 275 $ 55 $ 80 $ (172) $ (9)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 1 1 — — —
Investment gains (losses), net (4) — — — —
Subtotal (3) 1 — — —
Other comprehensive income (loss) — — — — —
Purchases
199 14 47 — —
Debt issuances
— — — (3) —
Sales (41) (16) — — —
Settlements — — — 17 1
Other
— — — — —
Activity related to consolidated VIEs/VOEs — (1) — — —
Transfers into Level 3 (2)
95 2 — — —
Transfers out of Level 3 (2)
(115) (42) — — —
Balance, end of period $ 410 $ 13 $ 127 $ (158) $ (8)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (3)
$ (1) $ 1 $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (3)
$ — $ — $ — $ — $ —
______________
(1)Other Equity Investments include other invested assets.
(2)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(3)For instruments held as of June 30, 2025, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Six Months Ended June 30, 2024
Corporate State and Political Subdivisions Asset-backed CMBS
(in millions)
Balance, beginning of period $ 2,158 $ 27 $ 47 $ 7
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 4 — — —
Investment gains (losses), net (2) — — —
Subtotal 2 — — —
Other comprehensive income (loss) 11 — — —
Purchases 757 — 46 —
Sales (421) — (22) —
Settlements — — — —
Other — — — —
Activity related to consolidated VIEs/VOEs — — — —
Transfers into Level 3 (1) 57 — — —
Transfers out of Level 3 (1) (46) (27) (14) —
Balance, end of period $ 2,518 $ — $ 57 $ 7
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ — $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ 11 $ — $ — $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2024, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Six Months Ended June 30, 2024
Fixed maturities, at FVO
Other
Equity Investments (1)
Trading Securities, at Fair Value Contingent Payment Arrangement
(in millions)
Balance, beginning of period $ 181 $ 57 $ 61 $ (253)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 4 1 — —
Investment gains (losses), net — — (4) —
Subtotal 4 1 (4) —
Other comprehensive income (loss) — — — —
Purchases 47 4 — —
Sales (33) (3) — —
Settlements — — — 3
Other — — — (5)
Activity related to consolidated VIEs/VOEs — — — —
Transfers into Level 3 (2)
79 — — —
Six Months Ended June 30, 2024
Fixed maturities, at FVO
Other
Equity Investments (1)
Trading Securities, at Fair Value Contingent Payment Arrangement
(in millions)
Transfers out of Level 3 (2)
(54) — — —
Balance, end of period $ 224 $ 59 $ 57 $ (255)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (3)
$ — $ 1 $ (4) $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (3)
$ 31 $ — $ — $ —
_____________
(1)Other Equity Investments include other invested assets.
(2)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(3)For instruments held as of June 30, 2024, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Quantitative and Qualitative Information about Level 3 Fair Value Measurements
The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities:
Quantitative Information about Level 3 Fair Value Measurements as of June 30, 2025

Fair
Value
Valuation
Technique
Significant
Unobservable Input
Range
Weighted Average (2)
(Dollars in millions)
Assets:
Investments:
Fixed maturities, AFS:
Corporate $ 1,119 Market comparable
companies
EBITDA multiples
Discount rate
Cash flow multiples
Loan to value
4.6x - 36.3x
7.9% - 19.7%
2.0x - 14.5x
(0.3)% - 54.7%
13.9x
3.2%
6.0x
9.1%
Trading securities, at fair value (5)
75 Discounted cash flow
Earnings multiple
Discount factor
Discount years
8.6x
10.0%
7
23 Market comparable
companies
EBITDA Multiples
Cashflow Multiples
8.5x - 26.3x
4.3x - 14.5x
16.2x
7.9x
Purchased MRB asset (1) (2) (4) 5,543 Discounted cash flow
Lapse rates
Withdrawal rates
GMIB Utilization rates
Non-performance risk
Volatility rates - Equity
Mortality: Ages 0-40
Ages 41-60
Ages 61-115

0.24%-13.05%
0.06%-11.65%
0.04%-66.70%
7 bps - 92 bps
13%-31%
0.01%-0.17%
0.06%-0.52%
0.32%-41.20%
2.18%
0.50%
6.71%
10 bps
23%
3.35%
(same for all ages)
(same for all ages)
Liabilities:
AB Contingent consideration payable $ 8 Discounted cash flow
Expected revenue growth rates
Discount rate
2.0% - 13.3%
1.9% - 1.9%
6.8%
1.9%
Direct MRB (1) (2) (3) (4) 9,411 Discounted cash flow
Non-performance risk
Lapse rates
Withdrawal rates
Annuitization rates
Mortality: Ages 0-40
Ages 41-60
Ages 61-115
105 bps
0.24%-36.18%
0.00%-11.65%
0.04%-100.00%
0.01%-0.17%
0.06%-0.52%
0.32%-41.20%
105 bps
3.72%
0.57%
5.09%
2.92%
(same for all ages)
(same for all ages)
______________
(1)Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
(2)Lapses and pro-rata withdrawal rates were developed as a function of the policy account value. Dollar for dollar withdrawal rates were developed as a function of the dollar for dollar threshold, the dollar for dollar limit. Utilization rates were developed as a function of the benefit base.
(3)MRB liabilities are shown net of MRB assets. Net amount is made up of $10.2 billion of MRB liabilities and $776 million of MRB assets.
(4)Includes Legacy and Core products.
(5)Certain newly acquired Level 3 Trading securities are not presented as cost basis approximates fair value as of June 30, 2025.
Quantitative Information about Level 3 Fair Value Measurements as of December 31, 2024
Fair
Value
Valuation
Technique
Significant
Unobservable Input
Range
Weighted Average (2)
(Dollars in millions)
Assets:
Investments:
Fixed maturities, AFS:
Corporate $ 402 Matrix pricing model
Spread over benchmark
70 bps - 220 bps
153 bps
981 Market comparable companies
EBITDA multiples
Discount rate
Cash flow multiples
Loan to value
4.7x - 36.5x
8.4% - 34.9%
1.8x-11.8x
0.0%-56.4%
12.2x
3.9%
4.5x
15.0%
Trading securities, at fair value (5) 75 Discounted cash flow
Earnings multiple
Discounts factor
Discount years
8.6x
10.0%
7
1 Market comparable companies
Cashflow Multiples

8.4x - 8.4x
8.4x
Purchased MRB asset (1) (2) (4) 7,376 Discounted cash flow
Lapse rates
Withdrawal rates
GMIB Utilization rates
Non-performance risk
Volatility rates - Equity
Mortality: Ages 0-40
Ages 41-60
Ages 61-115
0.24% - 13.05%
0.06% - 11.65%
0.04% - 66.70%
33 bps - 93 bps
12% - 29%
0.01% - 0.17%
0.06% - 0.52%
0.32% - 41.20%
2.17%
0.48%
6.75%
34 bps
23%
3.36%
(same for all ages)
(same for all ages)
Liabilities:
AB Contingent consideration payable $ 9 Discounted cash flow
Expected revenue growth rates
Discount rate
2.0% - 29.3%
1.9% - 10.4%
5.5%
7.3%
Direct MRB (1) (2) (3) (4) 10,947 Discounted cash flow
Non-performance risk
Lapse rates
Withdrawal rates
Annuitization rates
Mortality: Ages 0-40
Ages 41-60
Ages 61-115
94 bps
0.24% - 36.18%
0.00% - 11.65%
0.04% - 100.00%
0.01% - 0.17%
0.06% - 0.52%
0.32% - 41.20%
94 bps
3.57%
0.58%
5.15%
3.00%
(same for all ages)
(same for all ages)
______________
(1)Mortality rates vary by age and demographic characteristic such as gender and benefits elected with the policy. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
(2)Lapses and pro-rata withdrawal rates were developed as a function of the policy account value. Dollar for dollar withdrawal rates were developed as a function of the dollar for dollar threshold, the dollar for dollar limit. Utilization rates were developed as a function of the benefit base.
(3)MRB liabilities are shown net of MRB assets. Net amount is made up of $11.8 billion of MRB liabilities and $863 million of MRB assets.
(4)Includes Legacy and Core products.
(5)Certain newly acquired Level 3 Trading securities are not presented as cost basis approximates fair value as of December 31, 2024.
Level 3 Financial Instruments for which Quantitative Inputs are Not Available
Certain Privately Placed Debt Securities with Limited Trading Activity
Excluded from the tables above as of June 30, 2025 and December 31, 2024, respectively, are approximately $2.3 billion and $1.7 billion of Level 3 fair value measurements of investments for which the underlying quantitative inputs are not developed by the Company and are not readily available. These investments primarily consist of certain privately placed debt securities with limited trading activity, including residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company reporting significantly higher or lower fair value measurements for these Level 3 investments.
•The fair value of private placement securities is determined by application of a matrix pricing model or a market comparable company value technique. The significant unobservable input to the matrix pricing model valuation technique is the spread over the industry-specific benchmark yield curve. Generally, an increase or decrease in spreads would lead to directionally inverse movement in the fair value measurements of these securities. The significant unobservable input to the market comparable company valuation technique is the discount rate. Generally, a significant increase (decrease) in the discount rate would result in significantly lower (higher) fair value measurements of these securities.
•Residential mortgage-backed securities classified as Level 3 primarily consist of non-agency paper with low trading activity. Included in the tables above as of June 30, 2025 and December 31, 2024, there were no Level 3 securities that were determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Generally, a change in spreads would lead to directionally inverse movement in the fair value measurements of these securities.
•Asset-backed securities classified as Level 3 primarily consist of non-agency mortgage loan trust certificates, including subprime and Alt-A paper, credit risk transfer securities, and equipment financings. Included in the tables above as of June 30, 2025 and December 31, 2024, there were no securities that were determined by the application of matrix-pricing for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Significant increases (decreases) in spreads would have resulted in significantly lower (higher) fair value measurements.
Other Equity Investments
Included in other equity investments classified as Level 3 are venture capital securities in the Technology, Media and Telecommunications industries. The fair value measurements of these securities include significant unobservable inputs including an enterprise value to revenue multiples and a discount rate to account for liquidity and various risk factors. Significant increases (decreases) in the enterprise value to revenue multiple inputs in isolation would have resulted in a significantly higher (lower) fair value measurement. Significant increases (decreases) in the discount rate would have resulted in a significantly lower (higher) fair value measurement.
Market Risk Benefits
Significant unobservable inputs with respect to the fair value measurement of the purchased MRB assets and MRB liabilities identified in the table above are developed using Company data. Future policyholder behavior is an unobservable market assumption and, as such, all aspects of policyholder behavior are derived based on recent historical experience. These policyholder behaviors include lapses, pro-rata withdrawals, dollar for dollar withdrawals, GMIB utilization, deferred mortality and payout phase mortality. Many of these policyholder behaviors have dynamic adjustment factors based on the relative value of the rider as compared to the account value in different economic environments. This applies to all variable annuity related products; products with GMxB riders including but not limited to GMIB, GMDB, and GWL.
Lapse rates are adjusted at the contract level based on a comparison of the value of the GMxB rider and the current policyholder account value, which include other factors such as considering surrender charges. Generally, lapse rates are assumed to be lower in periods when a surrender charge applies. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. For valuing purchased MRB assets and MRB liabilities, lapse rates vary throughout the period over which cash flows are projected.
Carrying Value of Financial Instruments Not Otherwise Disclosed in Note 3 and Note 4 of the Notes to these Consolidated Financial Statements
The carrying values and fair values for financial instruments not otherwise disclosed in Note 3 and Note 4 of the Notes to these Consolidated Financial Statements were as follows:
Carrying Values and Fair Values for Financial Instruments Not Otherwise Disclosed

Carrying
Value
Fair Value

Level 1
Level 2
Level 3
Total
(in millions)
June 30, 2025:
Mortgage loans on real estate $ 21,536 $ — $ — $ 20,468 $ 20,468
Policy loans $ 4,355 $ — $ — $ 4,648 $ 4,648
Policyholders’ liabilities: Investment contracts $ 2,698 $ — $ — $ 2,667 $ 2,667
FHLB funding agreements $ 7,083 $ — $ 7,041 $ — $ 7,041
FABN funding agreements $ 9,278 $ — $ 9,110 $ — $ 9,110
Funding agreement-backed commercial paper (FABCP) $ 1,546 $ — $ 1,581 $ — $ 1,581
Long-term debt $ 4,332 $ — $ 4,277 $ — $ 4,277
Separate Accounts liabilities $ 12,207 $ — $ — $ 12,207 $ 12,207
December 31, 2024:
Mortgage loans on real estate $ 20,072 $ — $ — $ 18,567 $ 18,567
Policy loans $ 4,330 $ — $ — $ 4,559 $ 4,559
Policyholders’ liabilities: Investment contracts $ 2,046 $ — $ — $ 1,996 $ 1,996
FHLB funding agreements $ 7,167 $ — $ 7,113 $ — $ 7,113
FABN funding agreements $ 5,725 $ — $ 5,481 $ — $ 5,481
Funding agreement-backed commercial paper (FABCP) $ 74 $ — $ 75 $ — $ 75
Long-term debt $ 3,833 $ — $ 3,722 $ — $ 3,722
Separate Accounts liabilities $ 12,055 $ — $ — $ 12,055 $ 12,055

Mortgage Loans on Real Estate
Fair values for commercial, agricultural and residential mortgage loans on real estate are measured by discounting future contractual cash flows to be received on the mortgage loan using interest rates at which loans with similar characteristics and credit quality would be made. The discount rate is derived based on the appropriate U.S. Treasury rate with a like term to the remaining term of the loan to which a spread reflective of the risk premium associated with the specific loan is added. Fair values for mortgage loans anticipated to be foreclosed and problem mortgage loans are limited to the fair value of the underlying collateral, if lower.
Policy Loans
The fair value of policy loans is calculated by discounting expected cash flows based upon the U.S. Treasury yield curve and historical loan repayment patterns.
Policyholder Liabilities - Investment Contracts and Separate Accounts Liabilities
The fair values for deferred annuities and certain annuities, which are included in policyholders’ account balances, and liabilities for investment contracts with fund investments in Separate Accounts, are estimated using projected cash flows discounted at rates reflecting current market rates. Significant unobservable inputs reflected in the cash flows include lapse rates and withdrawal rates. Incremental adjustments may be made to the fair value to reflect non-performance risk. Certain other products such as the Company’s association plans contracts, supplementary contracts not involving life contingencies, Access Accounts and Escrow Shield Plus product reserves are held at book value.
FHLB Funding Agreements
The fair values of Equitable Financial’s FHLB long term funding agreements’ fair values are determined based on indicative market rates published by the FHLB, provided to AB and modeled for each note’s FMV. FHLB short-term funding agreements’ fair values are reflective of notional/par value plus accrued interest.
FABN Funding Agreements
The fair values of Equitable Financial’s FABN funding agreements are determined by Bloomberg’s evaluated pricing service, which uses direct observations or observed comparables.
FABCP Funding Agreements
The fair value of Equitable Financial’s FABCP funding agreements are reflective of the notional/par value outstanding.
Short-term Debt
The Company’s short-term debt primarily includes long-term debt that has been reclassified to short-term due to an upcoming maturity date within one year. The fair values for the Company’s short-term debt are determined by Bloomberg’s evaluated pricing service, which uses direct observations or observed comparables.
Long-term Debt
The fair values for the Company’s long-term debt are determined by Bloomberg’s evaluated pricing service, which uses direct observations or observed comparables.
Financial Instruments Exempt from Fair Value Disclosure or Otherwise Not Required to be Disclosed
Exempt from Fair Value Disclosure Requirements
Certain financial instruments are exempt from the requirements for fair value disclosure, such as insurance liabilities other than financial guarantees and investment contracts, limited partnerships accounted for under the equity method and pension and other postretirement obligations.
Otherwise Not Required to be Included in the Table Above
The Company’s investment in COLI policies are recorded at their cash surrender value and therefore are not required to be included in the table above. See Note 2 of the Notes to these Consolidated Financial Statements for further description of the Company’s accounting policy related to its investment in COLI policies.

v3.25.2

LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS
6 Months Ended

Jun. 30, 2025

Insurance [Abstract]

LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS DAC AND OTHER DEFERRED ASSETS/LIABILITIES
The following table presents a reconciliation of DAC to the consolidated balance sheets:
June 30 December 31
2025 2024
(in millions)
Protection Solutions
Term $ 301 $ 314
Universal Life
171 170
Variable Universal Life
1,122 1,083
Indexed Universal Life
186 186
Individual Retirement
GMxB Core
1,599 1,605
EQUI-VEST Individual
154 154
Investment Edge 250 225
SCS 2,107 1,938
Legacy Segment
GMxB Legacy 494 517
Group Retirement
EQUI-VEST Group
776 768
Momentum 80 83
Corporate and Other
103 107
Other
18 20
Total $ 7,361 $ 7,170
Annually, or as circumstances warrant, the Company reviews the associated decrements assumptions (i.e., mortality and lapse) based on our multi-year average of companies experience with actuarial judgements to reflect other observable industry trends. In addition to DAC, the unearned revenue liability and sales inducement asset (“SIA”) use similar techniques and quarterly update processes for balance amortization.
Changes in the DAC asset were as follows:
Six Months Ended June 30, 2025
Protection Solutions Individual Retirement Legacy Group Retirement Corporate and Other Total
Term UL VUL IUL GMxB Core EI IE SCS GMxB Legacy EG Momentum CB (1)
(in millions)
Balance, beginning of period $ 314 $ 170 $ 1,083 $ 186 $ 1,605 $ 154 $ 225 $ 1,938 $ 517 $ 768 $ 83 $ 107 $ 7,150
Capitalization 5 7 72 6 70 5 36 326 9 31 5 — 572
Amortization (2)
(18) (6) (33) (6) (76) (5) (11) (157) (32) (23) (8) (4) (379)
Balance, end of period $ 301 $ 171 $ 1,122 $ 186 $ 1,599 $ 154 $ 250 $ 2,107 $ 494 $ 776 $ 80 $ 103 $ 7,343
______________
(1)“CB” defined as Closed Block.
(2)DAC amortization of $2 million related to Other not reflected in table above.

Six Months Ended June 30, 2024
Protection Solutions Individual Retirement Legacy Group Retirement Corporate and Other Total
Term UL VUL IUL GMxB Core EI IE SCS GMxB Legacy EG Momentum
CB
(in millions)
Balance, beginning of period $ 337 $ 174 $ 987 $ 188 $ 1,602 $ 155 $ 172 $ 1,571 $ 555 $ 742 $ 82 $ 116 $ 6,681
Capitalization 8 4 77 5 74 6 29 306 14 32 5 — 560
Amortization (1) (19) (6) (30) (6) (74) (6) (8) (131) (31) (21) (2) (5) (339)
Balance, end of period $ 326 $ 172 $ 1,034 $ 187 $ 1,602 $ 155 $ 193 $ 1,746 $ 538 $ 753 $ 85 $ 111 $ 6,902
______________
(1)    DAC amortization of $2 million related to Other not reflected in table above.
Changes in the Individual Retirement sales inducement assets were as follows:
Six Months Ended June 30,
2025 2024
GMxB Core GMxB Legacy GMxB Core GMxB Legacy
(in millions)
Balance, beginning of period $ 117 $ 160 $ 127 $ 179
Capitalization 1 — 1 —
Amortization (6) (9) (6) (10)
Balance, end of period $ 112 $ 151 $ 122 $ 169
Changes in the Protection Solutions unearned revenue liability were as follows:
Six Months Ended June 30,
2025 2024
UL VUL IUL UL VUL IUL
(in millions)
Balance, beginning of period $ 114 $ 840 $ 250 $ 107 $ 754 $ 210
Capitalization 7 74 23 8 65 28
Amortization (4) (27) (8) (4) (24) (7)
Balance, end of period $ 117 $ 887 $ 265 $ 111 $ 795 $ 231
LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS
The following table reconciles the net liability for future policy benefits and liability of death benefits to the liability for future policy benefits in the consolidated balance sheets:
June 30, 2025 December 31, 2024
(in millions)
Reconciliation
Term $ 1,287 $ 1,285
Payout
4,936 5,050
Group Pension - Benefit Reserve & DPL 447 460
Health 1,336 1,362
UL 1,271 1,246
Subtotal 9,277 9,403
  Whole Life Closed Block and Open Block products 5,083 5,204
Other (1) 915 901
Future policyholder benefits total 15,275 15,508
  Other policyholder funds and dividends payable 2,282 2,105
Total $ 17,557 $ 17,613
_____________
(1)Primarily consists of future policy benefits related to Protective Life and Annuity, Assumed Life and Disability, Group Life Run off, Variable Interest Sensitive Life rider and EB.
The following table summarizes balances and changes in the liability for future policy benefits for nonparticipating traditional and limited pay contracts:
Six Months Ended June 30, 2025 Six Months Ended June 30, 2024
Protection Solutions Individual Retirement Corporate & Other Protection Solutions Individual Retirement Corporate & Other
Term Payout Group Pension Health Term Payout Group Pension Health
(in millions)
Present Value of Expected Net Premiums
Balance, beginning of period $ 1,932 $ — $ — $ (25) $ 2,133 $ — $ — $ (21)
Beginning balance at original discount rate 1,959 — — (26) 2,058 — — (22)
Effect of changes in cash flow assumptions — — — — (18) — — (3)
Effect of actual variances from expected experience (54) — — (2) (51) — — 2
Adjusted beginning of period balance 1,905 — — (28) 1,989 — — (23)
Issuances 20 — — — 26 — — —
Interest accrual 47 — — (1) 49 — — —
Net premiums collected (90) — — 3 (95) — — 1
Ending Balance at original discount rate 1,882 — — (26) 1,969 — — (22)
Effect of changes in discount rate assumptions — — — 1 (21) — — 1
Balance, end of period $ 1,882 $ — $ — $ (25) $ 1,948 $ — $ — $ (21)
Present Value of Expected Future Policy Benefits
Balance, beginning of period $ 3,216 $ 5,050 $ 460 $ 1,337 $ 3,480 $ 4,464 $ 490 $ 1,484
Beginning balance of original discount rate 3,215 5,390 514 1,555 3,330 4,680 536 1,672
Effect of changes in cash flow assumptions (1)
— (468) — — (20) — — —
Effect of actual variances from expected experience (73) (3) — (7) (66) (2) 1 7
Adjusted beginning of period balance 3,142 4,919 514 1,548 3,244 4,678 537 1,679
Issuances 22 398 — — 28 522 — —
Interest accrual 79 99 9 25 82 89 9 27
Benefits payments (120) (251) (31) (75) (116) (228) (31) (79)
Ending Balance at original discount rate 3,123 5,165 492 1,498 3,238 5,061 515 1,627
Effect of changes in discount rate assumptions 45 (229) (45) (187) 6 (359) (58) (234)
Balance, end of period $ 3,168 $ 4,936 $ 447 $ 1,311 $ 3,244 $ 4,702 $ 457 $ 1,393
Impact of flooring LFPB at zero 1 — — — 1 — — —
Net liability for future policy benefits 1,287 4,936 447 1,336 1,297 4,702 457 1,414
Less: Reinsurance recoverable 2 (1,027) — (1,044) 14 (1,144) — (1,116)
Net liability for future policy benefits, after reinsurance recoverable $ 1,289 $ 3,909 $ 447 $ 292 $ 1,311 $ 3,558 $ 457 $ 298
Weighted-average duration of liability for future policyholder benefits (years) 6.8 7.6 6.9 8.3 6.9 7.9 7.0 8.6
______________
(1)For the first quarter 2025, this is the net income impact due to novation as described in Note 1.
The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses related to nonparticipating traditional and limited payment contracts:
June 30, 2025 December 31, 2024
(in millions)
Term
Expected future benefit payments and expenses (undiscounted) $ 5,444 $ 5,613
Expected future gross premiums (undiscounted)
6,424 6,597
Expected future benefit payments and expenses (discounted; AOCI basis) 3,168 3,216
Expected future gross premiums (discounted; AOCI basis) 3,473 3,507
Payout
Expected future benefit payments and expenses (undiscounted) 7,338 7,686
Expected future gross premiums (undiscounted)
— —
Expected future benefit payments and expenses (discounted; AOCI basis) 4,814 4,938
Expected future gross premiums (discounted; AOCI basis) — —
Group Pension
Expected future benefit payments and expenses (undiscounted) 603 630
Expected future gross premiums (undiscounted)
— —
Expected future benefit payments and expenses (discounted; AOCI basis) 425 436
Expected future gross premiums (discounted; AOCI basis) — —
Health
Expected future benefit payments and expenses (undiscounted) 2,053 2,139
Expected future gross premiums (undiscounted)
65 70
Expected future benefit payments and expenses (discounted; AOCI basis) 1,299 1,323
Expected future gross premiums (discounted; AOCI basis) $ 52 $ 55
The table below summarizes the revenue and interest related to nonparticipating traditional and limited payment contracts:
Six Months Ended June 30,
2025 2024 2025 2024
Gross Premium Interest Accretion
(in millions)
Revenue and Interest Accretion
Term $ 161 $ 171 $ 32 $ 33
Payout
116 127 105 99
Group Pension — — 9 9
Health 5 6 26 28
Total $ 282 $ 304 $ 172 $ 169
The following table provides the weighted average interest rates for the liability for future policy benefits:
June 30, 2025 December 31, 2024
Weighted Average Interest Rate
Term
Interest accretion rate 5.6 % 5.6 %
Current discount rate 5.0 % 5.2 %
Payout
Interest accretion rate 4.5 % 4.4 %
Current discount rate 5.1 % 5.3 %
Group Pension
Interest accretion rate 3.4 % 3.4 %
Current discount rate 5.0 % 5.2 %
Health
Interest accretion rate 3.4 % 3.4 %
Current discount rate 5.2 % 5.4 %
The following table provides the balance, changes in and the weighted average durations of the additional insurance liabilities:
Six Months Ended June 30,
2025 2024
Protection Solutions
UL
(in millions)
Balance, beginning of period $ 1,246 $ 1,208
Beginning balance before AOCI adjustments 1,302 1,245
Effect of changes in interest rate & cash flow assumptions and model changes — —
Effect of actual variances from expected experience 4 (1)
Adjusted beginning of period balance 1,306 1,244
Interest accrual 29 27
Net assessments collected 34 35
Benefit payments (45) (35)
Ending balance before shadow reserve adjustments 1,324 1,271
Effect of reserve adjustment recorded in AOCI (53) (51)
Balance, end of period $ 1,271 $ 1,220
Net liability for additional liability $ 1,271 $ 1,220
Less: Reinsurance recoverable — —
Net liability for additional liability, after reinsurance recoverable $ 1,271 $ 1,220
Weighted-average duration of additional liability - death benefit (years) 19.1 19.5
The following tables provide the revenue, interest and weighted average interest rates, related to the additional insurance liabilities:
Six Months Ended June 30,
2025 2024 2025 2024
Assessments Interest Accretion
(in millions)
Revenue and Interest Accretion
UL $ 316 $ 338 $ 29 $ 27
Total $ 316 $ 338 $ 29 $ 27
Six Months Ended June 30,
2025 2024
Weighted Average Interest Rate
UL 4.5 % 4.5 %
Interest accretion rate 4.5 % 4.5 %
The discount rate used for additional insurance liabilities reserve is based on the crediting rate at issue.

v3.25.2

MARKET RISK BENEFITS
6 Months Ended

Jun. 30, 2025

Market Risk Benefit [Abstract]

MARKET RISK BENEFITS MARKET RISK BENEFITS
The following table presents the balances and changes to the balances for MRBs for the GMxB benefits on deferred variable annuities:
Three Months Ended June 30,
2025 2024
Individual Retirement Legacy Individual Retirement Legacy
GMxB Core GMxB Legacy
Purchased MRB
Net Legacy GMxB Core GMxB Legacy
Purchased MRB
Net Legacy
(in millions)
Balance, beginning of period $ 717 $ 9,505 $ (5,973) $ 3,532 $ 323 $ 11,715 $ (8,343) $ 3,372
Balance BOP before changes in the instrument specific credit risk 495 9,336 (5,957) 3,379 71 11,319 (8,312) 3,007
Model changes and effect of changes in cash flow assumptions
(7) 8 5 13 — — — —
Actual market movement effect (173) (620) 264 (356) (4) 45 5 50
Interest accrual 10 96 (58) 38 15 152 (111) 41
Attributed fees accrued (1)
109 161 (39) 122 111 198 (56) 142
Benefit payments (12) (285) 128 (157) (12) (310) 162 (148)
Actual policyholder behavior different from expected behavior 7 22 (14) 8 9 — (10) (10)
Changes in future economic assumptions (42) (232) 140 (92) (72) (518) 346 (172)
Issuances (2) — — — — — — —
Balance EOP before changes in the instrument-specific credit risk 385 8,486 (5,531) 2,955 118 10,886 (7,976) 2,910
Changes in the instrument-specific credit risk (2)
268 326 (10) 316 294 546 (22) 524
Balance, end of period $ 653 $ 8,812 $ (5,541) $ 3,271 $ 412 $ 11,432 $ (7,998) $ 3,434
Weighted-average age of policyholders (years) 65.9 74.0 73.4 N/A 64.9 73.3 72.9 N/A
Net amount at risk $ 2,953 $ 15,835 $ 7,099 N/A $ 2,867 $ 19,710 $ 10,443 N/A
______________
(1)Attributed fees accrued represents the portion of the fees needed to fund future GMxB claims.
(2)Changes are recorded in OCI except for reinsurer credit which is reflected in the consolidated income statement.
Six Months Ended June 30,
2025 2024
Individual Retirement Legacy Individual Retirement Legacy
GMxB Core GMxB Legacy Purchased MRB (3) Net Legacy GMxB Core GMxB Legacy Purchased MRB (3) Net Legacy
(in millions)
Balance, beginning of period $ 496 $ 10,508 $ (7,372) $ 3,136 $ 597 $ 13,425 $ (9,448) $ 3,977
Balance BOP before changes in the instrument specific credit risk 163 9,735 (7,368) 2,367 319 13,023 (9,409) 3,614
Model changes and effect of changes in cash flow assumptions (4)
(7) (1,336) 1,860 524 — — 169 169
Actual market movement effect (102) (271) 148 (123) (163) (747) 397 (350)
Interest accrual 25 202 (122) 80 31 313 (224) 89
Attributed fees accrued (1) 203 326 (99) 227 206 398 (136) 262
Benefit payments (23) (565) 257 (308) (22) (632) 331 (301)
Actual policyholder behavior different from expected behavior 20 42 (14) 28 14 (23) (1) (24)
Changes in future economic assumptions 105 353 (193) 160 (265) (1,446) 897 (549)
Issuances 1 — — — (2) — — —
Balance EOP before changes in the instrument-specific credit risk 385 8,486 (5,531) 2,955 118 10,886 (7,976) 2,910
Changes in the instrument-specific credit risk (2) 268 326 (10) 316 294 546 (22) 524
Balance, end of period $ 653 $ 8,812 $ (5,541) $ 3,271 $ 412 $ 11,432 $ (7,998) $ 3,434
Weighted-average age of policyholders (years) 65.9 74.0 73.4 N/A 64.9 73.3 72.9 N/A
Net amount at risk
$ 2,953 $ 15,835 $ 7,099 N/A $ 2,867 $ 19,710 $ 10,443 N/A
_____________
(1)Attributed fees accrued represents the portion of the fees needed to fund future GMxB claims.
(2)Changes are recorded in OCI except for reinsurer credit which is reflected in the consolidated income statement.
(3)Purchased MRB is the impact of non-affiliated reinsurance.
(4)Includes the net income impact of the novation, as described in Note 1, in the first quarter of 2025 and the impact primarily of a non-affiliated recapture of reinsurance completed in the first quarter of 2024.
The following table reconciles MRBs by the amounts in an asset position and amounts in a liability position to the MRB amounts in the consolidated balance sheets:
June 30, 2025 December 31, 2024
Direct Asset Direct Liability Net Direct MRB Purchased MRB Total Direct Asset Direct Liability Net Direct MRB Purchased MRB Total
(in millions)
Individual Retirement
GMxB Core $ (449) $ 1,102 $ 653 $ — $ 653 $ (514) $ 1,010 $ 496 $ — $ 496
Legacy Segment
GMxB Legacy (204) 9,016 8,812 (5,541) 3,271 (230) 10,738 10,508 (7,372) 3,136
Other (1) (123) 69 (54) (2) (56) (119) 62 (57) (4) (61)
Total $ (776) $ 10,187 $ 9,411 $ (5,543) $ 3,868 $ (863) $ 11,810 $ 10,947 $ (7,376) $ 3,571
______________
(1)Other primarily includes SCS.

v3.25.2

POLICYHOLDER ACCOUNT BALANCES
6 Months Ended

Jun. 30, 2025

Policyholder Account Balance [Abstract]

POLICYHOLDER ACCOUNT BALANCES POLICYHOLDER ACCOUNT BALANCES
The following table reconciles the policyholders account balances to the policyholders’ account balance liability in the consolidated balance sheets:

June 30, 2025 December 31, 2024
(in millions)
Policyholders’ account balance reconciliation
Protection Solutions
Universal Life $ 4,973 $ 5,065
Variable Universal Life 5,061 4,982
Legacy Segment
GMxB Legacy 253 226
Individual Retirement
GMxB Core (27) (4)
SCS 71,542 65,267
EQUI-VEST Individual 1,932 2,037
Group Retirement
EQUI-VEST Group 11,130 11,158
Momentum 498 527
Other (1)
10,071 8,658
Balance (exclusive of Funding Agreements) 105,433 97,916
Funding Agreements
17,926 13,013
Balance, end of period $ 123,359 $ 110,929
_____________
(1)Primarily reflects products IR Payout, IR Other, Indexed Universal Life, Investment Edge, Group Pension, Closed Block and Corporate and Other.
.
The following table summarizes the balances and changes in policyholder’s account balances:
Six Months Ended June 30, 2025
Protection Solutions Legacy Individual Retirement Group Retirement

Universal Life Variable Universal Life GMxB Legacy GMxB Core SCS (1) EQUI-VEST Individual EQUI-VEST Group Momentum
(Dollars in millions)
Balance, beginning of period $ 5,065 $ 4,982 $ 226 $ (4) $ 65,267 $ 2,037 $ 11,158 $ 527
Premiums received 300 60 5 91 5 18 293 26
Policy charges (335) (139) 18 4 (24) — (3) —
Surrenders and withdrawals (43) (2) (32) (15) (2,534) (127) (688) (53)
Benefit payments (122) (70) (8) (1) (179) (33) (32) (1)
Net transfers from (to) separate account — 117 5 (106) 6,760 8 237 (7)
Interest credited (2) 108 113 6 4 2,247 29 165 6
Other (4)
— — 33 — — — — —
Balance, end of period $ 4,973 $ 5,061 $ 253 $ (27) $ 71,542 $ 1,932 $ 11,130 $ 498
Weighted-average crediting rate 3.83% 3.67% 2.78% 1.97% N/A 2.96% 2.75% 2.48%
Net amount at risk (3) $ 32,105 $ 117,332 $ 15,835 $ 2,953 $ — $ 100 $ 7 $ —
Cash surrender value $ 3,323 $ 3,176 $ 452 $ 202 $ 68,284 $ 1,927 $ 11,084 $ 499
______________
(1)SCS sales are recorded as a Separate Account liability until they are swept into the General Account. This sweep is recorded as Net Transfers from (to) separate account.
(2)SCS and EQUI-VEST Group includes amounts related to the change in embedded derivative.
(3)For life insurance products, the net amount at risk is death benefit less account value for the policyholder. For variable annuity products, the net amount at risk is the maximum GMxB NAR for the policyholder.
(4)Includes the PAB from the policies novated to Venerable, as described in Note 1.
Six Months Ended June 30, 2024
Protection Solutions Legacy Individual Retirement Group Retirement

Universal Life Variable Universal Life GMxB Legacy GMxB Core SCS (1) EQUI-VEST Individual EQUI-VEST Group Momentum
(Dollars in millions)
Balance, beginning of period $ 5,202 $ 4,850 $ 618 $ 36 $ 49,002 $ 2,322 $ 11,563 $ 608
Premiums received 327 61 36 119 9 15 305 37
Policy charges (359) (130) 18 — (10) — (3) —
Surrenders and withdrawals (45) (25) (43) (18) (1,897) (168) (806) (69)
Benefit payments (106) (56) (49) (1) (149) (26) (35) (1)
Net transfers from (to) separate account — 86 3 (117) 6,325 6 170 (6)
Interest credited (2) 110 95 12 4 4,698 33 175 6
Other — — — — — — — —
Balance, end of period $ 5,129 $ 4,881 $ 595 $ 23 $ 57,978 $ 2,182 $ 11,369 $ 575
Weighted-average crediting rate 3.80% 3.71% 2.74% 1.67% N/A 2.98% 2.67% 2.32%
Net amount at risk (3) $ 34,364 $ 116,133 $ 19,710 $ 2,867 $ 1 $ 104 $ 9 $ —
Cash surrender value $ 3,393 $ 3,172 $ 531 $ 252 $ 54,146 $ 2,176 $ 11,313 $ 576
______________
(1)SCS sales are recorded as a Separate Account liability until they are swept into the General Account. This sweep is recorded as Net Transfers from (to) separate account.
(2)SCS and EQUI-VEST includes amounts related to the change in embedded derivative.
(3)For life insurance products, the net amount at risk is the death benefit less account value for the policyholder. For variable annuity products, the net amount at risk is the maximum GMxB NAR for the policyholder.
The following table presents the account values by range of guaranteed minimum crediting rates and the related range of the difference in basis points, between rates being credited policyholders and the respective guaranteed minimums:
June 30, 2025
Product

Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum
1 Basis Point - 50 Basis Points Above
51 Basis Points - 150 Basis Points Above
Greater Than 150 Basis Points Above
Total
( in millions)
Protection Solutions
Universal Life
0.00% - 1.50%
$ — $ — $ — $ 6 $ 6
1.51% - 2.50%
— 88 277 655 1,020
Greater than 2.50%
3,262 656 — — 3,918
Total
$ 3,262 $ 744 $ 277 $ 661 $ 4,944
Variable Universal Life
0.00% - 1.50%
$ 15 $ 10 $ 112 $ 52 $ 189
1.51% - 2.50%
38 370 232 — 640
Greater than 2.50%
3,651 27 4 — 3,682
Total
$ 3,704 $ 407 $ 348 $ 52 $ 4,511
Legacy Segment
June 30, 2025
Product

Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum
1 Basis Point - 50 Basis Points Above
51 Basis Points - 150 Basis Points Above
Greater Than 150 Basis Points Above
Total
( in millions)
GMxB Legacy
0.00% - 1.50%
$ — $ 62 $ 3 $ — $ 65
1.51% - 2.50%
17 — — — 17
Greater than 2.50%
371 — — — 371
Total
$ 388 $ 62 $ 3 $ — $ 453
Individual Retirement
GMxB Core
0.00% - 1.50%
$ — $ 10 $ 148 $ — $ 158
1.51% - 2.50%
11 — — — 11
Greater than 2.50%
37 — — — 37
Total
$ 48 $ 10 $ 148 $ — $ 206
EQUI-VEST Individual
0.00% - 1.50%
$ — $ 30 $ 159 $ — $ 189
1.51% - 2.50%
12 67 — — 79
Greater than 2.50%
1,664 — — — 1,664
Total
$ 1,676 $ 97 $ 159 $ — $ 1,932
Group Retirement
EQUI-VEST
Group
0.00% - 1.50%
$ 1 $ 945 $ 2,194 $ 262 $ 3,402
1.51% - 2.50%
342 — — — 342
Greater than 2.50%
5,988 — — — 5,988
Total
$ 6,331 $ 945 $ 2,194 $ 262 $ 9,732
Momentum
0.00% - 1.50%
$ — $ — $ 251 $ 86 $ 337
1.51% - 2.50%
74 26 — — 100
Greater than 2.50%
55 — 5 — 60
Total
$ 129 $ 26 $ 256 $ 86 $ 497

December 31, 2024
Product
Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum
1 Basis Point - 50 Basis Points Above
51 Basis Points - 150 Basis Points Above
Greater Than 150 Basis Points Above
Total
( in millions)
Protection Solutions
Universal Life
0.00% - 1.50%
$ — $ — $ — $ 6 $ 6
1.51% - 2.50%
— 90 284 655 1,029
Greater than 2.50%
3,402 598 — — 4,000
Total $ 3,402 $ 688 $ 284 $ 661 $ 5,035
Variable Universal Life
0.00% - 1.50%
$ 24 $ 13 $ 94 $ 40 $ 171
1.51% - 2.50%
37 357 223 — 617
Greater than 2.50%
3,667 2 20 — 3,689
Total $ 3,728 $ 372 $ 337 $ 40 $ 4,477
Legacy Segment
December 31, 2024
Product
Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum
1 Basis Point - 50 Basis Points Above
51 Basis Points - 150 Basis Points Above
Greater Than 150 Basis Points Above
Total
( in millions)
GMxB Legacy
0.00% - 1.50%
$ 67 $ 3 $ — $ — $ 70
1.51% - 2.50%
19 — — — 19
Greater than 2.50%
401 — — — 401
Total $ 487 $ 3 $ — $ — $ 490
Individual Retirement
GMxB Core
0.00% - 1.50%
$ 11 $ 160 $ — $ — $ 171
1.51% - 2.50%
12 — — — 12
Greater than 2.50%
52 — — — 52
Total $ 75 $ 160 $ — $ — $ 235
EQUI-VEST Individual
0.00% - 1.50%
$ 42 $ 198 $ — $ — $ 240
1.51% - 2.50%
38 — — — 38
Greater than 2.50%
1,758 — — — 1,758
Total $ 1,838 $ 198 $ — $ — $ 2,036
Group Retirement
EQUI-VEST Group
0.00% - 1.50%
$ 720 $ 2,391 $ 33 $ 258 $ 3,402
1.51% - 2.50%
349 — — — 349
Greater than 2.50%
6,076 — — — 6,076
Total $ 7,145 $ 2,391 $ 33 $ 258 $ 9,827
Momentum
0.00% - 1.50%
$ — $ — $ 269 $ 88 $ 357
1.51% - 2.50%
79 29 — — 108
Greater than 2.50%
56 — 5 — 61
Total $ 135 $ 29 $ 274 $ 88 $ 526
Separate Account - Summary
The following table reconciles the Separate Account liabilities to the Separate Account liability balance in the consolidated balance sheets:
June 30, 2025 December 31, 2024
(in millions)
Separate Account Reconciliation
Protection Solutions
Variable Universal Life $ 18,968 $ 18,176
Legacy Segment
GMxB Legacy 28,275 33,199
Individual Retirement
GMxB Core 30,057 30,411
EQUI-VEST Individual 4,756 4,782
Investment Edge 5,072 4,885
Group Retirement
EQUI-VEST Group 31,714 30,546
Momentum 5,008 4,813
Other (1) 7,833 7,905
Total $ 131,683 $ 134,717
______________
(1)Primarily reflects Corporate and Other products and Group Retirement products including Association and Group Retirement Other.
The following table presents the balances of and changes in Separate Account liabilities:
Six Months Ended June 30, 2025
Protection Solutions Legacy Individual Retirement Group Retirement
VUL GMxB Legacy GMxB Core EQUI-VEST Individual Investment Edge EQUI-VEST Group Momentum
(in millions)
Balance, beginning of period $ 18,176 $ 33,199 $ 30,411 $ 4,782 $ 4,885 $ 30,546 $ 4,813
Premiums and deposits 664 118 934 49 901 1,252 330
Policy charges (292) (265) (252) (2) — (8) (12)
Surrenders and withdrawals (350) (1,499) (1,861) (237) (242) (1,271) (433)
Benefit payments (54) (364) (145) (36) (17) (32) (5)
Investment performance (1) 941 907 864 208 247 1,464 308
Net transfers from (to) General Account
(117) (5) 106 (8) (702) (237) 7
Other charges (2)
— (3,816) — — — — —
Balance, end of period $ 18,968 $ 28,275 $ 30,057 $ 4,756 $ 5,072 $ 31,714 $ 5,008
Cash surrender value $ 18,600 $ 28,071 $ 29,218 $ 4,724 $ 4,983 $ 31,412 $ 5,001
_____________
(1)Investment performance is reflected net of M&E fees.
(2)Other charges include the Separate Account value novated to Venerable, as described in Note 1.
Six Months Ended June 30, 2024
Protection Solutions Legacy Individual Retirement Group Retirement
VUL GMxB Legacy GMxB Core EQUI-VEST Individual Investment Edge EQUI-VEST Group Momentum
(in millions)
Balance, beginning of period $ 15,821 $ 33,794 $ 29,829 $ 4,582 $ 4,275 $ 26,959 $ 4,421
Premiums and deposits 616 112 1,000 40 739 1,180 379
Policy charges (287) (324) (249) (1) — (8) (11)
Surrenders and withdrawals (330) (1,629) (1,720) (248) (254) (1,113) (476)
Benefit payments (30) (385) (135) (26) (15) (32) (7)
Investment performance (1) 1,508 (3) 117 (7) (465) (170) 6
Net transfers from (to) General Account
(86) 2,401 1,634 445 308 2,409 390
Other charges
— — — — — — —
Balance, end of period $ 17,212 $ 33,966 $ 30,476 $ 4,785 $ 4,588 $ 29,225 $ 4,702
Cash surrender value $ 16,840 $ 33,702 $ 29,644 $ 4,752 $ 4,501 $ 28,935 $ 4,694
______________
(1)Investment performance is reflected net of M&E fees.
The following table presents the aggregate fair value of Separate Account assets by major asset category:
June 30, 2025
Protection Solutions Individual Retirement Group Retirement     Corp & Other Legacy Segment Total
(in millions)
Asset Type
Debt securities $ 49 $ 1 $ 9 $ 17 $ — $ 76
Common Stock 68 37 512 1,731 — 2,348
Mutual Funds 19,417 41,709 38,075 637 28,299 128,137
Bonds and Notes 101 3 1 1,017 — 1,122
Total $ 19,635 $ 41,750 $ 38,597 $ 3,402 $ 28,299 $ 131,683

December 31, 2024
Protection Solutions Individual Retirement Group Retirement     Corp & Other Legacy Segment Total
(in millions)
Asset Type
Debt securities $ 51 $ 1 $ 14 $ 13 $ — $ 79
Common Stock 68 36 472 1,631 — 2,207
Mutual Funds 18,611 42,029 36,779 659 33,214 131,292
Bonds and Notes 98 4 1 1,036 — 1,139
Total $ 18,828 $ 42,070 $ 37,266 $ 3,339 $ 33,214 $ 134,717

v3.25.2

EMPLOYEE BENEFIT PLANS
6 Months Ended

Jun. 30, 2025

Retirement Benefits [Abstract]

EMPLOYEE BENEFIT PLANS EMPLOYEE BENEFIT PLANS
Pension Plans
Holdings and Equitable Financial Retirement Plans
Holdings sponsors the MONY Life Retirement Income Security Plan for Employees, which is a frozen qualified defined benefit plan covering eligible employees and financial professionals. Equitable Financial sponsors the Equitable Retirement Plan (the “Equitable Financial QP”), which was frozen on December 31, 2013 but reopened on January 1, 2025 and is a qualified defined benefit plan covering eligible employees and financial professionals. These pension plans are non-contributory, and their benefits are generally based on a cash balance formula and/or, for certain participants, years of service and average earnings over a specified period. Holdings and Equitable Financial also sponsor certain nonqualified deferred compensation plans, including the Equitable Excess Retirement Plan, that provide retirement benefits in excess of the amount permitted under the tax law for the qualified plans. Holdings has assumed primary liability for both plans. Equitable Financial remains secondarily liable for its obligations under the Equitable Financial QP and would recognize such liability in the event Holdings does not perform.
AB Retirement Plans
AB maintained a qualified, non-contributory, defined benefit retirement plan (the “Retirement Plan”) covering current and former employees who were employed by AB in the United States prior to October 2, 2000. During 2024, the Compensation Committee of the AB Board of Directors approved the termination of the Retirement Plan, effective May 22, 2024. AB began the process of settling benefits with vested participants and all lump sum disbursements elected by plan participants were distributed in December 2024 in the amount of $35 million. The remaining Retirement Plan participants who did not elect a lump sum disbursement elected to roll over their benefit to a group annuity contract from a qualified insurance company to administer all future payments. During the six months ended June 30, 2025, AB settled all future obligations under the Retirement Plan and transferred the remaining benefit obligations to a qualified third party insurance provider under a group annuity contract. The final annuity premium transferred was $59 million. Following the settlement related to the annuity purchase, the plans funded status was in a deficit and AB funded an additional $2 million to cover all remaining obligations. As a result of the settlement, AB recognized a non-cash settlement of approximately $21 million related to Retirement Plan losses and the reclassification from accumulated other comprehensive loss to general and administrative expenses in the unaudited consolidated statements of income.
Net Periodic Pension Expense
Components of net periodic pension expense for the Company’s plans were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Service cost $ 7 $ 2 $ 15 $ 4
Interest cost 28 31 56 59
Expected return on assets (33) (37) (67) (73)
Prior period service cost amortization — (1) (1) (1)
Net amortization 11 14 23 28
Impact of settlement — — 21 —
Net Periodic Pension Expense $ 13 $ 9 $ 47 $ 17

v3.25.2

INCOME TAXES
6 Months Ended

Jun. 30, 2025

Income Tax Disclosure [Abstract]

INCOME TAXES INCOME TAXES
Income tax expense for the three and six months ended June 30, 2025 and 2024 was computed using an estimated annual effective tax rate (“ETR”), with discrete items recognized in the period in which they occur. The estimated ETR is revised, as necessary, at the end of successive interim reporting periods.
In 2022, the Company established a valuation allowance against its deferred tax asset related to unrealized capital losses in the available for sale securities portfolio. In 2023, management took actions to increase its available liquidity so that the Company has the ability and intent to hold the majority of securities in its available for sale portfolio to recovery. For liquidity and other purposes, the Company maintains a smaller pool of securities that it does not intend to hold to recovery. The Company maintains a valuation allowance against the deferred tax asset on available for sale securities that will not be held to recovery. Adjustments to the valuation allowance due to changes in the portfolio’s unrealized capital loss are recorded in OCI. Adjustments to the valuation allowance due to new facts or evidence are recorded in net income.
For the three and six months ended June 30, 2025, the Company recorded increases to the valuation allowance of $33 million and $41 million, respectively, due to changes in the value of unrealized losses in the available for sale portfolio that will not be held to recovery. These adjustments were recorded in OCI. As of June 30, 2025, a valuation allowance of $258 million remains against the portion of the deferred tax asset that is still not more-likely-than-not to be realized.
The Company uses the aggregate portfolio approach related to the stranded or disproportionate income tax effects in accumulated other comprehensive income related to available for sale securities. Under this approach, the disproportionate tax effect remains intact as long as the investment portfolio remains.

v3.25.2

EQUITY
6 Months Ended

Jun. 30, 2025

Equity [Abstract]

EQUITY EQUITY
Preferred Stock
Preferred stock authorized, issued and outstanding was as follows:
June 30, 2025 December 31, 2024
Series Shares Authorized Shares
Issued Shares Outstanding Shares Authorized Shares
Issued Shares Outstanding
Series A 32,000 32,000 32,000 32,000 32,000 32,000
Series B 20,000 6,613 6,613 20,000 17,773 17,773
Series C 12,000 12,000 12,000 12,000 12,000 12,000
Total 64,000 50,613 50,613 64,000 61,773 61,773

On April 11, 2025, Holdings redeemed and retired $279 million of Series B Preferred Stock using proceeds from our Junior Subordinated Debt issuance.
Dividends declared per share were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
Series A dividends declared $ 328 $ 328 $ 656 $ 656
Series B dividends declared $ 619 $ 619 $ 619 $ 619
Series C dividends declared $ 269 $ 269 $ 538 $ 538
Common Stock
Dividends declared per share of common stock were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
Dividends declared $ 0.27 $ 0.24 $ 0.51 $ 0.46

Share Repurchase
On February 5, 2024, the Company’s Board of Directors (the “Board”) authorized a new $1.3 billion share repurchase program. On February 13, 2025, Holdings’s Board approved an additional $1.5 billion under Holdings’s share repurchase program. Under this program, the Company may, from time to time purchase shares of its common stock through various means. The Company may choose to suspend or discontinue the repurchase program at any time. The repurchase program does not obligate the Company to purchase any particular number of shares. As of June 30, 2025, Holdings had authorized capacity of approximately $1.5 billion remaining in its share repurchase program.
Holdings repurchased a total of 4.8 million and 9.8 million shares of its common stock at an average price of $51.71 and $50.79 through open market repurchases, ASRs and privately negotiated transactions for the three and six months ended June 30, 2025, respectively and repurchased a total of 6.3 million and 13.8 million shares of its common stock at an average price of $39.21 and $36.31 through open market repurchases, ASRs and privately negotiated transactions for the three and six months ended June 30, 2024, respectively.
During the three and six months ended June 30, 2025, Holdings repurchased 2.4 million and 4.7 million shares, of its common stock through open market repurchases. During the three and six months ended June 30, 2024, Holdings repurchased 3.2 million and 6.4 million shares, of its common stock through open market repurchases.
In March 2025, Holdings established an obligation to enter into an ASR with a third-party financial institution to repurchase an aggregate of $38 million of Holdings’ common stock. Pursuant to the ASR, Holdings made a pre-payment of $38 million and received initial delivery of 567,270 of Holdings’ shares. The ASR terminated in April 2025, at which time an additional 201,068 shares of common stock were received.
In March 2025, Holdings established an obligation to enter into an ASR with a third-party financial institution to repurchase an aggregate of $102 million of Holdings’ common stock. Pursuant to the ASR, on April 2, 2025, Holdings made a pre-payment of $102 million and received initial delivery of 1.6 million of Holdings’ shares. The ASR will be terminated in April 2025, at which time 629,617 additional shares of common stock were received.
In December 2024, Holdings established an obligation to enter into an ASR with a third-party financial institution to repurchase an aggregate of $105 million of Holdings’ common stock. Pursuant to the ASR, on January 3, 2025, Holdings made a pre-payment of $105 million and received initial delivery of 1.8 million of Holdings’ shares. The ASR terminated in February 2025, at which time 274,630 additional shares of common stock were received.
In December 2024, Holdings established an obligation to enter into an ASR with a third-party financial institution to repurchase an aggregate of $32 million of Holdings’ common stock. Pursuant to the ASR, in December, Holdings made a pre-payment of $32 million and received initial delivery of 550,301 of Holdings’ shares. The ASR terminated in January 2025, at which time an additional 105,468 shares of common stock were received.
Accumulated Other Comprehensive Income (Loss)
AOCI represents cumulative gains (losses) on items that are not reflected in net income (loss). The balances are as follows:

June 30, 2025 December 31, 2024

(in millions)
Unrealized gains (losses) on investments $ (6,501) $ (7,334)
Market risk benefits - instrument -specific credit risk component
(601) (1,125)
Liability for future policy benefits - current discount rate component
255 372
Defined benefit pension plans (553) (579)
Foreign currency translation adjustments (51) (88)
Total accumulated other comprehensive income (loss) (7,451) (8,754)
Less: Accumulated other comprehensive income (loss) attributable to noncontrolling interest (19) (42)
Accumulated other comprehensive income (loss) attributable to Holdings $ (7,432) $ (8,712)

The components of OCI, net of taxes for follows:
Three Months Ended June 30,

Six Months Ended June 30,
2025

2024

2025 2024

(in millions)
Change in net unrealized gains (losses) on investments:
Net unrealized gains (losses) arising during the period
$ 335 $ (443) $ 993 $ (986)
(Gains) losses reclassified into net income (loss) during the period (1)
28 — 34 21
Net unrealized gains (losses) on investments 363 (443) 1,027 (965)
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other (54) 34 (109) 43
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $124, $(102), $297 and $(235))
309 (409) 918 (922)
Change in LFPB discount rate and MRB credit risk, net of tax
Changes in instrument-specific credit risk - market risk benefits (net of deferred income tax expense (benefit) of $(45), $(42), $110 and $(37))
(170) (159) 414 (139)
Changes in current discount rate - liability for future policy benefits (net of deferred income tax expense (benefit) of $(8), $18, $(25) and $44)
(29) 67 (92) 165
Change in defined benefit plans:
Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost)
9 11 26 19
Change in defined benefit plans (net of deferred income tax expense (benefit) of $3, $7, $1 and $5)
9 11 26 19
Foreign currency translation adjustments:
Foreign currency translation gains (losses) arising during the period 26 9 37 (2)
Foreign currency translation adjustment 26 9 37 (2)
Total other comprehensive income (loss), net of income taxes 145 (481) 1,303 (879)
Three Months Ended June 30,

Six Months Ended June 30,
2025

2024

2025 2024

(in millions)
Less: Other comprehensive income (loss) attributable to noncontrolling interest 10 3 23 (1)
Other comprehensive income (loss) attributable to Holdings $ 135 $ (484) $ 1,280 $ (878)
______________
(1)See “reclassification adjustments” in Note 3 of the Notes to these Consolidated Financial Statements. Reclassification amounts presented net of income tax expense (benefit) of $(7) million, $0 million, $(9) million and $(6) million for the three and six months ended June 30, 2025 and 2024, respectively.
Investment gains and losses reclassified from AOCI to net income (loss) primarily consist of realized gains (losses) on sales and credit losses of AFS securities and are included in total investment gains (losses), net on the consolidated statements of income (loss). Amounts reclassified from AOCI to net income (loss) as related to defined benefit plans primarily consist of amortization of net (gains) losses and net prior service cost (credit) recognized as a component of net periodic cost and reported in compensation and benefits in the consolidated statements of income (loss). Amounts presented in the table above are net of tax.

v3.25.2

SHORT-TERM AND LONG-TERM DEBT
6 Months Ended

Jun. 30, 2025

Debt Disclosure [Abstract]

SHORT-TERM AND LONG-TERM DEBT SHORT-TERM AND LONG-TERM DEBT
Borrowings
Our financial strategy going forward will remain subject to market conditions and other factors. For example, we may from time to time enter into additional bank or other financing arrangements, including public or private debt, structured facilities and contingent capital arrangements, under which we could incur additional indebtedness.
The following table sets forth the Company’s total consolidated borrowings. Short-term and long-term debt consists of the following:
June 30, December 31,
2025 2024
(in millions)
Short-term debt:
Total short-term debt $ — $ —
Long-term debt:
Senior Debenture due 2028 250 250
Senior Note due 2028 1,495 1,494
Senior Note due 2029 305 303
Senior Note due 2033 497 497
Senior Note due 2048 1,290 1,289
Junior Sub Debt Securities due 2055 495 —
Total long-term debt 4,332 3,833
Total short and long-term debt $ 4,332 $ 3,833
Junior Subordinated Debt Securities
On March 26, 2025, Holdings issued $500 million aggregate principal amount of 6.7% Fixed-to-Fixed Reset Rate Junior Subordinated Debt Securities due 2055 (the “Junior Subordinated Debt Securities”). These amounts were recorded net of the underwriting discount and issuance costs of $6 million. Interest will be paid (i) from, and including, March 26, 2025 to, but excluding, March 28, 2035 at the rate of 6.7% per annum and (ii) from, and including, March 28, 2035, during each interest period, at a rate per annum equal to the five-year Treasury rate as of the most recent reset interest determination date, in each case to be reset on each interest reset date, plus 2.4%, payable semi-annually in arrears on March 28 and September 28 of each year, beginning on September 28, 2025, and on the maturity date.

v3.25.2

REDEEMABLE NONCONTROLLING INTEREST
6 Months Ended

Jun. 30, 2025

Noncontrolling Interest [Abstract]

REDEEMABLE NONCONTROLLING INTEREST REDEEMABLE NONCONTROLLING INTEREST
The changes in the components of redeemable noncontrolling interests were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Balance, beginning of period $ 289 $ 991 $ 125 $ 770
Net earnings (loss) attributable to redeemable noncontrolling interests (2) 16 1 34
Purchase/change of redeemable noncontrolling interests 71 81 232 284
Balance, end of period $ 358 $ 1,088 $ 358 $ 1,088

v3.25.2

COMMITMENTS AND CONTINGENT LIABILITIES
6 Months Ended

Jun. 30, 2025

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENT LIABILITIES COMMITMENTS AND CONTINGENT LIABILITIES
Litigation and Regulatory Matters
Litigation, regulatory and other loss contingencies arise in the ordinary course of the Company’s activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek, or they may be required only to state an amount sufficient to meet a court’s jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including, among other things, insurers’ sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, product design, features and accompanying disclosure, COI increases, payments of death benefits and the reporting and escheatment of unclaimed property, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters.
The outcome of a litigation or regulatory matter is difficult to predict, and the amount or range of potential losses associated with these or other loss contingencies requires significant management judgment. It is not possible to predict the ultimate outcome or to provide reasonably possible losses or ranges of losses for all pending regulatory matters, litigation and other loss contingencies. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters, nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company’s litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company’s results of operations or cash flows in a particular quarterly or annual period.
For some matters, the Company is able to estimate a range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of June 30, 2025, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $100 million.
For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company’s accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews.
As with other financial services companies, Equitable Financial periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters.
Obligations under Funding Agreements
Pre-Capitalized Trust Securities (“P-Caps”)
In April 2019, pursuant to separate Purchase Agreements among Holdings, Credit Suisse Securities (USA) LLC, as representative of the several initial purchasers, and the Trusts (as defined below), Pine Street Trust I, a Delaware statutory trust (the “2029 Trust”), completed the issuance and sale of 600,000 of its Pre-Capitalized Trust Securities redeemable February 15, 2029 (the “2029 P-Caps”) for an aggregate purchase price of $600 million and Pine Street Trust II, a Delaware statutory trust (the “2049 Trust” and, together with the 2029 Trust, the “Trusts”), completed the issuance and sale of 400,000 of its Pre-Capitalized Trust Securities redeemable February 15, 2049 (the “2049 P-Caps” and, together with the 2029 P-Caps, the “P-Caps”) for an aggregate purchase price of $400 million in each case to qualified institutional buyers in reliance on Rule 144A that are also “qualified purchasers” for purposes of Section 3(c)(7) of the Investment Company Act of 1940, as amended.
In June 2024, the Company exercised its issuance right under the Facility Agreement, dated April 5, 2019 (the “2029 Trust Facility Agreement”) to issue $600 million principal amount of the Company’s 4.572% Senior Notes due 2029 (the “2029 Notes”) in exchange for the portfolio of principal and interest strips of U.S. Treasury securities held by the 2029 Trust (the “2029 Trust Eligible Assets”). Following the Company’s exercise of its issuance right under the 2029 Trust Facility Agreement, the Company: (i) issued $600 million principal amount of the 2029 Notes to the 2029 Trust on June 6, 2024 in exchange for the 2029 Trust Eligible Assets; (ii) waived its right to repurchase the 2029 Notes; and (iii) directed the trustee of the 2029 Trust to dissolve the 2029 Trust in accordance with its declaration of trust and deliver the 2029 Notes to the beneficial holders of the 2029 P-Caps pro rata in respect of each 2029 P-Cap. The 2029 Trust was dissolved on June 11, 2024 and the beneficial holders of the 2029 P-Caps received the 2029 Notes through the facilities of The Depository Trust Company. See Note 14 of the Notes to these Consolidated Financial Statements for additional details on the 2029 Notes.
In addition, in June 2024, pursuant to the Purchase Agreement among Holdings, TD Securities (USA) LLC, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as representative of the several initial purchasers, and Pine Street Trust III, a Delaware statutory trust ( “2054 Trust”), completed the issuance and sale of 600,000 of its Pre-Capitalized Trust Securities redeemable May 15, 2054 (the “2054 P-Caps”) for an aggregate purchase price of $600 million to qualified institutional buyers in reliance on Rule 144A that are also “qualified purchasers” for purposes of Section 3(c)(7) of the Investment Company Act of 1940, as amended.
The P-Caps are an off-balance sheet contingent funding arrangement that, upon Holdings’ election, gives Holdings the right over a thirty-year period to issue senior notes to the 2049 Trust and the 2054 Trusts. The Trust have invested the proceeds from the respective sales of their P-Caps in separate portfolios of principal and/or interest strips of U.S. Treasury securities. In return, Holdings will, in the case of the 2054 Trust, pay, and in the case of the 2049 Trust, continue to pay, a semi-annual facility fee to the 2049 Trust and 2054 Trust calculated at a rate of 2.715% and 1.779% per annum, respectively, which will be applied to the unexercised portion of the contingent funding arrangement and Holdings will reimburse the Trusts for certain expenses. The facility fees are recorded in other operating costs and expenses in the consolidated statements of income (loss).
FHLB
As a member of the FHLB, Equitable Financial and Equitable America have access to collateralized borrowings. They also may issue funding agreements to the FHLB. Both the collateralized borrowings and funding agreements would require Equitable Financial or Equitable America to pledge qualified mortgage-backed assets and/or government securities as collateral. Equitable Financial and Equitable America issue short-term funding agreements to the FHLB and use the funds for asset, liability, and cash management purposes. Equitable Financial and Equitable America issue long-term funding agreements to the FHLB and use the funds for spread lending purposes.
Entering into FHLB membership, borrowings and funding agreements requires the ownership of FHLB stock and the pledge of assets as collateral. Equitable Financial has purchased FHLB stock of $323 million and pledged collateral with a carrying value of $11.0 billion as of June 30, 2025. Equitable America has purchased FHLB stock of $5 million and pledged collateral with a carrying value of $245 million as of June 30, 2025.
Funding agreements are reported in policyholders’ account balances in the consolidated balance sheets. For other instruments used for asset/liability and cash management purposes, see “Offsetting of Financial Assets and Liabilities and Derivative Instruments” included in Note 4 of the Notes to these Consolidated Financial Statements. The table below summarizes the Company’s activity of funding agreements with the FHLB.
Change in FHLB Funding Agreements during the Six Months Ended June 30, 2025
Outstanding Balance at December 31, 2024 Issued During the Period Repaid During the Period Long-term Agreements Maturing Within One Year Long-term Agreements Maturing Within Five Years Outstanding Balance at June 30, 2025
(in millions)
Short-term funding agreements:
Due in one year or less $ 5,843 $ 34,894 $ (35,194) $ 409 $ — $ 5,952
Long-term funding agreements:
Due in years two through five 829 200 — (388) — 641
Due in more than five years 493 — — (21) — 472
Total long-term funding agreements 1,322 200 — (409) — 1,113
Total funding agreements (1) $ 7,165 $ 35,094 $ (35,194) $ — $ — $ 7,065
_____________
(1)The $18 million and $2 million difference between the funding agreements carrying value shown in fair value table for June 30, 2025 and December 31, 2024, respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates.
FABN
Under the FABN programs, Equitable Financial and Equitable America may issue funding agreements in U.S. dollar or other foreign currencies, in each case, to a Delaware special purpose statutory trust (the “Trust”) in exchange for the proceeds from issuances of fixed and floating rate medium-term marketable notes issued by the applicable Trust from time to time (the “Trust Notes”). The funding agreements have matching interest, maturity and currency payment terms to the applicable Trust Notes. The Company hedges the foreign currency exposure of foreign currency denominated funding agreements using cross currency swaps as discussed in Note 4 of the Notes to these Consolidated Financial Statements. As of June 30, 2025, the maximum aggregate principal amount of Trust Notes permitted to be outstanding at any one time is $16.0 billion. Funding agreements issued to the applicable Trust, including any foreign currency transaction adjustments, are reported in policyholders’ account balances in the consolidated balance sheets. Foreign currency transaction adjustments to policyholder’s account balances are recognized in net income (loss) as an adjustment to interest credited to policyholders’ account balances and are offset in interest credited to policyholders’ account balances by a release of AOCI from deferred changes in fair value of designated and qualifying cross currency swap cash flow hedges. The table below summarizes activity of funding agreements under the FABN programs.
Change in FABN Funding Agreements during the Six Months Ended June 30, 2025
Outstanding Balance at December 31, 2024 Issued During the Period Repaid During the Period Long-term Agreements Maturing Within One Year Long-term Agreements Maturing Within Five Years Foreign Currency Transaction Adjustment Outstanding Balance at June 30,
2025
(in millions)
Short-term funding agreements:
Due in one year or less $ 1,050 $ 300 $ — $ 450 $ — $ — $ 1,800
Long-term funding agreements:
Due in years two through five 4,393 3,100 — (450) — 107 7,150
Due in more than five years 300 — — — — — 300
Total long-term funding agreements 4,693 3,100 — (450) — 107 7,450
Total funding agreements (1) $ 5,743 $ 3,400 $ — $ — $ — $ 107 $ 9,250
_____________
(1)The $28 million and $18 million difference between the funding agreements notional value shown and carrying value table as of June 30, 2025 and December 31, 2024, respectively, reflects the remaining amortization of the issuance cost of the funding agreements and the foreign currency transaction adjustment.
FABCP
In May 2023, Equitable Financial and Equitable America established a FABCP program, pursuant to which a SPLLC may issue commercial paper and deposit the proceeds with Equitable Financial or Equitable America pursuant to a funding agreement issued by Equitable Financial or Equitable America to the SPLLC. The current maximum aggregate principal amount permitted to be outstanding at any one time under the FABCP program is $3.0 billion for Equitable Financial and $1.0 billion for Equitable America. As of June 30, 2025, Equitable Financial and Equitable America had $1.6 billion and $0 million outstanding under the program, respectively.
Guarantees and Other Commitments
The Company provides certain guarantees or commitments to affiliates and others. As of June 30, 2025, these arrangements include commitments by the Company to provide equity financing of $1.1 billion to certain limited partnerships and real estate joint ventures under certain conditions as well as a guarantee of a subsidiary’s performance under a reinsurance arrangement that will no longer be in effect once certain conditions at the subsidiary are met and notice is provided. Management believes the Company will not incur material losses as a result of these commitments.
The Company had $17 million of undrawn letters of credit related to reinsurance as of June 30, 2025. The Company had $502 million of commitments under existing mortgage loan agreements as of June 30, 2025.
The Company is the obligor under certain structured settlement agreements it had entered into with unaffiliated insurance companies and beneficiaries. To satisfy its obligations under these agreements, the Company owns single premium annuities issued by previously wholly-owned life insurance subsidiaries. The Company has directed payment under these annuities to be made directly to the beneficiaries under the structured settlement agreements. A contingent liability exists with respect to these agreements should the previously wholly-owned subsidiaries be unable to meet their obligations. Management believes the need for the Company to satisfy those obligations is remote.

v3.25.2

BUSINESS SEGMENT INFORMATION
6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

BUSINESS SEGMENT INFORMATION BUSINESS SEGMENT INFORMATION
We have six reportable segments: Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management and Legacy.
These segments reflect the manner by which the Company’s chief operating decision maker (“CODM”) views and manages the business. A brief description of these segments follows:
•The Individual Retirement (“IR”) segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income.
•The Group Retirement (“GR”) segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities, and not-for-profit entities, as well as small and medium-sized businesses.
•The Asset Management (“AM”) segment provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail and Private Wealth.
•The Protection Solutions (“PS”) segment includes our life insurance and group EB businesses.
•The Wealth Management (“WM”) segment offers discretionary and non-discretionary investment advisory accounts, financial planning and advice, life insurance, and annuity products through Equitable Advisors.
•The Legacy (“L”) segment primarily consists of the capital intensive fixed-rate GMxB business written in the Individual Retirement market prior to 2011.
The CODM is the chief executive officer and President of Holdings. The CODM evaluates the reported measure of a segment’s profit or loss in assessing segment performance and deciding how to allocate resources. Significant segment expenses are part of the CODM review and are critically important to understand the level of profitability of operating segments but also the overall company performance. This assessment will inform the way the allocation of resources will be done among the different operating segments.
Measurement
Operating earnings (loss) is the financial measure which primarily focuses on the Company’s segments’ results of operations as well as the underlying profitability of the Company’s core business. By excluding items that can be distortive and unpredictable such as investment gains (losses) and investment income (loss) from derivative instruments, the Company believes operating earnings (loss) by segment enhances the understanding of the Company’s underlying drivers of profitability and trends in the Company’s segments.
Operating earnings is calculated by adjusting each segment’s net income (loss) attributable to Holdings for the following items:
•Items related to variable annuity product features, which include: (i) changes in the fair value of MRB and purchased MRB, including the related attributed fees and claims, offset by derivatives and other securities used to hedge the MRB which result in residual net income volatility as the change in fair value of certain securities is reflected in OCI and due to our statutory capital hedge program; and (ii) market adjustments to deposit asset or liability accounts arising from reinsurance agreements which do not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk;
•Investment (gains) losses, which includes credit loss impairments of securities/investments, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances;
•Net actuarial (gains) losses, which includes actuarial gains and losses as a result of differences between actual and expected experience on pension plan assets or projected benefit obligation during a given period related to pension, other postretirement benefit obligations, and the one-time impact of the settlement of the defined benefit obligation;
•Other adjustments, which primarily include restructuring costs related to severance and separation, lease write-offs related to non-recurring restructuring activities, net derivative gains (losses) on certain Non-GMxB derivatives, net investment income from certain items including consolidated VIE investments, seed capital mark-to-market adjustments, unrealized gain/losses and realized capital gains/losses from sales or disposals of select securities, certain legal accruals; a bespoke deal to repurchase UL policies from one entity that had invested in numerous policies purchased in the life settlement market, which disposed of the risk of additional COI litigation by that entity related to those UL policies, impact of the annual actuarial assumption updates attributable to LFPB when the majority of the impact relates to the non-core business; and
•Income tax expense (benefit) related to the above items and non-recurring tax items, which includes the effect of uncertain tax positions for a given audit period and changes to the deferred tax valuation allowance.
The General Account investment portfolio is used to support the insurance and annuity liabilities of our Individual Retirement, Group Retirement, Protection Solutions and Legacy business segments.
During the third quarter 2024, the Company moved revenues and expenses related to payout annuitizations from the Legacy segment to the Individual Retirement segment. Now all payout annuities are reported within the Individual Retirement segment as the block is managed on an aggregate basis. Prior periods have been recast to reflect this change.
Revenues derived from any customer did not exceed 10% of revenues for the three and six months ended June 30, 2025 and 2024.
The Company accounts for inter-segment sales and transfers as if the sales or transfers were to third parties, that is, at current market prices.
The table below presents operating earnings (loss) by segment and Corporate and Other (C&O):
Three Months Ended June 30, 2025
IR GR AM PS WM L C&O Eliminations
Total
(in millions)
Segment revenues $ 1,006 $ 309 $ 1,094 $ 825 $ 471 $ 100 $ 226 $ (230) $ 3,801
Benefits and other deductions
Policyholders’ benefits 76 — — 603 — — 108 — 787
Interest credited to policyholders’ account balances 408 68 — 145 — 9 175 — 805
Commissions and distribution related payments 101 44 197 41 296 29 2 (222) 488
Amortization of deferred policy acquisition costs 127 16 — 32 — 15 3 — 193
Compensation and benefits 6 9 429 27 82 5 11 — 569
Interest expense and financing fees — — 9 — — — 69 (6) 72
Significant segment expenses 718 137 635 848 378 58 368 (228) 2,914
Other segment items (1) 31 23 196 46 24 8 32 (2) 358
Income taxes (42) (25) (48) 11 (18) (6) 36 — (92)
Less: Operating (earnings) loss attributable to the noncontrolling interest — — 84 — — — 1 — 85
Operating earnings (loss) $ 215 $ 124 $ 131 $ (58) $ 51 $ 28 $ (139) $ — $ 352
_____________
(1)Other segment items include Remeasurement for liability for future policy benefits and Other operating expenses and costs. Additionally, other segment items reflected in Asset Management segment is primarily driven by other operating expense and costs related to general and administrative costs and promotion and servicing expenses.
Three Months Ended June 30, 2024
IR GR AM PS WM L C&O Eliminations Total
(in millions)
Segment revenues $ 888 $ 283 $ 1,051 $ 834 $ 442 $ 117 $ 230 $ (227) $ 3,618
Benefits and other deductions
Policyholders’ benefits 78 — — 473 — — 116 — 667
Interest credited to policyholders’ account balances 281 56 — 128 — 8 125 — 598
Commissions and distribution related payments 80 45 180 43 282 40 7 (214) 463
Amortization of deferred policy acquisition costs 111 8 — 32 — 15 3 — 169
Compensation and benefits 14 8 420 37 78 7 (1) — 563
Interest expense and financing fees — — 12 — — — 58 (7) 63
Significant segment expenses 564 117 612 713 360 70 308 (221) 2,523
Other segment items (1) 38 21 201 38 21 15 47 (6) 375
Income taxes (40) (20) (42) (12) (17) (4) 16 — (119)
Less: Operating (earnings) loss attributable to the noncontrolling interest — — 95 (1) — — 12 — 106
Operating earnings (loss) $ 246 $ 125 $ 101 $ 72 $ 44 $ 28 $ (121) $ — $ 495
_____________
(1)Other segment items include Remeasurement for liability for future policy benefits and Other operating expenses and costs. Additionally, other segment items reflected in Asset Management segment is primarily driven by other operating expense and costs related to general and administrative costs and promotion and servicing expenses.
Six Months Ended June 30, 2025
IR GR AM PS WM L C&O Eliminations
Total
(in millions)
Segment revenues $ 2,003 $ 625 $ 2,182 $ 1,651 $ 934 $ 220 $ 430 $ (460) $ 7,585
Benefits and other deductions
Policyholders’ benefits 168 — — 1,159 — — 219 — 1,546
Interest credited to policyholders’ account balances 773 131 — 266 — 16 282 — 1,468
Commissions and distribution related payments 199 87 398 83 589 65 8 (440) 989
Amortization of deferred policy acquisition costs 251 31 — 64 — 30 5 — 381
Compensation and benefits 24 21 851 65 164 12 24 — 1,161
Interest expense and financing fees — — 16 2 — — 122 (10) 130
Significant segment expenses 1,415 270 1,265 1,639 753 123 660 (450) 5,675
Other segment items (1) 76 53 381 100 51 35 63 (10) 749
Income taxes (81) (48) (89) 14 (33) (10) 53 — (194)
Less: Operating (earnings) loss attributable to the noncontrolling interest — — 190 1 — — 3 — 194
Operating earnings (loss) $ 431 $ 254 $ 257 $ (75) $ 97 $ 52 $ (243) $ — $ 773
_____________
(1)Other segment items include Remeasurement for liability for future policy benefits and Other operating expenses and costs. Additionally, other segment items reflected in Asset Management segment is primarily driven by other operating expense and costs related to general and administrative costs and promotion and servicing expenses.
Six Months Ended June 30, 2024
IR GR AM PS WM L C&O Eliminations Total
(in millions)
Segment revenues $ 1,728 $ 574 $ 2,144 $ 1,658 $ 865 $ 246 $ 485 $ (443) $ 7,257
Benefits and other deductions
Policyholders’ benefits 155 — — 960 — — 229 — 1,344
Interest credited to policyholders’ account balances 529 108 — 256 — 17 267 — 1,177
Commissions and distribution related payments 157 89 353 83 542 80 10 (414) 900
Amortization of deferred policy acquisition costs 220 23 — 62 — 31 5 — 341
Compensation and benefits 31 18 867 73 156 16 1 — 1,162
Interest expense and financing fees — — 29 — — — 114 (17) 126
Significant segment expenses 1,092 238 1,249 1,434 698 144 626 (431) 5,050
Other segment items (1) 72 46 409 90 48 31 108 (12) 792
Income taxes (80) (41) (86) (19) (32) (10) 39 — (229)
Less: Operating (earnings) loss attributable to the noncontrolling interest — — 193 (1) — — 22 — 214
Operating earnings (loss) $ 484 $ 249 $ 207 $ 116 $ 87 $ 61 $ (232) $ — $ 972
_____________
(1)Other segment items include Remeasurement for liability for future policy benefits and Other operating expenses and costs. Additionally, other segment items reflected in Asset Management segment is primarily driven by other operating expense and costs related to general and administrative costs and promotion and servicing expenses.
The table below presents a reconciliation to net income (loss) attributable to Holdings:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Net income (loss) attributable to Holdings $ (349) $ 428 $ (286) $ 520
Adjustments related to:
Variable annuity product (1)
934 81 1,145 411
Investment (gains) losses 71 16 85 55
Net actuarial (gains) losses related to pension and other postretirement benefit obligations 11 14 22 31
Other adjustments (2)
(137) (33) 68 58
Income tax expense (benefit) related to above adjustments (185) (16) (277) (116)
Non-recurring tax items
7 5 16 13
Operating earnings (loss) $ 352 $ 495 $ 773 $ 972
_____________
(1)As a result of the novation of certain Legacy VA policies completed during the first quarter of 2025, the Company recorded a loss of $499 million in pre-tax net income and an increase of $263 million in pre-tax AOCI, for a total impact loss of $236 million for the six months ended June 30, 2025.
(2)Includes a gain of $198 million and $33 million on Non-VA derivatives for the three and six months ended June 30, 2025, respectively. Also includes $14 million of expense related to a disputed billing practice of an AB third-party service provider for the
three and six months ended June 30, 2025, respectively, and certain gross legal expenses related to the COI litigation of $106 million for the six months ended June 30, 2024.
Segment revenues is a measure of the Company’s revenue by segment as adjusted to exclude certain items. The following table reconciles segment revenues to total revenues by excluding the following items:
•Items related to variable annuity product features, which include certain changes in the fair value of the derivatives and other securities we use to hedge these features and changes in the fair value of the embedded derivatives reflected within the net derivative results of variable annuity product features;
•Investment (gains) losses, which includes credit loss impairments of securities/investments, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances;
•Other adjustments, which primarily includes net derivative gains (losses) on certain Non-GMxB derivatives and Net investment income from certain items including consolidated VIE investments, seed capital mark-to-market adjustments and unrealized gain/losses associated with equity securities.
The table below presents revenues by segment and C&O:

Three Months Ended June 30, Six Months Ended June 30,

2025 2024 2025 2024
(in millions)
Segment revenues:
Individual Retirement (1) $ 1,006 $ 888 $ 2,003 $ 1,728
Group Retirement (1) 309 283 625 574
Asset Management (2) 1,094 1,051 2,182 2,144
Protection Solutions (1) 825 834 1,651 1,658
Wealth Management (3) 471 442 934 865
Legacy (1) 100 117 220 246
Corporate and Other (1) 226 230 430 485
Eliminations (230) (227) (460) (443)
Adjustments related to:
Variable annuity product features, excluding change in MRBs (4)
(1,549) (210) (574) (1,629)
Investment gains (losses), net (71) (16) (85) (55)
Other adjustments to segment revenues (4)
181 115 12 164
Total revenues $ 2,362 $ 3,507 $ 6,938 $ 5,737
______________
(1)Includes investment expenses charged by AB of $42 million and $76 million for the three and six months ended June 30, 2025, respectively, and $37 million and $73 million for the three and six months ended June 30, 2024, respectively, for services provided to the Company.
(2)Inter-segment investment management and other fees of $44 million and $86 million for the three and six months ended June 30, 2025, respectively, and $42 million and $84 million for the three and six months ended June 30, 2024, respectively, are included in segment revenues of the Asset Management segment.
(3)Inter-segment distribution fees of $222 million and $440 million for the three and six months ended June 30, 2025, respectively, and $214 million and $414 million for the three and six months ended June 30, 2024, respectively, are included in segment revenues of the Wealth Management segment.
(4)Prior periods were revised to conform with current presentation.
Total assets by segment were as follows:

June 30, 2025 December 31, 2024
(in millions)
Total assets by segment:
Individual Retirement $ 118,774 $ 110,358
Group Retirement 53,804 51,269
Asset Management 10,705 10,514
Protection Solutions 43,693 41,583
Wealth Management 222 168
Legacy 36,368 42,373
Corporate and Other 39,522 39,462
Total assets $ 303,088 $ 295,727

v3.25.2

INSURANCE STATUTORY FINANCIAL INFORMATION
6 Months Ended

Jun. 30, 2025

Insurance [Abstract]

INSURANCE STATUTORY FINANCIAL INFORMATION INSURANCE STATUTORY FINANCIAL INFORMATION
Prescribed and Permitted Accounting Practices
As of June 30, 2025, the following five prescribed and permitted practices resulted in net income (loss) and capital and surplus that is different from the statutory surplus that would have been reported had NAIC statutory accounting practices been applied.
Equitable Financial was granted a permitted practice by the NYDFS to apply SSAP 108, Derivatives Hedging Variable Annuity Guarantees on a retroactive basis from January 1, 2021 through June 30, 2021, after reflecting the impacts of our reinsurance transaction with Venerable. The permitted practice was amended to also permit Equitable Financial to adopt SSAP 108 prospectively as of July 1, 2021 and to consider the impact of both the interest rate derivatives and the General Account assets used to fully hedge the interest rate risk inherent in its variable annuity guarantees when determining the amount of the deferred asset or liability under SSAP 108. Application of the permitted practice partially mitigates the New York Insurance Regulation 213 (“Reg 213”) impact of the Venerable transaction on Equitable Financial’s statutory capital and surplus and enables Equitable Financial to more effectively neutralize the impact of interest rates on its statutory surplus and to better align with our economic hedging program. The impact of applying this permitted practice relative to SSAP 108 as written was a decrease of approximately $155 million in statutory special surplus funds as of June 30, 2025. The Reinsurance Treaty reduced the amount of interest rate hedging needed at Equitable Financial going forward, affecting future deferrals, but leaves our historical SSAP 108 deferred amounts unchanged. The permitted practice also reset Equitable Financial’s unassigned surplus to zero as of June 30, 2021 to reflect the transformative nature of the Venerable transaction.
The Manual has been adopted as a component of prescribed or permitted practices by the State of New York. However, Reg 213 adopted in May of 2019 and as amended in February 2020 and March 2021, differs from the NAIC variable annuity reserve and capital framework. Reg 213 requires Equitable Financial to carry statutory basis reserves for its variable annuity contract obligations equal to the greater of those required under (i) the NAIC standard or (ii) a revised version of the NYDFS requirement in effect prior to the adoption of the first amendment for contracts issued prior to January 1, 2020, and for policies issued after that date a new standard that in current market conditions imposes more conservative reserving requirements for variable annuity contracts than the NAIC standard.
The impact of the application of Reg 213 was a decrease of approximately $123 million in statutory surplus as of June 30, 2025 compared to statutory surplus under the NAIC variable annuity framework. Our hedging program is designed to hedge the economics of our insurance liabilities and largely offsets Reg 213 and NAIC framework reserve movements due to interest rates and equities. The NYDFS allows domestic insurance companies a five year phase-in provision for Reg 213 reserves. As of September 30, 2022, Equitable Financial’s Reg 213 reserves were 100% phased-in. As of June 30, 2025, given the prevailing market conditions and business mix, there are $111 million Reg 213 redundant reserves over the US RBC CTE 98 TAR.
During the fourth quarter 2020, Equitable Financial received approval from NYDFS for its proposed amended Plan of Operation for Separate Account No. 68 (“SA 68”) for our SCS product and Separate Account No. 69 (“SA 69”) for our EQUI-VEST product Structured Investment Option, to change the accounting basis of these two non-insulated Separate Accounts from fair value to book value in accordance with Section 1414 of the Insurance Law to align with how we manage and measure our overall General Account asset portfolio. In order to facilitate this change and comply
with Section 4240(a)(10), the Company also sought approval to amend the Plans to remove the requirement to comply with Section 4240(a)(5)(iii) and substitute it with a commitment to comply with Section 4240(a)(5)(i). Similarly, the Company updated the reserves section of each Plan to reflect the fact that Regulation 128 would no longer be applicable upon the change in accounting basis. We applied this change effective January 1, 2021. The impact of the application is an increase of approximately $770 million in statutory surplus as of June 30, 2025.
During 2022, Equitable America received approval from the Arizona Department of Insurance and Financial Institutions pursuant to A.R.S. 20-515 for Separate Account No. 68A (“SA 68A”) for our SCS product, Separate Account No. 69A (“SA 69A”) for our EQUI-VEST product Structured Investment Option and Separate Account No. 71A (“SA 71A”) for our Investment Edge Structured Investment Option, to permit us to use book value as the accounting basis of these three non-insulated Separate Accounts instead of fair value in accordance with the Manual to align with how we manage and measure our overall General Account asset portfolio. The impact of the application is a decrease of approximately $920 million in statutory surplus as of June 30, 2025.
The Arizona Department of Insurance and Financial Institutions granted to Equitable America a permitted practice to deviate from SSAP No. 108 by applying special accounting treatment for specific derivatives hedging variable annuity benefits subject to fluctuations as a result of interest rate sensitivities. The permitted practice expands on SSAP No. 108 hedge accounting to include equity risks for the full scope of Variable Annuity (VA) contracts (i.e., not just the rider guarantees but for the VA total contract). The permitted practice allows Equitable America to adopt SSAP 108 retroactively from October 1, 2023 and applies to both directly held VA hedges as well as VA hedges in the Equitable America funds withheld asset that resulted from the Reinsurance Treaty. In the calculation of the amount of excess VA equity and interest rate derivative hedging gains/losses to defer (including Net investment income on our Equity Total Return Swaps), the permitted practice allows us to compare our total equity and interest derivatives gains and losses to 100% of our target liability change. Any hedge gain or loss deferrals will follow SSAP No. 108 amortization rules (i.e. 10-year straight line). The impact of applying this revised permitted practice relative to SSAP 108 was an increase of approximately $1.4 billion in statutory special surplus funds as of June 30, 2025.

v3.25.2

EARNINGS PER COMMON SHARE
6 Months Ended

Jun. 30, 2025

Earnings Per Share [Abstract]

EARNINGS PER COMMON SHARE EARNINGS PER COMMON SHARE
The following table presents a reconciliation of net income (loss) and weighted-average common shares used in calculating basic and diluted earnings per common share:

Three Months Ended June 30, Six Months Ended June 30,

2025 2024 2025 2024
(in millions, except per share data)
Weighted-average common shares outstanding:
Weighted-average common shares outstanding — basic
303.2 324.2 305.5 327.2
Effect of dilutive potential common shares:
Employee share awards (1) — 3.1 — 3.2
Weighted-average common shares outstanding — diluted
303.2 327.3 305.5 330.4
Net income (loss):
Net income (loss) $ (283) $ 565 $ (133) $ 760
Less: Net income (loss) attributable to the noncontrolling interest 66 137 153 240
Net income (loss) attributable to Holdings (349) 428 (286) 520
Less: Preferred stock dividends 18 26 32 40
Net income (loss) available to Holdings’ common shareholders $ (367) $ 402 $ (318) $ 480
Earnings per common share:
Basic $ (1.21) $ 1.24 $ (1.04) $ 1.47
Diluted $ (1.21) $ 1.23 $ (1.04) $ 1.45
______________
(1)Calculated using the treasury stock method.
For the three and six months ended June 30, 2025 and 2024, 5.0 million, 5.5 million, 3.0 million and 3.1 million, respectively, of outstanding stock awards, were not included in the computation of diluted EPS because their effect was anti-dilutive.

v3.25.2

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS
6 Months Ended

Jun. 30, 2025

Accounting Changes and Error Corrections [Abstract]

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS
During the period ended March 31, 2025, the Company identified an immaterial error related to the initial bookkeeping of ceded accrued fees within policyholders’ account balance ultimately impacting the initial deposit accounting of a reinsurance transaction. The impact of this error to prior periods’ financial statements was not considered to be material. To improve the consistency and comparability of the financial statements, management voluntarily revised the financial statements to include the revisions discussed herein. As a result of the determination to revise previously issued financial statements for the deposit accounting discussed above, management also has corrected other previously identified but uncorrected errors and errors recorded in incorrect periods including, a) pension liability overstatement due to a reconciling item, b) incorrect FX impacting the FABN carrying value, c) incorrect inputs ratio in our MRB modeling and incorrect inputs in the deposit accounting calculation, d) the hedging impact of Treasury Inflation-Protected Securities (TIPS) hedging income was incorrectly recorded in Accumulated other comprehensive income, e) error in the manual accrual in an input calculation in the treasury package overstating Policyholders’ account balance and Interest credited to policyholders, f) incorrect actuarial indication impacting the Liability for MRB and purchased MRB, and g) incorrect allocation of earned premiums to loss ratio impacting reserves.
Management assessed the materiality of this change within prior period financial statements based upon SEC Staff Accounting Bulletin Number 99, Materiality, which is since codified in ASC 250, Accounting Changes and Error Corrections. The prior period comparative financial statements that are presented herein have been revised.
The following tables present line items for prior period financial statements that have been affected by the revision. For these line items, the tables detail the amounts as previously reported, the impact upon those line items due to the revision, and the amounts as currently revised within the financial statements.
June 30, 2024
As Previously
Reported Impact of Revisions As Revised
(in millions)
Consolidated Balance Sheets:
ASSETS
Amounts due from reinsurers $ 8,237 $ (150) $ 8,087
Current and deferred income taxes 2,117 12 2,129
Purchased market risk benefits 7,993 9 8,002
Other assets 3,825 3 3,828
Assets for market risk benefits 803 (4) 799
Total Assets $ 287,769 $ (130) $ 287,639
LIABILITIES
Policyholders’ account balances $ 104,072 $ (23) $ 104,049
Liability for market risk benefits 12,593 19 12,612
Future policy benefits and other policyholders’ liabilities 17,417 16 17,433
Amounts due to reinsurers 1,363 10 1,373
Other liabilities 6,718 (106) 6,612
Total Liabilities 283,296 (84) 283,212
EQUITY
Retained earnings 10,317 (16) 10,301
Accumulated other comprehensive income (loss) (8,645) (30) (8,675)
Total equity attributable to Holdings 1,644 (46) 1,598
Noncontrolling interest 1,741 — 1,741
Total Equity 3,385 (46) 3,339
Total Equity and Redeemable NCI 4,473 (46) 4,427
Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 287,769 $ (130) $ 287,639
Three Months Ended June 30, 2024
Six Months Ended June 30, 2024
As Previously
Reported Impact of Revisions As Revised As Previously
Reported Impact of Revisions As Revised
(in millions, except per share data)
Consolidated Statements of Income (Loss)
REVENUES
Premiums $ 282 $ — $ 282 $ 557 $ 10 $ 567
Net investment income (loss) 1,166 1 1,167 2,385 (8) 2,377
Investment management and service fees 1,240 — 1,240 2,518 — 2,518
Other income 429 (4) 425 688 (5) 683
Total revenues 3,510 (3) 3,507 5,740 (3) 5,737
BENEFITS AND OTHER DEDUCTIONS
Remeasurement of liability for future policy benefits (8) 1 (7) (7) 5 (2)
Change in market risk benefits and purchased market risk benefits (133) 1 (132) (1,233) 13 (1,220)
Interest credited to policyholders’ account balances 605 (6) 599 1,171 7 1,178
Other operating costs and expenses 427 1 428 980 — 980
Total benefits and other deductions 2,829 (3) 2,826 4,812 25 4,837
Income (loss) from continuing operations, before income taxes 681 — 681 928 (28) 900
Income tax (expense) benefit (116) — (116) (146) 6 (140)
Net income (loss) 565 — 565 782 (22) 760
Less: Net (income) loss attributable to the noncontrolling interest 137 — 137 240 — 240
Net income (loss) attributable to Holdings 428 — 428 542 (22) 520
Less: Preferred stock dividends 26 — 26 40 — 40
Net income (loss) available to Holdings’ common shareholders $ 402 $ — $ 402 $ 502 $ (22) $ 480
EARNINGS PER COMMON SHARE
Basic $ 1.24 $ — $ 1.24 $ 1.53 $ (0.06) $ 1.47
Diluted $ 1.23 $ — $ 1.23 $ 1.52 $ (0.07) $ 1.45
Shares Outstanding:
Basic 324.2 — 324.2 327.2 — 327.2
Diluted 327.3 — 327.3 330.4 — 330.4
Three Months Ended June 30, 2024
Six Months Ended June 30, 2024
As Previously
Reported Impact of Revisions As Revised As Previously
Reported Impact of Revisions As Revised
(in millions)
Consolidated Statements of Comprehensive Income (Loss)
Net income (loss) $ 565 $ — $ 565 $ 782 $ (22) $ 760
Other comprehensive income (loss) net of income taxes:
Change in unrealized gains (losses), net of reclassification adjustment (408) (1) (409) (921) (1) (922)
Change in market risk benefits - instrument-specific credit risk (153) (6) (159) (128) (11) (139)
Change in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment 10 1 11 18 1 19
Foreign currency translation adjustment 8 1 9 (3) 1 (2)
Total other comprehensive income (loss), net of income taxes (476) (5) (481) (869) (10) (879)
Comprehensive income (loss) 89 (5) 84 (87) (32) (119)
Less: Comprehensive income (loss) attributable to the noncontrolling interest 140 — 140 239 — 239
Comprehensive income (loss) attributable to Holdings $ (51) $ (5) $ (56) $ (326) $ (32) $ (358)
Three Months Ended June 30, 2024
Six Months Ended June 30, 2024
As Previously
Reported Impact of Revisions As Revised As Previously
Reported Impact of Revisions As Revised
(in millions)
Consolidated Statements of Equity:
Equity, beginning of period
$ 3,755 $ (40) $ 3,715 $ 4,388 $ (13) $ 4,375
Total Holdings’ equity, beginning of period 2,032 (40) 1,992 2,649 (13) 2,636
Retained earnings, beginning of year 10,110 (15) 10,095 10,243 7 10,250
Net income (loss) attributable to Holdings 428 — 428 542 (22) 520
Other
1 (1) — 1 (1) —
Retained earnings, end of period 10,317 (16) 10,301 10,317 (16) 10,301
Accumulated other comprehensive income (loss), beginning of year (8,166) (25) (8,191) (7,777) (20) (7,797)
Other comprehensive income (loss) (479) (5) (484) (868) (10) (878)
Accumulated other comprehensive income (loss), end of period (8,645) (30) (8,675) (8,645) (30) (8,675)
Total Holdings’ equity, end of period 1,644 (46) 1,598 1,644 (46) 1,598
Total equity, end of period $ 3,385 $ (46) $ 3,339 $ 3,385 $ (46) $ 3,339
Six Months Ended June 30, 2024
As Previously
Reported Impact of Revisions As Revised
(in millions)
Consolidated Statements of Cash Flows:
Cash flows from operating activities:
Net income (loss) $ 782 $ (22) $ 760
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances 1,171 7 1,178
Amortization and depreciation 429 5 434
Remeasurement of liability for future policy benefits (7) 5 (2)
Change in market risk benefits (1,233) 13 (1,220)
Reinsurance recoverable (626) (2) (628)
Current and deferred income taxes 155 (6) 149
Net cash provided by (used in) operating activities $ 923 $ — $ 923

v3.25.2

SUBSEQUENT EVENTS
6 Months Ended

Jun. 30, 2025

Subsequent Events [Abstract]

SUBSEQUENT EVENTS SUBSEQUENT EVENTS
ASR
In June 2025, Holdings established an obligation to enter into an ASR with a third-party financial institution to repurchase an aggregate of $96 million of Holdings’ common stock. Pursuant to the ASR, on July 2, 2025, Holdings made a pre-payment of $96 million and received initial delivery of 1.4 million shares. The ASR terminated in July 2025, at which time an additional 441,333 shares of common stock were received.
AB Unit Exchange
On July 10, 2025, AB and Holdings entered into an Amended and Restated Master Exchange Agreement to increase the AB Units that remain available for exchange from 4.8 million AB Units to 19.7 million AB Units, and Holdings exchanged 19.7 million AB Holding Units for an equal number of limited partnership interests in ABLP. After giving effect to the exchange Holdings continues to own approximately 68.6% of the economic interest in AB.
RGA Reinsurance Agreement
On July 31, 2025, Equitable Financial, as well as Equitable America and Equitable Financial L&A, completed the master transaction agreement with RGA entered into on February 23, 2025 pursuant to which and subject to the terms and conditions set forth in such agreement, RGA entered into reinsurance agreements, as reinsurer, with each such subsidiary, as ceding company, to effect the RGA Reinsurance Transaction.
At the closing of the transaction, (i) each of Equitable Financial and Equitable America entered into a separate coinsurance and modified coinsurance agreement with RGA and (ii) Equitable Financial L&A entered into a coinsurance agreement with RGA, each with an effective date of April 1, 2025, pursuant to which each ceding company ceded to RGA a 75% quota share of such ceding company’s in-force individual life insurance block. At the closing of the transaction, assets supporting the general account liabilities relating to the reinsured contracts were deposited into a trust account for the benefit of Equitable Financial and a trust account for the benefit of Equitable America and Equitable Financial L&A, which assets will secure RGA’s obligations to each ceding company under the applicable reinsurance agreement. Equitable Financial and Equitable America reinsured the applicable separate accounts relating to the applicable reinsured contracts on a modified coinsurance basis. In addition, the investment of assets in each trust account will be subject to investment guidelines and certain capital adequacy related triggers will require enhanced funding. The reinsurance agreements also contain additional counterparty risk management and mitigation provisions. Each ceding company will continue to administer the applicable reinsured contracts.
As part of the transaction, on June 16, 2025, ABLP entered into an investment advisory agreement with RGA, pursuant to which AB will manage certain assets to be specified representing approximately 70% of assets supporting the reserves associated with the ceded policies under the reinsurance agreements.
Credit Facility Revolver
On July 29, 2025, the Company terminated the Amended and Restated Revolving Credit Agreement entered into by the Company on June 24, 2021, as amended and restated from time to time, which provided for a $1.5 billion senior unsecured revolving credit facility, and entered into a new Revolving Credit Agreement which provides for a $1.0 billion five-year senior unsecured revolving credit facility (the “Credit Facility”) with a syndicate of banks.

v3.25.2

Insider Trading Arrangements
3 Months Ended 6 Months Ended

Jun. 30, 2025

shares

Jun. 30, 2025

shares

Trading Arrangements, by Individual

Material Terms of Trading Arrangement
The following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted by our executive officers during the three months ended June 30, 2025, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), referred to as Rule 10b5-1 trading plans. The plans listed below are only executed when the stock price reaches a required minimum. In addition, the executives identified in the table below are required to maintain an ownership of Holdings’ common stock with a value equal to at least a multiple of his annual base salary (6 times for Mr. Pearson, 3 times for Mr. Hurd).
Name and Title Date of Adoption of Rule 10b5-1 Trading Plan Scheduled Start Date of Rule 10b5-1 Trading Plan
Scheduled Expiration Date of Rule 10b5-1 Trading Plan(1)
Aggregate Number of Securities to be Purchased or Sold
Mark Pearson
President and Chief Executive Officer
6/15/2025
8/15/2025
8/18/2026
Sale of up to 476,400 shares(2) of common stock in several transactions through the scheduled expiration date in 2025.
Jeffrey Hurd
Chief Operating Officer
5/1/2025
8/15/2025
1/30/2026
Sale of up to 40,740 shares(3) of common stock in several transactions through the scheduled expiration date in 2026.
(1)In each case, a Rule 10b5-1 trading plan may also expire on such earlier date as all transactions under the Rule 10b5-1 trading plan are completed.
(2)326,400 of Mr. Pearson’s shares consist of stock options and 150,000 of Mr. Pearson’s shares consist of common stock already owned.
(3)40,740 of Mr. Hurd’s shares consist of common stock already owned.
Other than as set forth in the table above, during the three months ended June 30, 2025, none of the Company’s directors or executive officers adopted, terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).

Non-Rule 10b5-1 Arrangement Adopted false

Rule 10b5-1 Arrangement Terminated false

Non-Rule 10b5-1 Arrangement Terminated false

Mark Pearson [Member]

Trading Arrangements, by Individual

Name Mark Pearson

Title President and Chief Executive Officer

Rule 10b5-1 Arrangement Adopted true

Adoption Date 6/15/2025

Expiration Date 8/18/2026

Arrangement Duration 368 days

Aggregate Available 476,400 476,400

Jeffrey Hurd [Member]

Trading Arrangements, by Individual

Name Jeffrey Hurd

Title Chief Operating Officer

Rule 10b5-1 Arrangement Adopted true

Adoption Date 5/1/2025

Expiration Date 1/30/2026

Arrangement Duration 168 days

Aggregate Available 40,740 40,740

Mark Pearson Trading Arrangement, Stock Options [Member] | Mark Pearson [Member]

Trading Arrangements, by Individual

Aggregate Available 326,400 326,400

Mark Pearson Trading Arrangement, Common Stock [Member] | Mark Pearson [Member]

Trading Arrangements, by Individual

Aggregate Available 150,000 150,000

Jeffrey Hurd Trading Arrangement, Common Stock [Member] | Mark Pearson [Member]

Trading Arrangements, by Individual

Aggregate Available 40,740 40,740

v3.25.2

SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended

Jun. 30, 2025

Accounting Policies [Abstract]

Basis of Presentation and Principles of Consolidation
Basis of Presentation and Principles of Consolidation
The unaudited interim consolidated financial statements (the “consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to the Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”).
In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024.
The accompanying unaudited consolidated financial statements present the consolidated results of operations, financial condition, and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation.
All significant intercompany transactions and balances have been eliminated in consolidation. The terms “second quarter 2025” and “second quarter 2024” refer to the three months ended June 30, 2025 and 2024, respectively. The terms “first six months of 2025” and “first six months of 2024” refer to the six months ended June 30, 2025 and 2024, respectively.

Future Adoption of New Accounting Pronouncements
Future Adoption of New Accounting Pronouncements
Description
Effective Date and Method of Adoption
Effect on the Financial Statement or Other Significant Matters
ASU 2023-09: Income Taxes (Topic 740): Improvements to Income Tax Disclosures
Description
Effective Date and Method of Adoption
Effect on the Financial Statement or Other Significant Matters
The ASU enhanced existing income tax disclosures primarily related to the rate reconciliation and income taxes paid information. With regard to the improvements to disclosures of rate reconciliation, a public business entity is required on an annual basis to (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. Similarly, a public entity is required to provide the amount of income taxes paid (net of refunds received) disaggregated by (1) federal, state, and foreign taxes and by (2) individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received).
The ASU also includes certain other amendments to improve the effectiveness of income tax disclosures, for example, an entity is required to provide (1) pretax income (or loss) from continuing operations disaggregated between domestic and foreign, and (2) income tax expense (or benefit) from continuing operations disaggregated by federal, state, and foreign.

The ASU will be effective for annual periods beginning after December 15, 2024. Entities are required to apply the ASU on a prospective basis.
The adoption of ASU 2023-09 is not expected to materially impact the Company’s financial position, results of operation, or cash flows.
ASU 2024-03: Accounting Standards Update No. 2024-03-Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40)
This ASU requires a public business entity to disclose specific information about certain costs and expenses in the notes to its financial statements for interim and annual reporting periods. The objective of the disclosure requirements is to provide disaggregated information about a public business entity’s expenses to help investors (a) better understand the entity’s performance, (b) better assess the entity’s prospects for future cash flows, and (c) compare an entity’s performance over time and with that of other entities.
The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the notes to the financial statements.

The ASU will be effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. Entities are required to apply the ASU on a prospective basis.
The Company is currently assessing the impact to the financial statements of this ASU.

Accounting and Consolidation of VIEs
Accounting and Consolidation of VIEs
For all new investment products and entities developed by the Company, the Company first determines whether the entity is a VIE, which involves determining an entity’s variability and variable interests, identifying the holders of the equity investment at risk and assessing the five characteristics of a VIE. Once an entity is determined to be a VIE, the Company then determines whether it is the primary beneficiary of the VIE based on its beneficial interests. If the Company is deemed to be the primary beneficiary of the VIE, the Company consolidates the entity.
Quarterly, management of the Company reviews its investment management agreements and its investments in, and other financial arrangements with, certain entities that hold client AUM to determine the entities the Company is required to consolidate under this guidance. These entities include certain mutual fund products, hedge funds, structured products, group trusts, collective investment trusts, and limited partnerships.
The analysis performed to identify variable interests held, determine whether entities are VIEs or VOEs, and evaluate whether the Company has a controlling financial interest in such entities requires the exercise of judgment and is updated on a continuous basis as circumstances change or new entities are developed. The primary beneficiary evaluation generally is performed qualitatively based on all facts and circumstances, including consideration of economic interests in the VIE held directly and indirectly through related parties and entities under common control, as well as quantitatively, as appropriate.
Consolidated VIEs
Consolidated CLOs
The Company is the investment manager of certain asset-backed investment vehicles, commonly referred to as CLOs, and certain other vehicles for which the Company earns fee income for investment management services. The Company may sell or syndicate investments through these vehicles, principally as part of the strategic investing activity as part of its investment management businesses. Additionally, the Company may invest in securities issued by these vehicles which are eliminated in consolidation of the CLOs.
As of June 30, 2025 and December 31, 2024, respectively, Equitable Financial holds $123 million and $128 million of equity interests in the CLOs. The Company consolidated the CLOs as of June 30, 2025 and December 31, 2024 as it is the primary beneficiary due to the combination of both its equity interest held by Equitable Financial and the majority ownership of AB, which functions as the CLO’s loan manager. The assets of the CLOs are legally isolated from the Company’s creditors and can only be used to settle obligations of the CLOs. The liabilities of the CLOs are non-recourse to the Company and the Company has no obligation to satisfy the liabilities of the CLOs. As of June 30, 2025, Equitable Financial holds $0 million of equity interests in a SPE established to purchase loans from the market in anticipation of a new CLO transaction. The Company consolidated the SPE as of June 30, 2025 as it is the primary beneficiary due to the combination of both its equity interest held by Equitable Financial and the majority ownership of AB, which functions as the SPE loan manager.
Resulting from this consolidation in the Company’s consolidated balance sheets are fixed maturities, at fair value using the fair value option with total assets of $2.4 billion and $2.1 billion and total liabilities of $2.5 billion and $2.1 billion at June 30, 2025 and December 31, 2024, respectively. The unpaid outstanding principal balance of the notes and short-term borrowing is $2.3 billion and $1.9 billion at June 30, 2025 and December 31, 2024.
Consolidated Limited Partnerships and LLCs
As of June 30, 2025 and December 31, 2024 the Company consolidated limited partnerships and LLCs for which it was identified as the primary beneficiary under the VIE model. Included in other invested assets, mortgage loans on real estate, other equity investments, trading securities, cash and other liabilities in the Company’s consolidated balance sheets at June 30, 2025 and December 31, 2024 are total net assets of $2.7 billion and $2.1 billion, respectively related to these VIEs.
Consolidated AB-Sponsored Investment Funds
Included in the Company’s consolidated balance sheets as of June 30, 2025 and December 31, 2024 are assets of $421 million and $85 million, liabilities of $35 million and $0 million, and redeemable noncontrolling interests of $242 million and $32 million, respectively, associated with the consolidation of AB-sponsored investment funds under the VIE model. Also included in the Company’s consolidated balance sheets as of June 30, 2025 and December 31, 2024 are assets of $64 million and $73 million, liabilities of $2 million and $1 million, and redeemable noncontrolling interests of $20 million and $17 million, respectively, from consolidation of AB-sponsored investment funds under the VOE model.
Non-Consolidated VIEs
As of June 30, 2025 and December 31, 2024 respectively, the Company held approximately $3.1 billion and $3.0 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including CLOs, hedge funds, private equity funds and real estate-related funds. The Company continues to reflect these equity interests in the consolidated balance sheets as other equity investments and applies the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are approximately $377.4 billion and $350.7 billion as of June 30, 2025 and December 31, 2024 respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $3.1 billion and $3.0 billion and approximately $1.1 billion and $1.2 billion of unfunded commitments as of June 30, 2025 and December 31, 2024, respectively. The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations.
Non-Consolidated AB-Sponsored Investment Products
As of June 30, 2025 and December 31, 2024, the net assets of investment products sponsored by AB that are non-consolidated VIEs are approximately $46.4 billion and $46.9 billion, respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is its investment of $19 million and $17 million as of June 30, 2025 and December 31, 2024, respectively. The Company has no further commitments to or economic interest in these VIEs.

Revision of Previously Issued Financial Statements
Revision of Previously Issued Financial Statements
During the period ended March 31, 2025, the Company identified an immaterial error related to the initial bookkeeping of ceded accrued fees within policyholders’ account balance ultimately impacting the initial deposit accounting of a reinsurance transaction. The impact of this error to prior periods’ financial statements was not considered to be material. To improve the consistency and comparability of the financial statements, management voluntarily revised the financial statements to include the revisions discussed herein. As a result of the determination to revise previously issued financial statements for the deposit accounting discussed above, management also has corrected other previously identified but uncorrected errors and errors recorded in incorrect periods including, a) pension liability overstatement due to a reconciling item, b) incorrect FX impacting the FABN carrying value, c) incorrect inputs ratio in our MRB modeling and incorrect inputs in the deposit accounting calculation, d) the hedging impact of Treasury Inflation-Protected Securities (TIPS) hedging income was incorrectly recorded in Accumulated other comprehensive income, e) error in the manual accrual in an input calculation in the treasury package overstating Policyholders’ account balance and Interest credited to policyholders, f) incorrect actuarial indication impacting the Liability for MRB and purchased MRB, and g) incorrect allocation of earned premiums to loss ratio impacting reserves.
See Note 20 of the Notes to these Financial Statements for details of the revision.

Fair Value Disclosures
U.S. GAAP establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value:
Level 1    Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2    Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data.
Level 3    Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability.
The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value can neither be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument.
Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued are also considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness.

v3.25.2

INVESTMENTS (Tables)
6 Months Ended

Jun. 30, 2025

Investments, Debt and Equity Securities [Abstract]

Schedule of Available-for-Sale Fixed Maturities by Classification
The following tables provide information relating to the Company’s fixed maturities classified as AFS:
AFS Fixed Maturities by Classification

Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value

(in millions)
June 30, 2025
Fixed Maturities:
Corporate (1) $ 53,506 $ 3 $ 579 $ 5,378 $ 48,704
U.S. Treasury, government and agency
5,983 — 3 1,467 4,519
States and political subdivisions 467 — 2 84 385
Foreign governments
690 — 2 117 575
Residential mortgage-backed (2) 5,505 — 60 111 5,454
Asset-backed (3) 15,774 — 117 49 15,842
Commercial mortgage-backed 4,840 — 20 303 4,557
Redeemable preferred stock 54 — 4 — 58
Total at June 30, 2025 $ 86,819 $ 3 $ 787 $ 7,509 $ 80,094
December 31, 2024:
Fixed Maturities:
Corporate (1)
$ 55,218 $ 2 $ 251 $ 6,116 $ 49,351
U.S. Treasury, government and agency
5,801 — — 1,513 4,288
States and political subdivisions
472 — 2 88 386
Foreign governments
689 — 1 136 554
Residential mortgage-backed (2) 4,520 — 15 152 4,383
Asset-backed (3) 13,660 — 96 57 13,699
Commercial mortgage-backed 4,301 — 5 385 3,921
Redeemable preferred stock 56 — 3 — 59
Total at December 31, 2024 $ 84,717 $ 2 $ 373 $ 8,447 $ 76,641
______________
(1)Corporate fixed maturities include both public and private issues.
(2)Includes publicly traded agency pass-through securities and collateralized obligations.
(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.

Schedule of Contractual Maturities of Available-for-Sale Fixed Maturities
The contractual maturities of AFS fixed maturities as of June 30, 2025 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or pre-pay obligations with or without call or pre-payment penalties.
Contractual Maturities of AFS Fixed Maturities
Amortized Cost (Less Allowance for Credit Losses) Fair Value
(in millions)
June 30, 2025
Contractual maturities:
Due in one year or less $ 2,620 $ 2,605
Due in years two through five 16,176 15,949
Due in years six through ten 17,589 17,200
Due after ten years 24,258 18,429
Subtotal 60,643 54,183
Residential mortgage-backed 5,505 5,454
Asset-backed 15,774 15,842
Commercial mortgage-backed 4,840 4,557
Redeemable preferred stock 54 58
Total at June 30, 2025 $ 86,816 $ 80,094

Schedule of Proceeds and Gains (Losses) on Sales for Available-for-Sale Fixed Maturities
The following table shows proceeds from sales, gross gains (losses) from sales and allowance for credit losses for AFS fixed maturities:
Proceeds from Sales, Gross Gains (Losses) from Sales and Allowance for Credit and Intent to Sell Losses for AFS Fixed Maturities

Three Months Ended June 30, Six Months Ended June 30,

2025 2024 2025 2024

(in millions)
Proceeds from sales $ 2,961 $ 1,331 $ 4,263 $ 1,775
Gross gains on sales $ 7 $ 5 $ 9 $ 5
Gross losses on sales $ (30) $ (3) $ (33) $ (27)
Net (increase) decrease in Allowance for Credit and Intent to Sell losses $ (13) $ (3) $ (19) $ (5)

Schedule of Debt Securities, Available-for-Sale, Allowance for Credit Loss
The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts:
AFS Fixed Maturities - Credit and Intent to Sell Loss Impairments
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Balance, beginning of period $ 53 $ 48 $ 47 $ 48
Previously recognized impairments on securities that matured, paid, prepaid or sold (5) (4) (5) (8)
Recognized impairments on securities impaired to fair value this period (1)
— — — —
Credit losses recognized this period on securities for which credit losses were not previously recognized 12 3 17 6
Additional credit losses this period on securities previously impaired 1 3 2 4
Balance, end of period $ 61 $ 50 $ 61 $ 50
______________
(1)Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost.

Schedule of Net Unrealized Gains (Losses) on Available-for-Sale Fixed Maturities
The tables below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI:

Net Unrealized Gains (Losses) on AFS Fixed Maturities

Three Months Ended June 30, 2025
Net Unrealized Gains (Losses) on Investments Policyholders’ Liabilities
Deferred Income Tax Asset (Liability)
AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
(in millions)
Balance, beginning of period $ (7,226) $ 66 $ 279 $ (6,881)
Net investment gains (losses) arising during the period 466 — — 466
Reclassification adjustment:
Included in net income (loss) 36 — — 36
Excluded from net income (loss) — — — —
Other — — (33) (33)
Impact of net unrealized investment gains (losses) — — (106) (106)
Net unrealized investment gains (losses) excluding credit losses (6,724) 66 140 (6,518)
Net unrealized investment gains (losses) with credit losses 2 — — 2
Balance, end of period $ (6,722) $ 66 $ 140 $ (6,516)
Three Months Ended June 30, 2024
Balance, beginning of period $ (7,660) $ 63 $ 358 $ (7,239)
Net investment gains (losses) arising during the period (555) — — (555)
Reclassification adjustment:
Included in net income (loss) — — — —
Excluded from net income (loss) — — — —
Other
— — (4) (4)
Impact of net unrealized investment gains (losses) — 4 117 121
Net unrealized investment gains (losses) excluding credit losses (8,215) 67 471 (7,677)
Net unrealized investment gains (losses) with credit losses 1 — — 1
Balance, end of period $ (8,214) $ 67 $ 471 $ (7,676)

Six Months Ended June 30, 2025
Net Unrealized Gains (Losses) on Investments Policyholders’ Liabilities
Deferred Income Tax Asset (Liability)
AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
(in millions)
Balance, beginning of period $ (8,074) $ 71 $ 464 $ (7,539)
Net investment gains (losses) arising during the period 1,310 — — 1,310
Reclassification adjustment:
Included in net income (loss) 44 — — 44
Excluded from net income (loss) — — — —
Other — — (41) (41)
Impact of net unrealized investment gains (losses) — (5) (283) (288)
Net unrealized investment gains (losses) excluding credit losses (6,720) 66 140 (6,514)
Net unrealized investment gains (losses) with credit losses (2) — — (2)
Balance, end of period $ (6,722) $ 66 $ 140 $ (6,516)
Six Months Ended June 30, 2024
Balance, beginning of period $ (6,999) $ 50 $ 226 $ (6,723)
Net investment gains (losses) arising during the period (1,238) — — (1,238)
Reclassification adjustment:
Included in net income (loss) 26 — — 26
Other
— — (7) (7)
Impact of net unrealized investment gains (losses) — 17 251 268
Net unrealized investment gains (losses) excluding credit losses (8,211) 67 470 (7,674)
Net unrealized investment gains (losses) with credit losses (3) — 1 (2)
Balance, end of period $ (8,214) $ 67 $ 471 $ (7,676)

Schedule of Continuous Gross Unrealized Losses for Available-for-Sale Fixed Maturities
The following tables disclose the fair values and gross unrealized losses of the 3,685 issues as of June 30, 2025 and the 4,307 issues as of December 31, 2024 that are not deemed to have credit losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated:
AFS Fixed Maturities in an Unrealized Loss Position for Which No Allowance Is Recorded

Less Than 12 Months 12 Months or Longer Total
Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses
(in millions)
June 30, 2025
Fixed Maturities:
Corporate $ 4,283 $ 61 $ 27,192 $ 5,299 $ 31,475 $ 5,360
U.S. Treasury, government and agency 67 1 4,210 1,466 4,277 1,467
States and political subdivisions — — 261 84 261 84
Foreign governments 19 — 459 117 478 117
Residential mortgage-backed 488 4 826 107 1,314 111
Asset-backed 1,334 9 672 40 2,006 49
Commercial mortgage-backed 286 1 2,869 302 3,155 303
Total at June 30, 2025 $ 6,477 $ 76 $ 36,489 $ 7,415 $ 42,966 $ 7,491
December 31, 2024:
Fixed Maturities:
Corporate $ 9,147 $ 205 $ 28,684 $ 5,901 $ 37,831 $ 6,106
U.S. Treasury, government and agency 117 4 4,107 1,509 4,224 1,513
States and political subdivisions 40 — 271 88 311 88
Foreign governments 59 1 460 135 519 136
Residential mortgage-backed 1,986 26 851 126 2,837 152
Asset-backed 974 7 692 50 1,666 57
Commercial mortgage-backed 409 6 2,893 379 3,302 385
Total at December 31, 2024 $ 12,732 $ 249 $ 37,958 $ 8,188 $ 50,690 $ 8,437

Schedule of Financing Receivable, Allowance for Credit Loss
The change in the allowance for credit losses for commercial, agricultural and residential mortgage loans were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Allowance for credit losses on mortgage loans:
Commercial mortgages:
Balance, beginning of period $ 254 $ 288 $ 259 $ 272
Current-period provision for expected credit losses 39 9 34 25
Write-offs charged against the allowance — (75) — (75)
Recoveries of amounts previously written off — — — —
Net change in allowance 39 (66) 34 (50)
Balance, end of period $ 293 $ 222 $ 293 $ 222
Agricultural mortgages:
Balance, beginning of period $ 13 $ 6 $ 15 $ 6
Current-period provision for expected credit losses — 3 (2) 3
Write-offs charged against the allowance (8) — (8) —
Recoveries of amounts previously written off — — — —
Net change in allowance (8) 3 (10) 3
Balance, end of period $ 5 $ 9 $ 5 $ 9
Residential mortgages:
Balance, beginning of period $ 5 $ 3 $ 4 $ 1
Current-period provision for expected credit losses 2 — 3 2
Write-offs charged against the allowance — — — —
Recoveries of amounts previously written off — — — —
Net change in allowance 2 — 3 2
Balance, end of period $ 7 $ 3 $ 7 $ 3
Total allowance for credit losses $ 305 $ 234 $ 305 $ 234

Schedule of Financing Receivable Credit Quality Indicators
The Company’s commercial and agricultural mortgage loans segregated by risk rating exposure were as follows:
Loan to Value (“LTV”) Ratios (1) (3)
June 30, 2025
Amortized Cost Basis by Origination Year
2025 2024 2023 2022 2021 Prior Revolving Loans Amortized Cost Basis Revolving Loans Converted to Term Loans Amortized Cost Basis Total
(in millions)
Commercial and agricultural mortgage loans:
Commercial:
0% - 50% $ 60 $ 185 $ 268 $ 203 $ 206 $ 1,736 $ — $ — $ 2,658
50% - 70% 1,003 1,431 881 1,551 612 2,363 436 277 8,554
70% - 90% 292 73 316 764 698 1,756 122 205 4,226
90% plus — — — 547 558 1,217 — — 2,322
Total commercial $ 1,355 $ 1,689 $ 1,465 $ 3,065 $ 2,074 $ 7,072 $ 558 $ 482 $ 17,760
Agricultural:
0% - 50% $ 77 $ 47 $ 100 $ 149 $ 198 $ 1,105 $ — $ — $ 1,676
50% - 70% 56 158 52 133 128 364 — — 891
70% - 90% — — — — — — — — —
90% plus — — — — — 25 — — 25
Total agricultural $ 133 $ 205 $ 152 $ 282 $ 326 $ 1,494 $ — $ — $ 2,592
Total commercial and agricultural mortgage loans:
0% - 50% $ 137 $ 232 $ 368 $ 352 $ 404 $ 2,841 $ — $ — $ 4,334
50% - 70% 1,059 1,589 933 1,684 740 2,727 436 277 9,445
70% - 90% 292 73 316 764 698 1,756 122 205 4,226
90% plus — — — 547 558 1,242 — — 2,347
Total commercial and agricultural mortgage loans
$ 1,488 $ 1,894 $ 1,617 $ 3,347 $ 2,400 $ 8,566 $ 558 $ 482 $ 20,352
Debt Service Coverage (“DSC”) Ratios (2) (3)
June 30, 2025
Amortized Cost Basis by Origination Year
2025 2024 2023 2022 2021 Prior Revolving Loans Amortized Cost Basis Revolving Loans Converted to Term Loans Amortized Cost Basis Total
(in millions)
Commercial and agricultural mortgage loans:
Commercial:
Greater than 2.0x $ 67 $ 208 $ 175 $ 1,016 $ 1,081 $ 3,255 $ — $ — $ 5,802
1.8x to 2.0x 60 103 58 50 208 1,090 113 184 1,866
1.5x to 1.8x 85 472 233 753 48 1,209 59 165 3,024
1.2x to 1.5x 817 716 514 664 531 743 — 95 4,080
1.0x to 1.2x 326 190 475 260 74 669 386 38 2,418
Less than 1.0x — — 10 322 132 106 — — 570
Total commercial $ 1,355 $ 1,689 $ 1,465 $ 3,065 $ 2,074 $ 7,072 $ 558 $ 482 $ 17,760
Agricultural:
Greater than 2.0x $ 17 $ 9 $ 5 $ 40 $ 34 $ 193 $ — $ — $ 298
1.8x to 2.0x 17 12 17 23 53 100 — — 222
1.5x to 1.8x 11 48 10 44 27 283 — — 423
1.2x to 1.5x 38 46 44 88 135 505 — — 856
1.0x to 1.2x 30 71 45 63 67 372 — — 648
Less than 1.0x 20 19 31 24 10 41 — — 145
Total agricultural $ 133 $ 205 $ 152 $ 282 $ 326 $ 1,494 $ — $ — $ 2,592
Total commercial and agricultural mortgage loans:
Greater than 2.0x $ 84 $ 217 $ 180 $ 1,056 $ 1,115 $ 3,448 $ — $ — $ 6,100
1.8x to 2.0x 77 115 75 73 261 1,190 113 184 2,088
1.5x to 1.8x 96 520 243 797 75 1,492 59 165 3,447
1.2x to 1.5x 855 762 558 752 666 1,248 — 95 4,936
1.0x to 1.2x 356 261 520 323 141 1,041 386 38 3,066
Less than 1.0x 20 19 41 346 142 147 — — 715
Total commercial and agricultural mortgage loans
$ 1,488 $ 1,894 $ 1,617 $ 3,347 $ 2,400 $ 8,566 $ 558 $ 482 $ 20,352
______________
(1)The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan.
(2)The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service.
(3)Residential mortgage loans are excluded from the above tables.
LTV Ratios (1) (3)
December 31, 2024
Amortized Cost Basis by Origination Year
2024 2023 2022 2021 2020 Prior Revolving Loans Amortized Cost Basis Revolving Loans Converted to Term Loans Amortized Cost Basis Total
(in millions)
Commercial and agricultural mortgage loans:
Commercial:
0% - 50% $ 185 $ 363 $ 137 $ 212 $ 269 $ 1,548 $ — $ — $ 2,714
50% - 70% 1,501 910 1,622 628 318 2,083 441 201 7,704
70% - 90% — 246 707 918 396 1,187 101 206 3,761
90% plus — — 616 322 309 1,290 — — 2,537
Total commercial $ 1,686 $ 1,519 $ 3,082 $ 2,080 $ 1,292 $ 6,108 $ 542 $ 407 $ 16,716
Agricultural:
0% - 50% $ 49 $ 98 $ 160 $ 202 $ 269 $ 882 $ — $ — $ 1,660
50% - 70% 160 59 126 130 144 273 — — 892
70% - 90% — — — — — 16 — — 16
90% plus — — — — — — — — —
Total agricultural $ 209 $ 157 $ 286 $ 332 $ 413 $ 1,171 $ — $ — $ 2,568
Total commercial and agricultural mortgage loans:
0% - 50% $ 234 $ 461 $ 297 $ 414 $ 538 $ 2,430 $ — $ — $ 4,374
50% - 70% 1,661 969 1,748 758 462 2,356 441 201 8,596
70% - 90% — 246 707 918 396 1,203 101 206 3,777
90% plus — — 616 322 309 1,290 — — 2,537
Total commercial and agricultural mortgage loans
$ 1,895 $ 1,676 $ 3,368 $ 2,412 $ 1,705 $ 7,279 $ 542 $ 407 $ 19,284

DSC Ratios (2) (3)
December 31, 2024
Amortized Cost Basis by Origination Year
2024 2023 2022 2021 2020 Prior Revolving Loans Amortized Cost Basis Revolving Loans Converted to Term Loans Amortized Cost Basis Total
(in millions)
Commercial and agricultural mortgage loans:
Commercial:
Greater than 2.0x $ 208 $ 176 $ 609 $ 1,255 $ 916 $ 3,318 $ — $ — $ 6,482
1.8x to 2.0x 103 75 50 149 376 607 176 182 1,718
1.5x to 1.8x 472 211 727 — — 1,060 44 189 2,703
1.2x to 1.5x 756 566 542 433 — 661 — — 2,958
December 31, 2024
Amortized Cost Basis by Origination Year
2024 2023 2022 2021 2020 Prior Revolving Loans Amortized Cost Basis Revolving Loans Converted to Term Loans Amortized Cost Basis Total
(in millions)
1.0x to 1.2x 147 482 643 193 — 359 322 36 2,182
Less than 1.0x — 9 511 50 — 103 — — 673
Total commercial $ 1,686 $ 1,519 $ 3,082 $ 2,080 $ 1,292 $ 6,108 $ 542 $ 407 $ 16,716
Agricultural:
Greater than 2.0x $ 12 $ 5 $ 41 $ 34 $ 57 $ 157 $ — $ — $ 306
1.8x to 2.0x 11 17 24 54 28 79 — — 213
1.5x to 1.8x 49 11 44 27 120 175 — — 426
1.2x to 1.5x 47 46 89 138 113 422 — — 855
1.0x to 1.2x 71 47 63 68 87 307 — — 643
Less than 1.0x 19 31 25 11 8 31 — — 125
Total agricultural $ 209 $ 157 $ 286 $ 332 $ 413 $ 1,171 $ — $ — $ 2,568
Total commercial and agricultural mortgage loans:
Greater than 2.0x $ 220 $ 181 $ 650 $ 1,289 $ 973 $ 3,475 $ — $ — $ 6,788
1.8x to 2.0x 114 92 74 203 404 686 176 182 1,931
1.5x to 1.8x 521 222 771 27 120 1,235 44 189 3,129
1.2x to 1.5x 803 612 631 571 113 1,083 — — 3,813
1.0x to 1.2x 218 529 706 261 87 666 322 36 2,825
Less than 1.0x 19 40 536 61 8 134 — — 798
Total commercial and agricultural mortgage loans
$ 1,895 $ 1,676 $ 3,368 $ 2,412 $ 1,705 $ 7,279 $ 542 $ 407 $ 19,284
______________
(1)The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan.
(2)The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service.
(3)Residential mortgage loans are excluded from the above tables.
The amortized cost of residential mortgage loans by credit quality indicator and origination year was as follows:
June 30, 2025
Amortized Cost Basis by Origination Year
2025 2024 2023 2022 2021 Prior Total
(in millions)
Performance indicators:
Performing
$ 85 $ 700 $ 393 $ 178 $ 128 $ 4 $ 1,488
Nonperforming
— — 1 — — — 1
Total
$ 85 $ 700 $ 394 $ 178 $ 128 $ 4 $ 1,489
December 31, 2024
Amortized Cost Basis by Origination Year
2024 2023 2022 2021 2019 Prior Total
(in millions)
Performance indicators:
Performing
$ 313 $ 428 $ 186 $ 133 $ 4 $ 2 $ 1,066
Nonperforming
— — — — — — —
Total
$ 313 $ 428 $ 186 $ 133 $ 4 $ 2 $ 1,066

Schedule of Age Analysis of Past Due Mortgage Loans
The aging analysis of past-due mortgage loans were as follows:
Age Analysis of Past Due Mortgage Loans (1)
Accruing Loans Non-accruing Loans Total Loans Non-accruing Loans with No Allowance Interest Income on Non-accruing Loans
Past Due Current Total
30-59 Days 60-89 Days 90 Days or More Total
(in millions)
June 30, 2025:
Mortgage loans:
Commercial $ — $ — $ — $ — $ 17,642 $ 17,642 $ 118 $ 17,760 $ — $ 1
Agricultural 33 9 46 88 2,477 2,565 27 2,592 25 —
Residential
— — 5 5 1,483 1,488 1 1,489 1 —
Total $ 33 $ 9 $ 51 $ 93 $ 21,602 $ 21,695 $ 146 $ 21,841 $ 26 $ 1
December 31, 2024:
Mortgage loans:
Commercial $ — $ — $ — $ — $ 16,659 $ 16,659 $ 57 $ 16,716 $ — $ 1
Agricultural 12 1 33 46 2,486 2,532 36 2,568 — —
Residential
— 1 — 1 1,065 1,066 — 1,066 — —
Total $ 12 $ 2 $ 33 $ 47 $ 20,210 $ 20,257 $ 93 $ 20,350 $ — $ 1
______________
(1)Amounts presented at amortized cost basis.

Schedule of Unrealized and Realized Gains (Losses) from Equity Securities and Net Investment Income (Loss) from Trading Securities and Net Investment Income (Loss) from Fixed Maturities, at Fair Value using the Fair Value Option
The breakdown of unrealized and realized gains and (losses) on equity securities was as follows:
Unrealized and Realized Gains (Losses) from Equity Securities
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period $ (2) $ (6) $ (2) $ 9
Net investment gains (losses) recognized on securities sold during the period 2 3 2 2
Unrealized and realized gains (losses) on equity securities $ — $ (3) $ — $ 11
The breakdown of net investment income (loss) from trading securities was as follows:
Net Investment Income (Loss) from Trading Securities
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period $ 50 $ 6 $ 33 $ 42
Net investment gains (losses) recognized on securities sold during the period (10) — 6 1
Unrealized and realized gains (losses) on trading securities 40 6 39 43
Interest and dividend income from trading securities 25 21 34 32
Net investment income (loss) from trading securities $ 65 $ 27 $ 73 $ 75
The breakdown of net investment income (loss) from fixed maturities, at fair value using the fair value option were as follows:
Net Investment Income (Loss) from Fixed Maturities, at Fair Value using the Fair Value Option
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period $ 5 $ (2) $ 12 $ (5)
Net investment gains (losses) recognized on securities sold during the period (1) 2 1 3
Unrealized and realized gains (losses) from fixed maturities 4 — 13 (2)
Interest and dividend income from fixed maturities (4) 23 (4) 28
Net investment income (loss) from fixed maturities $ — $ 23 $ 9 $ 26

Schedule of Net Investment Income
The following tables provides the components of Net investment income by investment type:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Fixed maturities $ 938 $ 842 $ 1,874 $ 1,655
Mortgage loans on real estate 256 239 516 473
Other equity investments 39 (8) 83 52
Policy loans 52 56 107 110
Trading securities 65 27 73 75
Other investment income 40 21 17 45
Fixed maturities, at fair value using the fair value option — 23 9 26
Gross investment income (loss) 1,390 1,200 2,679 2,436
Investment expenses (35) (33) (76) (59)
Net investment income (loss) $ 1,355 $ 1,167 $ 2,603 $ 2,377

Schedule of Investment Gains (Losses), Net
Investment gains (losses), net, including changes in the valuation allowances and credit losses were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Fixed maturities $ (11) $ (1) $ (19) $ (27)
Mortgage loans on real estate (61) (14) (68) (32)
Other 1 (1) 2 4
Investment gains (losses), net $ (71) $ (16) $ (85) $ (55)

v3.25.2

DERIVATIVES (Tables)
6 Months Ended

Jun. 30, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments by Category
The following table presents the gross notional amount and fair value of the Company’s derivatives:

Derivative Instruments by Category
June 30, 2025 December 31, 2024
Fair Value Fair Value
Notional Amount Derivative Assets Derivative Liabilities
Net Derivatives
Notional Amount Derivative Assets Derivative Liabilities
Net Derivatives
(in millions)
Derivatives: designated for hedge accounting (1)
Cash flow hedges:
Currency swaps $ 2,962 $ 90 $ 157 $ (67) $ 2,940 $ 111 $ 95 $ 16
Interest swaps 952 — 335 (335) 952 — 306 (306)
Total: designated for hedge accounting 3,914 90 492 (402) 3,892 111 401 (290)
Derivatives: not designated for hedge accounting (1)
Equity contracts:
Futures 17,100 — 3 (3) 14,530 3 — 3
Swaps 16,942 59 71 (12) 16,264 65 19 46
Options 66,287 22,575 4,925 17,650 70,685 20,647 4,319 16,328
Interest rate contracts:
Futures 9,716 — — — 9,310 — — —
Swaps 610 12 5 7 672 — 41 (41)
Options 50 5 — 5 — — — —
Credit contracts:
Credit default swaps 437 11 20 (9) 275 12 10 2
Currency contracts:
Currency swaps 771 — 31 (31) 828 26 — 26
Currency forwards 83 15 17 (2) 28 17 17 —
Other freestanding contracts:
Margin — 1,173 — 1,173 — 796 — 796
Collateral — 155 16,634 (16,479) — 137 16,908 (16,771)
Total: not designated for hedge accounting 111,996 24,005 21,706 2,299 112,592 21,703 21,314 389
Embedded derivatives:
SCS, SIO, MSO and IUL indexed features (2) — — 18,311 (18,311) — — 17,212 (17,212)
Total embedded derivatives — — 18,311 (18,311) — — 17,212 (17,212)
Total derivative instruments $ 115,910 $ 24,095 $ 40,509 $ (16,414) $ 116,484 $ 21,814 $ 38,927 $ (17,113)
______________
(1)Reported in other invested assets in the consolidated balance sheets.
(2)Reported in policyholders’ account balances in the consolidated balance sheets.
The following table presents the effects of derivative instruments on the consolidated statements of income and comprehensive income (loss):
Derivative Instruments by Category
Three Months Ended June 30, 2025 Six Months Ended June 30, 2025
Net Derivative Gains (Losses) (1)
Net Investment Income
Interest Credited To Policyholders
Account Balances
AOCI
Net Derivative Gains (Losses) (1)
Net Investment Income Interest Credited To Policyholders Account Balances AOCI
(in millions)
Derivatives: designated for hedge accounting
Cash flow hedges:
Currency swaps $ — $ 9 $ 73 $ (151) $ — $ 15 $ 106 $ (188)
Interest swaps — (8) — 13 — (11) — (8)
Total: designated for hedge accounting — 1 73 (138) — 4 106 (196)
Derivatives: not Designated for hedge accounting
Equity contracts:
Futures 472 — — — 272 — — —
Swaps (1,204) — — — (499) — — —
Options 4,235 — — — 1,590 — — —
Interest rate contracts:
Futures (98) — — — (121) — — —
Swaps (16) — — — (1) — — —
Options
(1) — — — (2) — — —
Credit contracts:
Credit default swaps (3) — — — (3) — — —
Currency contracts:
Currency swaps (57) — — — (87) — — —
Currency forwards (6) — — — (6) — — —
Other freestanding contracts:
Margin — — — — — — — —
Collateral — — — — — — — —
Total: not designated for hedge accounting 3,322 — — — 1,143 — — —
Embedded derivatives:
SCS, SIO,MSO and IUL indexed features (4,696) — — — (1,718) — — —
Total embedded derivatives (4,696) — — — (1,718) — — —
Total derivative instruments $ (1,374) $ 1 $ 73 $ (138) $ (575) $ 4 $ 106 $ (196)
______________
(1)Reported in net derivative gains (losses) in the consolidated statements of income (loss).
Three Months Ended June 30, 2024 Six Months Ended June 30, 2024
Net Derivatives Gains (Losses) (1)
Net Investment Income Interest Credited To Policyholders Account Balances AOCI
Net Derivatives Gains (Losses) (1)
Net Investment Income Interest Credited To Policyholders Account Balances AOCI
(in millions)
Derivatives: designated for hedge accounting
Cash flow hedges:
Currency swaps $ — $ 4 $ (5) $ 22 $ 1 $ 7 $ (23) $ 38
Interest swaps — (17) — 13 — (14) — 6
Total: designated for hedge accounting — (13) (5) 35 1 (7) (23) 44
Derivatives: not Designated for hedge accounting
Equity contracts:
Futures 50 — — — 291 — — —
Swaps (99) — — — (1,214) — — —
Options 1,225 — — — 4,021 — — —
Interest rate contracts:
Futures (1) — — — (11) — — —
Swaps (88) — — — (253) — — —
Credit contracts:
Credit default swaps — — — — (1) — — —
Currency contracts:
Currency swaps 1 — — — 13 — — —
Currency forwards — — — — 1 — — —
Total: not designated for hedge accounting 1,088 — — — 2,847 — — —
Embedded derivatives:
SCS, SIO,MSO and IUL indexed features (1,296) — — — (4,432) — — —
Total embedded derivatives (1,296) — — — (4,432) — — —
Total derivative instruments (1)
$ (208) $ (13) $ (5) $ 35 $ (1,584) $ (7) $ (23) $ 44
______________
(1)Reported in net derivative gains (losses) in the consolidated statements of income (loss).

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
The following table presents a roll-forward of cash flow hedges recognized in AOCI:
Roll-forward of Cash flow hedges in AOCI
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Balance, beginning of period $ 22 $ (21) $ 80 $ (31)
Amount recorded in AOCI
Currency swaps (91) 19 (81) 19
Interest swaps — (9) (29) (17)
Total amount recorded in AOCI (91) 10 (110) 2
Amount reclassified from (to) income to AOCI
Currency swaps (1) (60) 3 (107) 20
Interest swaps (1) 13 21 21 22
Total amount reclassified from (to) income to AOCI
(47) 24 (86) 42
Balance, end of period (2) $ (116) $ 13 $ (116) $ 13
______________
(1) Currency swaps income is reported in Net investment income in the consolidated statements of income (loss). Interest swaps income is reported in net derivative gains (losses) in the consolidated statements of income (loss).
(2) The Company does not estimate the amount of the deferred losses in AOCI at June 30, 2025, and 2024 which will be released and reclassified into net income (loss) over the next 12 months as the amounts cannot be reasonably estimated.

Schedule of Offsetting Financial Assets and Liabilities and Derivative Instruments
The following tables present information about the Company’s offsetting of financial assets and liabilities and derivative instruments:
Offsetting of Financial Assets and Liabilities and Derivative Instruments
As of June 30, 2025

Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (3) Net Amount
(in millions)
Assets:
Derivative assets (1) $ 24,095 $ 17,684 $ 6,411 $ (4,509) $ 1,902
Secured lending
104 — 104 — 104
Other financial assets 1,786 — 1,786 — 1,786
Other invested assets $ 25,985 $ 17,684 $ 8,301 $ (4,509) $ 3,792
Liabilities:
Derivative liabilities (2) $ 17,689 $ 17,684 $ 5 $ — $ 5
Secured lending
104 — 104 — 104
Other financial liabilities 5,738 — 5,738 — 5,738
Other liabilities $ 23,531 $ 17,684 $ 5,847 $ — $ 5,847
______________
(1)Excludes Asset Management segment’s derivative assets of consolidated VIEs/VOEs.
(2)Excludes Asset Management segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)Financial instruments/collateral sent (held).
As of December 31, 2024

Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (3) Net Amount
(in millions)
Assets:
Derivative assets (1) $ 21,814 $ 14,924 $ 6,890 $ (6,080) $ 810
Secured Lending
137 — 137 — 137
Other financial assets 1,510 — 1,510 — 1,510
Other invested assets $ 23,461 $ 14,924 $ 8,537 $ (6,080) $ 2,457
Liabilities:
Derivative liabilities (2) $ 15,634 $ 14,924 $ 710 $ — $ 710
Secured Lending
137 — 137 — 137
Other financial liabilities 6,185 — 6,185 — 6,185
Other liabilities $ 21,956 $ 14,924 $ 7,032 $ — $ 7,032
______________
(1)Excludes Asset Management segment’s derivative assets of consolidated VIEs/VOEs.
(2)Excludes Asset Management segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)Financial instruments sent (held).

v3.25.2

CLOSED BLOCK (Tables)
6 Months Ended

Jun. 30, 2025

Closed Block Disclosure [Abstract]

Schedule of Closed Block Assets and Liabilities
Summarized financial information for the Company’s Closed Block is as follows:
June 30, 2025 December 31, 2024
(in millions)
Closed Block Liabilities:
Future policy benefits, policyholders’ account balances and other $ 5,100 $ 5,213
Other liabilities 47 62
Total Closed Block liabilities 5,147 5,275
Assets Designated to the Closed Block:
Fixed maturities AFS, at fair value (amortized cost of $2,674 and $2,888) (allowance for credit losses of $0 and$0)
2,591 2,746
Mortgage loans on real estate (net of allowance for credit losses of $22 and $21)
1,498 1,531
Policy loans 510 523
Cash and other invested assets 161 17
Other assets 107 130
Total assets designated to the Closed Block 4,867 4,947
Excess of Closed Block liabilities over assets designated to the Closed Block 280 328
Amounts included in AOCI:
Net unrealized investment gains (losses), net of income tax: $17 and $30
(66) (112)
Maximum future earnings to be recognized from Closed Block assets and liabilities $ 214 $ 216

Schedule of Closed Block Operations, Net Results
The Company’s Closed Block revenues and expenses were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Revenues:
Premiums and other income $ 24 $ 26 $ 51 $ 55
Net investment income (loss) 48 51 99 103
Investment gains (losses), net — — (1) (1)
Total revenues 72 77 149 157
Benefits and Other Deductions:
Policyholders’ benefits and dividends 72 64 146 141
Other operating costs and expenses 1 — 1 —
Total benefits and other deductions 73 64 147 141
Net income (loss), before income taxes (1) 13 2 16
Income tax (expense) benefit — (2) (1) (3)
Net income (loss) $ (1) $ 11 $ 1 $ 13

v3.25.2

DAC AND OTHER DEFERRED ASSETS/LIABILITIES (Tables)
6 Months Ended

Jun. 30, 2025

Contract Holder Bonus Interest Credits [Abstract]

Schedule of Reconciliation of Deferred Acquisition Cost
The following table presents a reconciliation of DAC to the consolidated balance sheets:
June 30 December 31
2025 2024
(in millions)
Protection Solutions
Term $ 301 $ 314
Universal Life
171 170
Variable Universal Life
1,122 1,083
Indexed Universal Life
186 186
Individual Retirement
GMxB Core
1,599 1,605
EQUI-VEST Individual
154 154
Investment Edge 250 225
SCS 2,107 1,938
Legacy Segment
GMxB Legacy 494 517
Group Retirement
EQUI-VEST Group
776 768
Momentum 80 83
Corporate and Other
103 107
Other
18 20
Total $ 7,361 $ 7,170

Schedule of Deferred Policy Acquisition Costs
Changes in the DAC asset were as follows:
Six Months Ended June 30, 2025
Protection Solutions Individual Retirement Legacy Group Retirement Corporate and Other Total
Term UL VUL IUL GMxB Core EI IE SCS GMxB Legacy EG Momentum CB (1)
(in millions)
Balance, beginning of period $ 314 $ 170 $ 1,083 $ 186 $ 1,605 $ 154 $ 225 $ 1,938 $ 517 $ 768 $ 83 $ 107 $ 7,150
Capitalization 5 7 72 6 70 5 36 326 9 31 5 — 572
Amortization (2)
(18) (6) (33) (6) (76) (5) (11) (157) (32) (23) (8) (4) (379)
Balance, end of period $ 301 $ 171 $ 1,122 $ 186 $ 1,599 $ 154 $ 250 $ 2,107 $ 494 $ 776 $ 80 $ 103 $ 7,343
______________
(1)“CB” defined as Closed Block.
(2)DAC amortization of $2 million related to Other not reflected in table above.

Six Months Ended June 30, 2024
Protection Solutions Individual Retirement Legacy Group Retirement Corporate and Other Total
Term UL VUL IUL GMxB Core EI IE SCS GMxB Legacy EG Momentum
CB
(in millions)
Balance, beginning of period $ 337 $ 174 $ 987 $ 188 $ 1,602 $ 155 $ 172 $ 1,571 $ 555 $ 742 $ 82 $ 116 $ 6,681
Capitalization 8 4 77 5 74 6 29 306 14 32 5 — 560
Amortization (1) (19) (6) (30) (6) (74) (6) (8) (131) (31) (21) (2) (5) (339)
Balance, end of period $ 326 $ 172 $ 1,034 $ 187 $ 1,602 $ 155 $ 193 $ 1,746 $ 538 $ 753 $ 85 $ 111 $ 6,902
______________
(1) DAC amortization of $2 million related to Other not reflected in table above.
Changes in the Individual Retirement sales inducement assets were as follows:
Six Months Ended June 30,
2025 2024
GMxB Core GMxB Legacy GMxB Core GMxB Legacy
(in millions)
Balance, beginning of period $ 117 $ 160 $ 127 $ 179
Capitalization 1 — 1 —
Amortization (6) (9) (6) (10)
Balance, end of period $ 112 $ 151 $ 122 $ 169
Changes in the Protection Solutions unearned revenue liability were as follows:
Six Months Ended June 30,
2025 2024
UL VUL IUL UL VUL IUL
(in millions)
Balance, beginning of period $ 114 $ 840 $ 250 $ 107 $ 754 $ 210
Capitalization 7 74 23 8 65 28
Amortization (4) (27) (8) (4) (24) (7)
Balance, end of period $ 117 $ 887 $ 265 $ 111 $ 795 $ 231

v3.25.2

FAIR VALUE DISCLOSURES (Tables)
6 Months Ended

Jun. 30, 2025

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
Assets and liabilities measured at fair value on a recurring basis are summarized below:
Fair Value Measurements as of June 30, 2025

Level 1
Level 2
Level 3
Total

(in millions)
Assets:
Investments
Fixed maturities, AFS:
Corporate (1)
$ — $ 46,695 $ 2,009 $ 48,704
U.S. Treasury, government and agency — 4,519 — 4,519
States and political subdivisions — 385 — 385
Foreign governments — 575 — 575
Residential mortgage-backed (2)
— 5,423 31 5,454
Asset-backed (3)
— 14,906 936 15,842
Commercial mortgage-backed — 4,538 19 4,557
Redeemable preferred stock — 58 — 58
Total fixed maturities, AFS — 77,099 2,995 80,094
Fixed maturities, at fair value using the fair value option — 2,018 410 2,428
Other equity investments (4) 307 265 12 584
Trading securities 368 800 127 1,295
Other invested assets:
Short-term investments — 5 — 5
Assets of consolidated VIEs/VOEs 37 424 1 462
Swaps — (438) — (438)
Credit default swaps
— (9) — (9)
Futures (3) — — (3)
Options — 17,655 — 17,655
Total other invested assets 34 17,637 1 17,672
Cash equivalents 6,066 — — 6,066
Segregated securities — 483 — 483
Purchased market risk benefits — — 5,543 5,543
Assets for market risk benefits — — 776 776
Separate Accounts assets (5)
128,654 2,528 — 131,182
Total Assets $ 135,429 $ 100,830 $ 9,864 $ 246,123
Liabilities:
Notes issued by consolidated VIE’s, at fair value using the fair value option (6)
$ — $ 2,294 $ 158 $ 2,452
SCS, SIO, MSO and IUL indexed features’ liability — 18,311 — 18,311
Liabilities of consolidated VIEs and VOEs 1 17 — 18
Liabilities for market risk benefits — — 10,187 10,187
Contingent payment arrangements — — 8 8
Total Liabilities $ 1 $ 20,622 $ 10,353 $ 30,976
______________
(1)Corporate fixed maturities includes both public and private issues.
(2)Includes publicly traded agency pass-through securities and collateralized obligations.
(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.
(4)Includes short position equity securities of $12 million that are reported in other liabilities.
(5)Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate. As of June 30, 2025, the fair value of such investments was $287 million.
(6)Accrued interest payable of $19 million is reported in Notes issued by consolidated VIE’s, at fair value using the fair value option in the consolidated balance sheets, which is not required to be measured at fair value on a recurring basis.
Fair Value Measurements as of December 31, 2024
Level 1
Level 2
Level 3
Total

(in millions)
Assets:
Investments
Fixed maturities, AFS:
Corporate (1)
$ — $ 46,879 $ 2,472 $ 49,351
U.S. Treasury, government and agency — 4,288 — 4,288
States and political subdivisions — 386 — 386
Foreign governments — 554 — 554
Residential mortgage-backed (2)
— 4,383 — 4,383
Asset-backed (3)
— 13,467 232 13,699
Commercial mortgage-backed (2)
— 3,913 8 3,921
Redeemable preferred stock — 59 — 59
Total fixed maturities, AFS — 73,929 2,712 76,641
Fixed maturities, at fair value using the fair value option — 1,778 275 2,053
Other equity investments (4)
319 251 53 623
Trading securities 433 576 80 1,089
Other invested assets:

Short-term investments — 36 — 36
Assets of consolidated VIEs/VOEs 16 137 2 155
Swaps — (259) — (259)
Credit default swaps
— 2 — 2
Futures 3 — — 3
Options — 16,328 — 16,328
Total other invested assets 19 16,244 2 16,265
Cash equivalents 5,356 45 — 5,401
Segregated securities 2 498 — 500
Purchased market risk benefits — — 7,376 7,376
Assets for market risk benefits — — 863 863
Separate Accounts assets (5)
131,714 2,489 — 134,203
Total Assets $ 137,843 $ 95,810 $ 11,361 $ 245,014
Liabilities:
Notes issued by consolidated VIE’s, at fair value using the fair value option (6)
$ — $ 1,933 $ 172 $ 2,105
SCS, SIO, MSO and IUL indexed features’ liability — 17,212 — 17,212
Liabilities for market risk benefits
— — 11,810 11,810
Contingent payment arrangements — — 9 9
Total Liabilities $ — $ 19,145 $ 11,991 $ 31,136
______________
(1)Corporate fixed maturities includes both public and private issues.
(2)Includes publicly traded agency pass-through securities and collateralized obligations.
(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.
(4)Includes short position equity securities of $20 million that are reported in other liabilities.
(5)Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate. As of December 31, 2024, the fair value of such investments was $320 million.
(6)Accrued interest payable of $11 million is reported in Notes issued by consolidated VIE’s, at fair value using the fair value option in the consolidated balance sheets, which is not required to be measured at fair value on a recurring basis.

Schedule of Reconciliation of Assets and Liabilities at Level 3
The tables below present reconciliations for all Level 3 assets and liabilities and changes in unrealized gains (losses). Not included below are the changes in balances related to MRBs and purchased MRBs level 3 assets and liabilities, which are included in Note 9 of the Notes to these Consolidated Financial Statements.
Three Months Ended June 30, 2025
Corporate State and Political Subdivisions Asset-backed RMBS CMBS
(in millions)
Balance, beginning of period $ 1,831 $ — $ 648 $ — $ 8
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 2 — — — —
Investment gains (losses), net — — — — —
Subtotal 2 — — — —
Other comprehensive income (loss) 17 — 3 1 1
Purchases 279 — 398 14 11
Sales (292) — (11) (5)
Settlements — — — (3) —
Other
— — — — —
Activity related to consolidated VIEs/VOEs — — — — —
Transfers into Level 3 (1) 98 — — 19 4
Transfers out of Level 3 (1) 74 — (102) — —
Balance, end of period $ 2,009 $ — $ 936 $ 31 $ 19
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ — $ — $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ 14 $ — $ — $ — $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2025, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Three Months Ended June 30, 2025
Fixed maturities, at FVO Other Equity Investments (3) Trading Securities, at Fair Value
Notes issued by consolidated VIE’s
Contingent Payment Arrangement
(in millions)
Balance, beginning of period $ 263 $ 18 $ 109 $ (168) $ (8)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) (1) 1 — — —
Investment gains (losses), net — — — — —
Subtotal (1) 1 — — —
Other comprehensive income (loss) — — — — —
Purchases 87 11 18 — —
Debt issuances — — — (2) —
Sales (27) (16) — — —
Settlements — — — 12 —
Other
— — — — —
Activity related to consolidated VIEs/VOEs — (1) — — —
Transfers into Level 3 (1) 63 — — — —
Transfers out of Level 3 (1) 25 — — — —
Balance, end of period $ 410 $ 13 $ 127 $ (158) $ (8)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ (1) $ 1 $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ — $ — $ — $ — $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2025, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
(3)Other Equity Investments include other invested assets.
Three Months Ended June 30, 2024
Corporate State and Political Subdivisions Asset-backed RMBS CMBS
(in millions)
Balance, beginning of period $ 2,338 $ — $ 71 $ — $ 7
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 2 — — — —
Investment gains (losses), net (1) — — — —
Subtotal 1 — — — —
Other comprehensive income (loss) 1 — — — —
Purchases 542 — (2) — —
Sales (365) — (12) — —
Settlements — — — — —
Other — — — — —
Activity related to consolidated VIEs/VOEs — — — — —
Transfers into Level 3 (1) — — — — —
Transfers out of Level 3 (1) 1 — — — —
Balance, end of period $ 2,518 $ — $ 57 $ — $ 7
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ — $ — $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ 1 $ — $ — $ — $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2024, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Three Months Ended June 30, 2024
Fixed maturities, at FVO Other Equity Investments (3) Trading Securities, at Fair Value Separate Accounts Assets Contingent Payment Arrangement
(in millions)
Balance, beginning of period $ 244 $ 58 $ 61 $ 1 $ (254)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) (12) — — — —
Investment gains (losses), net — — (4) — —
Subtotal (12) — (4) — —
Other comprehensive income (loss) — — — — —
Purchases (33) (38) — (1) —
Sales (18) 39 — — —
Settlements — — — — 2
Other — — — — (3)
Activity related to consolidated VIEs/VOEs — — — — —
Transfers into Level 3 (1) 16 — — — —
Transfers out of Level 3 (1) 27 — — — —
Balance, end of period $ 224 $ 59 $ 57 $ — $ (255)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ (12) $ — $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ — $ — $ — $ — $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2024, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
(3)Other Equity Investments include other invested assets.
Six Months Ended June 30, 2025
Corporate State and Political Subdivisions Asset-backed RMBS CMBS
(in millions)
Balance, beginning of period $ 2,472 $ — $ 232 $ — $ 8
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 3 — — — —
Investment gains (losses), net (3) — — — —
Subtotal — — — — —
Other comprehensive income (loss) 28 — 6 1 1
Purchases 424 — 784 14 11
Debt issuances
— — — —
Sales (390) — (133) (3) (5)
Settlements — — — — —
Other — — — — —
Activity related to consolidated VIEs/VOEs — — — — —
Transfers into Level 3 (1) 98 — 149 19 4
Transfers out of Level 3 (1) (623) — (102) — —
Balance, end of period $ 2,009 $ — $ 936 $ 31 $ 19
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ — $ — $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ 22 $ — $ 3 $ 1 $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2025, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Six Months Ended June 30, 2025
Fixed maturities, at FVO
Other Equity Investments (1)
Trading Securities, at Fair Value
Notes issued by consolidated VIE’s
Contingent Payment Arrangement
(in millions)
Balance, beginning of period $ 275 $ 55 $ 80 $ (172) $ (9)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 1 1 — — —
Investment gains (losses), net (4) — — — —
Subtotal (3) 1 — — —
Other comprehensive income (loss) — — — — —
Purchases
199 14 47 — —
Debt issuances
— — — (3) —
Sales (41) (16) — — —
Settlements — — — 17 1
Other
— — — — —
Activity related to consolidated VIEs/VOEs — (1) — — —
Transfers into Level 3 (2)
95 2 — — —
Transfers out of Level 3 (2)
(115) (42) — — —
Balance, end of period $ 410 $ 13 $ 127 $ (158) $ (8)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (3)
$ (1) $ 1 $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (3)
$ — $ — $ — $ — $ —
______________
(1)Other Equity Investments include other invested assets.
(2)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(3)For instruments held as of June 30, 2025, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Six Months Ended June 30, 2024
Corporate State and Political Subdivisions Asset-backed CMBS
(in millions)
Balance, beginning of period $ 2,158 $ 27 $ 47 $ 7
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 4 — — —
Investment gains (losses), net (2) — — —
Subtotal 2 — — —
Other comprehensive income (loss) 11 — — —
Purchases 757 — 46 —
Sales (421) — (22) —
Settlements — — — —
Other — — — —
Activity related to consolidated VIEs/VOEs — — — —
Transfers into Level 3 (1) 57 — — —
Transfers out of Level 3 (1) (46) (27) (14) —
Balance, end of period $ 2,518 $ — $ 57 $ 7
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2) $ — $ — $ — $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2) $ 11 $ — $ — $ —
______________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of June 30, 2024, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
Six Months Ended June 30, 2024
Fixed maturities, at FVO
Other
Equity Investments (1)
Trading Securities, at Fair Value Contingent Payment Arrangement
(in millions)
Balance, beginning of period $ 181 $ 57 $ 61 $ (253)
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss) 4 1 — —
Investment gains (losses), net — — (4) —
Subtotal 4 1 (4) —
Other comprehensive income (loss) — — — —
Purchases 47 4 — —
Sales (33) (3) — —
Settlements — — — 3
Other — — — (5)
Activity related to consolidated VIEs/VOEs — — — —
Transfers into Level 3 (2)
79 — — —
Six Months Ended June 30, 2024
Fixed maturities, at FVO
Other
Equity Investments (1)
Trading Securities, at Fair Value Contingent Payment Arrangement
(in millions)
Transfers out of Level 3 (2)
(54) — — —
Balance, end of period $ 224 $ 59 $ 57 $ (255)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (3)
$ — $ 1 $ (4) $ —
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (3)
$ 31 $ — $ — $ —
_____________
(1)Other Equity Investments include other invested assets.
(2)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(3)For instruments held as of June 30, 2024, amounts are included in Net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.

Schedule of Quantitative Information About Level 3 Fair Value Measurement
The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities:
Quantitative Information about Level 3 Fair Value Measurements as of June 30, 2025

Fair
Value
Valuation
Technique
Significant
Unobservable Input
Range
Weighted Average (2)
(Dollars in millions)
Assets:
Investments:
Fixed maturities, AFS:
Corporate $ 1,119 Market comparable
companies
EBITDA multiples
Discount rate
Cash flow multiples
Loan to value
4.6x - 36.3x
7.9% - 19.7%
2.0x - 14.5x
(0.3)% - 54.7%
13.9x
3.2%
6.0x
9.1%
Trading securities, at fair value (5)
75 Discounted cash flow
Earnings multiple
Discount factor
Discount years
8.6x
10.0%
7
23 Market comparable
companies
EBITDA Multiples
Cashflow Multiples
8.5x - 26.3x
4.3x - 14.5x
16.2x
7.9x
Purchased MRB asset (1) (2) (4) 5,543 Discounted cash flow
Lapse rates
Withdrawal rates
GMIB Utilization rates
Non-performance risk
Volatility rates - Equity
Mortality: Ages 0-40
Ages 41-60
Ages 61-115

0.24%-13.05%
0.06%-11.65%
0.04%-66.70%
7 bps - 92 bps
13%-31%
0.01%-0.17%
0.06%-0.52%
0.32%-41.20%
2.18%
0.50%
6.71%
10 bps
23%
3.35%
(same for all ages)
(same for all ages)
Liabilities:
AB Contingent consideration payable $ 8 Discounted cash flow
Expected revenue growth rates
Discount rate
2.0% - 13.3%
1.9% - 1.9%
6.8%
1.9%
Direct MRB (1) (2) (3) (4) 9,411 Discounted cash flow
Non-performance risk
Lapse rates
Withdrawal rates
Annuitization rates
Mortality: Ages 0-40
Ages 41-60
Ages 61-115
105 bps
0.24%-36.18%
0.00%-11.65%
0.04%-100.00%
0.01%-0.17%
0.06%-0.52%
0.32%-41.20%
105 bps
3.72%
0.57%
5.09%
2.92%
(same for all ages)
(same for all ages)
______________
(1)Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
(2)Lapses and pro-rata withdrawal rates were developed as a function of the policy account value. Dollar for dollar withdrawal rates were developed as a function of the dollar for dollar threshold, the dollar for dollar limit. Utilization rates were developed as a function of the benefit base.
(3)MRB liabilities are shown net of MRB assets. Net amount is made up of $10.2 billion of MRB liabilities and $776 million of MRB assets.
(4)Includes Legacy and Core products.
(5)Certain newly acquired Level 3 Trading securities are not presented as cost basis approximates fair value as of June 30, 2025.
Quantitative Information about Level 3 Fair Value Measurements as of December 31, 2024
Fair
Value
Valuation
Technique
Significant
Unobservable Input
Range
Weighted Average (2)
(Dollars in millions)
Assets:
Investments:
Fixed maturities, AFS:
Corporate $ 402 Matrix pricing model
Spread over benchmark
70 bps - 220 bps
153 bps
981 Market comparable companies
EBITDA multiples
Discount rate
Cash flow multiples
Loan to value
4.7x - 36.5x
8.4% - 34.9%
1.8x-11.8x
0.0%-56.4%
12.2x
3.9%
4.5x
15.0%
Trading securities, at fair value (5) 75 Discounted cash flow
Earnings multiple
Discounts factor
Discount years
8.6x
10.0%
7
1 Market comparable companies
Cashflow Multiples

8.4x - 8.4x
8.4x
Purchased MRB asset (1) (2) (4) 7,376 Discounted cash flow
Lapse rates
Withdrawal rates
GMIB Utilization rates
Non-performance risk
Volatility rates - Equity
Mortality: Ages 0-40
Ages 41-60
Ages 61-115
0.24% - 13.05%
0.06% - 11.65%
0.04% - 66.70%
33 bps - 93 bps
12% - 29%
0.01% - 0.17%
0.06% - 0.52%
0.32% - 41.20%
2.17%
0.48%
6.75%
34 bps
23%
3.36%
(same for all ages)
(same for all ages)
Liabilities:
AB Contingent consideration payable $ 9 Discounted cash flow
Expected revenue growth rates
Discount rate
2.0% - 29.3%
1.9% - 10.4%
5.5%
7.3%
Direct MRB (1) (2) (3) (4) 10,947 Discounted cash flow
Non-performance risk
Lapse rates
Withdrawal rates
Annuitization rates
Mortality: Ages 0-40
Ages 41-60
Ages 61-115
94 bps
0.24% - 36.18%
0.00% - 11.65%
0.04% - 100.00%
0.01% - 0.17%
0.06% - 0.52%
0.32% - 41.20%
94 bps
3.57%
0.58%
5.15%
3.00%
(same for all ages)
(same for all ages)
______________
(1)Mortality rates vary by age and demographic characteristic such as gender and benefits elected with the policy. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
(2)Lapses and pro-rata withdrawal rates were developed as a function of the policy account value. Dollar for dollar withdrawal rates were developed as a function of the dollar for dollar threshold, the dollar for dollar limit. Utilization rates were developed as a function of the benefit base.
(3)MRB liabilities are shown net of MRB assets. Net amount is made up of $11.8 billion of MRB liabilities and $863 million of MRB assets.
(4)Includes Legacy and Core products.
(5)Certain newly acquired Level 3 Trading securities are not presented as cost basis approximates fair value as of December 31, 2024.

Schedule of Fair Value Disclosure Financial Instruments Not Carried At Fair Value
The carrying values and fair values for financial instruments not otherwise disclosed in Note 3 and Note 4 of the Notes to these Consolidated Financial Statements were as follows:
Carrying Values and Fair Values for Financial Instruments Not Otherwise Disclosed

Carrying
Value
Fair Value

Level 1
Level 2
Level 3
Total
(in millions)
June 30, 2025:
Mortgage loans on real estate $ 21,536 $ — $ — $ 20,468 $ 20,468
Policy loans $ 4,355 $ — $ — $ 4,648 $ 4,648
Policyholders’ liabilities: Investment contracts $ 2,698 $ — $ — $ 2,667 $ 2,667
FHLB funding agreements $ 7,083 $ — $ 7,041 $ — $ 7,041
FABN funding agreements $ 9,278 $ — $ 9,110 $ — $ 9,110
Funding agreement-backed commercial paper (FABCP) $ 1,546 $ — $ 1,581 $ — $ 1,581
Long-term debt $ 4,332 $ — $ 4,277 $ — $ 4,277
Separate Accounts liabilities $ 12,207 $ — $ — $ 12,207 $ 12,207
December 31, 2024:
Mortgage loans on real estate $ 20,072 $ — $ — $ 18,567 $ 18,567
Policy loans $ 4,330 $ — $ — $ 4,559 $ 4,559
Policyholders’ liabilities: Investment contracts $ 2,046 $ — $ — $ 1,996 $ 1,996
FHLB funding agreements $ 7,167 $ — $ 7,113 $ — $ 7,113
FABN funding agreements $ 5,725 $ — $ 5,481 $ — $ 5,481
Funding agreement-backed commercial paper (FABCP) $ 74 $ — $ 75 $ — $ 75
Long-term debt $ 3,833 $ — $ 3,722 $ — $ 3,722
Separate Accounts liabilities $ 12,055 $ — $ — $ 12,055 $ 12,055

v3.25.2

LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS (Tables)
6 Months Ended

Jun. 30, 2025

Insurance [Abstract]

Schedule of Policyholder Account Balance and Liability for Unpaid Claims and Claims Adjustment Expense
The following table reconciles the net liability for future policy benefits and liability of death benefits to the liability for future policy benefits in the consolidated balance sheets:
June 30, 2025 December 31, 2024
(in millions)
Reconciliation
Term $ 1,287 $ 1,285
Payout
4,936 5,050
Group Pension - Benefit Reserve & DPL 447 460
Health 1,336 1,362
UL 1,271 1,246
Subtotal 9,277 9,403
  Whole Life Closed Block and Open Block products 5,083 5,204
Other (1) 915 901
Future policyholder benefits total 15,275 15,508
  Other policyholder funds and dividends payable 2,282 2,105
Total $ 17,557 $ 17,613
_____________
(1)Primarily consists of future policy benefits related to Protective Life and Annuity, Assumed Life and Disability, Group Life Run off, Variable Interest Sensitive Life rider and EB.

Schedule of Policyholder Account Balance
The following table summarizes balances and changes in the liability for future policy benefits for nonparticipating traditional and limited pay contracts:
Six Months Ended June 30, 2025 Six Months Ended June 30, 2024
Protection Solutions Individual Retirement Corporate & Other Protection Solutions Individual Retirement Corporate & Other
Term Payout Group Pension Health Term Payout Group Pension Health
(in millions)
Present Value of Expected Net Premiums
Balance, beginning of period $ 1,932 $ — $ — $ (25) $ 2,133 $ — $ — $ (21)
Beginning balance at original discount rate 1,959 — — (26) 2,058 — — (22)
Effect of changes in cash flow assumptions — — — — (18) — — (3)
Effect of actual variances from expected experience (54) — — (2) (51) — — 2
Adjusted beginning of period balance 1,905 — — (28) 1,989 — — (23)
Issuances 20 — — — 26 — — —
Interest accrual 47 — — (1) 49 — — —
Net premiums collected (90) — — 3 (95) — — 1
Ending Balance at original discount rate 1,882 — — (26) 1,969 — — (22)
Effect of changes in discount rate assumptions — — — 1 (21) — — 1
Balance, end of period $ 1,882 $ — $ — $ (25) $ 1,948 $ — $ — $ (21)
Present Value of Expected Future Policy Benefits
Balance, beginning of period $ 3,216 $ 5,050 $ 460 $ 1,337 $ 3,480 $ 4,464 $ 490 $ 1,484
Beginning balance of original discount rate 3,215 5,390 514 1,555 3,330 4,680 536 1,672
Effect of changes in cash flow assumptions (1)
— (468) — — (20) — — —
Effect of actual variances from expected experience (73) (3) — (7) (66) (2) 1 7
Adjusted beginning of period balance 3,142 4,919 514 1,548 3,244 4,678 537 1,679
Issuances 22 398 — — 28 522 — —
Interest accrual 79 99 9 25 82 89 9 27
Benefits payments (120) (251) (31) (75) (116) (228) (31) (79)
Ending Balance at original discount rate 3,123 5,165 492 1,498 3,238 5,061 515 1,627
Effect of changes in discount rate assumptions 45 (229) (45) (187) 6 (359) (58) (234)
Balance, end of period $ 3,168 $ 4,936 $ 447 $ 1,311 $ 3,244 $ 4,702 $ 457 $ 1,393
Impact of flooring LFPB at zero 1 — — — 1 — — —
Net liability for future policy benefits 1,287 4,936 447 1,336 1,297 4,702 457 1,414
Less: Reinsurance recoverable 2 (1,027) — (1,044) 14 (1,144) — (1,116)
Net liability for future policy benefits, after reinsurance recoverable $ 1,289 $ 3,909 $ 447 $ 292 $ 1,311 $ 3,558 $ 457 $ 298
Weighted-average duration of liability for future policyholder benefits (years) 6.8 7.6 6.9 8.3 6.9 7.9 7.0 8.6
______________
(1)For the first quarter 2025, this is the net income impact due to novation as described in Note 1.
The following table reconciles the policyholders account balances to the policyholders’ account balance liability in the consolidated balance sheets:

June 30, 2025 December 31, 2024
(in millions)
Policyholders’ account balance reconciliation
Protection Solutions
Universal Life $ 4,973 $ 5,065
Variable Universal Life 5,061 4,982
Legacy Segment
GMxB Legacy 253 226
Individual Retirement
GMxB Core (27) (4)
SCS 71,542 65,267
EQUI-VEST Individual 1,932 2,037
Group Retirement
EQUI-VEST Group 11,130 11,158
Momentum 498 527
Other (1)
10,071 8,658
Balance (exclusive of Funding Agreements) 105,433 97,916
Funding Agreements
17,926 13,013
Balance, end of period $ 123,359 $ 110,929
_____________
(1)Primarily reflects products IR Payout, IR Other, Indexed Universal Life, Investment Edge, Group Pension, Closed Block and Corporate and Other.
.
The following table summarizes the balances and changes in policyholder’s account balances:
Six Months Ended June 30, 2025
Protection Solutions Legacy Individual Retirement Group Retirement

Universal Life Variable Universal Life GMxB Legacy GMxB Core SCS (1) EQUI-VEST Individual EQUI-VEST Group Momentum
(Dollars in millions)
Balance, beginning of period $ 5,065 $ 4,982 $ 226 $ (4) $ 65,267 $ 2,037 $ 11,158 $ 527
Premiums received 300 60 5 91 5 18 293 26
Policy charges (335) (139) 18 4 (24) — (3) —
Surrenders and withdrawals (43) (2) (32) (15) (2,534) (127) (688) (53)
Benefit payments (122) (70) (8) (1) (179) (33) (32) (1)
Net transfers from (to) separate account — 117 5 (106) 6,760 8 237 (7)
Interest credited (2) 108 113 6 4 2,247 29 165 6
Other (4)
— — 33 — — — — —
Balance, end of period $ 4,973 $ 5,061 $ 253 $ (27) $ 71,542 $ 1,932 $ 11,130 $ 498
Weighted-average crediting rate 3.83% 3.67% 2.78% 1.97% N/A 2.96% 2.75% 2.48%
Net amount at risk (3) $ 32,105 $ 117,332 $ 15,835 $ 2,953 $ — $ 100 $ 7 $ —
Cash surrender value $ 3,323 $ 3,176 $ 452 $ 202 $ 68,284 $ 1,927 $ 11,084 $ 499
______________
(1)SCS sales are recorded as a Separate Account liability until they are swept into the General Account. This sweep is recorded as Net Transfers from (to) separate account.
(2)SCS and EQUI-VEST Group includes amounts related to the change in embedded derivative.
(3)For life insurance products, the net amount at risk is death benefit less account value for the policyholder. For variable annuity products, the net amount at risk is the maximum GMxB NAR for the policyholder.
(4)Includes the PAB from the policies novated to Venerable, as described in Note 1.
Six Months Ended June 30, 2024
Protection Solutions Legacy Individual Retirement Group Retirement

Universal Life Variable Universal Life GMxB Legacy GMxB Core SCS (1) EQUI-VEST Individual EQUI-VEST Group Momentum
(Dollars in millions)
Balance, beginning of period $ 5,202 $ 4,850 $ 618 $ 36 $ 49,002 $ 2,322 $ 11,563 $ 608
Premiums received 327 61 36 119 9 15 305 37
Policy charges (359) (130) 18 — (10) — (3) —
Surrenders and withdrawals (45) (25) (43) (18) (1,897) (168) (806) (69)
Benefit payments (106) (56) (49) (1) (149) (26) (35) (1)
Net transfers from (to) separate account — 86 3 (117) 6,325 6 170 (6)
Interest credited (2) 110 95 12 4 4,698 33 175 6
Other — — — — — — — —
Balance, end of period $ 5,129 $ 4,881 $ 595 $ 23 $ 57,978 $ 2,182 $ 11,369 $ 575
Weighted-average crediting rate 3.80% 3.71% 2.74% 1.67% N/A 2.98% 2.67% 2.32%
Net amount at risk (3) $ 34,364 $ 116,133 $ 19,710 $ 2,867 $ 1 $ 104 $ 9 $ —
Cash surrender value $ 3,393 $ 3,172 $ 531 $ 252 $ 54,146 $ 2,176 $ 11,313 $ 576
______________
(1)SCS sales are recorded as a Separate Account liability until they are swept into the General Account. This sweep is recorded as Net Transfers from (to) separate account.
(2)SCS and EQUI-VEST includes amounts related to the change in embedded derivative.
(3)For life insurance products, the net amount at risk is the death benefit less account value for the policyholder. For variable annuity products, the net amount at risk is the maximum GMxB NAR for the policyholder.
The following table reconciles the Separate Account liabilities to the Separate Account liability balance in the consolidated balance sheets:
June 30, 2025 December 31, 2024
(in millions)
Separate Account Reconciliation
Protection Solutions
Variable Universal Life $ 18,968 $ 18,176
Legacy Segment
GMxB Legacy 28,275 33,199
Individual Retirement
GMxB Core 30,057 30,411
EQUI-VEST Individual 4,756 4,782
Investment Edge 5,072 4,885
Group Retirement
EQUI-VEST Group 31,714 30,546
Momentum 5,008 4,813
Other (1) 7,833 7,905
Total $ 131,683 $ 134,717
______________
(1)Primarily reflects Corporate and Other products and Group Retirement products including Association and Group Retirement Other.
The following table presents the balances of and changes in Separate Account liabilities:
Six Months Ended June 30, 2025
Protection Solutions Legacy Individual Retirement Group Retirement
VUL GMxB Legacy GMxB Core EQUI-VEST Individual Investment Edge EQUI-VEST Group Momentum
(in millions)
Balance, beginning of period $ 18,176 $ 33,199 $ 30,411 $ 4,782 $ 4,885 $ 30,546 $ 4,813
Premiums and deposits 664 118 934 49 901 1,252 330
Policy charges (292) (265) (252) (2) — (8) (12)
Surrenders and withdrawals (350) (1,499) (1,861) (237) (242) (1,271) (433)
Benefit payments (54) (364) (145) (36) (17) (32) (5)
Investment performance (1) 941 907 864 208 247 1,464 308
Net transfers from (to) General Account
(117) (5) 106 (8) (702) (237) 7
Other charges (2)
— (3,816) — — — — —
Balance, end of period $ 18,968 $ 28,275 $ 30,057 $ 4,756 $ 5,072 $ 31,714 $ 5,008
Cash surrender value $ 18,600 $ 28,071 $ 29,218 $ 4,724 $ 4,983 $ 31,412 $ 5,001
_____________
(1)Investment performance is reflected net of M&E fees.
(2)Other charges include the Separate Account value novated to Venerable, as described in Note 1.
Six Months Ended June 30, 2024
Protection Solutions Legacy Individual Retirement Group Retirement
VUL GMxB Legacy GMxB Core EQUI-VEST Individual Investment Edge EQUI-VEST Group Momentum
(in millions)
Balance, beginning of period $ 15,821 $ 33,794 $ 29,829 $ 4,582 $ 4,275 $ 26,959 $ 4,421
Premiums and deposits 616 112 1,000 40 739 1,180 379
Policy charges (287) (324) (249) (1) — (8) (11)
Surrenders and withdrawals (330) (1,629) (1,720) (248) (254) (1,113) (476)
Benefit payments (30) (385) (135) (26) (15) (32) (7)
Investment performance (1) 1,508 (3) 117 (7) (465) (170) 6
Net transfers from (to) General Account
(86) 2,401 1,634 445 308 2,409 390
Other charges
— — — — — — —
Balance, end of period $ 17,212 $ 33,966 $ 30,476 $ 4,785 $ 4,588 $ 29,225 $ 4,702
Cash surrender value $ 16,840 $ 33,702 $ 29,644 $ 4,752 $ 4,501 $ 28,935 $ 4,694
______________
(1)Investment performance is reflected net of M&E fees.

Schedule of Liability for Future Policy Benefits, Undiscounted and Discounted Expected Gross Premiums and Expected Future Benefits and Expenses
The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses related to nonparticipating traditional and limited payment contracts:
June 30, 2025 December 31, 2024
(in millions)
Term
Expected future benefit payments and expenses (undiscounted) $ 5,444 $ 5,613
Expected future gross premiums (undiscounted)
6,424 6,597
Expected future benefit payments and expenses (discounted; AOCI basis) 3,168 3,216
Expected future gross premiums (discounted; AOCI basis) 3,473 3,507
Payout
Expected future benefit payments and expenses (undiscounted) 7,338 7,686
Expected future gross premiums (undiscounted)
— —
Expected future benefit payments and expenses (discounted; AOCI basis) 4,814 4,938
Expected future gross premiums (discounted; AOCI basis) — —
Group Pension
Expected future benefit payments and expenses (undiscounted) 603 630
Expected future gross premiums (undiscounted)
— —
Expected future benefit payments and expenses (discounted; AOCI basis) 425 436
Expected future gross premiums (discounted; AOCI basis) — —
Health
Expected future benefit payments and expenses (undiscounted) 2,053 2,139
Expected future gross premiums (undiscounted)
65 70
Expected future benefit payments and expenses (discounted; AOCI basis) 1,299 1,323
Expected future gross premiums (discounted; AOCI basis) $ 52 $ 55

Schedule of Liability for Future Policy Benefits, Revenue and Interest Accretion
The table below summarizes the revenue and interest related to nonparticipating traditional and limited payment contracts:
Six Months Ended June 30,
2025 2024 2025 2024
Gross Premium Interest Accretion
(in millions)
Revenue and Interest Accretion
Term $ 161 $ 171 $ 32 $ 33
Payout
116 127 105 99
Group Pension — — 9 9
Health 5 6 26 28
Total $ 282 $ 304 $ 172 $ 169

Schedule of Liability for Future Policy Benefits, Weighted Average Interest Rates
The following table provides the weighted average interest rates for the liability for future policy benefits:
June 30, 2025 December 31, 2024
Weighted Average Interest Rate
Term
Interest accretion rate 5.6 % 5.6 %
Current discount rate 5.0 % 5.2 %
Payout
Interest accretion rate 4.5 % 4.4 %
Current discount rate 5.1 % 5.3 %
Group Pension
Interest accretion rate 3.4 % 3.4 %
Current discount rate 5.0 % 5.2 %
Health
Interest accretion rate 3.4 % 3.4 %
Current discount rate 5.2 % 5.4 %

Schedule of Balances of and Changes in Additional Liabilities Related to Insurance Guarantees
The following table provides the balance, changes in and the weighted average durations of the additional insurance liabilities:
Six Months Ended June 30,
2025 2024
Protection Solutions
UL
(in millions)
Balance, beginning of period $ 1,246 $ 1,208
Beginning balance before AOCI adjustments 1,302 1,245
Effect of changes in interest rate & cash flow assumptions and model changes — —
Effect of actual variances from expected experience 4 (1)
Adjusted beginning of period balance 1,306 1,244
Interest accrual 29 27
Net assessments collected 34 35
Benefit payments (45) (35)
Ending balance before shadow reserve adjustments 1,324 1,271
Effect of reserve adjustment recorded in AOCI (53) (51)
Balance, end of period $ 1,271 $ 1,220
Net liability for additional liability $ 1,271 $ 1,220
Less: Reinsurance recoverable — —
Net liability for additional liability, after reinsurance recoverable $ 1,271 $ 1,220
Weighted-average duration of additional liability - death benefit (years) 19.1 19.5
The following tables provide the revenue, interest and weighted average interest rates, related to the additional insurance liabilities:
Six Months Ended June 30,
2025 2024 2025 2024
Assessments Interest Accretion
(in millions)
Revenue and Interest Accretion
UL $ 316 $ 338 $ 29 $ 27
Total $ 316 $ 338 $ 29 $ 27
Six Months Ended June 30,
2025 2024
Weighted Average Interest Rate
UL 4.5 % 4.5 %
Interest accretion rate 4.5 % 4.5 %

v3.25.2

MARKET RISK BENEFITS (Tables)
6 Months Ended

Jun. 30, 2025

Market Risk Benefit [Abstract]

Schedule of Market Risk Benefit, Activity
The following table presents the balances and changes to the balances for MRBs for the GMxB benefits on deferred variable annuities:
Three Months Ended June 30,
2025 2024
Individual Retirement Legacy Individual Retirement Legacy
GMxB Core GMxB Legacy
Purchased MRB
Net Legacy GMxB Core GMxB Legacy
Purchased MRB
Net Legacy
(in millions)
Balance, beginning of period $ 717 $ 9,505 $ (5,973) $ 3,532 $ 323 $ 11,715 $ (8,343) $ 3,372
Balance BOP before changes in the instrument specific credit risk 495 9,336 (5,957) 3,379 71 11,319 (8,312) 3,007
Model changes and effect of changes in cash flow assumptions
(7) 8 5 13 — — — —
Actual market movement effect (173) (620) 264 (356) (4) 45 5 50
Interest accrual 10 96 (58) 38 15 152 (111) 41
Attributed fees accrued (1)
109 161 (39) 122 111 198 (56) 142
Benefit payments (12) (285) 128 (157) (12) (310) 162 (148)
Actual policyholder behavior different from expected behavior 7 22 (14) 8 9 — (10) (10)
Changes in future economic assumptions (42) (232) 140 (92) (72) (518) 346 (172)
Issuances (2) — — — — — — —
Balance EOP before changes in the instrument-specific credit risk 385 8,486 (5,531) 2,955 118 10,886 (7,976) 2,910
Changes in the instrument-specific credit risk (2)
268 326 (10) 316 294 546 (22) 524
Balance, end of period $ 653 $ 8,812 $ (5,541) $ 3,271 $ 412 $ 11,432 $ (7,998) $ 3,434
Weighted-average age of policyholders (years) 65.9 74.0 73.4 N/A 64.9 73.3 72.9 N/A
Net amount at risk $ 2,953 $ 15,835 $ 7,099 N/A $ 2,867 $ 19,710 $ 10,443 N/A
______________
(1)Attributed fees accrued represents the portion of the fees needed to fund future GMxB claims.
(2)Changes are recorded in OCI except for reinsurer credit which is reflected in the consolidated income statement.
Six Months Ended June 30,
2025 2024
Individual Retirement Legacy Individual Retirement Legacy
GMxB Core GMxB Legacy Purchased MRB (3) Net Legacy GMxB Core GMxB Legacy Purchased MRB (3) Net Legacy
(in millions)
Balance, beginning of period $ 496 $ 10,508 $ (7,372) $ 3,136 $ 597 $ 13,425 $ (9,448) $ 3,977
Balance BOP before changes in the instrument specific credit risk 163 9,735 (7,368) 2,367 319 13,023 (9,409) 3,614
Model changes and effect of changes in cash flow assumptions (4)
(7) (1,336) 1,860 524 — — 169 169
Actual market movement effect (102) (271) 148 (123) (163) (747) 397 (350)
Interest accrual 25 202 (122) 80 31 313 (224) 89
Attributed fees accrued (1) 203 326 (99) 227 206 398 (136) 262
Benefit payments (23) (565) 257 (308) (22) (632) 331 (301)
Actual policyholder behavior different from expected behavior 20 42 (14) 28 14 (23) (1) (24)
Changes in future economic assumptions 105 353 (193) 160 (265) (1,446) 897 (549)
Issuances 1 — — — (2) — — —
Balance EOP before changes in the instrument-specific credit risk 385 8,486 (5,531) 2,955 118 10,886 (7,976) 2,910
Changes in the instrument-specific credit risk (2) 268 326 (10) 316 294 546 (22) 524
Balance, end of period $ 653 $ 8,812 $ (5,541) $ 3,271 $ 412 $ 11,432 $ (7,998) $ 3,434
Weighted-average age of policyholders (years) 65.9 74.0 73.4 N/A 64.9 73.3 72.9 N/A
Net amount at risk
$ 2,953 $ 15,835 $ 7,099 N/A $ 2,867 $ 19,710 $ 10,443 N/A
_____________
(1)Attributed fees accrued represents the portion of the fees needed to fund future GMxB claims.
(2)Changes are recorded in OCI except for reinsurer credit which is reflected in the consolidated income statement.
(3)Purchased MRB is the impact of non-affiliated reinsurance.
(4)Includes the net income impact of the novation, as described in Note 1, in the first quarter of 2025 and the impact primarily of a non-affiliated recapture of reinsurance completed in the first quarter of 2024.
The following table reconciles MRBs by the amounts in an asset position and amounts in a liability position to the MRB amounts in the consolidated balance sheets:
June 30, 2025 December 31, 2024
Direct Asset Direct Liability Net Direct MRB Purchased MRB Total Direct Asset Direct Liability Net Direct MRB Purchased MRB Total
(in millions)
Individual Retirement
GMxB Core $ (449) $ 1,102 $ 653 $ — $ 653 $ (514) $ 1,010 $ 496 $ — $ 496
Legacy Segment
GMxB Legacy (204) 9,016 8,812 (5,541) 3,271 (230) 10,738 10,508 (7,372) 3,136
Other (1) (123) 69 (54) (2) (56) (119) 62 (57) (4) (61)
Total $ (776) $ 10,187 $ 9,411 $ (5,543) $ 3,868 $ (863) $ 11,810 $ 10,947 $ (7,376) $ 3,571
______________
(1)Other primarily includes SCS.

v3.25.2

POLICYHOLDER ACCOUNT BALANCES (Tables)
6 Months Ended

Jun. 30, 2025

Policyholder Account Balance [Abstract]

Schedule of Policyholder Account Balance
The following table summarizes balances and changes in the liability for future policy benefits for nonparticipating traditional and limited pay contracts:
Six Months Ended June 30, 2025 Six Months Ended June 30, 2024
Protection Solutions Individual Retirement Corporate & Other Protection Solutions Individual Retirement Corporate & Other
Term Payout Group Pension Health Term Payout Group Pension Health
(in millions)
Present Value of Expected Net Premiums
Balance, beginning of period $ 1,932 $ — $ — $ (25) $ 2,133 $ — $ — $ (21)
Beginning balance at original discount rate 1,959 — — (26) 2,058 — — (22)
Effect of changes in cash flow assumptions — — — — (18) — — (3)
Effect of actual variances from expected experience (54) — — (2) (51) — — 2
Adjusted beginning of period balance 1,905 — — (28) 1,989 — — (23)
Issuances 20 — — — 26 — — —
Interest accrual 47 — — (1) 49 — — —
Net premiums collected (90) — — 3 (95) — — 1
Ending Balance at original discount rate 1,882 — — (26) 1,969 — — (22)
Effect of changes in discount rate assumptions — — — 1 (21) — — 1
Balance, end of period $ 1,882 $ — $ — $ (25) $ 1,948 $ — $ — $ (21)
Present Value of Expected Future Policy Benefits
Balance, beginning of period $ 3,216 $ 5,050 $ 460 $ 1,337 $ 3,480 $ 4,464 $ 490 $ 1,484
Beginning balance of original discount rate 3,215 5,390 514 1,555 3,330 4,680 536 1,672
Effect of changes in cash flow assumptions (1)
— (468) — — (20) — — —
Effect of actual variances from expected experience (73) (3) — (7) (66) (2) 1 7
Adjusted beginning of period balance 3,142 4,919 514 1,548 3,244 4,678 537 1,679
Issuances 22 398 — — 28 522 — —
Interest accrual 79 99 9 25 82 89 9 27
Benefits payments (120) (251) (31) (75) (116) (228) (31) (79)
Ending Balance at original discount rate 3,123 5,165 492 1,498 3,238 5,061 515 1,627
Effect of changes in discount rate assumptions 45 (229) (45) (187) 6 (359) (58) (234)
Balance, end of period $ 3,168 $ 4,936 $ 447 $ 1,311 $ 3,244 $ 4,702 $ 457 $ 1,393
Impact of flooring LFPB at zero 1 — — — 1 — — —
Net liability for future policy benefits 1,287 4,936 447 1,336 1,297 4,702 457 1,414
Less: Reinsurance recoverable 2 (1,027) — (1,044) 14 (1,144) — (1,116)
Net liability for future policy benefits, after reinsurance recoverable $ 1,289 $ 3,909 $ 447 $ 292 $ 1,311 $ 3,558 $ 457 $ 298
Weighted-average duration of liability for future policyholder benefits (years) 6.8 7.6 6.9 8.3 6.9 7.9 7.0 8.6
______________
(1)For the first quarter 2025, this is the net income impact due to novation as described in Note 1.
The following table reconciles the policyholders account balances to the policyholders’ account balance liability in the consolidated balance sheets:

June 30, 2025 December 31, 2024
(in millions)
Policyholders’ account balance reconciliation
Protection Solutions
Universal Life $ 4,973 $ 5,065
Variable Universal Life 5,061 4,982
Legacy Segment
GMxB Legacy 253 226
Individual Retirement
GMxB Core (27) (4)
SCS 71,542 65,267
EQUI-VEST Individual 1,932 2,037
Group Retirement
EQUI-VEST Group 11,130 11,158
Momentum 498 527
Other (1)
10,071 8,658
Balance (exclusive of Funding Agreements) 105,433 97,916
Funding Agreements
17,926 13,013
Balance, end of period $ 123,359 $ 110,929
_____________
(1)Primarily reflects products IR Payout, IR Other, Indexed Universal Life, Investment Edge, Group Pension, Closed Block and Corporate and Other.
.
The following table summarizes the balances and changes in policyholder’s account balances:
Six Months Ended June 30, 2025
Protection Solutions Legacy Individual Retirement Group Retirement

Universal Life Variable Universal Life GMxB Legacy GMxB Core SCS (1) EQUI-VEST Individual EQUI-VEST Group Momentum
(Dollars in millions)
Balance, beginning of period $ 5,065 $ 4,982 $ 226 $ (4) $ 65,267 $ 2,037 $ 11,158 $ 527
Premiums received 300 60 5 91 5 18 293 26
Policy charges (335) (139) 18 4 (24) — (3) —
Surrenders and withdrawals (43) (2) (32) (15) (2,534) (127) (688) (53)
Benefit payments (122) (70) (8) (1) (179) (33) (32) (1)
Net transfers from (to) separate account — 117 5 (106) 6,760 8 237 (7)
Interest credited (2) 108 113 6 4 2,247 29 165 6
Other (4)
— — 33 — — — — —
Balance, end of period $ 4,973 $ 5,061 $ 253 $ (27) $ 71,542 $ 1,932 $ 11,130 $ 498
Weighted-average crediting rate 3.83% 3.67% 2.78% 1.97% N/A 2.96% 2.75% 2.48%
Net amount at risk (3) $ 32,105 $ 117,332 $ 15,835 $ 2,953 $ — $ 100 $ 7 $ —
Cash surrender value $ 3,323 $ 3,176 $ 452 $ 202 $ 68,284 $ 1,927 $ 11,084 $ 499
______________
(1)SCS sales are recorded as a Separate Account liability until they are swept into the General Account. This sweep is recorded as Net Transfers from (to) separate account.
(2)SCS and EQUI-VEST Group includes amounts related to the change in embedded derivative.
(3)For life insurance products, the net amount at risk is death benefit less account value for the policyholder. For variable annuity products, the net amount at risk is the maximum GMxB NAR for the policyholder.
(4)Includes the PAB from the policies novated to Venerable, as described in Note 1.
Six Months Ended June 30, 2024
Protection Solutions Legacy Individual Retirement Group Retirement

Universal Life Variable Universal Life GMxB Legacy GMxB Core SCS (1) EQUI-VEST Individual EQUI-VEST Group Momentum
(Dollars in millions)
Balance, beginning of period $ 5,202 $ 4,850 $ 618 $ 36 $ 49,002 $ 2,322 $ 11,563 $ 608
Premiums received 327 61 36 119 9 15 305 37
Policy charges (359) (130) 18 — (10) — (3) —
Surrenders and withdrawals (45) (25) (43) (18) (1,897) (168) (806) (69)
Benefit payments (106) (56) (49) (1) (149) (26) (35) (1)
Net transfers from (to) separate account — 86 3 (117) 6,325 6 170 (6)
Interest credited (2) 110 95 12 4 4,698 33 175 6
Other — — — — — — — —
Balance, end of period $ 5,129 $ 4,881 $ 595 $ 23 $ 57,978 $ 2,182 $ 11,369 $ 575
Weighted-average crediting rate 3.80% 3.71% 2.74% 1.67% N/A 2.98% 2.67% 2.32%
Net amount at risk (3) $ 34,364 $ 116,133 $ 19,710 $ 2,867 $ 1 $ 104 $ 9 $ —
Cash surrender value $ 3,393 $ 3,172 $ 531 $ 252 $ 54,146 $ 2,176 $ 11,313 $ 576
______________
(1)SCS sales are recorded as a Separate Account liability until they are swept into the General Account. This sweep is recorded as Net Transfers from (to) separate account.
(2)SCS and EQUI-VEST includes amounts related to the change in embedded derivative.
(3)For life insurance products, the net amount at risk is the death benefit less account value for the policyholder. For variable annuity products, the net amount at risk is the maximum GMxB NAR for the policyholder.
The following table reconciles the Separate Account liabilities to the Separate Account liability balance in the consolidated balance sheets:
June 30, 2025 December 31, 2024
(in millions)
Separate Account Reconciliation
Protection Solutions
Variable Universal Life $ 18,968 $ 18,176
Legacy Segment
GMxB Legacy 28,275 33,199
Individual Retirement
GMxB Core 30,057 30,411
EQUI-VEST Individual 4,756 4,782
Investment Edge 5,072 4,885
Group Retirement
EQUI-VEST Group 31,714 30,546
Momentum 5,008 4,813
Other (1) 7,833 7,905
Total $ 131,683 $ 134,717
______________
(1)Primarily reflects Corporate and Other products and Group Retirement products including Association and Group Retirement Other.
The following table presents the balances of and changes in Separate Account liabilities:
Six Months Ended June 30, 2025
Protection Solutions Legacy Individual Retirement Group Retirement
VUL GMxB Legacy GMxB Core EQUI-VEST Individual Investment Edge EQUI-VEST Group Momentum
(in millions)
Balance, beginning of period $ 18,176 $ 33,199 $ 30,411 $ 4,782 $ 4,885 $ 30,546 $ 4,813
Premiums and deposits 664 118 934 49 901 1,252 330
Policy charges (292) (265) (252) (2) — (8) (12)
Surrenders and withdrawals (350) (1,499) (1,861) (237) (242) (1,271) (433)
Benefit payments (54) (364) (145) (36) (17) (32) (5)
Investment performance (1) 941 907 864 208 247 1,464 308
Net transfers from (to) General Account
(117) (5) 106 (8) (702) (237) 7
Other charges (2)
— (3,816) — — — — —
Balance, end of period $ 18,968 $ 28,275 $ 30,057 $ 4,756 $ 5,072 $ 31,714 $ 5,008
Cash surrender value $ 18,600 $ 28,071 $ 29,218 $ 4,724 $ 4,983 $ 31,412 $ 5,001
_____________
(1)Investment performance is reflected net of M&E fees.
(2)Other charges include the Separate Account value novated to Venerable, as described in Note 1.
Six Months Ended June 30, 2024
Protection Solutions Legacy Individual Retirement Group Retirement
VUL GMxB Legacy GMxB Core EQUI-VEST Individual Investment Edge EQUI-VEST Group Momentum
(in millions)
Balance, beginning of period $ 15,821 $ 33,794 $ 29,829 $ 4,582 $ 4,275 $ 26,959 $ 4,421
Premiums and deposits 616 112 1,000 40 739 1,180 379
Policy charges (287) (324) (249) (1) — (8) (11)
Surrenders and withdrawals (330) (1,629) (1,720) (248) (254) (1,113) (476)
Benefit payments (30) (385) (135) (26) (15) (32) (7)
Investment performance (1) 1,508 (3) 117 (7) (465) (170) 6
Net transfers from (to) General Account
(86) 2,401 1,634 445 308 2,409 390
Other charges
— — — — — — —
Balance, end of period $ 17,212 $ 33,966 $ 30,476 $ 4,785 $ 4,588 $ 29,225 $ 4,702
Cash surrender value $ 16,840 $ 33,702 $ 29,644 $ 4,752 $ 4,501 $ 28,935 $ 4,694
______________
(1)Investment performance is reflected net of M&E fees.

Schedule of Policyholder Account Balance, Guaranteed Minimum Crediting Rate
The following table presents the account values by range of guaranteed minimum crediting rates and the related range of the difference in basis points, between rates being credited policyholders and the respective guaranteed minimums:
June 30, 2025
Product

Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum
1 Basis Point - 50 Basis Points Above
51 Basis Points - 150 Basis Points Above
Greater Than 150 Basis Points Above
Total
( in millions)
Protection Solutions
Universal Life
0.00% - 1.50%
$ — $ — $ — $ 6 $ 6
1.51% - 2.50%
— 88 277 655 1,020
Greater than 2.50%
3,262 656 — — 3,918
Total
$ 3,262 $ 744 $ 277 $ 661 $ 4,944
Variable Universal Life
0.00% - 1.50%
$ 15 $ 10 $ 112 $ 52 $ 189
1.51% - 2.50%
38 370 232 — 640
Greater than 2.50%
3,651 27 4 — 3,682
Total
$ 3,704 $ 407 $ 348 $ 52 $ 4,511
Legacy Segment
June 30, 2025
Product

Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum
1 Basis Point - 50 Basis Points Above
51 Basis Points - 150 Basis Points Above
Greater Than 150 Basis Points Above
Total
( in millions)
GMxB Legacy
0.00% - 1.50%
$ — $ 62 $ 3 $ — $ 65
1.51% - 2.50%
17 — — — 17
Greater than 2.50%
371 — — — 371
Total
$ 388 $ 62 $ 3 $ — $ 453
Individual Retirement
GMxB Core
0.00% - 1.50%
$ — $ 10 $ 148 $ — $ 158
1.51% - 2.50%
11 — — — 11
Greater than 2.50%
37 — — — 37
Total
$ 48 $ 10 $ 148 $ — $ 206
EQUI-VEST Individual
0.00% - 1.50%
$ — $ 30 $ 159 $ — $ 189
1.51% - 2.50%
12 67 — — 79
Greater than 2.50%
1,664 — — — 1,664
Total
$ 1,676 $ 97 $ 159 $ — $ 1,932
Group Retirement
EQUI-VEST
Group
0.00% - 1.50%
$ 1 $ 945 $ 2,194 $ 262 $ 3,402
1.51% - 2.50%
342 — — — 342
Greater than 2.50%
5,988 — — — 5,988
Total
$ 6,331 $ 945 $ 2,194 $ 262 $ 9,732
Momentum
0.00% - 1.50%
$ — $ — $ 251 $ 86 $ 337
1.51% - 2.50%
74 26 — — 100
Greater than 2.50%
55 — 5 — 60
Total
$ 129 $ 26 $ 256 $ 86 $ 497

December 31, 2024
Product
Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum
1 Basis Point - 50 Basis Points Above
51 Basis Points - 150 Basis Points Above
Greater Than 150 Basis Points Above
Total
( in millions)
Protection Solutions
Universal Life
0.00% - 1.50%
$ — $ — $ — $ 6 $ 6
1.51% - 2.50%
— 90 284 655 1,029
Greater than 2.50%
3,402 598 — — 4,000
Total $ 3,402 $ 688 $ 284 $ 661 $ 5,035
Variable Universal Life
0.00% - 1.50%
$ 24 $ 13 $ 94 $ 40 $ 171
1.51% - 2.50%
37 357 223 — 617
Greater than 2.50%
3,667 2 20 — 3,689
Total $ 3,728 $ 372 $ 337 $ 40 $ 4,477
Legacy Segment
December 31, 2024
Product
Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum
1 Basis Point - 50 Basis Points Above
51 Basis Points - 150 Basis Points Above
Greater Than 150 Basis Points Above
Total
( in millions)
GMxB Legacy
0.00% - 1.50%
$ 67 $ 3 $ — $ — $ 70
1.51% - 2.50%
19 — — — 19
Greater than 2.50%
401 — — — 401
Total $ 487 $ 3 $ — $ — $ 490
Individual Retirement
GMxB Core
0.00% - 1.50%
$ 11 $ 160 $ — $ — $ 171
1.51% - 2.50%
12 — — — 12
Greater than 2.50%
52 — — — 52
Total $ 75 $ 160 $ — $ — $ 235
EQUI-VEST Individual
0.00% - 1.50%
$ 42 $ 198 $ — $ — $ 240
1.51% - 2.50%
38 — — — 38
Greater than 2.50%
1,758 — — — 1,758
Total $ 1,838 $ 198 $ — $ — $ 2,036
Group Retirement
EQUI-VEST Group
0.00% - 1.50%
$ 720 $ 2,391 $ 33 $ 258 $ 3,402
1.51% - 2.50%
349 — — — 349
Greater than 2.50%
6,076 — — — 6,076
Total $ 7,145 $ 2,391 $ 33 $ 258 $ 9,827
Momentum
0.00% - 1.50%
$ — $ — $ 269 $ 88 $ 357
1.51% - 2.50%
79 29 — — 108
Greater than 2.50%
56 — 5 — 61
Total $ 135 $ 29 $ 274 $ 88 $ 526

Schedule of Aggregate Fair Value of Separate Account Assets
The following table presents the aggregate fair value of Separate Account assets by major asset category:
June 30, 2025
Protection Solutions Individual Retirement Group Retirement     Corp & Other Legacy Segment Total
(in millions)
Asset Type
Debt securities $ 49 $ 1 $ 9 $ 17 $ — $ 76
Common Stock 68 37 512 1,731 — 2,348
Mutual Funds 19,417 41,709 38,075 637 28,299 128,137
Bonds and Notes 101 3 1 1,017 — 1,122
Total $ 19,635 $ 41,750 $ 38,597 $ 3,402 $ 28,299 $ 131,683

December 31, 2024
Protection Solutions Individual Retirement Group Retirement     Corp & Other Legacy Segment Total
(in millions)
Asset Type
Debt securities $ 51 $ 1 $ 14 $ 13 $ — $ 79
Common Stock 68 36 472 1,631 — 2,207
Mutual Funds 18,611 42,029 36,779 659 33,214 131,292
Bonds and Notes 98 4 1 1,036 — 1,139
Total $ 18,828 $ 42,070 $ 37,266 $ 3,339 $ 33,214 $ 134,717

v3.25.2

EMPLOYEE BENEFIT PLANS (Tables)
6 Months Ended

Jun. 30, 2025

Retirement Benefits [Abstract]

Schedule of Net Benefit Costs
Components of net periodic pension expense for the Company’s plans were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Service cost $ 7 $ 2 $ 15 $ 4
Interest cost 28 31 56 59
Expected return on assets (33) (37) (67) (73)
Prior period service cost amortization — (1) (1) (1)
Net amortization 11 14 23 28
Impact of settlement — — 21 —
Net Periodic Pension Expense $ 13 $ 9 $ 47 $ 17

v3.25.2

EQUITY (Tables)
6 Months Ended

Jun. 30, 2025

Equity [Abstract]

Schedule of Stock by Class
Preferred stock authorized, issued and outstanding was as follows:
June 30, 2025 December 31, 2024
Series Shares Authorized Shares
Issued Shares Outstanding Shares Authorized Shares
Issued Shares Outstanding
Series A 32,000 32,000 32,000 32,000 32,000 32,000
Series B 20,000 6,613 6,613 20,000 17,773 17,773
Series C 12,000 12,000 12,000 12,000 12,000 12,000
Total 64,000 50,613 50,613 64,000 61,773 61,773

Schedule of Dividends Declared
Dividends declared per share were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
Series A dividends declared $ 328 $ 328 $ 656 $ 656
Series B dividends declared $ 619 $ 619 $ 619 $ 619
Series C dividends declared $ 269 $ 269 $ 538 $ 538
Common Stock
Dividends declared per share of common stock were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
Dividends declared $ 0.27 $ 0.24 $ 0.51 $ 0.46

Schedule of Accumulated Other Comprehensive Income (Loss)
AOCI represents cumulative gains (losses) on items that are not reflected in net income (loss). The balances are as follows:

June 30, 2025 December 31, 2024

(in millions)
Unrealized gains (losses) on investments $ (6,501) $ (7,334)
Market risk benefits - instrument -specific credit risk component
(601) (1,125)
Liability for future policy benefits - current discount rate component
255 372
Defined benefit pension plans (553) (579)
Foreign currency translation adjustments (51) (88)
Total accumulated other comprehensive income (loss) (7,451) (8,754)
Less: Accumulated other comprehensive income (loss) attributable to noncontrolling interest (19) (42)
Accumulated other comprehensive income (loss) attributable to Holdings $ (7,432) $ (8,712)

Schedule of Components of Accumulated Other Comprehensive Income (Loss), Net of Taxes
The components of OCI, net of taxes for follows:
Three Months Ended June 30,

Six Months Ended June 30,
2025

2024

2025 2024

(in millions)
Change in net unrealized gains (losses) on investments:
Net unrealized gains (losses) arising during the period
$ 335 $ (443) $ 993 $ (986)
(Gains) losses reclassified into net income (loss) during the period (1)
28 — 34 21
Net unrealized gains (losses) on investments 363 (443) 1,027 (965)
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other (54) 34 (109) 43
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $124, $(102), $297 and $(235))
309 (409) 918 (922)
Change in LFPB discount rate and MRB credit risk, net of tax
Changes in instrument-specific credit risk - market risk benefits (net of deferred income tax expense (benefit) of $(45), $(42), $110 and $(37))
(170) (159) 414 (139)
Changes in current discount rate - liability for future policy benefits (net of deferred income tax expense (benefit) of $(8), $18, $(25) and $44)
(29) 67 (92) 165
Change in defined benefit plans:
Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost)
9 11 26 19
Change in defined benefit plans (net of deferred income tax expense (benefit) of $3, $7, $1 and $5)
9 11 26 19
Foreign currency translation adjustments:
Foreign currency translation gains (losses) arising during the period 26 9 37 (2)
Foreign currency translation adjustment 26 9 37 (2)
Total other comprehensive income (loss), net of income taxes 145 (481) 1,303 (879)
Three Months Ended June 30,

Six Months Ended June 30,
2025

2024

2025 2024

(in millions)
Less: Other comprehensive income (loss) attributable to noncontrolling interest 10 3 23 (1)
Other comprehensive income (loss) attributable to Holdings $ 135 $ (484) $ 1,280 $ (878)
______________
(1)See “reclassification adjustments” in Note 3 of the Notes to these Consolidated Financial Statements. Reclassification amounts presented net of income tax expense (benefit) of $(7) million, $0 million, $(9) million and $(6) million for the three and six months ended June 30, 2025 and 2024, respectively.

v3.25.2

SHORT-TERM AND LONG-TERM DEBT (Tables)
6 Months Ended

Jun. 30, 2025

Debt Disclosure [Abstract]

Schedule of Short-term and Long-term Debt
The following table sets forth the Company’s total consolidated borrowings. Short-term and long-term debt consists of the following:
June 30, December 31,
2025 2024
(in millions)
Short-term debt:
Total short-term debt $ — $ —
Long-term debt:
Senior Debenture due 2028 250 250
Senior Note due 2028 1,495 1,494
Senior Note due 2029 305 303
Senior Note due 2033 497 497
Senior Note due 2048 1,290 1,289
Junior Sub Debt Securities due 2055 495 —
Total long-term debt 4,332 3,833
Total short and long-term debt $ 4,332 $ 3,833

v3.25.2

REDEEMABLE NONCONTROLLING INTEREST (Tables)
6 Months Ended

Jun. 30, 2025

Noncontrolling Interest [Abstract]

Schedule of Redeemable Noncontrolling Interest
The changes in the components of redeemable noncontrolling interests were as follows:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Balance, beginning of period $ 289 $ 991 $ 125 $ 770
Net earnings (loss) attributable to redeemable noncontrolling interests (2) 16 1 34
Purchase/change of redeemable noncontrolling interests 71 81 232 284
Balance, end of period $ 358 $ 1,088 $ 358 $ 1,088

v3.25.2

COMMITMENTS AND CONTINGENT LIABILITIES (Tables)
6 Months Ended

Jun. 30, 2025

Commitments and Contingencies Disclosure [Abstract]

Schedule of Activity of Funding Agreements The table below summarizes the Company’s activity of funding agreements with the FHLB.
Change in FHLB Funding Agreements during the Six Months Ended June 30, 2025
Outstanding Balance at December 31, 2024 Issued During the Period Repaid During the Period Long-term Agreements Maturing Within One Year Long-term Agreements Maturing Within Five Years Outstanding Balance at June 30, 2025
(in millions)
Short-term funding agreements:
Due in one year or less $ 5,843 $ 34,894 $ (35,194) $ 409 $ — $ 5,952
Long-term funding agreements:
Due in years two through five 829 200 — (388) — 641
Due in more than five years 493 — — (21) — 472
Total long-term funding agreements 1,322 200 — (409) — 1,113
Total funding agreements (1) $ 7,165 $ 35,094 $ (35,194) $ — $ — $ 7,065
_____________
(1)The $18 million and $2 million difference between the funding agreements carrying value shown in fair value table for June 30, 2025 and December 31, 2024, respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates.
The table below summarizes activity of funding agreements under the FABN programs.
Change in FABN Funding Agreements during the Six Months Ended June 30, 2025
Outstanding Balance at December 31, 2024 Issued During the Period Repaid During the Period Long-term Agreements Maturing Within One Year Long-term Agreements Maturing Within Five Years Foreign Currency Transaction Adjustment Outstanding Balance at June 30,
2025
(in millions)
Short-term funding agreements:
Due in one year or less $ 1,050 $ 300 $ — $ 450 $ — $ — $ 1,800
Long-term funding agreements:
Due in years two through five 4,393 3,100 — (450) — 107 7,150
Due in more than five years 300 — — — — — 300
Total long-term funding agreements 4,693 3,100 — (450) — 107 7,450
Total funding agreements (1) $ 5,743 $ 3,400 $ — $ — $ — $ 107 $ 9,250
_____________
(1)The $28 million and $18 million difference between the funding agreements notional value shown and carrying value table as of June 30, 2025 and December 31, 2024, respectively, reflects the remaining amortization of the issuance cost of the funding agreements and the foreign currency transaction adjustment.

v3.25.2

BUSINESS SEGMENT INFORMATION (Tables)
6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment
The table below presents operating earnings (loss) by segment and Corporate and Other (C&O):
Three Months Ended June 30, 2025
IR GR AM PS WM L C&O Eliminations
Total
(in millions)
Segment revenues $ 1,006 $ 309 $ 1,094 $ 825 $ 471 $ 100 $ 226 $ (230) $ 3,801
Benefits and other deductions
Policyholders’ benefits 76 — — 603 — — 108 — 787
Interest credited to policyholders’ account balances 408 68 — 145 — 9 175 — 805
Commissions and distribution related payments 101 44 197 41 296 29 2 (222) 488
Amortization of deferred policy acquisition costs 127 16 — 32 — 15 3 — 193
Compensation and benefits 6 9 429 27 82 5 11 — 569
Interest expense and financing fees — — 9 — — — 69 (6) 72
Significant segment expenses 718 137 635 848 378 58 368 (228) 2,914
Other segment items (1) 31 23 196 46 24 8 32 (2) 358
Income taxes (42) (25) (48) 11 (18) (6) 36 — (92)
Less: Operating (earnings) loss attributable to the noncontrolling interest — — 84 — — — 1 — 85
Operating earnings (loss) $ 215 $ 124 $ 131 $ (58) $ 51 $ 28 $ (139) $ — $ 352
_____________
(1)Other segment items include Remeasurement for liability for future policy benefits and Other operating expenses and costs. Additionally, other segment items reflected in Asset Management segment is primarily driven by other operating expense and costs related to general and administrative costs and promotion and servicing expenses.
Three Months Ended June 30, 2024
IR GR AM PS WM L C&O Eliminations Total
(in millions)
Segment revenues $ 888 $ 283 $ 1,051 $ 834 $ 442 $ 117 $ 230 $ (227) $ 3,618
Benefits and other deductions
Policyholders’ benefits 78 — — 473 — — 116 — 667
Interest credited to policyholders’ account balances 281 56 — 128 — 8 125 — 598
Commissions and distribution related payments 80 45 180 43 282 40 7 (214) 463
Amortization of deferred policy acquisition costs 111 8 — 32 — 15 3 — 169
Compensation and benefits 14 8 420 37 78 7 (1) — 563
Interest expense and financing fees — — 12 — — — 58 (7) 63
Significant segment expenses 564 117 612 713 360 70 308 (221) 2,523
Other segment items (1) 38 21 201 38 21 15 47 (6) 375
Income taxes (40) (20) (42) (12) (17) (4) 16 — (119)
Less: Operating (earnings) loss attributable to the noncontrolling interest — — 95 (1) — — 12 — 106
Operating earnings (loss) $ 246 $ 125 $ 101 $ 72 $ 44 $ 28 $ (121) $ — $ 495
_____________
(1)Other segment items include Remeasurement for liability for future policy benefits and Other operating expenses and costs. Additionally, other segment items reflected in Asset Management segment is primarily driven by other operating expense and costs related to general and administrative costs and promotion and servicing expenses.
Six Months Ended June 30, 2025
IR GR AM PS WM L C&O Eliminations
Total
(in millions)
Segment revenues $ 2,003 $ 625 $ 2,182 $ 1,651 $ 934 $ 220 $ 430 $ (460) $ 7,585
Benefits and other deductions
Policyholders’ benefits 168 — — 1,159 — — 219 — 1,546
Interest credited to policyholders’ account balances 773 131 — 266 — 16 282 — 1,468
Commissions and distribution related payments 199 87 398 83 589 65 8 (440) 989
Amortization of deferred policy acquisition costs 251 31 — 64 — 30 5 — 381
Compensation and benefits 24 21 851 65 164 12 24 — 1,161
Interest expense and financing fees — — 16 2 — — 122 (10) 130
Significant segment expenses 1,415 270 1,265 1,639 753 123 660 (450) 5,675
Other segment items (1) 76 53 381 100 51 35 63 (10) 749
Income taxes (81) (48) (89) 14 (33) (10) 53 — (194)
Less: Operating (earnings) loss attributable to the noncontrolling interest — — 190 1 — — 3 — 194
Operating earnings (loss) $ 431 $ 254 $ 257 $ (75) $ 97 $ 52 $ (243) $ — $ 773
_____________
(1)Other segment items include Remeasurement for liability for future policy benefits and Other operating expenses and costs. Additionally, other segment items reflected in Asset Management segment is primarily driven by other operating expense and costs related to general and administrative costs and promotion and servicing expenses.
Six Months Ended June 30, 2024
IR GR AM PS WM L C&O Eliminations Total
(in millions)
Segment revenues $ 1,728 $ 574 $ 2,144 $ 1,658 $ 865 $ 246 $ 485 $ (443) $ 7,257
Benefits and other deductions
Policyholders’ benefits 155 — — 960 — — 229 — 1,344
Interest credited to policyholders’ account balances 529 108 — 256 — 17 267 — 1,177
Commissions and distribution related payments 157 89 353 83 542 80 10 (414) 900
Amortization of deferred policy acquisition costs 220 23 — 62 — 31 5 — 341
Compensation and benefits 31 18 867 73 156 16 1 — 1,162
Interest expense and financing fees — — 29 — — — 114 (17) 126
Significant segment expenses 1,092 238 1,249 1,434 698 144 626 (431) 5,050
Other segment items (1) 72 46 409 90 48 31 108 (12) 792
Income taxes (80) (41) (86) (19) (32) (10) 39 — (229)
Less: Operating (earnings) loss attributable to the noncontrolling interest — — 193 (1) — — 22 — 214
Operating earnings (loss) $ 484 $ 249 $ 207 $ 116 $ 87 $ 61 $ (232) $ — $ 972
_____________
(1)Other segment items include Remeasurement for liability for future policy benefits and Other operating expenses and costs. Additionally, other segment items reflected in Asset Management segment is primarily driven by other operating expense and costs related to general and administrative costs and promotion and servicing expenses.
The table below presents a reconciliation to net income (loss) attributable to Holdings:
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
(in millions)
Net income (loss) attributable to Holdings $ (349) $ 428 $ (286) $ 520
Adjustments related to:
Variable annuity product (1)
934 81 1,145 411
Investment (gains) losses 71 16 85 55
Net actuarial (gains) losses related to pension and other postretirement benefit obligations 11 14 22 31
Other adjustments (2)
(137) (33) 68 58
Income tax expense (benefit) related to above adjustments (185) (16) (277) (116)
Non-recurring tax items
7 5 16 13
Operating earnings (loss) $ 352 $ 495 $ 773 $ 972
_____________
(1)As a result of the novation of certain Legacy VA policies completed during the first quarter of 2025, the Company recorded a loss of $499 million in pre-tax net income and an increase of $263 million in pre-tax AOCI, for a total impact loss of $236 million for the six months ended June 30, 2025.
(2)Includes a gain of $198 million and $33 million on Non-VA derivatives for the three and six months ended June 30, 2025, respectively. Also includes $14 million of expense related to a disputed billing practice of an AB third-party service provider for the
three and six months ended June 30, 2025, respectively, and certain gross legal expenses related to the COI litigation of $106 million for the six months ended June 30, 2024.
The table below presents revenues by segment and C&O:

Three Months Ended June 30, Six Months Ended June 30,

2025 2024 2025 2024
(in millions)
Segment revenues:
Individual Retirement (1) $ 1,006 $ 888 $ 2,003 $ 1,728
Group Retirement (1) 309 283 625 574
Asset Management (2) 1,094 1,051 2,182 2,144
Protection Solutions (1) 825 834 1,651 1,658
Wealth Management (3) 471 442 934 865
Legacy (1) 100 117 220 246
Corporate and Other (1) 226 230 430 485
Eliminations (230) (227) (460) (443)
Adjustments related to:
Variable annuity product features, excluding change in MRBs (4)
(1,549) (210) (574) (1,629)
Investment gains (losses), net (71) (16) (85) (55)
Other adjustments to segment revenues (4)
181 115 12 164
Total revenues $ 2,362 $ 3,507 $ 6,938 $ 5,737
______________
(1)Includes investment expenses charged by AB of $42 million and $76 million for the three and six months ended June 30, 2025, respectively, and $37 million and $73 million for the three and six months ended June 30, 2024, respectively, for services provided to the Company.
(2)Inter-segment investment management and other fees of $44 million and $86 million for the three and six months ended June 30, 2025, respectively, and $42 million and $84 million for the three and six months ended June 30, 2024, respectively, are included in segment revenues of the Asset Management segment.
(3)Inter-segment distribution fees of $222 million and $440 million for the three and six months ended June 30, 2025, respectively, and $214 million and $414 million for the three and six months ended June 30, 2024, respectively, are included in segment revenues of the Wealth Management segment.
(4)Prior periods were revised to conform with current presentation.
Total assets by segment were as follows:

June 30, 2025 December 31, 2024
(in millions)
Total assets by segment:
Individual Retirement $ 118,774 $ 110,358
Group Retirement 53,804 51,269
Asset Management 10,705 10,514
Protection Solutions 43,693 41,583
Wealth Management 222 168
Legacy 36,368 42,373
Corporate and Other 39,522 39,462
Total assets $ 303,088 $ 295,727

v3.25.2

EARNINGS PER COMMON SHARE (Tables)
6 Months Ended

Jun. 30, 2025

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted
The following table presents a reconciliation of net income (loss) and weighted-average common shares used in calculating basic and diluted earnings per common share:

Three Months Ended June 30, Six Months Ended June 30,

2025 2024 2025 2024
(in millions, except per share data)
Weighted-average common shares outstanding:
Weighted-average common shares outstanding — basic
303.2 324.2 305.5 327.2
Effect of dilutive potential common shares:
Employee share awards (1) — 3.1 — 3.2
Weighted-average common shares outstanding — diluted
303.2 327.3 305.5 330.4
Net income (loss):
Net income (loss) $ (283) $ 565 $ (133) $ 760
Less: Net income (loss) attributable to the noncontrolling interest 66 137 153 240
Net income (loss) attributable to Holdings (349) 428 (286) 520
Less: Preferred stock dividends 18 26 32 40
Net income (loss) available to Holdings’ common shareholders $ (367) $ 402 $ (318) $ 480
Earnings per common share:
Basic $ (1.21) $ 1.24 $ (1.04) $ 1.47
Diluted $ (1.21) $ 1.23 $ (1.04) $ 1.45
______________
(1)Calculated using the treasury stock method.

v3.25.2

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables)
6 Months Ended

Jun. 30, 2025

Accounting Changes and Error Corrections [Abstract]

Schedule of Error Corrections and Prior Period Adjustments
The following tables present line items for prior period financial statements that have been affected by the revision. For these line items, the tables detail the amounts as previously reported, the impact upon those line items due to the revision, and the amounts as currently revised within the financial statements.
June 30, 2024
As Previously
Reported Impact of Revisions As Revised
(in millions)
Consolidated Balance Sheets:
ASSETS
Amounts due from reinsurers $ 8,237 $ (150) $ 8,087
Current and deferred income taxes 2,117 12 2,129
Purchased market risk benefits 7,993 9 8,002
Other assets 3,825 3 3,828
Assets for market risk benefits 803 (4) 799
Total Assets $ 287,769 $ (130) $ 287,639
LIABILITIES
Policyholders’ account balances $ 104,072 $ (23) $ 104,049
Liability for market risk benefits 12,593 19 12,612
Future policy benefits and other policyholders’ liabilities 17,417 16 17,433
Amounts due to reinsurers 1,363 10 1,373
Other liabilities 6,718 (106) 6,612
Total Liabilities 283,296 (84) 283,212
EQUITY
Retained earnings 10,317 (16) 10,301
Accumulated other comprehensive income (loss) (8,645) (30) (8,675)
Total equity attributable to Holdings 1,644 (46) 1,598
Noncontrolling interest 1,741 — 1,741
Total Equity 3,385 (46) 3,339
Total Equity and Redeemable NCI 4,473 (46) 4,427
Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 287,769 $ (130) $ 287,639
Three Months Ended June 30, 2024
Six Months Ended June 30, 2024
As Previously
Reported Impact of Revisions As Revised As Previously
Reported Impact of Revisions As Revised
(in millions, except per share data)
Consolidated Statements of Income (Loss)
REVENUES
Premiums $ 282 $ — $ 282 $ 557 $ 10 $ 567
Net investment income (loss) 1,166 1 1,167 2,385 (8) 2,377
Investment management and service fees 1,240 — 1,240 2,518 — 2,518
Other income 429 (4) 425 688 (5) 683
Total revenues 3,510 (3) 3,507 5,740 (3) 5,737
BENEFITS AND OTHER DEDUCTIONS
Remeasurement of liability for future policy benefits (8) 1 (7) (7) 5 (2)
Change in market risk benefits and purchased market risk benefits (133) 1 (132) (1,233) 13 (1,220)
Interest credited to policyholders’ account balances 605 (6) 599 1,171 7 1,178
Other operating costs and expenses 427 1 428 980 — 980
Total benefits and other deductions 2,829 (3) 2,826 4,812 25 4,837
Income (loss) from continuing operations, before income taxes 681 — 681 928 (28) 900
Income tax (expense) benefit (116) — (116) (146) 6 (140)
Net income (loss) 565 — 565 782 (22) 760
Less: Net (income) loss attributable to the noncontrolling interest 137 — 137 240 — 240
Net income (loss) attributable to Holdings 428 — 428 542 (22) 520
Less: Preferred stock dividends 26 — 26 40 — 40
Net income (loss) available to Holdings’ common shareholders $ 402 $ — $ 402 $ 502 $ (22) $ 480
EARNINGS PER COMMON SHARE
Basic $ 1.24 $ — $ 1.24 $ 1.53 $ (0.06) $ 1.47
Diluted $ 1.23 $ — $ 1.23 $ 1.52 $ (0.07) $ 1.45
Shares Outstanding:
Basic 324.2 — 324.2 327.2 — 327.2
Diluted 327.3 — 327.3 330.4 — 330.4
Three Months Ended June 30, 2024
Six Months Ended June 30, 2024
As Previously
Reported Impact of Revisions As Revised As Previously
Reported Impact of Revisions As Revised
(in millions)
Consolidated Statements of Comprehensive Income (Loss)
Net income (loss) $ 565 $ — $ 565 $ 782 $ (22) $ 760
Other comprehensive income (loss) net of income taxes:
Change in unrealized gains (losses), net of reclassification adjustment (408) (1) (409) (921) (1) (922)
Change in market risk benefits - instrument-specific credit risk (153) (6) (159) (128) (11) (139)
Change in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment 10 1 11 18 1 19
Foreign currency translation adjustment 8 1 9 (3) 1 (2)
Total other comprehensive income (loss), net of income taxes (476) (5) (481) (869) (10) (879)
Comprehensive income (loss) 89 (5) 84 (87) (32) (119)
Less: Comprehensive income (loss) attributable to the noncontrolling interest 140 — 140 239 — 239
Comprehensive income (loss) attributable to Holdings $ (51) $ (5) $ (56) $ (326) $ (32) $ (358)
Three Months Ended June 30, 2024
Six Months Ended June 30, 2024
As Previously
Reported Impact of Revisions As Revised As Previously
Reported Impact of Revisions As Revised
(in millions)
Consolidated Statements of Equity:
Equity, beginning of period
$ 3,755 $ (40) $ 3,715 $ 4,388 $ (13) $ 4,375
Total Holdings’ equity, beginning of period 2,032 (40) 1,992 2,649 (13) 2,636
Retained earnings, beginning of year 10,110 (15) 10,095 10,243 7 10,250
Net income (loss) attributable to Holdings 428 — 428 542 (22) 520
Other
1 (1) — 1 (1) —
Retained earnings, end of period 10,317 (16) 10,301 10,317 (16) 10,301
Accumulated other comprehensive income (loss), beginning of year (8,166) (25) (8,191) (7,777) (20) (7,797)
Other comprehensive income (loss) (479) (5) (484) (868) (10) (878)
Accumulated other comprehensive income (loss), end of period (8,645) (30) (8,675) (8,645) (30) (8,675)
Total Holdings’ equity, end of period 1,644 (46) 1,598 1,644 (46) 1,598
Total equity, end of period $ 3,385 $ (46) $ 3,339 $ 3,385 $ (46) $ 3,339
Six Months Ended June 30, 2024
As Previously
Reported Impact of Revisions As Revised
(in millions)
Consolidated Statements of Cash Flows:
Cash flows from operating activities:
Net income (loss) $ 782 $ (22) $ 760
Adjustments to reconcile Net income (loss) to Net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances 1,171 7 1,178
Amortization and depreciation 429 5 434
Remeasurement of liability for future policy benefits (7) 5 (2)
Change in market risk benefits (1,233) 13 (1,220)
Reinsurance recoverable (626) (2) (628)
Current and deferred income taxes 155 (6) 149
Net cash provided by (used in) operating activities $ 923 $ — $ 923

v3.25.2

ORGANIZATION (Details)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended 12 Months Ended

Apr. 03, 2025

USD ($)

shares

Feb. 24, 2025

USD ($)

$ / shares

shares

Jun. 30, 2025

USD ($)

segment

Jun. 30, 2024

USD ($)

Jun. 30, 2025

USD ($)

Jun. 30, 2024

USD ($)

Dec. 31, 2024

Organization Basis Of Presentation [Line Items]

Number of operating segments | segment 6

Loss on novation $ 499 $ 0

Increase (decrease) in remeasurement of liability for future policy benefits $ 13 $ 7 15 2

Decrease in amounts due from reinsurers $ 562 $ 628

AB Holding

Organization Basis Of Presentation [Line Items]

Maximum units available to purchase (in shares) | shares 19.7 46.0

Price per unit (in dollars per share) | $ / shares $ 38.50

Aggregate purchase price $ 758 $ 1,800

Percentage of issued and outstanding units 17.90% 17.90%

Economic interest percentage 68.60% 68.60%

Novation

Organization Basis Of Presentation [Line Items]

Loss on novation $ 499

Increase in Pre tax AOCI 263

Total Impact loss 236

Reduction of purchase MRB asset 2,000

Reduction of liabilities for MRBs 1,600

Decrease in reinsurance deposit liability 183

Increase in policyholders’ account balance 33

Increase (decrease) in remeasurement of liability for future policy benefits 458

Decrease in amounts due from reinsurers $ 432

Alliance Bernstein

Organization Basis Of Presentation [Line Items]

Economic interest in Subsidiary 69.00% 62.00%

v3.25.2

INVESTMENTS - Mortgage Loans (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Allowance for credit losses on mortgage loans:

Balance, beginning of period $ 278

Balance, end of period $ 305 $ 234 305 $ 234

Commercial mortgages:

Allowance for credit losses on mortgage loans:

Balance, beginning of period 254 288 259 272

Current-period provision for expected credit losses 39 9 34 25

Write-offs charged against the allowance 0 (75) 0 (75)

Recoveries of amounts previously written off 0 0 0 0

Net change in allowance 39 (66) 34 (50)

Balance, end of period 293 222 293 222

Agricultural mortgages:

Allowance for credit losses on mortgage loans:

Balance, beginning of period 13 6 15 6

Current-period provision for expected credit losses 0 3 (2) 3

Write-offs charged against the allowance (8) 0 (8) 0

Recoveries of amounts previously written off 0 0 0 0

Net change in allowance (8) 3 (10) 3

Balance, end of period 5 9 5 9

Residential mortgages:

Allowance for credit losses on mortgage loans:

Balance, beginning of period 5 3 4 1

Current-period provision for expected credit losses 2 0 3 2

Write-offs charged against the allowance 0 0 0 0

Recoveries of amounts previously written off 0 0 0 0

Net change in allowance 2 0 3 2

Balance, end of period $ 7 $ 3 $ 7 $ 3

v3.25.2

INVESTMENTS - Equity Securities (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Investments, Debt and Equity Securities [Abstract]

Net investment gains (losses) recognized during the period on securities held at the end of the period $ (2) $ (6) $ (2) $ 9

Net investment gains (losses) recognized on securities sold during the period 2 3 2 2

Unrealized and realized gains (losses) on equity securities $ 0 $ (3) $ 0 $ 11

v3.25.2

INVESTMENTS - Trading Securities (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Investments, Debt and Equity Securities [Abstract]

Net investment gains (losses) recognized during the period on securities held at the end of the period $ 50 $ 6 $ 33 $ 42

Net investment gains (losses) recognized on securities sold during the period (10) 0 6 1

Unrealized and realized gains (losses) on trading securities 40 6 39 43

Interest and dividend income from trading securities 25 21 34 32

Net investment income (loss) from trading securities $ 65 $ 27 $ 73 $ 75

v3.25.2

INVESTMENTS - Fixed Maturities (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Investments, Debt and Equity Securities [Abstract]

Net investment gains (losses) recognized during the period on securities held at the end of the period $ 5 $ (2) $ 12 $ (5)

Net investment gains (losses) recognized on securities sold during the period (1) 2 1 3

Unrealized and realized gains (losses) from fixed maturities 4 0 13 (2)

Interest and dividend income from fixed maturities (4) 23 (4) 28

Net investment income (loss) from fixed maturities $ 0 $ 23 $ 9 $ 26

v3.25.2

INVESTMENTS - Investment Gains (Losses), Net (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Net Investment Income [Line Items]

Investment gains (losses), net $ (71) $ (16) $ (85) $ (55)

Fixed maturities

Net Investment Income [Line Items]

Investment gains (losses), net (11) (1) (19) (27)

Mortgage loans on real estate

Net Investment Income [Line Items]

Investment gains (losses), net (61) (14) (68) (32)

Other

Net Investment Income [Line Items]

Investment gains (losses), net $ 1 $ (1) $ 2 $ 4

v3.25.2

DERIVATIVES - Rollforward for Cash Flows Hedges in AOCI (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]

Balance, beginning of period $ 1,565

Balance, ending of the period $ 1,149 $ 1,598 1,149 $ 1,598

Cash Flow Hedges Recognized in AOCI

AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]

Balance, beginning of period 22 (21) 80 (31)

Amount recorded in AOCI (91) 10 (110) 2

Amount reclassified from (to) income to AOCI (47) 24 (86) 42

Balance, ending of the period (116) 13 (116) 13

Cash Flow Hedges Recognized in AOCI | Currency swaps

AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]

Amount recorded in AOCI (91) 19 (81) 19

Amount reclassified from (to) income to AOCI (60) 3 (107) 20

Cash Flow Hedges Recognized in AOCI | Interest swaps

AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]

Amount recorded in AOCI 0 (9) (29) (17)

Amount reclassified from (to) income to AOCI $ 13 $ 21 $ 21 $ 22

v3.25.2

DERIVATIVES - Narrative (Details) - USD ($)
$ in Millions

Jun. 30, 2025

Dec. 31, 2024

Derivative [Line Items]

Cash and securities collateral for derivative contract $ 16,600 $ 16,900

Cash and securities collateral 155 137

S&P 500, Nasdaq, Russell 2000 And Emerging Market Indices

Derivative [Line Items]

Initial margin requirement 1,100 704

U.S. Treasury Notes, U.S. Treasury Bonds And Ultra-Long Bonds

Derivative [Line Items]

Initial margin requirement 110 99

Euro Stoxx, FTSE100, Topix, ASX200 and EAFE Indices

Derivative [Line Items]

Initial margin requirement $ 1 $ 11

v3.25.2

CLOSED BLOCK - Closed Block Summarized Financial Information (Details) - USD ($)
$ in Millions

Jun. 30, 2025

Dec. 31, 2024

Closed Block Liabilities:

Future policy benefits, policyholders’ account balances and other $ 5,100 $ 5,213

Other liabilities 47 62

Total Closed Block liabilities 5,147 5,275

Allowance for credit losses of fixed maturities AFS 0 0

Assets Designated to the Closed Block:

Fixed maturities AFS, at fair value (amortized cost of $2,674 and $2,888) (allowance for credit losses of $0 and$0) 2,591 2,746

Mortgage loans on real estate (net of allowance for credit losses of $22 and $21) 1,498 1,531

Policy loans 510 523

Cash and other invested assets 161 17

Other assets 107 130

Total assets designated to the Closed Block 4,867 4,947

Excess of Closed Block liabilities over assets designated to the Closed Block 280 328

Amounts included in AOCI:

Net unrealized investment gains (losses), net of income tax: $17 and $30 (66) (112)

Maximum future earnings to be recognized from Closed Block assets and liabilities 214 216

Amortized cost of fixed maturity AFS 2,674 2,888

Allowance for credit losses of mortgage loans on real estates 22 21

Income tax on net unrealized investment gains (losses) $ 17 $ 30

v3.25.2

CLOSED BLOCK - Closed Block Revenues and Expenses (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Revenues:

Premiums and other income $ 24 $ 26 $ 51 $ 55

Net investment income (loss) 48 51 99 103

Investment gains (losses), net 0 0 (1) (1)

Total revenues 72 77 149 157

Benefits and Other Deductions:

Policyholders’ benefits and dividends 72 64 146 141

Other operating costs and expenses 1 0 1 0

Total benefits and other deductions 73 64 147 141

Net income (loss), before income taxes (1) 13 2 16

Income tax (expense) benefit 0 (2) (1) (3)

Net income (loss) $ (1) $ 11 $ 1 $ 13

v3.25.2

DAC AND OTHER DEFERRED ASSETS/LIABILITIES - DAC Credits (Details) - USD ($)
$ in Millions
6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

GMxB Core

Movement in Deferred Sales Inducements [Roll Forward]

Balance, beginning of year $ 117 $ 127

Capitalization 1 1

Amortization (6) (6)

Balance, end of year 112 122

GMxB Legacy

Movement in Deferred Sales Inducements [Roll Forward]

Balance, beginning of year 160 179

Capitalization 0 0

Amortization (9) (10)

Balance, end of year 151 169

UL

Movement in Deferred Revenue [Roll Forward]

Balance, beginning of period 114 107

Capitalization 7 8

Amortization (4) (4)

Balance, end of period 117 111

VUL

Movement in Deferred Revenue [Roll Forward]

Balance, beginning of period 840 754

Capitalization 74 65

Amortization (27) (24)

Balance, end of period 887 795

IUL

Movement in Deferred Revenue [Roll Forward]

Balance, beginning of period 250 210

Capitalization 23 28

Amortization (8) (7)

Balance, end of period $ 265 $ 231

v3.25.2

FAIR VALUE DISCLOSURES - Narrative (Details) - USD ($)
$ in Millions
6 Months Ended 12 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Dec. 31, 2024

Fair Value Inputs Assets Quantitative Information [Line Items]

Change in purchased market risk benefit asset fair value $ 69 $ 382

AFS fixed maturities transferred from Level 3 to Level 2 882 $ 141

AFS fixed maturities transferred from Level 2 to Level 3 $ 367 $ 136

Percentage of total equity representing AFS fixed maturities transferred 47.90% 8.30%

Nonrecurring | Level 3

Fair Value Inputs Assets Quantitative Information [Line Items]

Investments, fair value $ 2,300 $ 1,700

v3.25.2

FAIR VALUE DISCLOSURES - Carrying Values and Fair Values of Financial Instruments (Details) - USD ($)
$ in Millions

Jun. 30, 2025

Dec. 31, 2024

Jun. 30, 2024

Consolidated Amounts [Abstract]

Mortgage loans on real estate ^[1] $ 21,536 $ 20,072

Policy loans 4,355 4,330

Policyholders’ liabilities: Investment contracts 123,359 110,929 $ 104,049

Separate Accounts liabilities 131,683 134,717

Carrying Value

Consolidated Amounts [Abstract]

Mortgage loans on real estate 21,536 20,072

Policy loans 4,355 4,330

Policyholders’ liabilities: Investment contracts 2,698 2,046

FHLB funding agreements 7,083 7,167

FABN funding agreements 9,278 5,725

Funding agreement-backed commercial paper (FABCP) 1,546 74

Long-term debt 4,332 3,833

Separate Accounts liabilities 12,207 12,055

Fair Value

Consolidated Amounts [Abstract]

Mortgage loans on real estate 20,468 18,567

Policy loans 4,648 4,559

Policyholders’ liabilities: Investment contracts 2,667 1,996

FHLB funding agreements 7,041 7,113

FABN funding agreements 9,110 5,481

Funding agreement-backed commercial paper (FABCP) 1,581 75

Long-term debt 4,277 3,722

Separate Accounts liabilities 12,207 12,055

Fair Value | Level 1

Consolidated Amounts [Abstract]

Mortgage loans on real estate 0 0

Policy loans 0 0

Policyholders’ liabilities: Investment contracts 0 0

FHLB funding agreements 0 0

FABN funding agreements 0 0

Funding agreement-backed commercial paper (FABCP) 0 0

Long-term debt 0 0

Separate Accounts liabilities 0 0

Fair Value | Level 2

Consolidated Amounts [Abstract]

Mortgage loans on real estate 0 0

Policy loans 0 0

Policyholders’ liabilities: Investment contracts 0 0

FHLB funding agreements 7,041 7,113

FABN funding agreements 9,110 5,481

Funding agreement-backed commercial paper (FABCP) 1,581 75

Long-term debt 4,277 3,722

Separate Accounts liabilities 0 0

Fair Value | Level 3

Consolidated Amounts [Abstract]

Mortgage loans on real estate 20,468 18,567

Policy loans 4,648 4,559

Policyholders’ liabilities: Investment contracts 2,667 1,996

FHLB funding agreements 0 0

FABN funding agreements 0 0

Funding agreement-backed commercial paper (FABCP) 0 0

Long-term debt 0 0

Separate Accounts liabilities $ 12,207 $ 12,055

[1] See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.

v3.25.2

LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Schedule of Liability for Future Policy Benefits, Revenue and Interest Accretion (Details) - USD ($)
$ in Millions
6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Liability for Future Policy Benefit, Activity [Line Items]

Gross Premium $ 282 $ 304

Interest Accretion 172 169

Term

Liability for Future Policy Benefit, Activity [Line Items]

Gross Premium 161 171

Interest Accretion 32 33

Payout

Liability for Future Policy Benefit, Activity [Line Items]

Gross Premium 116 127

Interest Accretion 105 99

Group Pension

Liability for Future Policy Benefit, Activity [Line Items]

Gross Premium 0 0

Interest Accretion 9 9

Health

Liability for Future Policy Benefit, Activity [Line Items]

Gross Premium 5 6

Interest Accretion $ 26 $ 28

v3.25.2

LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Schedule of Liability for Future Policy Benefits, Weighted Average Interest Rates (Details)

Jun. 30, 2025

Dec. 31, 2024

Jun. 30, 2024

Liability for Future Policy Benefit, Activity [Line Items]

Interest accretion rate 4.50% 4.50%

Term

Liability for Future Policy Benefit, Activity [Line Items]

Interest accretion rate 5.60% 5.60%

Current discount rate 5.00% 5.20%

Payout

Liability for Future Policy Benefit, Activity [Line Items]

Interest accretion rate 4.50% 4.40%

Current discount rate 5.10% 5.30%

Group Pension

Liability for Future Policy Benefit, Activity [Line Items]

Interest accretion rate 3.40% 3.40%

Current discount rate 5.00% 5.20%

Health

Liability for Future Policy Benefit, Activity [Line Items]

Interest accretion rate 3.40% 3.40%

Current discount rate 5.20% 5.40%

v3.25.2

LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Balances of and Changes in Additional Liabilities Related to Insurance Guarantees (Details) - USD ($)
$ in Millions
6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Dec. 31, 2024

Dec. 31, 2023

Present Value of Expected Future Policy Benefits

Net liability for additional liability $ 17,557 $ 17,433 $ 17,613

Weighted Average Interest Rate 4.50% 4.50%

Assessments

Present Value of Expected Future Policy Benefits

Revenue and Interest Accretion $ 316 $ 338

Interest Accretion

Present Value of Expected Future Policy Benefits

Revenue and Interest Accretion 29 $ 27

UL

Present Value of Expected Future Policy Benefits

Net liability for additional liability $ 1,271 1,246

Weighted Average Interest Rate 4.50% 4.50%

UL | Assessments

Present Value of Expected Future Policy Benefits

Revenue and Interest Accretion $ 316 $ 338

UL | Interest Accretion

Present Value of Expected Future Policy Benefits

Revenue and Interest Accretion 29 27

Protection Solutions | UL

Present Value of Expected Future Policy Benefits

Balance, beginning of period 1,246 1,208

Beginning balance before AOCI adjustments 1,302 1,245

Effect of changes in interest rate & cash flow assumptions and model changes 0 $ 0

Effect of actual variances from expected experience 4 (1)

Adjusted beginning of period balance $ 1,306 $ 1,244

Interest accrual 29 27

Net assessments collected 34 35

Benefits payments (45) (35)

Ending balance before shadow reserve adjustments 1,324 1,271

Effect of reserve adjustment recorded in AOCI (53) (51)

Balance, end of period 1,271 1,220

Net liability for additional liability 1,271 1,220

Less: Reinsurance recoverable 0 0

Net liability for future policy benefits, after reinsurance recoverable $ 1,271 $ 1,220

Weighted-average duration of additional liability - death benefit (years) 19 years 1 month 6 days 19 years 6 months

v3.25.2

MARKET RISK BENEFITS - Reconciles Market Risk Benefits (Details) - USD ($)
$ in Millions

Jun. 30, 2025

Dec. 31, 2024

Jun. 30, 2024

Market Risk Benefit [Line Items]

Direct Asset $ (776) $ (863) $ (799)

Direct Liability 10,187 11,810 $ 12,612

Net Direct MRB 9,411 10,947

Purchased MRB (5,543) (7,376)

Total 3,868 3,571

Individual Retirement | GMxB Core

Market Risk Benefit [Line Items]

Direct Asset (449) (514)

Direct Liability 1,102 1,010

Net Direct MRB 653 496

Purchased MRB 0 0

Total 653 496

Legacy | GMxB Legacy

Market Risk Benefit [Line Items]

Direct Asset (204) (230)

Direct Liability 9,016 10,738

Net Direct MRB 8,812 10,508

Purchased MRB (5,541) (7,372)

Total 3,271 3,136

Other

Market Risk Benefit [Line Items]

Direct Asset (123) (119)

Direct Liability 69 62

Net Direct MRB (54) (57)

Purchased MRB (2) (4)

Total $ (56) $ (61)

v3.25.2

EMPLOYEE BENEFIT PLANS (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended

Dec. 31, 2024

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

AB Retirement Plan

Defined Benefit Plan Disclosure [Line Items]

Settlements $ 35 $ 59

Additional fund to cover obligations $ 2 2

General and administration expense 21

Net Periodic Pension Expense

Defined Benefit Plan Disclosure [Line Items]

Service cost 7 $ 2 15 $ 4

Interest cost 28 31 56 59

Expected return on assets (33) (37) (67) (73)

Prior period service cost amortization 0 (1) (1) (1)

Net amortization 11 14 23 28

Impact of settlement 0 0 21 0

Net Periodic Pension Expense $ 13 $ 9 $ 47 $ 17

v3.25.2

INCOME TAXES (Details)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

USD ($)

Jun. 30, 2025

USD ($)

Income Tax Disclosure [Abstract]

Increase (decrease) in valuation allowance $ (33) $ (41)

Valuation allowance $ 258 $ 258

v3.25.2

EQUITY - Dividends Declared (Details) - $ / shares
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Class of Stock [Line Items]

Dividends declared per share of common stock (in dollars per share) $ 0.27 $ 0.24 $ 0.51 $ 0.46

Series A

Class of Stock [Line Items]

Dividends declared per share of preferred stock (in dollars per share) 328 328 656 656

Series B

Class of Stock [Line Items]

Dividends declared per share of preferred stock (in dollars per share) 619 619 619 619

Series C

Class of Stock [Line Items]

Dividends declared per share of preferred stock (in dollars per share) $ 269 $ 269 $ 538 $ 538

v3.25.2

EQUITY - Components of OCI, Net of Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Change in net unrealized gains (losses) on investments:

Net unrealized gains (losses) arising during the period $ 335 $ (443) $ 993 $ (986)

(Gains) losses reclassified into net income (loss) during the period 28 0 34 21

Net unrealized gains (losses) on investments 363 (443) 1,027 (965)

Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other (54) 34 (109) 43

Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $297, $(235) and $(1,364)) 309 (409) 918 (922)

Change in LFPB discount rate and MRB credit risk, net of tax

Changes in market risk benefits - instrument-specific credit risk (net of deferred income tax expense (benefit) of $110, $(37)and $332) (170) (159) 414 (139)

Changes in liability for future policy benefits - current discount rate (net of deferred income tax expense (benefit) of $(25), $44 and $285) (29) 67 (92) 165

Change in defined benefit plans:

Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost 9 11 26 19

Change in defined benefit plans (net of deferred income tax expense (benefit) of $3, $7, $1, and $5) 9 11 26 19

Foreign currency translation adjustments:

Foreign currency translation gains (losses) arising during the period 26 9 37 (2)

Foreign currency translation adjustment 26 9 37 (2)

Other comprehensive income (loss) 145 (481) 1,303 (879)

Less: Other comprehensive income (loss) attributable to noncontrolling interest 10 3 23 (1)

Other comprehensive income (loss) attributable to Holdings 135 (484) 1,280 (878)

Deferred income tax expense (benefit) for change in unrealized gains (losses) 124 (102) 297 (235)

Deferred income tax expense (benefit) for market risk benefits - change in instrument-specific credit risk (45) (42) 110 (37)

Deferred income tax expense (benefit) for liability for future policy benefits - change in current discount rate (8) 18 (25) 44

Deferred income tax expense (benefit) for change in defined benefit plans 3 7 1 5

Increase (decrease) in valuation allowance (33) (41)

Valuation allowance 258 258

Reclassification adjustment $ (7) $ 0 $ (9) $ (6)

v3.25.2

SHORT-TERM AND LONG-TERM DEBT - Summary of Short and Long-term Debt (Details) - USD ($)
$ in Millions

Jun. 30, 2025

Dec. 31, 2024

Debt Instrument [Line Items]

Total short-term debt $ 0 $ 0

Total long-term debt 4,332 3,833

Total short and long-term debt 4,332 3,833

Senior Notes | Senior Debenture due 2028

Debt Instrument [Line Items]

Total long-term debt 250 250

Senior Notes | Senior Note due 2028

Debt Instrument [Line Items]

Total long-term debt 1,495 1,494

Senior Notes | Senior Note due 2029

Debt Instrument [Line Items]

Total long-term debt 305 303

Senior Notes | Senior Note due 2033

Debt Instrument [Line Items]

Total long-term debt 497 497

Senior Notes | Senior Note due 2048

Debt Instrument [Line Items]

Total long-term debt 1,290 1,289

Junior Subordinated Debt | Junior Subordinated Debt Due 2055

Debt Instrument [Line Items]

Total long-term debt $ 495 $ 0

v3.25.2

SHORT-TERM AND LONG-TERM DEBT - Narrative (Details) - Junior Subordinated Debt - Junior Subordinated Debt Due 2055
$ in Millions

Mar. 26, 2025

USD ($)

Debt Instrument [Line Items]

Long-term debt $ 500

Interest rate 6.70%

Debt instrument, face amount $ 6

Debt instrument, stated percentage 6.70%

Effective Interest Rate 2.40%

v3.25.2

REDEEMABLE NONCONTROLLING INTEREST (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]

Balance, beginning of period $ 289 $ 991 $ 125 ^[1],[2] $ 770

Redeemable noncontrolling interest (2) 16 1 34

Purchase/change of redeemable noncontrolling interests 71 81 232 284

Balance, end of period $ 358 ^[1],[2] $ 1,088 $ 358 ^[1],[2] $ 1,088

[1] See Note 15 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.

[2] See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.

v3.25.2

BUSINESS SEGMENT INFORMATION - Narrative (Details)
6 Months Ended

Jun. 30, 2025

segment

clientChannel

Segment Reporting Information [Line Items]

Number of reportable segments | segment 6

Asset Management

Segment Reporting Information [Line Items]

Number of main client channels | clientChannel 3

v3.25.2

BUSINESS SEGMENT INFORMATION - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Segment Reporting Information [Line Items]

Net income (loss) attributable to Holdings $ (349) $ 428 $ (286) $ 520

Adjustments related to:

Operating earnings (loss) 352 495 773 972

Income (Loss) due to Novation in Pre-Tax Net Income 499 0

Other operating costs and expenses 427 428 1,377 980

Novation

Adjustments related to:

Income (Loss) due to Novation in Pre-Tax Net Income 499

Increase in Pre tax AOCI 263

Total Impact loss 236

Adjustments

Segment Reporting Information [Line Items]

Net income (loss) attributable to Holdings (349) 428 (286) 520

Adjustments related to:

Variable annuity product 934 81 1,145 411

Investment (gains) losses 71 16 85 55

Net actuarial (gains) losses related to pension and other postretirement benefit obligations 11 14 22 31

Other adjustments (137) (33) 68 58

Income tax expense (benefit) related to above adjustments (185) (16) (277) (116)

Non-recurring tax items 7 $ 5 16 13

Gross legal expenses related to cost of insurance litigation (198) (33) $ 106

Other operating costs and expenses $ 14 $ 14

v3.25.2

INSURANCE STATUTORY FINANCIAL INFORMATION (Details)
6 Months Ended

Jun. 30, 2025

USD ($)

prescribed_and_permitted_practice

Dec. 31, 2022

Jun. 30, 2021

USD ($)

Related Party Transaction [Line Items]

Number of prescribed and permitted practices | prescribed_and_permitted_practice 5

Impact of change in statutory surplus funds $ 920,000,000

Statement of Statutory Accounting Principles 108

Related Party Transaction [Line Items]

Change in statutory special surplus funds 155,000,000

Unassigned surplus balance $ 0

Impact of change in statutory surplus funds $ 1,400,000,000

Target liability change percentage 100.00%

Regulation Number 213

Related Party Transaction [Line Items]

Impact of change in statutory surplus funds $ (123,000,000)

Percentage of reserves phased-in 100.00%

Redundant reserve balance over TAR 111,000,000

Regulation Number 213 with Seperate Accounts

Related Party Transaction [Line Items]

Impact of change in statutory surplus funds $ 770,000,000

v3.25.2

EARNINGS PER COMMON SHARE - Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Weighted-average common shares outstanding:

Weighted-average common shares outstanding — basic (in shares) 303.2 324.2 305.5 327.2

Effect of dilutive potential common shares, employee share awards (in shares) 0.0 3.1 0.0 3.2

Weighted average common shares outstanding - diluted (in shares) 303.2 327.3 305.5 330.4

Net income (loss):

Net income (loss) $ (283) $ 565 $ (133) $ 760

Less: Net income (loss) attributable to the noncontrolling interest ^[1] 66 137 153 240

Net income (loss) attributable to Holdings (349) 428 (286) 520

Less: Preferred stock dividends 18 26 32 40

Net income (loss) available to Holdings’ common shareholders, basic (367) 402 (318) 480

Net income (loss) available to Holdings’ common shareholders, diluted $ (367) $ 402 $ (318) $ 480

Earnings per common share:

Basic (in dollars per share) $ (1.21) $ 1.24 $ (1.04) $ 1.47

Diluted (in dollars per share) $ (1.21) $ 1.23 $ (1.04) $ 1.45

[1] Includes redeemable noncontrolling interest. See Note 15 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.

v3.25.2

EARNINGS PER COMMON SHARE - Narrative (Details) - shares
shares in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Earnings Per Share [Abstract]

Antidilutive securities (in shares) 5.0 3.0 5.5 3.1

v3.25.2

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Balance Sheet (Details) - USD ($)
$ in Millions

Jun. 30, 2025

Mar. 31, 2025

Dec. 31, 2024

Jun. 30, 2024

Mar. 31, 2024

Dec. 31, 2023

ASSETS

Trading securities, at fair value $ 1,295 $ 1,089

Investments 121,798 116,441

Amounts due from reinsurers 7,501 7,899 $ 8,087

Current and deferred income taxes 1,749 2,003 2,129

Purchased Market Risk Benefits 5,543 7,376 8,002

Other assets ^[1] 3,962 4,462 3,828

Assets for market risk benefits 776 863 799

Separate Accounts assets 131,683 134,717

Total Assets 303,088 295,727 287,639

LIABILITIES

Policyholders’ account balances 123,359 110,929 104,049

Market risk benefits 10,187 11,810 12,612

Future policy benefits and other policyholders’ liabilities 17,557 17,613 17,433

Amounts due to reinsurers 1,350 1,421 1,373

Other liabilities 5,847 ^[1] 7,032 ^[1] 6,612

Separate Accounts liabilities 131,683 134,717

Total Liabilities 300,125 292,179 283,212

Equity attributable to Holdings:

Retained earnings 9,870 10,627 10,301

Accumulated other comprehensive income (loss) (7,432) (8,712) (8,675)

Total equity attributable to Holdings 1,149 1,565 1,598

Noncontrolling interest 1,456 1,858 1,741

Total Equity 2,605 $ 4,205 3,423 3,339 $ 3,715 $ 4,375

Total Equity and Redeemable NCI 4,427

Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 303,088 $ 295,727 287,639

As Previously  Reported

ASSETS

Amounts due from reinsurers 8,237

Current and deferred income taxes 2,117

Purchased Market Risk Benefits 7,993

Other assets ^[1] 3,825

Assets for market risk benefits 803

Total Assets 287,769

LIABILITIES

Policyholders’ account balances 104,072

Market risk benefits 12,593

Future policy benefits and other policyholders’ liabilities 17,417

Amounts due to reinsurers 1,363

Other liabilities 6,718

Total Liabilities 283,296

Equity attributable to Holdings:

Retained earnings 10,317

Accumulated other comprehensive income (loss) (8,645)

Total equity attributable to Holdings 1,644

Noncontrolling interest 1,741

Total Equity 3,385 3,755 4,388

Total Equity and Redeemable NCI 4,473

Total Liabilities, Redeemable Noncontrolling Interest and Equity 287,769

Impact of Revisions

ASSETS

Amounts due from reinsurers (150)

Current and deferred income taxes 12

Purchased Market Risk Benefits 9

Other assets ^[1] 3

Assets for market risk benefits (4)

Total Assets (130)

LIABILITIES

Policyholders’ account balances (23)

Market risk benefits 19

Future policy benefits and other policyholders’ liabilities 16

Amounts due to reinsurers 10

Other liabilities (106)

Total Liabilities (84)

Equity attributable to Holdings:

Retained earnings (16)

Accumulated other comprehensive income (loss) (30)

Total equity attributable to Holdings (46)

Noncontrolling interest 0

Total Equity (46) $ (40) $ (13)

Total Equity and Redeemable NCI (46)

Total Liabilities, Redeemable Noncontrolling Interest and Equity $ (130)

[1] See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.

v3.25.2

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Income Statement (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

REVENUES

Premiums $ 260 $ 282 $ 564 $ 567

Net investment income (loss) 1,355 1,167 2,603 2,377

Investment management and service fees 1,272 1,240 2,557 2,518

Other income 294 425 612 683

Total revenues 2,362 3,507 6,938 5,737

BENEFITS AND OTHER DEDUCTIONS

Policyholders’ benefits 787 667 1,546 1,344

Remeasurement of liability for future policy benefits (13) (7) (15) (2)

Change in market risk benefits and purchased market risk benefits (606) (132) 66 (1,220)

Interest credited to policyholders’ account balances 796 599 1,474 1,178

Compensation and benefits 592 577 1,193 1,197

Amortization of deferred policy acquisition costs 193 169 381 341

Other operating costs and expenses 427 428 1,377 980

Total benefits and other deductions 2,725 2,826 7,127 4,837

Income (loss) from continuing operations, before income taxes (363) 681 (189) 900

Income tax (expense) benefit 80 (116) 56 (140)

Net income (loss) (283) 565 (133) 760

Less: Net income (loss) attributable to the noncontrolling interest ^[1] 66 137 153 240

Net income (loss) attributable to Holdings (349) 428 (286) 520

Less: Preferred stock dividends 18 26 32 40

Net income (loss) available to Holdings’ common shareholders, basic (367) 402 (318) 480

Net income (loss) available to Holdings’ common shareholders, diluted $ (367) $ 402 $ (318) $ 480

EARNINGS PER COMMON SHARE

Basic (in dollars per share) $ (1.21) $ 1.24 $ (1.04) $ 1.47

Diluted (in dollars per share) $ (1.21) $ 1.23 $ (1.04) $ 1.45

Basic (in shares) 303.2 324.2 305.5 327.2

Diluted (in shares) 303.2 327.3 305.5 330.4

As Previously  Reported

REVENUES

Premiums $ 282 $ 557

Net investment income (loss) 1,166 2,385

Investment management and service fees 1,240 2,518

Other income 429 688

Total revenues 3,510 5,740

BENEFITS AND OTHER DEDUCTIONS

Remeasurement of liability for future policy benefits (8) (7)

Change in market risk benefits and purchased market risk benefits (133) (1,233)

Interest credited to policyholders’ account balances 605 1,171

Other operating costs and expenses 427 980

Total benefits and other deductions 2,829 4,812

Income (loss) from continuing operations, before income taxes 681 928

Income tax (expense) benefit (116) (146)

Net income (loss) 565 782

Less: Net income (loss) attributable to the noncontrolling interest 137 240

Net income (loss) attributable to Holdings 428 542

Less: Preferred stock dividends 26 40

Net income (loss) available to Holdings’ common shareholders, basic 402 502

Net income (loss) available to Holdings’ common shareholders, diluted $ 402 $ 502

EARNINGS PER COMMON SHARE

Basic (in dollars per share) $ 1.24 $ 1.53

Diluted (in dollars per share) $ 1.23 $ 1.52

Basic (in shares) 324.2 327.2

Diluted (in shares) 327.3 330.4

Impact of Revisions

REVENUES

Premiums $ 0 $ 10

Net investment income (loss) 1 (8)

Investment management and service fees 0 0

Other income (4) (5)

Total revenues (3) (3)

BENEFITS AND OTHER DEDUCTIONS

Remeasurement of liability for future policy benefits 1 5

Change in market risk benefits and purchased market risk benefits 1 13

Interest credited to policyholders’ account balances (6) 7

Other operating costs and expenses 1 0

Total benefits and other deductions (3) 25

Income (loss) from continuing operations, before income taxes 0 (28)

Income tax (expense) benefit 0 6

Net income (loss) 0 (22)

Less: Net income (loss) attributable to the noncontrolling interest 0 0

Net income (loss) attributable to Holdings 0 (22)

Less: Preferred stock dividends 0 0

Net income (loss) available to Holdings’ common shareholders, basic 0 (22)

Net income (loss) available to Holdings’ common shareholders, diluted $ 0 $ (22)

EARNINGS PER COMMON SHARE

Basic (in dollars per share) $ 0 $ (0.06)

Diluted (in dollars per share) $ 0 $ (0.07)

Basic (in shares) 0.0 0.0

Diluted (in shares) 0.0 0.0

[1] Includes redeemable noncontrolling interest. See Note 15 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.

v3.25.2

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Cash Flow (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2025

Jun. 30, 2024

Cash flows from operating activities:

Net income (loss) $ (283) $ 565 $ (133) $ 760

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

Interest credited to policyholders’ account balances 796 599 1,474 1,178

Non-cash long term incentive compensation expense 48 53

Amortization and depreciation 433 434

Remeasurement of liability for future policy benefits (13) (7) (15) (2)

Change in market risk benefits $ (606) (132) 66 (1,220)

Reinsurance recoverable (562) (628)

Future policy benefits 201 275

Current and deferred income taxes (129) 149

Other, net (93) 205

Net cash provided by (used in) operating activities $ 499 923

As Previously  Reported

Cash flows from operating activities:

Net income (loss) 565 782

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

Interest credited to policyholders’ account balances 605 1,171

Amortization and depreciation 429

Remeasurement of liability for future policy benefits (8) (7)

Change in market risk benefits (133) (1,233)

Reinsurance recoverable (626)

Current and deferred income taxes 155

Net cash provided by (used in) operating activities 923

Impact of Revisions

Cash flows from operating activities:

Net income (loss) 0 (22)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

Interest credited to policyholders’ account balances (6) 7

Amortization and depreciation 5

Remeasurement of liability for future policy benefits 1 5

Change in market risk benefits $ 1 13

Reinsurance recoverable (2)

Current and deferred income taxes (6)

Net cash provided by (used in) operating activities $ 0

{
 "version": "2.2",
 "instance": {
  "eqh-20250630.htm": {
   "nsprefix": "eqh",
   "nsuri": "http://www.equitable.com/20250630",
   "dts": {
    "inline": {
     "local": [
      "eqh-20250630.htm"
     ]
    },
    "schema": {
     "local": [
      "eqh-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "eqh-20250630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "eqh-20250630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "eqh-20250630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "eqh-20250630_pre.xml"
     ]
    }
   },
   "keyStandard": 468,
   "keyCustom": 183,
   "axisStandard": 45,
   "axisCustom": 9,
   "memberStandard": 105,
   "memberCustom": 148,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/dei/2025": 5,
    "http://xbrl.sec.gov/ecd/2025": 2
   },
   "contextCount": 1783,
   "entityCount": 1,
   "segmentCount": 267,
   "elementCount": 1252,
   "unitCount": 12,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 5269,
    "http://xbrl.sec.gov/dei/2025": 35,
    "http://xbrl.sec.gov/ecd/2025": 21,
    "http://fasb.org/srt/2025": 12
   },
   "report": {
    "R1": {
     "role": "http://www.equitable.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.equitable.com/role/ConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "eqh:OtherEquityInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ReinsuranceRecoverablesAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
     "longName": "9952153 - Statement - Consolidated Statements of Income (Loss)",
     "shortName": "Consolidated Statements of Income (Loss)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:InsuranceCommissionsAndFees",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "eqh:GainLossOnOtherInvestmentsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "longName": "9952154 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "eqh:OtherComprehensiveIncomeLossCurrentDiscountRateAdjustmentForFuturePolicyBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
     "longName": "9952155 - Statement - Consolidated Statements of Equity",
     "shortName": "Consolidated Statements of Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-86",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-78",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.equitable.com/role/ConsolidatedStatementsofEquityParenthetical",
     "longName": "9952156 - Statement - Consolidated Statements of Equity (Parenthetical)",
     "shortName": "Consolidated Statements of Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "9952157 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GainLossOnInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.equitable.com/role/ORGANIZATION",
     "longName": "9952158 - Disclosure - ORGANIZATION",
     "shortName": "ORGANIZATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIES",
     "longName": "9952159 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.equitable.com/role/INVESTMENTS",
     "longName": "9952160 - Disclosure - INVESTMENTS",
     "shortName": "INVESTMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.equitable.com/role/DERIVATIVES",
     "longName": "9952161 - Disclosure - DERIVATIVES",
     "shortName": "DERIVATIVES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.equitable.com/role/CLOSEDBLOCK",
     "longName": "9952162 - Disclosure - CLOSED BLOCK",
     "shortName": "CLOSED BLOCK",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ClosedBlockDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ClosedBlockDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIES",
     "longName": "9952163 - Disclosure - DAC AND OTHER DEFERRED ASSETS/LIABILITIES",
     "shortName": "DAC AND OTHER DEFERRED ASSETS/LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R15": {
     "role": "http://www.equitable.com/role/FAIRVALUEDISCLOSURES",
     "longName": "9952164 - Disclosure - FAIR VALUE DISCLOSURES",
     "shortName": "FAIR VALUE DISCLOSURES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITS",
     "longName": "9952165 - Disclosure - LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS",
     "shortName": "LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R17": {
     "role": "http://www.equitable.com/role/MARKETRISKBENEFITS",
     "longName": "9952166 - Disclosure - MARKET RISK BENEFITS",
     "shortName": "MARKET RISK BENEFITS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InsuranceContractAcquisitionCostTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InsuranceContractAcquisitionCostTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCES",
     "longName": "9952167 - Disclosure - POLICYHOLDER ACCOUNT BALANCES",
     "shortName": "POLICYHOLDER ACCOUNT BALANCES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "eqh:PolicyHolderAccountBalancesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "eqh:PolicyHolderAccountBalancesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.equitable.com/role/EMPLOYEEBENEFITPLANS",
     "longName": "9952168 - Disclosure - EMPLOYEE BENEFIT PLANS",
     "shortName": "EMPLOYEE BENEFIT PLANS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.equitable.com/role/INCOMETAXES",
     "longName": "9952169 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.equitable.com/role/EQUITY",
     "longName": "9952170 - Disclosure - EQUITY",
     "shortName": "EQUITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBT",
     "longName": "9952171 - Disclosure - SHORT-TERM AND LONG-TERM DEBT",
     "shortName": "SHORT-TERM AND LONG-TERM DEBT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.equitable.com/role/REDEEMABLENONCONTROLLINGINTEREST",
     "longName": "9952172 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST",
     "shortName": "REDEEMABLE NONCONTROLLING INTEREST",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIES",
     "longName": "9952173 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATION",
     "longName": "9952174 - Disclosure - BUSINESS SEGMENT INFORMATION",
     "shortName": "BUSINESS SEGMENT INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATION",
     "longName": "9952175 - Disclosure - INSURANCE STATUTORY FINANCIAL INFORMATION",
     "shortName": "INSURANCE STATUTORY FINANCIAL INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancialGuaranteeInsuranceContractsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancialGuaranteeInsuranceContractsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.equitable.com/role/EARNINGSPERCOMMONSHARE",
     "longName": "9952176 - Disclosure - EARNINGS PER COMMON SHARE",
     "shortName": "EARNINGS PER COMMON SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTS",
     "longName": "9952177 - Disclosure - REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS",
     "shortName": "REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.equitable.com/role/SUBSEQUENTEVENTS",
     "longName": "9952178 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "longName": "9955511 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "eqh:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "eqh:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.equitable.com/role/INVESTMENTSTables",
     "longName": "9955512 - Disclosure - INVESTMENTS (Tables)",
     "shortName": "INVESTMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.equitable.com/role/DERIVATIVESTables",
     "longName": "9955513 - Disclosure - DERIVATIVES (Tables)",
     "shortName": "DERIVATIVES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.equitable.com/role/CLOSEDBLOCKTables",
     "longName": "9955514 - Disclosure - CLOSED BLOCK (Tables)",
     "shortName": "CLOSED BLOCK (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfClosedBlockAssetsAndLiabilities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfClosedBlockAssetsAndLiabilities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESTables",
     "longName": "9955515 - Disclosure - DAC AND OTHER DEFERRED ASSETS/LIABILITIES (Tables)",
     "shortName": "DAC AND OTHER DEFERRED ASSETS/LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "eqh:ScheduleOfReconciliationOfDeferredAcquisitionCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "eqh:ScheduleOfReconciliationOfDeferredAcquisitionCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.equitable.com/role/FAIRVALUEDISCLOSURESTables",
     "longName": "9955516 - Disclosure - FAIR VALUE DISCLOSURES (Tables)",
     "shortName": "FAIR VALUE DISCLOSURES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSTables",
     "longName": "9955517 - Disclosure - LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS (Tables)",
     "shortName": "LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "eqh:PolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "eqh:PolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.equitable.com/role/MARKETRISKBENEFITSTables",
     "longName": "9955518 - Disclosure - MARKET RISK BENEFITS (Tables)",
     "shortName": "MARKET RISK BENEFITS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketRiskBenefitActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketRiskBenefitActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESTables",
     "longName": "9955519 - Disclosure - POLICYHOLDER ACCOUNT BALANCES (Tables)",
     "shortName": "POLICYHOLDER ACCOUNT BALANCES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PolicyholderAccountBalanceTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSTables",
     "longName": "9955520 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)",
     "shortName": "EMPLOYEE BENEFIT PLANS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.equitable.com/role/EQUITYTables",
     "longName": "9955521 - Disclosure - EQUITY (Tables)",
     "shortName": "EQUITY (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTTables",
     "longName": "9955522 - Disclosure - SHORT-TERM AND LONG-TERM DEBT (Tables)",
     "shortName": "SHORT-TERM AND LONG-TERM DEBT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.equitable.com/role/REDEEMABLENONCONTROLLINGINTERESTTables",
     "longName": "9955523 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST (Tables)",
     "shortName": "REDEEMABLE NONCONTROLLING INTEREST (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESTables",
     "longName": "9955524 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FederalHomeLoanBankAdvancesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FederalHomeLoanBankAdvancesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONTables",
     "longName": "9955525 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
     "shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.equitable.com/role/EARNINGSPERCOMMONSHARETables",
     "longName": "9955526 - Disclosure - EARNINGS PER COMMON SHARE (Tables)",
     "shortName": "EARNINGS PER COMMON SHARE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSTables",
     "longName": "9955527 - Disclosure - REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables)",
     "shortName": "REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.equitable.com/role/ORGANIZATIONDetails",
     "longName": "9955528 - Disclosure - ORGANIZATION (Details)",
     "shortName": "ORGANIZATION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
     "longName": "9955529 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:Investments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "eqh:NotesIssuedByConsolidatedVariableInterestEntityUnpaidOutstandingBalanceAndShortTermBorrowing",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.equitable.com/role/INVESTMENTSNarrativeDetails",
     "longName": "9955530 - Disclosure - INVESTMENTS - Narrative (Details)",
     "shortName": "INVESTMENTS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "unitRef": "issue",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "unitRef": "issue",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
     "longName": "9955531 - Disclosure - INVESTMENTS - Available-for-sale Securities (Details)",
     "shortName": "INVESTMENTS - Available-for-sale Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails",
     "longName": "9955532 - Disclosure - INVESTMENTS - Net Unrealized Gain (Losses) (Details)",
     "shortName": "INVESTMENTS - Net Unrealized Gain (Losses) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-136",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "eqh:UnrealizedGainLossOnInvestmentsWithOtherThanTemporaryImpairmentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails",
     "longName": "9955533 - Disclosure - INVESTMENTS - Fixed Maturities Available-for-sale (Details)",
     "shortName": "INVESTMENTS - Fixed Maturities Available-for-sale (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails",
     "longName": "9955534 - Disclosure - INVESTMENTS - Mortgage Loans (Details)",
     "shortName": "INVESTMENTS - Mortgage Loans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-217",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails",
     "longName": "9955535 - Disclosure - INVESTMENTS - Credit Quality (Details)",
     "shortName": "INVESTMENTS - Credit Quality (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:AgeAnalysisOfPastDueMortgageLoansTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "eqh:FinancingReceivableExcludingAccruedInterestAndNonaccrualLoansBeforeAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:AgeAnalysisOfPastDueMortgageLoansTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
     "longName": "9955536 - Disclosure - INVESTMENTS - Amortized Cost of Loans by Credit Quality Indicator and Origination Year (Details)",
     "shortName": "INVESTMENTS - Amortized Cost of Loans by Credit Quality Indicator and Origination Year (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:AgeAnalysisOfPastDueMortgageLoansTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-309",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.equitable.com/role/INVESTMENTSEquitySecuritiesDetails",
     "longName": "9955537 - Disclosure - INVESTMENTS - Equity Securities (Details)",
     "shortName": "INVESTMENTS - Equity Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "eqh:NetInvestmentIncomeLossEquitySecuritiesChangeInUnrealizedHoldingGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "eqh:NetInvestmentIncomeLossEquitySecuritiesChangeInUnrealizedHoldingGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.equitable.com/role/INVESTMENTSTradingSecuritiesDetails",
     "longName": "9955538 - Disclosure - INVESTMENTS - Trading Securities (Details)",
     "shortName": "INVESTMENTS - Trading Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "eqh:NetInvestmentIncomeLossTradingSecuritiesChangeInUnrealizedHoldingGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "eqh:NetInvestmentIncomeLossTradingSecuritiesChangeInUnrealizedHoldingGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesDetails",
     "longName": "9955539 - Disclosure - INVESTMENTS - Fixed Maturities (Details)",
     "shortName": "INVESTMENTS - Fixed Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "eqh:NetInvestmentIncomeLossFixedMaturitiesChangeInUnrealizedHoldingGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "eqh:NetInvestmentIncomeLossFixedMaturitiesChangeInUnrealizedHoldingGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails",
     "longName": "9955540 - Disclosure - INVESTMENTS - Net Investment Income (Details)",
     "shortName": "INVESTMENTS - Net Investment Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "eqh:OtherInvestmentIncomeLossGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "eqh:OtherInvestmentIncomeLossGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.equitable.com/role/INVESTMENTSInvestmentGainsLossesNetDetails",
     "longName": "9955541 - Disclosure - INVESTMENTS - Investment Gains (Losses), Net (Details)",
     "shortName": "INVESTMENTS - Investment Gains (Losses), Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "eqh:GainsLossOnInvestmentsAndDispositionOfBusiness",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:NetInvestmentGainsLossesIncludingChangesInValuationAllowancesAndCreditLossesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-364",
      "name": "eqh:GainsLossOnInvestmentsAndDispositionOfBusiness",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:NetInvestmentGainsLossesIncludingChangesInValuationAllowancesAndCreditLossesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
     "longName": "9955542 - Disclosure - DERIVATIVES - Derivatives by Category (Details)",
     "shortName": "DERIVATIVES - Derivatives by Category (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-426",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-426",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails",
     "longName": "9955543 - Disclosure - DERIVATIVES - Financial Statement Impact of Derivatives By Category (Details)",
     "shortName": "DERIVATIVES - Financial Statement Impact of Derivatives By Category (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-462",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails",
     "longName": "9955544 - Disclosure - DERIVATIVES - Rollforward for Cash Flows Hedges in AOCI (Details)",
     "shortName": "DERIVATIVES - Rollforward for Cash Flows Hedges in AOCI (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-494",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.equitable.com/role/DERIVATIVESNarrativeDetails",
     "longName": "9955545 - Disclosure - DERIVATIVES - Narrative (Details)",
     "shortName": "DERIVATIVES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "eqh:CollateralForDerivativeContractCashAndSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "eqh:CollateralForDerivativeContractCashAndSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails",
     "longName": "9955546 - Disclosure - DERIVATIVES - Offsetting of Financial Assets and Liabilities and Derivative Instruments (Details)",
     "shortName": "DERIVATIVES - Offsetting of Financial Assets and Liabilities and Derivative Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-518",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:OffsettingAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-518",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:OffsettingAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails",
     "longName": "9955547 - Disclosure - CLOSED BLOCK - Closed Block Summarized Financial Information (Details)",
     "shortName": "CLOSED BLOCK - Closed Block Summarized Financial Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ClosedBlockLiabilitiesFuturePolicyBenefitsAndPolicyholderAccountBalances",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfClosedBlockAssetsAndLiabilities",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ClosedBlockLiabilitiesFuturePolicyBenefitsAndPolicyholderAccountBalances",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfClosedBlockAssetsAndLiabilities",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails",
     "longName": "9955548 - Disclosure - CLOSED BLOCK - Closed Block Revenues and Expenses (Details)",
     "shortName": "CLOSED BLOCK - Closed Block Revenues and Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:ClosedBlockOperationsPremiums",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ClosedBlockOperationsNetResultsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:ClosedBlockOperationsPremiums",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ClosedBlockOperationsNetResultsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
     "longName": "9955549 - Disclosure - DAC AND OTHER DEFERRED ASSETS/LIABILITIES - Reconciliation of DAC (Details)",
     "shortName": "DAC AND OTHER DEFERRED ASSETS/LIABILITIES - Reconciliation of DAC (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredPolicyAcquisitionCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:ScheduleOfReconciliationOfDeferredAcquisitionCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-554",
      "name": "us-gaap:DeferredPolicyAcquisitionCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:ScheduleOfReconciliationOfDeferredAcquisitionCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
     "longName": "9955550 - Disclosure - DAC AND OTHER DEFERRED ASSETS/LIABILITIES - DAC Costs (Details)",
     "shortName": "DAC AND OTHER DEFERRED ASSETS/LIABILITIES - DAC Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:DeferredPolicyAcquisitionCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:ScheduleOfReconciliationOfDeferredAcquisitionCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-571",
      "name": "us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails",
     "longName": "9955551 - Disclosure - DAC AND OTHER DEFERRED ASSETS/LIABILITIES - DAC Credits (Details)",
     "shortName": "DAC AND OTHER DEFERRED ASSETS/LIABILITIES - DAC Credits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-612",
      "name": "us-gaap:DeferredSalesInducementsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-612",
      "name": "us-gaap:DeferredSalesInducementsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "longName": "9955552 - Disclosure - FAIR VALUE DISCLOSURES - Assets and Liabilities Measured on Recurring Basis (Details)",
     "shortName": "FAIR VALUE DISCLOSURES - Assets and Liabilities Measured on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "eqh:NotesIssuedByConsolidatedVariableInterestEntityAccruedInterestPayable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails",
     "longName": "9955553 - Disclosure - FAIR VALUE DISCLOSURES - Narrative (Details)",
     "shortName": "FAIR VALUE DISCLOSURES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketRiskBenefitIncreaseDecreaseFromOtherAssumption",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketRiskBenefitIncreaseDecreaseFromOtherAssumption",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
     "longName": "9955554 - Disclosure - FAIR VALUE DISCLOSURES - Fair Value Measurement Reconciliation for All Levels (Details)",
     "shortName": "FAIR VALUE DISCLOSURES - Fair Value Measurement Reconciliation for All Levels (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "eqh:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOther",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "eqh:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOther",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
     "longName": "9955555 - Disclosure - FAIR VALUE DISCLOSURES - Quantitative Information about Level 3 (Details)",
     "shortName": "FAIR VALUE DISCLOSURES - Quantitative Information about Level 3 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:MarketRiskBenefitLiabilityAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-919",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:FairValueInputsQuantitativeInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails",
     "longName": "9955556 - Disclosure - FAIR VALUE DISCLOSURES - Carrying Values and Fair Values of Financial Instruments (Details)",
     "shortName": "FAIR VALUE DISCLOSURES - Carrying Values and Fair Values of Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1020",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "eqh:FairValueDisclosureFinancialInstrumentsNotCarriedAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails",
     "longName": "9955557 - Disclosure - LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Policyholder Account Balance And Liability For Unpaid Claims And Claims Adjustment Expense (Details)",
     "shortName": "LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Policyholder Account Balance And Liability For Unpaid Claims And Claims Adjustment Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LiabilityForFuturePolicyBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "eqh:PolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1044",
      "name": "us-gaap:LiabilityForFuturePolicyBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "eqh:PolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
     "longName": "9955558 - Disclosure - LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Policyholder Account Balance (Details)",
     "shortName": "LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Policyholder Account Balance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LiabilityForFuturePolicyBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "eqh:PolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1048",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PolicyholderAccountBalanceTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails",
     "longName": "9955559 - Disclosure - LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Schedule of Liability for Future Policy Benefits, Undiscounted and Discounted Expected Gross Premiums and Expected Future Benefits and Expenses (Details)",
     "shortName": "LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Schedule of Liability for Future Policy Benefits, Undiscounted and Discounted Expected Gross Premiums and Expected Future Benefits and Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-1030",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "eqh:ScheduleOfLiabilityForFuturePolicyBenefitsUndiscountedAndDiscountedExpectedGrossPremiumsAndExpectedFutureBenefitsAndExpensesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1030",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "eqh:ScheduleOfLiabilityForFuturePolicyBenefitsUndiscountedAndDiscountedExpectedGrossPremiumsAndExpectedFutureBenefitsAndExpensesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsRevenueandInterestAccretionDetails",
     "longName": "9955560 - Disclosure - LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Schedule of Liability for Future Policy Benefits, Revenue and Interest Accretion (Details)",
     "shortName": "LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Schedule of Liability for Future Policy Benefits, Revenue and Interest Accretion (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitGrossPremiumIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "eqh:ScheduleOfLiabilityForFuturePolicyBenefitsRevenueAndInterestAccretionTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitGrossPremiumIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "eqh:ScheduleOfLiabilityForFuturePolicyBenefitsRevenueAndInterestAccretionTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsWeightedAverageInterestRatesDetails",
     "longName": "9955561 - Disclosure - LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Schedule of Liability for Future Policy Benefits, Weighted Average Interest Rates (Details)",
     "shortName": "LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Schedule of Liability for Future Policy Benefits, Weighted Average Interest Rates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:AdditionalLiabilityLongDurationInsuranceWeightedAverageInterestAccretionRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1030",
      "name": "us-gaap:AdditionalLiabilityLongDurationInsuranceWeightedAverageInterestAccretionRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "eqh:ScheduleOfLiabilityForFuturePolicyBenefitsWeightedAverageInterestRatesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
     "longName": "9955562 - Disclosure - LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Balances of and Changes in Additional Liabilities Related to Insurance Guarantees (Details)",
     "shortName": "LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Balances of and Changes in Additional Liabilities Related to Insurance Guarantees (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LiabilityForFuturePolicyBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "eqh:PolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1084",
      "name": "us-gaap:AdditionalLiabilityLongDurationInsuranceGrossPremiumIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails",
     "longName": "9955563 - Disclosure - MARKET RISK BENEFITS - Changes in the Market Risk Benefits for Deferred Variable Annuities (Details)",
     "shortName": "MARKET RISK BENEFITS - Changes in the Market Risk Benefits for Deferred Variable Annuities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-1088",
      "name": "us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1088",
      "name": "us-gaap:MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails",
     "longName": "9955564 - Disclosure - MARKET RISK BENEFITS - Reconciles Market Risk Benefits (Details)",
     "shortName": "MARKET RISK BENEFITS - Reconciles Market Risk Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:MarketRiskBenefitAssetAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "eqh:FairValueInputsQuantitativeInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "eqh:MarketRiskBenefitNetDirect",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
     "longName": "9955565 - Disclosure - POLICYHOLDER ACCOUNT BALANCES - Reconciliation of Policyholders Account Balances to Policyholders' Account Balance Liability (Details)",
     "shortName": "POLICYHOLDER ACCOUNT BALANCES - Reconciliation of Policyholders Account Balances to Policyholders' Account Balance Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "eqh:PolicyholderAccountBalanceBeforeFundingAgreements",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "eqh:PolicyholderAccountBalanceBeforeFundingAgreements",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
     "longName": "9955566 - Disclosure - POLICYHOLDER ACCOUNT BALANCES - Balances and Changes in Policyholders' Account Balances (Details)",
     "shortName": "POLICYHOLDER ACCOUNT BALANCES - Balances and Changes in Policyholders' Account Balances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:InterestCreditedToPolicyholdersAccountBalances",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R87": {
     "role": "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
     "longName": "9955567 - Disclosure - POLICYHOLDER ACCOUNT BALANCES - Guaranteed Minimum Interest Rates (Details)",
     "shortName": "POLICYHOLDER ACCOUNT BALANCES - Guaranteed Minimum Interest Rates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-1142",
      "name": "us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1142",
      "name": "us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails",
     "longName": "9955568 - Disclosure - POLICYHOLDER ACCOUNT BALANCES - Reconciliation of Separate Account Liabilities to Separate Account Liability balance (Details)",
     "shortName": "POLICYHOLDER ACCOUNT BALANCES - Reconciliation of Separate Account Liabilities to Separate Account Liability balance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:SeparateAccountsLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1128",
      "name": "us-gaap:SeparateAccountsLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
     "longName": "9955569 - Disclosure - POLICYHOLDER ACCOUNT BALANCES - Balances and Changes in Separate Accounts Liability (Details)",
     "shortName": "POLICYHOLDER ACCOUNT BALANCES - Balances and Changes in Separate Accounts Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:SeparateAccountsLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-559",
      "name": "us-gaap:SeparateAccountLiabilityPremiumAndDeposit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails",
     "longName": "9955570 - Disclosure - POLICYHOLDER ACCOUNT BALANCES - Aggregate Fair Value of Separate Account Assets (Details)",
     "shortName": "POLICYHOLDER ACCOUNT BALANCES - Aggregate Fair Value of Separate Account Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:SeparateAccountAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1493",
      "name": "us-gaap:SeparateAccountAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails",
     "longName": "9955571 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)",
     "shortName": "EMPLOYEE BENEFIT PLANS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c-1546",
      "name": "us-gaap:DefinedBenefitPlanSettlementsPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1546",
      "name": "us-gaap:DefinedBenefitPlanSettlementsPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.equitable.com/role/INCOMETAXESDetails",
     "longName": "9955572 - Disclosure - INCOME TAXES (Details)",
     "shortName": "INCOME TAXES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R93": {
     "role": "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails",
     "longName": "9955573 - Disclosure - EQUITY - Preferred Stock Activity (Details)",
     "shortName": "EQUITY - Preferred Stock Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.equitable.com/role/EQUITYDividendsDeclaredDetails",
     "longName": "9955574 - Disclosure - EQUITY - Dividends Declared (Details)",
     "shortName": "EQUITY - Dividends Declared (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1560",
      "name": "us-gaap:PreferredStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DividendsDeclaredTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails",
     "longName": "9955575 - Disclosure - EQUITY - Share Repurchase - Narrative (Details)",
     "shortName": "EQUITY - Share Repurchase - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c-1571",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1572",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails",
     "longName": "9955576 - Disclosure - EQUITY - Cumulative Gains (Losses) (Details)",
     "shortName": "EQUITY - Cumulative Gains (Losses) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1598",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails",
     "longName": "9955577 - Disclosure - EQUITY - Components of OCI, Net of Taxes (Details)",
     "shortName": "EQUITY - Components of OCI, Net of Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails",
     "longName": "9955578 - Disclosure - SHORT-TERM AND LONG-TERM DEBT - Summary of Short and Long-term Debt (Details)",
     "shortName": "SHORT-TERM AND LONG-TERM DEBT - Summary of Short and Long-term Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ShortTermBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ShortTermBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails",
     "longName": "9955579 - Disclosure - SHORT-TERM AND LONG-TERM DEBT - Narrative (Details)",
     "shortName": "SHORT-TERM AND LONG-TERM DEBT - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c-1614",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1614",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.equitable.com/role/REDEEMABLENONCONTROLLINGINTERESTDetails",
     "longName": "9955580 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "shortName": "REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
     "longName": "9955581 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES - Narrative (Details)",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "eqh:ReasonablyPossibleRangeOfLossesUnaccruedAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "eqh:ReasonablyPossibleRangeOfLossesUnaccruedAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails",
     "longName": "9955582 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES - Funding Agreements (Details)",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES - Funding Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c-1637",
      "name": "eqh:AdvancesFromFundingAgreement",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1637",
      "name": "eqh:AdvancesFromFundingAgreement",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails",
     "longName": "9955583 - Disclosure - BUSINESS SEGMENT INFORMATION - Narrative (Details)",
     "shortName": "BUSINESS SEGMENT INFORMATION - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
     "longName": "9955584 - Disclosure - BUSINESS SEGMENT INFORMATION - Operating Earning (Loss) By Segment (Details)",
     "shortName": "BUSINESS SEGMENT INFORMATION - Operating Earning (Loss) By Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "eqh:RevenuesAdjusted",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "eqh:PolicyholderBenefitsAndClaimsIncurredNetAdjusted",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R105": {
     "role": "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
     "longName": "9955585 - Disclosure - BUSINESS SEGMENT INFORMATION - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)",
     "shortName": "BUSINESS SEGMENT INFORMATION - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1694",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
     "longName": "9955586 - Disclosure - BUSINESS SEGMENT INFORMATION - Reconciliation of Revenue from Segments to Consolidated (Details)",
     "shortName": "BUSINESS SEGMENT INFORMATION - Reconciliation of Revenue from Segments to Consolidated (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "eqh:RevenuesAdjusted",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1698",
      "name": "us-gaap:InvestmentIncomeInvestmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
     "longName": "9955587 - Disclosure - BUSINESS SEGMENT INFORMATION - Reconciliation of Assets from Segment to Consolidated (Details)",
     "shortName": "BUSINESS SEGMENT INFORMATION - Reconciliation of Assets from Segment to Consolidated (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:Assets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1710",
      "name": "us-gaap:Assets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R108": {
     "role": "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails",
     "longName": "9955588 - Disclosure - INSURANCE STATUTORY FINANCIAL INFORMATION (Details)",
     "shortName": "INSURANCE STATUTORY FINANCIAL INFORMATION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "eqh:StatutoryAccountingPracticesNumberOfPrescribedAndPermittedPractices",
      "unitRef": "prescribed_and_permitted_practice",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "eqh:StatutoryAccountingPracticesNumberOfPrescribedAndPermittedPractices",
      "unitRef": "prescribed_and_permitted_practice",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R109": {
     "role": "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails",
     "longName": "9955589 - Disclosure - EARNINGS PER COMMON SHARE - Basic and Diluted Earnings Per Share (Details)",
     "shortName": "EARNINGS PER COMMON SHARE - Basic and Diluted Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R110": {
     "role": "http://www.equitable.com/role/EARNINGSPERCOMMONSHARENarrativeDetails",
     "longName": "9955590 - Disclosure - EARNINGS PER COMMON SHARE - Narrative (Details)",
     "shortName": "EARNINGS PER COMMON SHARE - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true,
      "unique": true
     }
    },
    "R111": {
     "role": "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails",
     "longName": "9955591 - Disclosure - REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Balance Sheet (Details)",
     "shortName": "REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:TradingSecuritiesDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-61",
      "name": "us-gaap:ReinsuranceRecoverablesOnPaidLosses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R112": {
     "role": "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails",
     "longName": "9955592 - Disclosure - REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Income Statement (Details)",
     "shortName": "REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Income Statement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:PremiumsEarnedNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1732",
      "name": "us-gaap:PremiumsEarnedNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R113": {
     "role": "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails",
     "longName": "9955593 - Disclosure - REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Comprehensive Income (Details)",
     "shortName": "REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1732",
      "name": "eqh:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R114": {
     "role": "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails",
     "longName": "9955594 - Disclosure - REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Equity (Details)",
     "shortName": "REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1740",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R115": {
     "role": "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails",
     "longName": "9955595 - Disclosure - REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Cash Flow (Details)",
     "shortName": "REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Cash Flow (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1734",
      "name": "eqh:OtherDepreciationAmortizationAndAccretion",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    },
    "R116": {
     "role": "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails",
     "longName": "9955596 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "c-1571",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1774",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eqh-20250630.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "eqh_A0To50Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "A0To50Member",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "0% - 50%",
        "label": "0% To 50% [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_A50To70Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "A50To70Member",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "50% - 70%",
        "label": "50% To 70% [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_A70To90Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "A70To90Member",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "70% - 90%",
        "label": "70% To 90% [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ABHoldingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ABHoldingMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AB Holding",
        "label": "AB Holding [Member]",
        "documentation": "AB Holding [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ABRetirementPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ABRetirementPlanMember",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AB Retirement Plan",
        "label": "AB Retirement Plan [Member]",
        "documentation": "AB Retirement Plan"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ABSponsoredInvestmentFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ABSponsoredInvestmentFundsMember",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AB-Sponsored Investment Funds",
        "label": "AB-Sponsored Investment Funds [Member]",
        "documentation": "AB-Sponsored Investment Funds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AOCIGainsLossesRelatedToNetUnrealizedInvestmentGainsLossesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AOCIGainsLossesRelatedToNetUnrealizedInvestmentGainsLossesMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "AOCI\u00a0Gain (Loss)\u00a0Related to Net Unrealized Investment Gains\u00a0(Losses)",
        "label": "AOCI Gains (Losses) Related To Net Unrealized Investment Gains (Losses) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AcceleratedShareRepurchaseAgreementDecember2024AndTerminatedFebruary2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AcceleratedShareRepurchaseAgreementDecember2024AndTerminatedFebruary2025Member",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "December 2024 And Terminated February 2025",
        "label": "Accelerated Share Repurchase Agreement, December 2024 And Terminated February 2025 [Member]",
        "documentation": "Accelerated Share Repurchase Agreement, December 2024 And Terminated February 2025"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AcceleratedShareRepurchaseAgreementDecember2024AndTerminatedJanuary2025MemberMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AcceleratedShareRepurchaseAgreementDecember2024AndTerminatedJanuary2025MemberMember",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "December 2024 and Terminated January 2025",
        "label": "AcceleratedShareRepurchaseAgreementDecember2024AndTerminatedJanuary2025Member [Member]",
        "documentation": "AcceleratedShareRepurchaseAgreementDecember2024AndTerminatedJanuary2025Member"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AcceleratedShareRepurchaseAgreementJune2025AndTerminatedJuly2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AcceleratedShareRepurchaseAgreementJune2025AndTerminatedJuly2025Member",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated Share Repurchase Agreement June And Terminated July [Member]",
        "label": "AcceleratedShareRepurchaseAgreementJune2025AndTerminatedJuly2025 [Member]",
        "documentation": "Accelerated Share Repurchase Agreement June2025 And Terminated July2025"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AcceleratedShareRepurchaseAgreementMarch2025AndTerminatedApril2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AcceleratedShareRepurchaseAgreementMarch2025AndTerminatedApril2025Member",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "March 2025 and Terminated April 2025",
        "label": "Accelerated Share Repurchase Agreement, March 2025 And Terminated April 2025 [Member]",
        "documentation": "Accelerated Share Repurchase Agreement, March 2025 And Terminated April 2025"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AcceleratedShareRepurchaseAgreementMarch2025AndTerminatedApril2025TwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AcceleratedShareRepurchaseAgreementMarch2025AndTerminatedApril2025TwoMember",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "March 2025 And Terminated April 2025 Second",
        "label": "Accelerated Share Repurchase Agreement, March 2025 And Terminated April 2025 Two [Member]",
        "documentation": "Accelerated Share Repurchase Agreement, March 2025 And Terminated April 2025 Two"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AcceleratedShareRepurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AcceleratedShareRepurchaseAgreementMember",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated Share Repurchase Agreement",
        "label": "Accelerated Share Repurchase Agreement [Member]",
        "documentation": "Accelerated Share Repurchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AcceleratedShareRepurchasesAveragePurchasePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AcceleratedShareRepurchasesAveragePurchasePrice",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share repurchases, average purchase price (in dollars per share)",
        "label": "Accelerated Share Repurchases, Average Purchase Price",
        "documentation": "Accelerated Share Repurchases, Average Purchase Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "documentation": "Information by date of execution of accelerated share repurchases."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "documentation": "Date upon which the accelerated share repurchase agreement was executed."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Pre-payment of share repurchases",
        "terseLabel": "Pre-payment of share repurchases",
        "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt",
        "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]",
        "label": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedInvestmentIncomeReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedInvestmentIncomeReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued investment income receivable",
        "label": "Accrued Investment Income Receivable",
        "documentation": "Interest, dividends, rents, ancillary and other revenues earned but not yet received by the entity on its investments."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r955",
      "r1483"
     ]
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "presentation": [
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit pension plans",
        "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r14",
      "r22",
      "r88",
      "r961",
      "r1493",
      "r1494",
      "r1495"
     ]
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "presentation": [
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustments",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r14",
      "r22",
      "r86",
      "r87",
      "r249",
      "r961",
      "r1494",
      "r1495"
     ]
    },
    "eqh_AccumulatedGainLossFinancialLiabilityLiabilityForFuturePolicyBenefitIncludingPortionAttributableToNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AccumulatedGainLossFinancialLiabilityLiabilityForFuturePolicyBenefitIncludingPortionAttributableToNoncontrollingInterestMember",
     "presentation": [
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability for future policy benefits - current discount rate component",
        "label": "Accumulated Gain (Loss), Financial Liability, Liability For Future Policy Benefit, Including Portion Attributable To Noncontrolling Interest [Member]",
        "documentation": "Accumulated Gain (Loss), Financial Liability, Liability For Future Policy Benefit, Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AccumulatedGainLossFinancialLiabilityMarketRiskBenefitIncludingPortionAttributableToNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AccumulatedGainLossFinancialLiabilityMarketRiskBenefitIncludingPortionAttributableToNoncontrollingInterestMember",
     "presentation": [
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market risk benefits - instrument-specific credit risk component",
        "label": "Accumulated Gain (Loss), Financial Liability, Market Risk Benefit, Including Portion Attributable To Noncontrolling Interest [Member]",
        "documentation": "Accumulated Gain (Loss), Financial Liability, Market Risk Benefit, Including Portion Attributable To Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flow Hedges Recognized in AOCI",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r250",
      "r251",
      "r719",
      "r791",
      "r792",
      "r793",
      "r794",
      "r1210",
      "r1493"
     ]
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "presentation": [
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gains (losses) on investments",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]",
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r242",
      "r249",
      "r961",
      "r1494",
      "r1495"
     ]
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r242",
      "r250",
      "r251",
      "r1493"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r250",
      "r791",
      "r792",
      "r793",
      "r794",
      "r845",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r89",
      "r231",
      "r950",
      "r1033",
      "r1037",
      "r1739"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r250",
      "r791",
      "r792",
      "r793",
      "r794",
      "r845",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "verboseLabel": "Accumulated other comprehensive income (loss) attributable to Holdings",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r14",
      "r22",
      "r786",
      "r789",
      "r860",
      "r1028",
      "r1029",
      "r1493",
      "r1494",
      "r1495",
      "r1552",
      "r1553",
      "r1554",
      "r1557"
     ]
    },
    "eqh_AccumulatedOtherComprehensiveIncomeUnrealizedGainLossOnAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AccumulatedOtherComprehensiveIncomeUnrealizedGainLossOnAvailableForSaleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized loss on available for sale securities",
        "label": "Accumulated Other Comprehensive Income, Unrealized Gain (Loss) On Available-For-Sale Securities",
        "documentation": "The balance as of the balance sheet date of accumulated other comprehensive income resulting from the net unrealized securities gains or losses on available for sale securities."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ActuarialGainLossAdjustmentsDefinedBenefitPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ActuarialGainLossAdjustmentsDefinedBenefitPlan",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net actuarial (gains) losses related to pension and other postretirement benefit obligations",
        "label": "Actuarial Gain (Loss) Adjustments, Defined Benefit Plan",
        "documentation": "Actuarial Gain (Loss) Adjustments, Defined Benefit Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1392"
     ]
    },
    "us-gaap_AdditionalLiabilityLongDurationInsuranceCurrentWeightedAverageDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalLiabilityLongDurationInsuranceCurrentWeightedAverageDiscountRate",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsWeightedAverageInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current discount rate",
        "label": "Additional Liability, Long-Duration Insurance, Current Weighted-Average Discount Rate",
        "documentation": "Current weighted-average discount rate used to measure present value of total expected payment to policyholder in excess of present value of total expected assessment. Excludes benefit classified as market risk benefit or under provisions of Topic 815 on derivative and hedging."
       }
      }
     },
     "auth_ref": [
      "r1016"
     ]
    },
    "us-gaap_AdditionalLiabilityLongDurationInsuranceGrossPremiumIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalLiabilityLongDurationInsuranceGrossPremiumIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue and Interest Accretion",
        "label": "Additional Liability, Long-Duration Insurance, Gross Premium Income",
        "documentation": "Amount of gross premium income recognized for present value of total expected payment to policyholder in excess of present value of total expected assessment. Excludes benefit classified as market risk benefit or under provisions of Topic 815 on derivative and hedging."
       }
      }
     },
     "auth_ref": [
      "r1013",
      "r1017"
     ]
    },
    "us-gaap_AdditionalLiabilityLongDurationInsuranceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalLiabilityLongDurationInsuranceTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Balances of and Changes in Additional Liabilities Related to Insurance Guarantees",
        "label": "Additional Liability, Long-Duration Insurance [Table Text Block]",
        "documentation": "Tabular disclosure of present value of total expected payment to policyholder in excess of present value of total expected assessment from application of revised benefit ratio as of contract issue date. Excludes benefit classified as market risk benefit or under provisions of Topic 815 on derivative and hedging."
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "us-gaap_AdditionalLiabilityLongDurationInsuranceWeightedAverageDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalLiabilityLongDurationInsuranceWeightedAverageDuration",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average age of policyholders (years)",
        "label": "Additional Liability, Long-Duration Insurance, Weighted-Average Duration",
        "documentation": "Weighted-average duration of present value of total expected payment to policyholder in excess of present value of total expected assessment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes benefit classified as market risk benefit or under provisions of Topic 815 on derivative and hedging."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_AdditionalLiabilityLongDurationInsuranceWeightedAverageInterestAccretionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalLiabilityLongDurationInsuranceWeightedAverageInterestAccretionRate",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsWeightedAverageInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest accretion rate",
        "terseLabel": "Weighted Average Interest Rate",
        "label": "Additional Liability, Long-Duration Insurance, Weighted-Average Interest Accretion Rate",
        "documentation": "Original weighted-average discount rate at contract issue date used to measure present value of total expected payment to policyholder in excess of present value of total expected assessment. Excludes benefit classified as market risk benefit or under provisions of Topic 815 on derivative and hedging."
       }
      }
     },
     "auth_ref": [
      "r1016"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r1287",
      "r1842"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r1071",
      "r1552",
      "r1553",
      "r1554",
      "r1557",
      "r1740",
      "r1847"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1405"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1405"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1405"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1405"
     ]
    },
    "eqh_AdjustmentsForPolicyholdersLiabilitiesInsuranceLiabilityLossRecognitionAndOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AdjustmentsForPolicyholdersLiabilitiesInsuranceLiabilityLossRecognitionAndOther",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails": {
       "parentTag": "eqh_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments for policyholders\u2019 liabilities, DAC, insurance liability loss recognition and other",
        "label": "Adjustments For Policyholders Liabilities, Insurance Liability, Loss Recognition And Other",
        "documentation": "Other comprehensive income (loss) adjustment related to policyholders liabilities, deferred policy acquisition costs, insurance liability loss recognition and other items arising during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AdvancesFromFundingAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AdvancesFromFundingAgreement",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding Balance, period start",
        "periodEndLabel": "Outstanding Balance, period end",
        "label": "Advances From Funding Agreement",
        "documentation": "Advances From Funding Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AdvancesFromFundingAgreementMaturingWithinFiveYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AdvancesFromFundingAgreementMaturingWithinFiveYears",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Agreements Maturing Within Five Years",
        "label": "Advances From Funding Agreement, Maturing Within Five Years",
        "documentation": "Advances From Funding Agreement, Maturing Within Five Years"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AdvancesFromFundingAgreementMaturingWithinOneYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AdvancesFromFundingAgreementMaturingWithinOneYear",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Agreements Maturing Within One Year",
        "label": "Advances From Funding Agreement, Maturing Within One Year",
        "documentation": "Advances From Funding Agreement, Maturing Within One Year"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AgeAnalysisOfPastDueMortgageLoansTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AgeAnalysisOfPastDueMortgageLoansTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Age Analysis of Past Due Mortgage Loans",
        "label": "Age Analysis Of Past Due Mortgage Loans [Table Text Block]",
        "documentation": "Tabular disclosure of aging analysis of past due mortgage loans."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1438"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1364",
      "r1374",
      "r1384",
      "r1416"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1367",
      "r1377",
      "r1387",
      "r1419"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1439"
     ]
    },
    "eqh_AgriculturalMortgageLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AgriculturalMortgageLoansMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails",
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agricultural mortgages:",
        "verboseLabel": "Agricultural",
        "label": "Agricultural Mortgage Loans [Member]",
        "documentation": "Agricultural Mortgage Loans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AgriculturalSectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AgriculturalSectorMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agricultural Sector",
        "label": "Agricultural Sector [Member]",
        "documentation": "Sector of the economy consisting of companies engaged in agricultural business activities."
       }
      }
     },
     "auth_ref": [
      "r1849",
      "r1850",
      "r1851",
      "r1852"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r1405"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r1412"
     ]
    },
    "eqh_AllFuturePolicyholderBenefitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AllFuturePolicyholderBenefitsMember",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future policyholder benefits total",
        "label": "All Future Policyholder Benefits [Member]",
        "documentation": "All Future Policyholder Benefits"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r1368",
      "r1378",
      "r1388",
      "r1412",
      "r1420",
      "r1424",
      "r1432"
     ]
    },
    "us-gaap_AllOtherSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllOtherSegmentsMember",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Operating Segment [Member]",
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r355",
      "r1222",
      "r1223"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1430"
     ]
    },
    "eqh_AllianceBernsteinMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AllianceBernsteinMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
      "http://www.equitable.com/role/ORGANIZATIONDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alliance Bernstein",
        "label": "Alliance Bernstein [Member]",
        "documentation": "Refers to an entity under the control of the same parent as another entity (that is, a sister company)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financing Receivable, Allowance for Credit Loss",
        "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable."
       }
      }
     },
     "auth_ref": [
      "r1597"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AnnuitiesAndInvestmentCertificatesTransferToFromSeparateAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AnnuitiesAndInvestmentCertificatesTransferToFromSeparateAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transfers (to) from Separate Accounts",
        "label": "Annuities And Investment Certificates, Transfer (To) From Separate Accounts",
        "documentation": "Annuities And Investment Certificates, Transfer (To) From Separate Accounts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "us-gaap_AociAttributableToNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AociAttributableToNoncontrollingInterestMember",
     "presentation": [
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Accumulated other comprehensive income (loss) attributable to noncontrolling interest",
        "label": "AOCI Attributable to Noncontrolling Interest [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r14",
      "r22",
      "r1493",
      "r1494",
      "r1495"
     ]
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "presentation": [
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total accumulated other comprehensive income (loss)",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r14",
      "r22",
      "r1493",
      "r1494",
      "r1495"
     ]
    },
    "us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Effect of changes in discount rate assumptions",
        "label": "AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax",
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in expected future policy benefit component of liability for future policy benefit from change in discount rate."
       }
      }
     },
     "auth_ref": [
      "r1308",
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of changes in discount rate assumptions",
        "label": "AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax",
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from increase (decrease) in expected net premium component of liability for future policy benefit from change in discount rate."
       }
      }
     },
     "auth_ref": [
      "r1308",
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "eqh_AssessmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AssessmentsMember",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assessments",
        "label": "Assessments [Member]",
        "documentation": "Assessments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetBackedSecuritiesMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Asset-backed",
        "label": "Asset-Backed Securities [Member]",
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans."
       }
      }
     },
     "auth_ref": [
      "r1248",
      "r1250",
      "r1288",
      "r1580",
      "r1586",
      "r1587"
     ]
    },
    "eqh_AssetManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AssetManagementMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Management",
        "label": "Asset Management [Member]",
        "documentation": "Asset Management"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails",
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "terseLabel": "Assets",
        "verboseLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r141",
      "r225",
      "r270",
      "r274",
      "r275",
      "r323",
      "r332",
      "r350",
      "r354",
      "r405",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r715",
      "r722",
      "r837",
      "r921",
      "r922",
      "r945",
      "r1115",
      "r1222",
      "r1223",
      "r1244",
      "r1287",
      "r1331",
      "r1334",
      "r1355",
      "r1615",
      "r1616",
      "r1772"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsDesignatedToClosedBlock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsDesignatedToClosedBlock",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": "us-gaap_ExcessOfReportedClosedBlockLiabilitiesOverAssetsDesignatedToClosedBlock",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets designated to the Closed Block",
        "label": "Assets Designated to Closed Block",
        "documentation": "The sum of cash, cash equivalents, investments and other assets allocated to the segregated group of participating or dividend-paying policies and contracts identified as the closed block."
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1838"
     ]
    },
    "us-gaap_AssetsDesignatedToClosedBlockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsDesignatedToClosedBlockAbstract",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets Designated to the Closed Block:",
        "label": "Assets Designated to Closed Block [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsDesignatedToClosedBlockCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsDesignatedToClosedBlockCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": "us-gaap_AssetsDesignatedToClosedBlock",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and other invested assets",
        "label": "Assets Designated to Closed Block, Cash and Cash Equivalents",
        "documentation": "Cash and highly liquid, safe investments that can be readily converted into cash (cash equivalents) allocated to the segregated group of participating or dividend-paying policies and contracts identified as the closed block."
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1839"
     ]
    },
    "us-gaap_AssetsDesignatedToClosedBlockFixedMaturityAvailableForSaleAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsDesignatedToClosedBlockFixedMaturityAvailableForSaleAtFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": "us-gaap_AssetsDesignatedToClosedBlock",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed maturities AFS, at fair value (amortized cost of $2,674 and $2,888) (allowance for credit losses of $0 and$0)",
        "label": "Assets Designated to Closed Block, Fixed Maturity, Available-for-Sale, at Fair Value",
        "documentation": "Fair value of investments in debt securities that are deemed to be available for sale that are allocated to the segregated group of participating or dividend-paying policies and contracts identified as the closed block. Change in fair of such securities is a component of change in other comprehensive income in the period, which is reflected in the closed block disclosure."
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1839"
     ]
    },
    "us-gaap_AssetsDesignatedToClosedBlockMortgageLoansOnRealEstate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsDesignatedToClosedBlockMortgageLoansOnRealEstate",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": "us-gaap_AssetsDesignatedToClosedBlock",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage loans on real estate (net of allowance for credit losses of $22 and $21)",
        "label": "Assets Designated to Closed Block, Mortgage Loans on Real Estate",
        "documentation": "Carrying amount of investments in mortgage loans on real estate allocated to the segregated group of participating or dividend-paying policies and contracts identified as the closed block."
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1839"
     ]
    },
    "eqh_AssetsDesignatedToClosedBlockMortgageLoansOnRealEstateCreditLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AssetsDesignatedToClosedBlockMortgageLoansOnRealEstateCreditLosses",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses of mortgage loans on real estates",
        "label": "Assets Designated To Closed Block, Mortgage Loans On Real Estate, Credit Losses",
        "documentation": "Assets Designated To Closed Block, Mortgage Loans On Real Estate, Credit Losses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsDesignatedToClosedBlockOtherClosedBlockAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsDesignatedToClosedBlockOtherClosedBlockAssets1",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": "us-gaap_AssetsDesignatedToClosedBlock",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Assets Designated to Closed Block, Other Closed Block Assets",
        "documentation": "Amount of other assets held by the closed block. Excludes other investments."
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1839"
     ]
    },
    "us-gaap_AssetsDesignatedToClosedBlockPolicyLoans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsDesignatedToClosedBlockPolicyLoans",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": "us-gaap_AssetsDesignatedToClosedBlock",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policy loans",
        "label": "Assets Designated to Closed Block, Policy Loans",
        "documentation": "Carrying amount of loans to policy holders secured by benefits under insurance policies that are allocated to the segregated group of participating or dividend-paying policies and contracts identified as the closed block."
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1838"
     ]
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r802",
      "r803",
      "r1274"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets:",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AssetsOfConsolidatedVIEsVOEsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AssetsOfConsolidatedVIEsVOEsMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets of consolidated VIEs/VOEs",
        "label": "Assets Of Consolidated VIEs/VOEs [Member]",
        "documentation": "Assets of Consolidated VIEs/VOEs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "eqh_AvailableForSaleFixedMaturitiesProceedsGrossGainsAndGrossLossesFromSalesAndOtherThanTemporaryImpairmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AvailableForSaleFixedMaturitiesProceedsGrossGainsAndGrossLossesFromSalesAndOtherThanTemporaryImpairmentsAbstract",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed Maturities Proceeds Gross Gains And Gross Losses From Sales And Other Than Temporary Impairments",
        "label": "Available For Sale Fixed Maturities Proceeds Gross Gains And Gross Losses From Sales And Other Than Temporary Impairments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AvailableForSaleFixedMaturitiesProceedsGrossGainsAndGrossLossesFromSalesAndOtherThanTemporaryImpairmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AvailableForSaleFixedMaturitiesProceedsGrossGainsAndGrossLossesFromSalesAndOtherThanTemporaryImpairmentsTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Proceeds and Gains (Losses) on Sales for Available-for-Sale Fixed Maturities",
        "label": "Available For Sale Fixed Maturities Proceeds Gross Gains And Gross Losses From Sales And Other Than Temporary Impairments [Table Text Block]",
        "documentation": "Tabular disclosure for proceeds from sales, gross gains and losses recognized from those sales and the amount of other than temporary impairments recognized during the periods presented separated by those recognized in earnings and those losses recognized in other comprehensive income (loss) for available for sale fixed maturities."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLineItems",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available-For-Sale Securities, Continuous Unrealized Loss Position [Line Items]",
        "label": "Available-For-Sale Securities, Continuous Unrealized Loss Position [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in years six through ten",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1583"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in years six through ten",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r929"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in years two through five",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1582"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in years two through five",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r928"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after ten years",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1584"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after ten years",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r930"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Cost (Less Allowance for Credit Losses)",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair\u00a0Value",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date."
       }
      }
     },
     "auth_ref": [
      "r1579",
      "r1580",
      "r1784"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date."
       }
      }
     },
     "auth_ref": [
      "r1579",
      "r1580",
      "r1783"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in one year or less",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1581"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in one year or less",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r378",
      "r927"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Without single maturity date",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping."
       }
      }
     },
     "auth_ref": [
      "r1579",
      "r1580"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Without single maturity date",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r926",
      "r1579"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1427"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1428"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1423"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1423"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1423"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1423"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1423"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1423"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1426"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1425"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1424"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1424"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r735",
      "r738",
      "r739",
      "r740",
      "r741",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r836",
      "r1269",
      "r1270",
      "r1456",
      "r1804"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Domain]",
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r735",
      "r738",
      "r739",
      "r740",
      "r741",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r836",
      "r1269",
      "r1270",
      "r1456",
      "r1804"
     ]
    },
    "eqh_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Principles of Consolidation",
        "label": "Basis Of Presentation And Principles Of Consolidation [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the general note to the financial statements for the reporting entity which may include basis of presentation and consolidations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BenefitsLossesAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BenefitsLossesAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total benefits and other deductions",
        "label": "Benefits, Losses and Expenses",
        "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r1331",
      "r1334"
     ]
    },
    "us-gaap_BenefitsLossesAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BenefitsLossesAndExpensesAbstract",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BENEFITS AND OTHER DEDUCTIONS",
        "verboseLabel": "Benefits and other deductions",
        "label": "Benefits, Losses and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_BenefitsLossesAndExpensesAdjusted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "BenefitsLossesAndExpensesAdjusted",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total benefits and other deductions",
        "label": "Benefits, Losses And Expenses, Adjusted",
        "documentation": "Benefits, Losses And Expenses, Adjusted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contingent payment arrangements",
        "terseLabel": "AB Contingent consideration payable",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r708",
      "r711",
      "r804",
      "r805",
      "r806",
      "r1262",
      "r1263"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected revenue growth and discount rate",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "documentation": "Value of input used to measure liability in contingent consideration arrangement in business combination."
       }
      }
     },
     "auth_ref": [
      "r709",
      "r711",
      "r804",
      "r805",
      "r806",
      "r1262",
      "r1263"
     ]
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying Value",
        "label": "Reported Value Measurement [Member]",
        "documentation": "Measured as reported on the statement of financial position (balance sheet)."
       }
      }
     },
     "auth_ref": [
      "r832",
      "r833",
      "r835",
      "r1200",
      "r1761"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r223",
      "r1203"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r832",
      "r833",
      "r1743",
      "r1744"
     ]
    },
    "us-gaap_CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and securities segregated, at fair value",
        "label": "Cash and Securities Segregated under Federal and Other Regulations",
        "documentation": "Amount of cash subject to withdrawal restrictions, restricted deposits held as compensating balances, and cash and securities segregated in compliance with regulations (such as cash deposited in a special reserve account for the exclusive benefit of customers)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r104",
      "r267"
     ]
    },
    "eqh_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsHeldForSaleIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsHeldForSaleIncludingExchangeRateEffect",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in cash of businesses held-for-sale",
        "label": "Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents, Held-For-Sale, Including Exchange Rate Effect",
        "documentation": "Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents, Held-For-Sale, Including Exchange Rate Effect"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Change in cash and cash equivalents",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r104"
     ]
    },
    "us-gaap_CashFlowHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashFlowHedgingMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flow Hedge",
        "label": "Cash Flow Hedging [Member]",
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_CashSurrenderValueDuePolicyholdersAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashSurrenderValueDuePolicyholdersAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash surrender value",
        "label": "Policyholder Account Balance, Cash Surrender Value",
        "documentation": "Amount of cash to be paid to policyholder upon termination and surrender of long-duration contract issued by insurance entity."
       }
      }
     },
     "auth_ref": [
      "r1021",
      "r1324"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1403"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1400"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1398"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.equitable.com/role/Cover",
      "http://www.equitable.com/role/EQUITYDividendsDeclaredDetails",
      "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r228",
      "r229",
      "r230",
      "r270",
      "r275",
      "r305",
      "r309",
      "r316",
      "r318",
      "r325",
      "r326",
      "r405",
      "r475",
      "r478",
      "r479",
      "r480",
      "r484",
      "r485",
      "r517",
      "r518",
      "r520",
      "r521",
      "r523",
      "r526",
      "r529",
      "r530",
      "r533",
      "r536",
      "r543",
      "r837",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1071",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1103",
      "r1124",
      "r1146",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1444",
      "r1547",
      "r1549",
      "r1558"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.equitable.com/role/EQUITYDividendsDeclaredDetails",
      "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails",
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r229",
      "r230",
      "r325",
      "r520",
      "r529",
      "r530",
      "r531",
      "r533",
      "r536",
      "r541",
      "r543",
      "r783",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1245",
      "r1444",
      "r1545",
      "r1547"
     ]
    },
    "us-gaap_ClosedBlockAssetsAndLiabilitiesEffectOnOtherComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockAssetsAndLiabilitiesEffectOnOtherComprehensiveIncomeAbstract",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts included in AOCI:",
        "label": "Closed Block Assets and Liabilities, Effect on Other Comprehensive Income (Loss) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClosedBlockAssetsAndLiabilitiesMaximumFutureEarningsToBeRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockAssetsAndLiabilitiesMaximumFutureEarningsToBeRecognized",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Maximum future earnings to be recognized from Closed Block assets and liabilities",
        "label": "Closed Block Assets and Liabilities, Maximum Future Earnings to be Recognized",
        "documentation": "The carrying amount of closed block liabilities in excess of the carrying amount of closed block assets at the date of demutualization (adjusted to eliminate the impact of related amounts in accumulated other comprehensive income)."
       }
      }
     },
     "auth_ref": [
      "r1058",
      "r1341",
      "r1342"
     ]
    },
    "us-gaap_ClosedBlockDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Closed Block Disclosure [Abstract]",
        "label": "Closed Block Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClosedBlockDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCK"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CLOSED BLOCK",
        "label": "Closed Block Disclosure [Text Block]",
        "documentation": "The entire disclosure pertaining to the closed block."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1340"
     ]
    },
    "eqh_ClosedBlockInvestmentsDebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ClosedBlockInvestmentsDebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses of fixed maturities AFS",
        "label": "Closed Block Investments, Debt Securities, Available-For-Sale, Allowance For Credit Loss",
        "documentation": "Closed Block Investments, Debt Securities, Available-For-Sale, Allowance For Credit Loss"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClosedBlockInvestmentsFixedMaturityAvailableForSaleAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockInvestmentsFixedMaturityAvailableForSaleAmortizedCost",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized cost of fixed maturity AFS",
        "label": "Closed Block Investments, Fixed Maturity, Available-for-Sale, Amortized Cost",
        "documentation": "The amortized cost as of the balance sheet date of those fixed maturity investments designated as available for sale and reported at fair value which are allocated to the closed block. Also a component of change in other comprehensive income in the period, which is reflected in the closed block disclosure."
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1838"
     ]
    },
    "us-gaap_ClosedBlockLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": "us-gaap_ExcessOfReportedClosedBlockLiabilitiesOverAssetsDesignatedToClosedBlock",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Closed Block liabilities",
        "label": "Closed Block Liabilities",
        "documentation": "For the segregated group of participating or dividend-paying policies and contracts along with the assets backing them (known as a closed block), the total of future policy benefits, policyholder account balance, policyholder dividend obligation and any other closed block liabilities."
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1838"
     ]
    },
    "us-gaap_ClosedBlockLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockLiabilitiesAbstract",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Closed Block Liabilities:",
        "label": "Closed Block Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClosedBlockLiabilitiesFuturePolicyBenefitsAndPolicyholderAccountBalances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockLiabilitiesFuturePolicyBenefitsAndPolicyholderAccountBalances",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": "us-gaap_ClosedBlockLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future policy benefits, policyholders\u2019 account balances and other",
        "label": "Closed Block Liabilities, Future Policy Benefits and Policyholder Account Balances",
        "documentation": "The liability as of the balance sheet date for future benefits to be paid to or on behalf of policyholders and expenses, less the present value of future net premiums payable under the insurance contracts and the policy cash accumulations, for the segregated group of participating or dividend-paying policies and contracts identified as a closed block."
       }
      }
     },
     "auth_ref": [
      "r1054",
      "r1341"
     ]
    },
    "us-gaap_ClosedBlockLiabilitiesOtherClosedBlockLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockLiabilitiesOtherClosedBlockLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": "us-gaap_ClosedBlockLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Closed Block Liabilities, Other Closed Block Liabilities",
        "documentation": "Amount of liabilities allocated to the closed block, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1838"
     ]
    },
    "eqh_ClosedBlockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ClosedBlockMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Corporate and Other",
        "terseLabel": "CB",
        "label": "Closed Block [Member]",
        "documentation": "Closed Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClosedBlockOperationsBenefitsAndExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsBenefitsAndExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails": {
       "parentTag": "us-gaap_ClosedBlockOperationsResultsBeforeIncomeTaxes",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total benefits and other deductions",
        "label": "Closed Block Operations, Benefits and Expense",
        "documentation": "Amount of benefits, claims and expenses that are related to an insurance entity's segregated group of participating or dividend-paying policies and contracts along with the assets allocated to them (known as a closed block). Includes, but is not limited to, death benefits, matured endowments, participating dividends, general expenses and deferred acquisition costs related to the closed block."
       }
      }
     },
     "auth_ref": [
      "r1342",
      "r1838"
     ]
    },
    "us-gaap_ClosedBlockOperationsBenefitsAndExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsBenefitsAndExpenseAbstract",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Benefits and Other Deductions:",
        "label": "Closed Block Operations, Benefits and Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ClosedBlockOperationsDeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ClosedBlockOperationsDeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax on net unrealized investment gains (losses)",
        "label": "Closed Block Operations, Deferred Income Tax Expense (Benefit)",
        "documentation": "The amount of deferred income tax expense or benefit allocated to the operations of the closed block for the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClosedBlockOperationsIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails": {
       "parentTag": "us-gaap_ClosedBlockOperationsNetResults",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax (expense) benefit",
        "label": "Closed Block Operations, Income Taxes",
        "documentation": "The amount of income tax expense or benefit allocated to the operations of the closed block for the period."
       }
      }
     },
     "auth_ref": [
      "r1342",
      "r1838"
     ]
    },
    "us-gaap_ClosedBlockOperationsNetInvestmentIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsNetInvestmentIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails": {
       "parentTag": "us-gaap_ClosedBlockOperationsRevenue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment income (loss)",
        "label": "Closed Block Operations, Net Investment Income",
        "documentation": "Income for the period from the investments allocated to an insurance entity's segregated group of participating or dividend-paying policies and contracts (known as a closed block), net of investment expenses, which are typically reported in a table of closed block operations."
       }
      }
     },
     "auth_ref": [
      "r1056",
      "r1342"
     ]
    },
    "us-gaap_ClosedBlockOperationsNetResults": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsNetResults",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income (loss)",
        "label": "Closed Block Operations, Net Results",
        "documentation": "Amount of net income (loss) from operations of the closed block."
       }
      }
     },
     "auth_ref": [
      "r1838"
     ]
    },
    "us-gaap_ClosedBlockOperationsNetResultsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsNetResultsTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Closed Block Operations, Net Results",
        "label": "Closed Block Operations, Net Results [Table Text Block]",
        "documentation": "Tabular disclosure of the closed block operations."
       }
      }
     },
     "auth_ref": [
      "r1838"
     ]
    },
    "us-gaap_ClosedBlockOperationsOtherExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsOtherExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other operating costs and expenses",
        "label": "Closed Block Operations, Other Expense",
        "documentation": "Amount of expense classified as other allocated to the closed block."
       }
      }
     },
     "auth_ref": [
      "r1342",
      "r1838"
     ]
    },
    "eqh_ClosedBlockOperationsPolicyholderBenefitAndDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ClosedBlockOperationsPolicyholderBenefitAndDividends",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails": {
       "parentTag": "us-gaap_ClosedBlockOperationsBenefitsAndExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholders\u2019 benefits and dividends",
        "label": "Closed Block Operations, Policyholder Benefit And Dividends",
        "documentation": "An expense for the period for estimated policy claims and distributions paid or accrued in an insurance entity's segregated group of participating or dividend-paying policies and contracts along with the assets allocated to them (known as a closed block), as typically reported in a table of closed block operations as part of summarized financial data."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClosedBlockOperationsPremiums": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsPremiums",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails": {
       "parentTag": "us-gaap_ClosedBlockOperationsRevenue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Premiums and other income",
        "label": "Closed Block Operations, Premiums",
        "documentation": "For the segregated group of participating or dividend-paying policies and contracts along with the assets allocated to them (known as a closed block), revenue for the period from insurance policy premiums; typically included in a table of closed block operations."
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1342"
     ]
    },
    "us-gaap_ClosedBlockOperationsRealizedInvestmentGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsRealizedInvestmentGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails": {
       "parentTag": "us-gaap_ClosedBlockOperationsRevenue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment gains (losses), net",
        "label": "Closed Block Operations, Realized Investment Gains (Losses)",
        "documentation": "Gains and losses realized for the period from the investments allocated to an insurance entity's segregated group of participating or dividend-paying policies and contracts (known as a closed block)."
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1342"
     ]
    },
    "us-gaap_ClosedBlockOperationsResultsBeforeIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsResultsBeforeIncomeTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails": {
       "parentTag": "us-gaap_ClosedBlockOperationsNetResults",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income (loss), before income taxes",
        "label": "Closed Block Operations, Results before Income Taxes",
        "documentation": "The revenues less expenses from operations of the closed block during the period, before income taxes allocated thereto."
       }
      }
     },
     "auth_ref": [
      "r1342",
      "r1838"
     ]
    },
    "us-gaap_ClosedBlockOperationsRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsRevenue",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails": {
       "parentTag": "us-gaap_ClosedBlockOperationsResultsBeforeIncomeTaxes",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total revenues",
        "label": "Closed Block Operations, Revenue",
        "documentation": "Total revenues from an insurance company's segregated group of participating or dividend-paying policies and contracts along with the assets allocated to them (known as a closed block)."
       }
      }
     },
     "auth_ref": [
      "r1342",
      "r1838"
     ]
    },
    "us-gaap_ClosedBlockOperationsRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClosedBlockOperationsRevenueAbstract",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockRevenuesandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues:",
        "label": "Closed Block Operations, Revenue [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1404"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1404"
     ]
    },
    "us-gaap_CollateralAlreadyPostedAggregateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollateralAlreadyPostedAggregateFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and securities collateral",
        "label": "Collateral Already Posted, Aggregate Fair Value",
        "documentation": "The aggregate fair value of assets that are already posted, at the end of the reporting period, as collateral for derivative instruments with credit-risk-related contingent features."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r1273"
     ]
    },
    "eqh_CollateralForDerivativeContractCashAndSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "CollateralForDerivativeContractCashAndSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and securities collateral for derivative contract",
        "label": "Collateral For Derivative Contract, Cash And Securities",
        "documentation": "Carrying amount as of the balance sheet date of cash and securities collateral held for derivative contracts, for which the cash and securities are not restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollateralizedLoanObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollateralizedLoanObligationsMember",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CLO Warehouse Debt",
        "label": "Collateralized Loan Obligations [Member]",
        "documentation": "Securities collateralized by a pool of loans."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollateralizedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollateralizedSecuritiesMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral",
        "label": "Collateralized Securities [Member]",
        "documentation": "Securities collateralized by other financial instruments or pools of financial instruments."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_CommercialAgriculturalAndResidentialMortgageLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "CommercialAgriculturalAndResidentialMortgageLoanMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial, Agricultural And Residential Mortgage Loan",
        "label": "Commercial, Agricultural And Residential Mortgage Loan [Member]",
        "documentation": "Commercial, Agricultural And Residential Mortgage Loan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommercialLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommercialLoanMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails",
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial mortgages:",
        "verboseLabel": "Commercial",
        "label": "Commercial Loan [Member]",
        "documentation": "A loan, whether secured or unsecured, to a company for purposes such as seasonal working capital needs, inventory financing, equipment purchases and acquisitions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial mortgage-backed",
        "verboseLabel": "CMBS",
        "label": "Commercial Mortgage-Backed Securities [Member]",
        "documentation": "Securities collateralized by commercial real estate mortgage loans."
       }
      }
     },
     "auth_ref": [
      "r1274",
      "r1275",
      "r1277",
      "r1580",
      "r1586",
      "r1587",
      "r1650",
      "r1678"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingent liabilities",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r126",
      "r948",
      "r1102"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r465",
      "r466",
      "r1196",
      "r1603",
      "r1608"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1847"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquityParenthetical",
      "http://www.equitable.com/role/EQUITYDividendsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash dividends declared per common share (in dollars per share)",
        "verboseLabel": "Dividends declared per share of common stock (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r1343",
      "r1344",
      "r1345",
      "r1347",
      "r1348",
      "r1349",
      "r1352",
      "r1552",
      "r1553",
      "r1557",
      "r1740",
      "r1840",
      "r1847"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r1103"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r79",
      "r1103",
      "r1121",
      "r1847",
      "r1848"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.01 par value, 2,000,000,000 shares authorized; 472,699,844 and 477,801,636 shares issued, respectively; 301,768,056 and 309,900,248 shares outstanding, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r518",
      "r525",
      "r949",
      "r1287"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1409"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1408"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1410"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1407"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits [Abstract]",
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income (loss) attributable to Holdings",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r246",
      "r248",
      "r256",
      "r918",
      "r965",
      "r967"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Less: Comprehensive income (loss) attributable to the noncontrolling interest",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r54",
      "r64",
      "r246",
      "r248",
      "r255",
      "r917",
      "r965",
      "r966"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income (loss)",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r117",
      "r246",
      "r248",
      "r254",
      "r916",
      "r965"
     ]
    },
    "eqh_ConsolidatedAmountsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ConsolidatedAmountsAbstract",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Amounts [Abstract]",
        "label": "Consolidated Amounts [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]",
        "documentation": "Information by consolidated entity or group of entities."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r186",
      "r271",
      "r281",
      "r715",
      "r716",
      "r721",
      "r722",
      "r723",
      "r864",
      "r924",
      "r1197",
      "r1472",
      "r1475",
      "r1476",
      "r1614",
      "r1617",
      "r1618"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]",
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r186",
      "r271",
      "r281",
      "r715",
      "r716",
      "r721",
      "r722",
      "r723",
      "r864",
      "r924",
      "r1197",
      "r1472",
      "r1475",
      "r1476",
      "r1614",
      "r1617",
      "r1618"
     ]
    },
    "us-gaap_ConsolidatedEntityExcludingVieMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidatedEntityExcludingVieMember",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entity, Excluding VIE",
        "label": "Consolidated Entity, Excluding VIE [Member]",
        "documentation": "Consolidated entity, excluding variable interest entity (VIE) for which reporting entity is or is not primary beneficiary."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ConsolidatedEntityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ConsolidatedEntityMember",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entity",
        "label": "Consolidated Entity [Member]",
        "documentation": "Consolidated Entity"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ConsolidatedLimitedPartnershipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ConsolidatedLimitedPartnershipsMember",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Limited Partnerships",
        "label": "Consolidated Limited Partnerships [Member]",
        "documentation": "Consolidated Limited Partnerships"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]",
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r174",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r270",
      "r271",
      "r278",
      "r281",
      "r323",
      "r334",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r475",
      "r476",
      "r477",
      "r478",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r924",
      "r1222",
      "r1223",
      "r1473",
      "r1474",
      "r1615",
      "r1616"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]",
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r174",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r270",
      "r271",
      "r278",
      "r281",
      "r323",
      "r334",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r475",
      "r476",
      "r477",
      "r478",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r924",
      "r1222",
      "r1223",
      "r1473",
      "r1474",
      "r1615",
      "r1616"
     ]
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting and Consolidation of VIEs",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "eqh_ContingentPaymentArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ContingentPaymentArrangementsMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Payment Arrangement",
        "label": "Contingent Payment Arrangements [Member]",
        "documentation": "Contingent Payment Arrangements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ContractHolderBonusInterestCreditsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ContractHolderBonusInterestCreditsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract holder Bonus Interest Credits [Abstract]",
        "label": "Contract Holder Bonus Interest Credits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_Core1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "Core1Member",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GMxB Core",
        "label": "Core1 [Member]",
        "documentation": "Core1"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_CorpAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "CorpAndOtherMember",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corp &amp; Other",
        "label": "Corp And Other [Member]",
        "documentation": "Corp And Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CorporateAndOtherMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate &amp; Other",
        "label": "Corporate Segment and Other Operating Segment [Member]",
        "documentation": "Component of entity providing financial and operational oversight and administrative support considered to be operating segment and operating segment, classified as other. Excludes intersegment elimination and reconciling item."
       }
      }
     },
     "auth_ref": [
      "r1562"
     ]
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Corporate",
        "verboseLabel": "Corporate",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r1248",
      "r1250",
      "r1252",
      "r1274",
      "r1288",
      "r1337",
      "r1834"
     ]
    },
    "us-gaap_CorporateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CorporateMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate Segment",
        "label": "Corporate Segment [Member]",
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items."
       }
      }
     },
     "auth_ref": [
      "r1562"
     ]
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate and Other",
        "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r349",
      "r350",
      "r351",
      "r352",
      "r355",
      "r1565"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]",
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r208",
      "r270",
      "r279",
      "r280",
      "r490",
      "r531",
      "r863",
      "r887",
      "r940",
      "r1206",
      "r1208",
      "r1209",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1489",
      "r1490",
      "r1491",
      "r1492",
      "r1734",
      "r1735",
      "r1736",
      "r1737"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_CreditAndIntentToSellLossesOnAvailableForSaleDebtSecuritiesAndLoans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "CreditAndIntentToSellLossesOnAvailableForSaleDebtSecuritiesAndLoans",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "eqh_GainsLossOnInvestmentsAndDispositionOfBusiness",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Credit and intent to sell losses on available for sale debt securities and loans",
        "terseLabel": "Credit and intent to sell losses on available for sale debt securities and loans",
        "label": "Credit And Intent To Sell, Losses On Available-For-Sale Debt Securities And Loans",
        "documentation": "Credit And Intent To Sell, Losses On Available-For-Sale Debt Securities And Loans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditDefaultSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CreditDefaultSwapMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Credit default swaps",
        "terseLabel": "Credit default swaps",
        "label": "Credit Default Swap [Member]",
        "documentation": "Credit derivative contract between credit default swap buyer and third party in which credit default swap buyer makes periodic payment to third party and third party guarantees to reimburse credit default swap buyer if original borrower defaults."
       }
      }
     },
     "auth_ref": [
      "r1350",
      "r1351",
      "r1732",
      "r1733"
     ]
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r1613"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r1613"
     ]
    },
    "eqh_CurrencyFowardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "CurrencyFowardMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency forwards",
        "label": "Currency Foward [Member]",
        "documentation": "Currency Foward"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrencySwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrencySwapMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency swaps",
        "label": "Currency Swap [Member]",
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency."
       }
      }
     },
     "auth_ref": [
      "r1729"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHORT-TERM AND LONG-TERM DEBT",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r270",
      "r272",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r473",
      "r474",
      "r486",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r502",
      "r509",
      "r510",
      "r512",
      "r783",
      "r853"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails",
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r69",
      "r70",
      "r123",
      "r125",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r493",
      "r498",
      "r499",
      "r500",
      "r501",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1285",
      "r1545",
      "r1546",
      "r1548",
      "r1551",
      "r1604",
      "r1605",
      "r1606",
      "r1768",
      "r1769",
      "r1782"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails": {
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total long-term debt",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r125",
      "r513"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r853",
      "r854",
      "r1240",
      "r1241",
      "r1285"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r505",
      "r1768"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective Interest Rate",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r514",
      "r853",
      "r854",
      "r1285"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, stated percentage",
        "verboseLabel": "Interest rate on debt instrument",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r488"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r493",
      "r498",
      "r499",
      "r500",
      "r501",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r511",
      "r783",
      "r924",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1285",
      "r1545",
      "r1546",
      "r1548",
      "r1551",
      "r1768",
      "r1769"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails",
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r493",
      "r498",
      "r499",
      "r500",
      "r501",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1285",
      "r1545",
      "r1546",
      "r1548",
      "r1551",
      "r1604",
      "r1605",
      "r1606",
      "r1768",
      "r1769",
      "r1782"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "documentation": "Information by period of debt redemption feature under terms of debt agreement."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r41",
      "r44",
      "r65",
      "r111",
      "r112",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r493",
      "r498",
      "r499",
      "r500",
      "r501",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r511",
      "r783",
      "r924",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1285",
      "r1545",
      "r1546",
      "r1548",
      "r1551",
      "r1768",
      "r1769"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, term",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total short and long-term debt",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DebtSecuritiesAvailableForSaleAllowanceForCreditLossExcludingAccruedInterestIncludingImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossExcludingAccruedInterestIncludingImpairment",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of period",
        "label": "Debt Securities, Available-For-Sale, Allowance For Credit Loss, Excluding Accrued Interest, Including Impairment",
        "documentation": "Debt Securities, Available-For-Sale, Allowance For Credit Loss, Excluding Accrued Interest, Including Impairment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses of fixed maturities available-for-sale",
        "verboseLabel": "Allowance for Credit Losses",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest",
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost (Less Allowance for Credit Losses)",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss",
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1600"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized cost of fixed maturities available-for-sale",
        "verboseLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss",
        "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "12 months or longer, fair value",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r435",
      "r1236"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "12 months or longer, gross unrealized losses",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r435"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less than 12 months, fair value",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r435",
      "r1236"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less than 12 months, gross unrealized losses",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r435"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Investments",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fixed maturities available-for-sale, at fair value (amortized cost of $86,819 and $84,717) (allowance for credit losses of $3 and $2)",
        "terseLabel": "Fair Value",
        "totalLabel": "Fair\u00a0Value",
        "netLabel": "Fixed maturities, AFS:",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest",
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1600"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit losses recognized this period on securities for which credit losses were not previously recognized",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Not Previously Recorded",
        "documentation": "Amount, excluding accrued interest, of credit loss expense on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) with no credit loss previously recorded."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r438"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net (increase) decrease in Allowance for Credit and Intent to Sell losses",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Period Increase (Decrease)",
        "documentation": "Amount, excluding accrued interest, of increase (decrease) in allowance for credit loss of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1602"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossRollForward",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed Maturities - Credit Loss Impairments",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recognized impairments on securities impaired to fair value this period",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Sell before Recovery",
        "documentation": "Amount, excluding accrued interest, of decrease in allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) from intent to sell or more likely than not will be required to sell before recovery of amortized cost basis."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "eqh_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSoldReversalOfSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSoldReversalOfSale",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Previously recognized impairments on securities that matured, paid, prepaid or sold",
        "label": "Debt Securities, Available-For-Sale, Excluding Accrued Interest, Allowance For Credit Loss, Sold (Reversal Of Sale)",
        "documentation": "Debt Securities, Available-For-Sale, Excluding Accrued Interest, Allowance For Credit Loss, Sold (Reversal Of Sale)"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoffRecovery": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoffRecovery",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional credit losses this period on securities previously impaired",
        "label": "Debt Securities, Available-For-Sale, Excluding Accrued Interest, Allowance For Credit Loss, Writeoff (Recovery)",
        "documentation": "Debt Securities, Available-For-Sale, Excluding Accrued Interest, Allowance For Credit Loss, Writeoff (Recovery)"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DebtSecuritiesAvailableForSaleNetUnrealizedInvestmentsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtSecuritiesAvailableForSaleNetUnrealizedInvestmentsRollForward",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-For-Sale, Net Unrealized Investments [Roll Forward]",
        "label": "Debt Securities, Available-For-Sale, Net Unrealized Investments [Roll Forward]",
        "documentation": "Debt Securities, Available-for-sale, Net Unrealized Investments [Roll Forward]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DebtSecuritiesAvailableForSaleSecuritiesAmortizedCostBasisOtherThanInvestmentGrade": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtSecuritiesAvailableForSaleSecuritiesAmortizedCostBasisOtherThanInvestmentGrade",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available-for-sale securities, amortized cost basis other than investment grade",
        "label": "Debt Securities, Available-For-Sale Securities, Amortized Cost Basis, Other Than Investment Grade",
        "documentation": "Debt Securities, Available-For-Sale Securities, Amortized Cost Basis, Other Than Investment Grade"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DebtSecuritiesAvailableForSaleSecuritiesGrossRealizedGainsOfSecuritiesSoldCostBasisMethodology": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtSecuritiesAvailableForSaleSecuritiesGrossRealizedGainsOfSecuritiesSoldCostBasisMethodology",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross gains on sales",
        "label": "Debt Securities, Available-For-Sale Securities, Gross Realized Gains Of Securities Sold, Cost Basis Methodology",
        "documentation": "Disclosure of the basis (methodology and assumptions) on which cost was determined (for example, specific identification, average cost, or other allowed methods) in computing realized gain on securities sold which were categorized neither as held-to-maturity nor trading."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DebtSecuritiesAvailableForSaleSecuritiesGrossRealizedLossesOfSecuritiesSoldCostBasisMethodology": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtSecuritiesAvailableForSaleSecuritiesGrossRealizedLossesOfSecuritiesSoldCostBasisMethodology",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gross losses on sales",
        "label": "Debt Securities, Available-For-Sale Securities, Gross Realized Losses Of Securities Sold, Cost Basis Methodology",
        "documentation": "Disclosure of the basis (methodology and assumptions) on which cost was determined (for example, specific identification, average cost, or other allowed methods) in computing realized (loss) on securities sold which were categorized neither as held-to-maturity nor trading."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails",
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Available-for-sale Securities [Table]",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Available-for-Sale Fixed Maturities by Classification",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1574",
      "r1575",
      "r1576",
      "r1577",
      "r1578",
      "r1579",
      "r1580",
      "r1581",
      "r1582",
      "r1583",
      "r1584",
      "r1588"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total fair value",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r432",
      "r1236"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total gross unrealized losses",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r433"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Continuous Gross Unrealized Losses for Available-for-Sale Fixed Maturities",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r1236",
      "r1601"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of positions in unrealized loss position",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r434"
     ]
    },
    "eqh_DebtSecuritiesExposureInSingleIssuerGreaterThanStatedPercentageOfTotalInvestments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtSecuritiesExposureInSingleIssuerGreaterThanStatedPercentageOfTotalInvestments",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt securities exposure in single issuer greater than stated percentage of total investments",
        "label": "Debt Securities Exposure In Single Issuer Greater Than Stated Percentage Of Total Investments",
        "documentation": "Investment disclosure of credit risk exposure to Debt securities in single issuer of less than a stated percentage of Company's total investments."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DebtSecuritiesExposureInSingleIssuerOfTotalInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtSecuritiesExposureInSingleIssuerOfTotalInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exposure in single issuer of total investments",
        "label": "Debt Securities, Exposure In Single Issuer Of Total Investments",
        "documentation": "Investment disclosure of credit risk exposure to Debt securities in single issuer of Company's total investments."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DebtSecuritiesExposureInSingleIssuerOfTotalInvestmentsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtSecuritiesExposureInSingleIssuerOfTotalInvestmentsPercentage",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt securities exposure in single issuer of total investments, percentage",
        "label": "Debt Securities, Exposure In Single Issuer Of Total Investments, Percentage",
        "documentation": "Debt Securities, Exposure In Single Issuer Of Total Investments, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DebtServiceCoverageRatioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtServiceCoverageRatioAxis",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Service Coverage Ratio [Axis]",
        "label": "Debt Service Coverage Ratio [Axis]",
        "documentation": "Debt Service Coverage Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DebtServiceCoverageRatioDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DebtServiceCoverageRatioDomain",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Service Coverage Ratio [Domain]",
        "label": "Debt Service Coverage Ratio [Domain]",
        "documentation": "Debt Service Coverage Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DeferredIncomeTaxAssetLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DeferredIncomeTaxAssetLiabilityMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred Income Tax\u00a0Asset (Liability)",
        "label": "Deferred Income Tax Asset (Liability) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current and deferred income taxes",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r684",
      "r685"
     ]
    },
    "us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredPolicyAcquisitionCostAmortizationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization",
        "label": "Deferred Policy Acquisition Costs, Amortization Expense",
        "documentation": "Amount of amortization expense (reversal of expense) for deferred policy acquisition costs."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r261",
      "r973",
      "r995",
      "r997",
      "r1031",
      "r1301",
      "r1331",
      "r1334",
      "r1544",
      "r1787"
     ]
    },
    "us-gaap_DeferredPolicyAcquisitionCostAmortizationExpenseNetInvestmentGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredPolicyAcquisitionCostAmortizationExpenseNetInvestmentGainsLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": "eqh_BenefitsLossesAndExpensesAdjusted",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization of deferred policy acquisition costs",
        "terseLabel": "Amortization of deferred policy acquisition costs",
        "label": "Deferred Policy Acquisition Cost, Amortization Expense, Net Investment Gains (Losses)",
        "documentation": "Amount of amortization expense (reversal of amortization expense) of deferred policy acquisition costs from realized net investment gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_DeferredPolicyAcquisitionCostLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredPolicyAcquisitionCostLineItems",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Policy Acquisition Cost [Line Items]",
        "label": "Deferred Policy Acquisition Cost [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r997",
      "r1031",
      "r1301"
     ]
    },
    "us-gaap_DeferredPolicyAcquisitionCostTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredPolicyAcquisitionCostTable",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Policy Acquisition Cost [Table]",
        "label": "Deferred Policy Acquisition Cost [Table]",
        "documentation": "Disclosure of information about deferred policy acquisition cost."
       }
      }
     },
     "auth_ref": [
      "r997",
      "r1031",
      "r1301"
     ]
    },
    "us-gaap_DeferredPolicyAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredPolicyAcquisitionCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred policy acquisition costs",
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of year",
        "label": "Deferred Policy Acquisition Cost",
        "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r956",
      "r997",
      "r998",
      "r1031",
      "r1301",
      "r1331",
      "r1334"
     ]
    },
    "us-gaap_DeferredPolicyAcquisitionCostsAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredPolicyAcquisitionCostsAdditions",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalization",
        "label": "Deferred Policy Acquisition Cost, Capitalization",
        "documentation": "Amount of deferred policy acquisition cost capitalized."
       }
      }
     },
     "auth_ref": [
      "r1301",
      "r1800",
      "r1832"
     ]
    },
    "us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredPolicyAcquisitionCostsTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Policy Acquisition Costs",
        "label": "Deferred Policy Acquisition Costs [Table Text Block]",
        "documentation": "Tabular disclosure of the movement in deferred policy acquisition costs."
       }
      }
     },
     "auth_ref": [
      "r997",
      "r1031",
      "r1301",
      "r1801"
     ]
    },
    "us-gaap_DeferredSalesInducementsAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredSalesInducementsAdditions",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalization",
        "label": "Deferred Sale Inducement Cost, Capitalization",
        "documentation": "Amount of deferred sale inducement cost capitalized."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r1800",
      "r1832"
     ]
    },
    "us-gaap_DeferredSalesInducementsAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredSalesInducementsAmortizationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amortization",
        "label": "Deferred Sales Inducement Cost, Amortization Expense",
        "documentation": "Amount of amortization expense (reversal of expense) for deferred sales inducement cost."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r994",
      "r1787",
      "r1800",
      "r1832"
     ]
    },
    "us-gaap_DeferredSalesInducementsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredSalesInducementsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of year",
        "periodEndLabel": "Balance, end of year",
        "label": "Deferred Sale Inducement Cost",
        "documentation": "Amount of deferred sale inducement cost capitalized on contract remaining in force."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r994",
      "r1800",
      "r1801",
      "r1832"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails",
      "http://www.equitable.com/role/INCOMETAXESDetails",
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r693"
     ]
    },
    "us-gaap_DefinedBenefitPlanAdministrationExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanAdministrationExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administration expense",
        "label": "Defined Benefit Plan, Plan Assets, Administration Expense",
        "documentation": "Amount of administration expense of defined benefit plan which decreases plan assets. Excludes plan administration expense paid by employer."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DefinedBenefitPlanAmortizationNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DefinedBenefitPlanAmortizationNet",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net amortization",
        "label": "Defined Benefit Plan, Amortization, Net",
        "documentation": "Defined Benefit Plan, Amortization, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior period service cost amortization",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r588",
      "r630",
      "r1252",
      "r1253"
     ]
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r634"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expected return on assets",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r586",
      "r628",
      "r1252",
      "r1253"
     ]
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional fund to cover obligations",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r570",
      "r605",
      "r1252"
     ]
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanInterestCost",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest cost",
        "label": "Defined Benefit Plan, Interest Cost",
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r553",
      "r585",
      "r627",
      "r1252",
      "r1253"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Periodic Pension Expense",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r624",
      "r625",
      "r1252",
      "r1253"
     ]
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Impact of settlement",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r590",
      "r632"
     ]
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanServiceCost",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service cost",
        "label": "Defined Benefit Plan, Service Cost",
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r551",
      "r584",
      "r626",
      "r1252",
      "r1253"
     ]
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlements",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "us-gaap_DerivativeAssetFairValueGrossLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeAssetFairValueGrossLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amount Offset\u00a0in\u00a0the Balance\u00a0Sheets",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, Liability Offset",
        "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r780",
      "r1164",
      "r1165"
     ]
    },
    "us-gaap_DerivativeCollateralObligationToReturnCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeCollateralObligationToReturnCash",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gross Amount not Offset in the Balance Sheets",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset",
        "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r236",
      "r780",
      "r781",
      "r782",
      "r1205",
      "r1207",
      "r1208"
     ]
    },
    "us-gaap_DerivativeCollateralRightToReclaimSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeCollateralRightToReclaimSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Amount not Offset in the Balance Sheets",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Security Not Offset",
        "documentation": "Amount of right to receive securities collateral under master netting arrangements that have not been offset against derivative liabilities."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r236",
      "r780",
      "r1205"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails",
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r1091",
      "r1094",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1160",
      "r1162",
      "r1163",
      "r1166",
      "r1205",
      "r1206",
      "r1209",
      "r1269",
      "r1270",
      "r1343",
      "r1345",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1489",
      "r1490",
      "r1491",
      "r1492",
      "r1734",
      "r1735",
      "r1736",
      "r1737",
      "r1748",
      "r1749",
      "r1750",
      "r1751",
      "r1752",
      "r1753",
      "r1755",
      "r1756"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amount Recognized",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r232",
      "r780",
      "r1205",
      "r1207",
      "r1208",
      "r1209"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeNet",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Assets",
        "totalLabel": "Net\u00a0Amount Presented\u00a0in\u00a0the Balance Sheets",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral",
        "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r1486",
      "r1734",
      "r1737"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Amount",
        "label": "Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction",
        "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r780",
      "r1205"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amount Recognized",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r232",
      "r780",
      "r1205",
      "r1207",
      "r1208",
      "r1209"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Liabilities",
        "totalLabel": "Net Amount Presented\u00a0in\u00a0the Balance Sheets",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral",
        "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r1486",
      "r1734"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Amount",
        "label": "Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction",
        "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r780",
      "r1205"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeFairValueOfDerivativeNet",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Derivatives",
        "label": "Derivative, Fair Value, Net",
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives."
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeGainLossOnDerivativeNet",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net derivative gains (losses)",
        "negatedLabel": "Net derivative (gains) losses",
        "verboseLabel": "Net Derivatives Gain (Losses)",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r1200",
      "r1725"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails",
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r1091",
      "r1094",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1160",
      "r1162",
      "r1163",
      "r1166",
      "r1205",
      "r1206",
      "r1209",
      "r1269",
      "r1270",
      "r1343",
      "r1345",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1489",
      "r1490",
      "r1491",
      "r1492",
      "r1734",
      "r1735",
      "r1736",
      "r1737",
      "r1748",
      "r1749",
      "r1750",
      "r1751",
      "r1752",
      "r1753",
      "r1755",
      "r1756"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DERIVATIVES",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r766",
      "r767",
      "r768",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r784",
      "r795",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Axis]",
        "label": "Hedging Relationship [Axis]",
        "documentation": "Information by type of hedging relationship."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DerivativeInstrumentsIncludingEmbeddedDerivativeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DerivativeInstrumentsIncludingEmbeddedDerivativeMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total derivative instruments",
        "label": "Derivative Instruments Including Embedded Derivative [Member]",
        "documentation": "Derivative Instruments Including Embedded Derivative"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeLiabilityFairValueGrossAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeLiabilityFairValueGrossAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amount Offset\u00a0in\u00a0the Balance\u00a0Sheets",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, Asset Offset",
        "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r780",
      "r1164",
      "r1165",
      "r1207",
      "r1208"
     ]
    },
    "us-gaap_DerivativeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeLineItems",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESNarrativeDetails",
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails",
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Line Items]",
        "label": "Derivative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r1738"
     ]
    },
    "us-gaap_DerivativeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "label": "Derivative [Member]",
        "documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender)."
       }
      }
     },
     "auth_ref": [
      "r1275"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notional Amount",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1269",
      "r1721",
      "r1722"
     ]
    },
    "us-gaap_DerivativeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeTable",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESNarrativeDetails",
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails",
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Table]",
        "label": "Derivative [Table]",
        "documentation": "Disclosure of information about derivative instrument or group of derivative instruments, including, but not limited to, type of derivative instrument, risk being hedged, notional amount, hedge designation, related hedged item, inception date, and maturity date."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r1738"
     ]
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativesFairValueLineItems",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives, Fair Value [Line Items]",
        "label": "Derivatives, Fair Value [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r738",
      "r739",
      "r740",
      "r741",
      "r1270"
     ]
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated for Hedge Accounting",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_DiscountedCashFlowValuationTechniqueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "DiscountedCashFlowValuationTechniqueMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discounted cash flow",
        "label": "Discounted Cash Flow, Valuation Technique [Member]",
        "documentation": "Discounted cash flow valuation technique used to measure fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DividendsCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividends on common stock",
        "label": "Dividends, Common Stock",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r113"
     ]
    },
    "us-gaap_DividendsDeclaredTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DividendsDeclaredTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/EQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Dividends Declared",
        "label": "Dividends Declared [Table Text Block]",
        "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DividendsPreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends on preferred stock",
        "label": "Dividends, Preferred Stock",
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r113"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r1359"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1391"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1402"
     ]
    },
    "eqh_EQUIVESTGroupMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "EQUIVESTGroupMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "EQUI-VEST Group",
        "terseLabel": "EG",
        "label": "EQUI-VEST Group [Member]",
        "documentation": "EQUI-VEST Group"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_EQUIVESTIndividualMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "EQUIVESTIndividualMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "EQUI-VEST Individual",
        "terseLabel": "EI",
        "label": "EQUI-VEST Individual [Member]",
        "documentation": "EQUI-VEST Individual"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EARNINGS PER COMMON SHARE",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r257",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r296",
      "r302",
      "r305",
      "r316",
      "r317",
      "r318",
      "r322",
      "r516",
      "r681",
      "r706",
      "r713",
      "r799",
      "r800",
      "r919",
      "r968",
      "r1215"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income (loss) applicable to Holdings\u2019 common shareholders per common share:",
        "verboseLabel": "Earnings per common share:",
        "label": "Earnings Per Share, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r257",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r296",
      "r305",
      "r316",
      "r317",
      "r318",
      "r322",
      "r516",
      "r681",
      "r706",
      "r713",
      "r799",
      "r800",
      "r919",
      "r968",
      "r1215"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHARE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EARNINGS PER COMMON SHARE",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r319",
      "r320",
      "r321"
     ]
    },
    "eqh_EconomicInterestInSubsidiary": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "EconomicInterestInSubsidiary",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Economic interest in Subsidiary",
        "label": "Economic Interest In Subsidiary",
        "documentation": "Percentage of economic interest held in a subsidiary or sister company"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Direct MRB",
        "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability",
        "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability."
       }
      }
     },
     "auth_ref": [
      "r1724",
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "us-gaap_EmbeddedDerivativeFinancialInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmbeddedDerivativeFinancialInstrumentsMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total embedded derivatives",
        "label": "Embedded Derivative Financial Instruments [Member]",
        "documentation": "Derivative instrument embedded in host contract."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_EmbeddedDerivativeGMIBReinsuranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "EmbeddedDerivativeGMIBReinsuranceMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchased MRB asset",
        "label": "Embedded Derivative, GMIB Reinsurance [Member]",
        "documentation": "GMIB reinsurance contracts"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_EmbeddedDerivativeNonGMxBInsuranceProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "EmbeddedDerivativeNonGMxBInsuranceProductsMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "SCS, SIO, MSO and IUL Indexed Features",
        "terseLabel": "SCS, SIO, MSO and IUL indexed features\u2019 liability",
        "label": "Embedded Derivative, Non-GMxB Insurance Products [Member]",
        "documentation": "Represents non-GMXB insurance products considered embedded derivatives."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1690",
      "r1691",
      "r1692",
      "r1693",
      "r1694",
      "r1695",
      "r1696",
      "r1697",
      "r1698",
      "r1699",
      "r1700",
      "r1701",
      "r1702",
      "r1703",
      "r1704",
      "r1705",
      "r1706",
      "r1707",
      "r1708",
      "r1709",
      "r1710",
      "r1711",
      "r1712",
      "r1713",
      "r1714",
      "r1715"
     ]
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entities [Table]",
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1357"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
      "http://www.equitable.com/role/ORGANIZATIONDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1357"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1357"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1441"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1357"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1357"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r1357"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1357"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1396"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1437"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r1437"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1437"
     ]
    },
    "eqh_EquitableAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "EquitableAmericaMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equitable America",
        "label": "Equitable America [Member]",
        "documentation": "Equitable America"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_EquitableFinancialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "EquitableFinancialMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equitable Financial",
        "label": "Equitable Financial [Member]",
        "documentation": "Equitable Financial"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EQUITY",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails",
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails",
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r213",
      "r215",
      "r216",
      "r249",
      "r250",
      "r251",
      "r282",
      "r283",
      "r284",
      "r286",
      "r294",
      "r297",
      "r299",
      "r324",
      "r406",
      "r409",
      "r450",
      "r515",
      "r545",
      "r681",
      "r695",
      "r696",
      "r703",
      "r704",
      "r705",
      "r707",
      "r712",
      "r713",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r798",
      "r845",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r855",
      "r857",
      "r860",
      "r961",
      "r1028",
      "r1029",
      "r1030",
      "r1071",
      "r1146"
     ]
    },
    "eqh_EquityFuturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "EquityFuturesMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Futures",
        "label": "Equity Futures [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_EquityIncomeLossFromLimitedPartnerships": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "EquityIncomeLossFromLimitedPartnerships",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity (income) loss from limited partnerships",
        "label": "Equity Income (Loss) From Limited Partnerships",
        "documentation": "Equity Income (Loss) From Limited Partnerships"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_EquityInvestmentSeparateAccountsCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "EquityInvestmentSeparateAccountsCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separate account equity investment carrying value",
        "label": "Equity Investment, Separate Accounts, Carrying Value",
        "documentation": "Represents the carrying value of Other equity investments included the General Account's investment in Separate Accounts"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]",
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r702",
      "r837",
      "r1445",
      "r1446",
      "r1447",
      "r1717",
      "r1718",
      "r1719",
      "r1720"
     ]
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r270",
      "r275",
      "r405",
      "r837",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300"
     ]
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r270",
      "r275",
      "r405",
      "r837",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300"
     ]
    },
    "us-gaap_EquityMethodInvestmentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityMethodInvestmentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other equity investments",
        "label": "Equity Method Investments, Fair Value Disclosure",
        "documentation": "Fair value portion of investments accounted under the equity method."
       }
      }
     },
     "auth_ref": [
      "r835",
      "r1200",
      "r1284",
      "r1480",
      "r1743",
      "r1744",
      "r1754"
     ]
    },
    "us-gaap_EquityMethodInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityMethodInvestmentsMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
      "http://www.equitable.com/role/INVESTMENTSInvestmentGainsLossesNetDetails",
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other equity investments",
        "label": "Equity Method Investments [Member]",
        "documentation": "Investment in the stock of an investee which is adjusted for the investor's share of the earnings or losses of the investee after the date of acquisition."
       }
      }
     },
     "auth_ref": [
      "r1200",
      "r1284"
     ]
    },
    "us-gaap_EquitySecuritiesByIndustryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquitySecuritiesByIndustryAxis",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Industry Sector [Axis]",
        "label": "Industry Sector [Axis]",
        "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate."
       }
      }
     },
     "auth_ref": [
      "r1085",
      "r1088",
      "r1090",
      "r1153",
      "r1155",
      "r1159",
      "r1172",
      "r1232",
      "r1233",
      "r1274",
      "r1275",
      "r1277",
      "r1345"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquitySecuritiesFvNiGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSEquitySecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSEquitySecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Unrealized and realized gains (losses) on equity securities",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r970",
      "r1592"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquitySecuritiesFvNiMeasurementInput",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage measurement input of equity securities",
        "label": "Equity Securities, FV-NI, Measurement Input",
        "documentation": "Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r804",
      "r805",
      "r806"
     ]
    },
    "us-gaap_EquitySecuritiesIndustryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquitySecuritiesIndustryMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Industry Sector [Domain]",
        "label": "Industry Sector [Domain]",
        "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate."
       }
      }
     },
     "auth_ref": [
      "r1085",
      "r1088",
      "r1090",
      "r1153",
      "r1155",
      "r1159",
      "r1172",
      "r1232",
      "r1233",
      "r1274",
      "r1275",
      "r1277",
      "r1345"
     ]
    },
    "us-gaap_EquitySwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquitySwapMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Swaps",
        "label": "Equity Swap [Member]",
        "documentation": "Contracts in which the counterparties exchange a series of cash payments based on (a) an equity index and (b) a fixed or floating interest rate on a notional principal amount. Equity swap contracts typically are tied to a stock index, but sometimes they relate to a particular stock or a defined basket of stocks."
       }
      }
     },
     "auth_ref": [
      "r1730"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1406"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1364",
      "r1374",
      "r1384",
      "r1416"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r1361",
      "r1371",
      "r1381",
      "r1413"
     ]
    },
    "us-gaap_ErrorCorrectionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ErrorCorrectionTextBlock",
     "presentation": [
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS",
        "label": "Error Correction [Text Block]",
        "documentation": "The entire disclosure for reporting error correction."
       }
      }
     },
     "auth_ref": [
      "r295"
     ]
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "presentation": [
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r296",
      "r297",
      "r298",
      "r299",
      "r322"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Estimate of Fair Value Measurement [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r830",
      "r832",
      "r835",
      "r1200",
      "r1240",
      "r1241"
     ]
    },
    "eqh_EuroStoxxFTSE100TopixASX200AndEAFEIndicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "EuroStoxxFTSE100TopixASX200AndEAFEIndicesMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Euro Stoxx, FTSE100, Topix, ASX200 and EAFE Indices",
        "label": "Euro Stoxx, FTSE100, Topix, ASX200 and EAFE Indices [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExcessOfReportedClosedBlockLiabilitiesOverAssetsDesignatedToClosedBlock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ExcessOfReportedClosedBlockLiabilitiesOverAssetsDesignatedToClosedBlock",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": "us-gaap_ClosedBlockAssetsAndLiabilitiesMaximumFutureEarningsToBeRecognized",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Excess of Closed Block liabilities over assets designated to the Closed Block",
        "label": "Excess of Reported Closed Block Liabilities over Assets Designated to Closed Block",
        "documentation": "The difference between the liabilities of and the assets allocated to the segregated group of participating or dividend-paying policies and contracts identified as the closed block."
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1838"
     ]
    },
    "eqh_ExchangeTradedFutureContractInitialMarginRequirement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ExchangeTradedFutureContractInitialMarginRequirement",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial margin requirement",
        "label": "Exchange-Traded Future Contract, Initial Margin Requirement",
        "documentation": "Exchange-Traded Future Contract, Initial Margin Requirement."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ExchangeTradedFutureContractMarketAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ExchangeTradedFutureContractMarketAxis",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange Traded Future Contract, Market [Axis]",
        "label": "Exchange Traded Future Contract, Market [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ExchangeTradedFutureContractMarketDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ExchangeTradedFutureContractMarketDomain",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange Traded Future Contract, Market [Domain]",
        "label": "Exchange Traded Future Contract, Market [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1412"
     ]
    },
    "us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ExpenseRelatedToDistributionOrServicingAndUnderwritingFees",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense related to distribution fees",
        "label": "Expense Related to Distribution or Servicing and Underwriting Fees",
        "documentation": "Expense related to distribution, servicing and underwriting fees."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_ExternalCreditRatingByGroupingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ExternalCreditRatingByGroupingAxis",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "External Credit Rating by Grouping [Axis]",
        "label": "External Credit Rating by Grouping [Axis]",
        "documentation": "Information by external rating classified as investment grade or non investment grade."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r1598"
     ]
    },
    "us-gaap_ExternalCreditRatingByGroupingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ExternalCreditRatingByGroupingDomain",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "External Credit Rating by Grouping [Domain]",
        "label": "External Credit Rating by Grouping [Domain]",
        "documentation": "External credit rating classified as investment grade or non-investment grade."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExternalCreditRatingNonInvestmentGradeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ExternalCreditRatingNonInvestmentGradeMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Investment Grade",
        "label": "External Credit Rating, Noninvestment Grade [Member]",
        "documentation": "External credit rating used to describe current status of payment and performance risk of credit derivative and guarantee obligation that connote noninvestment grade."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period",
        "label": "Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) recognized in income from asset (liability) measured at fair value on recurring basis using unobservable input (level 3) and still held."
       }
      }
     },
     "auth_ref": [
      "r1753"
     ]
    },
    "us-gaap_FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossOci": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossOci",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period",
        "label": "Fair Value, Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), OCI",
        "documentation": "Amount of unrealized gain (loss) recognized in other comprehensive income (OCI) from asset (liability) measured at fair value on recurring basis using unobservable input (level 3) and still held."
       }
      }
     },
     "auth_ref": [
      "r1753"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r802",
      "r803",
      "r818",
      "r1274"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r802",
      "r803",
      "r818",
      "r1274"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Domain]",
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r819",
      "r1200",
      "r1275",
      "r1284"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r819",
      "r1275"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument asset measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r819",
      "r1275"
     ]
    },
    "eqh_FairValueAssetsUnrealizedGainsLossesByCategoryLevel3AssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FairValueAssetsUnrealizedGainsLossesByCategoryLevel3AssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Assets and Liabilities at Level 3",
        "label": "Fair Value Assets, Unrealized Gains (Losses) By Category, Level 3 Assets And Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of unrealized gains (losses) by category for Level 3 assets and liabilities still held at the end of the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r832",
      "r833",
      "r1200",
      "r1284",
      "r1761"
     ]
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Axis]",
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r819",
      "r1200",
      "r1275",
      "r1284"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r833",
      "r1200",
      "r1284",
      "r1759",
      "r1761"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r831",
      "r834",
      "r1200",
      "r1284",
      "r1761"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r608",
      "r609",
      "r801",
      "r803",
      "r804",
      "r805",
      "r806",
      "r815",
      "r818",
      "r820",
      "r830",
      "r871",
      "r872",
      "r873",
      "r1200",
      "r1240",
      "r1241",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1274",
      "r1277",
      "r1284"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r830",
      "r832",
      "r833",
      "r835",
      "r837",
      "r838",
      "r1200",
      "r1240",
      "r1241",
      "r1761"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r802",
      "r803",
      "r804",
      "r806",
      "r1274",
      "r1746",
      "r1757"
     ]
    },
    "eqh_FairValueDisclosureFinancialInstrumentsNotCarriedAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FairValueDisclosureFinancialInstrumentsNotCarriedAtFairValueTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Disclosure Financial Instruments Not Carried At Fair Value",
        "label": "Fair Value Disclosure, Financial Instruments Not Carried At Fair Value [Table Text Block]",
        "documentation": "Disclosure of carrying values and estimated fair values for assets and liabilities, not carried at fair value where the fair value differs from the carrying value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r1240",
      "r1241"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FAIR VALUE DISCLOSURES",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r804",
      "r811",
      "r813",
      "r814",
      "r815",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r913",
      "r1274",
      "r1278"
     ]
    },
    "eqh_FairValueInputsAssetsQuantitativeInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FairValueInputsAssetsQuantitativeInformationLineItems",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Inputs Assets Quantitative Information [Line Items]",
        "label": "Fair Value Inputs Assets Quantitative Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FairValueInputsAssetsQuantitativeInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FairValueInputsAssetsQuantitativeInformationTable",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Inputs Assets Quantitative Information [Table]",
        "label": "Fair Value Inputs Assets Quantitative Information [Table]",
        "documentation": "Tabular disclosure for quantitative fair value information."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FairValueInputsDiscountPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FairValueInputsDiscountPeriod",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount years",
        "label": "Fair Value Inputs, Discount Period",
        "documentation": "Fair Value Inputs, Discount Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a01",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r574",
      "r579",
      "r608",
      "r803",
      "r818",
      "r830",
      "r871",
      "r1200",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1274",
      "r1284"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a02",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r574",
      "r579",
      "r608",
      "r610",
      "r803",
      "r804",
      "r818",
      "r830",
      "r872",
      "r1200",
      "r1240",
      "r1241",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1274",
      "r1284"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a03",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r608",
      "r609",
      "r803",
      "r804",
      "r805",
      "r806",
      "r818",
      "r830",
      "r873",
      "r1200",
      "r1240",
      "r1241",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1274",
      "r1277",
      "r1284"
     ]
    },
    "eqh_FairValueInputsQuantitativeInformationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FairValueInputsQuantitativeInformationTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Quantitative Information About Level 3 Fair Value Measurement",
        "label": "Fair Value Inputs, Quantitative Information [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "NAV",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "documentation": "Fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r574",
      "r608",
      "r801",
      "r820",
      "r1274"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r802",
      "r803",
      "r804",
      "r806",
      "r1274",
      "r1746",
      "r1757"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetConsolidationOfVariableInterestEntities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetConsolidationOfVariableInterestEntities",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Activity related to consolidated VIEs/VOEs",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Consolidation Of Variable Interest Entities",
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Consolidation of Variable Interest Entities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r808",
      "r819",
      "r1275",
      "r1276"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss)",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r809",
      "r819",
      "r1275"
     ]
    },
    "eqh_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails": {
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment gains (losses), net",
        "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) On Investments",
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) On Investments"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetInvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetInvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails": {
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment income (loss)",
        "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Investment Income, Net",
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Investment Income, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Debt issuances",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances",
        "documentation": "Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r816",
      "r819",
      "r1275"
     ]
    },
    "eqh_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOther",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Other",
        "documentation": "Fair Value Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r816",
      "r819",
      "r1275"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Sales",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r819",
      "r1275"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Settlements",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r819",
      "r1275"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "AFS fixed maturities transferred from Level 2 to Level 3",
        "terseLabel": "Transfers into level 3",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r811",
      "r817",
      "r819",
      "r1275"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AFS fixed maturities transferred from Level 3 to Level 2",
        "negatedTerseLabel": "Transfers out of level 3",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy."
       }
      }
     },
     "auth_ref": [
      "r811",
      "r817",
      "r819",
      "r1275"
     ]
    },
    "eqh_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersPercentage",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of total equity representing AFS fixed maturities transferred",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers, Percentage",
        "documentation": "Percentage of transfers into assets measured at fair value that have taken place during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of period",
        "terseLabel": "Fair value of fixed maturities AFS",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r807",
      "r819",
      "r1275"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r608",
      "r609",
      "r801",
      "r803",
      "r804",
      "r805",
      "r806",
      "r815",
      "r818",
      "r820",
      "r830",
      "r871",
      "r872",
      "r873",
      "r1200",
      "r1240",
      "r1241",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1274",
      "r1277",
      "r1284"
     ]
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsNonrecurringMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonrecurring",
        "label": "Fair Value, Nonrecurring [Member]",
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r802",
      "r803",
      "r804",
      "r806",
      "r1274",
      "r1746"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r1274",
      "r1743",
      "r1744",
      "r1745",
      "r1746",
      "r1747",
      "r1757"
     ]
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "documentation": "Disclosure of information about location and fair value of derivative instrument and nonderivative instrument designated as hedging instrument."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r738",
      "r739",
      "r740",
      "r741",
      "r1270"
     ]
    },
    "us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value of collateral pledged for federal home loan bank",
        "label": "Federal Home Loan Bank, Advances, General Debt Obligations, Disclosures, Collateral Pledged",
        "documentation": "Amount of the collateral pledged in support of federal home loan bank advances outstanding."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r136"
     ]
    },
    "us-gaap_FederalHomeLoanBankAdvancesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FederalHomeLoanBankAdvancesTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Activity of Funding Agreements",
        "label": "Federal Home Loan Bank, Advances [Table Text Block]",
        "documentation": "Tabular disclosure of advances made and reported by Federal Home Loan Bank (FHLBank)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FederalHomeLoanBankCertificatesAndObligationsFHLBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FederalHomeLoanBankCertificatesAndObligationsFHLBMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal Home Loan Bank (FHLB)",
        "label": "Federal Home Loan Bank Certificates and Obligations (FHLB) [Member]",
        "documentation": "Investments in securities issued by or through the member banks of the federal home loan bank (FHLB)."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r125"
     ]
    },
    "us-gaap_FederalHomeLoanBankStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FederalHomeLoanBankStock",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal home loan bank stock",
        "label": "Federal Home Loan Bank Stock",
        "documentation": "Federal Home Loan Bank (FHLB) stock represents an equity interest in a FHLB. It does not have a readily determinable fair value because its ownership is restricted and it lacks a market (liquidity)."
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "us-gaap_FinancialAssetNotPastDueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialAssetNotPastDueMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current",
        "label": "Financial Asset, Not Past Due [Member]",
        "documentation": "Financial asset not past due."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r1235"
     ]
    },
    "us-gaap_FinancialAssetPastDueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialAssetPastDueMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Past Due",
        "label": "Financial Asset, Past Due [Member]",
        "documentation": "Financial asset past due."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r419",
      "r1235"
     ]
    },
    "us-gaap_FinancialGuaranteeInsuranceContractsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialGuaranteeInsuranceContractsTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INSURANCE STATUTORY FINANCIAL INFORMATION",
        "label": "Financial Guarantee Insurance Contracts [Text Block]",
        "documentation": "The entire disclosure for financial guarantee insurance contracts (as defined) issued by the entity. Such disclosure is intended to enable users of the financial information to understand the factors affecting the present and future recognition and measurement of the entity's financial guarantee insurance contracts."
       }
      }
     },
     "auth_ref": [
      "r1027",
      "r1042"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r411",
      "r412",
      "r419",
      "r420",
      "r426",
      "r431",
      "r436",
      "r437",
      "r511",
      "r541",
      "r783",
      "r795",
      "r825",
      "r836",
      "r839",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r885",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r933",
      "r962",
      "r1236",
      "r1274",
      "r1275",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1288",
      "r1462",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467",
      "r1468",
      "r1588",
      "r1589",
      "r1590",
      "r1591",
      "r1742",
      "r1745",
      "r1746",
      "r1747",
      "r1754",
      "r1757",
      "r1758",
      "r1759"
     ]
    },
    "us-gaap_FinancialInstrumentPerformanceStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialInstrumentPerformanceStatusAxis",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument Performance Status [Axis]",
        "label": "Financial Instrument Performance Status [Axis]",
        "documentation": "Information by category of performance or non-performance status of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r1599"
     ]
    },
    "us-gaap_FinancialInstrumentPerformanceStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialInstrumentPerformanceStatusDomain",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument Performance Status [Domain]",
        "label": "Financial Instrument Performance Status [Domain]",
        "documentation": "Category of performance or non-performance status of financial instruments, including but not limited to, financing receivables, loans, debt, and investments."
       }
      }
     },
     "auth_ref": [
      "r1599"
     ]
    },
    "us-gaap_FinancingReceivableAccruedInterestWriteoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableAccruedInterestWriteoff",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest written off",
        "label": "Financing Receivable, Accrued Interest, Writeoff",
        "documentation": "Amount of writeoff of accrued interest on financing receivable recognized by reversing interest income."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Allowance for credit losses of mortgage loans on real estate",
        "terseLabel": "Allowance for credit losses",
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of period",
        "label": "Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest",
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r1596"
     ]
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableAllowanceForCreditLossesLineItems",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Line Items]",
        "label": "Financing Receivable, Allowance for Credit Loss [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418"
     ]
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableAllowanceForCreditLossesRollForward",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses on mortgage loans:",
        "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivableBeforeAllowanceForCreditLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableBeforeAllowanceForCreditLossAbstract",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Receivable, before Allowance for Credit Loss [Abstract]",
        "label": "Financing Receivable, before Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableCreditQualityIndicatorsTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financing Receivable Credit Quality Indicators",
        "label": "Financing Receivable Credit Quality Indicators [Table Text Block]",
        "documentation": "Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics."
       }
      }
     },
     "auth_ref": [
      "r1598"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Investments",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage loans on real estate (net of allowance for credit losses of $278 and $279)",
        "verboseLabel": "Mortgage loans on real estate",
        "label": "Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss",
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r1596"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in allowance",
        "label": "Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Period Increase (Decrease)",
        "documentation": "Amount, excluding accrued interest, of increase (decrease) in allowance for credit loss on financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r1597"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Recoveries of amounts previously written off",
        "label": "Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Recovery",
        "documentation": "Amount, excluding accrued interest, of increase in allowance for credit loss on financing receivable from recovery. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Write-offs charged against the allowance",
        "label": "Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss, Writeoff",
        "documentation": "Amount, excluding accrued interest, of decrease in allowance for credit loss on financing receivable from writeoff. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r428"
     ]
    },
    "eqh_FinancingReceivableExcludingAccruedInterestAndNonaccrualLoansBeforeAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FinancingReceivableExcludingAccruedInterestAndNonaccrualLoansBeforeAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails_1": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Financing Receivable, Excluding Accrued Interest And Nonaccrual Loans, Before Allowance For Credit Loss",
        "documentation": "Financing Receivable, Excluding Accrued Interest And Nonaccrual Loans, Before Allowance For Credit Loss"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss",
        "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r427",
      "r1596"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossByOriginationYearAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossByOriginationYearAbstract",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Cost Basis by Origination Year",
        "label": "Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss, by Origination Year [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current-period provision for expected credit losses",
        "label": "Financing Receivable, Excluding Accrued Interest, Credit Loss Expense (Reversal)",
        "documentation": "Amount, excluding accrued interest, of credit loss expense (reversal of expense) on financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r414"
     ]
    },
    "eqh_FinancingReceivableExcludingAccruedInterestModifiedInPeriodNumberOfContracts": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FinancingReceivableExcludingAccruedInterestModifiedInPeriodNumberOfContracts",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of loans split into notes",
        "label": "Financing Receivable, Excluding Accrued Interest, Modified In Period, Number Of Contracts",
        "documentation": "Financing Receivable, Excluding Accrued Interest, Modified In Period, Number Of Contracts"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FinancingReceivableExcludingAccruedInterestModifiedInPeriodNumberOfContractsWithOriginalLoanTerms": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FinancingReceivableExcludingAccruedInterestModifiedInPeriodNumberOfContractsWithOriginalLoanTerms",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of notes with original loan terms",
        "label": "Financing Receivable, Excluding Accrued Interest, Modified In Period, Number Of Contracts With Original Loan Terms",
        "documentation": "Financing Receivable, Excluding Accrued Interest, Modified In Period, Number Of Contracts With Original Loan Terms"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestNonaccrual",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails_1": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-accruing Loans",
        "label": "Financing Receivable, Excluding Accrued Interest, Nonaccrual",
        "documentation": "Amortized cost excluding accrued interest, of financing receivable on nonaccrual status. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrualNoAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestNonaccrualNoAllowance",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-accruing Loans with No Allowance",
        "label": "Financing Receivable, Excluding Accrued Interest, Nonaccrual, No Allowance",
        "documentation": "Amortized cost excluding accrued interest, of financing receivable on nonaccrual status with no allowance for credit loss. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior",
        "label": "Financing Receivable, Excluding Accrued Interest, Originated, More than Five Years before Current Fiscal Year",
        "documentation": "Amortized cost excluding accrued interest, of financing receivable originated more than five years prior to current fiscal year. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r428",
      "r1234"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestRevolving": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestRevolving",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Loans Amortized Cost Basis",
        "label": "Financing Receivable, Excluding Accrued Interest, Revolving",
        "documentation": "Amortized cost excluding accrued interest, of financing receivable that can be withdrawn, repaid, and redrawn."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r428",
      "r1234"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Loans Converted to Term Loans Amortized Cost Basis",
        "label": "Financing Receivable, Excluding Accrued Interest, Revolving, Converted to Term Loan",
        "documentation": "Amortized cost excluding accrued interest, of revolving financing receivable converted to term loan."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r429",
      "r1234"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Four years before current fiscal year",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Five, Originated, Four Years before Current Fiscal Year",
        "documentation": "Amortized cost excluding accrued interest, of financing receivable originated four years prior to current fiscal year. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r428",
      "r1234"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Three years before current fiscal year",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Four, Originated, Three Years before Current Fiscal Year",
        "documentation": "Amortized cost excluding accrued interest, of financing receivable originated three years prior to current fiscal year. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r428",
      "r1234"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current fiscal year",
        "label": "Financing Receivable, Excluding Accrued Interest, Year One, Originated, Current Fiscal Year",
        "documentation": "Amortized cost excluding accrued interest, of financing receivable originated in current fiscal year. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r428",
      "r1234"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two years before current fiscal year",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Three, Originated, Two Years before Current Fiscal Year",
        "documentation": "Amortized cost excluding accrued interest, of financing receivable originated two years prior to current fiscal year. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r428",
      "r1234"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails": {
       "parentTag": "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fiscal year before current fiscal year",
        "label": "Financing Receivable, Excluding Accrued Interest, Year Two, Originated, Fiscal Year before Current Fiscal Year",
        "documentation": "Amortized cost excluding accrued interest of financing receivable originated in fiscal year prior to current fiscal year. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r428",
      "r1234"
     ]
    },
    "eqh_FinancingReceivableModificationsContractsModifiedDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FinancingReceivableModificationsContractsModifiedDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Receivable, Modifications Contracts Modified During Period,",
        "label": "Financing Receivable, Modifications Contracts Modified During Period,",
        "documentation": "Financing Receivable, Modifications Contracts Modified During Period, Legal Fees"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FinancingReceivableModificationsContractsModifiedDuringPeriodAccruedDefaultInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FinancingReceivableModificationsContractsModifiedDuringPeriodAccruedDefaultInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Receivable, Modifications Contracts Modified During Period, Accrued Default Interest",
        "label": "Financing Receivable, Modifications Contracts Modified During Period, Accrued Default Interest",
        "documentation": "Financing Receivable, Modifications Contracts Modified During Period, Accrued Default Interest"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FinancingReceivableModificationsContractsModifiedDuringPeriodAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FinancingReceivableModificationsContractsModifiedDuringPeriodAmortizedCost",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized cost",
        "label": "Financing Receivable, Modifications Contracts Modified During Period, Amortized Cost",
        "documentation": "Financing Receivable, Modifications Contracts Modified During Period, Amortized Cost"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FinancingReceivableModificationsContractsModifiedDuringPeriodPercentageOfLoans": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FinancingReceivableModificationsContractsModifiedDuringPeriodPercentageOfLoans",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of total commercial mortgage loans representing amortized cost",
        "label": "Financing Receivable, Modifications, Contracts Modified During Period, Percentage Of Loans",
        "documentation": "Financing Receivable Modifications Contracts Modified During Period, Total Loans"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FinancingReceivableModificationsContractsModifiedDuringPeriodPrincipalBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FinancingReceivableModificationsContractsModifiedDuringPeriodPrincipalBalance",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Receivable, Modifications Contracts Modified During Period, Principal Balance",
        "label": "Financing Receivable, Modifications Contracts Modified During Period, Principal Balance",
        "documentation": "Financing Receivable, Modifications Contracts Modified During Period, Principal Balance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivableNonaccrualInterestIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableNonaccrualInterestIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Income on Non-accruing Loans",
        "label": "Financing Receivable, Nonaccrual, Interest Income",
        "documentation": "Amount of interest income on financing receivable on nonaccrual status."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails",
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Financing Receivable [Axis]",
        "label": "Class of Financing Receivable [Axis]",
        "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r145",
      "r146",
      "r147",
      "r170",
      "r171",
      "r172",
      "r173",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r419",
      "r420",
      "r426",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1234",
      "r1235",
      "r1462",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467",
      "r1468",
      "r1469",
      "r1470",
      "r1471",
      "r1570"
     ]
    },
    "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails",
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Financing Receivable [Domain]",
        "label": "Class of Financing Receivable [Domain]",
        "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r170",
      "r171",
      "r172",
      "r173",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1462",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467",
      "r1468",
      "r1469",
      "r1470",
      "r1471",
      "r1570"
     ]
    },
    "us-gaap_FinancingReceivables30To59DaysPastDueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivables30To59DaysPastDueMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "30-59 Days",
        "label": "Financial Asset, 30 to 59 Days Past Due [Member]",
        "documentation": "Financial asset more than 29 days past due but fewer than 60 days past due."
       }
      }
     },
     "auth_ref": [
      "r1235"
     ]
    },
    "us-gaap_FinancingReceivables60To89DaysPastDueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivables60To89DaysPastDueMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "60-89 Days",
        "label": "Financial Asset, 60 to 89 Days Past Due [Member]",
        "documentation": "Financial asset more than 59 days past due but fewer than 90 days past due."
       }
      }
     },
     "auth_ref": [
      "r1235"
     ]
    },
    "us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivablesEqualToGreaterThan90DaysPastDueMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "90 Days or More",
        "label": "Financial Asset, Equal to or Greater than 90 Days Past Due [Member]",
        "documentation": "Financial asset equal to or greater than 90 days past due."
       }
      }
     },
     "auth_ref": [
      "r1235"
     ]
    },
    "us-gaap_FinancingReceivablesPeriodPastDueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivablesPeriodPastDueAxis",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Asset, Aging [Axis]",
        "label": "Financial Asset, Aging [Axis]",
        "documentation": "Information by period in which financial asset is past due or not past due."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r419",
      "r1235"
     ]
    },
    "us-gaap_FinancingReceivablesPeriodPastDueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancingReceivablesPeriodPastDueDomain",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Asset, Aging [Domain]",
        "label": "Financial Asset, Aging [Domain]",
        "documentation": "Period in which financial asset is past due or not past due. For past due, element name and standard label in Financial Asset, [numeric lower end] to [numeric higher end] [date measure] Past Due [Member] or Financial Asset, Greater than [low end numeric value] [date measure] Past Due [Member] or Financial Asset, Less than [high end numeric value] [date measure] Past Due [Member] formats."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r419",
      "r1235"
     ]
    },
    "eqh_FixedMaturitiesAtFairValueUsingTheFairValueOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FixedMaturitiesAtFairValueUsingTheFairValueOptionMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed maturities, at FVO",
        "label": "Fixed Maturities, At Fair Value Using The Fair Value Option [Member]",
        "documentation": "Fixed Maturities, At Fair Value Using The Fair Value Option"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FixedMaturitiesFairValueUsingFairValueOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FixedMaturitiesFairValueUsingFairValueOptionMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed maturities, at fair value using the fair value option",
        "label": "Fixed Maturities, Fair Value Using Fair Value Option [Member]",
        "documentation": "Fixed Maturities, Fair Value Using Fair Value Option"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FixedMaturitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FixedMaturitiesMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSInvestmentGainsLossesNetDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails",
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed maturities",
        "label": "Fixed Maturities [Member]",
        "documentation": "This element provides types of investments that may be contained within the fixed maturity category which are securities having a stated final repayment date. Examples of items within this category may include bonds, including convertibles and bonds with warrants, and redeemable preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r1834"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Transaction Adjustment",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r1122",
      "r1353",
      "r1764",
      "r1765",
      "r1846"
     ]
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign governments",
        "label": "Debt Security, Government, Non-US [Member]",
        "documentation": "Debt security issued by government not domiciled in United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r1288",
      "r1650",
      "r1678",
      "r1834"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1368",
      "r1378",
      "r1388",
      "r1420"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1368",
      "r1378",
      "r1388",
      "r1420"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1368",
      "r1378",
      "r1388",
      "r1420"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1368",
      "r1378",
      "r1388",
      "r1420"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1368",
      "r1378",
      "r1388",
      "r1420"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1401"
     ]
    },
    "eqh_FundingAgreementBackedCommercialPaperProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FundingAgreementBackedCommercialPaperProgramMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Funding Agreement-Backed Commercial Paper Program",
        "label": "Funding Agreement, Backed Commercial Paper Program [Member]",
        "documentation": "Funding Agreement, Backed Commercial Paper Program"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FundingAgreementBackedNotesProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FundingAgreementBackedNotesProgramMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Funding Agreement-Backed Notes Program (FABN)",
        "label": "Funding Agreement, Backed Notes Program [Member]",
        "documentation": "Funding Agreement, Backed Notes Program"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FundingAgreementDifferenceRelatedToRemainingAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FundingAgreementDifferenceRelatedToRemainingAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Difference related to remaining amortization",
        "label": "Funding Agreement, Difference Related To Remaining Amortization",
        "documentation": "Funding Agreement, Difference Related To Remaining Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FundsBackedByCommercialPaperFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FundsBackedByCommercialPaperFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Funding agreement-backed commercial paper (FABCP)",
        "label": "Funds Backed By Commercial Paper, Fair Value Disclosure",
        "documentation": "Funds Backed By Commercial Paper, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_FundsBackedByReinsuranceAgreementsAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FundsBackedByReinsuranceAgreementsAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FABN funding agreements",
        "label": "Funds Backed By Reinsurance Agreements, Asset",
        "documentation": "Funds Backed By Reinsurance Agreements, Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FundsHeldUnderReinsuranceAgreementsAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FundsHeldUnderReinsuranceAgreementsAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FHLB funding agreements",
        "label": "Funds Held under Reinsurance Agreements, Asset",
        "documentation": "Amount of the reinsurer's funds held on its behalf by the ceding insurer, including funds held in trust, under reinsurance treaties or contracts with the assuming insurer as security for the payment of the obligations thereunder."
       }
      }
     },
     "auth_ref": [
      "r1789"
     ]
    },
    "eqh_FutureIncludingNettingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "FutureIncludingNettingMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Futures",
        "label": "Future, Including Netting [Member]",
        "documentation": "Future, Including Netting"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_GMIBReinsuranceContractsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GMIBReinsuranceContractsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets for market risk benefits",
        "label": "GMIB Reinsurance Contracts, Fair Value Disclosure",
        "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents investments GMIB reinsurance contracts as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_GMxBCoreMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GMxBCoreMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GMxB Core",
        "label": "GMxB Core [Member]",
        "documentation": "GMxB Core"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_GMxBLegacyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GMxBLegacyMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GMxB Legacy",
        "label": "GMxB Legacy [Member]",
        "documentation": "GMxB Legacy"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Investment (gains) losses, net",
        "label": "Gain (Loss) on Investments",
        "documentation": "Amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r99",
      "r1443"
     ]
    },
    "eqh_GainLossOnInvestmentsAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GainLossOnInvestmentsAdjustments",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Investment (gains) losses",
        "label": "Gain (Loss) On Investments, Adjustments",
        "documentation": "Gain (Loss) On Investments, Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_GainLossOnOtherInvestmentsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GainLossOnOtherInvestmentsNet",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "eqh_GainsLossOnInvestmentsAndDispositionOfBusiness",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other investment gains (losses), net",
        "label": "Gain (Loss) On Other Investments, Net",
        "documentation": "Gain (Loss) On Other Investments, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnSaleOfBusiness",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "(Gains) losses on businesses held-for-sale",
        "label": "Gain (Loss) on Disposition of Business",
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant."
       }
      }
     },
     "auth_ref": [
      "r720",
      "r1544"
     ]
    },
    "eqh_GainsLossOnInvestmentsAndDispositionOfBusiness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GainsLossOnInvestmentsAndDispositionOfBusiness",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/INVESTMENTSInvestmentGainsLossesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total investment gains (losses), net",
        "terseLabel": "Investment gains (losses), net",
        "label": "Gains (Loss) On Investments And Disposition Of Business",
        "documentation": "Gains (Loss) On Investments And Disposition Of Business"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_GoodwillAndOtherIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GoodwillAndOtherIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and other intangible assets, net",
        "label": "Goodwill And Other Intangible Assets, Net",
        "documentation": "Goodwill plus Other Intangible Assets."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_GreaterThan90Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GreaterThan90Member",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "90% plus",
        "label": "Greater Than 90% [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_GrossLegacyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GrossLegacyMember",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GMxB Legacy",
        "label": "Gross Legacy [Member]",
        "documentation": "Gross Legacy"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_GroupPensionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GroupPensionMember",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsRevenueandInterestAccretionDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsWeightedAverageInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Group Pension - Benefit Reserve &amp; DPL",
        "terseLabel": "Group Pension",
        "label": "Group Pension [Member]",
        "documentation": "Group Pension"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_GroupRetirementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GroupRetirementMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Group Retirement",
        "label": "Group Retirement [Member]",
        "documentation": "Group Retirement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_GuaranteedMinimumInsuranceBenefitsNoLapseGuaranteeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GuaranteedMinimumInsuranceBenefitsNoLapseGuaranteeMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Direct MRB",
        "label": "Guaranteed Minimum Insurance Benefits, No Lapse Guarantee [Member]",
        "documentation": "Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GuaranteesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GuaranteesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantees",
        "label": "Guarantees, Fair Value Disclosure",
        "documentation": "Fair value portion of guarantee, including, but not limited to, financial standby letter of credit, fair value guarantee, guarantee of collection of scheduled contractual cash flows from financial assets, and contracts that contingently require the guarantor to make payments or perform services."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r832",
      "r833",
      "r835",
      "r1743",
      "r1744",
      "r1754"
     ]
    },
    "eqh_GuarantyApplicationEquityCommitmentToCertainLimitedPartnerships": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "GuarantyApplicationEquityCommitmentToCertainLimitedPartnerships",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments by the company to provide equity financing",
        "label": "Guaranty Application, Equity Commitment To Certain Limited Partnerships",
        "documentation": "Guaranty Application, Equity Commitment To Certain Limited Partnerships"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_HealthMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "HealthMember",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsRevenueandInterestAccretionDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsWeightedAverageInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Health",
        "label": "Health [Member]",
        "documentation": "Health"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r1725",
      "r1727"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r1725",
      "r1727"
     ]
    },
    "us-gaap_HedgingRelationshipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "HedgingRelationshipDomain",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Domain]",
        "label": "Hedging Relationship [Domain]",
        "documentation": "Nature or intent of a hedge."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_HoldingsRevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "HoldingsRevolvingCreditFacilityMember",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Holdings Revolving Credit Facility",
        "label": "Holdings Revolving Credit Facility [Member]",
        "documentation": "Holdings Revolving Credit Facility [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_IncomeLossDueToNovationInPreTaxNetIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IncomeLossDueToNovationInPreTaxNetIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income (Loss) due to Novation in Pre-Tax Net Income",
        "negatedLabel": "Loss on novation",
        "label": "Income (Loss) due to Novation in Pre-Tax Net Income",
        "documentation": "Income (loss) due to Novation in pre-tax net income"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndAfterAOCI": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndAfterAOCI",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Impact loss",
        "label": "Income (Loss) from Continuing Operations before Income Taxes and after AOCI",
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax and after changes in accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income (loss) from continuing operations, before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r133",
      "r140",
      "r921",
      "r923",
      "r957",
      "r1212",
      "r1213",
      "r1214",
      "r1217",
      "r1222",
      "r1561",
      "r1564",
      "r1566",
      "r1567",
      "r1568"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INCOMETAXES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME TAXES",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r276",
      "r683",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r694",
      "r697",
      "r699",
      "r700",
      "r701",
      "r932",
      "r1043",
      "r1068",
      "r1261"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax (expense) benefit",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r164",
      "r270",
      "r298",
      "r299",
      "r323",
      "r340",
      "r354",
      "r686",
      "r687",
      "r698",
      "r975",
      "r1212",
      "r1213",
      "r1214",
      "r1261"
     ]
    },
    "eqh_IncomeTaxExpenseBenefitAdjusted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IncomeTaxExpenseBenefitAdjusted",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income taxes",
        "label": "Income Tax Expense (Benefit), Adjusted",
        "documentation": "Income Tax Expense (Benefit), Adjusted"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_IncomeTaxExpenseBenefitResultingFromAdjustmentsToIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IncomeTaxExpenseBenefitResultingFromAdjustmentsToIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income tax expense (benefit) related to above adjustments",
        "label": "Income Tax Expense (Benefit), Resulting From Adjustments To Income",
        "documentation": "Income Tax Expense (Benefit), Resulting From Adjustments To Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current and deferred income taxes",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInAssetRetirementObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAssetRetirementObligations",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AB Retirement plan losses",
        "label": "Increase (Decrease) in Asset Retirement Obligations",
        "documentation": "The increase (decrease) during the reporting period in the carrying amount of asset retirement obligations."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInBrokerDealerRelatedReceivablesPayablesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInBrokerDealerRelatedReceivablesPayablesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net broker-dealer and customer related receivables/payables",
        "label": "Increase (Decrease) in Broker-Dealer Related Receivables (Payables), Net",
        "documentation": "The increase (decrease) during the reporting period in receivables or payables that result from buying and selling securities for the firm's own account or from acting as an agent or intermediary in the sale of securities."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "eqh_IncreaseDecreaseInCashAndSecuritiesSegregatedUnderFederalAndOtherRegulations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IncreaseDecreaseInCashAndSecuritiesSegregatedUnderFederalAndOtherRegulations",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Segregated cash and securities, net",
        "label": "Increase (Decrease) In Cash And Securities Segregated Under Federal And Other Regulations",
        "documentation": "The change during the period, either increase or decrease, in the amount of cash subject to withdrawal restrictions, restricted deposits, and cash and securities segregated in compliance with regulations (such as cash deposited in a special reserve account for the exclusive benefit of customers)."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_IncreaseDecreaseInCollateralizedPledgedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IncreaseDecreaseInCollateralizedPledgedAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in collateralized pledged assets",
        "label": "Increase (Decrease) In Collateralized Pledged Assets",
        "documentation": "Increase in collateralized pledged assets"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_IncreaseDecreaseInCollateralizedPledgedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IncreaseDecreaseInCollateralizedPledgedLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in collateralized pledged liabilities",
        "label": "Increase (Decrease) In Collateralized Pledged Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amount of collateralized pledged liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInDeferredPolicyAcquisitionCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capitalization of deferred policy acquisition costs",
        "label": "Increase (Decrease) in Deferred Policy Acquisition Costs",
        "documentation": "The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash long term incentive compensation expense",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInFuturePolicyBenefitReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInFuturePolicyBenefitReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future policy benefits",
        "label": "Increase (Decrease) in Future Policy Benefit Reserves",
        "documentation": "The change in the future policy benefit reserve balance on the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in reinsurance deposit liability",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "documentation": "The increase (decrease) in insurance liability balances during the period."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "eqh_IncreaseDecreaseInMarketRiskBenefitAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IncreaseDecreaseInMarketRiskBenefitAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reduction of purchase MRB asset",
        "label": "Increase (Decrease) in Market Risk Benefit, Assets",
        "documentation": "The increase (decrease) in market risk benefit, assets during the period."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_IncreaseDecreaseInMarketRiskBenefitLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IncreaseDecreaseInMarketRiskBenefitLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reduction of liabilities for MRBs",
        "label": "Increase (Decrease) in Market Risk Benefit, Liabilities",
        "documentation": "The increase (decrease) in market risk benefit, liabilities during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInReinsuranceRecoverable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInReinsuranceRecoverable",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/ORGANIZATIONDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reinsurance recoverable",
        "verboseLabel": "Decrease in amounts due from reinsurers",
        "label": "Increase (Decrease) in Reinsurance Recoverable",
        "documentation": "The increase (decrease) during the reporting period in the amount of benefits the ceding insurer expects to recover on insurance policies ceded to other insurance entities as of the balance sheet date for all guaranteed benefit types."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInSecuritiesLendingPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInSecuritiesLendingPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in securities lending",
        "label": "Increase (Decrease) in Securities Lending Payable",
        "documentation": "The increase (decrease) during the period in the carrying amount of the liability pertaining to obligations to return collateral that the entity received when it loaned securities to the counterparty to the transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Effect of dilutive potential common shares, employee share awards (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r318",
      "r652"
     ]
    },
    "eqh_IndexedUniversalLifeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IndexedUniversalLifeMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Indexed Universal Life",
        "terseLabel": "IUL",
        "label": "Indexed Universal Life [Member]",
        "documentation": "Indexed Universal Life"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1368",
      "r1378",
      "r1388",
      "r1412",
      "r1420",
      "r1424",
      "r1432"
     ]
    },
    "eqh_IndividualRetirementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IndividualRetirementMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual Retirement",
        "label": "Individual Retirement [Member]",
        "documentation": "Individual Retirement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_IndividuallyAssessedMortgageLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "IndividuallyAssessedMortgageLoansMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individually Assessed Mortgage Loans",
        "label": "Individually Assessed Mortgage Loans [Member]",
        "documentation": "Individually Assessed Mortgage Loans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1430"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1360",
      "r1436"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1360",
      "r1436"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1360",
      "r1436"
     ]
    },
    "us-gaap_InsuranceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InsuranceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance [Abstract]",
        "label": "Insurance [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InsuranceCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InsuranceCommissions",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": "eqh_BenefitsLossesAndExpensesAdjusted",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commissions and distribution-related payments",
        "label": "Insurance Commissions",
        "documentation": "The expense incurred by an insurance company to persons or entities for generating or placing insurance or investment contracts with the company, usually determined as a percentage of policy or contract premiums. Excludes advances or draws to be applied against commissions earned."
       }
      }
     },
     "auth_ref": [
      "r1799"
     ]
    },
    "us-gaap_InsuranceCommissionsAndFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InsuranceCommissionsAndFees",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policy charges and fee income",
        "negatedLabel": "Policy charges and fee income",
        "label": "Insurance Commissions and Fees",
        "documentation": "Income from agency and brokerage operations (includes sales of annuities and supplemental contracts); service charges, commissions, and fees from the sale of insurance and related services; and management fees from separate accounts, deferred annuities, and universal life products."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131"
     ]
    },
    "us-gaap_InsuranceContractAcquisitionCostTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InsuranceContractAcquisitionCostTextBlock",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MARKET RISK BENEFITS",
        "label": "Insurance Contract, Acquisition Cost [Text Block]",
        "documentation": "The entire disclosure for cost related directly to successful acquisition of new and renewal of insurance contract. Includes, but is not limited to, deferred policy acquisition cost, deferred sale inducement cost, and present value of future profit of insurance contract acquired in business combination."
       }
      }
     },
     "auth_ref": [
      "r938",
      "r939",
      "r993",
      "r996"
     ]
    },
    "us-gaap_InsuranceDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InsuranceDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIES",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "DAC AND OTHER DEFERRED ASSETS/LIABILITIES",
        "terseLabel": "LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS",
        "label": "Insurance Disclosure [Text Block]",
        "documentation": "The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items."
       }
      }
     },
     "auth_ref": [
      "r934",
      "r937",
      "r1002",
      "r1003",
      "r1039",
      "r1040",
      "r1329",
      "r1330"
     ]
    },
    "eqh_InsuranceMeasurementTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InsuranceMeasurementTypeAxis",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance Measurement Type [Axis]",
        "label": "Insurance Measurement Type [Axis]",
        "documentation": "Insurance Measurement Type"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_InsuranceMeasurementTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InsuranceMeasurementTypeDomain",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance Measurement Type [Domain]",
        "label": "Insurance Measurement Type [Domain]",
        "documentation": "Insurance Measurement Type [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_InterestAccretionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InterestAccretionMember",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Accretion",
        "label": "Interest Accretion [Member]",
        "documentation": "Interest Accretion"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestAndDebtExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestAndDebtExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": "eqh_BenefitsLossesAndExpensesAdjusted",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense and financing fees",
        "label": "Interest and Debt Expense",
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r1498"
     ]
    },
    "us-gaap_InterestCreditedToPolicyholdersAccountBalances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestCreditedToPolicyholdersAccountBalances",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest credited to policyholders\u2019 account balances",
        "verboseLabel": "Interest credited to policyholders\u2019 account balances",
        "netLabel": "Interest credited",
        "label": "Policyholder Account Balance, Interest Expense",
        "documentation": "Amount of interest expense for allocation to policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1314",
      "r1324",
      "r1786",
      "r1798",
      "r1823"
     ]
    },
    "eqh_InterestCreditedToPolicyholdersAccountBalancesParticipatingGroupAnnuityContracts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InterestCreditedToPolicyholdersAccountBalancesParticipatingGroupAnnuityContracts",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest credited to policyholders account balances participating group annuity contracts",
        "label": "Interest Credited To Policyholders Account Balances, Participating Group Annuity Contracts",
        "documentation": "Represents investment results passed through certain annuity contracts as interest credited to policyholders' account balances."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseOperating",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense, Operating",
        "documentation": "Amount of interest expense classified as operating."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r920",
      "r1213",
      "r1496"
     ]
    },
    "eqh_InterestRateFuturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InterestRateFuturesMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Futures",
        "label": "Interest Rate Futures [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_InterestRateOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InterestRateOptionMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option",
        "label": "Interest Rate option [Member]",
        "documentation": "Interest Rate option."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestRateSwapMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest swaps",
        "label": "Interest Rate Swap [Member]",
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period."
       }
      }
     },
     "auth_ref": [
      "r1269",
      "r1350",
      "r1351",
      "r1728"
     ]
    },
    "us-gaap_IntersegmentEliminationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntersegmentEliminationMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Eliminations",
        "label": "Intersegment Eliminations [Member]",
        "documentation": "Eliminating entries used in operating segment consolidation."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r323",
      "r334",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r355",
      "r1222"
     ]
    },
    "us-gaap_InvestmentAdviceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentAdviceMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investment Management and Other Fees",
        "label": "Investment Advice [Member]",
        "documentation": "Investment recommendation and research provided to customer."
       }
      }
     },
     "auth_ref": [
      "r1626",
      "r1627"
     ]
    },
    "eqh_InvestmentAssetsSpecialPurposeEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InvestmentAssetsSpecialPurposeEntity",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment assets, special purpose entity",
        "label": "Investment Assets, Special Purpose Entity",
        "documentation": "Investment Assets, Special Purpose Entity"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_InvestmentEdgeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InvestmentEdgeMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investment Edge",
        "terseLabel": "IE",
        "label": "Investment Edge [Member]",
        "documentation": "Investment Edge"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_InvestmentFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InvestmentFairValueDisclosureAbstract",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investment Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_InvestmentInCapitalizedSoftwareLeaseholdImprovementsAndEDPEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InvestmentInCapitalizedSoftwareLeaseholdImprovementsAndEDPEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Investment in capitalized software, leasehold improvements and EDP equipment",
        "label": "Investment In Capitalized Software, Leasehold Improvements And EDP Equipment",
        "documentation": "Purchase/Sales of capitalized software, leasehold improvements and EDP Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeInvestmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails": {
       "parentTag": "us-gaap_NetInvestmentIncome",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Investment expenses",
        "terseLabel": "Investment expenses",
        "label": "Investment Income, Investment Expense",
        "documentation": "Amount of expenses related to the generation of investment income."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r1353",
      "r1795"
     ]
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Investment Income",
        "label": "Investment Income [Table Text Block]",
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r98",
      "r100",
      "r1796"
     ]
    },
    "eqh_InvestmentManagementAndServiceFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InvestmentManagementAndServiceFees",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment management and service fees",
        "label": "Investment Management And Service Fees",
        "documentation": "Investment Management And Service Fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSInvestmentGainsLossesNetDetails",
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Type [Axis]",
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r1084",
      "r1086",
      "r1087",
      "r1089",
      "r1092",
      "r1151",
      "r1153",
      "r1155",
      "r1158",
      "r1159",
      "r1167",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1345"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSInvestmentGainsLossesNetDetails",
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments [Domain]",
        "label": "Investments [Domain]",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r1084",
      "r1086",
      "r1087",
      "r1089",
      "r1092",
      "r1151",
      "r1153",
      "r1155",
      "r1158",
      "r1159",
      "r1167",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1345"
     ]
    },
    "us-gaap_Investments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Investments",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails",
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total investments",
        "terseLabel": "Investments",
        "label": "Investments",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments."
       }
      }
     },
     "auth_ref": [
      "r940",
      "r942",
      "r1331",
      "r1334",
      "r1336",
      "r1339"
     ]
    },
    "us-gaap_InvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentsAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments:",
        "label": "Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Contractual Maturities of Available-for-Sale Fixed Maturities",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]",
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, fair value",
        "label": "Investments, Fair Value Disclosure",
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method."
       }
      }
     },
     "auth_ref": [
      "r1743",
      "r1744",
      "r1754",
      "r1758",
      "r1759",
      "r1760",
      "r1762"
     ]
    },
    "eqh_InvestmentsFixedMaturitiesFairValueOptionVariableInterestEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "InvestmentsFixedMaturitiesFairValueOptionVariableInterestEntity",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Investments",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed maturities, at fair value using the fair value option",
        "label": "Investments, Fixed Maturities, Fair Value Option, Variable Interest Entity",
        "documentation": "Investments, Fixed Maturities, Fair Value Option, Variable Interest Entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTMENTS",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r169",
      "r367",
      "r369",
      "r826",
      "r827",
      "r1781"
     ]
    },
    "eqh_JeffreyHurdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "JeffreyHurdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jeffrey Hurd [Member]",
        "documentation": "Jeffrey Hurd"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_JeffreyHurdTradingArrangementCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "JeffreyHurdTradingArrangementCommonStockMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jeffrey Hurd Trading Arrangement, Common Stock [Member]",
        "documentation": "Jeffrey Hurd Trading Arrangement, Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_JuniorSubordinatedDebtDue2055Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "JuniorSubordinatedDebtDue2055Member",
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Junior Subordinated Debt Due 2055",
        "label": "Junior Subordinated Debt Due 2055 [Member]",
        "documentation": "Junior Subordinated Debt Due 2055 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_JuniorSubordinatedDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "JuniorSubordinatedDebtMember",
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Junior Subordinated Debt",
        "label": "Junior Subordinated Debt [Member]",
        "documentation": "Borrowing that has a lower priority than senior instruments in event of liquidation of the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation and benefits",
        "label": "Labor and Related Expense",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r914",
      "r1213",
      "r1497"
     ]
    },
    "eqh_LaborAndRelatedExpenseAdjusted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LaborAndRelatedExpenseAdjusted",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": "eqh_BenefitsLossesAndExpensesAdjusted",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation and benefits",
        "label": "Labor and Related Expense, Adjusted",
        "documentation": "Labor and Related Expense, Adjusted"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_LegacyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LegacyMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legacy",
        "label": "Legacy [Member]",
        "documentation": "Legacy"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_LegacySegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LegacySegmentMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legacy Segment",
        "label": "Legacy Segment [Member]",
        "documentation": "Legacy Segment"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
      "http://www.equitable.com/role/ORGANIZATIONDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LegalFees",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross legal expenses related to cost of insurance litigation",
        "label": "Legal Fees",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r1461",
      "r1844",
      "r1845"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of Credit",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails",
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "terseLabel": "Liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r69",
      "r70",
      "r71",
      "r74",
      "r75",
      "r76",
      "r77",
      "r270",
      "r274",
      "r275",
      "r405",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r716",
      "r722",
      "r723",
      "r837",
      "r1101",
      "r1216",
      "r1244",
      "r1355",
      "r1615",
      "r1772",
      "r1773"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "LIABILITIES",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities, Redeemable Noncontrolling Interest and Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r128",
      "r953",
      "r1287",
      "r1331",
      "r1334",
      "r1545",
      "r1550",
      "r1593",
      "r1763"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r803",
      "r1743"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitActivityLineItems",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsRevenueandInterestAccretionDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsWeightedAverageInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability for Future Policy Benefit, Activity [Line Items]",
        "label": "Liability for Future Policy Benefit, Activity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1031",
      "r1323"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitActivityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitActivityTable",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsRevenueandInterestAccretionDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsWeightedAverageInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability for Future Policy Benefit Activity [Table]",
        "label": "Liability for Future Policy Benefit Activity [Table]",
        "documentation": "Disclosure of information about activity for liability for future policy benefit. Includes, but is not limited to, beginning and ending balance, issuance, interest income (expense), net premium collected, benefit payment, derecognition, experience adjustment, change in cash flow assumption, and change in discount rate assumption."
       }
      }
     },
     "auth_ref": [
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1031",
      "r1323"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitAfterReinsurance",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net liability for future policy benefits, after reinsurance recoverable",
        "label": "Liability for Future Policy Benefit, after Reinsurance",
        "documentation": "Amount, after effect of reinsurance, of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Adjusted beginning of period balance",
        "label": "Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change",
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption, of expected future benefit and expense component for liability for future policy benefit, discounted at original rate."
       }
      }
     },
     "auth_ref": [
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected future gross premiums (discounted; AOCI basis)",
        "label": "Liability for Future Policy Benefit, Expected Future Gross Premium, Discounted, before Reinsurance",
        "documentation": "Amount, before effect of reinsurance, of discounted balance for expected future gross premium component of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected future gross premiums (undiscounted)",
        "label": "Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance",
        "documentation": "Amount, before effect of reinsurance, of undiscounted balance for expected future gross premium component of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1011",
      "r1323"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of period",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change",
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected future policy benefit and expense component of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1010",
      "r1011",
      "r1031",
      "r1323"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of changes in cash flow assumptions",
        "periodStartLabel": "Beginning balance before AOCI adjustments",
        "periodEndLabel": "Ending balance before shadow reserve adjustments",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change",
        "documentation": "Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from cash flow assumption change for future cash flows."
       }
      }
     },
     "auth_ref": [
      "r1307",
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of actual variances from expected experience",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience",
        "documentation": "Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from effect of variance from cash flow assumption change for actual experience."
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1306",
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "eqh_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitDiscountedBeforeReinsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitDiscountedBeforeReinsurance",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected future benefit payments and expenses (discounted; AOCI basis)",
        "label": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Discounted, Before Reinsurance",
        "documentation": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Discounted, Before Reinsurance"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitEffectOfShadowReserveAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitEffectOfShadowReserveAdjustment",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of reserve adjustment recorded in AOCI",
        "label": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Effect Of Shadow Reserve Adjustment",
        "documentation": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Effect Of Shadow Reserve Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitImpactOfFlooringAtZeroBeforeReinsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitImpactOfFlooringAtZeroBeforeReinsurance",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of flooring LFPB at zero",
        "label": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Impact Of Flooring At Zero, Before Reinsurance",
        "documentation": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Impact Of Flooring At Zero, Before Reinsurance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest accrual",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense",
        "documentation": "Amount of interest expense for expected future policy benefit and expense component of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1303",
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "eqh_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestRateAndCashFlowAssumptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestRateAndCashFlowAssumptions",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of changes in interest rate &amp; cash flow assumptions and model changes",
        "label": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Interest Rate And Cash Flow Assumptions",
        "documentation": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Rate and Cash Flow Assumptions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuances",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Issuance",
        "documentation": "Amount of increase in expected future policy benefit and expense component of liability for future policy benefit from contract issuance."
       }
      }
     },
     "auth_ref": [
      "r1302",
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "eqh_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitNetAssessments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitNetAssessments",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net assessments collected",
        "label": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Net Assessments",
        "documentation": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Net Assessments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance of original discount rate",
        "periodEndLabel": "Ending Balance at original discount rate",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance",
        "documentation": "Amount, before effect of reinsurance and current period update of cash flow assumption, of expected future policy benefit and expense component of liability for future policy benefit, discounted at original rate."
       }
      }
     },
     "auth_ref": [
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Present Value of Expected Future Policy Benefits",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected future benefit payments and expenses (undiscounted)",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance",
        "documentation": "Amount, before effect of reinsurance, of undiscounted balance for expected future policy benefit and expense component of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1011",
      "r1323"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of period",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change",
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected net premium component of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1010",
      "r1011",
      "r1031",
      "r1323"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Effect of changes in cash flow assumptions",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Cash Flow Change",
        "documentation": "Amount of cumulative increase (decrease) in expected net premium component of liability for future policy benefit from cash flow assumption change for future cash flows."
       }
      }
     },
     "auth_ref": [
      "r1307",
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Effect of actual variances from expected experience",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) of Actual Variance from Expected Experience",
        "documentation": "Amount of cumulative increase (decrease) in expected net premium component for liability of future policy benefit from effect of variance from cash flow assumption change for actual experience."
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1306",
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest accrual",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Interest Income",
        "documentation": "Amount of interest income for expected net premium component of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1303",
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumIssuance",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuances",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Issuance",
        "documentation": "Amount of increase in expected net premium component of liability for future policy benefit from contract issuance."
       }
      }
     },
     "auth_ref": [
      "r1302",
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net premiums collected",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected",
        "documentation": "Amount of premium collected from policyholder to fund expected benefit payment for expected net premium component of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1304",
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance at original discount rate",
        "periodEndLabel": "Ending Balance at original discount rate",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance",
        "documentation": "Amount, before effect of reinsurance and current period update of cash flow assumption, of expected net premium component of liability for future policy benefit, discounted at original rate."
       }
      }
     },
     "auth_ref": [
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Adjusted beginning of period balance",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Reinsurance, after Cash Flow Change",
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption, of expected net premium component for liability for future policy benefit, discounted at original rate."
       }
      }
     },
     "auth_ref": [
      "r1323",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Present Value of Expected Net Premiums",
        "label": "Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForFuturePolicyBenefitGrossPremiumIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitGrossPremiumIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsRevenueandInterestAccretionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Premium",
        "label": "Liability for Future Policy Benefit, Gross Premium Income",
        "documentation": "Amount of gross premium income recognized for liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1013",
      "r1017",
      "r1323"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsRevenueandInterestAccretionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Accretion",
        "label": "Liability for Future Policy Benefit, Interest Expense",
        "documentation": "Amount of interest expense recognized for liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1013",
      "r1017",
      "r1323"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: Reinsurance recoverable",
        "label": "Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance",
        "documentation": "Amount, after allowance for credit loss, recoverable under reinsurance of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1014",
      "r1031",
      "r1323",
      "r1815"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitRemeasurementGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitRemeasurementGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": -1.0,
       "order": 8.0
      },
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/ORGANIZATIONDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Remeasurement of liability for future policy benefits",
        "negatedLabel": "Remeasurement of liability for future policy benefits",
        "terseLabel": "Increase (decrease) in remeasurement of liability for future policy benefits",
        "label": "Liability for Future Policy Benefit, Remeasurement Gain (Loss)",
        "documentation": "Amount of remeasurement gain (loss) on liability for future policy benefit from application of revised benefit ratio as of contract issue. Includes, but is not limited to, remeasurement gain (loss) for annuitization insurance benefit, death and other insurance benefits, and traditional and limited-payment contracts."
       }
      }
     },
     "auth_ref": [
      "r1004",
      "r1005",
      "r1007"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitWeightedAverageDuration",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average duration of liability for future policyholder benefits (years)",
        "terseLabel": "Weighted-average duration of additional liability - death benefit (years)",
        "label": "Liability for Future Policy Benefit, Weighted-Average Duration",
        "documentation": "Weighted-average duration of liability for future policy benefit, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefits",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails": {
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future policy benefits and other policyholders\u2019 liabilities",
        "netLabel": "Liability for future policy benefits",
        "verboseLabel": "Net liability for additional liability",
        "label": "Liability for Future Policy Benefit, before Reinsurance",
        "documentation": "Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract."
       }
      }
     },
     "auth_ref": [
      "r1010",
      "r1017",
      "r1031",
      "r1323",
      "r1334",
      "r1790"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForFuturePolicyBenefitsPaymentForBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Benefits payments",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment",
        "documentation": "Amount of cash outflow to policyholder from benefit payment for expected future policy benefit and expense component of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r1305",
      "r1323",
      "r1543",
      "r1815",
      "r1832"
     ]
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term line of credit outstanding",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r125",
      "r1793"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r73"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Undrawn balance",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r73",
      "r474"
     ]
    },
    "eqh_LoanToValueRatioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LoanToValueRatioAxis",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan To Value Ratio [Axis]",
        "label": "Loan To Value Ratio [Axis]",
        "documentation": "Loan To Value Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_LoanToValueRatioDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LoanToValueRatioDomain",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan To Value Ratio [Domain]",
        "label": "Loan To Value Ratio [Domain]",
        "documentation": "Loan To Value Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansInsurancePolicy": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LoansInsurancePolicy",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Investments",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policy loans",
        "label": "Loans, Gross, Insurance Policy",
        "documentation": "Amount before allowance of loans made to policy and contract holders using their life insurance contracts' cash value or separate accounts as collateral. Includes deferred interest and fees, undisbursed portion of loan balance, unamortized costs and premiums over and discounts from face amounts. Excludes loans and leases covered under loss sharing agreements."
       }
      }
     },
     "auth_ref": [
      "r940",
      "r941"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt",
        "label": "Long-Term Debt, Fair Value",
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission."
       }
      }
     },
     "auth_ref": [
      "r1200",
      "r1284",
      "r1743",
      "r1745",
      "r1746",
      "r1747",
      "r1758",
      "r1759",
      "r1760",
      "r1762"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "eqh_LongTermFundingAgreementsMaturingBetweenOneAndFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LongTermFundingAgreementsMaturingBetweenOneAndFiveYearsMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in years two through five",
        "label": "Long-Term Funding Agreements, Maturing Between One And Five Years [Member]",
        "documentation": "Long-Term Funding Agreements Maturing Between Two and Five Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_LongTermFundingAgreementsMaturingInGreaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LongTermFundingAgreementsMaturingInGreaterThanFiveYearsMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in more than five years",
        "label": "Long-Term Funding Agreements, Maturing In Greater Than Five Years [Member]",
        "documentation": "Long-Term Funding Agreements Maturing in Greater than Five Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_LongTermFundingAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "LongTermFundingAgreementsMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total long-term funding agreements",
        "label": "Long-Term Funding Agreements [Member]",
        "documentation": "Long-Term Funding Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r1604",
      "r1605",
      "r1606"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r38",
      "r1604",
      "r1605",
      "r1606"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r467",
      "r468",
      "r469",
      "r472",
      "r682",
      "r1238",
      "r1609",
      "r1610"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r467",
      "r468",
      "r469",
      "r472",
      "r682",
      "r1238",
      "r1609",
      "r1610"
     ]
    },
    "eqh_MarginMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MarginMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Margin",
        "label": "Margin [Member]",
        "documentation": "Margin"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_MarkPearsonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MarkPearsonMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mark Pearson [Member]",
        "documentation": "Mark Pearson"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_MarkPearsonTradingArrangementCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MarkPearsonTradingArrangementCommonStockMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mark Pearson Trading Arrangement, Common Stock [Member]",
        "documentation": "Mark Pearson Trading Arrangement, Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_MarkPearsonTradingArrangementStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MarkPearsonTradingArrangementStockOptionsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mark Pearson Trading Arrangement, Stock Options [Member]",
        "documentation": "Mark Pearson Trading Arrangement, Stock Options"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_MarketComparableCompaniesValuationTechniqueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MarketComparableCompaniesValuationTechniqueMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market comparable\u00a0 companies",
        "label": "Market Comparable Companies, Valuation Technique [Member]",
        "documentation": "market comparable companies valuation technique used to measure fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketRiskBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Market Risk Benefit [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketRiskBenefitActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitActivityTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Market Risk Benefit, Activity",
        "label": "Market Risk Benefit, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of beginning balance to ending balance for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r1024",
      "r1325"
     ]
    },
    "us-gaap_MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails": {
       "parentTag": "us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in the instrument-specific credit risk",
        "label": "Market Risk Benefit, after Increase (Decrease) from Instrument-Specific Credit Risk",
        "documentation": "Amount, before effect of reinsurance and after accumulated increase (decrease) in instrument-specific credit risk, of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r1006",
      "r1024",
      "r1036",
      "r1325"
     ]
    },
    "us-gaap_MarketRiskBenefitAfterReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitAfterReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails": {
       "parentTag": "us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance BOP before changes in the instrument specific credit risk",
        "periodEndLabel": "Balance EOP before changes in the instrument-specific credit risk",
        "label": "Market Risk Benefit, after Reinsurance and Cumulative Increase (Decrease) from Instrument-Specific Credit Risk Change",
        "documentation": "Amount, after effect of reinsurance and cumulative increase (decrease) in instrument-specific credit risk, of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r1325",
      "r1829",
      "r1833"
     ]
    },
    "us-gaap_MarketRiskBenefitAssetAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitAssetAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails": {
       "parentTag": "eqh_MarketRiskBenefitNetDirect",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets for market risk benefits",
        "negatedLabel": "Direct Asset",
        "label": "Market Risk Benefit, Asset, Amount",
        "documentation": "Amount of asset position for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1325",
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "us-gaap_MarketRiskBenefitAttributedFeeCollected": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitAttributedFeeCollected",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Attributed fees accrued",
        "label": "Market Risk Benefit, Attributed Fee Collected",
        "documentation": "Amount of cash inflow to contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk from attributed fee collected."
       }
      }
     },
     "auth_ref": [
      "r1317",
      "r1325",
      "r1829",
      "r1833"
     ]
    },
    "us-gaap_MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of period",
        "label": "Market Risk Benefit, before Reinsurance and Cumulative Increase (Decrease) from Instrument-Specific Credit Risk Change",
        "documentation": "Amount, before effect of reinsurance and cumulative increase (decrease) in instrument-specific credit risk, of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r1024",
      "r1036",
      "r1325"
     ]
    },
    "us-gaap_MarketRiskBenefitBenefitPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitBenefitPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Benefit payments",
        "label": "Market Risk Benefit, Benefit Payment",
        "documentation": "Amount of cash outflow to policyholder from benefit payment for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r1318",
      "r1325",
      "r1829",
      "r1833"
     ]
    },
    "us-gaap_MarketRiskBenefitChangeInFairValueGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitChangeInFairValueGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in market risk benefits and purchased market risk benefits",
        "negatedLabel": "Change in market risk benefits",
        "label": "Market Risk Benefit, Change in Fair Value, Gain (Loss)",
        "documentation": "Amount of gain (loss) from (increase) decrease in fair value of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Excludes change attributable to instrument-specific credit risk."
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "us-gaap_MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actual policyholder behavior different from expected behavior",
        "label": "Market Risk Benefit, Increase (Decrease) from Actual Policyholder Behavior Different from Expected",
        "documentation": "Amount of increase (decrease) in contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk from change associated with actual policyholder behavior different from expected."
       }
      }
     },
     "auth_ref": [
      "r1320",
      "r1325",
      "r1829",
      "r1833"
     ]
    },
    "us-gaap_MarketRiskBenefitIncreaseDecreaseFromEquityMarketChange": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitIncreaseDecreaseFromEquityMarketChange",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actual market movement effect",
        "label": "Market Risk Benefit, Increase (Decrease) from Equity Market Change",
        "documentation": "Amount of increase (decrease) in contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk from change in equity market assumption."
       }
      }
     },
     "auth_ref": [
      "r1319",
      "r1325",
      "r1829",
      "r1833"
     ]
    },
    "eqh_MarketRiskBenefitIncreaseDecreaseFromFutureEconomicAssumption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MarketRiskBenefitIncreaseDecreaseFromFutureEconomicAssumption",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in future economic assumptions",
        "label": "Market Risk Benefit, Increase (Decrease) From Future Economic Assumption",
        "documentation": "Market Risk Benefit, Increase (Decrease) From Future Economic Assumption"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketRiskBenefitIncreaseDecreaseFromFutureExpectedPolicyholderBehaviorAssumption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitIncreaseDecreaseFromFutureExpectedPolicyholderBehaviorAssumption",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Model changes and effect of changes in cash flow assumptions",
        "label": "Market Risk Benefit, Increase (Decrease) from Future Expected Policyholder Behavior Assumption",
        "documentation": "Amount of increase (decrease) in contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk from change in future expected policyholder behavior assumption."
       }
      }
     },
     "auth_ref": [
      "r1321",
      "r1325",
      "r1829",
      "r1833"
     ]
    },
    "us-gaap_MarketRiskBenefitIncreaseDecreaseFromOtherAssumption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitIncreaseDecreaseFromOtherAssumption",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in purchased market risk benefit asset fair value",
        "label": "Market Risk Benefit, Increase (Decrease) from Other Assumption",
        "documentation": "Amount of increase (decrease) in contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk from change in assumption, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1322",
      "r1325",
      "r1829",
      "r1833"
     ]
    },
    "us-gaap_MarketRiskBenefitInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest accrual",
        "label": "Market Risk Benefit, Interest Expense",
        "documentation": "Amount of interest expense for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r1316",
      "r1325",
      "r1829",
      "r1833"
     ]
    },
    "us-gaap_MarketRiskBenefitIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitIssuance",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuances",
        "label": "Market Risk Benefit, Issuance",
        "documentation": "Amount of increase in contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk from contract issuance."
       }
      }
     },
     "auth_ref": [
      "r1315",
      "r1325",
      "r1829",
      "r1833"
     ]
    },
    "us-gaap_MarketRiskBenefitLiabilityAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitLiabilityAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails": {
       "parentTag": "eqh_MarketRiskBenefitNetDirect",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liability for market risk benefits",
        "netLabel": "Direct Liability",
        "terseLabel": "Market risk benefits",
        "label": "Market Risk Benefit, Liability, Amount",
        "documentation": "Amount of liability position for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1325",
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "us-gaap_MarketRiskBenefitLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitLineItems",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Risk Benefit [Line Items]",
        "label": "Market Risk Benefit [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1024",
      "r1025",
      "r1026",
      "r1325"
     ]
    },
    "eqh_MarketRiskBenefitNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MarketRiskBenefitNet",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Market Risk Benefit, Net",
        "documentation": "Market Risk Benefit, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketRiskBenefitNetAmountAtRisk": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitNetAmountAtRisk",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net amount at risk",
        "label": "Market Risk Benefit, Net Amount at Risk",
        "documentation": "Amount of guaranteed benefit in excess of current account balance of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r1025"
     ]
    },
    "eqh_MarketRiskBenefitNetDirect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MarketRiskBenefitNetDirect",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails": {
       "parentTag": "eqh_MarketRiskBenefitNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Direct MRB",
        "label": "Market Risk Benefit, Net Direct",
        "documentation": "Market Risk Benefit, Net Direct"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_MarketRiskBenefitPurchased": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MarketRiskBenefitPurchased",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails": {
       "parentTag": "eqh_MarketRiskBenefitNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchased MRB",
        "label": "Market Risk Benefit, Purchased",
        "documentation": "Market Risk Benefit, Purchased"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketRiskBenefitRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitRollForward",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Risk Benefit [Roll Forward]",
        "label": "Market Risk Benefit [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketRiskBenefitTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MarketRiskBenefitTable",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Risk Benefit [Table]",
        "label": "Market Risk Benefit [Table]",
        "documentation": "Disclosure of information about contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r1024",
      "r1025",
      "r1026",
      "r1325"
     ]
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MaterialReconcilingItemsMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments",
        "label": "Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]",
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r352",
      "r355",
      "r1222",
      "r1223"
     ]
    },
    "eqh_MatrixPricingModelValuationTechniqueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MatrixPricingModelValuationTechniqueMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Matrix pricing model",
        "label": "Matrix Pricing Model, Valuation Technique [Member]",
        "documentation": "Matrix pricing model valuation technique used to measure fair value."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r188",
      "r190",
      "r191",
      "r211",
      "r212",
      "r327",
      "r468",
      "r469",
      "r470",
      "r471",
      "r644",
      "r676",
      "r677",
      "r678",
      "r682",
      "r806",
      "r903",
      "r1009",
      "r1023",
      "r1038",
      "r1093",
      "r1094",
      "r1152",
      "r1154",
      "r1156",
      "r1157",
      "r1168",
      "r1184",
      "r1186",
      "r1188",
      "r1189",
      "r1198",
      "r1199",
      "r1227",
      "r1245",
      "r1260",
      "r1262",
      "r1263",
      "r1264",
      "r1277",
      "r1278",
      "r1282",
      "r1283",
      "r1324",
      "r1619",
      "r1774",
      "r1775",
      "r1776",
      "r1777",
      "r1778",
      "r1779"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1404"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1404"
     ]
    },
    "eqh_MeasurementInputAnnuitizationRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MeasurementInputAnnuitizationRateMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annuitization Rate",
        "label": "Measurement Input, Annuitization Rate [Member]",
        "documentation": "Measurement Input, Annuitization Rate [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_MeasurementInputCashFlowMultiplesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MeasurementInputCashFlowMultiplesMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flow Multiples",
        "label": "Measurement Input, Cash Flow Multiples [Member]",
        "documentation": "Measurement Input, Cash Flow Multiples"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount Rate",
        "label": "Measurement Input, Discount Rate [Member]",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r1262",
      "r1263",
      "r1264",
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "us-gaap_MeasurementInputEbitdaMultipleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputEbitdaMultipleMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBITDA Multiples",
        "label": "Measurement Input, EBITDA Multiple [Member]",
        "documentation": "Measurement input using earnings before interest, tax, depreciation and amortization (EBITDA) multiple."
       }
      }
     },
     "auth_ref": [
      "r1262",
      "r1264",
      "r1277",
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "eqh_MeasurementInputEquityVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MeasurementInputEquityVolatilityMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility Rate - Equity",
        "label": "Measurement Input, Equity Volatility [Member]",
        "documentation": "Measurement Input, Equity Volatility"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputLapseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputLapseRateMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lapse Rate",
        "label": "Measurement Input, Lapse Rate [Member]",
        "documentation": "Measurement input using rate insurance policy terminates due to non-payment of premium."
       }
      }
     },
     "auth_ref": [
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "eqh_MeasurementInputLoanToValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MeasurementInputLoanToValueMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan to Value",
        "label": "Measurement Input, Loan To Value [Member]",
        "documentation": "Measurement Input, Loan To Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputLongTermRevenueGrowthRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputLongTermRevenueGrowthRateMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected Revenue Growth Rate",
        "label": "Measurement Input, Long-Term Revenue Growth Rate [Member]",
        "documentation": "Measurement input using compounded annualized rate of long-term growth in revenue."
       }
      }
     },
     "auth_ref": [
      "r1262",
      "r1264",
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "us-gaap_MeasurementInputMortalityRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputMortalityRateMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortality",
        "label": "Measurement Input, Mortality Rate [Member]",
        "documentation": "Measurement input using likelihood of death in specific group to population."
       }
      }
     },
     "auth_ref": [
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "eqh_MeasurementInputNonperformanceRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MeasurementInputNonperformanceRiskMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Performance Risk",
        "label": "Measurement Input, Nonperformance Risk [Member]",
        "documentation": "Measurement Input, Nonperformance Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputRevenueMultipleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputRevenueMultipleMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Earnings/Revenue Multiple",
        "label": "Measurement Input, Revenue Multiple [Member]",
        "documentation": "Measurement input using market valuation of entity divided by revenue."
       }
      }
     },
     "auth_ref": [
      "r1262",
      "r1263",
      "r1277",
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "eqh_MeasurementInputSpreadOverBenchmarkMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MeasurementInputSpreadOverBenchmarkMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spread over Benchmark",
        "label": "Measurement Input, Spread Over Benchmark [Member]",
        "documentation": "Measurement Input, Spread Over Benchmark"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r804",
      "r805",
      "r806",
      "r1262",
      "r1263",
      "r1264",
      "r1277"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r804",
      "r805",
      "r806",
      "r1262",
      "r1263",
      "r1264",
      "r1277"
     ]
    },
    "us-gaap_MeasurementInputUtilizationRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputUtilizationRateMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "GMIB Utilization Rate",
        "label": "Measurement Input, Utilization Rate [Member]",
        "documentation": "Measurement input using rate at which policyholder exercises optional benefit upon eligibility under insurance contract."
       }
      }
     },
     "auth_ref": [
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "us-gaap_MeasurementInputWithdrawalRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputWithdrawalRateMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Withdrawal Rate",
        "label": "Measurement Input, Withdrawal Rate [Member]",
        "documentation": "Measurement input using rate at which policyholder begins withdrawal of benefit relative to maximum allowable under insurance contract."
       }
      }
     },
     "auth_ref": [
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "eqh_MeasurementInputsDiscountFactorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MeasurementInputsDiscountFactorMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount Factor",
        "label": "Measurement Inputs, Discount Factor [Member]",
        "documentation": "Measurement Inputs, Discount Factor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r188",
      "r190",
      "r191",
      "r211",
      "r212",
      "r327",
      "r468",
      "r469",
      "r470",
      "r471",
      "r644",
      "r676",
      "r677",
      "r678",
      "r682",
      "r806",
      "r903",
      "r1009",
      "r1023",
      "r1038",
      "r1093",
      "r1094",
      "r1152",
      "r1154",
      "r1156",
      "r1157",
      "r1168",
      "r1184",
      "r1186",
      "r1188",
      "r1189",
      "r1198",
      "r1199",
      "r1227",
      "r1245",
      "r1260",
      "r1262",
      "r1263",
      "r1264",
      "r1277",
      "r1278",
      "r1282",
      "r1324",
      "r1619",
      "r1774",
      "r1775",
      "r1776",
      "r1777",
      "r1778",
      "r1779"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interest",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r127",
      "r270",
      "r274",
      "r275",
      "r405",
      "r475",
      "r478",
      "r479",
      "r480",
      "r484",
      "r485",
      "r952",
      "r1105",
      "r1763"
     ]
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestChangeInRedemptionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/REDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase/change of redeemable noncontrolling interests",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends paid to noncontrolling interest",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of AB Holding units",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests)."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r113",
      "r118"
     ]
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/REDEEMABLENONCONTROLLINGINTEREST"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REDEEMABLE NONCONTROLLING INTEREST",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1423"
     ]
    },
    "eqh_MomentumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MomentumMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Momentum",
        "label": "Momentum [Member]",
        "documentation": "Momentum"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_MortalityRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MortalityRangeAxis",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortality Range [Axis]",
        "label": "Mortality Range [Axis]",
        "documentation": "Mortality Range [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_MortalityRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MortalityRangeDomain",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortality Range [Domain]",
        "label": "Mortality Range [Domain]",
        "documentation": "[Domain] for Mortality Range [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_MortgageLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "MortgageLoansMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage Loans",
        "label": "Mortgage Loans [Member]",
        "documentation": "Mortgage Loans"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MortgageLoansOnRealEstateFaceAmountOfMortgages": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MortgageLoansOnRealEstateFaceAmountOfMortgages",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments under existing mortgage loan agreements",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages",
        "documentation": "Amount of contractual principal due at origination of mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r1184",
      "r1192"
     ]
    },
    "srt_MortgageLoansOnRealEstateLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MortgageLoansOnRealEstateLineItems",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195"
     ]
    },
    "us-gaap_MortgagesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MortgagesMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSInvestmentGainsLossesNetDetails",
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage loans on real estate",
        "label": "Mortgages [Member]",
        "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]",
        "label": "Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MovementInDeferredRevenueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MovementInDeferredRevenueRollForward",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement in Deferred Revenue [Roll Forward]",
        "label": "Movement in Deferred Revenue [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MovementInDeferredSalesInducementsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MovementInDeferredSalesInducementsRollForward",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement in Deferred Sales Inducements [Roll Forward]",
        "label": "Movement in Deferred Sales Inducements [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MovementInMinorityInterestRollForward",
     "presentation": [
      "http://www.equitable.com/role/REDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "label": "Equity, Attributable to Noncontrolling Interest [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1431"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1405"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r266"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r266"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) operating activities",
        "verboseLabel": "Net cash provided by (used in) operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r106"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "verboseLabel": "Cash flows from operating activities:",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetChangeAnnuitiesAndInvestmentCertificatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetChangeAnnuitiesAndInvestmentCertificatesAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholders\u2019 account balances:",
        "label": "Net Change Annuities and Investment Certificates [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income (loss) attributable to Holdings",
        "netLabel": "Net income (loss) attributable to Holdings",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r106",
      "r134",
      "r216",
      "r222",
      "r244",
      "r247",
      "r251",
      "r270",
      "r274",
      "r275",
      "r278",
      "r285",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r298",
      "r299",
      "r314",
      "r405",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r516",
      "r519",
      "r522",
      "r527",
      "r681",
      "r706",
      "r713",
      "r800",
      "r837",
      "r960",
      "r1123",
      "r1144",
      "r1145",
      "r1212",
      "r1213",
      "r1214",
      "r1353",
      "r1615"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Net income (loss) attributable to the noncontrolling interest",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r119",
      "r244",
      "r247",
      "r294",
      "r298",
      "r299",
      "r959",
      "r1495"
     ]
    },
    "eqh_NetIncomeLossAttributableToNoncontrollingInterestAdjusted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterestAdjusted",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Operating (earnings) loss attributable to the noncontrolling interest",
        "label": "Net Income (Loss) Attributable To Noncontrolling Interest, Adjusted",
        "documentation": "Operating Income (Loss), Attributable To Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetIncomeLossAttributableToParentAdjusted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetIncomeLossAttributableToParentAdjusted",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating earnings (loss)",
        "label": "Net Income (Loss) Attributable To Parent, Adjusted",
        "documentation": "Net Income (Loss) Attributable To Parent, Adjusted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/REDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable noncontrolling interest",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToReportingEntityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAttributableToReportingEntityAbstract",
     "presentation": [
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income (loss):",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income (loss) available to Holdings\u2019 common shareholders, basic",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r258",
      "r289",
      "r290",
      "r292",
      "r293",
      "r302",
      "r303",
      "r315",
      "r318",
      "r519",
      "r522",
      "r527",
      "r713"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income (loss) available to Holdings\u2019 common shareholders, diluted",
        "totalLabel": "Net income (loss) available to Holdings\u2019 common shareholders, diluted",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r304",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r318"
     ]
    },
    "eqh_NetIncomeLossPortionAttributableToNonRedeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetIncomeLossPortionAttributableToNonRedeemableNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net income (loss)",
        "label": "Net Income (Loss), Portion Attributable To Non-Redeemable Noncontrolling Interest",
        "documentation": "Net Income (Loss), Portion Attributable To Non-Redeemable Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentGainsLossesIncludingChangesInValuationAllowancesAndCreditLossesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentGainsLossesIncludingChangesInValuationAllowancesAndCreditLossesTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investment Gains (Losses), Net",
        "label": "Net Investment Gains (Losses), Including Changes In Valuation Allowances And Credit Losses [Table Text Block]",
        "documentation": "Net Investment Gains (Losses), Including Changes In Valuation Allowances And Credit Losses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetInvestmentIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetInvestmentIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net investment income (loss)",
        "label": "Net Investment Income",
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r963",
      "r964",
      "r1131",
      "r1331",
      "r1334",
      "r1353"
     ]
    },
    "eqh_NetInvestmentIncomeLossEquitySecuritiesChangeInUnrealizedHoldingGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentIncomeLossEquitySecuritiesChangeInUnrealizedHoldingGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSEquitySecuritiesDetails": {
       "parentTag": "us-gaap_EquitySecuritiesFvNiGainLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSEquitySecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment gains (losses) recognized during the period on securities held at the end of the period",
        "label": "Net Investment Income (Loss), Equity Securities, Change In Unrealized Holding Gain (Loss)",
        "documentation": "Net Investment Income (Loss), Equity Securities, Change In Unrealized Holding Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentIncomeLossFixedMaturities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentIncomeLossFixedMaturities",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net investment income (loss) from fixed maturities",
        "label": "Net Investment Income (Loss), Fixed Maturities",
        "documentation": "Net Investment Income (Loss), Fixed Maturities"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentIncomeLossFixedMaturitiesChangeInUnrealizedHoldingGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentIncomeLossFixedMaturitiesChangeInUnrealizedHoldingGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesDetails": {
       "parentTag": "eqh_NetInvestmentIncomeLossFixedMaturitiesNetRealizedAndUnrealizedGainLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment gains (losses) recognized during the period on securities held at the end of the period",
        "label": "Net Investment Income (Loss), Fixed Maturities, Change In Unrealized Holding Gain (Loss)",
        "documentation": "Net Investment Income (Loss), Fixed Maturities, Change In Unrealized Holding Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentIncomeLossFixedMaturitiesInterestAndDividendIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentIncomeLossFixedMaturitiesInterestAndDividendIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesDetails": {
       "parentTag": "eqh_NetInvestmentIncomeLossFixedMaturities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and dividend income from fixed maturities",
        "label": "Net Investment Income (Loss), Fixed Maturities, Interest And Dividend Income",
        "documentation": "Net Investment Income (Loss), Fixed Maturities, Interest And Dividend Income"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentIncomeLossFixedMaturitiesNetRealizedAndUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentIncomeLossFixedMaturitiesNetRealizedAndUnrealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesDetails": {
       "parentTag": "eqh_NetInvestmentIncomeLossFixedMaturities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Unrealized and realized gains (losses) from fixed maturities",
        "label": "Net Investment Income (Loss), Fixed Maturities, Net Realized And Unrealized Gain (Loss)",
        "documentation": "Net Investment Income (Loss), Fixed Maturities, Net Realized And Unrealized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentIncomeLossFixedMaturitiesRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentIncomeLossFixedMaturitiesRealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesDetails": {
       "parentTag": "eqh_NetInvestmentIncomeLossFixedMaturitiesNetRealizedAndUnrealizedGainLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment gains (losses) recognized on securities sold during the period",
        "label": "Net Investment Income (Loss), Fixed Maturities, Realized Gain (Loss)",
        "documentation": "Net Investment Income (Loss), Fixed Maturities, Realized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentIncomeLossTradingSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentIncomeLossTradingSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSTradingSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTradingSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net investment income (loss) from trading securities",
        "label": "Net Investment Income (Loss), Trading Securities"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentIncomeLossTradingSecuritiesChangeInUnrealizedHoldingGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentIncomeLossTradingSecuritiesChangeInUnrealizedHoldingGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSTradingSecuritiesDetails": {
       "parentTag": "eqh_NetInvestmentIncomeLossTradingSecuritiesNetRealizedAndUnrealizedGainLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTradingSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment gains (losses) recognized during the period on securities held at the end of the period",
        "label": "Net Investment Income (Loss), Trading Securities, Change In Unrealized Holding Gain (Loss)",
        "documentation": "Net Investment Income (Loss), Trading Securities, Change In Unrealized Holding Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentIncomeLossTradingSecuritiesInterestAndDividendIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentIncomeLossTradingSecuritiesInterestAndDividendIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSTradingSecuritiesDetails": {
       "parentTag": "eqh_NetInvestmentIncomeLossTradingSecurities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTradingSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and dividend income from trading securities",
        "label": "Net Investment Income (Loss), Trading Securities, Interest And Dividend Income",
        "documentation": "Net Investment Income (Loss), Trading Securities, Interest And Dividend Income"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentIncomeLossTradingSecuritiesNetRealizedAndUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentIncomeLossTradingSecuritiesNetRealizedAndUnrealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSTradingSecuritiesDetails": {
       "parentTag": "eqh_NetInvestmentIncomeLossTradingSecurities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTradingSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Unrealized and realized gains (losses) on trading securities",
        "label": "Net Investment Income (Loss), Trading Securities, Net Realized And Unrealized Gain (Loss)",
        "documentation": "Net Investment Income (Loss), Trading Securities, Net Realized And Unrealized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentIncomeLossTradingSecuritiesRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentIncomeLossTradingSecuritiesRealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSTradingSecuritiesDetails": {
       "parentTag": "eqh_NetInvestmentIncomeLossTradingSecuritiesNetRealizedAndUnrealizedGainLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTradingSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment gains (losses) recognized on securities sold during the period",
        "label": "Net Investment Income (Loss), Trading Securities, Realized Gain (Loss)",
        "documentation": "Net Investment Income (Loss), Trading Securities, Realized Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetInvestmentNetRealizedAndUnrealizedGainLossOnTradingSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetInvestmentNetRealizedAndUnrealizedGainLossOnTradingSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Realized and unrealized (gains) losses on trading securities",
        "label": "Net Investment, Net Realized And Unrealized Gain (Loss) On Trading Securities",
        "documentation": "Net Investment, Net Realized And Unrealized Gain (Loss) On Trading Securities"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetLegacyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetLegacyMember",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Legacy",
        "label": "Net Legacy [Member]",
        "documentation": "Net Legacy"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetRealizedAndUnrealizedGainLossOnEquitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetRealizedAndUnrealizedGainLossOnEquitySecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSEquitySecuritiesDetails": {
       "parentTag": "us-gaap_EquitySecuritiesFvNiGainLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSEquitySecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment gains (losses) recognized on securities sold during the period",
        "label": "Net Realized And Unrealized Gain (Loss) On Equity Securities",
        "documentation": "Net Realized And Unrealized Gain (Loss) On Equity Securities"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetUnrealizedGainsLossesOnInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetUnrealizedGainsLossesOnInvestmentsMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Unrealized Gains (Losses) on Investments",
        "label": "Net Unrealized Gains (Losses) On Investments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetUnrealizedInvestmentGainsLossesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetUnrealizedInvestmentGainsLossesAxis",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Unrealized Investment Gains (Losses) [Axis]",
        "label": "Net Unrealized Investment Gains (Losses) [Axis]",
        "documentation": "Represents the axis for the schedule of unrealized gains (losses) on available for sale fixed maturities and equity securities shown by gross unrealized investment gains (losses), effects of DAC, Policyholder Liabilities and deferred taxes on AOCI."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NetUnrealizedInvestmentGainsLossesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NetUnrealizedInvestmentGainsLossesDomain",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Unrealized Investment Gains (Losses) [Domain]",
        "label": "Net Unrealized Investment Gains (Losses) [Domain]",
        "documentation": "Represents the domain for the schedule of unrealized gains (losses) on available for sale fixed maturities and equity securities shown by gross unrealized investment gains (losses), effects of DAC, Policyholder Liabilities and deferred taxes on AOCI."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future Adoption of New Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NonConsolidatedVairableInterestEntitiesVIEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NonConsolidatedVairableInterestEntitiesVIEMember",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-consolidated Vairable Interest Entities",
        "label": "Non-consolidated Vairable Interest Entities (VIE) [Member]",
        "documentation": "Non-consolidated Vairable Interest Entities (VIE)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1404"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r1368",
      "r1378",
      "r1388",
      "r1412",
      "r1420"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1395"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1394"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1412"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1431"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1431"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash transactions from investing and financing activities:",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncontrollingInterestAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest [Abstract]",
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling Interest",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r545",
      "r1552",
      "r1553",
      "r1554",
      "r1557",
      "r1847"
     ]
    },
    "us-gaap_NondesignatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NondesignatedMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Not Designated for Hedge Accounting",
        "label": "Not Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonperformingFinancingReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonperformingFinancingReceivableMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonperforming",
        "label": "Nonperforming Financial Instruments [Member]",
        "documentation": "Category status of financial instruments in which payments are past due in accordance with the terms of the contract. Financial instruments include, but are not limited to, financing receivables, loans, debt, and investments."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r1599"
     ]
    },
    "eqh_Note1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "Note1Member",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Note 1",
        "label": "Note 1 [Member]",
        "documentation": "Note 1"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_Note2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "Note2Member",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Note 2",
        "label": "Note 2 [Member]",
        "documentation": "Note 2"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_Note3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "Note3Member",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Note 3",
        "label": "Note 3 [Member]",
        "documentation": "Note 3"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NotesIssuedByConsolidatedVariableInterestEntitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NotesIssuedByConsolidatedVariableInterestEntitiesMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes issued by consolidated VIE\u2019s",
        "label": "Notes Issued By Consolidated Variable Interest Entities [Member]",
        "documentation": "Notes Issued By Consolidated Variable Interest Entities"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NotesIssuedByConsolidatedVariableInterestEntityAccruedInterestPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NotesIssuedByConsolidatedVariableInterestEntityAccruedInterestPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest payable for notes issued by consolidated variable interest entity",
        "label": "Notes Issued By Consolidated Variable Interest Entity, Accrued Interest Payable",
        "documentation": "Notes Issued By Consolidated Variable Interest Entity, Accrued Interest Payable"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NotesIssuedByConsolidatedVariableInterestEntityFairValueOption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NotesIssuedByConsolidatedVariableInterestEntityFairValueOption",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes issued by consolidated variable interest entities, at fair value using the fair value option",
        "verboseLabel": "Notes issued by consolidated VIE's, at fair value using the fair value option",
        "label": "Notes Issued By Consolidated Variable Interest Entity, Fair Value Option",
        "documentation": "Notes Issued By Consolidated Variable Interest Entity, Fair Value Option"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NotesIssuedByConsolidatedVariableInterestEntityUnpaidOutstandingBalanceAndShortTermBorrowing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NotesIssuedByConsolidatedVariableInterestEntityUnpaidOutstandingBalanceAndShortTermBorrowing",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unpaid outstanding balance and short-term borrowing",
        "label": "Notes Issued By Consolidated Variable Interest Entity, Unpaid Outstanding Balance And Short-Term Borrowing",
        "documentation": "Notes Issued By Consolidated Variable Interest Entity, Unpaid Outstanding Balance And Short-Term Borrowing"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NovationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NovationMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Novation",
        "label": "Novation [Member]",
        "documentation": "Company novate certain legacy variable annuity policies sold between years, comprised of policies containing fixed rate Guaranteed Minimum Income Benefit and/or Guaranteed Minimum Death Benefit guarantees"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NumberOfClientChannels": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NumberOfClientChannels",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of main client channels",
        "label": "Number Of Client Channels",
        "documentation": "Number Of Client Channels"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NumberOfLoans": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NumberOfLoans",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of loans",
        "label": "Number Of Loans",
        "documentation": "Number Of Loans"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NumberOfMortgageLoansForeclosureProbable": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NumberOfMortgageLoansForeclosureProbable",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of mortgage loans, foreclosure probable",
        "label": "Number Of Mortgage Loans, Foreclosure Probable",
        "documentation": "Number Of Mortgage Loans, Foreclosure Probable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r1223",
      "r1563"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r1218",
      "r1226",
      "r1563"
     ]
    },
    "eqh_NumberOfSharesAvailableForExchange": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NumberOfSharesAvailableForExchange",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available for exchange, shares",
        "label": "NumberOfSharesAvailableForExchange",
        "documentation": "Number Of Shares Available For Exchange"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_NumberOfTroubledDebtRestructuringExtensions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "NumberOfTroubledDebtRestructuringExtensions",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of troubled debt restructuring extensions",
        "label": "Number Of Troubled Debt Restructuring Extensions",
        "documentation": "Number Of Troubled Debt Restructuring Extensions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTaxParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTaxParent",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in liability for future policy benefits - current discount rate (net of deferred income tax expense (benefit) of $(25), $44 and $285)",
        "label": "OCI, Liability for Future Policy Benefit, Gain (Loss), after Reclassification Adjustment and Tax, Parent",
        "documentation": "Amount, after tax and reclassification adjustment, of unrealized gain (loss) from (increase) decrease in liability for future policy benefit from change in discount rate, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r714",
      "r719"
     ]
    },
    "us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentTaxParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentTaxParent",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax expense (benefit) for liability for future policy benefits - change in current discount rate",
        "label": "OCI, Liability for Future Policy Benefit, Gain (Loss), after Reclassification Adjustment, Tax, Parent",
        "documentation": "Amount, after reclassification adjustment, of tax expense (benefit) for unrealized gain (loss) from (increase) decrease in liability for future policy benefit from change in discount rate, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r714",
      "r719"
     ]
    },
    "us-gaap_OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in market risk benefits - instrument-specific credit risk (net of deferred income tax expense (benefit) of $110, $(37)and $332)",
        "label": "OCI, Market Risk Benefit, Instrument-Specific Credit Risk, Gain (Loss), after Adjustments and Tax",
        "documentation": "Amount, after tax and adjustments, of unrealized gain (loss) from (increase) decrease in instrument-specific credit risk on contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r240",
      "r961",
      "r1006"
     ]
    },
    "us-gaap_OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTaxAbstract",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in LFPB discount rate and MRB credit risk, net of tax",
        "label": "OCI, Market Risk Benefit, Instrument-Specific Credit Risk, Gain (Loss), after Adjustments and Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsTax",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax expense (benefit) for market risk benefits - change in instrument-specific credit risk",
        "label": "OCI, Market Risk Benefit, Instrument-Specific Credit Risk, Gain (Loss), after Adjustments, Tax",
        "documentation": "Amount, after adjustments, of tax expense (benefit) for unrealized gain (loss) from (increase) decrease in instrument-specific credit risk on contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk."
       }
      }
     },
     "auth_ref": [
      "r241"
     ]
    },
    "eqh_OffsettingAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OffsettingAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Offsetting Financial Assets and Liabilities and Derivative Instruments",
        "label": "Offsetting Assets And Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of derivative and other financial assets and liabilities that are subject to offsetting, including master netting arrangements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingDerivativeAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OffsettingDerivativeAssetsAbstract",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets:",
        "label": "Offsetting Derivative Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingDerivativeLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OffsettingDerivativeLiabilitiesAbstract",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Offsetting Derivative Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r355",
      "r1222",
      "r1223"
     ]
    },
    "us-gaap_OptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OptionMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options",
        "label": "Options Held [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received)."
       }
      }
     },
     "auth_ref": [
      "r1111",
      "r1116",
      "r1134",
      "r1140",
      "r1160",
      "r1161",
      "r1162",
      "r1343",
      "r1344"
     ]
    },
    "eqh_OrganizationBasisOfPresentationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OrganizationBasisOfPresentationLineItems",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization Basis Of Presentation [Line Items]",
        "label": "Organization Basis Of Presentation [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OrganizationBasisOfPresentationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OrganizationBasisOfPresentationTable",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization Basis Of Presentation [Table]",
        "label": "Organization Basis Of Presentation [Table]",
        "documentation": "Schedule of transations related to organization baiss and presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ORGANIZATION",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r217",
      "r219",
      "r220",
      "r1059",
      "r1060"
     ]
    },
    "eqh_OtherAdjustmentsToIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherAdjustmentsToIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other adjustments",
        "label": "Other Adjustments To Income",
        "documentation": "Other Adjustments To Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r224",
      "r943",
      "r1223",
      "r1331",
      "r1334",
      "r1355"
     ]
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other invested assets:",
        "label": "Other Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of other assets."
       }
      }
     },
     "auth_ref": [
      "r1743",
      "r1744",
      "r1754",
      "r1758",
      "r1759",
      "r1760",
      "r1762"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in net unrealized gains (losses) on investments:",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in defined benefit plans:",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustments:",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation gains (losses) arising during the period",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r86",
      "r87",
      "r89",
      "r840",
      "r841",
      "r844"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax",
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r89",
      "r243",
      "r591",
      "r615"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails": {
       "parentTag": "eqh_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails",
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net unrealized investment gains (losses)",
        "totalLabel": "Net unrealized gains (losses) on investments",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r240",
      "r961"
     ]
    },
    "eqh_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax1",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in unrealized gains (losses), net of reclassification adjustment",
        "totalLabel": "Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $297, $(235) and $(1,364))",
        "label": "Other Comprehensive Income (Loss), Available-For-Sale Securities Adjustment, Net Of Tax1",
        "documentation": "Net of tax amount of the appreciation (loss) in the value of unsold available-for-sale securities. Includes amounts related to other than temporary impairment (OTTI) losses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax expense (benefit) for change in unrealized gains (losses)",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax",
        "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r241"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount recorded in AOCI",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r22",
      "r250",
      "r792",
      "r845",
      "r848",
      "r851",
      "r961",
      "r1493"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in Pre tax AOCI",
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent",
        "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r14",
      "r117"
     ]
    },
    "eqh_OtherComprehensiveIncomeLossCurrentDiscountRateAdjustmentForFuturePolicyBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherComprehensiveIncomeLossCurrentDiscountRateAdjustmentForFuturePolicyBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in liability for future policy benefits - current discount rate",
        "label": "Other Comprehensive Income (Loss), Current Discount Rate Adjustment For Future Policy Benefits",
        "documentation": "Other Comprehensive Income (Loss), Current Discount Rate for Future Policy Benefits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustment",
        "totalLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r961"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "(Gains) losses reclassified into net income (loss) during the period",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax",
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7",
      "r89",
      "r243",
      "r843"
     ]
    },
    "eqh_OtherComprehensiveIncomeLossMarketRiskBenefitAfterAdjustmentFromInstrumentOfSpecialCreditRisk": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherComprehensiveIncomeLossMarketRiskBenefitAfterAdjustmentFromInstrumentOfSpecialCreditRisk",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in market risk benefits - instrument-specific credit risk",
        "label": "Other Comprehensive Income (Loss), Market Risk Benefit, After Adjustment From Instrument Of Special Credit Risk",
        "documentation": "Other Comprehensive Income (Loss), Market Risk Benefit, After Adjustment From Instrument Of Special Credit Risk"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other comprehensive income (loss), net of income taxes",
        "terseLabel": "Other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r18",
      "r245",
      "r248",
      "r253",
      "r294",
      "r845",
      "r846",
      "r851",
      "r915",
      "r961",
      "r1493",
      "r1494"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss) net of income taxes:",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Less: Other comprehensive income (loss) attributable to noncontrolling interest",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r14",
      "r117",
      "r245",
      "r248",
      "r294"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income (loss) attributable to Holdings",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r14",
      "r117",
      "r245",
      "r248",
      "r294"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment",
        "negatedTerseLabel": "Change in defined benefit plans (net of deferred income tax expense (benefit) of $3, $7, $1, and $5)",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r88",
      "r89",
      "r961"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred income tax expense (benefit) for change in defined benefit plans",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r88",
      "r117"
     ]
    },
    "eqh_OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleAndWriteDownOfSecuritiesExcludedFromNetIncomeLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleAndWriteDownOfSecuritiesExcludedFromNetIncomeLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Excluded from net income (loss)",
        "label": "Other Comprehensive Income Loss Reclassification Adjustment For Sale And Write Down Of Securities Excluded From Net Income Loss Before Tax",
        "documentation": "Other Comprehensive Income Loss Reclassification Adjustment For Sale And Write Down Of Securities Excluded From Net Income Loss Before Tax"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OtherComprehensiveIncomeReclassificationAdjustmentForSaleAndWriteDownOfSecuritiesIncludedInIncomeLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherComprehensiveIncomeReclassificationAdjustmentForSaleAndWriteDownOfSecuritiesIncludedInIncomeLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Included in net income (loss)",
        "label": "Other Comprehensive Income, Reclassification Adjustment For Sale And Write Down Of Securities Included In Income (Loss), Before Tax",
        "documentation": "Other Comprehensive Income, Reclassification Adjustment For Sale And Write Down Of Securities Included In Income (Loss), Before Tax"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OtherComprehensiveIncomeReclassificationAdjustmentFromAOCISaleAndWriteDownOfSecuritiesTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherComprehensiveIncomeReclassificationAdjustmentFromAOCISaleAndWriteDownOfSecuritiesTax",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification adjustment",
        "label": "Other Comprehensive Income, Reclassification Adjustment From AOCI, Sale And Write Down Of Securities, Tax",
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities or other than temporary impairment."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OtherComprehensiveIncomeReclassificationAdjustmentOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherComprehensiveIncomeReclassificationAdjustmentOther",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Other Comprehensive Income, Reclassification Adjustment, Other",
        "documentation": "Other Comprehensive Income, Reclassification Adjustment, Other"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OtherComprehensiveIncomeReclassificationAdjustmentSaleAndWriteDownOfSecuritiesIncludedInNetIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherComprehensiveIncomeReclassificationAdjustmentSaleAndWriteDownOfSecuritiesIncludedInNetIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Gains) losses reclassified into net income (loss) during the period",
        "label": "Other Comprehensive Income, Reclassification Adjustment, Sale And Write Down Of Securities, Included In Net Income",
        "documentation": "Reclassification adjustment for unrealized gains or losses realized upon the sale of securities, after tax and for for unrealized gains or losses realized upon the write-down of securities, after tax."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment gains (losses) arising during the period",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax",
        "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r240",
      "r401"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net unrealized gains (losses) arising during the period",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r240",
      "r401"
     ]
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCostAndExpenseOperating",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other operating costs and expenses",
        "label": "Other Cost and Expense, Operating",
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r974",
      "r1222"
     ]
    },
    "eqh_OtherDepreciationAmortizationAndAccretion": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherDepreciationAmortizationAndAccretion",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amortization and depreciation",
        "label": "Other Depreciation, Amortization And Accretion",
        "documentation": "Other Depreciation, Amortization And Accretion"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OtherEquityInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherEquityInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Investments",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other equity investments",
        "label": "Other Equity Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. This element also includes equity securities classified as available for sale carried at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OtherFinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherFinancialAssetsMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial assets",
        "label": "Other Financial Assets [Member]",
        "documentation": "Financial statement disclosure encompassing other investments, not including derivatives."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OtherFinancialLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherFinancialLiabilitiesMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial liabilities",
        "label": "Other Financial Liabilities [Member]",
        "documentation": "Financial statement disclosure encompassing other liabilities, not including derivatives."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OtherFuturePolicyholderBenefitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherFuturePolicyholderBenefitsMember",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Future Policyholder Benefits [Member]",
        "documentation": "Other Future Policyholder Benefits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income",
        "label": "Other Income",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r971",
      "r1125",
      "r1169",
      "r1170",
      "r1171",
      "r1331",
      "r1334"
     ]
    },
    "eqh_OtherInvestedAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherInvestedAssetsMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other invested assets",
        "label": "Other Invested Assets [Member]",
        "documentation": "Other invested assets"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OtherInvestmentIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherInvestmentIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment income (loss)",
        "verboseLabel": "Net Investment Income",
        "label": "Other Investment Income (Loss)",
        "documentation": "Other investment income"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OtherInvestmentIncomeLossGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherInvestmentIncomeLossGross",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails": {
       "parentTag": "us-gaap_NetInvestmentIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross investment income (loss)",
        "label": "Other Investment Income (Loss), Gross",
        "documentation": "Other Investment Income (Loss), Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Investments",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other invested assets",
        "label": "Other Investments",
        "documentation": "Amount of investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r954",
      "r1480"
     ]
    },
    "us-gaap_OtherInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherInvestmentsMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSInvestmentGainsLossesNetDetails",
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other investment income",
        "terseLabel": "Other",
        "label": "Other Investments [Member]",
        "documentation": "Primary financial statement caption encompassing other investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r946",
      "r1097",
      "r1098",
      "r1244",
      "r1331",
      "r1334",
      "r1355",
      "r1794",
      "r1841"
     ]
    },
    "us-gaap_OtherLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other liabilities."
       }
      }
     },
     "auth_ref": [
      "r1270"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other, net",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1404"
     ]
    },
    "eqh_OtherPolicyholderFundsAndDividendsPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OtherPolicyholderFundsAndDividendsPayableMember",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other policyholder funds and dividends payable",
        "label": "Other Policyholder Funds And Dividends Payable [Member]",
        "documentation": "Other Policyholder Funds And Dividends Payable"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_OthersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "OthersMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Others [Member]",
        "documentation": "Others"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1366",
      "r1376",
      "r1386",
      "r1418"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1369",
      "r1379",
      "r1389",
      "r1421"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1369",
      "r1379",
      "r1389",
      "r1421"
     ]
    },
    "us-gaap_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ParentMember",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Holdings Equity",
        "label": "Parent [Member]",
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1393"
     ]
    },
    "srt_PayablesToBrokerDealersAndClearingOrganizations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "PayablesToBrokerDealersAndClearingOrganizations",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Broker-dealer related payables",
        "label": "Broker-Dealer, Payable to Other Broker-Dealer and Clearing Organization",
        "documentation": "Amount payable to other broker-dealer and clearing organization, including, but not limited to, security failed-to-receive, deposit received for security loaned, open transaction, and floor-brokerage payable."
       }
      }
     },
     "auth_ref": [
      "r1477",
      "r1780"
     ]
    },
    "srt_PayablesToCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "PayablesToCustomers",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer related payables",
        "label": "Broker-Dealer, Payable to Customer",
        "documentation": "Amount payable to customer by broker-dealer."
       }
      }
     },
     "auth_ref": [
      "r1477"
     ]
    },
    "us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForProceedsFromDerivativeInstrumentInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash settlements related to derivative instruments, net",
        "label": "Payments for (Proceeds from) Derivative Instrument, Investing Activities",
        "documentation": "The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other, net",
        "label": "Payment for (Proceeds from) Other Investing Activity",
        "documentation": "Amount of cash (inflow) outflow from investing activity, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1448",
      "r1540"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of treasury shares",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfPreferredStockAndPreferenceStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRepurchaseOfPreferredStockAndPreferenceStock",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Redemption of preferred stock",
        "label": "Payments for Repurchase of Preferred Stock and Preference Stock",
        "documentation": "The cash outflow to reacquire preferred stock during the period."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfDividendsCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends paid on common stock",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends paid on preferred stock",
        "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "eqh_PaymentsOfFundingAgreementFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PaymentsOfFundingAgreementFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repaid During the Period",
        "label": "Payments Of Funding Agreement, Financing Activities",
        "documentation": "Payments Of Funding Agreement, Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PaymentsOfMarketRiskBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PaymentsOfMarketRiskBenefits",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments of market risk benefits",
        "label": "Payments Of Market Risk Benefits",
        "documentation": "Payments Of Market Risk Benefits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Fixed maturities, available-for-sale",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r263",
      "r368"
     ]
    },
    "eqh_PaymentsToAcquireFixedMaturitiesAtFairValueUsingFairValueOption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PaymentsToAcquireFixedMaturitiesAtFairValueUsingFairValueOption",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Fixed maturities, at fair value using the fair value option",
        "label": "Payments To Acquire Fixed Maturities At Fair Value Using Fair Value Option",
        "documentation": "Payments To Acquire Fixed Maturities At Fair Value Using Fair Value Option"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireInvestmentsAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for the purchase/origination of:",
        "label": "Payments to Acquire Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireMortgageNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireMortgageNotesReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Mortgage loans on real estate",
        "label": "Payments to Acquire Mortgage Notes Receivable",
        "documentation": "The cash outflow from the purchase of receivables arising from the mortgage note on real estate."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "eqh_PaymentsToAcquireNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PaymentsToAcquireNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of AllianceBernstein Units",
        "label": "Payments To Acquire Noncontrolling Interests",
        "documentation": "Payments To Acquire Noncontrolling Interests"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireOtherInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Payments to Acquire Other Investments",
        "documentation": "Amount of cash outflow to acquire investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireShortTermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Short term investments",
        "label": "Payments to Acquire Short-Term Investments",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireTradingSecuritiesHeldforinvestment",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Trading account securities",
        "label": "Payment for Acquisition, Trading Security, Held-for-Investment",
        "documentation": "The cash outflow to acquire securities classified as trading securities and held for investment purposes. Excludes payments for trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time)."
       }
      }
     },
     "auth_ref": [
      "r1540"
     ]
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToMinorityShareholders",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Distribution to noncontrolling interest of consolidated subsidiaries",
        "label": "Payments to Noncontrolling Interests",
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "eqh_PaymentsToRedemptionsFromNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PaymentsToRedemptionsFromNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds",
        "label": "Payments To (Redemptions From) Noncontrolling Interests",
        "documentation": "Payments To (Redemptions From) Noncontrolling Interests"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PayoutMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PayoutMember",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsRevenueandInterestAccretionDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsWeightedAverageInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payout",
        "netLabel": "Payout",
        "label": "Payout [Member]",
        "documentation": "Payout"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1403"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1403"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EMPLOYEE BENEFIT PLANS",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r546",
      "r571",
      "r573",
      "r579",
      "r596",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r636",
      "r637",
      "r638",
      "r1252"
     ]
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PensionPlansDefinedBenefitMember",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Periodic Pension Expense",
        "label": "Pension Plan [Member]",
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r597",
      "r600",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r638",
      "r639",
      "r650",
      "r1252",
      "r1253",
      "r1257",
      "r1258",
      "r1259"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1395"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1412"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1405"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1394"
     ]
    },
    "eqh_PercentageOfDebtSecuritiesAvailableForSaleSecurities": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PercentageOfDebtSecuritiesAvailableForSaleSecurities",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of available for sale securities",
        "label": "Percentage Of Debt Securities, Available-For-Sale Securities",
        "documentation": "Other than investment grade Securities as a percentage of aggregate amortized cost of fixed maturities held by the Company."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PercentageOfLoansReceivableFairValueDisclosure": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PercentageOfLoansReceivableFairValueDisclosure",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of loans receivable, fair value disclosure",
        "label": "Percentage Of Loans Receivable, Fair Value Disclosure",
        "documentation": "Percentage Of Loans Receivable, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PerformingFinancingReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PerformingFinancingReceivableMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performing",
        "label": "Performing Financial Instruments [Member]",
        "documentation": "Category status of financial instruments in which payments are received or paid on a timely basis in accordance with the terms of the contract. Financial instruments include, but are not limited to, financing receivables, loans, debt instruments, and investments."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r1599"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1396"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1440"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1395"
     ]
    },
    "eqh_PolicyHolderAccountBalancesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyHolderAccountBalancesTextBlock",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "POLICYHOLDER ACCOUNT BALANCES",
        "label": "Policy Holder Account Balances [Text Block]",
        "documentation": "Policy Holder Account Balances"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PolicyLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyLoansMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policy loans",
        "label": "Policy Loans [Member]",
        "documentation": "Loan issued by an insurance company, collateralized by the cash value of the borrower's life insurance policy."
       }
      }
     },
     "auth_ref": [
      "r1834"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRate": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRate",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis points above guaranteed minimum crediting rate",
        "label": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate",
        "documentation": "Value above guaranteed minimum crediting rate on policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1324"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateAxis",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Axis]",
        "label": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Axis]",
        "documentation": "Information by range above guaranteed minimum crediting rate on policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1324"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateDomain",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Domain]",
        "label": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate [Domain]",
        "documentation": "Range above guaranteed minimum crediting rate on policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1324"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0001To0050Member",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1 Basis Point - 50 Basis Points Above",
        "label": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 [Member]",
        "documentation": "Range from 1 basis point to 50 basis points above guaranteed minimum crediting rate on policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1324",
      "r1828"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "51 Basis Points - 150 Basis Points Above",
        "label": "Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 [Member]",
        "documentation": "Range from 51 basis points to 150 basis points above guaranteed minimum crediting rate on policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1324",
      "r1828"
     ]
    },
    "eqh_PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeGreaterThan0150Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeGreaterThan0150Member",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Greater Than 150 Basis Points Above",
        "label": "Policyholder Account Balance, Above Guaranteed Minimum Crediting Rate, Range Greater Than 0150 [Member]",
        "documentation": "Policyholder Account Balance, Above Guaranteed Minimum Crediting Rate, Range Greater Than 0150"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PolicyholderAccountBalanceAfterFundingAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountBalanceAfterFundingAgreements",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Balance, end of period",
        "label": "Policyholder Account Balance, After Funding Agreements",
        "documentation": "Policyholder Account Balance, After Funding Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Policyholder Account Balance and Liability for Unpaid Claims and Claims Adjustment Expense",
        "label": "Policyholder Account Balance And Liability For Unpaid Claims And Claims Adjustment Expense [Table Text Block]",
        "documentation": "Policyholder Account Balance And Liability For Unpaid Claims And Claims Adjustment Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At Guaranteed Minimum",
        "label": "Policyholder Account Balance, at Guaranteed Minimum Crediting Rate [Member]",
        "documentation": "Range at zero basis point above guaranteed minimum crediting rate on policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1324",
      "r1828"
     ]
    },
    "eqh_PolicyholderAccountBalanceBeforeFundingAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountBalanceBeforeFundingAgreements",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails": {
       "parentTag": "eqh_PolicyholderAccountBalanceAfterFundingAgreements",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance (exclusive of Funding Agreements)",
        "label": "Policyholder Account Balance, Before Funding Agreements",
        "documentation": "Policyholder Account Balance, Before Funding Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PolicyholderAccountBalanceBenefitPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceBenefitPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Benefit payments",
        "label": "Policyholder Account Balance, Benefit Payment",
        "documentation": "Amount of cash outflow to policyholder account balance from benefit payment."
       }
      }
     },
     "auth_ref": [
      "r1312",
      "r1324",
      "r1823"
     ]
    },
    "eqh_PolicyholderAccountBalanceFundingAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountBalanceFundingAgreements",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails": {
       "parentTag": "eqh_PolicyholderAccountBalanceAfterFundingAgreements",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Funding Agreements",
        "label": "Policyholder Account Balance, Funding Agreements",
        "documentation": "Policyholder Account Balance, Funding Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditRating": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditRating",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range of Guaranteed Minimum Crediting Rate",
        "label": "Policyholder Account Balance, Guaranteed Minimum Credit Rating",
        "documentation": "Guaranteed minimum crediting rate on policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1324"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeAxis",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Axis]",
        "label": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Axis]",
        "documentation": "Information by range of guaranteed minimum crediting rate on policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1324"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeDomain",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Domain]",
        "label": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate Range [Domain]",
        "documentation": "Range of guaranteed minimum crediting rate on policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1324"
     ]
    },
    "eqh_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom000To150Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom000To150Member",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "0.00% - 1.50%",
        "label": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0.00% To 1.50% [Member]",
        "documentation": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 0.00% To 1.50%"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom150To250Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom150To250Member",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1.51% - 2.50%",
        "label": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 1.50% To 2.50% [Member]",
        "documentation": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range From 1.50% To 2.50%"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeGreaterThan250Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeGreaterThan250Member",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Greater than 2.50%",
        "label": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Greater Than 2.50% [Member]",
        "documentation": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range Greater Than 2.50%"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PolicyholderAccountBalanceGuaranteedMinimumCreditingRateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceGuaranteedMinimumCreditingRateTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Policyholder Account Balance, Guaranteed Minimum Crediting Rate",
        "label": "Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Table Text Block]",
        "documentation": "Tabular disclosure of policyholder account balance by range of guaranteed minimum crediting rate and related range of difference between rate being credited to policyholder and respective guaranteed minimum."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1324"
     ]
    },
    "eqh_PolicyholderAccountBalanceInterestCredited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountBalanceInterestCredited",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest Credited To Policyholders Account Balances",
        "label": "Policyholder Account Balance, Interest Credited",
        "documentation": "Policyholder Account Balance, Interest Credited"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PolicyholderAccountBalanceInterestExpenseAdjusted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountBalanceInterestExpenseAdjusted",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": "eqh_BenefitsLossesAndExpensesAdjusted",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest credited to policyholders\u2019 account balances",
        "label": "Policyholder Account Balance, Interest Expense, Adjusted",
        "documentation": "Policyholder Account Balance, Interest Expense, Adjusted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PolicyholderAccountBalanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceLineItems",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholder Account Balance [Line Items]",
        "label": "Policyholder Account Balance [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1324"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceNetAmountAtRisk": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceNetAmountAtRisk",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net amount at risk",
        "label": "Policyholder Account Balance, Net Amount at Risk",
        "documentation": "Amount of guaranteed benefit in excess of current account balance of policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1020",
      "r1324"
     ]
    },
    "eqh_PolicyholderAccountBalanceOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountBalanceOther",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other (4)",
        "label": "Policyholder Account Balance, Other",
        "documentation": "Policyholder Account Balance, Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PolicyholderAccountBalancePeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalancePeriodIncreaseDecrease",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in policyholders\u2019 account balance",
        "label": "Policyholder Account Balance, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in liability for policyholder account balance."
       }
      }
     },
     "auth_ref": [
      "r1823"
     ]
    },
    "us-gaap_PolicyholderAccountBalancePolicyCharge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalancePolicyCharge",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Policy charges",
        "label": "Policyholder Account Balance, Policy Charge",
        "documentation": "Amount of decrease in liability for policyholder account balance from policy charge."
       }
      }
     },
     "auth_ref": [
      "r1310",
      "r1324",
      "r1823"
     ]
    },
    "us-gaap_PolicyholderAccountBalancePremiumReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalancePremiumReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Premiums received",
        "label": "Policyholder Account Balance, Premium Received",
        "documentation": "Amount of cash inflow to policyholder account balance from premium received."
       }
      }
     },
     "auth_ref": [
      "r1309",
      "r1324",
      "r1823"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceRollForward",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholder Account Balance [Roll Forward]",
        "label": "Policyholder Account Balance [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceSurrenderAndWithdrawal",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Surrenders and withdrawals",
        "label": "Policyholder Account Balance, Surrender and Withdrawal",
        "documentation": "Amount of decrease in liability for policyholder account balance from contract redemption and withdrawal of funds."
       }
      }
     },
     "auth_ref": [
      "r1311",
      "r1324",
      "r1823"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceTable",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholder Account Balance [Table]",
        "label": "Policyholder Account Balance [Table]",
        "documentation": "Disclosure of information about policyholder account balance, including, but not limited to change in liability and related cash surrender value."
       }
      }
     },
     "auth_ref": [
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1324"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSTables",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Policyholder Account Balance",
        "label": "Policyholder Account Balance [Table Text Block]",
        "documentation": "Tabular disclosure of information about policyholder account balance, including, but not limited to change in liability and related cash surrender value."
       }
      }
     },
     "auth_ref": [
      "r1018",
      "r1324"
     ]
    },
    "us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderAccountBalanceWeightedAverageCreditingRate",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average crediting rate",
        "label": "Policyholder Account Balance, Weighted Average Crediting Rate",
        "documentation": "Weighted-average crediting rate for liability for policyholder account balance, calculated at a point in time."
       }
      }
     },
     "auth_ref": [
      "r1019",
      "r1324"
     ]
    },
    "eqh_PolicyholderAccountValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderAccountValue",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholder account value",
        "label": "Policyholder Account Value",
        "documentation": "Policyholder Account Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderBenefitsAndClaimsIncurredNet",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholders\u2019 benefits",
        "label": "Policyholder Benefits and Claims Incurred, Net",
        "documentation": "Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred."
       }
      }
     },
     "auth_ref": [
      "r1331",
      "r1332",
      "r1334",
      "r1785",
      "r1797"
     ]
    },
    "eqh_PolicyholderBenefitsAndClaimsIncurredNetAdjusted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholderBenefitsAndClaimsIncurredNetAdjusted",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": "eqh_BenefitsLossesAndExpensesAdjusted",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholders\u2019 benefits",
        "label": "Policyholder Benefits and Claims Incurred, Net, Adjusted",
        "documentation": "Policyholder Benefits and Claims Incurred, Net, Adjusted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PolicyholderContractDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderContractDeposits",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholders\u2019 account balances",
        "verboseLabel": "Policyholders\u2019 liabilities: Investment contracts",
        "label": "Policyholder Contract Deposit",
        "documentation": "Amount of liability due to policyholder for deposit held under long-duration contract issued by insurance entity."
       }
      }
     },
     "auth_ref": [
      "r1334",
      "r1805"
     ]
    },
    "us-gaap_PolicyholderFunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderFunds",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholders\u2019 account balance reconciliation",
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of period",
        "label": "Policyholder Account Balance",
        "documentation": "Amount due to policyholder. Includes, but is not limited to, unpaid policy dividend, retrospective refund, and undistributed earnings on participating business. Excludes future policy benefit and claim expense."
       }
      }
     },
     "auth_ref": [
      "r1018",
      "r1022",
      "r1023",
      "r1324",
      "r1791"
     ]
    },
    "us-gaap_PolicyholderFundsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PolicyholderFundsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Policyholder Account Balance [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PolicyholdersLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PolicyholdersLiabilitiesMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Policyholders\u2019 Liabilities",
        "label": "Policyholders Liabilities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r829",
      "r830",
      "r832",
      "r833",
      "r835",
      "r837",
      "r838",
      "r1200",
      "r1761"
     ]
    },
    "eqh_PreCapitalizedTrustSecurities2029PCAPsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PreCapitalizedTrustSecurities2029PCAPsMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029 Trust",
        "label": "Pre-Capitalized Trust Securities, 2029 P-CAPs [Member]",
        "documentation": "Pre-Capitalized Trust Securities, Tranche One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PreCapitalizedTrustSecurities2049PCapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PreCapitalizedTrustSecurities2049PCapsMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2049 Trust",
        "label": "Pre-Capitalized Trust Securities, 2049 P-Caps [Member]",
        "documentation": "Pre-Capitalized Trust Securities, Tranche Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PreCapitalizedTrustSecurities2054PCapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PreCapitalizedTrustSecurities2054PCapsMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2054 Trust",
        "label": "Pre-Capitalized Trust Securities, 2054 P-Caps [Member]",
        "documentation": "Pre-Capitalized Trust Securities, 2054 P-Caps"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PreCapitalizedTrustSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PreCapitalizedTrustSecuritiesMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Capitalized Trust Securities",
        "label": "Pre-Capitalized Trust Securities [Member]",
        "documentation": "Pre-Capitalized Trust Securities"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PreferredStockAndAdditionalPaidInCapitalValueIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PreferredStockAndAdditionalPaidInCapitalValueIssued",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock and additional paid-in capital, $1 par value and $25,000 liquidation preference",
        "label": "Preferred Stock And Additional Paid-In Capital, Value, Issued",
        "documentation": "Preferred Stock And Additional Paid-In Capital, Value, Issued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockDividendsAndOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockDividendsAndOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Preferred stock dividends",
        "label": "Preferred Stock Dividends and Other Adjustments",
        "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r1442",
      "r1560"
     ]
    },
    "us-gaap_PreferredStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.equitable.com/role/EQUITYDividendsDeclaredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared per share of preferred stock (in dollars per share)",
        "label": "Preferred Stock, Dividends Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockIncludingAdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockIncludingAdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock and Additional Paid-In Capital",
        "label": "Preferred Stock Including Additional Paid in Capital [Member]",
        "documentation": "Preferred stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockLiquidationPreferenceValue",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, liquidation preference",
        "label": "Preferred Stock, Liquidation Preference, Value",
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r273",
      "r533",
      "r544"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r529"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r1103"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r529"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r1103",
      "r1121",
      "r1847",
      "r1848"
     ]
    },
    "us-gaap_PremiumsEarnedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PremiumsEarnedNet",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Premiums",
        "label": "Premiums Earned, Net",
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r935",
      "r991",
      "r1041",
      "r1331",
      "r1332",
      "r1333",
      "r1334",
      "r1335"
     ]
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revision of Previously Issued Financial Statements",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r1479"
     ]
    },
    "us-gaap_ProceedsFromAnnuitiesAndInvestmentCertificates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromAnnuitiesAndInvestmentCertificates",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits",
        "label": "Proceeds from Annuities and Investment Certificates",
        "documentation": "The cash inflow from an insurance contract under which the policy holder make a lump sum payment or a series of payments in exchange for periodic payments to the policyholder beginning immediately or at some future date."
       }
      }
     },
     "auth_ref": [
      "r1542"
     ]
    },
    "eqh_ProceedsFromCollateralizedLoanObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ProceedsFromCollateralizedLoanObligations",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from collateralized loan obligations",
        "label": "Proceeds From Collateralized Loan Obligations",
        "documentation": "Proceeds From Collateralized Loan Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ProceedsFromFundingAgreementFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ProceedsFromFundingAgreementFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued During the Period",
        "label": "Proceeds From Funding Agreement, Financing Activities",
        "documentation": "Proceeds From Funding Agreement, Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ProceedsFromIssuanceOfDebtConsolidatedVariableInterestEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ProceedsFromIssuanceOfDebtConsolidatedVariableInterestEntity",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from notes issued by consolidated VIEs",
        "label": "Proceeds From Issuance Of Debt, Consolidated Variable Interest Entity",
        "documentation": "Proceeds From Issuance Of Debt, Consolidated Variable Interest Entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of long-term debt",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r1063"
     ]
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other, net",
        "label": "Proceeds from (Payment for) Other Financing Activity",
        "documentation": "Amount of cash inflow (outflow) from financing activity, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1449",
      "r1541"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayment of short-term financings",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndCollectionOfMortgageNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleAndCollectionOfMortgageNotesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage loans on real estate",
        "label": "Proceeds from Sale and Collection of Mortgage Notes Receivable",
        "documentation": "The cash inflow from proceeds from sale of receivables arising from the mortgage note on real estate; includes collections on mortgage notes receivable that are not classified as operating cash flows."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "eqh_ProceedsFromSaleAndMaturityAtFairValueUsingFairValueOption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ProceedsFromSaleAndMaturityAtFairValueUsingFairValueOption",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed maturities, at fair value using the fair value option",
        "label": "Proceeds From Sale And Maturity At Fair Value Using Fair Value Option",
        "documentation": "Proceeds From Sale And Maturity At Fair Value Using Fair Value Option"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed maturities, available-for-sale",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r264",
      "r1572"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Proceeds from Sale and Maturity of Other Investments",
        "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading account securities",
        "label": "Proceeds from Sale and Maturity, Debt Security, Trading, and Equity Security, FV-NI, Held-for-Investment",
        "documentation": "The cash inflow associated with the sale, maturities, repayments and calls of securities classified as trading securities and held for investment purposes. Excludes proceeds from trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestmentsAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the sale/maturity/pre-payment of:",
        "label": "Proceeds from Sale, Maturity and Collection of Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sales",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r263",
      "r368",
      "r400"
     ]
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term investments",
        "label": "Proceeds from Sale of Short-Term Investments",
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProductAndServiceOtherMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Product and Service, Other [Member]",
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1626",
      "r1627"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsRevenueandInterestAccretionDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsWeightedAverageInterestRatesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails",
      "http://www.equitable.com/role/ORGANIZATIONDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r209",
      "r357",
      "r904",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r1008",
      "r1201",
      "r1211",
      "r1213",
      "r1214",
      "r1246",
      "r1247",
      "r1301",
      "r1324",
      "r1326",
      "r1328",
      "r1338",
      "r1455",
      "r1478",
      "r1499",
      "r1500",
      "r1501",
      "r1502",
      "r1503",
      "r1504",
      "r1505",
      "r1506",
      "r1507",
      "r1508",
      "r1509",
      "r1510",
      "r1511",
      "r1512",
      "r1513",
      "r1514",
      "r1515",
      "r1516",
      "r1517",
      "r1518",
      "r1519",
      "r1520",
      "r1521",
      "r1522",
      "r1523",
      "r1524",
      "r1525",
      "r1526",
      "r1527",
      "r1528",
      "r1529",
      "r1530",
      "r1531",
      "r1532",
      "r1533",
      "r1534",
      "r1535",
      "r1536",
      "r1537",
      "r1538",
      "r1539",
      "r1611",
      "r1612",
      "r1800",
      "r1806",
      "r1807",
      "r1808",
      "r1809",
      "r1810",
      "r1811",
      "r1812",
      "r1813",
      "r1814",
      "r1815",
      "r1816",
      "r1817",
      "r1818",
      "r1819",
      "r1820",
      "r1821",
      "r1822",
      "r1823",
      "r1824",
      "r1825",
      "r1826",
      "r1827",
      "r1828",
      "r1829",
      "r1830",
      "r1831",
      "r1836",
      "r1837"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsRevenueandInterestAccretionDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsWeightedAverageInterestRatesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails",
      "http://www.equitable.com/role/ORGANIZATIONDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r209",
      "r357",
      "r904",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r1008",
      "r1201",
      "r1211",
      "r1213",
      "r1214",
      "r1246",
      "r1247",
      "r1301",
      "r1324",
      "r1326",
      "r1328",
      "r1338",
      "r1455",
      "r1478",
      "r1499",
      "r1500",
      "r1501",
      "r1502",
      "r1503",
      "r1504",
      "r1505",
      "r1506",
      "r1507",
      "r1508",
      "r1509",
      "r1510",
      "r1511",
      "r1512",
      "r1513",
      "r1514",
      "r1515",
      "r1516",
      "r1517",
      "r1518",
      "r1519",
      "r1520",
      "r1521",
      "r1522",
      "r1523",
      "r1524",
      "r1525",
      "r1526",
      "r1527",
      "r1528",
      "r1529",
      "r1530",
      "r1531",
      "r1532",
      "r1533",
      "r1534",
      "r1535",
      "r1536",
      "r1537",
      "r1538",
      "r1539",
      "r1611",
      "r1612",
      "r1800",
      "r1806",
      "r1807",
      "r1808",
      "r1809",
      "r1810",
      "r1811",
      "r1812",
      "r1813",
      "r1814",
      "r1815",
      "r1816",
      "r1817",
      "r1818",
      "r1819",
      "r1820",
      "r1821",
      "r1822",
      "r1823",
      "r1824",
      "r1825",
      "r1826",
      "r1827",
      "r1828",
      "r1829",
      "r1830",
      "r1831",
      "r1836",
      "r1837"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.equitable.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)",
        "terseLabel": "Net income (loss)",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r222",
      "r244",
      "r247",
      "r265",
      "r270",
      "r274",
      "r275",
      "r278",
      "r285",
      "r294",
      "r298",
      "r299",
      "r405",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r516",
      "r681",
      "r706",
      "r713",
      "r714",
      "r717",
      "r718",
      "r800",
      "r837",
      "r921",
      "r923",
      "r958",
      "r1070",
      "r1123",
      "r1144",
      "r1145",
      "r1265",
      "r1266",
      "r1354",
      "r1495",
      "r1615"
     ]
    },
    "eqh_ProtectionSolutionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ProtectionSolutionsMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Protection Solutions",
        "label": "Protection Solutions [Member]",
        "documentation": "Protection Solutions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PublicCorporateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PublicCorporateMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate",
        "label": "Public Corporate [Member]",
        "documentation": "Public Corporate"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PurchaseOfNoncontrollingInterestsForShareBasedCompensationPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PurchaseOfNoncontrollingInterestsForShareBasedCompensationPlan",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of AB Holding Units to fund long-term incentive compensation plan awards, net",
        "label": "Purchase Of Noncontrolling Interests For Share-Based Compensation Plan",
        "documentation": "Purchase Of Noncontrolling Interests For Share-Based Compensation Plan"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PurchasedMRBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PurchasedMRBMember",
     "presentation": [
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchased MRB",
        "label": "Purchased MRB [Member]",
        "documentation": "Purchased MRB"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_PurchasedMarketRiskBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "PurchasedMarketRiskBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Purchased market risk benefits",
        "terseLabel": "Purchased Market Risk Benefits",
        "label": "Purchased Market Risk Benefits",
        "documentation": "Purchased Market Risk Benefits"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r1393"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1393"
     ]
    },
    "eqh_RGAReinsuranceCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RGAReinsuranceCompanyMember",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RGA Reinsurance Company",
        "label": "RGA Reinsurance Company [Member]",
        "documentation": "RGA Reinsurance Company [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r188",
      "r190",
      "r191",
      "r211",
      "r212",
      "r327",
      "r468",
      "r469",
      "r470",
      "r471",
      "r571",
      "r644",
      "r676",
      "r677",
      "r678",
      "r680",
      "r682",
      "r806",
      "r874",
      "r886",
      "r903",
      "r1009",
      "r1023",
      "r1038",
      "r1093",
      "r1094",
      "r1152",
      "r1154",
      "r1156",
      "r1157",
      "r1168",
      "r1184",
      "r1186",
      "r1188",
      "r1189",
      "r1198",
      "r1199",
      "r1227",
      "r1245",
      "r1260",
      "r1262",
      "r1263",
      "r1264",
      "r1277",
      "r1278",
      "r1282",
      "r1283",
      "r1324",
      "r1345",
      "r1607",
      "r1619",
      "r1746",
      "r1775",
      "r1776",
      "r1777",
      "r1778",
      "r1779"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r188",
      "r190",
      "r191",
      "r211",
      "r212",
      "r327",
      "r468",
      "r469",
      "r470",
      "r471",
      "r571",
      "r644",
      "r676",
      "r677",
      "r678",
      "r680",
      "r682",
      "r806",
      "r874",
      "r886",
      "r903",
      "r1009",
      "r1023",
      "r1038",
      "r1093",
      "r1094",
      "r1152",
      "r1154",
      "r1156",
      "r1157",
      "r1168",
      "r1184",
      "r1186",
      "r1188",
      "r1189",
      "r1198",
      "r1199",
      "r1227",
      "r1245",
      "r1260",
      "r1262",
      "r1263",
      "r1264",
      "r1277",
      "r1278",
      "r1282",
      "r1283",
      "r1324",
      "r1345",
      "r1607",
      "r1619",
      "r1746",
      "r1775",
      "r1776",
      "r1777",
      "r1778",
      "r1779"
     ]
    },
    "eqh_RangeOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RangeOneMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ages 0 - 40",
        "label": "Range One [Member]",
        "documentation": "Range One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RangeThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RangeThreeMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ages 61 - 115",
        "label": "Range Three [Member]",
        "documentation": "Range Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RangeTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RangeTwoMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ages 41 - 60",
        "label": "Range Two [Member]",
        "documentation": "Range Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RatioBetween12To15TimesMultipleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RatioBetween12To15TimesMultipleMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1.2x\u00a0to 1.5x",
        "label": "Ratio Between 1.2 To 1.5 Times Multiple [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RatioBetween15To18TimesMultipleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RatioBetween15To18TimesMultipleMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1.5x\u00a0to 1.8x",
        "label": "Ratio Between 1.5 To 1.8 Times Multiple [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RatioBetween18To2TimesMultipleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RatioBetween18To2TimesMultipleMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1.8x\u00a0to 2.0x",
        "label": "Ratio Between 1.8 To 2 Times Multiple [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RatioBetween1To12TimesMultipleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RatioBetween1To12TimesMultipleMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1.0x\u00a0to 1.2x",
        "label": "Ratio Between 1 To 1.2 Times Multiple [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RatioGreaterThan2TimesMultipleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RatioGreaterThan2TimesMultipleMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Greater than\u00a02.0x",
        "label": "Ratio Greater Than 2 Times Multiple [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RatioLessThan1TimesMultipleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RatioLessThan1TimesMultipleMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less than 1.0x",
        "label": "Ratio Less Than 1 Times Multiple [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RealizedAndUnrealizedGainsLossesIncludedInNetIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RealizedAndUnrealizedGainsLossesIncludedInNetIncomeAbstract",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total gains and (losses), realized and unrealized, included in:",
        "label": "Realized And Unrealized Gains (Losses) Included In Net Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RealizedInvestmentGainsLossesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RealizedInvestmentGainsLossesAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment gains (losses), net:",
        "label": "Realized Investment Gains (Losses) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ReasonablyPossibleRangeOfLossesUnaccruedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ReasonablyPossibleRangeOfLossesUnaccruedAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unaccrued amounts of reasonably possible range of losses",
        "label": "Reasonably Possible Range Of Losses, Unaccrued Amount",
        "documentation": "Reasonably Possible Range Of Losses, Unaccrued Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesFromBrokersDealersAndClearingOrganizations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReceivablesFromBrokersDealersAndClearingOrganizations",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Broker-dealer related receivables",
        "label": "Receivable from Broker-Dealer and Clearing Organization",
        "documentation": "Amount receivable from broker-dealers and clearing organizations, including, but not limited to, securities failed-to-deliver, certain deposits for securities borrowed, open transactions, good faith and margin deposits, commissions and floor brokerage receivables."
       }
      }
     },
     "auth_ref": [
      "r1780"
     ]
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "AOCI",
        "terseLabel": "Amount reclassified from (to) income to AOCI",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r22",
      "r250",
      "r793",
      "r845",
      "r850",
      "r851",
      "r961",
      "r1493"
     ]
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ReconciliationOfRevenueFromSegmentsToConsolidatedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedAbstract",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments related to:",
        "label": "Reconciliation Of Revenue From Segments To Consolidated [Abstract]",
        "documentation": "Reconciliation of Revenue from Segments to Consolidated [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1361",
      "r1371",
      "r1381",
      "r1413"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable noncontrolling interest",
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of period",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity."
       }
      }
     },
     "auth_ref": [
      "r518",
      "r524",
      "r1620",
      "r1622",
      "r1623"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/REDEEMABLENONCONTROLLINGINTERESTTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Redeemable Noncontrolling Interest",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r1622",
      "r1623"
     ]
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RedeemablePreferredStockMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Redeemable preferred stock",
        "terseLabel": "Redeemable preferred stock",
        "label": "Redeemable Preferred Stock [Member]",
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r270",
      "r275",
      "r405",
      "r475",
      "r478",
      "r479",
      "r480",
      "r484",
      "r485",
      "r517",
      "r518",
      "r520",
      "r521",
      "r523",
      "r526",
      "r1549"
     ]
    },
    "eqh_RegulationNumber213Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RegulationNumber213Member",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Regulation Number 213",
        "label": "Regulation Number 213 [Member]",
        "documentation": "Regulation Number 213"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RegulationNumber213WithSeparateAccountsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RegulationNumber213WithSeparateAccountsMember",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Regulation Number 213 with Seperate Accounts",
        "label": "Regulation Number 213, With Separate Accounts [Member]",
        "documentation": "Regulation Number 213, With Separate Accounts"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ReinsuranceDueFromReinsurerFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ReinsuranceDueFromReinsurerFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchased market risk benefits",
        "label": "Reinsurance, Due From Reinsurer, Fair Value Disclosure",
        "documentation": "Reinsurance, Due From Reinsurer, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReinsurancePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReinsurancePayable",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts due to reinsurers",
        "label": "Reinsurance Payable",
        "documentation": "The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReinsuranceRecoverablesAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReinsuranceRecoverablesAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses of amounts due from reinsurers",
        "label": "Reinsurance Recoverable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on reinsurance recoverable."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r413",
      "r418",
      "r936",
      "r999",
      "r1000",
      "r1001"
     ]
    },
    "us-gaap_ReinsuranceRecoverablesOnPaidLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReinsuranceRecoverablesOnPaidLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts due from reinsurers (allowance for credit losses of $7 and $8)",
        "verboseLabel": "Amounts due from reinsurers",
        "label": "Reinsurance Recoverable for Paid Claims and Claims Adjustments",
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to and paid by the ceding insurer."
       }
      }
     },
     "auth_ref": [
      "r1788",
      "r1802",
      "r1803"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r277",
      "r278",
      "r361",
      "r861",
      "r862",
      "r863",
      "r1128",
      "r1129",
      "r1130"
     ]
    },
    "us-gaap_RepaymentsOfAnnuitiesAndInvestmentCertificates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfAnnuitiesAndInvestmentCertificates",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Withdrawals",
        "label": "Repayments of Annuities and Investment Certificates",
        "documentation": "The cash outflow for an insurance contract under which the policy holder make a lump sum payment or a series of payments in exchange for periodic payments to the policyholder beginning immediately or at some future date."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "eqh_RepaymentsOfCollateralizedLoanObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RepaymentsOfCollateralizedLoanObligations",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment of collateralized loan obligations",
        "label": "Repayments Of Collateralized Loan Obligations",
        "documentation": "Repayments Of Collateralized Loan Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RepaymentsOfIssuanceOfDebtConsolidatedVariableInterestEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RepaymentsOfIssuanceOfDebtConsolidatedVariableInterestEntity",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment of notes issued by consolidated VIEs",
        "label": "Repayments Of Issuance Of Debt, Consolidated Variable Interest Entity",
        "documentation": "Repayments Of Issuance Of Debt, Consolidated Variable Interest Entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfSeniorDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments of Senior Debt",
        "label": "Repayments of Senior Debt",
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]",
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r208",
      "r270",
      "r279",
      "r280",
      "r490",
      "r531",
      "r863",
      "r887",
      "r940",
      "r1206",
      "r1208",
      "r1209",
      "r1484",
      "r1485",
      "r1486",
      "r1487",
      "r1488",
      "r1489",
      "r1490",
      "r1491",
      "r1492",
      "r1734",
      "r1735",
      "r1736",
      "r1737"
     ]
    },
    "eqh_RequiredPercentageOfFairValueOfLoanedSecuritiesHeldAsCollateralMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RequiredPercentageOfFairValueOfLoanedSecuritiesHeldAsCollateralMinimum",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum requirement percentage of the fair value of the loaned securities to be held as cash collateral",
        "label": "Required Percentage Of Fair Value Of Loaned Securities Held As Collateral, Minimum",
        "documentation": "Required Percentage Of Fair Value Of Loaned Securities Held As Collateral, Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Residential mortgage-backed",
        "verboseLabel": "RMBS",
        "label": "Residential Mortgage-Backed Securities [Member]",
        "documentation": "Securities collateralized by residential real estate mortgage loans."
       }
      }
     },
     "auth_ref": [
      "r1274",
      "r1275",
      "r1277",
      "r1573",
      "r1580",
      "r1585",
      "r1586",
      "r1587",
      "r1650",
      "r1678"
     ]
    },
    "us-gaap_ResidentialMortgageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResidentialMortgageMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails",
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Residential mortgages:",
        "label": "Residential Mortgage [Member]",
        "documentation": "Loan to purchase or refinance residential real estate for example, but not limited to, a home, in which the real estate itself serves as collateral for the loan."
       }
      }
     },
     "auth_ref": [
      "r1234"
     ]
    },
    "srt_RestatementAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementAdjustmentMember",
     "presentation": [
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of Revisions",
        "label": "Revision of Prior Period, Adjustment [Member]",
        "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r296",
      "r297",
      "r322",
      "r798",
      "r799",
      "r856",
      "r1450",
      "r1451",
      "r1453",
      "r1454",
      "r1459",
      "r1460",
      "r1556",
      "r1569"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementAxis",
     "presentation": [
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement [Axis]",
        "label": "Revision of Prior Period [Axis]",
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r214",
      "r215",
      "r216",
      "r218",
      "r262",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r289",
      "r290",
      "r291",
      "r292",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r322",
      "r407",
      "r408",
      "r515",
      "r516",
      "r681",
      "r704",
      "r705",
      "r706",
      "r707",
      "r712",
      "r713",
      "r797",
      "r798",
      "r799",
      "r800",
      "r856",
      "r859",
      "r860",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1061",
      "r1569"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1362",
      "r1372",
      "r1382",
      "r1414"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1363",
      "r1373",
      "r1383",
      "r1415"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1370",
      "r1380",
      "r1390",
      "r1422"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementDomain",
     "presentation": [
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement [Domain]",
        "label": "Revision of Prior Period [Domain]",
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r214",
      "r215",
      "r216",
      "r218",
      "r262",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r289",
      "r290",
      "r291",
      "r292",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r322",
      "r407",
      "r408",
      "r515",
      "r516",
      "r681",
      "r704",
      "r705",
      "r706",
      "r707",
      "r712",
      "r713",
      "r797",
      "r798",
      "r799",
      "r800",
      "r856",
      "r859",
      "r860",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1061",
      "r1569"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464"
     ]
    },
    "us-gaap_RestructuringReserveRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringReserveRollForward",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Reserve [Roll Forward]",
        "label": "Restructuring Reserve [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r113",
      "r951",
      "r1032",
      "r1037",
      "r1067",
      "r1104",
      "r1287"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r215",
      "r216",
      "r282",
      "r283",
      "r284",
      "r286",
      "r294",
      "r297",
      "r299",
      "r406",
      "r409",
      "r450",
      "r515",
      "r681",
      "r695",
      "r696",
      "r703",
      "r704",
      "r705",
      "r707",
      "r712",
      "r713",
      "r785",
      "r787",
      "r788",
      "r790",
      "r798",
      "r855",
      "r857",
      "r1028",
      "r1030",
      "r1071",
      "r1847"
     ]
    },
    "us-gaap_RetirementPlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetirementPlanNameAxis",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Name [Axis]",
        "label": "Retirement Plan Name [Axis]",
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r1260",
      "r1452",
      "r1628",
      "r1629",
      "r1630",
      "r1631",
      "r1632",
      "r1633",
      "r1634",
      "r1635",
      "r1636",
      "r1637",
      "r1638",
      "r1639",
      "r1640",
      "r1641",
      "r1642",
      "r1643",
      "r1644",
      "r1645",
      "r1646",
      "r1647",
      "r1648",
      "r1649",
      "r1650",
      "r1651",
      "r1652",
      "r1653",
      "r1654",
      "r1655",
      "r1656",
      "r1657",
      "r1658",
      "r1659",
      "r1660",
      "r1661",
      "r1662",
      "r1663",
      "r1664",
      "r1665",
      "r1666",
      "r1667",
      "r1668",
      "r1669",
      "r1670",
      "r1671",
      "r1672",
      "r1673",
      "r1674",
      "r1675",
      "r1676",
      "r1677",
      "r1680",
      "r1681",
      "r1682",
      "r1683",
      "r1684",
      "r1685",
      "r1686",
      "r1687",
      "r1688",
      "r1689"
     ]
    },
    "us-gaap_RetirementPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetirementPlanNameDomain",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Name [Domain]",
        "label": "Retirement Plan Name [Domain]",
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r1260",
      "r1452",
      "r1628",
      "r1629",
      "r1630",
      "r1631",
      "r1632",
      "r1633",
      "r1634",
      "r1635",
      "r1636",
      "r1637",
      "r1638",
      "r1639",
      "r1640",
      "r1641",
      "r1642",
      "r1643",
      "r1644",
      "r1645",
      "r1646",
      "r1647",
      "r1648",
      "r1649",
      "r1650",
      "r1651",
      "r1652",
      "r1653",
      "r1654",
      "r1655",
      "r1656",
      "r1657",
      "r1658",
      "r1659",
      "r1660",
      "r1661",
      "r1662",
      "r1663",
      "r1664",
      "r1665",
      "r1666",
      "r1667",
      "r1668",
      "r1669",
      "r1670",
      "r1671",
      "r1672",
      "r1673",
      "r1674",
      "r1675",
      "r1676",
      "r1677",
      "r1680",
      "r1681",
      "r1682",
      "r1683",
      "r1684",
      "r1685",
      "r1686",
      "r1687",
      "r1688",
      "r1689"
     ]
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetirementPlanTypeAxis",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Type [Axis]",
        "label": "Retirement Plan Type [Axis]",
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r597",
      "r600",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r638",
      "r639",
      "r640",
      "r650",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259"
     ]
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetirementPlanTypeDomain",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Type [Domain]",
        "label": "Retirement Plan Type [Domain]",
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r597",
      "r600",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r638",
      "r639",
      "r640",
      "r650",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259"
     ]
    },
    "eqh_RevenueAdjustmentsGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RevenueAdjustmentsGainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment gains (losses), net",
        "label": "Revenue Adjustments, Gain (Loss) On Investments",
        "documentation": "Revenue Adjustments, Gain (Loss) On Investments"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RevenueAdjustmentsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RevenueAdjustmentsOther",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other adjustments to segment revenues",
        "label": "Revenue Adjustments, Other",
        "documentation": "Revenue Adjustments, Other"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RevenueAdjustmentsVariableAnnuityProductFeatures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RevenueAdjustmentsVariableAnnuityProductFeatures",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Variable annuity product features, excluding change in MRBs",
        "label": "Revenue Adjustments, Variable Annuity Product Features",
        "documentation": "Revenue Adjustments, Variable Annuity Product Features"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total revenues",
        "terseLabel": "Total revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r139",
      "r252",
      "r270",
      "r274",
      "r275",
      "r323",
      "r333",
      "r334",
      "r348",
      "r354",
      "r357",
      "r359",
      "r360",
      "r405",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r837",
      "r921",
      "r923",
      "r1222",
      "r1267",
      "r1331",
      "r1334",
      "r1615"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVENUES",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_RevenuesAdjusted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "RevenuesAdjusted",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Segment revenues",
        "terseLabel": "Revenues, Adjusted",
        "label": "Revenues, Adjusted",
        "documentation": "Revenues, Adjusted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r858",
      "r1286"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1431"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1431"
     ]
    },
    "eqh_SCSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SCSMember",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SCS",
        "label": "SCS [Member]",
        "documentation": "SCS"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SP500NasdaqRussell2000AndEmergingMarketIndicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SP500NasdaqRussell2000AndEmergingMarketIndicesMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "S&amp;P 500, Nasdaq, Russell 2000 And Emerging Market Indices",
        "label": "S&amp;P 500, Nasdaq, Russell 2000 And Emerging Market Indices [Member]",
        "documentation": "S&amp;P 500, Nasdaq, Russell 2000 And Emerging Market Indices"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from offering",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SaleOfStockContingentFundingArrangementIssuancePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SaleOfStockContingentFundingArrangementIssuancePeriod",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period to issue senior notes to Trusts",
        "label": "Sale Of Stock, Contingent Funding Arrangement, Issuance Period",
        "documentation": "Sale Of Stock, Funding Arrangement, Issuance Of Senior Notes To Trust, Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SaleOfStockSemiAnnualFacilityFeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SaleOfStockSemiAnnualFacilityFeeRate",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Semi-annual facility fee rate",
        "label": "Sale Of Stock, Semi-Annual Facility Fee, Rate",
        "documentation": "Sale Of Stock, Semi-Annual Facility Fee, Rate"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As Previously \u2028Reported",
        "label": "Previously Reported [Member]",
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r282",
      "r284",
      "r285",
      "r286",
      "r289",
      "r290",
      "r299",
      "r322",
      "r515",
      "r516",
      "r681",
      "r704",
      "r706",
      "r707",
      "r712",
      "r713",
      "r797",
      "r798",
      "r799",
      "r856",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1061",
      "r1457",
      "r1458",
      "r1459",
      "r1555",
      "r1556",
      "r1569",
      "r1594",
      "r1595",
      "r1741",
      "r1770",
      "r1771"
     ]
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/EQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r1766",
      "r1767"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381"
     ]
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings."
       }
      }
     },
     "auth_ref": [
      "r1723",
      "r1726",
      "r1731"
     ]
    },
    "us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfClosedBlockAssetsAndLiabilities",
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Closed Block Assets and Liabilities",
        "label": "Schedule of Closed Block Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of summarized financial data of the closed block, typically including the liabilities of the closed block, assets allocated thereto, and maximum expected future earnings from the operations thereof."
       }
      }
     },
     "auth_ref": [
      "r1341",
      "r1838"
     ]
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/EQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Accumulated Other Comprehensive Income (Loss), Net of Taxes",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Short-term and Long-term Debt",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "label": "Defined Benefit Plan [Table]",
        "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r48",
      "r49",
      "r50",
      "r51",
      "r604",
      "r605",
      "r606",
      "r609",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r634"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Instruments by Category",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHARETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1559"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r702",
      "r837",
      "r1445",
      "r1446",
      "r1447",
      "r1717",
      "r1718",
      "r1719",
      "r1720"
     ]
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "presentation": [
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSCashFlowDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSComprehensiveIncomeDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]",
        "label": "Error Correction [Table]",
        "documentation": "Disclosure of information about prior period adjustment to correct error in previously issued financial statement. Includes, but is not limited to, effect of correction on financial statement line item, affected per-share amount, cumulative effect of change on retained earnings and other appropriate component of equity or net assets in statement of financial position, and effect of prior period adjustment on net income of each prior period presented."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r296",
      "r297",
      "r298",
      "r299",
      "r322"
     ]
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "presentation": [
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Error Corrections and Prior Period Adjustments",
        "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]",
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32"
     ]
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separate Accounts assets",
        "label": "Schedule of Fair Value of Separate Accounts by Major Category of Investment, Fair Value",
        "documentation": "Fair value amount of the specified investment category of assets maintained in separate accounts as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r158"
     ]
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Aggregate Fair Value of Separate Account Assets",
        "label": "Fair Value, Separate Account Investment [Table Text Block]",
        "documentation": "Tabular disclosure of fair value of asset supporting separate account."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r1337",
      "r1834"
     ]
    },
    "us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFinancingReceivableAllowanceForCreditLossesTable",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSAmortizedCostofLoansbyCreditQualityIndicatorandOriginationYearDetails",
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails",
      "http://www.equitable.com/role/INVESTMENTSMortgageLoansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Table]",
        "label": "Financing Receivable, Allowance for Credit Loss [Table]",
        "documentation": "Disclosure of information about allowance for credit loss on financing receivable."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418"
     ]
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSInvestmentGainsLossesNetDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails",
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Investment Income [Line Items]",
        "label": "Net Investment Income [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSInvestmentGainsLossesNetDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails",
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Income [Table]",
        "label": "Investment Income [Table]",
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r98",
      "r962"
     ]
    },
    "eqh_ScheduleOfLiabilityForFuturePolicyBenefitsRevenueAndInterestAccretionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ScheduleOfLiabilityForFuturePolicyBenefitsRevenueAndInterestAccretionTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Liability for Future Policy Benefits, Revenue and Interest Accretion",
        "label": "Schedule Of Liability For Future Policy Benefits, Revenue And Interest Accretion [Table Text Block]",
        "documentation": "Schedule Of Liability For Future Policy Benefits, Revenue And Interest Accretion"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ScheduleOfLiabilityForFuturePolicyBenefitsUndiscountedAndDiscountedExpectedGrossPremiumsAndExpectedFutureBenefitsAndExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ScheduleOfLiabilityForFuturePolicyBenefitsUndiscountedAndDiscountedExpectedGrossPremiumsAndExpectedFutureBenefitsAndExpensesTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Liability for Future Policy Benefits, Undiscounted and Discounted Expected Gross Premiums and Expected Future Benefits and Expenses",
        "label": "Schedule Of Liability For Future Policy Benefits, Undiscounted And Discounted Expected Gross Premiums And Expected Future Benefits And Expenses [Table Text Block]",
        "documentation": "Schedule Of Liability For Future Policy Benefits, Undiscounted And Discounted Expected Gross Premiums And Expected Future Benefits And Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_ScheduleOfLiabilityForFuturePolicyBenefitsWeightedAverageInterestRatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ScheduleOfLiabilityForFuturePolicyBenefitsWeightedAverageInterestRatesTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Liability for Future Policy Benefits, Weighted Average Interest Rates",
        "label": "Schedule Of Liability For Future Policy Benefits, Weighted Average Interest Rates [Table Text Block]",
        "documentation": "Schedule Of Liability For Future Policy Benefits, Weighted Average Interest Rates"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/EMPLOYEEBENEFITPLANSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Benefit Costs",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r1679"
     ]
    },
    "eqh_ScheduleOfReconciliationOfDeferredAcquisitionCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ScheduleOfReconciliationOfDeferredAcquisitionCostTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Deferred Acquisition Cost",
        "label": "Schedule Of Reconciliation Of Deferred Acquisition Cost [Table Text Block]",
        "documentation": "Schedule Of Reconciliation Of Deferred Acquisition Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r277",
      "r278",
      "r861",
      "r862",
      "r863",
      "r1128",
      "r1129",
      "r1130"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r90"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r36"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r36"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.equitable.com/role/EQUITYDividendsDeclaredDetails",
      "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails",
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r111",
      "r112",
      "r113",
      "r228",
      "r229",
      "r230",
      "r325",
      "r529",
      "r530",
      "r531",
      "r533",
      "r536",
      "r541",
      "r543",
      "r783",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1245",
      "r1444",
      "r1545",
      "r1547"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTextBlock",
     "presentation": [
      "http://www.equitable.com/role/EQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r78",
      "r79",
      "r111",
      "r112",
      "r113"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "label": "Variable Interest Entity [Table]",
        "documentation": "Disclosure of information about variable interest held, whether or not such variable interest entity (VIE) is included in consolidated financial statements."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r59",
      "r61",
      "r715",
      "r716",
      "r722",
      "r723",
      "r882",
      "r883",
      "r884"
     ]
    },
    "eqh_SecuredLendingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SecuredLendingMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESOffsettingofFinancialAssetsandLiabilitiesandDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured lending",
        "label": "Secured Lending [Member]",
        "documentation": "Secured Lending"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuritiesLoanedFairValueOfCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SecuritiesLoanedFairValueOfCollateral",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loaned securities",
        "label": "Securities Loaned, Fair Value of Collateral",
        "documentation": "Fair value of the securities pledged as collateral against securities loaned."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r236"
     ]
    },
    "us-gaap_SecuritiesReceivedAsCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SecuritiesReceivedAsCollateral",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash collateral",
        "label": "Securities Received as Collateral",
        "documentation": "The carrying value as of the balance sheet date of the assets received as collateral against securities loaned to other broker-dealers. Borrowers of securities generally are required to provide collateral to the lenders of securities, commonly cash but sometimes other securities or standby letters of credit, with a value slightly higher than that of the securities borrowed. In instances where the entity is permitted to sell or re-pledge these securities, the entity reports the fair value of the collateral received and the related obligation to return the collateral as a liability."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1356"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1358"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r141",
      "r323",
      "r329",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r360",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r461",
      "r464",
      "r710",
      "r711",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r1219",
      "r1222",
      "r1223",
      "r1237",
      "r1327",
      "r1800",
      "r1806",
      "r1807",
      "r1808",
      "r1809",
      "r1810",
      "r1811",
      "r1812",
      "r1813",
      "r1814",
      "r1815",
      "r1816",
      "r1817",
      "r1818",
      "r1819",
      "r1820",
      "r1821",
      "r1822",
      "r1823",
      "r1824",
      "r1825",
      "r1826",
      "r1827",
      "r1828",
      "r1829",
      "r1830",
      "r1831",
      "r1836",
      "r1837"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BUSINESS SEGMENT INFORMATION",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r323",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r344",
      "r346",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r1218",
      "r1220",
      "r1221",
      "r1222",
      "r1224",
      "r1225",
      "r1226"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r323",
      "r346",
      "r347",
      "r354",
      "r1222"
     ]
    },
    "eqh_SegregatedSecuritiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SegregatedSecuritiesFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segregated securities",
        "label": "Segregated Securities, Fair Value Disclosure",
        "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents investments in segregated securities as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SeniorDebenturesNotesDue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SeniorDebenturesNotesDue2028Member",
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Debenture due 2028",
        "label": "Senior Debentures Notes Due 2028 [Member]",
        "documentation": "Senior Debentures Notes Due 2028"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SeniorNotesDue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SeniorNotesDue2028Member",
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Note due 2028",
        "label": "Senior Notes Due 2028 [Member]",
        "documentation": "Senior Notes Due 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SeniorNotesDue2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SeniorNotesDue2029Member",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Note due 2029",
        "label": "Senior Notes Due 2029 [Member]",
        "documentation": "Senior Notes Due 2029"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SeniorNotesDue2033Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SeniorNotesDue2033Member",
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Note due 2033",
        "label": "Senior Notes Due 2033 [Member]",
        "documentation": "Senior Notes Due 2033"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SeniorNotesDue2048Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SeniorNotesDue2048Member",
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Note due 2048",
        "label": "Senior Notes Due 2048 [Member]",
        "documentation": "Senior Notes Due 2048 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeparateAccountAssetCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountAssetCategoryAxis",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separate Account Asset Category [Axis]",
        "label": "Separate Account Asset Category [Axis]",
        "documentation": "Information by separate account asset investment."
       }
      }
     },
     "auth_ref": [
      "r1046",
      "r1337"
     ]
    },
    "us-gaap_SeparateAccountAssetCategoryDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountAssetCategoryDomain",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separate Account Asset Category [Domain]",
        "label": "Separate Account Asset Category [Domain]",
        "documentation": "Separate account asset investment."
       }
      }
     },
     "auth_ref": [
      "r1046",
      "r1337"
     ]
    },
    "us-gaap_SeparateAccountAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separate Accounts assets",
        "label": "Separate Account Asset",
        "documentation": "Amount of asset at fair value held for benefit of separate account policyholder."
       }
      }
     },
     "auth_ref": [
      "r944",
      "r1044",
      "r1045",
      "r1046",
      "r1336",
      "r1337",
      "r1339"
     ]
    },
    "eqh_SeparateAccountBondsAndNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SeparateAccountBondsAndNotesMember",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bonds and Notes",
        "label": "Separate Account, Bonds And Notes [Member]",
        "documentation": "Separate Account, Bonds And Notes"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SeparateAccountCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SeparateAccountCommonStockMember",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Separate Account, Common Stock [Member]",
        "documentation": "Separate Account, Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeparateAccountDebtSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountDebtSecurityMember",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt securities",
        "label": "Separate Account, Debt Security [Member]",
        "documentation": "Debt instrument issued by corporation, government, or governmental agency, municipality, and other institution; in which separate account asset is invested."
       }
      }
     },
     "auth_ref": [
      "r1834"
     ]
    },
    "us-gaap_SeparateAccountLiabilityBenefitPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountLiabilityBenefitPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Benefit payments",
        "label": "Separate Account, Liability, Benefit Payment",
        "documentation": "Amount of cash outflow to separate account policyholder from benefit payment."
       }
      }
     },
     "auth_ref": [
      "r1338",
      "r1835"
     ]
    },
    "us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountLiabilityCashSurrenderValueAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash surrender value",
        "label": "Separate Account, Liability, Cash Surrender Value, Amount",
        "documentation": "Amount of separate account liability payable to policyholder upon surrender of contract before maturity."
       }
      }
     },
     "auth_ref": [
      "r1048",
      "r1338"
     ]
    },
    "us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment performance",
        "label": "Separate Account, Liability, Increase (Decrease) from Invested Performance",
        "documentation": "Amount of increase (decrease) in separate account liability from performance of investment."
       }
      }
     },
     "auth_ref": [
      "r969",
      "r1338",
      "r1835"
     ]
    },
    "us-gaap_SeparateAccountLiabilityPolicyCharge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountLiabilityPolicyCharge",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Policy charges",
        "label": "Separate Account, Liability, Policy Charge",
        "documentation": "Amount of decrease in separate account liability from policy charge."
       }
      }
     },
     "auth_ref": [
      "r1338",
      "r1835"
     ]
    },
    "us-gaap_SeparateAccountLiabilityPremiumAndDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountLiabilityPremiumAndDeposit",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Premiums and deposits",
        "label": "Separate Account, Liability, Premium and Deposit",
        "documentation": "Amount of cash inflow to separate account liability from premium and deposit from cash received."
       }
      }
     },
     "auth_ref": [
      "r1338",
      "r1835"
     ]
    },
    "us-gaap_SeparateAccountLiabilityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountLiabilityRollForward",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separate Account, Liability [Roll Forward]",
        "label": "Separate Account, Liability [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountLiabilitySurrenderAndWithdrawal",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Surrenders and withdrawals",
        "label": "Separate Account, Liability, Surrender and Withdrawal",
        "documentation": "Amount of decrease in separate account liability from contract redemption and withdrawal of funds."
       }
      }
     },
     "auth_ref": [
      "r1338",
      "r1835"
     ]
    },
    "eqh_SeparateAccountMutualFundMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SeparateAccountMutualFundMember",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESAggregateFairValueofSeparateAccountAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mutual Funds",
        "label": "Separate Account, Mutual Fund [Member]",
        "documentation": "Separate Account, Mutual Fund"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeparateAccountsLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeparateAccountsLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESCarryingValuesandFairValuesofFinancialInstrumentsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separate Accounts liabilities",
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of period",
        "label": "Separate Account, Liability",
        "documentation": "Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account."
       }
      }
     },
     "auth_ref": [
      "r947",
      "r1044",
      "r1045",
      "r1047",
      "r1049",
      "r1338",
      "r1339"
     ]
    },
    "eqh_SeparateAccountsLiabilityOtherCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SeparateAccountsLiabilityOtherCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other charges (2)",
        "label": "Separate Accounts, Liability, Other Charges",
        "documentation": "Separate Accounts, Liability, Other Charges"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SeparateAccountsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SeparateAccountsMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes issued by consolidated VIE\u2019s",
        "label": "Separate Accounts [Member]",
        "documentation": "Separate Accounts assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://www.equitable.com/role/Cover",
      "http://www.equitable.com/role/EQUITYDividendsDeclaredDetails",
      "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A",
        "verboseLabel": "Series A",
        "label": "Series A Preferred Stock [Member]",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1481",
      "r1482",
      "r1621",
      "r1624"
     ]
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://www.equitable.com/role/EQUITYDividendsDeclaredDetails",
      "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B",
        "label": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1481",
      "r1482",
      "r1621",
      "r1624"
     ]
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesCPreferredStockMember",
     "presentation": [
      "http://www.equitable.com/role/Cover",
      "http://www.equitable.com/role/EQUITYDividendsDeclaredDetails",
      "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C",
        "verboseLabel": "Series C",
        "label": "Series C Preferred Stock [Member]",
        "documentation": "Series C preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1481",
      "r1482",
      "r1621",
      "r1624"
     ]
    },
    "us-gaap_ServicingLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ServicingLiabilityMeasurementInput",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement input of servicing liability",
        "label": "Servicing Liability, Measurement Input",
        "documentation": "Value of input used to measure servicing liability."
       }
      }
     },
     "auth_ref": [
      "r804",
      "r805",
      "r806"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Award Types",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679"
     ]
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails": {
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/SHORTTERMANDLONGTERMDEBTSummaryofShortandLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Total short-term debt",
        "label": "Short-Term Debt",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r123",
      "r1287",
      "r1792"
     ]
    },
    "eqh_ShortTermFundingAgreementsMaturingInLessThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "ShortTermFundingAgreementsMaturingInLessThanOneYearMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESFundingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in one year or less",
        "label": "Short-Term Funding Agreements, Maturing In Less Than One Year [Member]",
        "documentation": "Short-Term Funding Agreements Maturing in Less Than One Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermInvestmentsMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "label": "Short-Term Investments [Member]",
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1175",
      "r1176",
      "r1202"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r269"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSChangesintheMarketRiskBenefitsforDeferredVariableAnnuitiesDetails",
      "http://www.equitable.com/role/MARKETRISKBENEFITSReconcilesMarketRiskBenefitsDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r141",
      "r221",
      "r323",
      "r329",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r355",
      "r356",
      "r360",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r461",
      "r464",
      "r710",
      "r711",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r1219",
      "r1222",
      "r1223",
      "r1237",
      "r1327",
      "r1800",
      "r1806",
      "r1807",
      "r1808",
      "r1809",
      "r1810",
      "r1811",
      "r1812",
      "r1813",
      "r1814",
      "r1815",
      "r1816",
      "r1817",
      "r1818",
      "r1819",
      "r1820",
      "r1821",
      "r1822",
      "r1823",
      "r1824",
      "r1825",
      "r1826",
      "r1827",
      "r1828",
      "r1829",
      "r1830",
      "r1831",
      "r1836",
      "r1837"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.equitable.com/role/Cover",
      "http://www.equitable.com/role/EQUITYDividendsDeclaredDetails",
      "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r228",
      "r229",
      "r230",
      "r270",
      "r275",
      "r305",
      "r309",
      "r316",
      "r318",
      "r325",
      "r326",
      "r405",
      "r475",
      "r478",
      "r479",
      "r480",
      "r484",
      "r485",
      "r517",
      "r518",
      "r520",
      "r521",
      "r523",
      "r526",
      "r529",
      "r530",
      "r533",
      "r536",
      "r543",
      "r837",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1071",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1103",
      "r1124",
      "r1146",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1444",
      "r1547",
      "r1549",
      "r1558"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails",
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails",
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r79",
      "r82",
      "r83",
      "r213",
      "r215",
      "r216",
      "r249",
      "r250",
      "r251",
      "r282",
      "r283",
      "r284",
      "r286",
      "r294",
      "r297",
      "r299",
      "r324",
      "r406",
      "r409",
      "r450",
      "r515",
      "r545",
      "r681",
      "r695",
      "r696",
      "r703",
      "r704",
      "r705",
      "r707",
      "r712",
      "r713",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r798",
      "r845",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r855",
      "r857",
      "r860",
      "r961",
      "r1028",
      "r1029",
      "r1030",
      "r1071",
      "r1146"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r324",
      "r517",
      "r518",
      "r520",
      "r523",
      "r857",
      "r904",
      "r1062",
      "r1072",
      "r1083",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1103",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1126",
      "r1127",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1146",
      "r1213",
      "r1214",
      "r1346",
      "r1843"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_StatementOfStatutoryAccountingPrinciples108Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StatementOfStatutoryAccountingPrinciples108Member",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Statutory Accounting Principles 108",
        "label": "Statement Of Statutory Accounting, Principles 108 [Member]",
        "documentation": "Statement Of Statutory Accounting, Principles 108"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r324",
      "r361",
      "r517",
      "r518",
      "r520",
      "r523",
      "r857",
      "r904",
      "r1062",
      "r1072",
      "r1083",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1103",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1126",
      "r1127",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1146",
      "r1213",
      "r1214",
      "r1346",
      "r1843"
     ]
    },
    "eqh_StatutoryAccountingPracticesNumberOfPrescribedAndPermittedPractices": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StatutoryAccountingPracticesNumberOfPrescribedAndPermittedPractices",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of prescribed and permitted practices",
        "label": "Statutory Accounting Practices, Number Of Prescribed And Permitted Practices",
        "documentation": "Statutory Accounting Practices, Number Of Prescribed And Permitted Practices"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_StatutoryAccountingPracticesRegulationNumberAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StatutoryAccountingPracticesRegulationNumberAxis",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statutory Accounting Practices, Regulation Number [Axis]",
        "label": "Statutory Accounting Practices, Regulation Number [Axis]",
        "documentation": "Statutory Accounting Practices, Regulation Number"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_StatutoryAccountingPracticesRegulationNumberDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StatutoryAccountingPracticesRegulationNumberDomain",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statutory Accounting Practices, Regulation Number [Domain]",
        "label": "Statutory Accounting Practices, Regulation Number [Domain]",
        "documentation": "Statutory Accounting Practices, Regulation Number [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_StatutoryAccountingPracticesReservesPhasedInPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StatutoryAccountingPracticesReservesPhasedInPercentage",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of reserves phased-in",
        "label": "Statutory Accounting Practices, Reserves Phased-In, Percentage",
        "documentation": "Statutory Accounting Practices, Reserves Phased-In, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_StatutoryAccountingPracticesStatutorySurplusIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StatutoryAccountingPracticesStatutorySurplusIncreaseDecrease",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in statutory special surplus funds",
        "label": "Statutory Accounting Practices, Statutory Surplus, Increase (Decrease)",
        "documentation": "Statutory Accounting Practices, Statutory Surplus, Increase (Decrease)"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_StatutoryAccountingPracticesStatutorySurplusIncreaseDecreaseToNewStandardApplication": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StatutoryAccountingPracticesStatutorySurplusIncreaseDecreaseToNewStandardApplication",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Impact of change in statutory surplus funds",
        "label": "Statutory Accounting Practices, Statutory Surplus, Increase (Decrease) To New Standard Application",
        "documentation": "Statutory Accounting Practices, Statutory Surplus, Increase (Decrease) To New Standard Application"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_StatutoryAccountingPracticesStatutorySurplusTargetLiabilityPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StatutoryAccountingPracticesStatutorySurplusTargetLiabilityPercentage",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Target liability change percentage",
        "label": "Statutory Accounting Practices, Statutory Surplus, Target Liability Percentage",
        "documentation": "Statutory Accounting Practices, Statutory Surplus, Target Liability Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_StatutoryAccountingPracticesStatutoryUnassignedCapitalAndSurplusBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StatutoryAccountingPracticesStatutoryUnassignedCapitalAndSurplusBalance",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unassigned surplus balance",
        "label": "Statutory Accounting Practices, Statutory Unassigned Capital And Surplus, Balance",
        "documentation": "Statutory Accounting Practices, Statutory Unassigned Capital And Surplus, Balance"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_StatutoryAccountingPracticesTotalAssetRequirementReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StatutoryAccountingPracticesTotalAssetRequirementReserves",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/INSURANCESTATUTORYFINANCIALINFORMATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redundant reserve balance over TAR",
        "label": "Statutory Accounting Practices, Total Asset Requirement, Reserves",
        "documentation": "Statutory Accounting Practices, Total Asset Requirement Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1365",
      "r1375",
      "r1385",
      "r1417"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1690",
      "r1691",
      "r1692",
      "r1693",
      "r1694",
      "r1695",
      "r1696",
      "r1697",
      "r1698",
      "r1699",
      "r1700",
      "r1701",
      "r1702",
      "r1703",
      "r1704",
      "r1705",
      "r1706",
      "r1707",
      "r1708",
      "r1709",
      "r1710",
      "r1711",
      "r1712",
      "r1713",
      "r1714",
      "r1715"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Redemption of preferred stock",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r78",
      "r79",
      "r113",
      "r1071",
      "r1146",
      "r1178",
      "r1354"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueTreasuryStockReissued",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reissuance of treasury stock",
        "label": "Stock Issued During Period, Value, Treasury Stock Reissued",
        "documentation": "Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r46",
      "r78",
      "r79",
      "r113"
     ]
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockOptionMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESDerivativesbyCategoryDetails",
      "http://www.equitable.com/role/DERIVATIVESFinancialStatementImpactofDerivativesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options",
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r1345",
      "r1730"
     ]
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Redemption of preferred stock",
        "label": "Stock Redeemed or Called During Period, Value",
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "eqh_StockRepurchaseProgramAdditionalSharesReceived": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StockRepurchaseProgramAdditionalSharesReceived",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional shares received (in shares)",
        "label": "Stock Repurchase Program, Additional Shares Received",
        "documentation": "Stock Repurchase Program, Additional Shares Received"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount of share repurchases authorized",
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1625"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share repurchase program, remaining authorized repurchase amount",
        "label": "Share Repurchase Program, Remaining Authorized, Amount",
        "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
      "http://www.equitable.com/role/EQUITYPreferredStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Retirement of common stock",
        "terseLabel": "Redeemed and retired stock",
        "label": "Stock Repurchased and Retired During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r78",
      "r79",
      "r113"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://www.equitable.com/role/EQUITYShareRepurchaseNarrativeDetails",
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares repurchased (in shares)",
        "label": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r78",
      "r79",
      "r113",
      "r1066",
      "r1146",
      "r1180"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/DERIVATIVESRollforwardforCashFlowsHedgesinAOCIDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity attributable to Holdings",
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, ending of the period",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r82",
      "r83",
      "r107",
      "r1105",
      "r1121",
      "r1147",
      "r1148",
      "r1287",
      "r1355",
      "r1545",
      "r1549",
      "r1550",
      "r1593",
      "r1763",
      "r1847"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity attributable to Holdings:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
      "http://www.equitable.com/role/EQUITYCumulativeGainsLossesDetails",
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Equity",
        "periodStartLabel": "Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance",
        "periodEndLabel": "Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance",
        "netLabel": "Accumulated other comprehensive income (loss) attributable to Holdings",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r62",
      "r213",
      "r214",
      "r215",
      "r216",
      "r250",
      "r282",
      "r283",
      "r284",
      "r286",
      "r294",
      "r297",
      "r406",
      "r409",
      "r450",
      "r515",
      "r545",
      "r681",
      "r695",
      "r696",
      "r703",
      "r704",
      "r705",
      "r707",
      "r712",
      "r713",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r798",
      "r845",
      "r847",
      "r851",
      "r856",
      "r860",
      "r1029",
      "r1030",
      "r1069",
      "r1105",
      "r1121",
      "r1147",
      "r1148",
      "r1182",
      "r1331",
      "r1334",
      "r1354",
      "r1545",
      "r1549",
      "r1550",
      "r1593",
      "r1763",
      "r1847"
     ]
    },
    "eqh_StockholdersEquityIncludingPortionAttributableToRedeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StockholdersEquityIncludingPortionAttributableToRedeemableNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Equity and Redeemable NCI",
        "label": "Stockholders Equity Including Portion Attributable To Redeemable Noncontrolling Interest",
        "documentation": "Stockholders Equity Including Portion Attributable To Redeemable Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.equitable.com/role/EQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EQUITY",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r528",
      "r530",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r542",
      "r545",
      "r783",
      "r796",
      "r1149",
      "r1150",
      "r1183"
     ]
    },
    "us-gaap_StockholdersEquityOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityOther",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "terseLabel": "Stockholders' Equity, Other",
        "label": "Stockholders' Equity, Other",
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_StructuredCapitalStrategiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "StructuredCapitalStrategiesMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SCS",
        "label": "Structured Capital Strategies [Member]",
        "documentation": "Structured Capital Strategies"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r852",
      "r866"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r852",
      "r866"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r852",
      "r866"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r852",
      "r866"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r852",
      "r866"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.equitable.com/role/SUBSEQUENTEVENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUBSEQUENT EVENTS",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r865",
      "r867"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SubtotalProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SubtotalProductsMember",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subtotal",
        "label": "Subtotal - Products [Member]",
        "documentation": "Subtotal - Products"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_SwapsIncludingNettingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "SwapsIncludingNettingMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Swaps",
        "label": "Swaps Including Netting [Member]",
        "documentation": "Swaps Including Netting"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1411"
     ]
    },
    "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-recurring tax items",
        "label": "Tax Adjustments, Settlements, and Unusual Provisions",
        "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement."
       }
      }
     },
     "auth_ref": [
      "r1716"
     ]
    },
    "eqh_TenderOfferAggregatePurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TenderOfferAggregatePurchasePrice",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate purchase price",
        "label": "Tender Offer, Aggregate Purchase Price",
        "documentation": "Tender Offer, Aggregate Purchase Price"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_TenderOfferAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TenderOfferAxis",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tender Offer [Axis]",
        "label": "Tender Offer [Axis]",
        "documentation": "Tender Offer"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_TenderOfferDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TenderOfferDomain",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tender Offer [Domain]",
        "label": "Tender Offer [Domain]",
        "documentation": "Tender Offer"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_TenderOfferEconomicInterestPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TenderOfferEconomicInterestPercentage",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Economic interest percentage",
        "label": "Tender Offer, Economic Interest Percentage",
        "documentation": "Tender Offer, Economic Interest Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_TenderOfferNumberOfSharesAvailableForPurchaseMaximum": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TenderOfferNumberOfSharesAvailableForPurchaseMaximum",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum units available to purchase (in shares)",
        "label": "Tender Offer, Number Of Shares Available For Purchase, Maximum",
        "documentation": "Tender Offer, Number Of Shares Available For Purchase, Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_TenderOfferPercentageOfIssuedAndOutstandingShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TenderOfferPercentageOfIssuedAndOutstandingShares",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of issued and outstanding units",
        "label": "Tender Offer, Percentage Of Issued And Outstanding Shares",
        "documentation": "Tender Offer, Percentage Of Issued And Outstanding Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_TenderOfferSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TenderOfferSharePrice",
     "presentation": [
      "http://www.equitable.com/role/ORGANIZATIONDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per unit (in dollars per share)",
        "label": "Tender Offer, Share Price",
        "documentation": "Tender Offer, Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_TermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TermMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsRevenueandInterestAccretionDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsUndiscountedandDiscountedExpectedGrossPremiumsandExpectedFutureBenefitsandExpensesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSScheduleofLiabilityforFuturePolicyBenefitsWeightedAverageInterestRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term",
        "label": "Term [Member]",
        "documentation": "Term"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_TotalCommercialAndAgriculturalMortgageLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TotalCommercialAndAgriculturalMortgageLoansMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSCreditQualityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total commercial and agricultural mortgage loans:",
        "label": "Total Commercial And Agricultural Mortgage Loans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1403"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1410"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1430"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1432"
     ]
    },
    "us-gaap_TradingAssetsExcludingDebtAndEquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradingAssetsExcludingDebtAndEquitySecuritiesMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetInvestmentIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trading securities",
        "label": "Trading Assets, Excluding Debt and Equity Securities [Member]",
        "documentation": "Investments which the entity trades for its own profit, which may include, but is not limited to, mortgage-backed and asset-backed securities, loans, interest rate swaps, credit derivatives, commodity contracts, foreign exchange contracts and equity swaps. Excludes debt and equity securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradingSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradingSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading securities, at fair value",
        "verboseLabel": "Trading securities",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r226",
      "r1204"
     ]
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrealized and Realized Gains (Losses) from Equity Securities and Net Investment Income (Loss) from Trading Securities and Net Investment Income (Loss) from Fixed Maturities, at Fair Value using the Fair Value Option",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "us-gaap_TradingSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradingSecuritiesDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Investments",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading securities, at fair value",
        "label": "Debt Securities, Trading",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading)."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r802",
      "r828",
      "r830",
      "r832",
      "r833",
      "r1200",
      "r1204",
      "r1284",
      "r1571",
      "r1745",
      "r1746",
      "r1747"
     ]
    },
    "eqh_TradingSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TradingSecuritiesMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Securities, at Fair Value",
        "label": "Trading Securities [Member]",
        "documentation": "Trading Securities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.equitable.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransferToFromPolicyholderAccountBalanceToFromSeparateAccount",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net transfers from (to) General Account",
        "negatedLabel": "Net transfers from (to) separate account",
        "label": "Transfer to (from) Policyholder Account Balance (to) from Separate Account",
        "documentation": "Amount of transfer to (from) liability for policyholder account balance (to) from liability for separate account."
       }
      }
     },
     "auth_ref": [
      "r1313",
      "r1324",
      "r1338",
      "r1823",
      "r1835"
     ]
    },
    "eqh_TransferToFromSeparateAccountToFromGeneralAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TransferToFromSeparateAccountToFromGeneralAccount",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net transfers from (to) General Account",
        "label": "Transfer To (From) Separate Account (To) From General Account",
        "documentation": "Transfer To (From) Separate Account (To) From General Account"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails",
      "http://www.equitable.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r511",
      "r541",
      "r783",
      "r795",
      "r825",
      "r836",
      "r839",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r885",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r933",
      "r962",
      "r1274",
      "r1275",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1288",
      "r1462",
      "r1463",
      "r1464",
      "r1465",
      "r1466",
      "r1467",
      "r1468",
      "r1588",
      "r1589",
      "r1590",
      "r1591",
      "r1742",
      "r1745",
      "r1746",
      "r1747",
      "r1754",
      "r1757",
      "r1758",
      "r1759"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1433"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1434"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1434"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1432"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1432"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1435"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1433"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.equitable.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury stock, at cost,$170,931,788 and 167,901,388 shares, respectively",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r82"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of treasury stock",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r46",
      "r113"
     ]
    },
    "eqh_TrustNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "TrustNotesMember",
     "presentation": [
      "http://www.equitable.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trust Notes",
        "label": "Trust Notes [Member]",
        "documentation": "Trust Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESFairValueMeasurementReconciliationforAllLevelsDetails",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "States and political subdivisions",
        "terseLabel": "States and political subdivisions",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments."
       }
      }
     },
     "auth_ref": [
      "r1248",
      "r1250",
      "r1288",
      "r1337",
      "r1834"
     ]
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "USTreasuryAndGovernmentMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/INVESTMENTSAvailableforsaleSecuritiesDetails",
      "http://www.equitable.com/role/INVESTMENTSFixedMaturitiesAvailableforsaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "U.S. government, agencies and authorities",
        "terseLabel": "U.S. Treasury, government and agency",
        "netLabel": "U.S. Treasury, government and\u00a0agency",
        "label": "US Treasury and Government [Member]",
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r925",
      "r1248",
      "r1250",
      "r1288",
      "r1337",
      "r1834"
     ]
    },
    "eqh_USTreasuryNotesUSTreasuryBondsAndUltraLongBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "USTreasuryNotesUSTreasuryBondsAndUltraLongBondsMember",
     "presentation": [
      "http://www.equitable.com/role/DERIVATIVESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Treasury Notes, U.S. Treasury Bonds And Ultra-Long Bonds",
        "label": "U.S. Treasury Notes, U.S. Treasury Bonds And Ultra-Long Bonds [Member]",
        "documentation": "U.S. Treasury Notes, U.S. Treasury Bonds And Ultra-Long Bonds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnderlyingAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnderlyingAssetClassAxis",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Asset Class [Axis]",
        "label": "Underlying Asset Class [Axis]",
        "documentation": "Information by underlying asset class."
       }
      }
     },
     "auth_ref": [
      "r1268"
     ]
    },
    "us-gaap_UnderlyingAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnderlyingAssetClassDomain",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Asset Class [Domain]",
        "label": "Underlying Asset Class [Domain]",
        "documentation": "Major types of referenced/underlying asset classes (for example, corporate debt, sovereign debt, and structured finance)."
       }
      }
     },
     "auth_ref": [
      "r1268"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1429"
     ]
    },
    "eqh_UnearnedRevenueLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "UnearnedRevenueLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of period",
        "periodEndLabel": "Balance, end of period",
        "label": "Unearned Revenue, Liability",
        "documentation": "Unearned Revenue, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_UnearnedRevenueLiabilityAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "UnearnedRevenueLiabilityAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amortization",
        "label": "Unearned Revenue, Liability, Amortization",
        "documentation": "Unearned Revenue, Liability, Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_UnearnedRevenueLiabilityCapitalization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "UnearnedRevenueLiabilityCapitalization",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalization",
        "label": "Unearned Revenue, Liability, Capitalization",
        "documentation": "Unearned Revenue, Liability, Capitalization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UniversalLifeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UniversalLifeMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSBalancesofandChangesinAdditionalLiabilitiesRelatedtoInsuranceGuaranteesDetails",
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Universal Life",
        "terseLabel": "UL",
        "label": "Universal Life [Member]",
        "documentation": "Life insurance contract under which premiums are generally flexible, the level of death benefits may be adjusted, and mortality expense, and other charges may vary."
       }
      }
     },
     "auth_ref": [
      "r1301",
      "r1324"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of net unrealized investment gains (losses)",
        "label": "Unrealized Gain (Loss) on Investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "eqh_UnrealizedGainLossOnInvestmentsWithOtherThanTemporaryImpairmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "UnrealizedGainLossOnInvestmentsWithOtherThanTemporaryImpairmentTableTextBlock",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Unrealized Gains (Losses) on Available-for-Sale Fixed Maturities",
        "label": "Unrealized Gain (Loss) On Investments With Other Than Temporary Impairment [Table Text Block]",
        "documentation": "Tabular disclosure of unrealized gains and losses on investments with other than temporary investments."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_UnrealizedInvestmentGainsLossesAllOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "UnrealizedInvestmentGainsLossesAllOtherMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Investment Gains (Losses), All Other",
        "label": "Unrealized Investment Gains (Losses), All Other [Member]",
        "documentation": "Represents the unrealized investment gain (loss) on available for sale fixed maturities and equity securities which have never been other than temporarily impaired."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_UnrealizedInvestmentGainsLossesExcludingCreditLossesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "UnrealizedInvestmentGainsLossesExcludingCreditLossesMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net unrealized investment gains (losses) excluding credit losses",
        "label": "Unrealized Investment Gains (Losses), Excluding Credit Losses [Member]",
        "documentation": "Unrealized Investment Gains (Losses), Excluding Credit Losses"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_UnrealizedInvestmentGainsLossesIncludingCreditLossesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "UnrealizedInvestmentGainsLossesIncludingCreditLossesMember",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net unrealized investment gains (losses) with credit losses",
        "label": "Unrealized Investment Gains (Losses), Including Credit Losses [Member]",
        "documentation": "Unrealized Investment Gains (Losses), Including Credit Losses"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_UnrealizedInvestmentGainsLossesNetOfDeferredIncomeTaxExpenseBenefitAndPolicyholderDividendObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "UnrealizedInvestmentGainsLossesNetOfDeferredIncomeTaxExpenseBenefitAndPolicyholderDividendObligation",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails": {
       "parentTag": "us-gaap_ClosedBlockAssetsAndLiabilitiesMaximumFutureEarningsToBeRecognized",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/CLOSEDBLOCKClosedBlockSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net unrealized investment gains (losses), net of income tax: $17 and $30",
        "label": "Unrealized Investment Gains (Losses), Net Of Deferred Income Tax Expense (Benefit) And Policyholder Dividend Obligation",
        "documentation": "Net increase or decrease in the period in the fair market value of investments that were allocated to the closed block net of deferred income tax (expense) benefit and policyholder dividend obligation."
       }
      }
     },
     "auth_ref": []
    },
    "eqh_UnrealizedInvestmentGainsLossesWithOTTIAndAllOtherAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "UnrealizedInvestmentGainsLossesWithOTTIAndAllOtherAxis",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Investment Gains (Losses) With OTTI And All Other [Axis]",
        "label": "Unrealized Investment Gains (Losses) With OTTI And All Other [Axis]",
        "documentation": "Represents the axis for the schedule of unrealized gains (losses) on available for sale fixed maturities and equity securities split between those with OTTI and all other unrealized gains (losses)"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_UnrealizedInvestmentGainsLossesWithOTTIAndAllOtherDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "UnrealizedInvestmentGainsLossesWithOTTIAndAllOtherDomain",
     "presentation": [
      "http://www.equitable.com/role/INVESTMENTSNetUnrealizedGainLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Investment Gains (Losses) With OTTI And All Other [Domain]",
        "label": "Unrealized Investment Gains (Losses) With OTTI And All Other [Domain]",
        "documentation": "Represents the domain for the schedule of unrealized gains (losses) on available for sale fixed maturities and equity securities split between those with OTTI and all other unrealized gains (losses)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/EQUITYComponentsofOCINetofTaxesDetails",
      "http://www.equitable.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in valuation allowance",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r692"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Axis]",
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r804",
      "r805",
      "r1262",
      "r1264",
      "r1277",
      "r1747"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Domain]",
        "label": "Valuation Approach and Technique [Domain]",
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r804",
      "r805",
      "r1262",
      "r1264",
      "r1277",
      "r1747"
     ]
    },
    "eqh_VariableAnnuityProductFeaturesAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "VariableAnnuityProductFeaturesAdjustments",
     "crdr": "credit",
     "calculation": {
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails": {
       "parentTag": "eqh_NetIncomeLossAttributableToParentAdjusted",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofOperatingProfitLossfromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable annuity product",
        "label": "Variable Annuity Product Features, Adjustments",
        "documentation": "Variable Annuity Product Features, Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable interest entity, maximum loss exposure",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE)."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r120"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Line Items]",
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r716",
      "r722",
      "r723",
      "r882",
      "r883",
      "r884"
     ]
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity, Primary Beneficiary",
        "verboseLabel": "Liabilities of consolidated VIEs and VOEs",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r715",
      "r716",
      "r722",
      "r723"
     ]
    },
    "eqh_VariableInterestEntityUnusedCommitments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "VariableInterestEntityUnusedCommitments",
     "crdr": "credit",
     "presentation": [
      "http://www.equitable.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unfunded commitments",
        "label": "Variable Interest Entity, Unused Commitments",
        "documentation": "Variable Interest Entity, Unused Commitments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableUniversalLifeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableUniversalLifeMember",
     "presentation": [
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCostsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESDACCreditsDetails",
      "http://www.equitable.com/role/DACANDOTHERDEFERREDASSETSLIABILITIESReconciliationofDACDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinPolicyholdersAccountBalancesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESBalancesandChangesinSeparateAccountsLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESGuaranteedMinimumInterestRatesDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofPolicyholdersAccountBalancestoPolicyholdersAccountBalanceLiabilityDetails",
      "http://www.equitable.com/role/POLICYHOLDERACCOUNTBALANCESReconciliationofSeparateAccountLiabilitiestoSeparateAccountLiabilitybalanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Variable Universal Life",
        "terseLabel": "VUL",
        "label": "Variable Universal Life [Member]",
        "documentation": "Contract providing life insurance that combines both adjustability of premium, coverage and investment features, and variability of benefit payable upon death or surrender from investment experience of separate account supporting contract."
       }
      }
     },
     "auth_ref": [
      "r1301",
      "r1338"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1399"
     ]
    },
    "eqh_WealthManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "WealthManagementMember",
     "presentation": [
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONOperatingEarningLossBySegmentDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofAssetsfromSegmenttoConsolidatedDetails",
      "http://www.equitable.com/role/BUSINESSSEGMENTINFORMATIONReconciliationofRevenuefromSegmentstoConsolidatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Wealth Management",
        "label": "Wealth Management [Member]",
        "documentation": "Wealth Management"
       }
      }
     },
     "auth_ref": []
    },
    "srt_WeightedAverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "WeightedAverageMember",
     "presentation": [
      "http://www.equitable.com/role/FAIRVALUEDISCLOSURESQuantitativeInformationaboutLevel3Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average",
        "label": "Weighted Average [Member]",
        "documentation": "Average of a range of values, calculated with consideration of proportional relevance."
       }
      }
     },
     "auth_ref": [
      "r676",
      "r677",
      "r806",
      "r886",
      "r1198",
      "r1199",
      "r1277",
      "r1774",
      "r1776",
      "r1779"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average common shares outstanding - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r318"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails",
      "http://www.equitable.com/role/REVISIONOFPRIORPERIODFINANCIALSTATEMENTSIncomeStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average common shares outstanding \u2014 basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r318"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.equitable.com/role/ConsolidatedStatementsofIncomeLoss",
      "http://www.equitable.com/role/EARNINGSPERCOMMONSHAREBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares outstanding (in millions):",
        "verboseLabel": "Weighted-average common shares outstanding:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eqh_WholeLifeClosedBlockAndOpenBlockProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.equitable.com/20250630",
     "localname": "WholeLifeClosedBlockAndOpenBlockProductsMember",
     "presentation": [
      "http://www.equitable.com/role/LIABILITIESFORFUTUREPOLICYHOLDERBENEFITSPolicyholderAccountBalanceAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Whole Life Closed Block and Open Block products",
        "label": "Whole Life Closed Block And Open Block Products [Member]",
        "documentation": "Whole Life Closed Block And Open Block Products"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1397"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(j)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-16"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)",
   "SubTopic": "30",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(c)(2)",
   "SubTopic": "20",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4D"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-21"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-24"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-9"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "45",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481138/505-30-25-5"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-23"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/942-320/tableOfContent"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478878/942-470-45-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-7"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-7A"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481774/310-40-40-7A"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-7"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479808/944-20-55-15"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-3"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-3"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478219/944-825-45-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(n)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "220",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-5"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(1))",
   "SubTopic": "220",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "SubTopic": "220",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "SubTopic": "805",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/944-805/tableOfContent"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "b",
   "Publisher": "SEC"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1404",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1404",
   "Paragraph": "b",
   "Publisher": "SEC"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "a",
   "Subparagraph": "(4)",
   "Publisher": "SEC"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "c",
   "Publisher": "SEC"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "3",
   "Publisher": "SEC"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column G",
   "Footnote": "3",
   "Publisher": "SEC"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(C)",
   "Publisher": "SEC"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "m",
   "Subparagraph": "(1)(iii)",
   "Publisher": "SEC"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "m",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "M",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-17A"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-23"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-11"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-42"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-42"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-42"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "44",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-44"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3B"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3D"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-6"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-6A"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-5"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3A"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3A"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(j)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-7"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-8"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480126/715-20-S99-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480266/715-60-50-3"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480606/715-80-35-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-9"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2AG",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-2AG"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CCC",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CCC",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CCC",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4H"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4H"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4H"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4I"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "15",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480960/815-15-50-3"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2G",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2G"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2G",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2G"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-9"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-3"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481724/830-30-40-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-12"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-15"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-33"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-35A"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477974/942-325-45-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/944/tableOfContent"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479838/944-20-50-1"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479838/944-20-50-5"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479838/944-20-50-7"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479797/944-20-S50-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479735/944-20-S99-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/944-30/tableOfContent"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479460/944-30-45-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2A"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477409/944-310-45-5"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477409/944-310-45-6"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(4)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(4)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480112/944-40-45-1"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480112/944-40-45-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480112/944-40-45-3"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480112/944-40-45-4"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477845/944-470-50-1"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477908/944-505-50-5"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-4"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480141/944-80-45-1"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480141/944-80-45-2"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-2"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-2"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-2"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-3"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-3"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-3"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-3"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-3"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-3"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-6"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5D"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column G)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "SubTopic": "320",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-15"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-20"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-12"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "79",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-79"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "80",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-80"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-18"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4L",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4L"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "181",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-181"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "183",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-183"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "185",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-185"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-12"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-34"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-3"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-7"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13I"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13I"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13I"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13I"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13I",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13I"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13I",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13I"
  },
  "r1308": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13I",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13I"
  },
  "r1309": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13J",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13J"
  },
  "r1310": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13J",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13J"
  },
  "r1311": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13J",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13J"
  },
  "r1312": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13J",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13J"
  },
  "r1313": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13J",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13J"
  },
  "r1314": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13J",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13J"
  },
  "r1315": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13K",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13K"
  },
  "r1316": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13K",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13K"
  },
  "r1317": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13K",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13K"
  },
  "r1318": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13K",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13K"
  },
  "r1319": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13K",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13K"
  },
  "r1320": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13K",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13K"
  },
  "r1321": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13K",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13K"
  },
  "r1322": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13K",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13K"
  },
  "r1323": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29E"
  },
  "r1324": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r1325": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29G"
  },
  "r1326": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1327": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1328": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r1329": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478420/944-505-55-1"
  },
  "r1330": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478420/944-505-55-2"
  },
  "r1331": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r1332": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r1333": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-12"
  },
  "r1334": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r1335": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-15"
  },
  "r1336": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-14"
  },
  "r1337": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17"
  },
  "r1338": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r1339": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-9"
  },
  "r1340": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477301/944-805-55-3"
  },
  "r1341": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477301/944-805-55-4"
  },
  "r1342": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477301/944-805-55-5"
  },
  "r1343": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1344": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1345": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r1346": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r1347": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1348": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1349": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1350": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1351": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1352": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1353": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r1354": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r1355": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r1356": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1357": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1358": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1359": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r1360": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r1361": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1362": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1363": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1364": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1365": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1366": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1367": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1368": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1369": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1370": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1371": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1372": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1373": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1374": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1375": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1376": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1377": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1378": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1379": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1380": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1381": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1382": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1383": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1384": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1385": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1386": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1387": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1388": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1389": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1390": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1391": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1392": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1393": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1394": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1395": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1396": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1397": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1398": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1399": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1400": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1401": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1402": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1403": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1404": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1405": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1406": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1407": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1408": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1409": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1410": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1411": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1412": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1413": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1414": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1415": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1416": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1417": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1418": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1419": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1420": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1421": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1422": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1423": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1424": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1425": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1426": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1427": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1428": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1429": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1430": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1431": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1432": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1433": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1434": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1435": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1436": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1437": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1438": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1439": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1440": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1441": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1442": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r1443": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1444": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1445": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1446": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1447": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1448": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r1449": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r1450": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r1451": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r1452": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1453": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r1454": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r1455": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1456": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "SubTopic": "310",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1457": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r1458": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r1459": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r1460": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r1461": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1462": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1463": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1464": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1465": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1466": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1467": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1468": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1469": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "a",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1470": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "a",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1471": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "a",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1472": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r1473": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(ii)",
   "Publisher": "SEC"
  },
  "r1474": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)",
   "Publisher": "SEC"
  },
  "r1475": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r1476": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r1477": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Rule 15c3-1",
   "Number": "240",
   "Section": "15c3-1",
   "Publisher": "SEC"
  },
  "r1478": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r1479": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r1480": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1481": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1482": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1483": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1484": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1485": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1486": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1487": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1488": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1489": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1490": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1491": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r1492": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r1493": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1494": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1495": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1496": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1497": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1498": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1499": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1500": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1501": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1502": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1503": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1504": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1505": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1506": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1507": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1508": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1509": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1510": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1511": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1512": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1513": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1514": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1515": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1516": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1517": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1518": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1519": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1520": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1521": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1522": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1523": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1524": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1525": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1526": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1527": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1528": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1529": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1530": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1531": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1532": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r1533": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r1534": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r1535": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r1536": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1537": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1538": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1539": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1540": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r1541": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1542": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1543": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r1544": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1545": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1546": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r1547": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1548": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1549": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1550": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1551": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1552": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1553": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1554": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1555": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r1556": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r1557": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1558": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1559": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1560": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1561": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1562": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r1563": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1564": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1565": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1566": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1567": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1568": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1569": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r1570": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r1571": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r1572": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r1573": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1574": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1575": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1576": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1577": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1578": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1579": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1580": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1581": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1582": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1583": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1584": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1585": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r1586": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r1587": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r1588": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1589": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1590": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1591": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1592": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-4"
  },
  "r1593": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1594": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r1595": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r1596": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r1597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r1598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r1599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r1600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r1601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r1602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r1603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r1619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r1621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r1622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r1623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r1624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r1625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r1676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r1677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r1678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1689": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-8"
  },
  "r1690": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1691": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1692": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1693": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1694": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1695": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1696": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1697": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1698": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1699": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1700": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1701": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1702": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1703": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1704": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1705": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1706": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1707": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1708": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1709": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1710": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1711": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1712": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1713": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1714": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1716": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1717": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1718": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1719": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1720": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1721": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r1722": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r1723": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r1724": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r1725": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r1726": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r1727": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC"
  },
  "r1728": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r1729": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r1730": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r1731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r1732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r1733": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r1734": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1735": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1736": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1737": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1738": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480682/815-20-25-6A"
  },
  "r1739": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1740": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1741": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1742": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1743": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1744": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1745": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1746": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1747": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1748": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1749": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1750": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1751": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1752": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1753": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1754": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1755": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1756": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1757": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1758": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r1759": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1760": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1761": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-13"
  },
  "r1762": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1763": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1764": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r1765": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r1766": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r1767": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r1768": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1769": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1770": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1771": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1772": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1773": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1774": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1775": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1776": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1777": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1778": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1779": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1780": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481833/940-20-45-3"
  },
  "r1781": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/940-320/tableOfContent"
  },
  "r1782": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1783": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3"
  },
  "r1784": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r1785": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479868/944-20-45-2"
  },
  "r1786": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479868/944-20-45-2"
  },
  "r1787": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479868/944-20-45-2"
  },
  "r1788": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479838/944-20-50-5"
  },
  "r1789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(14)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477409/944-310-45-6"
  },
  "r1803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-2"
  },
  "r1804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479250/944-40-25-14"
  },
  "r1806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1"
  },
  "r1835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-3"
  },
  "r1839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-3"
  },
  "r1840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}

Cover - shares	6 Months Ended
Cover - shares	Jun. 30, 2025	Aug. 07, 2025
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2025
Document Transition Report	false
Entity File Number	001-38469
Entity Registrant Name	Equitable Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	90-0226248
Entity Address, Address Line One	1345 Avenue of the Americas
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10105
City Area Code	212
Local Phone Number	554-1234
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		299,536,468
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2025
Amendment Flag	false
Entity Central Index Key	0001333986
Current Fiscal Year End Date	--12-31
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common Stock
Trading Symbol	EQH
Security Exchange Name	NYSE
Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A
Trading Symbol	EQH PR A
Security Exchange Name	NYSE
Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C
Trading Symbol	EQH PR C
Security Exchange Name	NYSE

Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2025	Dec. 31, 2024
Statement of Financial Position [Abstract]
Amortized cost of fixed maturities available-for-sale	$ 86,819,000,000	$ 84,717,000,000
Allowance for credit losses of fixed maturities available-for-sale	3,000,000	2,000,000
Allowance for credit losses of mortgage loans on real estate	305,000,000	278,000,000
Allowance for credit losses of amounts due from reinsurers	$ 7,000,000	$ 8,000,000
Preferred stock par value (in dollars per share)	$ 1	$ 1
Preferred stock, liquidation preference	$ 25,000	$ 25,000
Common stock par value (in dollars per share)	$ 0.01	$ 0.01
Common stock authorized (in shares)	2,000,000,000	2,000,000,000
Common stock issued (in shares)	472,699,844	477,801,636
Common stock outstanding (in shares)	301,768,056	309,900,248
Treasury stock (in shares)	170,931,788	167,901,388

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (283)	$ 565	$ (133)	$ 760
Other comprehensive income (loss) net of income taxes:
Change in unrealized gains (losses), net of reclassification adjustment	309	(409)	918	(922)
Change in market risk benefits - instrument-specific credit risk	(170)	(159)	414	(139)
Change in liability for future policy benefits - current discount rate	(29)	67	(92)	165
Change in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment	9	11	26	19
Foreign currency translation adjustment	26	9	37	(2)
Total other comprehensive income (loss), net of income taxes	145	(481)	1,303	(879)
Comprehensive income (loss)	(138)	84	1,170	(119)
Less: Comprehensive income (loss) attributable to the noncontrolling interest	76	140	176	239
Comprehensive income (loss) attributable to Holdings	$ (214)	$ (56)	$ 994	$ (358)

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Total Holdings Equity	Preferred Stock and Additional Paid-In Capital	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Non-controlling Interest
Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2023	$ 4,375	$ 2,636	$ 1,562	$ 5	$ 2,328	$ (3,712)	$ 10,250	$ (7,797)	$ 1,739
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation	70	49	0	0	32	17	0	0	21
Purchase of treasury stock	(500)	(500)	0	0	(2)	(498)	0	0	0
Reissuance of treasury stock	(17)	(17)	0	0	0	0	(17)	0	0
Retirement of common stock	0	0	0	0	0	261	(261)	0	0
Purchase of AB Holding units	(34)	0	0	0	0	0	0	0	(34)
Dividends paid to noncontrolling interest	(189)	0	0	0	0	0	0	0	(189)
Dividends on common stock	(151)	(151)	0	0	0	0	(151)	0
Dividends on preferred stock	(40)	(40)	0	0	0	0	(40)	0	0
Net income (loss)	726	520	0	0	0	0	520	0	206
Total other comprehensive income (loss), net of income taxes	(879)	(878)	0	0	0	0	0	(878)	(1)
Other	(22)	(21)	0	0	(21)	0	0	0	(1)
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2024	3,339	1,598	1,562	5	2,337	(3,932)	10,301	(8,675)	1,741
Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2024	3,715	1,992	1,562	5	2,322	(3,801)	10,095	(8,191)	1,723
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation	26	14	0	0	16	(2)	0	0	12
Purchase of treasury stock	(247)	(247)	0	0		(247)	0	0	0
Reissuance of treasury stock	0	0	0	0	0	0	0	0	0
Retirement of common stock	0	0	0	0	0	118	(118)	0	0
Purchase of AB Holding units	(28)	0	0	0	0	0	0	0	(28)
Dividends paid to noncontrolling interest	(90)	0	0	0	0	0	0	0	(90)
Dividends on common stock	(78)	(78)	0	0	0	0	(78)	0	0
Dividends on preferred stock	(26)	(26)	0	0	0	0	(26)	0	0
Net income (loss)	549	428	0	0	0	0	428	0	121
Total other comprehensive income (loss), net of income taxes	(481)	(484)	0	0	0	0	0	(484)	3
Other	(1)	(1)	0	0	(1)	0	0	0	0
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2024	3,339	1,598	1,562	5	2,337	(3,932)	10,301	(8,675)	1,741
Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2024	3,423	1,565	1,507	5	2,336	(4,198)	10,627	(8,712)	1,858
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation	73	62	0	0	37	25	0	0	11
Purchase of treasury stock	(497)	(497)	0	0	10	(507)	0	0	0
Reissuance of treasury stock	(19)	(19)	0	0	0	0	(19)	0	0
Retirement of common stock	0	0	0	0	0	257	(257)	0	0
Purchase of AB Holding units	(802)	(443)	0	0	(443)	0	0	0	(359)
Dividends paid to noncontrolling interest	(229)	0	0	0	0	0	0	0	(229)
Dividends on common stock	(156)	(156)	0	0	0	0	(156)	0	0
Dividends on preferred stock	(32)	(32)	0	0	0	0	(32)	0	0
Redemption of preferred stock	(279)	(279)	(279)	0	0	0	0	0	0
Net income (loss)	(134)	(286)	0	0	0	0	(286)	0	152
Total other comprehensive income (loss), net of income taxes	1,303	1,280	0	0	0	0	0	1,280	23
Other	(46)	(46)	0	0	(39)	0	(7)	0	0
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2025	2,605	1,149	1,228	5	1,901	(4,423)	9,870	(7,432)	1,456
Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2025	4,205	2,401	1,507	5	2,305	(4,296)	10,447	(7,567)	1,804
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation	23	20	0	0	19	1	0	0	3
Purchase of treasury stock	(235)	(235)	0	0	15	(250)	0	0	0
Reissuance of treasury stock	(1)	(1)	0	0	0	0	(1)	0	0
Retirement of common stock	0	0	0	0	0	122	(122)	0	0
Purchase of AB Holding units	(772)	(443)	0	0	(443)	0	0	0	(329)
Dividends paid to noncontrolling interest	(99)	0	0	0	0	0	0	0	(99)
Dividends on common stock	(82)	(82)	0	0	0	0	(82)	0	0
Redemption of preferred stock	(279)	(279)	(279)	0	0	0	0	0	0
Dividends on preferred stock	(18)	(18)	0	0	0	0	(18)	0	0
Net income (loss)	(281)	(349)	0	0	0	0	(349)	0	68
Total other comprehensive income (loss), net of income taxes	145	135	0	0	0	0	0	135	10
Other	(3)	(2)	0	0	5	0	(7)	0	(1)
Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2025	$ 2,605	$ 1,149	$ 1,228	$ 5	$ 1,901	$ (4,423)	$ 9,870	$ (7,432)	$ 1,456

Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ (133)	$ 760
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances	1,474	1,178
Policy charges and fee income	(1,262)	(1,231)
Net derivative (gains) losses	575	1,584
Credit and intent to sell losses on available for sale debt securities and loans	54	35
Investment (gains) losses, net	31	20
(Gains) losses on businesses held-for-sale	0	(135)
Realized and unrealized (gains) losses on trading securities	(39)	(43)
Income (Loss) due to Novation in Pre-Tax Net Income	499	0
AB Retirement plan losses	21	0
Non-cash long term incentive compensation expense	48	53
Amortization and depreciation	433	434
Remeasurement of liability for future policy benefits	(15)	(2)
Change in market risk benefits	66	(1,220)
Equity (income) loss from limited partnerships	(87)	(58)
Changes in:
Net broker-dealer and customer related receivables/payables	(26)	(168)
Reinsurance recoverable	(562)	(628)
Segregated cash and securities, net	17	276
Capitalization of deferred policy acquisition costs	(574)	(561)
Future policy benefits	201	275
Current and deferred income taxes	(129)	149
Other, net	(93)	205
Net cash provided by (used in) operating activities	499	923
Proceeds from the sale/maturity/pre-payment of:
Fixed maturities, available-for-sale	9,368	5,284
Fixed maturities, at fair value using the fair value option	299	399
Mortgage loans on real estate	664	460
Trading account securities	269	512
Short term investments	132	571
Other	283	331
Payment for the purchase/origination of:
Fixed maturities, available-for-sale	(11,576)	(10,523)
Fixed maturities, at fair value using the fair value option	(709)	(426)
Mortgage loans on real estate	(2,103)	(1,148)
Trading account securities	(395)	(1,446)
Short term investments	(99)	(384)
Other	(83)	(473)
Cash settlements related to derivative instruments, net	571	(1,438)
Investment in capitalized software, leasehold improvements and EDP equipment	(17)	(99)
Other, net	(321)	453
Net cash provided by (used in) investing activities	(3,717)	(7,927)
Policyholders’ account balances:
Deposits	14,931	9,033
Withdrawals	(4,637)	(4,719)
Transfers (to) from Separate Accounts	932	832
Payments of market risk benefits	(366)	(376)
Repayment of short-term financings	0	(254)
Change in collateralized pledged assets	17	(75)
Change in collateralized pledged liabilities	1,298	4,829
Issuance of long-term debt	495	0
Repayments of Senior Debt	0	(565)
Proceeds from collateralized loan obligations	46	0
Repayment of collateralized loan obligations	(38)	0
Proceeds from notes issued by consolidated VIEs	1,203	176
Repayment of notes issued by consolidated VIEs	(839)	0
Dividends paid on common stock	(156)	(151)
Dividends paid on preferred stock	(32)	(40)
Redemption of preferred stock	(279)	0
Purchase of AllianceBernstein Units	(758)	0
Purchase of AB Holding Units to fund long-term incentive compensation plan awards, net	(44)	(34)
Purchase of treasury shares	(497)	(500)
Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds	173	291
Distribution to noncontrolling interest of consolidated subsidiaries	(229)	(189)
Change in securities lending	(33)	36
Other, net	(17)	15
Net cash provided by (used in) financing activities	11,170	8,309
Effect of exchange rate changes on cash and cash equivalents	41	(13)
Change in cash and cash equivalents	7,993	1,292
Cash and cash equivalents, beginning of period	6,964	8,239
Change in cash of businesses held-for-sale	0	153
Cash and cash equivalents, end of period	14,957	9,684
Non-cash transactions from investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations	$ 24	$ 222

ORGANIZATION	6 Months Ended
ORGANIZATION	Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	ORGANIZATION Equitable Holdings, Inc. is the holding company for a diversified financial services organization. The Company conducts operations in six segments: Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management and Legacy. The Company’s management evaluates the performance of each of these segments independently. Effective April 1, 2024, the Company renamed its Investment Management and Research segment to Asset Management following the close of the previously announced joint venture between AllianceBernstein and Societe Generale. Following the close of the transaction, Bernstein Research Services (“BRS”) business results are no longer consolidated within the financial results for AllianceBernstein and Equitable Holdings, Inc. •The Individual Retirement segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income. •The Group Retirement segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities and not-for-profit entities, as well as small and medium-sized businesses. •The Asset Management segment provides diversified investment management and related services globally to a broad range of clients through three main client channels - Institutional, Retail and Private Wealth. The Asset Management segment reflects the business of AB Holding and ABLP and their subsidiaries (collectively, AB). •The Protection Solutions segment includes the Company’s life insurance and group employee benefits (“EB”) businesses. •The Wealth Management segment is an emerging leader in the wealth management space with a differentiated advice value proposition that offers discretionary and non-discretionary investment advisory accounts, financial planning and advice, life insurance, and annuity products. •The Legacy segment consists of our capital intensive fixed-rate GMxB business written prior to 2011. The Company reports certain activities and items that are not included in our segments in Corporate and Other. Corporate and Other includes certain of our financing and investment expenses. It also includes closed block of life insurance (the “Closed Block”), run-off variable annuity reinsurance business, run-off group pension business, run-off health business, benefit plans for our employees, certain strategic investments and certain unallocated items, including capital and related investments, interest expense and corporate expense. AB’s results of operations are reflected in the Asset Management segment. Accordingly, Corporate and Other does not include any items applicable to AB. As of June 30, 2025 and December 31, 2024, the Company’s economic interest in AB was approximately 69% and 62%, respectively. The General Partner of AB is a wholly owned subsidiary of the Company. Because the General Partner has the authority to manage and control the business of AB, AB is consolidated in the Company’s financial statements for all periods presented. The increase in economic interest was due to the purchase of AB Holding Units relating to the AB Tender Offer transaction completed on April 3, 2025. RGA Reinsurance Transaction On February 23, 2025, Equitable Financial, as well as Equitable America and Equitable Financial L&A, entered into a master transaction agreement with Reinsurance Group of America (“RGA”) pursuant to which at closing and subject to the terms and conditions set forth in such agreement, RGA would enter into reinsurance agreements, as reinsurer, with each such subsidiary, as ceding company, to effect the RGA Reinsurance Transaction. The transaction closed on July 31, 2025, see Note 21 of the Notes to these Consolidated Financial Statements. Novation Effective January 17, 2025, Equitable Financial novated certain legacy variable annuity policies sold between 2006-2008, comprised of non-New York “Accumulator” policies containing fixed rate Guaranteed Minimum Income Benefit and/or Guaranteed Minimum Death Benefit guarantees reinsured by Venerable under the combined co-insurance and modified coinsurance basis agreement executed on June 1, 2021. As a result of the novation of certain Legacy VA policies completed during the first quarter 2025, the Company recorded a loss of $499 million in pre-tax net income and an increase of $263 million in pre-tax AOCI, for a total impact loss of $236 million. The negative net income impact is mostly driven by the reduction of the purchased market risk benefits (“MRB”) asset of $2.0 billion and the reduction of Liability for MRBs of $1.6 billion, offset by a decrease in reinsurance deposit liability of $183 million. Purchased MRB asset reduction is larger than the direct MRB liability reduction since the Venerable reinsurance assets sit in a collateralized trust and thus materially reduce the non-performance risk. Deposit account liability decreases as novation leads to faster amortization of the liability. The novation impact from the base contracts and the contracts in payout status is less material, as the increase in policyholders’ account balance of $33 million and decrease in liability for future policyholders’ benefits of $458 million are largely offset by a decrease in Amounts due from reinsurers of $432 million. AB Tender Offer On February 24, 2025, Holdings commenced a cash tender offer (the “AB Tender Offer”) to purchase up to 46 million AB Holding Units at a price of $38.50 per unit, less any applicable tax withholding, for an aggregate purchase price of $1.8 billion. On April 3, 2025, Holdings purchased 19.7 million AB Holdings Units pursuant to the AB Tender Offer for an aggregate cost of $758 million. The AB Holdings Units accepted for purchase represented approximately 17.9% of the outstanding units at the time of purchase. At June 30, 2025, Holdings owned approximately 68.6% of the economic interest in AllianceBernstein L.P., the operating partnership of AB Holding.

INCOME TAXES	6 Months Ended
INCOME TAXES	Jun. 30, 2025
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Income tax expense for the three and six months ended June 30, 2025 and 2024 was computed using an estimated annual effective tax rate (“ETR”), with discrete items recognized in the period in which they occur. The estimated ETR is revised, as necessary, at the end of successive interim reporting periods. In 2022, the Company established a valuation allowance against its deferred tax asset related to unrealized capital losses in the available for sale securities portfolio. In 2023, management took actions to increase its available liquidity so that the Company has the ability and intent to hold the majority of securities in its available for sale portfolio to recovery. For liquidity and other purposes, the Company maintains a smaller pool of securities that it does not intend to hold to recovery. The Company maintains a valuation allowance against the deferred tax asset on available for sale securities that will not be held to recovery. Adjustments to the valuation allowance due to changes in the portfolio’s unrealized capital loss are recorded in OCI. Adjustments to the valuation allowance due to new facts or evidence are recorded in net income. For the three and six months ended June 30, 2025, the Company recorded increases to the valuation allowance of $33 million and $41 million, respectively, due to changes in the value of unrealized losses in the available for sale portfolio that will not be held to recovery. These adjustments were recorded in OCI. As of June 30, 2025, a valuation allowance of $258 million remains against the portion of the deferred tax asset that is still not more-likely-than-not to be realized. The Company uses the aggregate portfolio approach related to the stranded or disproportionate income tax effects in accumulated other comprehensive income related to available for sale securities. Under this approach, the disproportionate tax effect remains intact as long as the investment portfolio remains.

INSURANCE STATUTORY FINANCIAL INFORMATION	6 Months Ended
INSURANCE STATUTORY FINANCIAL INFORMATION	Jun. 30, 2025
Insurance [Abstract]
INSURANCE STATUTORY FINANCIAL INFORMATION	INSURANCE STATUTORY FINANCIAL INFORMATION Prescribed and Permitted Accounting Practices As of June 30, 2025, the following five prescribed and permitted practices resulted in net income (loss) and capital and surplus that is different from the statutory surplus that would have been reported had NAIC statutory accounting practices been applied. Equitable Financial was granted a permitted practice by the NYDFS to apply SSAP 108, Derivatives Hedging Variable Annuity Guarantees on a retroactive basis from January 1, 2021 through June 30, 2021, after reflecting the impacts of our reinsurance transaction with Venerable. The permitted practice was amended to also permit Equitable Financial to adopt SSAP 108 prospectively as of July 1, 2021 and to consider the impact of both the interest rate derivatives and the General Account assets used to fully hedge the interest rate risk inherent in its variable annuity guarantees when determining the amount of the deferred asset or liability under SSAP 108. Application of the permitted practice partially mitigates the New York Insurance Regulation 213 (“Reg 213”) impact of the Venerable transaction on Equitable Financial’s statutory capital and surplus and enables Equitable Financial to more effectively neutralize the impact of interest rates on its statutory surplus and to better align with our economic hedging program. The impact of applying this permitted practice relative to SSAP 108 as written was a decrease of approximately $155 million in statutory special surplus funds as of June 30, 2025. The Reinsurance Treaty reduced the amount of interest rate hedging needed at Equitable Financial going forward, affecting future deferrals, but leaves our historical SSAP 108 deferred amounts unchanged. The permitted practice also reset Equitable Financial’s unassigned surplus to zero as of June 30, 2021 to reflect the transformative nature of the Venerable transaction. The Manual has been adopted as a component of prescribed or permitted practices by the State of New York. However, Reg 213 adopted in May of 2019 and as amended in February 2020 and March 2021, differs from the NAIC variable annuity reserve and capital framework. Reg 213 requires Equitable Financial to carry statutory basis reserves for its variable annuity contract obligations equal to the greater of those required under (i) the NAIC standard or (ii) a revised version of the NYDFS requirement in effect prior to the adoption of the first amendment for contracts issued prior to January 1, 2020, and for policies issued after that date a new standard that in current market conditions imposes more conservative reserving requirements for variable annuity contracts than the NAIC standard. The impact of the application of Reg 213 was a decrease of approximately $123 million in statutory surplus as of June 30, 2025 compared to statutory surplus under the NAIC variable annuity framework. Our hedging program is designed to hedge the economics of our insurance liabilities and largely offsets Reg 213 and NAIC framework reserve movements due to interest rates and equities. The NYDFS allows domestic insurance companies a five year phase-in provision for Reg 213 reserves. As of September 30, 2022, Equitable Financial’s Reg 213 reserves were 100% phased-in. As of June 30, 2025, given the prevailing market conditions and business mix, there are $111 million Reg 213 redundant reserves over the US RBC CTE 98 TAR. During the fourth quarter 2020, Equitable Financial received approval from NYDFS for its proposed amended Plan of Operation for Separate Account No. 68 (“SA 68”) for our SCS product and Separate Account No. 69 (“SA 69”) for our EQUI-VEST product Structured Investment Option, to change the accounting basis of these two non-insulated Separate Accounts from fair value to book value in accordance with Section 1414 of the Insurance Law to align with how we manage and measure our overall General Account asset portfolio. In order to facilitate this change and comply with Section 4240(a)(10), the Company also sought approval to amend the Plans to remove the requirement to comply with Section 4240(a)(5)(iii) and substitute it with a commitment to comply with Section 4240(a)(5)(i). Similarly, the Company updated the reserves section of each Plan to reflect the fact that Regulation 128 would no longer be applicable upon the change in accounting basis. We applied this change effective January 1, 2021. The impact of the application is an increase of approximately $770 million in statutory surplus as of June 30, 2025. During 2022, Equitable America received approval from the Arizona Department of Insurance and Financial Institutions pursuant to A.R.S. 20-515 for Separate Account No. 68A (“SA 68A”) for our SCS product, Separate Account No. 69A (“SA 69A”) for our EQUI-VEST product Structured Investment Option and Separate Account No. 71A (“SA 71A”) for our Investment Edge Structured Investment Option, to permit us to use book value as the accounting basis of these three non-insulated Separate Accounts instead of fair value in accordance with the Manual to align with how we manage and measure our overall General Account asset portfolio. The impact of the application is a decrease of approximately $920 million in statutory surplus as of June 30, 2025. The Arizona Department of Insurance and Financial Institutions granted to Equitable America a permitted practice to deviate from SSAP No. 108 by applying special accounting treatment for specific derivatives hedging variable annuity benefits subject to fluctuations as a result of interest rate sensitivities. The permitted practice expands on SSAP No. 108 hedge accounting to include equity risks for the full scope of Variable Annuity (VA) contracts (i.e., not just the rider guarantees but for the VA total contract). The permitted practice allows Equitable America to adopt SSAP 108 retroactively from October 1, 2023 and applies to both directly held VA hedges as well as VA hedges in the Equitable America funds withheld asset that resulted from the Reinsurance Treaty. In the calculation of the amount of excess VA equity and interest rate derivative hedging gains/losses to defer (including Net investment income on our Equity Total Return Swaps), the permitted practice allows us to compare our total equity and interest derivatives gains and losses to 100% of our target liability change. Any hedge gain or loss deferrals will follow SSAP No. 108 amortization rules (i.e. 10-year straight line). The impact of applying this revised permitted practice relative to SSAP 108 was an increase of approximately $1.4 billion in statutory special surplus funds as of June 30, 2025.

SUBSEQUENT EVENTS	6 Months Ended
SUBSEQUENT EVENTS	Jun. 30, 2025
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS ASR In June 2025, Holdings established an obligation to enter into an ASR with a third-party financial institution to repurchase an aggregate of $96 million of Holdings’ common stock. Pursuant to the ASR, on July 2, 2025, Holdings made a pre-payment of $96 million and received initial delivery of 1.4 million shares. The ASR terminated in July 2025, at which time an additional 441,333 shares of common stock were received. AB Unit Exchange On July 10, 2025, AB and Holdings entered into an Amended and Restated Master Exchange Agreement to increase the AB Units that remain available for exchange from 4.8 million AB Units to 19.7 million AB Units, and Holdings exchanged 19.7 million AB Holding Units for an equal number of limited partnership interests in ABLP. After giving effect to the exchange Holdings continues to own approximately 68.6% of the economic interest in AB. RGA Reinsurance Agreement On July 31, 2025, Equitable Financial, as well as Equitable America and Equitable Financial L&A, completed the master transaction agreement with RGA entered into on February 23, 2025 pursuant to which and subject to the terms and conditions set forth in such agreement, RGA entered into reinsurance agreements, as reinsurer, with each such subsidiary, as ceding company, to effect the RGA Reinsurance Transaction. At the closing of the transaction, (i) each of Equitable Financial and Equitable America entered into a separate coinsurance and modified coinsurance agreement with RGA and (ii) Equitable Financial L&A entered into a coinsurance agreement with RGA, each with an effective date of April 1, 2025, pursuant to which each ceding company ceded to RGA a 75% quota share of such ceding company’s in-force individual life insurance block. At the closing of the transaction, assets supporting the general account liabilities relating to the reinsured contracts were deposited into a trust account for the benefit of Equitable Financial and a trust account for the benefit of Equitable America and Equitable Financial L&A, which assets will secure RGA’s obligations to each ceding company under the applicable reinsurance agreement. Equitable Financial and Equitable America reinsured the applicable separate accounts relating to the applicable reinsured contracts on a modified coinsurance basis. In addition, the investment of assets in each trust account will be subject to investment guidelines and certain capital adequacy related triggers will require enhanced funding. The reinsurance agreements also contain additional counterparty risk management and mitigation provisions. Each ceding company will continue to administer the applicable reinsured contracts. As part of the transaction, on June 16, 2025, ABLP entered into an investment advisory agreement with RGA, pursuant to which AB will manage certain assets to be specified representing approximately 70% of assets supporting the reserves associated with the ceded policies under the reinsurance agreements. Credit Facility Revolver On July 29, 2025, the Company terminated the Amended and Restated Revolving Credit Agreement entered into by the Company on June 24, 2021, as amended and restated from time to time, which provided for a $1.5 billion senior unsecured revolving credit facility, and entered into a new Revolving Credit Agreement which provides for a $1.0 billion five-year senior unsecured revolving credit facility (the “Credit Facility”) with a syndicate of banks.

ORGANIZATION (Details) $ / shares in Units, shares in Millions, $ in Millions			3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 03, 2025 USD ($) shares	Feb. 24, 2025 USD ($) $ / shares shares	Jun. 30, 2025 USD ($) segment	Jun. 30, 2024 USD ($)	Jun. 30, 2025 USD ($)	Jun. 30, 2024 USD ($)	Dec. 31, 2024
Organization Basis Of Presentation [Line Items]
Number of operating segments \| segment			6
Loss on novation					$ 499	$ 0
Increase (decrease) in remeasurement of liability for future policy benefits			$ 13	$ 7	15	2
Decrease in amounts due from reinsurers					$ 562	$ 628
AB Holding
Organization Basis Of Presentation [Line Items]
Maximum units available to purchase (in shares) \| shares	19.7	46.0
Price per unit (in dollars per share) \| $ / shares		$ 38.50
Aggregate purchase price	$ 758	$ 1,800
Percentage of issued and outstanding units			17.90%		17.90%
Economic interest percentage			68.60%		68.60%
Novation
Organization Basis Of Presentation [Line Items]
Loss on novation					$ 499
Increase in Pre tax AOCI					263
Total Impact loss					236
Reduction of purchase MRB asset					2,000
Reduction of liabilities for MRBs					1,600
Decrease in reinsurance deposit liability					183
Increase in policyholders’ account balance					33
Increase (decrease) in remeasurement of liability for future policy benefits					458
Decrease in amounts due from reinsurers					$ 432
Alliance Bernstein
Organization Basis Of Presentation [Line Items]
Economic interest in Subsidiary					69.00%		62.00%

INVESTMENTS - Narrative (Details)	3 Months Ended		6 Months Ended		12 Months Ended
INVESTMENTS - Narrative (Details)	Jun. 30, 2025 USD ($) note issue Loan	Jun. 30, 2024 USD ($)	Jun. 30, 2025 USD ($) issue note Loan	Jun. 30, 2024 USD ($)	Dec. 31, 2024 USD ($) issue note	Dec. 31, 2023 USD ($) loan extension
Net Investment Income [Line Items]
Number of positions in unrealized loss position \| issue	3,685		3,685		4,307
Debt securities exposure in single issuer greater than stated percentage of total investments	0.50%		0.50%
Amortized cost of fixed maturities available-for-sale	$ 86,819,000,000		$ 86,819,000,000		$ 84,717,000,000
12 months or longer, gross unrealized losses	7,415,000,000		7,415,000,000		8,188,000,000
Loaned securities	983,000,000		$ 983,000,000		134,000,000
Minimum requirement percentage of the fair value of the loaned securities to be held as cash collateral			102.00%
Cash collateral	1,000,000,000.0		$ 1,000,000,000.0		137,000,000
Allowance for credit losses	305,000,000	$ 234,000,000	305,000,000	$ 234,000,000	278,000,000
Non-accruing Loans	$ 146,000,000		$ 146,000,000		$ 93,000,000
Number of loans \| loan						4
Number of loans split into notes \| note	3		3		2
Number of notes with original loan terms \| note					1
Amortized cost					$ 65,000,000	$ 228,000,000
Percentage of total commercial mortgage loans representing amortized cost					0.40%	1.30%
Number of troubled debt restructuring extensions \| extension						2
Separate account equity investment carrying value	$ 56,000,000		$ 56,000,000		$ 64,000,000
Interest credited to policyholders account balances participating group annuity contracts	0	$ 0	1,000,000	1,000,000
Financing Receivable, Modifications Contracts Modified During Period, Principal Balance	$ 15,000,000		$ 15,000,000
Agricultural Sector
Net Investment Income [Line Items]
Percentage of total commercial mortgage loans representing amortized cost	0.30%		0.30%
Cash
Net Investment Income [Line Items]
Cash collateral	$ 104,000,000		$ 104,000,000		137,000,000
Recurring
Net Investment Income [Line Items]
Trading securities, at fair value	1,295,000,000		1,295,000,000		1,089,000,000
Minimum
Net Investment Income [Line Items]
Debt instrument, term						17 months
Maximum
Net Investment Income [Line Items]
Debt instrument, term						4 years
Commercial, Agricultural And Residential Mortgage Loan
Net Investment Income [Line Items]
Accrued investment income receivable	$ 110,000,000		110,000,000		96,000,000
Accrued interest written off			$ 0	0
Individually Assessed Mortgage Loans
Net Investment Income [Line Items]
Number of mortgage loans, foreclosure probable \| Loan	0		0
Mortgage Loans
Net Investment Income [Line Items]
Non-accruing Loans	$ 89,000,000		$ 89,000,000		36,000,000
Note 1 \| Agricultural Sector
Net Investment Income [Line Items]
Amortized cost	9,000,000		9,000,000
Fixed maturities
Net Investment Income [Line Items]
Accrued investment income receivable	740,000,000		740,000,000		693,000,000
Accrued interest written off			0	$ 0
Amortized cost of fixed maturities available-for-sale	86,800,000,000		86,800,000,000		84,700,000,000
Fixed maturities \| Non-Investment Grade
Net Investment Income [Line Items]
Available-for-sale securities, amortized cost basis other than investment grade	$ 2,100,000,000		$ 2,100,000,000		$ 1,900,000,000
Percentage of available for sale securities	2.40%		2.40%		2.30%
Unrealized loss on available for sale securities	$ 67,000,000		$ 67,000,000		$ 64,000,000
Public Corporate
Net Investment Income [Line Items]
Exposure in single issuer of total investments	$ 427,000,000		$ 427,000,000		$ 400,000,000
Debt securities exposure in single issuer of total investments, percentage	16.40%		16.40%		11.70%
Amortized cost of fixed maturities available-for-sale	$ 53,506,000,000		$ 53,506,000,000		$ 55,218,000,000
12 months or longer, gross unrealized losses	$ 5,299,000,000		$ 5,299,000,000		$ 5,901,000,000

INVESTMENTS - Fixed Maturities Available-for-sale (Details) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024
Available-For-Sale Securities, Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	$ 6,477	$ 12,732
Less than 12 months, gross unrealized losses	76	249
12 months or longer, fair value	36,489	37,958
12 months or longer, gross unrealized losses	7,415	8,188
Total fair value	42,966	50,690
Total gross unrealized losses	7,491	8,437
Corporate
Available-For-Sale Securities, Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	4,283	9,147
Less than 12 months, gross unrealized losses	61	205
12 months or longer, fair value	27,192	28,684
12 months or longer, gross unrealized losses	5,299	5,901
Total fair value	31,475	37,831
Total gross unrealized losses	5,360	6,106
U.S. Treasury, government and agency
Available-For-Sale Securities, Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	67	117
Less than 12 months, gross unrealized losses	1	4
12 months or longer, fair value	4,210	4,107
12 months or longer, gross unrealized losses	1,466	1,509
Total fair value	4,277	4,224
Total gross unrealized losses	1,467	1,513
States and political subdivisions
Available-For-Sale Securities, Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	0	40
Less than 12 months, gross unrealized losses	0	0
12 months or longer, fair value	261	271
12 months or longer, gross unrealized losses	84	88
Total fair value	261	311
Total gross unrealized losses	84	88
Foreign governments
Available-For-Sale Securities, Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	19	59
Less than 12 months, gross unrealized losses	0	1
12 months or longer, fair value	459	460
12 months or longer, gross unrealized losses	117	135
Total fair value	478	519
Total gross unrealized losses	117	136
Residential mortgage-backed
Available-For-Sale Securities, Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	488	1,986
Less than 12 months, gross unrealized losses	4	26
12 months or longer, fair value	826	851
12 months or longer, gross unrealized losses	107	126
Total fair value	1,314	2,837
Total gross unrealized losses	111	152
Asset-backed
Available-For-Sale Securities, Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	1,334	974
Less than 12 months, gross unrealized losses	9	7
12 months or longer, fair value	672	692
12 months or longer, gross unrealized losses	40	50
Total fair value	2,006	1,666
Total gross unrealized losses	49	57
Commercial mortgage-backed
Available-For-Sale Securities, Continuous Unrealized Loss Position [Line Items]
Less than 12 months, fair value	286	409
Less than 12 months, gross unrealized losses	1	6
12 months or longer, fair value	2,869	2,893
12 months or longer, gross unrealized losses	302	379
Total fair value	3,155	3,302
Total gross unrealized losses	$ 303	$ 385

INVESTMENTS - Amortized Cost of Loans by Credit Quality Indicator and Origination Year (Details) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024
Amortized Cost Basis by Origination Year
Total	$ 21,841	$ 20,350
Residential mortgages:
Amortized Cost Basis by Origination Year
Current fiscal year	85	313
Fiscal year before current fiscal year	700	428
Two years before current fiscal year	394	186
Three years before current fiscal year	178	133
Four years before current fiscal year	128	4
Prior	4	2
Total	1,489	1,066
Residential mortgages: \| Performing
Amortized Cost Basis by Origination Year
Current fiscal year	85	313
Fiscal year before current fiscal year	700	428
Two years before current fiscal year	393	186
Three years before current fiscal year	178	133
Four years before current fiscal year	128	4
Prior	4	2
Total	1,488	1,066
Residential mortgages: \| Nonperforming
Amortized Cost Basis by Origination Year
Current fiscal year	0	0
Fiscal year before current fiscal year	0	0
Two years before current fiscal year	1	0
Three years before current fiscal year	0	0
Four years before current fiscal year	0	0
Prior	0	0
Total	$ 1	$ 0

DERIVATIVES - Derivatives by Category (Details) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024
Total derivative instruments
Derivatives, Fair Value [Line Items]
Notional Amount	$ 115,910	$ 116,484
Derivative Assets	24,095	21,814
Derivative Liabilities	40,509	38,927
Net Derivatives	(16,414)	(17,113)
Designated for Hedge Accounting \| Cash Flow Hedge
Derivatives, Fair Value [Line Items]
Notional Amount	3,914	3,892
Derivative Assets	90	111
Derivative Liabilities	492	401
Net Derivatives	(402)	(290)
Designated for Hedge Accounting \| Cash Flow Hedge \| Currency swaps
Derivatives, Fair Value [Line Items]
Notional Amount	2,962	2,940
Derivative Assets	90	111
Derivative Liabilities	157	95
Net Derivatives	(67)	16
Designated for Hedge Accounting \| Cash Flow Hedge \| Interest swaps
Derivatives, Fair Value [Line Items]
Notional Amount	952	952
Derivative Assets	0	0
Derivative Liabilities	335	306
Net Derivatives	(335)	(306)
Not Designated for Hedge Accounting
Derivatives, Fair Value [Line Items]
Notional Amount	111,996	112,592
Derivative Assets	24,005	21,703
Derivative Liabilities	21,706	21,314
Net Derivatives	2,299	389
Not Designated for Hedge Accounting \| Currency swaps
Derivatives, Fair Value [Line Items]
Notional Amount	771	828
Derivative Assets	0	26
Derivative Liabilities	31	0
Net Derivatives	(31)	26
Not Designated for Hedge Accounting \| Interest swaps
Derivatives, Fair Value [Line Items]
Notional Amount	610	672
Derivative Assets	12	0
Derivative Liabilities	5	41
Net Derivatives	7	(41)
Not Designated for Hedge Accounting \| Futures
Derivatives, Fair Value [Line Items]
Notional Amount	17,100	14,530
Derivative Assets	0	3
Derivative Liabilities	3	0
Net Derivatives	(3)	3
Not Designated for Hedge Accounting \| Swaps
Derivatives, Fair Value [Line Items]
Notional Amount	16,942	16,264
Derivative Assets	59	65
Derivative Liabilities	71	19
Net Derivatives	(12)	46
Not Designated for Hedge Accounting \| Options
Derivatives, Fair Value [Line Items]
Notional Amount	66,287	70,685
Derivative Assets	22,575	20,647
Derivative Liabilities	4,925	4,319
Net Derivatives	17,650	16,328
Not Designated for Hedge Accounting \| Futures
Derivatives, Fair Value [Line Items]
Notional Amount	9,716	9,310
Derivative Assets	0	0
Derivative Liabilities	0	0
Net Derivatives	0	0
Not Designated for Hedge Accounting \| Option
Derivatives, Fair Value [Line Items]
Notional Amount	50	0
Derivative Assets	5	0
Derivative Liabilities	0	0
Net Derivatives	5	0
Not Designated for Hedge Accounting \| Credit default swaps
Derivatives, Fair Value [Line Items]
Notional Amount	437	275
Derivative Assets	11	12
Derivative Liabilities	20	10
Net Derivatives	(9)	2
Not Designated for Hedge Accounting \| Currency forwards
Derivatives, Fair Value [Line Items]
Notional Amount	83	28
Derivative Assets	15	17
Derivative Liabilities	17	17
Net Derivatives	(2)	0
Not Designated for Hedge Accounting \| Margin
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Derivative Assets	1,173	796
Derivative Liabilities	0	0
Net Derivatives	1,173	796
Not Designated for Hedge Accounting \| Collateral
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Derivative Assets	155	137
Derivative Liabilities	16,634	16,908
Net Derivatives	(16,479)	(16,771)
Not Designated for Hedge Accounting \| Total embedded derivatives
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Derivative Assets	0	0
Derivative Liabilities	18,311	17,212
Net Derivatives	(18,311)	(17,212)
Not Designated for Hedge Accounting \| SCS, SIO, MSO and IUL Indexed Features
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Derivative Assets	0	0
Derivative Liabilities	18,311	17,212
Net Derivatives	$ (18,311)	$ (17,212)

DERIVATIVES - Narrative (Details) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024
Derivative [Line Items]
Cash and securities collateral for derivative contract	$ 16,600	$ 16,900
Cash and securities collateral	155	137
S&P 500, Nasdaq, Russell 2000 And Emerging Market Indices
Derivative [Line Items]
Initial margin requirement	1,100	704
U.S. Treasury Notes, U.S. Treasury Bonds And Ultra-Long Bonds
Derivative [Line Items]
Initial margin requirement	110	99
Euro Stoxx, FTSE100, Topix, ASX200 and EAFE Indices
Derivative [Line Items]
Initial margin requirement	$ 1	$ 11

DERIVATIVES - Offsetting of Financial Assets and Liabilities and Derivative Instruments (Details) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024
Derivatives
Assets:
Gross Amount Recognized	$ 24,095	$ 21,814
Gross Amount Offset in the Balance Sheets	17,684	14,924
Net Amount Presented in the Balance Sheets	6,411	6,890
Gross Amount not Offset in the Balance Sheets	(4,509)	(6,080)
Net Amount	1,902	810
Liabilities:
Gross Amount Recognized	17,689	15,634
Gross Amount Offset in the Balance Sheets	17,684	14,924
Net Amount Presented in the Balance Sheets	5	710
Gross Amount not Offset in the Balance Sheets	0	0
Net Amount	5	710
Secured lending
Assets:
Gross Amount Recognized	104	137
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	104	137
Gross Amount not Offset in the Balance Sheets	0	0
Net Amount	104	137
Liabilities:
Gross Amount Recognized	104	137
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	104	137
Gross Amount not Offset in the Balance Sheets	0	0
Net Amount	104	137
Other financial assets
Assets:
Gross Amount Recognized	1,786	1,510
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	1,786	1,510
Gross Amount not Offset in the Balance Sheets	0	0
Net Amount	1,786	1,510
Other invested assets
Assets:
Gross Amount Recognized	25,985	23,461
Gross Amount Offset in the Balance Sheets	17,684	14,924
Net Amount Presented in the Balance Sheets	8,301	8,537
Gross Amount not Offset in the Balance Sheets	(4,509)	(6,080)
Net Amount	3,792	2,457
Other financial liabilities
Liabilities:
Gross Amount Recognized	5,738	6,185
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	5,738	6,185
Gross Amount not Offset in the Balance Sheets	0	0
Net Amount	5,738	6,185
Other liabilities
Liabilities:
Gross Amount Recognized	23,531	21,956
Gross Amount Offset in the Balance Sheets	17,684	14,924
Net Amount Presented in the Balance Sheets	5,847	7,032
Gross Amount not Offset in the Balance Sheets	0	0
Net Amount	$ 5,847	$ 7,032

CLOSED BLOCK - Closed Block Summarized Financial Information (Details) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024
Closed Block Liabilities:
Future policy benefits, policyholders’ account balances and other	$ 5,100	$ 5,213
Other liabilities	47	62
Total Closed Block liabilities	5,147	5,275
Allowance for credit losses of fixed maturities AFS	0	0
Assets Designated to the Closed Block:
Fixed maturities AFS, at fair value (amortized cost of $2,674 and $2,888) (allowance for credit losses of $0 and$0)	2,591	2,746
Mortgage loans on real estate (net of allowance for credit losses of $22 and $21)	1,498	1,531
Policy loans	510	523
Cash and other invested assets	161	17
Other assets	107	130
Total assets designated to the Closed Block	4,867	4,947
Excess of Closed Block liabilities over assets designated to the Closed Block	280	328
Amounts included in AOCI:
Net unrealized investment gains (losses), net of income tax: $17 and $30	(66)	(112)
Maximum future earnings to be recognized from Closed Block assets and liabilities	214	216
Amortized cost of fixed maturity AFS	2,674	2,888
Allowance for credit losses of mortgage loans on real estates	22	21
Income tax on net unrealized investment gains (losses)	$ 17	$ 30

DAC AND OTHER DEFERRED ASSETS/LIABILITIES - Reconciliation of DAC (Details) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024	Jun. 30, 2024	Dec. 31, 2023
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	$ 7,361	$ 7,170
Protection Solutions \| Term
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	301	314	$ 326	$ 337
Protection Solutions \| Universal Life
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	171	170	172	174
Protection Solutions \| Variable Universal Life
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	1,122	1,083	1,034	987
Protection Solutions \| Indexed Universal Life
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	186	186	187	188
Individual Retirement \| GMxB Core
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	1,599	1,605	1,602	1,602
Individual Retirement \| EQUI-VEST Individual
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	154	154	155	155
Individual Retirement \| Investment Edge
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	250	225	193	172
Individual Retirement \| SCS
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	2,107	1,938	1,746	1,571
Legacy Segment \| GMxB Legacy
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	494	517	538	555
Group Retirement \| EQUI-VEST Group
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	776	768	753	742
Group Retirement \| Momentum
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	80	83	85	82
Corporate & Other \| Corporate and Other
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	103	107	$ 111	$ 116
Corporate & Other \| Other
Deferred Policy Acquisition Cost [Line Items]
Deferred policy acquisition costs	$ 18	$ 20

DAC AND OTHER DEFERRED ASSETS/LIABILITIES - DAC Costs (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	$ 7,170
Balance, end of year	7,361
Other
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Amortization	(2)	$ (2)
Corporate Segment
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	7,150	6,681
Capitalization	572	560
Amortization	(379)	(339)
Balance, end of year	7,343	6,902
Protection Solutions \| Term
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	314	337
Capitalization	5	8
Amortization	(18)	(19)
Balance, end of year	301	326
Protection Solutions \| UL
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	170	174
Capitalization	7	4
Amortization	(6)	(6)
Balance, end of year	171	172
Protection Solutions \| VUL
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	1,083	987
Capitalization	72	77
Amortization	(33)	(30)
Balance, end of year	1,122	1,034
Protection Solutions \| IUL
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	186	188
Capitalization	6	5
Amortization	(6)	(6)
Balance, end of year	186	187
Individual Retirement \| GMxB Core
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	1,605	1,602
Capitalization	70	74
Amortization	(76)	(74)
Balance, end of year	1,599	1,602
Individual Retirement \| EI
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	154	155
Capitalization	5	6
Amortization	(5)	(6)
Balance, end of year	154	155
Individual Retirement \| IE
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	225	172
Capitalization	36	29
Amortization	(11)	(8)
Balance, end of year	250	193
Individual Retirement \| SCS
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	1,938	1,571
Capitalization	326	306
Amortization	(157)	(131)
Balance, end of year	2,107	1,746
Legacy Segment \| GMxB Legacy
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	517	555
Capitalization	9	14
Amortization	(32)	(31)
Balance, end of year	494	538
Group Retirement \| EG
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	768	742
Capitalization	31	32
Amortization	(23)	(21)
Balance, end of year	776	753
Group Retirement \| Momentum
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	83	82
Capitalization	5	5
Amortization	(8)	(2)
Balance, end of year	80	85
Corporate & Other \| CB
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of period	107	116
Capitalization	0	0
Amortization	(4)	(5)
Balance, end of year	$ 103	$ 111

FAIR VALUE DISCLOSURES - Quantitative Information about Level 3 (Details) $ in Millions	6 Months Ended
	Jun. 30, 2025 USD ($)	Dec. 31, 2024 USD ($)	Jun. 30, 2024 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liability for market risk benefits	$ 10,187	$ 11,810	$ 12,612
Assets for market risk benefits	776	863	$ 799
Level 3 \| Discounted cash flow \| Alliance Bernstein
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
AB Contingent consideration payable	$ 8	$ 9
Level 3 \| Discounted cash flow \| Discount Rate \| Minimum \| Alliance Bernstein
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Expected revenue growth and discount rate	0.019	0.019
Level 3 \| Discounted cash flow \| Discount Rate \| Maximum \| Alliance Bernstein
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Expected revenue growth and discount rate	0.019	0.104
Level 3 \| Discounted cash flow \| Discount Rate \| Weighted Average \| Alliance Bernstein
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Expected revenue growth and discount rate	0.019	0.073
Level 3 \| Discounted cash flow \| Expected Revenue Growth Rate \| Minimum \| Alliance Bernstein
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Expected revenue growth and discount rate	0.020	0.020
Level 3 \| Discounted cash flow \| Expected Revenue Growth Rate \| Maximum \| Alliance Bernstein
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Expected revenue growth and discount rate	0.133	0.293
Level 3 \| Discounted cash flow \| Expected Revenue Growth Rate \| Weighted Average \| Alliance Bernstein
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Expected revenue growth and discount rate	0.068	0.055
Level 3 \| Corporate \| Matrix pricing model
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of fixed maturities AFS		$ 402
Level 3 \| Corporate \| Matrix pricing model \| Spread over Benchmark \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities		0.0070
Level 3 \| Corporate \| Matrix pricing model \| Spread over Benchmark \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities		0.0220
Level 3 \| Corporate \| Matrix pricing model \| Spread over Benchmark \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities		0.0153
Level 3 \| Corporate \| Market comparable companies
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of fixed maturities AFS	$ 1,119	$ 981
Level 3 \| Corporate \| Market comparable companies \| EBITDA Multiples \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	4.6	4.7
Level 3 \| Corporate \| Market comparable companies \| EBITDA Multiples \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	36.3	36.5
Level 3 \| Corporate \| Market comparable companies \| EBITDA Multiples \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	13.9	12.2
Level 3 \| Corporate \| Market comparable companies \| Discount Rate \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.079	0.084
Level 3 \| Corporate \| Market comparable companies \| Discount Rate \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.197	0.349
Level 3 \| Corporate \| Market comparable companies \| Discount Rate \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.032	0.039
Level 3 \| Corporate \| Market comparable companies \| Cash Flow Multiples \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	2.0	1.8
Level 3 \| Corporate \| Market comparable companies \| Cash Flow Multiples \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	14.5	11.8
Level 3 \| Corporate \| Market comparable companies \| Cash Flow Multiples \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	6.0	4.5
Level 3 \| Corporate \| Market comparable companies \| Loan to Value \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	(0.003)	0.000
Level 3 \| Corporate \| Market comparable companies \| Loan to Value \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.547	0.564
Level 3 \| Corporate \| Market comparable companies \| Loan to Value \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.091	0.150
Level 3 \| Trading Securities, at Fair Value \| Market comparable companies
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of fixed maturities AFS	$ 23	$ 1
Level 3 \| Trading Securities, at Fair Value \| Market comparable companies \| Cash Flow Multiples \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	8.5	8.4
Level 3 \| Trading Securities, at Fair Value \| Market comparable companies \| Cash Flow Multiples \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	26.3	8.4
Level 3 \| Trading Securities, at Fair Value \| Market comparable companies \| Cash Flow Multiples \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	16.2	8.4
Level 3 \| Trading Securities, at Fair Value \| Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of fixed maturities AFS	$ 75	$ 75
Discount years	7 years
Level 3 \| Trading Securities, at Fair Value \| Discounted cash flow \| Earnings/Revenue Multiple
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	8.6	8.6
Level 3 \| Trading Securities, at Fair Value \| Discounted cash flow \| Discount Factor
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.100	0.100
Level 3 \| Other equity investments \| Discounted cash flow \| Earnings/Revenue Multiple \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	4.3
Level 3 \| Other equity investments \| Discounted cash flow \| Earnings/Revenue Multiple \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	14.5
Level 3 \| Other equity investments \| Discounted cash flow \| Earnings/Revenue Multiple \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	7.9
Level 3 \| Purchased MRB asset \| Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of fixed maturities AFS	$ 5,543	$ 7,376
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Lapse Rate \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0024	0.0024
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Lapse Rate \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.1305	0.1305
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Lapse Rate \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0218	0.0217
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Withdrawal Rate \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0006	0.0006
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Withdrawal Rate \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.1165	0.1165
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Withdrawal Rate \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0050	0.0048
Level 3 \| Purchased MRB asset \| Discounted cash flow \| GMIB Utilization Rate \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0004	0.0004
Level 3 \| Purchased MRB asset \| Discounted cash flow \| GMIB Utilization Rate \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.6670	0.6670
Level 3 \| Purchased MRB asset \| Discounted cash flow \| GMIB Utilization Rate \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0671	0.0675
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Non-Performance Risk \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0007	0.0033
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Non-Performance Risk \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0092	0.0093
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Non-Performance Risk \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0010	0.0034
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Volatility Rate - Equity \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.13	0.12
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Volatility Rate - Equity \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.31	0.29
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Volatility Rate - Equity \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.23	0.23
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Mortality \| Ages 0 - 40 \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0001	0.0001
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Mortality \| Ages 0 - 40 \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0017	0.0017
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Mortality \| Ages 0 - 40 \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0335	0.0336
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Mortality \| Ages 41 - 60 \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0006	0.0006
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Mortality \| Ages 41 - 60 \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0052	0.0052
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Mortality \| Ages 61 - 115 \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.0032	0.0032
Level 3 \| Purchased MRB asset \| Discounted cash flow \| Mortality \| Ages 61 - 115 \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage measurement input of equity securities	0.4120	0.4120
Level 3 \| Direct MRB \| Discounted cash flow
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Direct MRB	$ 9,411	$ 10,947
Level 3 \| Direct MRB \| Discounted cash flow \| Lapse Rate \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0024	0.0024
Level 3 \| Direct MRB \| Discounted cash flow \| Lapse Rate \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.3618	0.3618
Level 3 \| Direct MRB \| Discounted cash flow \| Lapse Rate \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0372	0.0357
Level 3 \| Direct MRB \| Discounted cash flow \| Withdrawal Rate \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0000	0.0000
Level 3 \| Direct MRB \| Discounted cash flow \| Withdrawal Rate \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.1165	0.1165
Level 3 \| Direct MRB \| Discounted cash flow \| Withdrawal Rate \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0057	0.0058
Level 3 \| Direct MRB \| Discounted cash flow \| Non-Performance Risk
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0105	0.0094
Level 3 \| Direct MRB \| Discounted cash flow \| Non-Performance Risk \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0105	0.0094
Level 3 \| Direct MRB \| Discounted cash flow \| Mortality \| Ages 0 - 40 \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0001	0.0001
Level 3 \| Direct MRB \| Discounted cash flow \| Mortality \| Ages 0 - 40 \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0017	0.0017
Level 3 \| Direct MRB \| Discounted cash flow \| Mortality \| Ages 0 - 40 \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0292	0.0300
Level 3 \| Direct MRB \| Discounted cash flow \| Mortality \| Ages 41 - 60 \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0006	0.0006
Level 3 \| Direct MRB \| Discounted cash flow \| Mortality \| Ages 41 - 60 \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0052	0.0052
Level 3 \| Direct MRB \| Discounted cash flow \| Mortality \| Ages 61 - 115 \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0032	0.0032
Level 3 \| Direct MRB \| Discounted cash flow \| Mortality \| Ages 61 - 115 \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.4120	0.4120
Level 3 \| Direct MRB \| Discounted cash flow \| Annuitization Rate \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0004	0.0004
Level 3 \| Direct MRB \| Discounted cash flow \| Annuitization Rate \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	1.0000	1.0000
Level 3 \| Direct MRB \| Discounted cash flow \| Annuitization Rate \| Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement input of servicing liability	0.0509	0.0515

LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Policyholder Account Balance And Liability For Unpaid Claims And Claims Adjustment Expense (Details) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024	Jun. 30, 2024
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits and other policyholders’ liabilities	$ 17,557	$ 17,613	$ 17,433
Future policyholder benefits total
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits and other policyholders’ liabilities	15,275	15,508
Subtotal
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits and other policyholders’ liabilities	9,277	9,403
Term
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits and other policyholders’ liabilities	1,287	1,285
Payout
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits and other policyholders’ liabilities	4,936	5,050
Group Pension - Benefit Reserve & DPL
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits and other policyholders’ liabilities	447	460
Health
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits and other policyholders’ liabilities	1,336	1,362
UL
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits and other policyholders’ liabilities	1,271	1,246
Whole Life Closed Block and Open Block products
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits and other policyholders’ liabilities	5,083	5,204
Other
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits and other policyholders’ liabilities	915	901
Other policyholder funds and dividends payable
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits and other policyholders’ liabilities	$ 2,282	$ 2,105

LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS - Schedule of Liability for Future Policy Benefits, Weighted Average Interest Rates (Details)	Jun. 30, 2025	Dec. 31, 2024	Jun. 30, 2024
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	4.50%		4.50%
Term
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	5.60%	5.60%
Current discount rate	5.00%	5.20%
Payout
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	4.50%	4.40%
Current discount rate	5.10%	5.30%
Group Pension
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	3.40%	3.40%
Current discount rate	5.00%	5.20%
Health
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	3.40%	3.40%
Current discount rate	5.20%	5.40%

MARKET RISK BENEFITS - Reconciles Market Risk Benefits (Details) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024	Jun. 30, 2024
Market Risk Benefit [Line Items]
Direct Asset	$ (776)	$ (863)	$ (799)
Direct Liability	10,187	11,810	$ 12,612
Net Direct MRB	9,411	10,947
Purchased MRB	(5,543)	(7,376)
Total	3,868	3,571
Individual Retirement \| GMxB Core
Market Risk Benefit [Line Items]
Direct Asset	(449)	(514)
Direct Liability	1,102	1,010
Net Direct MRB	653	496
Purchased MRB	0	0
Total	653	496
Legacy \| GMxB Legacy
Market Risk Benefit [Line Items]
Direct Asset	(204)	(230)
Direct Liability	9,016	10,738
Net Direct MRB	8,812	10,508
Purchased MRB	(5,541)	(7,372)
Total	3,271	3,136
Other
Market Risk Benefit [Line Items]
Direct Asset	(123)	(119)
Direct Liability	69	62
Net Direct MRB	(54)	(57)
Purchased MRB	(2)	(4)
Total	$ (56)	$ (61)

POLICYHOLDER ACCOUNT BALANCES - Reconciliation of Separate Account Liabilities to Separate Account Liability balance (Details) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024	Jun. 30, 2024	Dec. 31, 2023
Liability for Future Policy Benefit, Activity [Line Items]
Separate Accounts liabilities	$ 131,683	$ 134,717
Protection Solutions \| Variable Universal Life
Liability for Future Policy Benefit, Activity [Line Items]
Separate Accounts liabilities	18,968	18,176	$ 17,212	$ 15,821
Legacy Segment \| GMxB Legacy
Liability for Future Policy Benefit, Activity [Line Items]
Separate Accounts liabilities	28,275	33,199	33,966	33,794
Individual Retirement \| GMxB Core
Liability for Future Policy Benefit, Activity [Line Items]
Separate Accounts liabilities	30,057	30,411	30,476	29,829
Individual Retirement \| EQUI-VEST Individual
Liability for Future Policy Benefit, Activity [Line Items]
Separate Accounts liabilities	4,756	4,782	4,785	4,582
Individual Retirement \| Investment Edge
Liability for Future Policy Benefit, Activity [Line Items]
Separate Accounts liabilities	5,072	4,885	4,588	4,275
Group Retirement \| EQUI-VEST Group
Liability for Future Policy Benefit, Activity [Line Items]
Separate Accounts liabilities	31,714	30,546	29,225	26,959
Group Retirement \| Momentum
Liability for Future Policy Benefit, Activity [Line Items]
Separate Accounts liabilities	5,008	4,813	$ 4,702	$ 4,421
Other
Liability for Future Policy Benefit, Activity [Line Items]
Separate Accounts liabilities	$ 7,833	$ 7,905

POLICYHOLDER ACCOUNT BALANCES - Balances and Changes in Separate Accounts Liability (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Separate Account, Liability [Roll Forward]
Balance, beginning of period	$ 134,717
Balance, end of period	131,683
Protection Solutions \| VUL
Separate Account, Liability [Roll Forward]
Balance, beginning of period	18,176	$ 15,821
Premiums and deposits	664	616
Policy charges	(292)	(287)
Surrenders and withdrawals	(350)	(330)
Benefit payments	(54)	(30)
Investment performance	941	1,508
Net transfers from (to) General Account	(117)	(86)
Other charges (2)	0	0
Balance, end of period	18,968	17,212
Cash surrender value	18,600	16,840
Legacy Segment \| GMxB Legacy
Separate Account, Liability [Roll Forward]
Balance, beginning of period	33,199	33,794
Premiums and deposits	118	112
Policy charges	(265)	(324)
Surrenders and withdrawals	(1,499)	(1,629)
Benefit payments	(364)	(385)
Investment performance	907	(3)
Net transfers from (to) General Account	(5)	2,401
Other charges (2)	(3,816)	0
Balance, end of period	28,275	33,966
Cash surrender value	28,071	33,702
Individual Retirement \| GMxB Core
Separate Account, Liability [Roll Forward]
Balance, beginning of period	30,411	29,829
Premiums and deposits	934	1,000
Policy charges	(252)	(249)
Surrenders and withdrawals	(1,861)	(1,720)
Benefit payments	(145)	(135)
Investment performance	864	117
Net transfers from (to) General Account	106	1,634
Other charges (2)	0	0
Balance, end of period	30,057	30,476
Cash surrender value	29,218	29,644
Individual Retirement \| EQUI-VEST Individual
Separate Account, Liability [Roll Forward]
Balance, beginning of period	4,782	4,582
Premiums and deposits	49	40
Policy charges	(2)	(1)
Surrenders and withdrawals	(237)	(248)
Benefit payments	(36)	(26)
Investment performance	208	(7)
Net transfers from (to) General Account	(8)	445
Other charges (2)	0	0
Balance, end of period	4,756	4,785
Cash surrender value	4,724	4,752
Individual Retirement \| Investment Edge
Separate Account, Liability [Roll Forward]
Balance, beginning of period	4,885	4,275
Premiums and deposits	901	739
Policy charges	0	0
Surrenders and withdrawals	(242)	(254)
Benefit payments	(17)	(15)
Investment performance	247	(465)
Net transfers from (to) General Account	(702)	308
Other charges (2)	0	0
Balance, end of period	5,072	4,588
Cash surrender value	4,983	4,501
Group Retirement \| EQUI-VEST Group
Separate Account, Liability [Roll Forward]
Balance, beginning of period	30,546	26,959
Premiums and deposits	1,252	1,180
Policy charges	(8)	(8)
Surrenders and withdrawals	(1,271)	(1,113)
Benefit payments	(32)	(32)
Investment performance	1,464	(170)
Net transfers from (to) General Account	(237)	2,409
Other charges (2)	0	0
Balance, end of period	31,714	29,225
Cash surrender value	31,412	28,935
Group Retirement \| Momentum
Separate Account, Liability [Roll Forward]
Balance, beginning of period	4,813	4,421
Premiums and deposits	330	379
Policy charges	(12)	(11)
Surrenders and withdrawals	(433)	(476)
Benefit payments	(5)	(7)
Investment performance	308	6
Net transfers from (to) General Account	7	390
Other charges (2)	0	0
Balance, end of period	5,008	4,702
Cash surrender value	$ 5,001	$ 4,694

POLICYHOLDER ACCOUNT BALANCES - Aggregate Fair Value of Separate Account Assets (Details) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024
Policyholder Account Balance [Line Items]
Separate Accounts assets	$ 131,683	$ 134,717
Debt securities
Policyholder Account Balance [Line Items]
Separate Accounts assets	76	79
Common Stock
Policyholder Account Balance [Line Items]
Separate Accounts assets	2,348	2,207
Mutual Funds
Policyholder Account Balance [Line Items]
Separate Accounts assets	128,137	131,292
Bonds and Notes
Policyholder Account Balance [Line Items]
Separate Accounts assets	1,122	1,139
Protection Solutions
Policyholder Account Balance [Line Items]
Separate Accounts assets	19,635	18,828
Protection Solutions \| Debt securities
Policyholder Account Balance [Line Items]
Separate Accounts assets	49	51
Protection Solutions \| Common Stock
Policyholder Account Balance [Line Items]
Separate Accounts assets	68	68
Protection Solutions \| Mutual Funds
Policyholder Account Balance [Line Items]
Separate Accounts assets	19,417	18,611
Protection Solutions \| Bonds and Notes
Policyholder Account Balance [Line Items]
Separate Accounts assets	101	98
Individual Retirement
Policyholder Account Balance [Line Items]
Separate Accounts assets	41,750	42,070
Individual Retirement \| Debt securities
Policyholder Account Balance [Line Items]
Separate Accounts assets	1	1
Individual Retirement \| Common Stock
Policyholder Account Balance [Line Items]
Separate Accounts assets	37	36
Individual Retirement \| Mutual Funds
Policyholder Account Balance [Line Items]
Separate Accounts assets	41,709	42,029
Individual Retirement \| Bonds and Notes
Policyholder Account Balance [Line Items]
Separate Accounts assets	3	4
Group Retirement
Policyholder Account Balance [Line Items]
Separate Accounts assets	38,597	37,266
Group Retirement \| Debt securities
Policyholder Account Balance [Line Items]
Separate Accounts assets	9	14
Group Retirement \| Common Stock
Policyholder Account Balance [Line Items]
Separate Accounts assets	512	472
Group Retirement \| Mutual Funds
Policyholder Account Balance [Line Items]
Separate Accounts assets	38,075	36,779
Group Retirement \| Bonds and Notes
Policyholder Account Balance [Line Items]
Separate Accounts assets	1	1
Corp & Other
Policyholder Account Balance [Line Items]
Separate Accounts assets	3,402	3,339
Corp & Other \| Debt securities
Policyholder Account Balance [Line Items]
Separate Accounts assets	17	13
Corp & Other \| Common Stock
Policyholder Account Balance [Line Items]
Separate Accounts assets	1,731	1,631
Corp & Other \| Mutual Funds
Policyholder Account Balance [Line Items]
Separate Accounts assets	637	659
Corp & Other \| Bonds and Notes
Policyholder Account Balance [Line Items]
Separate Accounts assets	1,017	1,036
Legacy Segment
Policyholder Account Balance [Line Items]
Separate Accounts assets	28,299	33,214
Legacy Segment \| Debt securities
Policyholder Account Balance [Line Items]
Separate Accounts assets	0	0
Legacy Segment \| Common Stock
Policyholder Account Balance [Line Items]
Separate Accounts assets	0	0
Legacy Segment \| Mutual Funds
Policyholder Account Balance [Line Items]
Separate Accounts assets	28,299	33,214
Legacy Segment \| Bonds and Notes
Policyholder Account Balance [Line Items]
Separate Accounts assets	$ 0	$ 0

EMPLOYEE BENEFIT PLANS (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		6 Months Ended
EMPLOYEE BENEFIT PLANS (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
AB Retirement Plan
Defined Benefit Plan Disclosure [Line Items]
Settlements	$ 35			$ 59
Additional fund to cover obligations		$ 2		2
General and administration expense				21
Net Periodic Pension Expense
Defined Benefit Plan Disclosure [Line Items]
Service cost		7	$ 2	15	$ 4
Interest cost		28	31	56	59
Expected return on assets		(33)	(37)	(67)	(73)
Prior period service cost amortization		0	(1)	(1)	(1)
Net amortization		11	14	23	28
Impact of settlement		0	0	21	0
Net Periodic Pension Expense		$ 13	$ 9	$ 47	$ 17

INCOME TAXES (Details) $ in Millions	3 Months Ended	6 Months Ended
INCOME TAXES (Details) $ in Millions	Jun. 30, 2025 USD ($)	Jun. 30, 2025 USD ($)
Income Tax Disclosure [Abstract]
Increase (decrease) in valuation allowance	$ (33)	$ (41)
Valuation allowance	$ 258	$ 258

EQUITY - Preferred Stock Activity (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
	Apr. 11, 2025	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares)		64,000		64,000		64,000
Preferred stock, shares issued (in shares)		50,613		50,613		61,773
Preferred stock, shares outstanding (in shares)		50,613		50,613		61,773
Redeemed and retired stock		$ 0	$ 0	$ 0	$ 0
Series A
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares)		32,000		32,000		32,000
Preferred stock, shares issued (in shares)		32,000		32,000		32,000
Preferred stock, shares outstanding (in shares)		32,000		32,000		32,000
Series B
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares)		20,000		20,000		20,000
Preferred stock, shares issued (in shares)		6,613		6,613		17,773
Preferred stock, shares outstanding (in shares)		6,613		6,613		17,773
Redeemed and retired stock	$ 279
Series C
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares)		12,000		12,000		12,000
Preferred stock, shares issued (in shares)		12,000		12,000		12,000
Preferred stock, shares outstanding (in shares)		12,000		12,000		12,000

EQUITY - Dividends Declared (Details) - $ / shares	3 Months Ended		6 Months Ended
EQUITY - Dividends Declared (Details) - $ / shares	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Class of Stock [Line Items]
Dividends declared per share of common stock (in dollars per share)	$ 0.27	$ 0.24	$ 0.51	$ 0.46
Series A
Class of Stock [Line Items]
Dividends declared per share of preferred stock (in dollars per share)	328	328	656	656
Series B
Class of Stock [Line Items]
Dividends declared per share of preferred stock (in dollars per share)	619	619	619	619
Series C
Class of Stock [Line Items]
Dividends declared per share of preferred stock (in dollars per share)	$ 269	$ 269	$ 538	$ 538